sentence	label
In EM individuals treated with paroxetine or fluoxetine, the AUC of @DRUG$ is approximately 6- to 8-fold and Css,max is about 3- to 4-fold greater than @DRUG$ alone.	DDI-false
The possibility of hypotensive effects with enalapril or @DRUG$ can be minimized by either discontinuing the @DRUG$ or increasing the salt intake prior to initiation of treatment with enalapril or enalaprilat .	DDI-effect
Other concomitant therapy Although specific interaction studies were not performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, @DRUG$, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., narcotics, @DRUG$, antiemetics, sedatives, @DRUG$).	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - @DRUG$ - Eproxindine - Ethanol: Flupenthixol and @DRUG$ cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Although glucocorticoids have been shown to reduce @DRUG$-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of @DRUG$ and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-false
Potential pharmacokinetic interactions have been studied in clinical pharmacokinetic studies ( @DRUG$ , valproate, oral contraceptives, digoxin, warfarin, @DRUG$ ) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients .	DDI-false
however, it adversely affected response duration suggesting that pyridoxine should not be administered with @DRUG$ and/or @DRUG$.1	DDI-false
In EM-persons treated with @DRUG$ The AUC of atomoxetine is about 6- to 8-fold and Css, max is about 3- to 4-fold greater than @DRUG$ alone .	DDI-false
Although studies designed to examine drug interactions have not been done, it was noted that corticosteroid or @DRUG$ treatment of relapses for periods of up to 28 days has been administered to patients (N=180) receiving @DRUG$.	DDI-false
@DRUG$ : @DRUG$ is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid , signs and symptoms of carbamazepine toxicity should be monitored closely , and appropriate dosage adjustment of the anticonvulsant should be made .	DDI-false
In rats, simultaneous ingestion of @DRUG$ and nitrite in the diet for 78 weeks has been reported to cause tumors, and it has been suggested that disulfiram may react with @DRUG$ in the rat stomach to form a nitrosamine, which is tumorigenic.	DDI-false
Although no specific studies have been performed, co-administration with medicinal products primarily metabolised by CYP3A4 (e. g. @DRUG$ , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , @DRUG$ , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
The possibility of hypotensive effects with enalapril or enalaprilat can be minimized by either discontinuing the @DRUG$ or increasing the salt intake prior to initiation of treatment with @DRUG$ or enalaprilat.	DDI-false
In general, these drugs have one or more pharmacological activities, similar to bepridil hydrochloride, including @DRUG$ such as quinidine and procainamide , cardiac glycosides and @DRUG$.	DDI-false
Multivalent Cation-Containing products: Concomitant administration of quinolone, including ciprofloxacin, with multivalent cation-containing products such as @DRUG$ or aluminum antacids , sucralfate , VIDEX chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of @DRUG$ , which leads to serum and urine levels significantly lower than desired.	DDI-false
Diuretics: Etodolac has no apparent pharmacokinetic interaction when administered with @DRUG$ or @DRUG$.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with @DRUG$, beta-blockers, felodipine, digoxin, warfarin, isosorbide mononitrate, carvedilol, ethanol or @DRUG$.	DDI-false
Therophylline : A recent study has shown that @DRUG$ and theophylline may cause elevated plasma levels of theophylline , and in some instances a slight decrease in the elimination of @DRUG$.	DDI-false
(Concurrent use with @DRUG$ may enhance the possibility of @DRUG$ toxicity associated with hypokalemia.)	DDI-effect
This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with @DRUG$), and monoamine oxidase (MAO) inhibitors (concurrent use with @DRUG$ may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , disopyramide , @DRUG$ Amiodarone, quinidine, warfarin, tacrolimus, cyclosporin, ergot derivatives, pimozide, @DRUG$ , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, @DRUG$, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and @DRUG$.	DDI-false
@DRUG$ and @DRUG$ The prolongation of the QT interval observed with bepridil hydrochloride could exaggerate.	DDI-false
At a median follow-up of 33 months , the combination of @DRUG$ and @DRUG$ There was no benefit to efficacy in all patients and in the hormone receptor-positive subpopulation compared to tamoxifen.	DDI-false
@DRUG$ : The concomitant use of DURAGESIC   ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other @DRUG$ Anaesthetics, hypnosis, tranquilizers (e.g. benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants and alcohol may cause respiratory depression, hypotension and deep sedation, or possibly lead to coma or death.	DDI-false
Data from in vitro studies with benzodiazepines other than: @DRUG$ suggest a possible drug interaction for the following : ergotamine , cyclosporine , amiodarone , @DRUG$ And nifedipine.	DDI-int
Drug interactions between Keppra and other antiepileptic drugs ( @DRUG$ Phenytoin Keppra ( 3000 mg daily ) had no effect on the pharmacokinetics of @DRUG$ In patients with refractory epilepsy.	DDI-false
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies (phenytoin, @DRUG$, oral @DRUG$, digoxin, warfarin, probenecid) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients.	DDI-false
Drugs Interactions : Flupentixol may interact with some medicines such as monoamine oxidase inhibitors (MAOI): MAOI may theoretically affect flupentixol pharmacodynamics - Arecoline - Eproxindine - @DRUG$ Flupentixol and ethanol cause additive CNS depression - tricyclic antidepressants : flupentixol increases the effect of @DRUG$	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$: NSAIDs have produced an elevation of plasma lithium levels and a reduction in renal @DRUG$ clearance.	DDI-false
@DRUG$ may suppress certain CYP450 enzymes , including @DRUG$ CYP2C9, CYP2D6 and CYP3A4.	DDI-false
@DRUG$ inhibits @DRUG$.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, @DRUG$, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, @DRUG$, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (@DRUG$, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of @DRUG$.	DDI-false
The intensity , uniformity and time course of @DRUG$ interference by @DRUG$ , secobarbital, glutethimide, chloral hydrate and methaqualone have been systematically studied in 16 patients treated with coumarin.	DDI-false
The effects of @DRUG$ were very strong and completely depressed the @DRUG$-induced hyperlocomotion.	DDI-effect
Therefore , interactions could occur following concomitant administration of psychotropic drugs ( e.g. , @DRUG$ , analgesics , antiemetics , @DRUG$ , tranquilizers ) .	DDI-false
Warfarin: Eszopiclone 3 mg administered daily for 5 days did not affect the pharmacokinetics of (R)- or @DRUG$, nor were there any changes in the pharmacodynamic profile (prothrombin time) following a single 25 mg oral dose of @DRUG$	DDI-false
When Nortriptyline hydrochloride is used with other medicinal products, close monitoring and careful dose adjustment is required. @DRUG$ or @DRUG$.	DDI-false
@DRUG$ or other medications with anticholinergic activity - anticholinergic effects may be potentiated when these medications are used concurrently with @DRUG$ ;	DDI-false
@DRUG$ ( 5 mg/kg), moclobemid ( 30 mg/kg), clonazepam ( 0.25 mg/kg), @DRUG$ Sertraline ( 30 mg/kg) or vehicle was administered.	DDI-false
Other concomitant therapy Although no specific interaction studies have been conducted, 1 mg or more of finasteride doses have been used in clinical trials with acetaminophen, acetylsalicylic acid, A-blockers, @DRUG$ , @DRUG$ , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , H2 antagonists , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
Then, the effects of metabotropic glutamate receptor (mGluR) agonists, @DRUG$ and @DRUG$, on the above behavioral changes induced by PCP were found.	DDI-false
The results of the studies in patients with multiple sclerosis who: @DRUG$   and concomitant interferon beta-1a ( AVONEX   30 mcg IM once weekly ) or glatiramer acetate were inconclusive with regard to the need for dose adjustment of the beta-interferon or @DRUG$.	DDI-false
@DRUG$ may augment the activity of other @DRUG$.	DDI-effect
Cholestyramine and colestipol resins: Absorption of @DRUG$ is impaired in the presence of @DRUG$.	DDI-mechanism
In clinical studies performed with Fondaparinux , the concomitant use of oral anticoagulants ( warfarin ) , @DRUG$ ( acetylsalicylic acid ) , NSAIDs ( piroxicam ) , and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of @DRUG$.	DDI-false
ketoconazole, intraconazole, ritonavir, indinavir, saquinavir, @DRUG$ , etc.) is indicated, reduction of the @DRUG$ dose should be considered .	DDI-advise
In single and multiple dose studies in healthy subjects receiving both @DRUG$ and @DRUG$ The prothrombin time (measured as INR) was increased by about 8% to 11%.	DDI-effect
Furthermore it has been proposed that @DRUG$ resulted In induction of P-450IIE1 in the patients liver which, in turn, resulted in a greater proportion of the ingested @DRUG$ being converted to the toxic metabolites.	DDI-mechanism
It is assumed that increased interaction between @DRUG$ and high affinity binding sites for apomorphine on dopamine2- and serotonin2-receptors underlies the antipsychotic action of @DRUG$ after their prolonged administration.	DDI-false
Cardiovasculars: Cardiac glycosides: In patients receiving @DRUG$ therapy, administration of oral amiodarone regularly results in an increase in serum @DRUG$ concentration that may reach toxic levels with resultant clinical toxicity.	DDI-false
- Anabolic steroids (nandrolone [e.g., Anabolin], @DRUG$ [e.g., @DRUG$], oxymetholone [e.g., Anadrol], stanozolol [e.g., Winstrol]) or	DDI-false
therefore , nitroglycerin or other @DRUG$ ( as used for management of angina ) or other drugs having vasodilator activity should , if possible , be discontinued before starting @DRUG$.	DDI-advise
Other potent inhibitors of CYP3A4 (e.g. @DRUG$ , clarithromycin, nefazodon, @DRUG$ , ritonavir , nelfinavir ) would be expected to behave similarly .	DDI-false
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies (phenytoin, valproate, oral contraceptive, @DRUG$, warfarin, @DRUG$) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients.	DDI-false
Use with @DRUG$: The use of @DRUG$ to control hypertension in patients on azathioprine has been reported to induce severe leukopenia.	DDI-false
Drug-Drug Interactions Between Keppra  And Other @DRUG$ (AEDs) Phenytoin Keppra  (3000 mg daily) had no effect on the pharmacokinetic disposition of @DRUG$ in patients with refractory epilepsy.	DDI-false
The superiority of @DRUG$ over @DRUG$-based regimens has been observed in comparative data in a subset of patients with high viral loads .	DDI-false
@DRUG$-Orlistat may decrease the absorption of @DRUG$.	DDI-false
BACKGROUND : Effects of combined administration of bombsin and verapamil hydrochloride ( @DRUG$ ) , a @DRUG$ The incidence of peritoneal metastasis of intestinal adenocarcinoma induced by azoxymethane (AOM) and the index of colorectal cancers were studied in male Wistar rats.	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, @DRUG$, and other @DRUG$.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
It may be necessary to reduce the dosage of oral @DRUG$ After starting or stopping @DRUG$. as disulfiram can prolong the prothrombin time.	DDI-advise
- Anabolic steroids (@DRUG$ [e.g., @DRUG$], oxandrolone [e.g., Anavar], oxymetholone [e.g., Anadrol], stanozolol [e.g., Winstrol]) or	DDI-false
- @DRUG$ ( e.g. , @DRUG$ ) or	DDI-false
In EM individuals treated with paroxetine or @DRUG$ , the AUC of atomoxetine is approximately 6- to 8-fold and Css , max is about 3- to 4-fold greater than @DRUG$ alone .	DDI-false
A possible interaction between @DRUG$ and ciprofloxacin, a fluoroquinolone antibiotic, has been reported, resulting in a potentiation of the hypoglycemic action of @DRUG$.	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, @DRUG$, lamotrigine, phenobarbital, phenytoin, primidone and @DRUG$) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
OTHER CONCOMITANT THERAPY : Although specific interaction studies were not performed , in clinical studies , cerivastatin sodium was used concomitantly with angiotensin- converting enzyme ( ACE ) inhibitors , betablockers , calcium-channel blockers , @DRUG$ , and nonsteroidal anti-inflammatory drugs ( @DRUG$ ) without evidence of clinically significant adverse interactions.	DDI-false
Acetaminophen, lidocaine, @DRUG$, @DRUG$, theophylline, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
Rhabdomyolysis has been observed in patients receiving HMG-CoA reductase inhibitors administered alone (at recommended dosages) or concomitantly with @DRUG$ including @DRUG$.	DDI-false
Both efavirenz and @DRUG$ have been compared to triple therapy with the PI @DRUG$ over 48 weeks as initial therapy, with similar responses being observed with nevirapine regimens and superiority observed with efavirenz.	DDI-false
@DRUG$ including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as nonsteroidal anti-inflammatory drugs (NSAIDs), and aspirin may increase the risk of bleeding when administered concomitantly with @DRUG$.	DDI-effect
Both @DRUG$ Indinavir was compared with PI for 48 weeks as initial therapy, with similar response rates observed in chronic renal failure patients. @DRUG$ Regimes and superiority observed with efavirenz.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with @DRUG$ , beta-blockers , felodipine , digoxin , warfarin , isosorbide mononitrate , carvedilol , ethanol or @DRUG$.	DDI-false
@DRUG$: Meclofenamate sodium enhances the effect of @DRUG$.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, @DRUG$, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, @DRUG$ (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$/@DRUG$: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
Hydrochlorothiazide: In normal volunteers, concomitant administration of @DRUG$ and hydrochlorothiazide resulted in significantly increased plasma levels of @DRUG$.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, @DRUG$, and simethicone) with fosinopril reduced serum levels and urinary excretion of @DRUG$ as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
The possibility of hypotensive effects with @DRUG$ Treatment with enalaprilat may occur either by stopping the diuretic or by increasing the intake of salt before starting treatment with @DRUG$ or enalaprilat .	DDI-false
The concomitant intake of alcohol and @DRUG$ does not affect the pharmacokinetics of either alcohol or @DRUG$.	DDI-false
In vitro binding studies with human serum proteins indicate that glipizide binds differently than @DRUG$ and does not interact with salicylate or @DRUG$.	DDI-false
however, it adversely affected response duration suggesting that @DRUG$ should not be administered with HEXALEN and/or @DRUG$.1	DDI-advise
@DRUG$: Rofecoxib 75 mg once daily for 11 days does not alter the plasma concentration profile or renal elimination of @DRUG$ after a single 0.5 mg oral dose.	DDI-false
Other potent inhibitors of CYP3A4 (e.g. @DRUG$ , @DRUG$ , nefazodone , troleandomycin , ritonavir , nelfinavir ) would be expected to behave similarly .	DDI-false
@DRUG$: Concomitant administration of low-dose aspirin with @DRUG$ may result in an increased rate of GI ulceration or other complications, compared to use of VIOXX alone.	DDI-false
@DRUG$, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, @DRUG$ and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-mechanism
The hypoglycemic action of @DRUG$ may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, @DRUG$, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-effect
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, @DRUG$, and simethicone) with @DRUG$ reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-mechanism
Like ibogaine (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of morphine and @DRUG$ and the oral self-administration of @DRUG$ and nicotine in rats;	DDI-false
Aspirin: Concomitant administration of low-dose aspirin with @DRUG$ may result in an increased rate of GI ulceration or other complications, compared to use of @DRUG$ alone.	DDI-false
@DRUG$: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of @DRUG$ as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
Other interactions : @DRUG$ • no effects on pharmacodynamics of @DRUG$ ( glucose and insulin concentrations ) and warfarin ( prothrombin time or other pharmacodynamic parameters ) .	DDI-false
@DRUG$/theophylline, @DRUG$/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
(In some patients, the @DRUG$ can reduce the diuretic, natriuretic, and antihypertensive effects of @DRUG$.	DDI-effect
@DRUG$: Amphetamines may counteract the sedative effect of @DRUG$.	DDI-false
Coadministration of @DRUG$ decreased the maximum plasma concentration of @DRUG$ by 6 % , decreased clearance by 38 % , and increased half-life by 58 % .	DDI-mechanism
As with other @DRUG$, it should be noted that HALDOL may be capable of potentiating CNS depressants such as anesthetics, opiates, and @DRUG$.	DDI-effect
Drug Interactions : Flupenthixol may interact with some drugs , like Monoamine oxidase inhibitors ( MAOI ): MAOI could theoretically affect @DRUG$ pharmacodynamics - Arecoline - Eproxindine - Ethanol : Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants : @DRUG$ Increases the effect of tricyclic antidepressants	DDI-false
The concomitant use of other CYP3A4 inhibitors such as @DRUG$ and erythromycin with transdermal @DRUG$ may also result in an increase in fentanyl plasma concentrations, which could increase or prolong adverse drug effects and may cause serious respiratory depression.	DDI-mechanism
There was no significant difference in the pharmacodynamic effect of warfarin administered alone and @DRUG$ administered with @DRUG$ As measured by prothrombin time.	DDI-false
There have been reports of @DRUG$-related side effects in patients on concomitant therapy with norfloxacin and @DRUG$.	DDI-false
Antihypertensive medications, other, especially diazoxide, or pre@DRUG$ and anesthetic agents used in surgery or @DRUG$, nondepolarizing, used in surgery	DDI-false
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, @DRUG$, @DRUG$, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
Higher concentrations of dexamethasone (10(-8) - 10(-6) M) or @DRUG$ (3 X 10(-8) - 10(-7) M) enhance the mitogenic activity of @DRUG$.	DDI-effect
Urinary acidifying agents These agents (@DRUG$, sodium acid phosphate, etc.) increase the concentration of the ionized species of the @DRUG$ molecule, thereby increasing urinary excretion.	DDI-mechanism
Aminosalicylic acid may decrease the amount of @DRUG$ (@DRUG$, Lanoxicaps) that gets absorbed into your body.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, @DRUG$, beta blockers, @DRUG$, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
These results suggest that an acute @DRUG$ "Influence would not affect behaviors that are closest to @DRUG$ intoxication .	DDI-false
Other Drug Interactions : No pharmacokinetic interactions were observed between vardenafil and the following drugs : glyburide , @DRUG$ , @DRUG$ ==References====External links==	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., @DRUG$, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, asparaginase) effects with @DRUG$ may increase toxicity in these organ systems.	DDI-effect
ERYTHROMYCIN : In hypercholesterolemic patients , steady-state @DRUG$ AUC and Cmax increased after 10 days when co-administered with @DRUG$ A known inhibitor of cytochrome P450 3A4.	DDI-mechanism
The co-administration of alcohol and @DRUG$ The pharmacokinetics of alcohol or @DRUG$ are not affected.	DDI-false
Potential drug interactions between @DRUG$  and other AEDs (carbamazepine, @DRUG$, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including @DRUG$, with multivalent cation-containing products such as magnesium or @DRUG$ antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
Other Chemotherapy Agents In a separate study, concomitant administration of lapatinib with @DRUG$ did not meaningfully alter the pharmacokinetics of either agent (or the metabolites of @DRUG$).	DDI-false
@DRUG$ and its active metabolite, norfluoxe-tine, have long half-lives (4 to 16 days for @DRUG$), that may affect strategies during conversion from one drug to the other.	DDI-false
Other Drug Interactions Oral Contraceptives Keppra   ( 500 mg twice daily ) did not influence the pharmacokinetics of an oral contraceptive containing 0.03 mg @DRUG$ and 0.15 mg @DRUG$ , or luteinising hormone and progesterone levels, suggesting that adverse effects on contraceptive efficacy are unlikely.	DDI-false
Like ibogaine ( 40 mg/kg ) , @DRUG$ 40 mg/kg decreases intravenous self-administration of morphine and cocaine and oral self-administration of ethanol and @DRUG$ in rats ;	DDI-false
Caution should be exercised in monitoring if: @DRUG$ is administered concurrently with @DRUG$.	DDI-advise
Compounds tested in man include @DRUG$, theophylline, @DRUG$, diazepam, aminopyrine and antipyrine.	DDI-false
It is assumed that increased interaction between @DRUG$ and high affinity binding sites for @DRUG$ on dopamine2- and serotonin2-receptors underlies the antipsychotic action of neuroleptics after their prolonged administration.	DDI-false
The effects of DCG-IV and @DRUG$ upon @DRUG$ (PCP)-induced locomotion and behavioral changes in mice .	DDI-false
Data from in vitro studies @DRUG$ suggest a possible drug interaction with alprazolam for the following : @DRUG$ and paroxetine .	DDI-false
Possible drug interactions between Keppra and other AEDs (carbamazepine, gabapentin, @DRUG$ , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these @DRUG$ during placebo-controlled clinical studies .	DDI-false
Acetaminophen/theophylline, lidocaine/chinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, @DRUG$/acetaminophen and valproic acid/phenobarbital.	DDI-false
Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving Alprazolam (caution is recommended during coadministration with @DRUG$): Coadministration of @DRUG$ with alprazolam increased the maximum plasma concentration of alprazolam by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance.	DDI-false
Potential pharmacokinetic interactions have been reported in clinical pharmacokinetic studies (phenytoin, valproate, oral @DRUG$ , digoxin, warfarin, @DRUG$ ) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients .	DDI-false
- @DRUG$ ( @DRUG$ [ e.g. , Anabolin ] , oxandrolone [ e.g. , Anavar ] , oxymetholone [ e.g. , Anadrol ] , stanozolol [ e.g. , Winstrol ] ) or	DDI-false
OBJECTIVE: Our objective was to characterize the steady-state pharmacokinetics of @DRUG$ and @DRUG$ (INN, ciclosporin) when coadministered in de novo kidney allograft recipients during the first year after transplantation.	DDI-false
Short-term pharmacokinetic studies have shown that concomitant use of warfarin and lodine ( @DRUG$ Capsules and tablets) leads to reduced protein binding of warfarin, but there was no change in clearance of free @DRUG$.	DDI-false
@DRUG$ and @DRUG$ may reduce or reverse the pressor effect of epinephrine .	DDI-false
HIV Protease Inhibitors: @DRUG$ (800 mg t.i.d.) co-administered with Vardenafil 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in vardenafil Cmax and a 2-fold increase in @DRUG$ half-life.	DDI-false
Coadministration with compounds that are potent inducers of CYP3A4 (eg, @DRUG$, @DRUG$, dexamethasone, carbamazepine) may result in decreased plasma levels of saquinavir.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, @DRUG$, diazepam, certain @DRUG$, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
• Aspirin/@DRUG$: Pharmacokinetic or pharmacodynamic drug-effect interactions between argatroban and co-administered aspirin ( 162.5 mg orally 26 and 2 hours before starting argatroban 1 g/kg/min for 4 hours), or @DRUG$ ( 1000 mg orally given 12 , 6 and 0 hours prior to , and 6 and 12 hours subsequent to , initiation of Argatroban 1.5   g/kg/min . over 18 hours ) .	DDI-false
Patients taking low-dose @DRUG$ plus @DRUG$ were not studied.	DDI-false
Injection : Lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , @DRUG$ , barbiturates, MAO inhibitors, and other antidepressants. If scopolamine is used simultaneously with injectable @DRUG$ An increased incidence of sedation, hallucinations, and irrational behaviour has been observed.	DDI-false
The possibility of hypotensive effects with captopril can be minimized by either @DRUG$ or increasing the salt intake approximately one week prior to initiation of treatment with captopril ( @DRUG$ tablets , USP ) or initiating therapy with small doses ( 6.25 or 12.5 mg ) .	DDI-false
@DRUG$ * ( 200 mg once daily ) to a 10-fold increase in vardenafil AUC and a 4-fold increase in Cmax when co-administered with @DRUG$ ( 5 mg ) in healthy volunteers .	DDI-false
Reported examples include the following : @DRUG$ : @DRUG$ It is known that CYP3A4 inhibits to varying degrees.	DDI-false
These drugs include: @DRUG$ and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , @DRUG$ , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .	DDI-false
@DRUG$ : @DRUG$ 3 mg administered daily for 5 days did not affect the pharmacokinetics of (R)- or (S)-warfarin , nor were there any changes in the pharmacodynamic profile ( prothrombin time ) following a single 25 mg oral dose of warfarin	DDI-false
@DRUG$ may interact with alcohol , blood thinners , @DRUG$ ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , NSAIDs like Aleve or Ibuprofen , and high blood pressure medications .	DDI-int
Other strong inhibitors of CYP3A4 (e.g., itraconazole, clarithromycin, @DRUG$, troleandomycin, @DRUG$, nelfinavir) would be expected to behave similarly.	DDI-false
Acetaminophen , @DRUG$ , phenobarbital, quinidine, @DRUG$ , and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
Other concomitant therapy Although no specific interaction studies have been performed, clinical trials with 1 mg or more of finasteride doses have been conducted at the same time. @DRUG$ , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ACE ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , H2 antagonists , HMG-CoA reductase inhibitors , @DRUG$ ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
@DRUG$ Reports suggest that NSAIDs may diminish the antihypertensive effect of @DRUG$.	DDI-false
INOmax has been co-administered with tolazolen, @DRUG$ , dobutamine , steroids , @DRUG$ , and high-frequency ventilation .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
- @DRUG$ (e.g., Mesantoin) Use of @DRUG$ with these medicines may increase the chance of side effects of these medicines	DDI-false
Other cardiovascular agents: Enalapril and Enalapril IV were co-administered with beta-adrenergic blockers, @DRUG$ , nitrates , @DRUG$ , hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ In a study in healthy male subjects, no significant pharmacokinetic interactions occurred if: @DRUG$ and allopurinol were administered concomitantly for 6 days .	DDI-false
@DRUG$ : generally should not be given with @DRUG$.	DDI-advise
acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
It has been reported that QTc prolongation with or without TdP has been reported in patients taking amiodarone, @DRUG$ , @DRUG$ ==References====External links==	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, @DRUG$, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, @DRUG$, quinidine, and verapamil.	DDI-false
@DRUG$: In hypercholesterolemic patients, steady-state cerivastatin AUC and Cmax increased approximately 50% and 24% respectively after 10 days with co-administration of @DRUG$, a known inhibitor of cytochrome P450 3A4.	DDI-false
@DRUG$ MAOI antidepressants , as well as a metabolite of @DRUG$ Slow amphetamine metabolism.	DDI-false
While all selective serotonin reuptake inhibitors ( SSRIs), e.g. @DRUG$ , escitalopram , fluoxetine , @DRUG$ , and paroxetine, inhibit P450 2D6, they may vary in extent of inhibition.	DDI-false
Tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain @DRUG$ , lidocaine, theophylline and @DRUG$ , thereby delaying elimination and increasing blood levels of these drugs .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Cephalosporins-@DRUG$ containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, cefotetan, cefamandole, latamoxef) or methylthiadiazole (@DRUG$) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Amiodarone taken concomitantly with @DRUG$ for less than seven days increases plasma concentrations of @DRUG$ and n-acetyl procainamide by 55% and 33%, respectively.	DDI-false
Other concomitant therapy Although no specific interaction studies have been conducted, 1 mg or more of fissteride doses have been co-administered in clinical trials with acetaminophen, @DRUG$ , A-blockers, analgesics, @DRUG$ , anticonvulsants, benzodiazepines, beta-blockers, calcium channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also known as NSAIDs), and quinolone anti-infections without evidence of clinically significant adverse interactions.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
In general , these are drugs that have one or more pharmacologic activities similar to @DRUG$ , including @DRUG$ Like quinidine and procainamide, cardiac glycosides and tricyclic antidepressants.	DDI-false
Acetaminophen/theophylline, lidocaine/chinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$ and valproic acid/phenobarbital.	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or @DRUG$, @DRUG$, antihistamines or H1-blocking agents, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-false
Like @DRUG$ 40 mg/kg and 18-MC ( 40 mg/kg) reduce intravenous self-administration of morphine and @DRUG$ and the oral self-administration of ethanol and nicotine in rats ;	DDI-false
In a comparison of @DRUG$ Tolerance in dogs stunned with @DRUG$ Innovar Vet, or pentobarbital, the dosage of Ouabain needed to cause ventricular tachycardia was significantly higher, such as the LD50 of Ouabain, with ketamine or innovar than with pentobarbital.	DDI-false
Therophylline: A recent study has shown that concomitan administration of @DRUG$ and theophylline may cause elevated plasma levels of theophylline, and in some instances a slight decrease in the elimination of @DRUG$.	DDI-false
@DRUG$ , an anionic-binding resin, has a significant effect in reducing the rate and volume of @DRUG$ bioavailability .	DDI-mechanism
Fenfluramine may slightly increase the effect of antihypertensive agents, e.g. @DRUG$ , methyldopa, @DRUG$.	DDI-false
Example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , @DRUG$ , @DRUG$ , Nefazodone, Nicardipine, Propofol, Protease inhibitors, quinidine, and verapamil.	DDI-false
@DRUG$ (600 mg b.i.d.) co-administered with Vardenafil 5 mg resulted in a 49-fold increase in @DRUG$ AUC and a 13-fold increase in vardenafil Cmax.	DDI-false
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., @DRUG$, analgesics, antiemetics, sedatives, @DRUG$).	DDI-false
While all the @DRUG$ ( @DRUG$ ) , e.g. , citalopram , escitalopram , fluoxetine , sertraline , and paroxetine , inhibit P450 2D6 , they may vary in the extent of inhibition .	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, @DRUG$, ritonavir, indinavir, @DRUG$, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
The effects of oral @DRUG$ on @DRUG$ Induced hypertension has been studied in conscious sheep.	DDI-false
The concomitant use of other CYP3A4 inhibitors such as @DRUG$ Erythromycin with transdermal fentanyl may also lead to an increase in @DRUG$ Plasma concentrations that may increase or prolong adverse drug reactions and may cause severe respiratory depression.	DDI-false
WARFARIN : Co- administration of warfarin and @DRUG$ No changes in prothrombin time or coagulation factor VII occurred in healthy volunteers compared to concomitant use of @DRUG$ and placebo .	DDI-false
acetaminophen/theophylline , @DRUG$/quinidine , phenobarbital/acetaminophen , phenobarbital/valproic acid , quinidine/lidocaine , @DRUG$/acetaminophen , and valproic acid/phenobarbital .	DDI-false
Anticoagulants : Potentiation of warfarin-type ( @DRUG$ and @DRUG$ The substrate) Anticoagulant response is almost always seen in patients receiving amiodarone and can lead to severe or fatal bleeding.	DDI-false
@DRUG$ : Coadministration of @DRUG$ 3 mg and 10 mg olanzapine resulted in a decrease in DSST.	DDI-false
The intensity, uniformity and time course of @DRUG$ interference by phenobarbital, secobarbital, glutethimide, @DRUG$ and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
@DRUG$ • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • @DRUG$ 3 mg and paroxetine 20 mg daily for 7 days produced no pharmacokinetic or pharmacodynamic interaction .	DDI-false
@DRUG$: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and @DRUG$) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
Ritonavir and @DRUG$ When vardenafil 5 mg is co-administered with 600 mg BID ritonavir, Cmax and AUC @DRUG$ were reduced by approximately 20 % .	DDI-false
Short-term pharmacokinetic studies have demonstrated that concomitant administration of @DRUG$ and Lodine  (@DRUG$ capsules and tablets) results in reduced protein binding of warfarin, but there was no change in the clearance of free warfarin.	DDI-mechanism
Data from in vitro studies of @DRUG$ other than alprazolam suggest a possible drug interaction for the following : ergotamine , cyclosporine , amiodarone , @DRUG$ , and nifedipine .	DDI-int
A drug interaction study investigated the effect of using ACZONE gel, 5%, in combination with double strength (160 mg/800 mg) @DRUG$/@DRUG$ ( TMP/SMX ).	DDI-false
Lithium : @DRUG$ • have caused an increase in plasma @DRUG$ levels and a reduction in renal lithium clearance .	DDI-mechanism
Multivalent Cation-Containing products: co-administration of quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or @DRUG$ Antacids, sucralfate, VIDEX chewable tablets or pediatric powders or products which: @DRUG$ Iron or zinc can significantly reduce the absorption of ciprofloxacin, resulting in significantly lower serum and urine levels than desired.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as @DRUG$ or aluminum @DRUG$, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Methotrexate Renal tubular transport of methotrexate may be inhibited by concomitant administration of @DRUG$, potentially leading to increased plasma levels of @DRUG$.	DDI-false
Cimetidine (400 mg b.i.d.) had no effect on vardenafil bioavailability (AUC) and maximum concentration (Cmax) of @DRUG$ when co-administered with 20 mg @DRUG$ in healthy volunteers.	DDI-false
The intensity , uniformity and time course of @DRUG$ - influence by phenobarbital, secobarbital, glutethimide, @DRUG$ and methaqualone were systematically investigated in 16 patients receiving coumarin therapy .	DDI-false
The hypoglycemic action of @DRUG$ may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , @DRUG$ , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .	DDI-effect
Sulindac: The concomitant administration of @DRUG$ and @DRUG$ in normal volunteers resulted in lowering of the plasma levels of the active sulindac sulfide metabolite by approximately one-third.	DDI-mechanism
Antihypertensive agents: amiodarone should be used with caution in patients receiving antihypertensive agents (e.g. @DRUG$ , a CYP3A4 inhibitor) or calcium channel antagonists (e.g. verapamil, a CYP3A4 substrate and diltiazem, @DRUG$ inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and AV block ;	DDI-false
Potential drug interactions between Keppra   and other AEDs ( @DRUG$ , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and @DRUG$ ) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies .	DDI-false
· Folic acid in large quantities can counteract the antiepileptic action of phenobarbital, @DRUG$ and @DRUG$ , and increase the frequency of seizures in susceptible pediatric patients .	DDI-false
@DRUG$: When multiple doses of @DRUG$ and digoxin were coadministered, steady-state plasma digoxin concentrations increased by approximately 20%.	DDI-false
@DRUG$ In a clinical pharmacology study, the concomitant use of antazide (aluminium hydroxide, magnesium hydroxide and simethicone) with: @DRUG$ reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .	DDI-false
The pressor effects of catecholamines such as @DRUG$ Noradrenaline or noradrenaline are enhanced by @DRUG$.	DDI-effect
Alpha-blockers : When @DRUG$ 10 or 20 mg were administered to healthy subjects at the same time or 6 hours after a 10 mg dose. @DRUG$ , significant hypotension developed in a substantial number of subjects .	DDI-effect
Co-administration of phenytoin with 40 mg @DRUG$ tablets in epileptic patients lowered the @DRUG$ Plasma concentrations up to undetectable concentrations.	DDI-false
@DRUG$ increases enterohepatic elimination of @DRUG$ and may reduce its serum levels and t1/2.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, @DRUG$, imatinib, @DRUG$, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
The management of the local @DRUG$ containing epinephrine or @DRUG$ to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe , prolonged hypertension .	DDI-false
Ergot Derivatives : @DRUG$ Ergotamine, ergotamine, ergotamine, ergotamine, ergotamine, ergotamine, ergotamine, ergotamine, ergotamine, ergotamine, ergotamine, ergotamine, ergotamine, ergotamine, ergotamine, ergotamine, ergotamine, ergotamine, ergotamine, ergotamine, ergotamine, ergotamine, ergotamine, ergotamine, ergotamine, ergotamine @DRUG$ CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues .	DDI-false
Two groups (SH/DA; SH/FA) were treated daily with synthetic hydroalcoholic solutions which: @DRUG$ , methanol , higher @DRUG$ and acetaldehyde in the same proportions as those found in most common distilled and fermented alcoholic beverages ;	DDI-false
therefore concomitant administration of @DRUG$ with @DRUG$ is contraindicated.	DDI-advise
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (alcohol, barbiturates, @DRUG$, @DRUG$, anesthetics) should be considered.	DDI-false
Results of studies in multiple sclerosis patients taking TYSABRI  and concomitant interferon beta-1a (@DRUG$  30 mcg IM once weekly) or glatiramer acetate were inconclusive with regard to the need for dose adjustment of the beta-interferon or @DRUG$.	DDI-false
@DRUG$ Supplements and Potassium-Sparing Diuretics: Fosinopril sodium can attenuate potassium loss caused by @DRUG$.	DDI-false
Because of the increased risk of adverse reactions in patients who: @DRUG$ At regular intervals, it is particularly important that physicians carefully treat patients or their guardians over benzodiazepine, alcohol and sedative use as part of the history of a procedure in which the use of @DRUG$ is planned .	DDI-false
Amiodarone taken concomitantly with @DRUG$ for less than seven days increases plasma concentrations of procainamide and n-acetyl @DRUG$ by 55% and 33%, respectively.	DDI-false
However, concomitant administration of aspirin with @DRUG$ may result in an increased rate of GI ulceration or other complications, compared to use of @DRUG$ alone.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, @DRUG$, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and @DRUG$, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
* Exacerbation or the first appearance of a series of autoimmune and inflammatory disorders following concomitant administration of @DRUG$ and @DRUG$ , including crescentic IgA glomerulonephritis , oculo-bulbar myasthenia gravis , inflammatory arthritis , thyroiditis , bullous pemphigoid , and Stevens-Johnson syndrome .	DDI-effect
- @DRUG$ ( e.g. , @DRUG$ ) or	DDI-false
Garlic Capsules Garlic capsules should not be used while taking saquinavir ( @DRUG$ ) as the sole @DRUG$ Because of the risk of decreased saquinavir plasma concentration.	DDI-false
Dextromethorphan is a substrate for both @DRUG$ and @DRUG$.	DDI-false
Ethosuximide: @DRUG$ may delay intestinal absorption of @DRUG$.	DDI-mechanism
@DRUG$ The rate and extent of absorption of ciprofloxacin were bioequivalent if Proquin XR was given alone or if @DRUG$ was given 2 hours after omeprazole at the dose that maximally suppresses gastric acid secretion .	DDI-false
Antihypertensives : @DRUG$ should be used with caution in patients receiving   -receptor blocking agents ( e.g. , propranolol , a @DRUG$ inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a CYP3A4 substrate , and diltiazem , a CYP3A4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and AV block ;	DDI-false
@DRUG$ : rifampin CONTRAINDICATED since the coadministration of this product with @DRUG$ In an antiretroviral regimen, this reduces the plasma concentrations of saquinavir.	DDI-false
The administration of local anesthetic solutions containing @DRUG$ or @DRUG$ to patients receiving monoamine oxidase inhibitors , tricyclic antidepressants or phenothiazines may produce severe , prolonged hypotension or hypertension .	DDI-false
In addition, Fondaparinux neither influenced the pharmacodynamics of warfarin, acetylsalicylic acid, @DRUG$, and digoxin, nor the pharmacokinetics of @DRUG$ at steady state.	DDI-false
Cyclosporin, digoxin, methotrexate lodine, like others @DRUG$ By effects on renal prostaglandins, changes in the elimination of these drugs can lead to increased serum levels of cyclosporin, @DRUG$ , methotrexate , and increased toxicity .	DDI-mechanism
Monoamine Oxidase Inhibitors and @DRUG$ : @DRUG$ should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents .	DDI-false
The availability of potent @DRUG$ (NNRTI)-based regimens for antiretroviral therapy and concerns regarding protease inhibitor (@DRUG$)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection.	DDI-false
Short-term pharmacokinetic studies have demonstrated that concomitant administration of @DRUG$ and Lodine  (etodolac capsules and tablets) results in reduced protein binding of warfarin, but there was no change in the clearance of free @DRUG$.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, @DRUG$, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, @DRUG$, and isoniazid.	DDI-false
Potassium Supplements and @DRUG$: @DRUG$ can attenuate potassium loss caused by thiazide diuretics.	DDI-false
As with other antipsychotic agents, it should be noted that HALDOL may be able to treat CNS depressants such as: @DRUG$ , @DRUG$ And alcohol.	DDI-false
Other concomitant therapies : In clinical trials , the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics , @DRUG$ and sedatives ( including benzodiazepines ) , or @DRUG$ was similar to that of subjects taking placebo with these concomitant medications .	DDI-false
@DRUG$: Concomitant administration of @DRUG$ may reduce plasma levels of diflunisal.	DDI-false
Concomitant cyclophosphamide, @DRUG$, @DRUG$, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, @DRUG$, teniposide, and prednisone with @DRUG$ plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Other Cardiovascular Agents: @DRUG$ and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, @DRUG$, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Central Nervous System Depressants : The concomitant use of @DRUG$   ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , @DRUG$ Anaesthetics (e.g. benzodiazepines), general anaesthetics, phenothiazines, skeletal muscle relaxants and alcohol can cause respiratory depression, hypotension and deep sedation, or possibly lead to coma or death.	DDI-effect
In order to evaluate the effects of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL ), the authors retrospectively compared a group of 24 patients with HIV-NHL who had been treated with the @DRUG$ , doxorubicin , @DRUG$ , and prednisone ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , doxorubicin , teniposide , and prednisone with vincristine plus bleomycin ) without receiving antiretroviral therapy .	DDI-false
@DRUG$ and @DRUG$ exert additive ocular and renal vasodilator effects on healthy humans .	DDI-false
While all the selective serotonin reuptake inhibitors (SSRIs), e.g., citalopram, @DRUG$, fluoxetine, @DRUG$, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
Both the toxicity of @DRUG$ and the therapeutic value of @DRUG$ can be rationalized at the cellular and molecular level by the following observations: (i) these polyene antibiotics showed differential effects on cells;	DDI-false
Therophylline : A recent study has shown that concomitan administration of isoniazid and @DRUG$ may cause elevated plasma levels of theophylline , and in some instances a slight decrease in the elimination of @DRUG$.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (@DRUG$ transdermal system) with other central nervous system depressants, including but not limited to other @DRUG$, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
Other Drug Interactions: No pharmacokinetic interactions were observed between vardenafil and the following drugs: @DRUG$, warfarin, digoxin, Maalox, and @DRUG$.	DDI-false
In general , these are drugs that have one or more pharmacologic activities similar to @DRUG$ , including anti-arrhythmic agents such as quinidine and procainamide , @DRUG$ and tricyclic anti-depressants .	DDI-false
Although the specific drug interaction was not studied in a clinical trial, there have been more than 50 episodes of concomitant use of antifibrinolytic therapies (i.e., @DRUG$, aminocaproic acid) and @DRUG$.	DDI-false
@DRUG$ (but not @DRUG$): These drugs in combination with very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies.	DDI-false
@DRUG$ - prior ingestion of diphenidol may decrease the emetic response to @DRUG$ in the treatment of poisoning.	DDI-false
The following precautions should be kept in mind in the treatment of anticholinesterase poisoning although they do not bear directly on the use of @DRUG$ and @DRUG$.	DDI-advise
medicines that cause a significant sustained increase in the pH of the stomach ( @DRUG$ The plasma concentrations of ranitidine or cimetidine may be higher than the plasma concentrations of the active substance (e. g. ranitidine or cimetidine) and may be higher than the plasma concentrations of the active substance (e. g. ranitidine or cimetidine). @DRUG$ and therefore potentially may reduce efficacy .	DDI-mechanism
Non-selective MAO inhibitors including tranylcypromine sulfate , @DRUG$ , and pargyline HC1 : Concomitant use of @DRUG$ and non-selective MAO inhibitors may cause hypertension .	DDI-false
Administration of @DRUG$ • during treatment with a @DRUG$ It has been shown that some depressive patients have a stimulating effect.	DDI-effect
Drugs that may alter @DRUG$ plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, @DRUG$, erythromycin, clarithromycin).	DDI-false
@DRUG$ or other medications with anticholinergic activity - anticholinergic effects may be potentiated when these medications are used concurrently with @DRUG$;	DDI-false
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$ , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ACE ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , H2 antagonists , @DRUG$ Prostaglandin synthetase inhibitors (also known as NSAIDs) and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
The hypoglycemic action of @DRUG$ may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, @DRUG$, and beta adrenergic blocking agents.	DDI-effect
- Anabolic steroids (nandrolone [e.g., Anabolin], oxandrolone [e.g., @DRUG$], oxymetholone [e.g., Anadrol], stanozolol [e.g., @DRUG$]) or	DDI-false
Since Nalfon has not been shown to have any additional effect over the @DRUG$ alone and because @DRUG$ increases the rate of excretion of Nalfon , the concomitant use of Nalfon and salicylates is not recommended .	DDI-false
High-dose @DRUG$ resulting in concentrations above 2000 ng/mL administered with oral etoposide has led to an 80% increase in etoposide exposure with a 38% decrease in total body clearance of @DRUG$ compared to etoposide alone.	DDI-false
Omeprazole: The rate and extent of absorption of ciprofloxacin was bioequivalent when @DRUG$ was given alone or when @DRUG$ was given 2 hours after omeprazole at the dose that maximally suppresses gastric acid secretion.	DDI-false
@DRUG$ did not alter the pharmacokinetics of @DRUG$.	DDI-false
Ergot Derivatives : @DRUG$ , ergonovine, ergotamine, methylergonovine CONTRAINDICATED due to the potential for serious and life-threatening reactions such as acute @DRUG$ toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues .	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other @DRUG$, sedatives, hypnotics, @DRUG$ (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Anticoagulants : Potentiation of @DRUG$-type ( CYP2C9 and @DRUG$ The substrate) Anticoagulant response is almost always seen in patients receiving amiodarone and can lead to severe or fatal bleeding.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (@DRUG$ transdermal system) with other central nervous system depressants, including but not limited to other opioids, @DRUG$, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (@DRUG$): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
@DRUG$ has been administered with tolazoline, dopamine, @DRUG$, steroids, surfactant, and high-frequency ventilation.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, @DRUG$, @DRUG$, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.	DDI-false
@DRUG$: When Lodine is administered with aspirin, its protein binding is reduced, although the clearance of free @DRUG$ is not altered.	DDI-false
Drug-Drug Interactions Between @DRUG$  And Other @DRUG$ (AEDs) Phenytoin Keppra  (3000 mg daily) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy.	DDI-false
@DRUG$ Adrenergic blockers are inhibited by @DRUG$.	DDI-false
Other Drug Interactions: No pharmacokinetic interactions were observed between vardenafil and the following drugs: @DRUG$, warfarin, @DRUG$, Maalox, and ranitidine.	DDI-false
The effects of @DRUG$ ( RR ) on inositol 1,4,5-trisphosphate (@DRUG$)-induced responses were studied in rat bone marrow megakaryocytes with the patch-clamp whole-cell recording technique in combination with fura-2 microfluorometry .	DDI-false
This study demonstrated that the potent cytochrome P450 enzyme-inducer @DRUG$ did indeed have a marked effect on the metabolism of @DRUG$, resulting in a 5-fold increase in clearance when administered concomitantly to patients with DSM-IV-diagnosed schizophrenia, schizoaffective disorder, or bipolar disorder.	DDI-mechanism
In EM individuals treated with paroxetine or fluoxetine , the AUC of @DRUG$ This is about 6- to 8-fold and Css, max is about 3- to 4-fold larger than @DRUG$ alone .	DDI-false
Other Cardiovascular Agents : @DRUG$ , methyldopa, nitrates, calcium blockers, @DRUG$ , prazosin and digoxin without evidence of clinically significant adverse interactions .	DDI-false
Erythromycin : In healthy individuals , plasma concentrations of @DRUG$ increased approximately 40 % with coadministration of @DRUG$ Erythromycin, a known inhibitor of cytochrome P450 3A4.	DDI-false
This increase is due to the inhibition of @DRUG$ metabolism via P450 2C9 by @DRUG$ (see CLINICAL PHARMACOLOGY - Pharmacokinetics: Metabolism).	DDI-mechanism
@DRUG$-@DRUG$ may sterilize the bowel and decrease the vitamin K contribution to the body by the intestinal microflora.	DDI-false
Both efavirenz and @DRUG$ The treatment with PI indinavir was compared with triple therapy as early therapy for 48 weeks, with similar reactions observed with nevirapine therapies and superiority with @DRUG$.	DDI-false
Nonsteroidal Anti-Inflammatory Drugs : The administration of @DRUG$ to normal volunteers receiving @DRUG$ Elevated renal clearance and significantly increased plasma levels of indomethacin.	DDI-mechanism
Antacids : In a clinical pharmacology study , coadministration of an antacid ( @DRUG$ Magnesium hydroxide and @DRUG$ In combination with fosinopril reduced serum levels and urinary excretion of fosinoprilat given alone, suggesting that antacids may impair the absorption of fosinopril.	DDI-false
Antiarrhythmics : Other antiarrhythmic drugs , such as quinidine , procainamide , disopyramide , and @DRUG$ , have been used concurrently with @DRUG$.	DDI-false
The effect of @DRUG$ As regards our patient's warfarin requirement, it seemed to be at most 5 to 7 days after the onset of treatment. @DRUG$ A similar length of time after rifampin withdrawal is prolonged and prolonged.	DDI-false
Erythromycin: In healthy individuals, plasma concentrations of @DRUG$ increased approximately 40% with coadministration of @DRUG$ and erythromycin, a known inhibitor of cytochrome P450 3A4.	DDI-false
@DRUG$ and @DRUG$ : a drug interaction .	DDI-int
Example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , @DRUG$ , imatinib, isoniazid, nefazodon, nicardipine, @DRUG$ , protease inhibitors, quinidine, and verapamil.	DDI-false
@DRUG$, or other products containing iron or zinc, antacids or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of @DRUG$, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.	DDI-advise
Other strong inhibitors of CYP3A4 ( e.g. , itraconazole , clarithromycin , nefazodone , @DRUG$ , @DRUG$ , nelfinavir ) would be expected to behave similarly .	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, @DRUG$, @DRUG$, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
The effects of @DRUG$ and L-CCG-1 upon phencyclidine (@DRUG$)-induced locomotion and behavioral changes in mice.	DDI-false
Tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , @DRUG$ , nifedipine , chlordiazepoxide , @DRUG$ , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, @DRUG$, @DRUG$, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, @DRUG$, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Anticoagulants including coumarin derivatives , indandione derivatives , and @DRUG$ - Non-steroidal anti-inflammatory medicines ( @DRUG$ ) , and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac @DRUG$, diuretics, @DRUG$, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, @DRUG$, probenecid, coumarins, monoamine oxidase inhibitors, and @DRUG$.	DDI-false
Because @DRUG$ has not been shown to produce any additional effect beyond that obtained with aspirin alone and because @DRUG$ increases the rate of excretion of Nalfon , the concomitant use of Nalfon and salicylates is not recommended .	DDI-false
Patients treated with @DRUG$ The effect of @DRUG$ can be resistant.	DDI-effect
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/@DRUG$, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$ : @DRUG$ It affects dopamine receptors and thus inhibits the central stimulant effect of amphetamines.	DDI-false
Iodine or @DRUG$ Surplus may reduce the effect of carbimazole, and a @DRUG$ Deficiency can increase the effect of carbimazole.	DDI-false
This medication may interact with alcohol or other CNS depressants (may potentiate the CNS depressive effect of either these drugs or antihistamines), @DRUG$ - or other medicines with anticholinergic activity (anticholinergic effects can be intensified if these drugs are used at the same time as antihistamines), and @DRUG$ ( concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines ) .	DDI-false
Warfarin-@DRUG$ can antagonize the effect of @DRUG$	DDI-effect
Substances that are potent inhibitors of CYP3A4 activity (eg, ketoconazole and itraconazole) decrease @DRUG$ metabolism and increase @DRUG$ plasma concentrations.	DDI-false
Sinus bradycardia has been reported with oral amiodarone in combination with @DRUG$ ( CYP3A4 substrate ) given for local @DRUG$.	DDI-false
Anticoagulants: @DRUG$ type potentiation ( CYP2C9 and CYP3A4 substrate ) @DRUG$ response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding .	DDI-false
ACE Inhibitors and @DRUG$ (Hypertension)- In clinical studies of patients with hypertension , the addition of @DRUG$ 50 to 100 mg to ACE inhibitors and angiotensin II receptor antagonists slightly increased the mean serum potassium (approximately 0.09 - 0.13 mEq/L).	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, @DRUG$, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of @DRUG$ and these AEDs during placebo-controlled clinical studies.	DDI-false
Potential drug interactions between Keppra   and other @DRUG$ ( carbamazepine , gabapentin , @DRUG$ , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies .	DDI-false
@DRUG$ • potentiates the muscle relaxant effect of all muscle relaxants, especially @DRUG$ MAC (minimum alveolar concentration) is reduced by the concomitant use of N 2O.	DDI-effect
@DRUG$: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., @DRUG$, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Study results in patients with multiple sclerosis, TYSABRI and concomitantly @DRUG$ ( AVONEX   30 mcg IM once weekly ) or @DRUG$ This was not conclusive in terms of the need for dose adjustment of beta interferon or glatiramer acetate.	DDI-false
@DRUG$: @DRUG$ should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Multivalent Cation-Containing Products : Concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum @DRUG$ , sucralfate , VIDEX chewable/buffered tablets or pediatric powder , or products containing @DRUG$ , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .	DDI-false
Other Drugs:Drugs such as quinidine, @DRUG$, procainamide, phenothiazines, antihistamines, and @DRUG$ may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
@DRUG$: astemizole*, @DRUG$* CONTRAINDICATED due to potential for serious and/or life-threatening cardiac arrhythmias.	DDI-false
These medicines include thiazides and other diuretics, corticosteroids, phe-nothiazines, @DRUG$ , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimet-ics , calcium channel blocking drugs , and @DRUG$.	DDI-false
@DRUG$ and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or @DRUG$ (ACEI/ARB).	DDI-false
- @DRUG$ (e.g., @DRUG$) or	DDI-false
Sinus bradycardia has been reported with oral @DRUG$ in combination with lidocaine (@DRUG$ substrate) given for local anesthesia.	DDI-false
@DRUG$: @DRUG$ toxicity has been reported in patients receiving lithium concomitantly with drugs which cause elimination of sodium, including ACE inhibitors.	DDI-false
Concomitant administration of Mefloquine and other related compounds ( eg , quinine , @DRUG$ and @DRUG$ ) may cause electrocardiographic abnormalities and increase the risk of convulsions.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
METHOD : This study was a multicenter randomized double-blind study of 101 patients who were randomly assigned 1:1:1 to receive @DRUG$ Tablets at doses of 0.5 mg, 1 mg or 2 mg twice daily with cyclosporin and @DRUG$.	DDI-false
After multiple dosing , @DRUG$ ( @DRUG$ 30 mcg IM once weekly) reduced TYSABRI clearance by approximately 30%.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with @DRUG$, beta-blockers, felodipine, digoxin, warfarin, isosorbide mononitrate, @DRUG$, ethanol or itraconazole.	DDI-false
@DRUG$/@DRUG$ Rofecoxib had no clinically important effect on the pharmacokinetics of prednisolone or prednisone.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, @DRUG$, felodipine, digoxin, @DRUG$, isosorbide mononitrate, carvedilol, ethanol or itraconazole.	DDI-false
@DRUG$ Co-administration of ciprofloxacin with sulphonylurea @DRUG$ has , on rare occasions , resulted in severe hypoglycemia .	DDI-false
@DRUG$-cephalosporins containing side chains of N-methylthiotetrazole ( @DRUG$ , cefoperazone , cefotetan , cefamandole , latamoxef ) or methylthiadiazole ( cefazolin ) can cause vitamin K deficiency and hypoprothrombinemia .	DDI-false
However, in the second study, administration of 12 g @DRUG$ 1 hour before the evening meal and 0.3 mg cerivastatin sodium approximately 4 hours after the same evening meal resulted in a decrease in the @DRUG$ AUC of less than 8%, and a decrease in Cmax of about 30% when compared to dosing cerivastatin sodium alone.	DDI-false
@DRUG$ As with some others @DRUG$ Concomitant administration of ciprofloxacin and theophylline may lead to increased serum concentrations of theophylline and an extension of the elimination half-life.	DDI-false
@DRUG$: In some patients with compromised renal function who are being treated with @DRUG$, the co-administration of enalapril may result in a further deterioration of renal function.	DDI-false
The hypoglycaemic effect of @DRUG$ • may be exacerbated by certain drugs, including nonsteroidal anti-inflammatory drugs and other medicines that are highly protein bound, salicylates, sulphonamides, chloramphenicol, probenecid, coumarine, @DRUG$ , and beta adrenergic blocking agents .	DDI-effect
acetaminophen/theophylline , lidocaine/quinidine , phenobarbital/acetaminophen , phenobarbital/valproic acid , quinidine/@DRUG$ , theophylline/@DRUG$ , and valproic acid/phenobarbital .	DDI-false
Dose adjustment is not recommended.Levetiracetam had no effect on plasma concentrations of @DRUG$, valproate, topiramate, or @DRUG$.	DDI-false
@DRUG$: A report of severe @DRUG$ toxicity was reported in a patient receiving Isoniazid.	DDI-false
There were no significant interactions between: @DRUG$ and warfarin or @DRUG$.	DDI-false
Other cardiovascular agents: Enalapril and Enalapril IV were co-administered with @DRUG$ , methyldopa , nitrates , calcium-blocking agents , @DRUG$ , prazosin and digoxin without evidence of clinically significant adverse interactions .	DDI-false
@DRUG$: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels @DRUG$ levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.	DDI-false
The pressor effects of catecholamines such as dopamine or @DRUG$ are enhanced by @DRUG$.	DDI-effect
Particular caution is necessary when using @DRUG$ in cases of mixed drug overdosage since the toxic effects (such as convulsions and cardiac dysrhythmias) of other drugs taken in overdose (especially cyclic antidepressants) may emerge with the reversal of the benzodiazepine effect by @DRUG$.	DDI-false
Acetaminophen, @DRUG$, phenobarbital, quinidine, theophylline, and @DRUG$ were added to pooled human serum at therapeutic concentrations.	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , @DRUG$ , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , @DRUG$ When co-administered with saquinavir, increased plasma concentrations may occur;	DDI-false
To evaluate the effect of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL), the authors retrospectively compared a group of 24 patients with HIV-NHL treated with cyclophosphamide, @DRUG$ , vincristine and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or with a CHOP-like regimen (i.e. cyclophosphamide, @DRUG$ , teniposide , and prednisone with vincristine plus bleomycin ) without receiving antiretroviral therapy .	DDI-false
However, a crossover study in healthy subjects receiving either @DRUG$ 300 mg q.i.d. or 800 mg h.s. concomitantly with a 300 mg b.i.d. dosage of theophylline (@DRUG$ , Key Pharmaceuticals, Inc.) demonstrated less alteration in steady-state theophylline peak serum levels with the 800 mg h.s. regimen, particularly in subjects aged 54 years and older.	DDI-mechanism
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, @DRUG$, phenobarbital, phenytoin, primidone and @DRUG$) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Accordingly , when @DRUG$ It is used with oral @DRUG$ Prothrombin time should be closely monitored during and for several days after co-administration of medicinal products.	DDI-advise
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, @DRUG$, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Example inhibitors include azole antifungals, @DRUG$, clarithromycin, @DRUG$, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Other concomitant therapies : In clinical trials , the safety profile in subjects treated with @DRUG$ - together with anxiolytics, @DRUG$ The occurrence of sedatives (including benzodiazepines) or non-opioid analgesics was similar to those in patients receiving placebo with these concomitant drugs.	DDI-false
Drug Interactions : Flupenthixol may interact with some drugs , like @DRUG$ MAOI could theoretically influence the pharmacodynamics of flupentixol - Arecoline - Eproxindine - Ethanol : @DRUG$ - Tricyclic antidepressants : Flupentixol increases the effect of tricyclic antidepressants	DDI-false
Drugs that may alter @DRUG$ plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, erythromycin, @DRUG$).	DDI-false
Digoxin @DRUG$  (1000 mg twice daily) did not influence the pharmacokinetics and pharmacodynamics (ECG) of @DRUG$ given as a 0.25 mg dose every day.	DDI-false
In case you take @DRUG$ while taking @DRUG$ , higher doses of digoxin may be needed.	DDI-advise
Other concomitant therapy Although no specific interaction studies have been conducted, 1 mg or more of finasteride doses have been used in clinical trials with acetaminophen, acetylsalicylic acid, A-blockers, analgesics, @DRUG$ , anticonvulsants, benzodiazepines, beta-blockers, calcium channel blockers, cardiac nitrates, @DRUG$ , H2 antagonists , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
@DRUG$/prednisolone: Rofecoxib did not have any clinically important effect on the pharmacokinetics of prednisolone or @DRUG$.	DDI-false
Glyburide : The concomitant administration of @DRUG$ with the @DRUG$ Glyburide has, in rare cases, led to severe hypoglycaemia.	DDI-effect
Urinary acidifying agents These agents ( ammonium chloride , @DRUG$ ) increase the concentration of ionized species of @DRUG$ ==References====External links==* Official website	DDI-mechanism
ACE Inhibitors and @DRUG$ 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or @DRUG$ ( ACEI/ARB ) .	DDI-false
@DRUG$ : Haloperidol blocks dopamine receptors , thus inhibiting the central stimulant effects of @DRUG$.	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, betablockers, @DRUG$, diuretics, and @DRUG$ (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
acetaminophen/theophylline , lidocaine/quinidine , phenobarbital/acetaminophen , phenobarbital/@DRUG$ , @DRUG$/lidocaine , theophylline/acetaminophen , and valproic acid/phenobarbital .	DDI-false
Multivitamins, or other products containing iron or @DRUG$, antacids or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of @DRUG$, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.	DDI-advise
Because Nalfon has not been shown to produce any additional effect beyond that obtained with aspirin alone and because @DRUG$ increases the rate of excretion of Nalfon, the concomitant use of @DRUG$ and salicylates is not recommended.	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, @DRUG$, niacin (nicotinic acid), erythromycin, @DRUG$.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and @DRUG$.	DDI-false
@DRUG$ including coumarin derivatives, indandione derivatives, and @DRUG$ such as nonsteroidal anti-inflammatory drugs (NSAIDs), and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
* Chloramphenicol has shown itself to be antagonistic to @DRUG$ , including @DRUG$ , based on in vitro studies and time-killing curves with enteric gram-negative bacilli.	DDI-false
@DRUG$ should be used with caution in patients taking @DRUG$, and renal function should be carefully monitored.	DDI-advise
Lithium: @DRUG$ have produced an elevation of plasma @DRUG$ levels and a reduction in renal lithium clearance.	DDI-mechanism
@DRUG$: Isoniazid is known to slow the metabolism of @DRUG$ and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.	DDI-false
* Delayed side effects on @DRUG$ A review of the literature showed that 12.6% (range 11 - 28 %) of 501 patients with various @DRUG$ The treatment regimens, which subsequently received radiographic iodised contrast agents, showed acute, atypical adverse reactions.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, @DRUG$, diazepam, certain tricyclic antidepressants, lidocaine, @DRUG$ and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Drug/Laboratory Test Interaction @DRUG$ may cause a false low measurement of serum digoxin levels with the Digi- Tab   RIA Kit for @DRUG$.	DDI-false
This drug may interact with alcohol or other CNS depressants ( may potentiate the CNS depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with @DRUG$ ) , and @DRUG$ Concomitant use of antihistamines may prolong and increase the anticholinergic and CNS depressive effects of antihistamines.	DDI-false
Drug-Drug Interactions Between Keppra   And Other @DRUG$ ( AEDs ) Phenytoin Keppra   ( 3000 mg daily ) had no effect on the pharmacokinetic disposition of @DRUG$ In patients with refractory epilepsy.	DDI-false
Urinary acidifying agents These agents (ammonium chloride, @DRUG$, etc.) increase the concentration of the ionized species of the @DRUG$ molecule, thereby increasing urinary excretion.	DDI-mechanism
Previous studies have demonstrated a significant reduction in the oral bioavailability of trovafloxacin and @DRUG$ If co-administered with an intravenous @DRUG$ such as morphine .	DDI-mechanism
@DRUG$/prednisolone: @DRUG$ did not have any clinically important effect on the pharmacokinetics of prednisolone or prednisone.	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, @DRUG$, sulfonamides, chloramphenicol, probenecid, @DRUG$, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
Moreover, additional interaction studies with niacin and propranolol have not demonstrated any effect on fluvastatin plasma levels, and administration to a patient population chronically receiving @DRUG$ resulted in no difference in the extent of bioavailability of @DRUG$ relative to control data.	DDI-false
This interaction should be given consideration in patients taking @DRUG$ concomitantly with @DRUG$.	DDI-advise
Data from in vitro studies of benzodiazepines other than @DRUG$ suggest a possible drug interaction for the following: @DRUG$, cyclosporine, amiodarone, nicardipine, and nifedipine.	DDI-int
unlike @DRUG$ , @DRUG$ "Does not affect the reaction to a non-drug booster (water).	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, @DRUG$, felodipine, @DRUG$, warfarin, isosorbide mononitrate, carvedilol, ethanol or itraconazole.	DDI-false
@DRUG$, @DRUG$ and Diuretics: Concomitant treatment with xanthine derivatives, steroids, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
In addition, fondaparinux did not affect the pharmacodynamics of warfarin, @DRUG$ , piroxicam, and @DRUG$ The pharmacokinetics of digoxin in steady state.	DDI-false
Lack of an effect of azithromycin on the disposition of @DRUG$ and @DRUG$ In HIV-infected patients.	DDI-false
@DRUG$, including norfloxacin, may enhance the effects of oral @DRUG$, including warfarin or its derivatives or similar agents.	DDI-effect
Note: dissolution of aerosol particles of budesonide in @DRUG$, a model @DRUG$.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general @DRUG$, phenothiazines, @DRUG$, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of @DRUG$ - 0.5 % ophthalmic solution, the possibility of an additive or potentiating effect with CNS depressants (alcohol, @DRUG$ , opiates, sedatives, anaesthetics) should be considered.	DDI-advise
@DRUG$ (NSAIDs)-A drug interaction study of @DRUG$ with an NSAID has not been conducted.	DDI-false
@DRUG$ In healthy people, plasma concentrations of @DRUG$ increased approximately 40 % with coadministration of atorvastatin and erythromycin , a known inhibitor of cytochrome P450 3A4 .	DDI-false
Other cardiovascular agents: Enalapril and Enalapril IV together with beta-adrenergic blocking agents, methyldopa, nitrates, calcium-blocking agents, hydralacin, @DRUG$ and @DRUG$ without evidence of clinically significant adverse interactions .	DDI-false
These drugs include the @DRUG$ and other @DRUG$, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
The similarity of the @DRUG$ -associated adverse event profile between Study 1 (without co-administered AVONEX ) and Study 2 (with co-administered @DRUG$ ) indicates that this alteration in clearance does not necessitate reduction of the TYSABRI  dose to maintain safety, General).	DDI-false
The effects of @DRUG$ are antagonized by methylxanthines such as @DRUG$ and theophylline.	DDI-effect
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , @DRUG$ , anticonvulsants , @DRUG$ Beta blockers, calcium channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also known as NSAIDs) and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
As with other antipsychotic agents, it should be noted that HALDOL may be capable of potentiating @DRUG$ such as anesthetics, @DRUG$, and alcohol.	DDI-false
Both ibogaine and 18-MC block @DRUG$-induced and @DRUG$-induced dopamine release in the nucleus accumbens ;	DDI-false
Antiarrhythmics: Other antiarrhythmic drugs, such as @DRUG$, @DRUG$, disopyramide, and phenytoin, have been used concurrently with amiodarone.	DDI-false
BACKGROUND : The effects of the combined administration of bombsin and verapamil hydrochloride (Verapamil ), a calcium channel blocker, on the incidence of peritoneal metastases of intestinal adenocarcinoma induced by @DRUG$ ( @DRUG$ ) and the labeling index of intestinal cancers were investigated in male Wistar rats .	DDI-false
@DRUG$, tricyclic Amphetamines may enhance the activity of tricyclic antidepressants or @DRUG$;	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (@DRUG$): MAOI could theoretically affect flupenthixol pharmacodynamics - @DRUG$ - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Cimetidine (400 mg b.i.d.) had no effect on @DRUG$ bioavailability (AUC) and maximum concentration (Cmax) of @DRUG$ when co-administered with 20 mg Vardenafil in healthy volunteers.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of @DRUG$ as compared with @DRUG$ administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
Lithium : Increased serum lithium levels and symptoms of @DRUG$ toxicity have been reported in patients receiving concomitant lithium and @DRUG$ therapy .	DDI-false
Injection: Lorazepam injection, like other injectable @DRUG$, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When @DRUG$ is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
Diuretics : Etodolac has no apparent pharmacokinetic interaction if it is associated with @DRUG$ or @DRUG$.	DDI-false
@DRUG$ Congestive Heart Failure Post-myocardial infarction In EPHESUS, 3020 (91%) patients who: @DRUG$ 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists ( ACEI/ARB ) .	DDI-false
To determine whether injection of @DRUG$ would permit larger doses of cisplatin to be administered, a fixed 9.9-g/m2 dose of thiosulfate was given intravenously over three hours concurrently with escalating doses of @DRUG$.	DDI-false
@DRUG$ : Chlorpromazine blocks dopamine and norepinephrine receptors , thus inhibiting the central stimulant effects of @DRUG$ And can be used to treat amphetamine poisoning.	DDI-false
@DRUG$: Coadministration of single doses of @DRUG$ 3 mg and lorazepam 2 mg did not have clinically relevant effects on the pharmacodynamics or pharmacokinetics of either drug.	DDI-false
@DRUG$ Keppra  (1000 mg twice daily) did not influence the pharmacokinetics of R and @DRUG$.	DDI-false
After multiple dosing, @DRUG$ ( AVONEX 30 mcg IM once weekly ) reduced @DRUG$ Clearance is approximately 30%.	DDI-mechanism
@DRUG$ The effects of warfarin and @DRUG$ on GI bleeding are synergistic , such that users of both drugs together have a risk of serious GI bleeding higher than that of users of either drug alone .	DDI-false
acetaminophen/theophylline, lidocaine/@DRUG$, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral @DRUG$ (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of @DRUG$.	DDI-false
Phenytoin : altered serum levels of @DRUG$ Patients receiving @DRUG$ have been reported to increase and decrease the dose.	DDI-mechanism
In a comparison of digitalis tolerance in dogs anesthetized with ketamine , @DRUG$ , or pentobarbital , the dosage of ouabain needed to cause ventricular tachycardia was significantly higher , as was the LD50 of ouabain , with ketamine or Innovar than with @DRUG$.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Benzthiazide can interact with alcohol, blood thinners, decongestant medications (allergic agents, colds, and sinus drugs), diabetic drugs, @DRUG$ , norepinephrine, NSAIDs such as Aleve or @DRUG$ , and high blood pressure medications .	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
For example, inhibitors are azole antimycotics, @DRUG$ , clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, @DRUG$ , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .	DDI-false
Cholestyramine-Concomitant intake of @DRUG$ and @DRUG$ may reduce the absorption of vitamin K.	DDI-mechanism
Concurrent administration of drugs possessing nephrotoxic ( e.g. , aminoglycosides , indomethacin ) , myelotoxic ( e.g. , cytotoxic chemotherapy ) , cardiotoxic ( e.g. , @DRUG$ ) or hepatotoxic ( e.g. , @DRUG$ Asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
CYP2D6 inhibitors - @DRUG$ The metabolism is primarily via the CYP2D6 route to @DRUG$.	DDI-false
The steady state plasma concentrations of imipramine and @DRUG$ have been reported to be increased an average of 31% and 20%, respectively, by the concomitant administration of @DRUG$ tablets in doses up to 4 mg/day.	DDI-mechanism
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, @DRUG$, benzodiazepines, beta blockers, calcium-channel blockers, cardiac @DRUG$, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Digoxin : @DRUG$ 75 mg once daily for 11 days does not alter the plasma concentration profile or renal elimination of @DRUG$ after a single 0.5 mg oral dose .	DDI-false
Human pharmacokinetics data indicate that oral @DRUG$ potently inhibits the metabolism of @DRUG$ resulting in an eight-fold increase in the mean AUC of cisapride.	DDI-mechanism
The pharmacokinetics of @DRUG$ and its major metabolite 6-beta-naltrexol were unaffected following co-administration with @DRUG$.	DDI-false
Other potent inhibitors of CYP3A4 (e.g. itraconazole, @DRUG$ , nefazodone , troleandomycin , @DRUG$ nelfinavir is expected to behave similarly.	DDI-false
Human pharmacokinetics data indicate that oral @DRUG$ potently inhibits the metabolism of cisapride resulting in an eight-fold increase in the mean AUC of @DRUG$.	DDI-false
In clinical studies performed with @DRUG$, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), @DRUG$ (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Antihypertensives : Amiodarone should be used with caution in patients receiving   -@DRUG$ blocking agents ( e.g. , propranolol , a CYP3A4 inhibitor ) or calcium channel antagonists ( e.g. , @DRUG$ , a CYP3A4 substrate , and diltiazem , a CYP3A4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and AV block ;	DDI-false
Lorazepam: Coadministration of single doses of @DRUG$ 3 mg and @DRUG$ 2 mg did not have clinically relevant effects on the pharmacodynamics or pharmacokinetics of either drug.	DDI-false
Benzthiazide may interact with alcohol, @DRUG$s, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like Aleve or @DRUG$, and high blood pressure medications.	DDI-false
These results suggest that both dexamethasone and retinyl acetate, and possibly other @DRUG$ and @DRUG$, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF.	DDI-false
Compounds tested in man include warfarin, theophylline, phenytoin, @DRUG$, aminopyrine and @DRUG$.	DDI-false
Agents Causing Renin Release: The antihypertensive effect of @DRUG$ and enalapril IV is augmented by @DRUG$ that cause renin release (e.g., diuretics).	DDI-effect
Multivalent Cation-Containing Products : Concomitant administration of a quinolone, including @DRUG$ , with multivalent cation-containing products such as magnesium or @DRUG$ antacids , sucralfate , VIDEX chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .	DDI-mechanism
@DRUG$ and colestipol @DRUG$ The absorption of hydrochlorothiazide is impaired in the presence of anionic resins.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Serum @DRUG$ levels should be monitored frequently if @DRUG$ is administered concomitantly with lithium.	DDI-false
Ritonavir and indinavir : Upon concomitant administration of 5 mg of @DRUG$ with 600 mg BID ritonavir , the Cmax and AUC of @DRUG$ were reduced by approximately 20 % .	DDI-false
@DRUG$ ( neostgmine , @DRUG$ ) , lignocaine , quinine , procainamide can enhance toxicity and cause cardio respiratory depression .	DDI-false
When @DRUG$ is added to or withdrawn from treatment, dosage adjustment of @DRUG$ may be required.	DDI-advise
Antacids: In a clinical pharmacology study, coadministration of an antacid (@DRUG$, @DRUG$, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
Tagamet, apparently due to an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, @DRUG$ , chlordiazepoxide , @DRUG$ , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .	DDI-false
Primary and secondary @DRUG$ deficiencies constitute the sole indication of physiological oral @DRUG$ therapy.	DDI-false
In a study with concomitant use of @DRUG$ and @DRUG$.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and @DRUG$, specifically, dacarbazine, @DRUG$, tamoxifen and interferon-alfa.	DDI-false
These results suggest that both @DRUG$ Acetate and retinyl acetate, and possibly other @DRUG$ Prostate epithelium proliferation can be regulated by dose-dependent changes in insulin and EGF activity.	DDI-false
Although there have been no formal interaction studies other than with @DRUG$, based on these in vivo and in vitro studies, it is unlikely that co-administration of a 1 mg dose of @DRUG$ with other drugs will result in clinically significant drug inhibition of cytochrome P450-mediated metabolism of the other drugs.	DDI-false
These drugs include thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, @DRUG$ , oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, @DRUG$ , and isoniazid .	DDI-false
INOmax has been administered with tolazoline, @DRUG$, dobutamine, steroids, @DRUG$, and high-frequency ventilation.	DDI-false
In a similar study with @DRUG$ 1 in 24 subjects treated with vardenafil 20 mg and @DRUG$ 0.4 mg separated by 6 hours experienced a standing systolic blood pressure below 85 mm Hg .	DDI-false
acetaminophen/theophylline, @DRUG$/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
This appears to be the only clinically relevant interaction of this species with @DRUG$ , although theoretically , coadministration of other drugs known to alter cardiac conduction ( eg , anti-arrhythmic or @DRUG$ Also calcium channel blockers, antihistamines or H1-blockers, tricyclic antidepressants and phenothiazines could contribute to an extension of the QTc interval.	DDI-effect
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , @DRUG$ , vincristine , and prednisone ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , @DRUG$ , doxorubicin , teniposide , and prednisone with vincristine plus bleomycin ) without receiving antiretroviral therapy .	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, Dapson, disopyramide, quinine, amiodarone, quinidine, @DRUG$ , tacrolimus, cyclosporin, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$ When co-administered with saquinavir, increased plasma concentrations may occur;	DDI-false
Although no specific studies have been performed, co-administration with medicinal products primarily metabolised by CYP3A4 (e. g. @DRUG$ , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , @DRUG$ When co-administered with saquinavir, carbamazepine, fentanyl, alfentanyl, alprazolam and triazolam may exhibit increased plasma concentrations;	DDI-false
Other concomitant therapy Although specific interaction studies have not been performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ACE ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , @DRUG$ H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also known as NSAIDs) and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
In vitro binding studies with human serum proteins indicate that glipizide binds differently than tolbutamide and does not interact with @DRUG$ or @DRUG$.	DDI-false
@DRUG$: As with some other quinolones, concurrent administration of ciprofloxacin with theophylline may lead to elevated serum concentrations of @DRUG$ and prolongation of its elimination half-life.	DDI-false
Higher concentrations of @DRUG$ (10(-8) - 10(-6) M) or retinyl acetate (3 X 10(-8) - 10(-7) M) enhance the mitogenic activity of @DRUG$.	DDI-effect
Nifedipine: @DRUG$ 20 mg, when co-administered with slow-release nifedipine 30 mg or 60 mg once daily, did not affect the relative bioavailability (AUC) or maximum concentration (Cmax) of @DRUG$, a drug that is metabolized via CYP3A4.	DDI-false
@DRUG$: Increased serum @DRUG$ levels and symptoms of lithium toxicity have been reported in patients receiving concomitant lithium and ACE inhibitor therapy.	DDI-false
In addition, Fondaparinux neither influenced the pharmacodynamics of @DRUG$, acetylsalicylic acid, @DRUG$, and digoxin, nor the pharmacokinetics of digoxin at steady state.	DDI-false
Cholestyramine and colestipol @DRUG$: Absorption of @DRUG$ is impaired in the presence of anionic exchange resins.	DDI-false
@DRUG$: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, @DRUG$, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Amiodarone may suppress certain CYP450 enzymes, including CYP1A2. @DRUG$ , @DRUG$ , and CYP3A4.	DDI-false
Non-selective MAO inhibitors including @DRUG$ , Phenelzinsulfate, and Pargylin HC1: Concurrent use of L-tyrosine and non-selective @DRUG$ - May cause high blood pressure.	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, ritonavir, indinavir, saquinavir, @DRUG$, etc.) is indicated, reduction of the @DRUG$ dose should be considered.	DDI-advise
Severe anticholinergic symptoms (i.e. severe dry mouth, urinary retention and blurred vision) have been reported with increases in serum levels of @DRUG$ when @DRUG$ The therapy is initiated.	DDI-effect
These drugs include the thiazides and other diuretics, corticosteroids, @DRUG$, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and @DRUG$.	DDI-false
Therefore, a starting dose of 25 mg daily should be administered. @DRUG$ Treatment of osteoarthritis should be considered if: @DRUG$ is co-administered with potent inducers of hepatic metabolism .	DDI-false
Therefore , interactions could occur following concomitant administration of @DRUG$ ( e.g. , narcotics , analgesics , antiemetics , @DRUG$ , sedatives).	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering @DRUG$ with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, erythromycin, @DRUG$).	DDI-advise
Central Nervous System Depressants : The concomitant use of DURAGESIC   ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general @DRUG$ , @DRUG$ , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	DDI-false
BACKGROUND : The effects of the combined administration of bombsin and @DRUG$ ( verapamil ) , a calcium channel blocker , on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by @DRUG$ The label index for colorectal cancer (AOM) was examined on male Wistar rats.	DDI-false
Oral Contraceptives: Coadministration of atorvastatin and an oral @DRUG$ increased AUC values for norethindrone and @DRUG$ by approximately 30% and 20%.	DDI-false
Other concomitant therapy Although no specific interaction studies have been conducted, 1 mg or more of fissteride doses have been co-administered in clinical trials with acetaminophen, @DRUG$ , A-blockers, analgesics, angiotensin converting enzyme ( ACE) inhibitors, anticonvulsants, benzodiazepines, beta-blockers, calcium channel blockers, heart nitrates, @DRUG$ H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also known as NSAIDs) and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
In addition to the above interactions, the chronic (2 weeks) oral administration of Cordaron affects the metabolism of @DRUG$ , Dextromethorphan, and @DRUG$.	DDI-false
Other strong inhibitors of CYP3A4 (e.g., itraconazole, clarithromycin, @DRUG$, troleandomycin, ritonavir, @DRUG$) would be expected to behave similarly.	DDI-false
@DRUG$ Other antiarrhythmic drugs, such as quinidine, @DRUG$ ==References====External links==* Official website* Official website	DDI-false
In a similar study with tamsulosin in healthy volunteers, 1 of 24 subjects dosed with @DRUG$ 20 mg and @DRUG$ 0.4 mg separated by 6 hours experienced a standing systolic blood pressure below 85 mm Hg.	DDI-effect
Other concomitant therapy Although specific interaction studies have not been performed, @DRUG$ Doses of 1 mg or more have been associated with acetaminophene, acetylsalicylic acid, A-blockers, analgesics, angiotensin converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta-blockers, calcium channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, @DRUG$ ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
@DRUG$ has a tendency to antagonize the skeletal muscle relaxing effect of tubocurarine and may potentiate the action of @DRUG$.	DDI-effect
Other @DRUG$ (e.g., @DRUG$) may also have this effect.	DDI-false
Some @DRUG$/substances are known to accelerate the metabolism of amiodarone by stimulating the synthesis of @DRUG$ ( enzyme induction ) .	DDI-false
For information on the pharmacokinetics of @DRUG$ and @DRUG$ in combination , see Drug Interactions under CLINICAL PHARMACOLOGY section .	DDI-false
Because Nalfon has not been shown to produce any additional effect beyond that obtained with @DRUG$ alone and because aspirin increases the rate of excretion of Nalfon, the concomitant use of Nalfon and @DRUG$ is not recommended.	DDI-false
@DRUG$: Because atorvastatin does not affect the pharmacokinetics of antipyrine, interactions with other @DRUG$ metabolized via the same cytochrome isozymes are not expected.	DDI-false
While all the selective serotonin reuptake inhibitors (@DRUG$), e.g., @DRUG$, escitalopram, fluoxetine, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
Cardiovasculars: @DRUG$: In patients receiving digoxin therapy, administration of oral @DRUG$ regularly results in an increase in serum digoxin concentration that may reach toxic levels with resultant clinical toxicity.	DDI-false
SINCE THE CONCOMITANT ADMINISTRATION OF THESE TWO DRUGS CAN LEAD TO PHENYTOIN INTOXICATION , PRIOR TO ADMINISTERING @DRUG$ TO A PATIENT @DRUG$ THERAPY , A BASELINE PHENYTOIN SERUM LEVEL SHOULD BE OBTAINED .	DDI-effect
Vitamin A : Because of the relationship of @DRUG$ to vitamin A , patients should be advised against taking vitamin supplements containing @DRUG$ To avoid additive toxic effects	DDI-false
Acetaminophen, @DRUG$, @DRUG$, quinidine, theophylline, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
The concomitant use of BOTOX with aminoglycosides or other substances that impair neuromuscular transmission (e.g. @DRUG$ ) should only be performed with caution as the effect of the @DRUG$ It can be potentiated.	DDI-false
Another oral azole antifungal, @DRUG$, inhibits the metabolism of astemizole, resulting in elevated plasma concentrations of astemizole and its active metabolite @DRUG$ which may prolong QT intervals.	DDI-false
@DRUG$: DURAGESIC  is not recommended for use in patients who have received MAOI within 14 days because severe and unpredictable potentiation by @DRUG$ has been reported with opioid analgesics	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Although no specific drug interactions with topical glaucoma or systemic medications have been identified in clinical studies, there has been an increase in the incidence of adverse drug reactions. @DRUG$ 0,5 % ophthalmic solution, the possibility of an additive or potentiating effect with @DRUG$ ( alcohol , barbiturates , opiates , sedatives , anesthetics ) should be considered .	DDI-advise
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, @DRUG$, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
This appears to be the only clinically relevant interaction of this species with mefloquines, although theoretically, co-administration of other drugs known to alter the heart conduction (e.g., anti-arrhythmic or beta-adrenergic blockers, calcium channel blockers, @DRUG$ or H1-blocking agents , @DRUG$ ) could also contribute to an extension of the QTc interval.	DDI-false
The co-administration of medicinal products which are nephrotoxic (e. g. @DRUG$ , indomethacin), myelotoxic (e.g. cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, @DRUG$ ) effects with PROLEUKIN may increase toxicity in these organ systems .	DDI-false
Cimetidine: @DRUG$ has been reported to produce clinically significant fluctuations in steady-state serum concentrations of various @DRUG$.	DDI-mechanism
Plasma valproate concentration should be monitored if isoniazide and @DRUG$ Dose adjustments will be made at the same time. @DRUG$ should be made .	DDI-false
@DRUG$: Potentiation of warfarin-type (CYP2C9 and CYP3A4 substrate) @DRUG$ response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, @DRUG$, calcium-blocking agents, hydralazine, @DRUG$ and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, @DRUG$, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, @DRUG$, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ Histamine H2 receptor antagonists do not appear to have a significant influence on the bioavailability of @DRUG$.	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, @DRUG$ was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, betablockers, calcium-channel blockers, diuretics, and @DRUG$ (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5 % Ophthalmic Solution , the possibility of an additive or potentiating effect with CNS depressants ( @DRUG$ , barbiturates , opiates , @DRUG$ Anaesthetics) should be considered.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, @DRUG$, nitrates, calcium-blocking agents, @DRUG$, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Cardiovasculars: @DRUG$: In patients receiving digoxin therapy, administration of oral amiodarone regularly results in an increase in serum @DRUG$ concentration that may reach toxic levels with resultant clinical toxicity.	DDI-false
Coingestion of @DRUG$ with theophylline, phenobarbital with acetaminophen, and valproic acid with @DRUG$ at high to toxic concentrations decreases the binding of the target drug.	DDI-false
Co-medications that induce CYP3A4 (e.g., dexamethasone, phenytoin, @DRUG$, rifampin, @DRUG$ or St.	DDI-false
@DRUG$ Renal tubular transport of methotrexate may be inhibited by concomitant administration of ciprofloxacin, potentially leading to increased plasma levels of @DRUG$.	DDI-false
@DRUG$ - is a substrate for both @DRUG$ and CYP3A4 .	DDI-false
These medicines include thiazides and other diuretics, corticosteroids, phe-nothiazines, @DRUG$ , estrogens , oral contraceptives , phenytoin , @DRUG$ , sympathomimetics, calcium channel block drugs, and isoniazid.	DDI-false
The effects of catecholamines such as dopamine or @DRUG$ The value is increased by @DRUG$.	DDI-effect
OTHER CONCOMITANT THERAPY : Although specific interaction studies were not performed , in clinical studies , @DRUG$ was used concomitantly with angiotensin- converting enzyme ( ACE ) inhibitors , @DRUG$ , calcium-channel blockers , diuretics , and nonsteroidal anti-inflammatory drugs ( NSAIDs ) without evidence of clinically significant adverse interactions .	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, @DRUG$, @DRUG$, diuretics, and nonsteroidal anti-inflammatory drugs (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
This appears to be the only clinically relevant interaction of this species with mefloquines, although theoretically, co-administration of other drugs known to alter the heart conduction (e.g., anti-arrhythmic or beta-adrenergic blockers, calcium channel blockers, @DRUG$ or @DRUG$ , tricyclic antidepressants and phenothiazines ) might also contribute to a prolongation of the QTc interval .	DDI-false
Ritonavir (600 mg b.i.d.) co-administered with @DRUG$ 5 mg resulted in a 49-fold increase in @DRUG$ AUC and a 13-fold increase in vardenafil Cmax.	DDI-false
@DRUG$ : @DRUG$ Co-administration of vardenafil 10 mg (800 mg t.i.d.) resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in vardenafil Cmax and a 2-fold increase in the half-life of vardenafil.	DDI-false
Co-administration of @DRUG$ and @DRUG$ The effect of the toxin should only be increased with caution if neuromuscular transmission (e.g. curare-like compounds) is impaired.	DDI-advise
Plasma levels of @DRUG$ It has been reported that the number of oral @DRUG$ ;	DDI-false
Concomitant administration of @DRUG$ and other related compounds (eg, quinine, quinidine and @DRUG$) may produce electrocardiographic abnormalities and increase the risk of convulsions.	DDI-effect
@DRUG$ : @DRUG$   is not recommended for use in patients who have received MAOI within 14 days because severe and unpredictable potentiation by MAO inhibitors has been reported with opioid analgesics	DDI-false
Antihypertensive agents: amiodarone should be used with caution in patients who block -@DRUG$ (e.g. propranolol, @DRUG$ inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a CYP3A4 substrate , and diltiazem , a CYP3A4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and AV block ;	DDI-false
It is assumed that increased interaction between @DRUG$ and high affinity binding sites for apomorphine on dopamine2- and serotonin2-receptors underlies the antipsychotic action of @DRUG$ after their prolonged administration .	DDI-false
Because of the increased risk of adverse reactions in patients who have regularly taken benzodiazepines, it is particularly important that doctors consult patients or their guardians carefully about benzodiazepine, @DRUG$ and @DRUG$ use as part of the history prior to any procedure in which the use of ROMAZICON is planned .	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, @DRUG$, and isoniazid.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, @DRUG$, prostaglandin synthetase inhibitors (also referred to as @DRUG$), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$: Other antiarrhythmic drugs, such as quinidine, procainamide, @DRUG$, and phenytoin, have been used concurrently with amiodarone.	DDI-false
These drugs include the thiazides and other diuretics, @DRUG$, phe-nothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
In addition to the interactions noted above, chronic (  2 weeks) oral Cordarone administration impairs metabolism of phenytoin, @DRUG$, and @DRUG$.	DDI-false
Patients receiving @DRUG$ , @DRUG$ , or sulfonylureas should be observed for increased activity of these drugs and , therefore , signs of toxicity from these drugs .	DDI-false
Co-medications that induce CYP3A4 ( e.g. , dexamethasone , @DRUG$ , @DRUG$ , rifampin, phenobarbital or St.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Delayed Adverse Reactions to @DRUG$: A review of the literature revealed that 12.6% (range 11-28%) of 501 patients treated with various @DRUG$ containing regimens who were subsequently administered radiographic iodinated contrast media experienced acute, atypical adverse reactions.	DDI-false
however , no deleterious interactions were seen when @DRUG$ was administered after @DRUG$ Inhalation anesthetics, muscle relaxants and muscle relaxant antagonists are administered in combination with sedation or anesthesia.	DDI-false
Drugs that cause significant sustained elevation in gastric pH (@DRUG$ such as ranitidine or cimetidine) may reduce plasma concentrations of @DRUG$ and therefore potentially may reduce efficacy.	DDI-mechanism
These drugs include the thiazides and other diuretics , corticosteroids , @DRUG$ , thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, @DRUG$ , calcium channel blocking drugs , and isoniazid .	DDI-false
@DRUG$ In general, diuretics should not be administered as they reduce renal clearance of lithium and a high risk of @DRUG$ toxicity .	DDI-false
In a comparison of @DRUG$ tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with @DRUG$ or Innovar than with pentobarbital.	DDI-false
@DRUG$ @DRUG$ The treatment is inhibited by amphetamines.	DDI-false
Phenylbutazone: @DRUG$ causes increase (by about 80%) in the free fraction of @DRUG$.	DDI-mechanism
@DRUG$ products containing iron or zinc, @DRUG$ The use of norfloxacin or sucralfate should not occur simultaneously with or within 2 hours of administration of norfloxacin as it may impair absorption, resulting in lower serum and urine levels of norfloxacin.	DDI-false
Levosimendan has no clinically important pharmacokinetic interactions with captopril, @DRUG$ , felodipine, digoxin, warfarin, isosorbide mononitrate, schnitztilol, ethanol or @DRUG$.	DDI-false
@DRUG$-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, @DRUG$, cefamandole, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, @DRUG$, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving @DRUG$ therapy.	DDI-false
It is not known if @DRUG$ differ in their effectiveness when used with @DRUG$.	DDI-false
@DRUG$, lidocaine, @DRUG$, quinidine, theophylline, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
Aspirin/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between @DRUG$ and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of @DRUG$ 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
Oral anticoagulant agents: Pharmacokinetic drug-drug interactions between @DRUG$ and @DRUG$ (7.5 mg single oral dose) have not been demonstrated.	DDI-false
Monoamine Oxidase Inhibitors and Tricyclic Antidepressants: FORADIL should be administered with extreme caution in patients being treated with @DRUG$ or tricyclic antidepressants because the action of @DRUG$ on the cardiovascular system may be potentiated by these agents.	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to @DRUG$, including anti-arrhythmic agents such as quinidine and procainamide, cardiac glycosides and @DRUG$.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, @DRUG$, nicardipine, propofol, protease inhibitors, @DRUG$, and verapamil.	DDI-false
Dose adjustment is not recommended.@DRUG$ had no effect on plasma concentrations of carbamazepine, @DRUG$, topiramate, or lamotrigine.	DDI-false
No pharmacokinetic interactions between: @DRUG$ and isoflurane , propofol , alfentanil , and @DRUG$ It's been detected.	DDI-false
@DRUG$-A Study on the Interaction of Eplerenone with @DRUG$ has not been conducted .	DDI-false
Coadministration of Itraconazole and cyclosporine, @DRUG$ or @DRUG$ has led to increased plasma concentrations of the latter three drugs.	DDI-false
ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received @DRUG$ or angiotensin II receptor antagonists (@DRUG$/ARB).	DDI-false
These active substances ( @DRUG$ , @DRUG$ , etc . ) increase the concentration of the ionized species of the amphetamine molecule , thereby increasing urinary excretion .	DDI-false
Therefore, when @DRUG$ and non-steroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the @DRUG$ is obtained.	DDI-false
Compounds that have been tested in man include antipyrine, digoxin, propranolol, @DRUG$, and @DRUG$ and no clinically meaningful interactions were found.	DDI-false
The effects of adenosine are antagonized by methylxanthines such as @DRUG$ and @DRUG$.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an @DRUG$ (aluminum hydroxide, @DRUG$, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, @DRUG$, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ or iodine excess may decrease the effect of @DRUG$ , and an iodine deficiency can increase the effect of Carbimazole .	DDI-effect
High-dose @DRUG$ The concentrations above 2000 ng/ml administered with oral etoposide resulted in an 80% increase in etoposide exposure with a 38% decrease in total body clearance. @DRUG$ compared to etoposide alone .	DDI-false
@DRUG$ , apparently due to an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain @DRUG$ , lidocaine, theophylline and metronidazole, delaying the elimination and increase in blood levels of these drugs.	DDI-mechanism
Non-selective MAO inhibitors including tranylcypromine sulfate , phenelzine sulfate , and pargyline HC1 : Concomitant use of @DRUG$ and non-selective @DRUG$ may cause hypertension .	DDI-effect
Acetaminophen , @DRUG$ , phenobarbital , @DRUG$ , theophylline , and valproic acid were added to pooled human serum at therapeutic concentrations .	DDI-false
The effect of @DRUG$ on the @DRUG$ The need of our patient seemed to be a maximum of 5 to 7 days after the initiation of rifampin and extended a similar time after the withdrawal of rifampin.	DDI-effect
Anticoagulants: Potentiation of warfarin-type (@DRUG$ and @DRUG$ substrate) anticoagulant response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other @DRUG$, @DRUG$, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
@DRUG$: Concomitant administration of low-dose @DRUG$ with VIOXX may result in an increased rate of GI ulceration or other complications, compared to use of VIOXX alone.	DDI-false
In a comparison of @DRUG$ The tolerance in dogs that are stunned with ketamine, @DRUG$ To cause ventricular tachycardia, or pentobarbital, the dosage of Ouabain required to cause ventricular tachycardia was significantly higher, such as the LD50 of Ouabain, with ketamine or innovar than with pentobarbital.	DDI-false
Multivalent Cation-Containing products: Concomitant administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminium antacids, sucralfate, VIDEX chew/buffer tablets or child powder, or products containing calcium, @DRUG$ , or @DRUG$ may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, @DRUG$, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, @DRUG$, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Nephrotoxicity has been reported following concomitant administration of cephalosporins with aminoglycoside antibiotics or potent @DRUG$ such as @DRUG$.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics , @DRUG$ , haloperidol, phenothiazine, @DRUG$ , tricyclic antidepressants or some antihistamines .	DDI-false
CONCLUSIONS/INTERPRETATION : @DRUG$ and @DRUG$ can exert additive vasodilator properties on renal and ocular circulation .	DDI-false
@DRUG$ : Concomitant administration of low-dose @DRUG$ with VIOXX may result in an increased rate of GI ulceration or other complications , compared to use of VIOXX alone .	DDI-false
FLEXERIL may have the effect of @DRUG$ , Barbiturates, and others @DRUG$.	DDI-false
At a median follow-up of 33 months, the combination of @DRUG$ and tamoxifen did not demonstrate any efficacy benefit when compared with @DRUG$ in all patients as well as in the hormone receptor-positive subpopulation.	DDI-false
The hypoglycaemic effect of sulphonylureas can be enhanced by certain medications, including non-steroidal anti-inflammatory drugs and other medicines that are highly protein-bound, @DRUG$ , sulphonamides, chloramphenicol, probenecid, coumarine, monoamine oxidase inhibitors, and @DRUG$.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ increases enterohepatic elimination of @DRUG$ There may be a reduction in serum levels and t1/2.	DDI-false
Potential drug interactions between Keppra  and other AEDs (@DRUG$, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and @DRUG$) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, doxorubicin, teniposide, and prednisone with vincristine plus @DRUG$) without receiving antiretroviral therapy.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a @DRUG$ substrate, and diltiazem, a @DRUG$ inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
@DRUG$ including tranylcypromine sulfate, @DRUG$, and pargyline HC1: Concomitant use of L-tyrosine and non-selective MAO inhibitors may cause hypertension.	DDI-false
Substances that are potent inhibitors of CYP3A4 activity (eg, ketoconazole and @DRUG$) decrease @DRUG$ metabolism and increase gefitinib plasma concentrations.	DDI-mechanism
; Naproxen : Simultaneous use of @DRUG$ In normal subjects, naproxene and naproxene did not affect naproxene plasma levels, but significantly reduced the urinary excretion of naproxene. @DRUG$ And his glucuronide metabolite.	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, Dapson, disopyramide, quinine, amiodarone, quinidine, @DRUG$ , tacrolimus , @DRUG$ When co-administered with saquinavir, increased plasma concentrations may occur when it contains its derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam and triazolam.	DDI-false
@DRUG$ serum levels should be monitored and appropriate dose adjustments considered for patients given both @DRUG$ and PEGASYS.	DDI-false
The hypoglycemic action of @DRUG$ may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, @DRUG$, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-effect
The effect of rifampin on the @DRUG$ requirement of our patient appeared to be maximal 5 to 7 days after the initiation of @DRUG$ and extended a similar length of time after rifampin withdrawal.	DDI-false
These results suggest that both dexamethasone and retinyl acetate, and possibly other @DRUG$ Prostate epithelium proliferation can be regulated by dose-dependent changes in insulin and @DRUG$ activity.	DDI-effect
In clinical studies performed with @DRUG$, the concomitant use of oral @DRUG$ (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen and valproic acid/phenobarbital.	DDI-false
These drugs include the @DRUG$ and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, @DRUG$, and isoniazid.	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , @DRUG$ , tacrolimus, cyclosporin, ergot derivatives, pimozide, @DRUG$ (e. g., fentanyl, alfentanyl, alprazolam and triazolam) may exhibit increased plasma concentrations when co-administered with saquinavir;	DDI-false
Other Drug Interactions : No pharmacokinetic interactions were observed between vardenafil and the following drugs : glyburide , warfarin , @DRUG$ , @DRUG$ , and ranitidine .	DDI-false
The concomitant use of @DRUG$ is not recommended since nitrofurantoin may antagonize the antibacterial effect of @DRUG$ In the urinary tract.	DDI-false
It is recommended to avoid concurrent administration of @DRUG$ Aluminium hydroxide, the antacid for at least 4 hours after @DRUG$ administration .	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or @DRUG$ antagonists (e.g., verapamil, a @DRUG$ substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations : Caution is recommended when administering @DRUG$ with inhibitors of the CYP3A4 family ( e.g. , ketoconazole , @DRUG$ , erythromycin , clarithromycin ) .	DDI-advise
Thus , concomitant therapy with @DRUG$ and @DRUG$ A dose adjustment of the two drugs should not be required.	DDI-false
Lithium: @DRUG$ have produced an elevation of plasma @DRUG$ levels and a reduction in renal lithium clearance.	DDI-mechanism
As with other antipsychotic agents, it should be noted that HALDOL may be capable of potentiating @DRUG$ such as @DRUG$, opiates, and alcohol.	DDI-false
No Important Interactions To Date @DRUG$ does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, warfarin, isosorbide mononitrate, @DRUG$, ethanol or itraconazole.	DDI-false
Potential drug interactions between Keppra  and other AEDs (@DRUG$, gabapentin, lamotrigine, phenobarbital, @DRUG$, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
All subjects received @DRUG$ alone and following treatment with 100 mg of @DRUG$ as a single daily oral dose for seven days.	DDI-false
@DRUG$ : @DRUG$ , ergonovine, ergotamine, methylergonovine CONTRAINDICATED due to the potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasms and ischaemia of extremities and other tissues.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, @DRUG$, doxycycline, erythromycin, imatinib, @DRUG$, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Warfarin: @DRUG$ have been reported to enhance the effects of the oral @DRUG$ warfarin or its derivatives.	DDI-false
The risk of myopathy during treatment with medicines in this class is increased with concomitant administration of cyclosporin, fibric acid derivatives, niacin ( @DRUG$ ), erythromycin, @DRUG$.	DDI-false
Corticosteroids, @DRUG$ and Diuretics: Concomitant treatment with xanthine derivatives, steroids, or diuretics may potentiate a possible hypokalemic effect of  @DRUG$	DDI-false
No significant interactions were found between @DRUG$ and @DRUG$ or digoxin.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, @DRUG$, or zinc may substantially decrease the absorption of @DRUG$, resulting in serum and urine levels considerably lower than desired.	DDI-false
Potassium-sparing diuretics (e.g., spironolactone, triamterene, or @DRUG$), potassium supplements, or @DRUG$-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ Isoniazid is known to slow down your metabolism @DRUG$ Carbamazepine levels should be determined prior to co-administration with isooniazide, signs and symptoms of carbamazepine toxicity should be closely monitored and an appropriate dose adjustment of the anticonvulsant should be made.	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, @DRUG$, @DRUG$ (nicotinic acid), erythromycin, azole antifungals.	DDI-false
While all the selective serotonin reuptake inhibitors (SSRIs), e.g., @DRUG$, @DRUG$, fluoxetine, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
Since Nalfon has not been shown to have any additional effect over the @DRUG$ alone and because aspirin increases the rate of excretion of @DRUG$ Co-administration of nalfone and salicylates is not recommended.	DDI-false
@DRUG$ , @DRUG$ and Diuretics : Concomitant treatment with xanthine derivatives , steroids , or diuretics may potentiate a possible hypokalemic effect of   beta2-agonists .	DDI-false
Antiarrhythmics: Amiodarone, bepridil, @DRUG$, @DRUG$, quinidine CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
The intensity, uniformity and time course of the anticoagulant interference by phenobarbital, secobarbital, @DRUG$ , chloralhydrate and @DRUG$ were systematically investigated in 16 patients receiving coumarin therapy .	DDI-false
- @DRUG$ ( nandrolone [ e.g. , Anabolin ] , oxandrolone [ e.g. , Anavar ] , oxymetholone [ e.g. , @DRUG$ ], stanozolol [ e.g. Winstrol ] or	DDI-false
Moreover, the mechanisms underlying the development of dependence may be similar for @DRUG$ and @DRUG$.	DDI-false
Because @DRUG$ has not been shown to produce any additional effect beyond that obtained with aspirin alone and because aspirin increases the rate of excretion of Nalfon, the concomitant use of @DRUG$ and salicylates is not recommended.	DDI-false
Suppression by @DRUG$ of bombesin-enhanced peritoneal metastasis of intestinal adenocarcinomas induced by @DRUG$ By Wistar rats.	DDI-false
Other Cardiovascular Agents: Enalapril and @DRUG$ IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, hydralazine, @DRUG$ and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Injection : Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system if with @DRUG$ , phenothiazines , @DRUG$ An increased incidence of sedation, hallucinations and irrational behaviour was observed with co-administration of scopolamine with injectable lorazepam.	DDI-false
Drug Interactions : @DRUG$ MAOI could theoretically influence flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol : Flupenthixol and ethanol cause additive CNS depression - Tricyclic antidepressants : @DRUG$ increases the effect of Tricyclic antidepressants	DDI-false
@DRUG$ It has been shown that these are antagonistic beta-lactam antibiotics, including @DRUG$ , based on in vitro studies and time-killing curves with enteric gram-negative bacilli.	DDI-effect
These drugs include thiazides and other @DRUG$ , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , @DRUG$ , calcium channel blocking drugs , and isoniazid .	DDI-false
In addition , @DRUG$ neither influenced the pharmacodynamics of warfarin , acetylsalicylic acid , piroxicam , and @DRUG$ , nor the pharmacokinetics of digoxin at steady state .	DDI-false
Results of studies in multiple sclerosis patients taking TYSABRI  and concomitant interferon beta-1a (AVONEX  30 mcg IM once weekly) or glatiramer acetate were inconclusive with regard to the need for dose adjustment of the @DRUG$ or @DRUG$.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, @DRUG$, barbiturates, MAO inhibitors, and other antidepressants.When @DRUG$ is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
Acetaminophen/@DRUG$, @DRUG$/chinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen and valproic acid/phenobarbital.	DDI-false
Like ibogaine ( 40 mg/kg ) , @DRUG$ 40 mg/kg decreases the intravenous self-administration of morphine and @DRUG$ • oral self-administration of ethanol and nicotine in rats;	DDI-false
For example, inhibitors are azole antimycotics, @DRUG$ , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , @DRUG$ , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .	DDI-false
Rhabdomyolysis has been observed in patients receiving @DRUG$ administered alone ( at recommended dosages ) or concomitantly with @DRUG$ including cyclosporine .	DDI-effect
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), @DRUG$ (acetylsalicylic acid), NSAIDs (piroxicam), and @DRUG$ did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (@DRUG$, cefoperazone, cefotetan, cefamandole, @DRUG$) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Antacids : In a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of @DRUG$ as compared with @DRUG$ administered alone , suggesting that antacids may impair absorption of fosinopril .	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, @DRUG$, nefazodone, nicardipine, @DRUG$, protease inhibitors, quinidine, and verapamil.	DDI-false
If treatment with inhibitors of CYP3A4 activity ( such as ketoconazole , intraconazole , ritonavir , @DRUG$ , saquinavir , erythromycin , etc . ) is indicated , reduction of the @DRUG$ The dose should be considered.	DDI-advise
Other cardiovascular agents: Enalapril and Enalapril IV were co-administered with @DRUG$ , @DRUG$ Nitrates, calcium blockers, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Results of studies in multiple sclerosis patients taking TYSABRI   and concomitant @DRUG$ ( @DRUG$ 30 mcg IM once weekly) or glatiramer acetate were not consistent with the need for dose adjustment of beta interferon or glatiramer acetate.	DDI-false
Multivalent Cation-Containing products: Concomitant administration of quinolone, including ciprofloxacin, with multivalent cation-containing products such as @DRUG$ Antacids or aluminium antacids, sucralfate, VIDEX chewable/buffer tablets or pediatric powder or products containing calcium, iron or @DRUG$ The absorption of ciprofloxacin can be significantly reduced, resulting in significantly lower serum and urine levels than desired.	DDI-false
@DRUG$: The concomitant administration of diflunisal and @DRUG$ in normal volunteers resulted in lowering of the plasma levels of the active sulindac sulfide metabolite by approximately one-third.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$, sympathomimet-ics, calcium channel blocking drugs, and @DRUG$.	DDI-false
Compounds tested in man include warfarin, @DRUG$, phenytoin, diazepam, @DRUG$ and antipyrine.	DDI-false
ACE Inhibitors and Angiotensin II Receptor Antagonists ( Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS , 3020 ( 91 % ) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or @DRUG$ ( @DRUG$/ARB ) .	DDI-false
Tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , @DRUG$ , diazepam , certain tricyclic antidepressants , @DRUG$ , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .	DDI-false
Lithium: @DRUG$ have produced an elevation of plasma lithium levels and a reduction in renal @DRUG$ clearance.	DDI-false
Interaction with @DRUG$, @DRUG$ and theophylline has also been reported to produce adverse clinical effects.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$ is the first @DRUG$ to be approved for clinical use, and has been studied extensively in humans since 1986.	DDI-false
Patients on @DRUG$ treatment should be closely monitored when @DRUG$ is introduced or withdrawn .	DDI-advise
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , @DRUG$ , and @DRUG$ Concomitant use with saquinavir may result in increased plasma concentrations.	DDI-false
Both @DRUG$ and its major metabolite, @DRUG$, are inhibitors of the cytochrome P450 3A4 enzyme system.	DDI-false
Moreover , additional interaction studies with niacin and propranolol have not demonstrated any effect on fluvastatin plasma levels , and administration to a patient population chronically receiving @DRUG$ resulted in no difference in the extent of bioavailability of @DRUG$ relative to control data .	DDI-false
Antimycobacterial Agents: @DRUG$ CONTRAINDICATED since the coadministration of this product with saquinavir in an antiretroviral regimen reduces the plasma concentrations of @DRUG$.	DDI-false
Other cardiovascular agents: Enalapril and Enalapril IV were co-administered with @DRUG$ , methyldopa , @DRUG$ , calcium blockers, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$: Caution should be used if @DRUG$ is administered concomitantly with methotrexate.	DDI-false
Although no studies have been conducted, concomitant administration of @DRUG$ and @DRUG$ may alter the metabolism of phenytoin;	DDI-mechanism
Injection : Lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , @DRUG$ An increased incidence of sedation, hallucinations and irrational behaviour was observed with co-administration of scopolamine with injectable lorazepam.	DDI-false
@DRUG$: In healthy subjects receiving the CYP3A4 inducer, carbamazepine, at 100 mg twice daily for 3 days and 200 mg twice daily for 17 days, systemic exposure (AUC) to @DRUG$ was decreased approximately 72%.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, @DRUG$, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, @DRUG$ (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Ritonavir and indinavir: Upon concomitant administration of 5 mg of @DRUG$ with 600 mg BID @DRUG$, the Cmax and AUC of ritonavir were reduced by approximately 20%.	DDI-mechanism
Cardiovascular diseases : Cardiovascular glycoside disorders : In patients who have @DRUG$ Administration of oral amiodarone regularly leads to an increase in serum levels. @DRUG$ Concentration that can achieve toxic values with resulting clinical toxicity.	DDI-false
Drug Interactions : @DRUG$ Maybe interact with some medications such as monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect @DRUG$ pharmacodynamics - Arecoline - Eproxindine - Ethanol : Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants : Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Co-administration : Concomitant use of Argatroban with antiplatelet agents , @DRUG$ , and other @DRUG$ The risk of bleeding can be increased.	DDI-false
The doctor is recommended to maintain plasma concentrations of @DRUG$ If one of these medications is taken at the same time and to increase the dose @DRUG$ if necessary .	DDI-false
Although there are no study data to evaluate the possibility , @DRUG$ , including sodium nitroprusside and nitroglycerin, may have an additive effect with @DRUG$ on the risk of developing methemoglobinemia .	DDI-effect
Although glucocorticoids have been shown to reduce @DRUG$-induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of @DRUG$ and thus should be avoided . 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN .	DDI-false
Haemodynamic effects of @DRUG$ and @DRUG$ were additive when somatostatin was co-administered but not under basal conditions .	DDI-false
Concomitant use of LEVSIN with other antimuscarinic agents may lead to additive side effects due to cholinergic blockade. @DRUG$ , @DRUG$ , phenothiazine, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.	DDI-false
No pharmacokinetic interactions between: @DRUG$ and @DRUG$ , propofol , alfentanil , and midazolam have been demonstrated .	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
When LEVSIN is co-administered with others @DRUG$ , amantadine , @DRUG$ , phenothiazine, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.	DDI-false
Multivalent Cation-Containing Products : Concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as @DRUG$ or @DRUG$ Antacids, sucralfate, VIDEX chewable tablets or paediatric powders or products containing calcium, iron or zinc may significantly reduce the absorption of ciprofloxacin, resulting in significantly lower serum and urine levels than desired.	DDI-false
@DRUG$-Concomitant intake of cholestyramine and vitamin K may reduce the absorption of @DRUG$.	DDI-false
Although in clinical studies with IOPIDINE 0.5 % ophthalmic solution no specific drug interactions with topical glaucoma or systemic drugs have been identified, there is a possibility of additive or potentiating effects with: @DRUG$ ( @DRUG$ , barbiturates, opiates, sedatives, anaesthetics) should be considered.	DDI-false
Other concomitant therapy Although no specific interaction studies have been conducted, 1 mg or more of fissteride doses have been co-administered in clinical trials with acetaminophen, @DRUG$ , a-blockers , analgesics , angiotensin-converting enzyme ( ACE ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac @DRUG$ , diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also known as NSAIDs), and quinolones anti-infections without evidence of clinically significant adverse interactions.	DDI-false
- Anabolic steroids ( nandrolone [ e.g. , Anabolin ] , oxandrolone [ e.g. , Anavar ] , oxymetholone [ e.g. , Anadrol ] , @DRUG$ [ e.g. , @DRUG$ ] ) or	DDI-false
Although @DRUG$ have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other @DRUG$ may potentiate the hypotension seen with PROLEUKIN.	DDI-false
ACE Inhibitors and @DRUG$ (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (ACEI/@DRUG$).	DDI-false
Intravenous Adenocard (adenosine) has been effectively administered in the presence of other cardioactive drugs, such as @DRUG$, @DRUG$, calcium channel blocking agents, and angiotensin converting enzyme inhibitors, without any change in the adverse reaction profile.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - @DRUG$: Flupenthixol increases the effect of @DRUG$	DDI-false
@DRUG$-Concomitant intake of mineral oil and @DRUG$ may reduce the absorption of vitamin K.	DDI-false
An additive hypotensive effect has been reported with the combination of systemic @DRUG$ and @DRUG$ therapy .	DDI-effect
acetaminophen/@DRUG$ , lidocaine/quinidine , phenobarbital/acetaminophen , phenobarbital/valproic acid , quinidine/lidocaine , theophylline/acetaminophen , and @DRUG$/phenobarbital .	DDI-false
Agents Causing Renin Release: The antihypertensive effect of enalapril and enalapril IV is augmented by @DRUG$ that cause renin release (e.g., @DRUG$).	DDI-false
Concurrent administration of @DRUG$ and antidepressants of the MAO inhibitor class may cause severe orthostatic hypotension.@DRUG$, an inhibitor of microsomal drug metabolism, increased altretamines half-life and toxicity in a rat model.	DDI-false
Antacids : In a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with @DRUG$ administered alone , suggesting that @DRUG$ The absorption of Fosinopril may be impaired.	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of @DRUG$ and thus should be avoided . 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with @DRUG$.	DDI-false
Therefore , agents affecting sympathetic activity ( e.g. , @DRUG$ or @DRUG$ ) should be used with caution .	DDI-false
The data from in vitro studies with benzodiazepines other than alprazolam indicate a possible interaction with the following medicinal products: ergotamine, cyclosporin, @DRUG$ , nicardipine, and @DRUG$.	DDI-false
Antihypertensives : Amiodarone should be used with caution in patients receiving   -receptor blocking agents ( e.g. , propranolol , a CYP3A4 inhibitor ) or @DRUG$ • antagonists (e.g. verapamil, a CYP3A4 substrate and diltiazem, @DRUG$ Inhibitor) because of the potential for bradycardia, sinus arrest and AV block;	DDI-false
The @DRUG$ are a family of anxiolytic and @DRUG$.	DDI-false
@DRUG$ and @DRUG$ use may be rarely associated with ventricular fibrillation when combined with Adenocard .	DDI-false
Although there is no study data to evaluate the possibility of nitric oxide donor compounds, including @DRUG$ and @DRUG$ , may have an additive effect with INOmax on the risk of developing methaemoglobinaemia.	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride, including anti-arrhythmic agents such as quinidine and @DRUG$, @DRUG$ and tricyclic anti-depressants.	DDI-false
Veratrum alkaloids : @DRUG$ inhibit the hypotensive effect of @DRUG$.	DDI-effect
The effects of @DRUG$ - antagonised by methylxanthines such as @DRUG$ and theophylline .	DDI-effect
Plasma levels of @DRUG$ have been reported to increase in the presence of oral @DRUG$;	DDI-false
While @DRUG$ and @DRUG$ have similar affinities for kappa opioid and possibly nicotinic receptors, 18-MC has much lower affinities than ibogaine for NMDA and sigma-2 receptors, sodium channels, and the 5-HT transporter.	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of @DRUG$ - 0.5 % ophthalmic solution, the possibility of additive or potentiating effects with CNS depressants (alcohol, barbiturates, @DRUG$ , sedatives , anesthetics ) should be considered .	DDI-advise
However, if Argatroban is to be initiated after cessation of @DRUG$ therapy, allow sufficient time for heparins effect on the aPTT to decrease prior to initiation of @DRUG$ therapy.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
The availability of potent @DRUG$ (NNRTI)-based regimens for @DRUG$ therapy and concerns regarding protease inhibitor (PI)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection .	DDI-false
Therophylline: A recent study has shown that concomitan administration of isoniazid and @DRUG$ may cause elevated plasma levels of theophylline, and in some instances a slight decrease in the elimination of @DRUG$.	DDI-false
Chlorpromazine: @DRUG$ blocks dopamine and norepinephrine receptors, thus inhibiting the central stimulant effects of amphetamines and can be used to treat @DRUG$ poisoning.	DDI-false
These results suggest that the hepatoxicity of @DRUG$ in alcoholic beverages is enhanced by interaction with its congeners and @DRUG$ ;	DDI-effect
As with other antipsychotics, it should be noted that HALDOL may be able to potentiate CNS depressants such as anesthetics, @DRUG$ , and @DRUG$.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, @DRUG$/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Aspirin/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between @DRUG$ and concomitantly administered @DRUG$ (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, @DRUG$, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, @DRUG$ (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Standard monitoring of @DRUG$-related toxicity should be continued if @DRUG$ and methotrexate are administered concomitantly.	DDI-false
However , in the second study , administration of 12 g @DRUG$ 1 hour before the evening meal and 0.3 mg cerivastatin sodium about 4 hours after the same evening meal led to a decrease in the @DRUG$ AUC of less than 8 % , and a decrease in Cmax of about 30 % when compared to dosing cerivastatin sodium alone .	DDI-false
@DRUG$ ♪ Don't affect the serum ♪ @DRUG$ levels .	DDI-false
@DRUG$ : Amiodarone should be used with caution in patients receiving   -receptor blocking agents ( e.g. , propranolol , a CYP3A4 inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a @DRUG$ substrate , and diltiazem , a CYP3A4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and AV block ;	DDI-false
@DRUG$ Supplements and Potassium Sparing Diuretics : Fosinopril Sodium may weaken potassium loss by @DRUG$.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, @DRUG$, cardiac nitrates, diuretics, H2 antagonists, @DRUG$, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, @DRUG$ chewable/buffered tablets or pediatric powder, or products containing calcium, @DRUG$, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral @DRUG$ (@DRUG$), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
In general , these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride , including anti-arrhythmic agents such as quinidine and @DRUG$ , @DRUG$ and tricyclic anti-depressants .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Theophylline: As with some other @DRUG$, concurrent administration of ciprofloxacin with @DRUG$ may lead to elevated serum concentrations of theophylline and prolongation of its elimination half-life.	DDI-mechanism
Antihypertensives: @DRUG$ should be used with caution in patients receiving  -@DRUG$ blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Particular caution is recommended when administering @DRUG$ CYP3A4 substrates that have a narrow therapeutic window (e.g. @DRUG$ ==References====External links==	DDI-advise
Like @DRUG$ The intravenous self-administration of morphine and cocaine and the oral self-administration of ethanol is reduced ( 40 mg/kg), 18-MC ( 40 mg/kg) and @DRUG$ in rats ;	DDI-false
@DRUG$ SHOULD BE USED WITH CAUTION IN THOSE PATIENTS REVEIVING @DRUG$ AND ITS CONGENERS.	DDI-advise
Multivitamins, or other products containing @DRUG$ or zinc, @DRUG$ or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.	DDI-false
In the presence of these @DRUG$ , larger doses of adenosine may be required or @DRUG$ may not be effective .	DDI-advise
Antihypertensives : Amiodarone should be used with caution in patients receiving   -receptor blocking agents ( e.g. , propranolol , a @DRUG$ inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a @DRUG$ Substrate, and diltiazem, an inhibitor of CYP3A4) due to the potential for bradycardia, sinus arrest, and AV block;	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, @DRUG$, probenecid, @DRUG$, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
Other concomitant therapy Although specific interaction studies have not been performed, 1 mg or more of finasteride doses have been co-administered in clinical trials with acetaminophen, acetylsalicylic acid, A-blockers, analgesics, angiotensin converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta-blockers, calcium channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, @DRUG$ (also referred to as NSAIDs), and @DRUG$ without evidence of clinically significant adverse interactions .	DDI-false
Specific studies have these effects with sevoflurane, isoflurane, propofol, @DRUG$ , and @DRUG$.	DDI-false
Coadministration of @DRUG$ did not affect the pharmacokinetics of @DRUG$.	DDI-false
Specific studies have confirmed these effects with sevoflurane, @DRUG$, propofol, alfentanil, and @DRUG$.	DDI-false
@DRUG$: @DRUG$*, terfenadine* CONTRAINDICATED due to potential for serious and/or life-threatening cardiac arrhythmias.	DDI-false
SINCE THE CONCOMITANT ADMINISTRATION OF THESE TWO DRUGS CAN LEAD TO PHENYTOIN INTOXICATION, PRIOR TO ADMINISTERING @DRUG$ TO A PATIENT ON @DRUG$ THERAPY, A BASELINE PHENYTOIN SERUM LEVEL SHOULD BE OBTAINED.	DDI-effect
Specific studies have confirmed these effects with sevoflurane , @DRUG$ , @DRUG$ , alfentanil , and midazolam .	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and @DRUG$/@DRUG$.	DDI-false
No pharmacokinetic interactions between dexmedetomidine and isoflurane, propofol, @DRUG$, and @DRUG$ have been demonstrated.	DDI-false
Although @DRUG$ have been shown to reduce PROLEUKIN-induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of @DRUG$ Beta-blockers and other antihypertensive agents may increase the hypotension observed with PROLEUKIN.	DDI-false
Azithromycin had no significant impact on the Cmax and AUC of @DRUG$, although it significantly decreased the @DRUG$ tmax by 44% and increased the intracellular exposure to phosphorylated zidovudine by 110%.	DDI-false
There is a significant increase in exposure to imatinib when @DRUG$ is coadministered with @DRUG$ ( CYP3A4 inhibitor ) .	DDI-mechanism
@DRUG$ Including tranylcypromin sulfate, phenelzinsulfate and pargylin HC1: Concomitant use of L-tyrosine and non-selective @DRUG$ may cause hypertension .	DDI-false
Antiarrhythmics: Other @DRUG$ drugs, such as @DRUG$, procainamide, disopyramide, and phenytoin, have been used concurrently with amiodarone.	DDI-false
Fluoxetine and @DRUG$ increased blood @DRUG$ at different times after the glucose overload.	DDI-false
Since Nalfon has not been shown to produce any additional effect over being obtained with aspirin alone and because aspirin increases the rate of excretion of @DRUG$ , the concomitant use of @DRUG$ and salicylates is not recommended .	DDI-false
Ketoconazole (200 mg once daily) produced a 10-fold increase in @DRUG$ AUC and a 4-fold increase in Cmax when co-administered with @DRUG$ (5 mg) in healthy volunteers.	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , disopyramide , @DRUG$ Amiodarone, quinidine, @DRUG$ , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
- Warfarin-@DRUG$ may have the effect of @DRUG$	DDI-effect
Central Nervous System Depressants: The concomitant use of DURAGESIC  (@DRUG$ transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, @DRUG$ (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies ( phenytoin , @DRUG$ , oral contraceptives, @DRUG$ , warfarin , probenecid ) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients .	DDI-false
Examples of inhibitors are azole antimycotics, ciprofloxacin, clarithromycin, @DRUG$ , doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and @DRUG$.	DDI-false
Since higher doses of ketoconazole (400 mg daily) may result in higher increases in Cmax and AUC, a single 2.5 mg dose of @DRUG$ should not be exceeded in a 24-hour period when used in combination with @DRUG$ 400 mg daily.	DDI-advise
Compounds that have been tested in man include @DRUG$, digoxin, propranolol, @DRUG$, and warfarin and no clinically meaningful interactions were found.	DDI-false
The use of acetaminophene with acetaminophene @DRUG$ , phenobarbital with acetaminophen , and @DRUG$ The binding of the target medication is reduced with phenobarbital at high to toxic concentrations.	DDI-false
It may be necessary to adjust the dosage of oral anticoagulants after initiation or discontinuation of @DRUG$. @DRUG$ may prolong prothrombin time .	DDI-false
Garlic Capsules Garlic capsules should not be used while taking @DRUG$ ( @DRUG$ ) as the sole protease inhibitor due to the risk of decreased saquinavir plasma concentrations .	DDI-false
Cardiovasculars: Cardiac glycosides: In patients receiving digoxin therapy, administration of oral @DRUG$ regularly results in an increase in serum @DRUG$ concentration that may reach toxic levels with resultant clinical toxicity.	DDI-false
These drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral @DRUG$ , phenytoin, nicotinic acid, sympathomimetics, @DRUG$ , and isoniazid .	DDI-false
These drugs include thiazides and other @DRUG$ , corticosteroids , phenothiazines , thyroid products , @DRUG$ , oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel block drugs, and isoniazide.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Both efavirenz and @DRUG$ Treatment with PI indinavir was compared with triple therapy for 48 weeks as an initial therapy, with similar response rates as in patients with PI indinavir. @DRUG$ regimens and superiority observed with efavirenz .	DDI-false
Central Nervous System Depressants : The concomitant use of DURAGESIC   ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , @DRUG$ - narcotics (e.g. benzodiazepines), general anaesthetics, phenothiazines, skeletal muscle relaxants, and @DRUG$ , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	DDI-false
@DRUG$ (e.g., @DRUG$, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
@DRUG$ : Amiodarone should be used with caution in patients receiving   -receptor blocking agents ( e.g. , propranolol , a CYP3A4 inhibitor ) or @DRUG$ • antagonists (e.g. verapamil, a CYP3A4 substrate and diltiazem, a CYP3A4 inhibitor) because of the potential for bradycardia, sinus arrest and AV block;	DDI-false
Dosage adjustment of STRATTERA may be necessary when coadministered with CYP2D6 inhibitors , e.g. , @DRUG$ , @DRUG$ , and quinidine .	DDI-false
Substances that are potent inhibitors of CYP3A4 activity (eg, @DRUG$ and @DRUG$) decrease gefitinib metabolism and increase gefitinib plasma concentrations.	DDI-false
Chronic administration of @DRUG$, a known enzyme inducer, may be associated with a decrease in the plasma half-life of @DRUG$.	DDI-mechanism
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: @DRUG$ and Ethanol cause additive CNS depression - @DRUG$: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
@DRUG$ (e.g. spironolactone, triamterene or @DRUG$ ) , potassium supplements , or potassium-containing salt substitutes may lead to significant increases in serum potassium .	DDI-false
There was no significant difference in the pharmacodynamic effect of @DRUG$ administered alone and warfarin administered with @DRUG$ as measured by prothrombin time.	DDI-false
In a comparison of digitalis tolerance in dogs stunned with ketamine, Innovar Vet, or pentobarbital, the dosage of Ouabain was needed to cause ventricular tachycardia significantly higher, such as the LD50 of Ouabain, with @DRUG$ or @DRUG$ than with pentobarbital .	DDI-false
The successive application of glycine (5 or 10 mg/kg egg weight (e.w.) and @DRUG$ (15 mg/kg e.w.) in a 10 min interval significantly increased the activation of spontaneous motility of 17-day-old chick embryos in comparison with the effect of @DRUG$ alone.	DDI-false
Tetracyclines: Concomitant treatment with Accutane and @DRUG$ should be avoided because @DRUG$ use has been associated with a number of cases of pseudotumor cerebri (benign intracranial hypertension), some of which involved concomitant use of tetracyclines	DDI-false
@DRUG$ should be taken as directed and @DRUG$ should be taken with a main meal of the day , preferably the evening meal ..	DDI-false
Interaction between @DRUG$ and @DRUG$ In the development of spontaneous motility in chick embryos.	DDI-effect
Injection: @DRUG$ injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When @DRUG$ is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ : In hypercholesterolemic patients , steady-state @DRUG$ AUC and Cmax increased by approximately 50% and 24% respectively after 10 days of co-administration of erythromycin, a known inhibitor of cytochrome P450 3A4.	DDI-false
The concomitant administration of medicinal products that are nephrotoxic (e.g. aminoglycosides, @DRUG$ ) , myelotoxic ( e.g. , cytotoxic chemotherapy ) , cardiotoxic ( e.g. , doxorubicin ) or hepatotoxic ( e.g. , @DRUG$ , asparaginase ) effects with PROLEUKIN may increase toxicity in these organ systems .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, @DRUG$, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, @DRUG$, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Aspirin/@DRUG$ : Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered @DRUG$ ( 162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1   g/kg/min . over 4 hours ) or acetaminophen ( 1000 mg orally given 12 , 6 and 0 hours prior to , and 6 and 12 hours subsequent to , initiation of Argatroban 1.5   g/kg/min . over 18 hours ) .	DDI-false
High-dose @DRUG$ This resulted in concentrations above 2000 ng/ml administered with oral etoposide and resulted in an 80% increase in oral etoposide concentrations. @DRUG$ Exposure with a 38% decrease in total body clearance of etoposide compared to etoposide alone.	DDI-false
In patients receiving Nalfon and a @DRUG$ concomitantly, any reduction in @DRUG$ dosage should be gradual in order to avoid the possible complications of sudden steroid withdrawal.	DDI-false
The data suggest that @DRUG$ has a narrower spectrum of actions and will have a substantially greater therapeutic index than @DRUG$.	DDI-false
@DRUG$: A report of severe acetaminophen toxicity was reported in a patient receiving @DRUG$.	DDI-false
Mineral Oil-Concomitant intake of mineral oil and @DRUG$ may reduce the absorption of @DRUG$.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): @DRUG$ could theoretically affect @DRUG$ pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-effect
The results of studies in patients with multiple sclerosis receiving TYSABRI and interferon beta-1a (AVONEX 30 mcg IM once weekly) or glatiramer acetate were not consistent with the need for dose adjustment. @DRUG$ or @DRUG$.	DDI-false
To evaluate the effect of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL), the authors retrospectively compared a group of 24 patients with HIV-NHL treated with cyclophosphamide, @DRUG$ , vincristine , and prednisone ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , doxorubicin , @DRUG$ , and prednisone with vincristine plus bleomycin ) without receiving antiretroviral therapy .	DDI-false
DIGOXIN: Plasma @DRUG$ levels and @DRUG$ clearance at steady-state were not affected by co-administration of 0.2 mg cerivastatin sodium.	DDI-false
Potassium-sparing diuretics (e.g. spironolactone, @DRUG$ Potassium supplements or salt substitutes containing @DRUG$ may lead to significant increases in serum potassium.	DDI-false
Dexamethasone and @DRUG$ similarly inhibit and stimulate EGF- or @DRUG$-induced proliferation of prostatic epithelium.	DDI-effect
The blood pressure effect of SULAR tended to be greater in patients on @DRUG$ As in patients on no other @DRUG$ therapy .	DDI-false
@DRUG$ The administration of diflunisal to normal volunteers, the @DRUG$ decreased the renal clearance and significantly increased the plasma levels of indomethacin .	DDI-false
Therefore you may need to take a @DRUG$ supplement while taking @DRUG$.	DDI-advise
ACE Inhibitors and @DRUG$ (Hypertension)- In clinical studies of patients with hypertension, the addition of INSPRA 50 to 100 mg to @DRUG$ and angiotensin II receptor antagonists increased mean serum potassium slightly (about 0.09-0.13 mEq/L).	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, @DRUG$ (e.g., @DRUG$), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
@DRUG$ : In normal volunteers , concomitant administration of @DRUG$ Acetaminophene and acetaminophene resulted in an approximate 50% increase in acetaminophene plasma levels.	DDI-false
Drug-Drug Interactions Between @DRUG$   And Other @DRUG$ Phenytoin Keppra ( 3000 mg daily ) did not affect the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy.	DDI-false
Since the concomitant administration of @DRUG$ with @DRUG$ increases the prothrombin time by 100% after 3 to 4 days, the dose of the anticoagulant should be reduced by one-third to one-half, and prothrombin times should be monitored closely.	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , @DRUG$ (i) increased plasma concentrations (e. g., disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporin, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may be associated with increased plasma concentrations with: @DRUG$ ;	DDI-mechanism
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - @DRUG$: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: @DRUG$ increases the effect of Tricyclic antidepressants	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Benzthiazide may interact with alcohol , blood thinners , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , @DRUG$ , norepinephrine , @DRUG$ like Aleve or Ibuprofen , and high blood pressure medications .	DDI-false
@DRUG$ ( e.g. , spironolactone , triamterene , or amiloride ) , @DRUG$ supplements , or potassium-containing salt substitutes may lead to significant increases in serum potassium .	DDI-false
These drugs include thiazides and other diuretics, corticosteroids, @DRUG$ , thyroid products, estrogens, oral contraceptives, @DRUG$ , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, @DRUG$, @DRUG$ and digoxin without evidence of clinically significant adverse interactions.	DDI-false
A drug-drug interaction study evaluated the effect of the use of @DRUG$ Gel, 5%, in combination with double strength (160 mg/800 mg) trimethoprim/sulfamethoxazole (TMP/@DRUG$).	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
In vitro binding studies with human serum proteins indicate that @DRUG$ binds differently than tolbutamide and does not interact with @DRUG$ or dicumarol.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of @DRUG$	DDI-false
Corticosteroids , @DRUG$ And diuretics: concomitant treatment with xanthine derivatives, steroids, or @DRUG$ A potential hypokalemic effect of beta2-agonists may be increased.	DDI-false
@DRUG$-Broad-spectrum antibiotics may sterilize the bowel and decrease the @DRUG$ contribution to the body by the intestinal microflora.	DDI-false
( @DRUG$ may increase the responsiveness to @DRUG$. )	DDI-effect
These drugs include thiazides and other diuretics, @DRUG$ , phenothiazines, thyroid products, estrogens, orally @DRUG$ , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .	DDI-false
This interaction should be given consideration in patients taking @DRUG$ concomitantly with @DRUG$.	DDI-advise
Tagamet, apparently due to an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, @DRUG$ , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , @DRUG$ And metronidazole, which delays the elimination and increase in blood levels of these drugs.	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Results of studies in multiple sclerosis patients taking TYSABRI  and concomitant @DRUG$ (@DRUG$  30 mcg IM once weekly) or glatiramer acetate were inconclusive with regard to the need for dose adjustment of the beta-interferon or glatiramer acetate.	DDI-false
@DRUG$ inhibits @DRUG$.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., @DRUG$, a @DRUG$ inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Alcohol : @DRUG$ 0,5 g/kg body weight: approx. 40 ml absolute alcohol content at 70 kg persons) and @DRUG$ Plasma levels were not altered when co-administered.	DDI-false
Skeletal muscle relaxants, nondepolarizing (e.g., @DRUG$): possible increased responsiveness to the @DRUG$.	DDI-false
Close supervision and careful adjustment of the dosage are required when nortriptyline hydrochloride is used with other @DRUG$ or @DRUG$.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a @DRUG$, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, @DRUG$ chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
Short-term pharmacokinetic studies have demonstrated that concomitant administration of warfarin and @DRUG$  (etodolac capsules and tablets) results in reduced protein binding of @DRUG$, but there was no change in the clearance of free warfarin.	DDI-false
Levosimendan has no clinically important pharmacokinetic interactions with captopril, beta-blockers, @DRUG$ , digoxin, warfarin, @DRUG$ ==References====External links==	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, @DRUG$, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or @DRUG$ may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , doxorubicin , vincristine , and prednisone ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , doxorubicin , @DRUG$ And prednisone with vincristine plus @DRUG$ ) without receiving antiretroviral therapy .	DDI-false
Acetaminophen : In normal volunteers, concomitant use of diflunisal and @DRUG$ resulted in an approximate 50 % increase in plasma levels of @DRUG$.	DDI-false
Blood glucose concentrations should be carefully monitored when @DRUG$ and oral @DRUG$ are coadministered.	DDI-advise
@DRUG$ 150 mg twice daily did not interact significantly with @DRUG$ The AUC was reduced by 15 - 20 %.	DDI-false
Micro-dosed Progesterone Preparations: Micro-dosed progesterone preparations (minipills that do not contain an @DRUG$) may be an inadequate method of contraception during @DRUG$ therapy.	DDI-false
Benzthiazide may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, @DRUG$, norepinephrine, NSAIDs like @DRUG$ or Ibuprofen, and high blood pressure medications.	DDI-false
@DRUG$ may interact with alcohol , blood thinners , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , NSAIDs like @DRUG$ Or ibuprofen, and high blood pressure medications.	DDI-int
In a pharmacokinetic interaction study with @DRUG$, bioavailability parameters, the degree of protein binding, and the anticoagulant effect (measured by prothrombin time) of @DRUG$ were not significantly changed.	DDI-false
Antacids : In a clinical pharmacology study, concomitant administration of antacids (aluminium hydroxide, magnesium hydroxide and simethicone) with @DRUG$ - Decreased serum levels and urinary excretion of fosinoprilat compared to @DRUG$ Administration alone, suggesting that antacids may affect the absorption of fosinopril.	DDI-false
Other reported interactions with amiodarone : Fentanyl ( @DRUG$ Substrate) in combination with @DRUG$ may cause hypotension , bradycardia , and decreased cardiac output .	DDI-false
Concomitant cyclophosphamide, @DRUG$, vincristine, and prednisone chemotherapy plus @DRUG$ therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
Other medicines: medicines such as quinidine, disopyramide, @DRUG$ , @DRUG$ , antihistamines , and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia .	DDI-false
In a comparison of @DRUG$ The tolerance in dogs stunned with ketamine, Innovar Vet or pentobarbital was significantly higher than the LD50 of ouabain, which was necessary to cause ventricular tachycardia. @DRUG$ , with ketamine or Innovar than with pentobarbital .	DDI-false
Co-medications that induce CYP3A4 (e.g., @DRUG$, @DRUG$, carbamazepine, rifampin, phenobarbital or St.	DDI-false
@DRUG$/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
OTHER CONCOMITANT THERAPY : Although specific interaction studies were not performed , in clinical studies , cerivastatin sodium was used concomitantly with angiotensin- converting enzyme ( ACE ) inhibitors , @DRUG$ - Calcium channel blockers, @DRUG$ , and nonsteroidal anti-inflammatory drugs ( NSAIDs ) without evidence of clinically significant adverse interactions .	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, @DRUG$, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some @DRUG$.	DDI-false
The concomitant administration of medicinal products that are nephrotoxic (e.g. aminoglycosides, @DRUG$ Myelotoxic (e.g. cytotoxic chemotherapy), cardiotoxic (e.g. doxorubicin) or hepatotoxic (e.g. methotrexate, asparaginase) effects with: @DRUG$ The toxicity in these organ systems can be increased.	DDI-effect
Drugs that may alter imatinib plasma concentrations Drugs that may increase @DRUG$ plasma concentrations : Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family ( e.g. , ketoconazole , itraconazole , erythromycin , @DRUG$ ) .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, @DRUG$, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as @DRUG$), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Administration of @DRUG$ concomitantly with oral amiodarone has been shown to result in decreases in serum concentrations of @DRUG$ and desethylamiodarone.	DDI-false
@DRUG$: @DRUG$ enhances the effect of warfarin.	DDI-effect
To assess the effect of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL), the authors retrospectively compared a group of 24 patients with HIV-NHL treated with cyclophosphamide, doxorubicin, vincristine, and @DRUG$ ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , doxorubicin , @DRUG$ , and prednisone with vincristine plus bleomycin ) without receiving antiretroviral therapy .	DDI-false
acetaminophen/theophylline , lidocaine/@DRUG$ , phenobarbital/acetaminophen , phenobarbital/valproic acid , quinidine/@DRUG$ , theophylline/acetaminophen , and valproic acid/phenobarbital .	DDI-false
@DRUG$ ( e.g. , @DRUG$ Potassium supplements or salt substitutes containing potassium may lead to significant increases in serum potassium.	DDI-false
Notably, systemic exposure (AUC0-12) of @DRUG$ (DHA) was more than doubled in the presence of TMP/@DRUG$.	DDI-false
A potential interaction between oral @DRUG$ and oral @DRUG$ leading to severe hypoglycemia has been reported.	DDI-int
Although @DRUG$ have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 @DRUG$ and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-false
- @DRUG$ (e.g., @DRUG$) or	DDI-false
@DRUG$/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, @DRUG$, isosorbide mononitrate, @DRUG$, ethanol or itraconazole.	DDI-false
@DRUG$ Vardenafil ( 10 mg and 20 mg ) has increased bleeding time by @DRUG$ Two 81 mg tablets).	DDI-false
Concomitant cyclophosphamide, doxorubicin, @DRUG$, and @DRUG$ chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
Other interactions: @DRUG$ had no effect on the pharmacodynamics of @DRUG$ (glucose and insulin concentrations) and warfarin (prothrombin time or other pharmacodynamic parameters).	DDI-false
@DRUG$: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other @DRUG$, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Corticosteroids , @DRUG$ and Diuretics : Concomitant treatment with xanthine derivatives , @DRUG$ , or diuretics may potentiate a possible hypokalemic effect of   beta2-agonists .	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and @DRUG$ cause additive CNS depression - @DRUG$: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Drugs Interactions : Flupentixol may interact with some medicines, such as monoamine oxidase inhibitors (MAOI): MAOI may theoretically affect @DRUG$ pharmacodynamics - @DRUG$ Eproxindine - ethanol : flupenthixol and ethanol cause additive CNS depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants	DDI-false
Patients receiving high doses of salicylates concomitantly with @DRUG$, as in rheumatic disease, may experience @DRUG$ toxicity at lower doses because of competitive renal excretory sites.	DDI-false
Acetaminophen/theophylline, @DRUG$/chinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen and valproic acid/phenobarbital.	DDI-false
Specific studies have confirmed these effects with sevoflurane, isoflurane, @DRUG$, @DRUG$, and midazolam.	DDI-false
INOmax has been co-administered with tolazolen, @DRUG$ , @DRUG$ , steroids , surfactant , and high-frequency ventilation .	DDI-false
These data indicate that @DRUG$ does not influence the plasma concentration of other @DRUG$ and that these AEDs do not influence the pharmacokinetics of levetiracetam.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen and valproic acid/phenobarbital.	DDI-false
Both efavirenz and nevirapine have been compared to triple therapy with the PI @DRUG$ over 48 weeks as initial therapy, with similar responses being observed with nevirapine regimens and superiority observed with @DRUG$.	DDI-false
In some patients, the combined use of @DRUG$ and @DRUG$ It was associated with fatal gastrointestinal bleeding.	DDI-effect
The risk of myopathy during treatment with medicines in this class is increased with concomitant administration of cyclosporin, fibric acid derivatives, @DRUG$ ( @DRUG$ ) , erythromycin , azole antifungals .	DDI-false
Drug-Drug Interactions Between @DRUG$  And Other Antiepileptic Drugs (AEDs) Phenytoin @DRUG$  (3000 mg daily) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy.	DDI-false
Ritonavir (600 mg b.i.d.) co-administered with @DRUG$ 5 mg resulted in a 49-fold increase in vardenafil AUC and a 13-fold increase in @DRUG$ Cmax.	DDI-false
@DRUG$, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, @DRUG$, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-mechanism
It is recommended to avoid concurrent administration of ethambutol with @DRUG$ containing antacids for at least 4 hours following @DRUG$ administration.	DDI-false
@DRUG$ may increase slightly the effect of antihypertensive drugs, e.g., guanethidine, @DRUG$, reserpine.	DDI-effect
Since amiodarone is a substrate for CYP3A4, there is the potential that the use of St. John s Wort in patients receiving @DRUG$ could result in reduced @DRUG$ levels.	DDI-false
To assess the effect of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL), the authors retrospectively compared a group of 24 patients with HIV-NHL treated with cyclophosphamide, doxorubicin, @DRUG$ , and prednisone ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , @DRUG$ , teniposide, and prednisone with vincristine plus bleomycin) without antiretroviral therapy.	DDI-false
Monitoring for @DRUG$ toxicity and serial measurement of amiodarone serum concentration during concomitant @DRUG$ therapy should be considered.	DDI-false
Naproxen : The concomitant administration of diflunisal and @DRUG$ in normal volunteers had no effect on the plasma levels of naproxen , but significantly decreased the urinary excretion of @DRUG$ And his glucuronide metabolite.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed , @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ACE ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , H2 antagonists , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and @DRUG$ Without evidence of clinically significant adverse interactions.	DDI-false
Example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , @DRUG$ , nicardipine , @DRUG$ , protease inhibitors, quinidine, and verapamil.	DDI-false
@DRUG$: Concomitant administration of fluconazole at 200 mg QD resulted in a two-fold increase in @DRUG$ plasma concentration.	DDI-false
"Ergot derivatives: dihydroergotamine, ergovine, @DRUG$ , @DRUG$ CONTRAINDICATE because of the potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasms and ischaemia of extremities and other tissues.	DDI-false
Drugs that cause significant sustained elevation in gastric pH (histamine H2-receptor antagonists such as @DRUG$ or @DRUG$) may reduce plasma concentrations of IRESSA and therefore potentially may reduce efficacy.	DDI-false
Other concomitant therapy Although specific interaction studies have not been performed, 1 mg or more of finasteride doses have been co-administered in clinical trials with acetaminophen, acetylsalicylic acid, A-blockers, analgesics, angiotensin converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta-blockers, @DRUG$ , cardiac nitrates , @DRUG$ , H2 antagonists , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
@DRUG$: In a single-dose interaction study in NIDDM subjects, decreases in @DRUG$ AUC and Cmax were observed, but were highly variable.	DDI-false
acetaminophen/@DRUG$, lidocaine/quinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$/theophylline , lidocaine/quinidine , phenobarbital/acetaminophen , phenobarbital/valproic acid , quinidine/lidocaine , @DRUG$/acetaminophen , and valproic acid/phenobarbital .	DDI-false
These drugs include the thiazides and other diuretics, @DRUG$, phenothiazines, @DRUG$, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
For example, inhibitors are azole antimycotics, ciprofloxacin, @DRUG$ , diclofenac, doxycycline, erythromycin, @DRUG$ , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .	DDI-false
A single dose of @DRUG$ 3 mg did not affect the pharmacokinetics of @DRUG$ After a dose of 0.5 mg twice daily for one day and 0.25 mg daily for the next 6 days, measured at steady state.	DDI-false
Antacids : In a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium hydroxide , and @DRUG$ In combination with fosinopril, reduced serum levels and urinary excretion of fosinoprilat are administered alone, suggesting that antacids may affect the absorption of @DRUG$.	DDI-false
Acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen and valproic acid/phenobarbital.	DDI-false
Co-administration: Concomitant use of Argatroban with @DRUG$, @DRUG$, and other anticoagulants may increase the risk of bleeding.	DDI-false
Corticosteroids, Methylxanthines and @DRUG$: Concomitant treatment with xanthine derivatives, steroids, or @DRUG$ may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
@DRUG$-Cephalosporins containing side chains of N-methylthiotetrazole ( cefmenoxime , @DRUG$ Cefotetan, cefamandol, latamoxef) or methylthiadiazole (cefazolin) may cause vitamin K deficiency and hypoprothrombinaemia.	DDI-false
Central Nervous System Depressants : The concomitant use of DURAGESIC   ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , @DRUG$ ( e.g. , benzodiazepines ) , general anesthetics , @DRUG$ , skeletal muscle relaxants, and alcohol, may result in respiratory depression, hypotension, and deep sedation, or possibly in coma or death.	DDI-false
Aminosalicylic acid may decrease the amount of @DRUG$ ( @DRUG$ , Lanoxicaps ) that gets absorbed into your body .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, @DRUG$, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, @DRUG$, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ (increases bioavailability by 50%), @DRUG$, and valproates.	DDI-false
* Blood sampling for the pharmacokinetics of @DRUG$ and @DRUG$ ==References====External links==* Official website* Official website* Official website	DDI-false
When @DRUG$ was coadministered with @DRUG$ , rifampin , or H2antagonists , reduced plasma concentrations of itraconazole were reported .	DDI-mechanism
@DRUG$: Amiodarone, bepridil, flecainide, propafenone, @DRUG$ CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
The results increase the possibility that the ethanocyte reaction can occur in the stomach of people who consume @DRUG$ and @DRUG$ Regularly.	DDI-mechanism
The intensity , uniformity and time course of anticoagulant interference by @DRUG$ , @DRUG$ In 16 patients receiving coumarin therapy, glutethimide, chloral hydrate and methaqualone were systematically studied.	DDI-false
Concomitant administration of Mefloquine and other related compounds (eg, @DRUG$, @DRUG$ and chloroquine) may produce electrocardiographic abnormalities and increase the risk of convulsions.	DDI-false
Although the specific drug interaction was not studied in a clinical trial , there have been more than 50 episodes of concomitant use of antifibrinolytic therapies ( i.e. , tranexamic acid , @DRUG$ ) and @DRUG$.	DDI-false
Probenecid: @DRUG$ interferes with renal tubular secretion of ciprofloxacin and produces an increase in the level of @DRUG$ in serum.	DDI-mechanism
Other Drug Interactions Oral Contraceptives Keppra   ( 500 mg twice daily ) did not influence the pharmacokinetics of an oral @DRUG$ containing 0.03 mg @DRUG$ The decisive factor for impairment of the efficacy of contraception is impairment of levonorgestrel and 0.15 mg levonorgestrel or luteinisation hormone and progesterone levels.	DDI-false
A drug-drug interaction study evaluated the effect of the use of ACZONE Gel, 5%, in combination with double strength (160 mg/800 mg) trimethoprim/@DRUG$ (@DRUG$/SMX).	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, @DRUG$, hypnotics, @DRUG$ (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Cimetidine ( 400 mg b.i.d . ) had no effect on @DRUG$ bioavailability ( AUC ) and maximum concentration ( Cmax ) of @DRUG$ when co-administered with 20 mg Vardenafil in healthy volunteers .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ACE ) inhibitors , anticonvulsants , @DRUG$ , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , H2 antagonists , HMG-CoA reductase inhibitors , @DRUG$ ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, @DRUG$, @DRUG$, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Other CONCOMITANT THERAPY: Although no specific interaction studies have been conducted, cerivastatin sodium was co-administered with @DRUG$ , betablockers , @DRUG$ , diuretics , and nonsteroidal anti-inflammatory drugs ( NSAIDs ) without evidence of clinically significant adverse interactions .	DDI-false
@DRUG$: In normal volunteers, concomitant administration of diflunisal and acetaminophen resulted in an approximate 50% increase in plasma levels of @DRUG$.	DDI-false
A drug-drug interaction study evaluated the effect of the use of ACZONE Gel , 5 % , in combination with double strength ( 160 mg/800 mg ) trimethoprim/@DRUG$ ( @DRUG$/SMX ) .	DDI-false
Other concomitant therapy Although specific interaction studies have not been performed, @DRUG$ Doses of 1 mg or more have been associated with acetaminophene, acetylsalicylic acid, A-blockers, analgesics, @DRUG$ , anticonvulsants, benzodiazepines, beta-blockers, calcium channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also known as NSAIDs), and quinolone anti-infections without evidence of clinically significant adverse interactions.	DDI-false
Central Nervous System Depressants : The concomitant use of DURAGESIC   ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , @DRUG$ (e.g. benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and @DRUG$ , respiratory depression, hypotension, and deep sedation, or possibly lead to coma or death.	DDI-false
In patients with chronic hepatitis C treated with PEGASYS in combination with @DRUG$, @DRUG$ treatment did not affect ribavirin distribution or clearance.	DDI-false
Moreover , additional interaction studies with niacin and @DRUG$ have not demonstrated any effect on fluvastatin plasma levels , and administration to a patient population chronically receiving @DRUG$ resulted in no difference in the extent of bioavailability of digoxin relative to control data .	DDI-false
Warfarin: The effect of celecoxib on the anti-coagulant effect of @DRUG$ was studied in a group of healthy subjects receiving daily doses of 2-5 mg of @DRUG$.	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, @DRUG$, primidone and @DRUG$) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
A crossover study in healthy subjects that either @DRUG$ 300 mg q.i.d. or 800 mg h.s. with a dose of 300 mg b.i.d. @DRUG$ Theo major, Key Pharmaceuticals, Inc., showed a lower change in steady-state theophylline peak serum levels with the 800 mg hs regimen, especially in subjects aged 54 years and older.	DDI-mechanism
Fenfluramine may have the effect of @DRUG$ , e.g. , guanethidine , methyldopa , @DRUG$.	DDI-false
The coadministration of @DRUG$ decreases the biologic half-life of fenoprofen because of an increase in metabolic clearance that results in a greater amount of @DRUG$ in the urine.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, @DRUG$, propranolol, nifedipine, chlordiazepoxide, diazepam, certain @DRUG$, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
No Important Interactions To Date @DRUG$ does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, @DRUG$, isosorbide mononitrate, carvedilol, ethanol or itraconazole.	DDI-false
Cyclosporine, Digoxin, Methotrexate Lodine, like other NSAIDs, through effects on renal prostaglandins, may cause changes in the elimination of these drugs leading to elevated serum levels of @DRUG$, @DRUG$, methotrexate, and increased toxicity.	DDI-false
It is recommended to avoid concurrent administration of @DRUG$ with aluminum hydroxide containing @DRUG$ for at least 4 hours following ethambutol administration.	DDI-false
@DRUG$ diminished binding of @DRUG$ by a net change of 9.9% (percentage increase in FDF, 21.2%) at 1732 micromol/L.	DDI-mechanism
The hypoglycaemic effect of sulphonylureas can be enhanced by certain medications, including nonsteroidal anti-inflammatory drugs and other medicines that are highly protein bound, salicylates, sulphonamides, chloramphenicol, probenecid, coumarine, @DRUG$ , and @DRUG$.	DDI-false
Aspirin/@DRUG$: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of @DRUG$ 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
@DRUG$ (NSAIDs)-A drug interaction study of @DRUG$ with an NSAID has not been conducted .	DDI-false
Administration of @DRUG$ concomitantly with oral @DRUG$ The serum concentrations of amiodarone and desethylamiodaron have been shown to decrease.	DDI-false
Caution should be exercised if an HMG-CoA reductase inhibitor is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones , such as ketoconazole , @DRUG$ , and @DRUG$.	DDI-false
ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (@DRUG$/@DRUG$).	DDI-false
Digoxin: In controlled studies in healthy volunteers, @DRUG$ either had no effect (one study) or was associated with modest increases, about 30% (two studies) in steady-state serum @DRUG$ concentrations.	DDI-mechanism
Potential drug interactions between Keppra  and other @DRUG$ (@DRUG$, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Warfarin : Eszopiclone 3 mg administered daily for 5 days had no effect on the pharmacokinetics of@DRUG-DRUG$ nor were there any changes in the pharmacodynamic profile (prothrombin time) after a single oral dose of 25 mg warfarin	DDI-false
Pre-treatment of megakaryocytes with extracellular @DRUG$ ( 50 microM ) also inhibited @DRUG$-induced responses .	DDI-effect
However, the concomitant use of @DRUG$ and @DRUG$ The oral starting dose of 5 - 7.5 mg, followed by 2.5 - 6 mg/day orally for 6 - 10 days, leads to an increase in prothrombin time ( PT ) and International Normalised Ratio ( INR ).	DDI-effect
Concurrent administration of HEXALEN and @DRUG$ may cause severe orthostatic hypotension . Cimetidine , an inhibitor of microsomal drug metabolism , increased @DRUG$s half-life and toxicity in a rat model .	DDI-false
Since @DRUG$ is a substrate for CYP3A4, there is the potential that the use of St. John s Wort in patients receiving amiodarone could result in reduced @DRUG$ levels.	DDI-false
@DRUG$: Probenecid interferes with renal tubular secretion of ciprofloxacin and produces an increase in the level of @DRUG$ in serum.	DDI-false
The application of local anaesthetic solutions that @DRUG$ - Nonepinephrine in patients who: @DRUG$ or tricyclic antidepressants may produce severe , prolonged hypertension .	DDI-effect
Clinical studies with @DRUG$ have identified potentially significant interactions with @DRUG$ and lithium.	DDI-int
Moreover, additional interaction studies with niacin and propranolol have not demonstrated any effect on @DRUG$ plasma levels, and administration to a patient population chronically receiving digoxin resulted in no difference in the extent of bioavailability of @DRUG$ relative to control data.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - @DRUG$: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of @DRUG$	DDI-false
@DRUG$: Patients on diuretics, especially those with intravascular volume depletion, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with @DRUG$.	DDI-false
Corticosteroids , Methylxanthines and Diuretics : Concomitant treatment with xanthine derivatives , @DRUG$ , or @DRUG$ may potentiate a possible hypokalemic effect of   beta2-agonists .	DDI-false
@DRUG$: Amiodarone, @DRUG$, flecainide, propafenone, quinidine CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
There have been reports of QTc prolongation, with or without TdP, in patients who: @DRUG$ when @DRUG$ Macrolide antibiotics, or azoles, have been co-administered.	DDI-false
Other Cardiovascular Agents : Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents , methyldopa , @DRUG$ , @DRUG$ , hydralazine , prazosin and digoxin without evidence of clinically significant adverse interactions .	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, @DRUG$, ritonavir, indinavir, saquinavir, @DRUG$, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
Treatment with CYP3A4 inhibitors (such as ketoconazole, @DRUG$ , ritonavir , indinavir , saquinavir , @DRUG$ , etc . ) is indicated , reduction of the budesonide dose should be considered .	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral @DRUG$ (warfarin), @DRUG$ (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including @DRUG$, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of @DRUG$, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
In general, these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride, including @DRUG$ such as @DRUG$ and procainamide, cardiac glycosides and tricyclic anti-depressants.	DDI-false
- @DRUG$ (Nandrolone [e.g. Anaboline], Oxandrolone [e.g. Anavar], Oxymetholone [e.g. Anadrol], @DRUG$ (e.g. Winstrol ]) or	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral @DRUG$, @DRUG$, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Because of the increased risk of adverse reactions in patients who have been taking @DRUG$ on a regular basis, it is particularly important that physicians query patients or their guardians carefully about benzodiazepine, alcohol and @DRUG$ use as part of the history prior to any procedure in which the use of ROMAZICON is planned.	DDI-false
Pediatric Use The safety and effectiveness of @DRUG$, alone or in combination with @DRUG$ in patients below the age of 18 years have not been established.	DDI-false
@DRUG$ The extension of the QT interval observed with @DRUG$ could be exaggerated by tricyclic antidepressants.	DDI-effect
Acetaminophen/theophylline, lidocaine/chinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen and @DRUG$/phenobarbital.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (@DRUG$ transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, @DRUG$, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
It has been reported that @DRUG$ enhances the anticoagulant effect of @DRUG$-like drugs.	DDI-effect
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, @DRUG$, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as @DRUG$), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ ( Neostgmin, Physostigmin), @DRUG$ , quinine , procainamide can enhance toxicity and cause cardio respiratory depression .	DDI-false
@DRUG$ : Etodolac has no apparent pharmacokinetic interaction when administered with @DRUG$.	DDI-false
These drugs include the @DRUG$ and other diuretics, @DRUG$, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, dapsones, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporin, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$ , and triazolam ) may have elevated plasma concentrations when coadministered with @DRUG$ ;	DDI-mechanism
Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: @DRUG$, @DRUG$, amiodarone, nicardipine, and nifedipine.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with @DRUG$ reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that @DRUG$ may impair absorption of fosinopril.	DDI-false
@DRUG$ is a neutralizing agent for @DRUG$ that protects against renal damage.	DDI-effect
Other Cardiovascular Agents: Enalapril and @DRUG$ IV have been used concomitantly with @DRUG$, methyldopa, nitrates, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Potential drug interactions between Keppra   and other AEDs ( @DRUG$ , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of @DRUG$ and these AEDs during placebo-controlled clinical studies .	DDI-false
For example, inhibitors are azole antimycotics, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, @DRUG$ , protease inhibitors , @DRUG$ ==References====External links==	DDI-false
Among the @DRUG$ , many, like @DRUG$ , can not be used clinically because they are toxic;	DDI-false
@DRUG$ should be taken as directed and @DRUG$ should be taken with a main meal of the day, preferably the evening meal..	DDI-false
@DRUG$ : @DRUG$ have been reported to enhance the effects of the oral anticoagulant warfarin or its derivatives .	DDI-false
Antacids : In a clinical pharmacology study, the concomitant use of a @DRUG$ ( aluminum hydroxide , magnesium hydroxide , and simethicone ) with @DRUG$ • decreased serum levels and urinary excretion of fosinoprilat compared to fosinopril alone, suggesting that antacids may impair the absorption of fosinopril.	DDI-mechanism
Central Nervous System Depressants : The concomitant use of DURAGESIC   ( @DRUG$ transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general @DRUG$ , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	DDI-effect
ACE inhibitors and angiotensin II receptor antagonists (Congestive Heart Failure Post-myocardial infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25-50 mg also received ACE inhibitors or angiotensin II receptor antagonists ( @DRUG$/@DRUG$ ) .	DDI-false
No pharmacokinetic interactions between @DRUG$ and isoflurane, propofol, @DRUG$, and midazolam have been demonstrated.	DDI-false
Example inhibitors include @DRUG$ , @DRUG$ , clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine and verapamil.	DDI-false
@DRUG$ : May decrease renal tubular secretion of @DRUG$ resulting in increased blood levels and/or ampicillin toxicity .	DDI-mechanism
@DRUG$: @DRUG$ inhibit the hypotensive effect of veratrum alkaloids.	DDI-false
Acetaminophen, lidocaine, @DRUG$, quinidine, @DRUG$, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
Central Nervous System Depressants : The concomitant use of DURAGESIC   ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , @DRUG$ , @DRUG$ • (e.g. benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants and alcohol, may cause respiratory depression, hypotension and deep sedation, or may lead to coma or death.	DDI-false
"Folic acid in large quantities can be the antiepileptic effect of @DRUG$ , phenytoin and @DRUG$ , and increase the frequency of seizures in susceptible pediatric patients .	DDI-false
@DRUG$ : The concomitant administration of @DRUG$ and naproxen in normal volunteers had no effect on the plasma levels of naproxen , but significantly decreased the urinary excretion of naproxen and its glucuronide metabolite .	DDI-false
Potassium Supplements and @DRUG$ : Fosinopril sodium can attenuate potassium loss caused by @DRUG$.	DDI-false
Central Nervous System Depressants : The concomitant use of DURAGESIC   ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , @DRUG$ ) , general anesthetics , phenothiazines , @DRUG$ , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
- single doses of cholestyramine, or @DRUG$ @DRUG$ bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent , respectively .	DDI-false
MAO Inhibitors : @DRUG$   is not recommended for use in patients who have received MAOI within 14 days because severe and unpredictable potentiation by MAO inhibitors has been reported with @DRUG$	DDI-false
Coadministration with compounds that are potent inducers of CYP3A4 ( eg , phenobarbital , phenytoin , @DRUG$ , @DRUG$ This may lead to decreased plasma levels of saquinavir.	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, fibric acid derivatives, niacin (@DRUG$), @DRUG$, azole antifungals.	DDI-false
Carbamazepine : @DRUG$ It is known to slow the metabolism of carbamazepine and increase its serum levels. @DRUG$ levels should be determined prior to concurrent administration with isoniazid , signs and symptoms of carbamazepine toxicity should be monitored closely , and appropriate dosage adjustment of the anticonvulsant should be made .	DDI-false
In order to determine whether the injection of @DRUG$ would permit larger doses of @DRUG$ to be administered , a fixed 9.9-g/m2 dose of thiosulfate was given intravenously over three hours concurrently with escalating doses of cisplatin .	DDI-false
Vitamin A: Because of the relationship of @DRUG$ to vitamin A, patients should be advised against taking @DRUG$ containing vitamin A to avoid additive toxic effects	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , @DRUG$ (e. g., warfarin, tacrolimus, cyclosporin, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam and triazolam) may increase plasma concentrations when co-administered with @DRUG$ ;	DDI-mechanism
The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving @DRUG$ or @DRUG$ may produce severe , prolonged hypertension .	DDI-false
Warfarin : @DRUG$ The effects of oral anticoagulant have been reported to be increased. @DRUG$ ==References==<br>	DDI-effect
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$-@DRUG$ in large doses may inhibit vitamin K epoxide reductase resulting in vitamin K deficiency.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, @DRUG$, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, @DRUG$, and verapamil.	DDI-false
Drug interactions : Flupentixol may interact with some medicines, such as monoamine oxidase inhibitors (MAOI): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - @DRUG$ - Eproxindine - Ethanol : Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants : Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
In a clinical pharmacology study, @DRUG$ or sulindac was administered to hypertensive patients receiving @DRUG$.	DDI-false
Benzthiazide can be used with @DRUG$ - blood thinners, inflammatory medications (allergic agents, colds and sinus drugs), diabetics, lithium, norepinephrine, NSAIDs such as aleve or @DRUG$ , and high blood pressure medications .	DDI-false
Carbamazepine: Isoniazid is known to slow the metabolism of @DRUG$ and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the @DRUG$ should be made.	DDI-false
Multivitamins or other products containing iron or zinc, @DRUG$ or @DRUG$ The use of norfloxacin should not be performed simultaneously with or within 2 hours after the administration of norfloxacin as it may impair absorption, resulting in lower serum and urine levels of norfloxacin.	DDI-false
@DRUG$: @DRUG$ (CYP3A4 substrate) in combination with amiodarone has been associated with reports of myopathy/rhabdomyolysis.	DDI-false
@DRUG$: In a study conducted in healthy subjects, mean steady-state lithium plasma levels increased approximately 17% in subjects receiving lithium 450 mg BID with @DRUG$ 200 mg BID as compared to subjects receiving lithium alone.	DDI-false
Drug/Laboratory Test Interactions @DRUG$ , including @DRUG$ , are known to occasionally induce a positive direct Coombs test .	DDI-false
@DRUG$ may displace acidic drugs such as phenytoin or @DRUG$ from their binding sites.	DDI-mechanism
Anticholinesterases (neostgmine, @DRUG$ ), lignocaine, quinine, @DRUG$ The toxicity can be increased and lead to heart respiratory depression.	DDI-false
Concomitant use of LEVSIN with other antimuscarinic agents may lead to additive side effects due to cholinergic blockade. @DRUG$ , haloperidol , @DRUG$ , monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, @DRUG$, H2 antagonists, HMG-CoA reductase inhibitors, @DRUG$ (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
The possibility of hypotensive effects with captopril can be minimized by either discontinuing the diuretic or increasing the salt intake approximately one week prior to initiation of treatment with @DRUG$ ( @DRUG$ tablets , USP ) or initiating therapy with small doses ( 6.25 or 12.5 mg ) .	DDI-false
- Anabolic steroids (nandrolone [e.g., @DRUG$], oxandrolone [e.g., @DRUG$], oxymetholone [e.g., Anadrol], stanozolol [e.g., Winstrol]) or	DDI-false
Stavudine and @DRUG$ @DRUG$ can antagonize the in vitro antiviral activity of stavudine and zidovudine against HIV .	DDI-false
Therefore , when @DRUG$ The dose is given to a patient receiving warfarin. @DRUG$ To prevent excessive prolongation of prothrombin time, the dose should be reduced.	DDI-false
Other concomitant therapies : In clinical trials , the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics , hypnotics and sedatives ( including @DRUG$ ) , or @DRUG$ was similar to that of subjects taking placebo with these concomitant medications .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ - chloramphenicol, erythromycins, sulphonamides, or @DRUG$ may interfere with the bactericidal effect of penicillins .	DDI-false
• The intake of acetaminophene with theophylline, phenobarbital with @DRUG$ , and valproic acid with @DRUG$ At high to toxic concentrations, binding of the target medication is reduced.	DDI-false
During co-administration, systemic levels of @DRUG$ and @DRUG$ were essentially unchanged.	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5 % Ophthalmic Solution , the possibility of an additive or potentiating effect with CNS depressants ( alcohol , barbiturates , @DRUG$ , @DRUG$ , anesthetics ) should be considered .	DDI-false
For treatment with CYP3A4 inhibitors (such as ketoconazole, intraconazole, @DRUG$ , indinavir, saquinavir, @DRUG$ A reduction in the dose of budesonide should be considered.	DDI-false
acetaminophen/theophylline , lidocaine/@DRUG$ , phenobarbital/acetaminophen , phenobarbital/valproic acid , quinidine/lidocaine , theophylline/@DRUG$ , and valproic acid/phenobarbital .	DDI-false
@DRUG$: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, @DRUG$, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
BACKGROUND: The effects of combined administration of bombesin and @DRUG$ (verapamil), a @DRUG$, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane (AOM) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
Although there is little published information on concomitant administration of @DRUG$ and @DRUG$ These drugs are often administered at the same time without any evidence of interactions leading to undesirable effects or reduced efficacy.	DDI-false
@DRUG$ : In controlled studies in healthy volunteers , @DRUG$ either had no effect ( one study ) or was associated with modest increases , about 30 % ( two studies ) in steady-state serum digoxin concentrations .	DDI-false
These drugs include the @DRUG$ and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Although neither @DRUG$ Neither retinyl acetate influences prostatic epithelium proliferation in RPMI1640 with transferrin alone, modifying the mitogenic effect of EGF and @DRUG$.	DDI-effect
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ Keppra  (1500 mg twice daily) did not alter the pharmacokinetics of @DRUG$ in healthy volunteers.	DDI-false
Colestipol-Concomitant intake of @DRUG$ The intake of @DRUG$ can be reduced by vitamin K.	DDI-false
@DRUG$: @DRUG$ is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.	DDI-false
Acetaminophen : In normal volunteers, concomitant use of @DRUG$ and @DRUG$ resulted in an approximate 50 % increase in plasma levels of acetaminophen .	DDI-mechanism
In a comparison of digital tolerance in dogs stunned with ketamine, Innovar Vet, or pentobarbital, the dosage of @DRUG$ needed to cause ventricular tachycardia was significantly higher , as was the LD50 of ouabain , with ketamine or Innovar than with @DRUG$.	DDI-false
Expected changes in laboratory assessments of PT and INR were observed after @DRUG$ administration, but these changes were not affected by concomitant @DRUG$ administration.	DDI-false
Co-administration: Concomitant use of @DRUG$ with antiplatelet agents, @DRUG$, and other anticoagulants may increase the risk of bleeding.	DDI-effect
• Methotrexate kidney tube transport of @DRUG$ may be inhibited by concomitant administration of ciprofloxacin , potentially leading to increased plasma levels of @DRUG$.	DDI-false
Treatment with @DRUG$ can directly interfere with blood glucose levels or may interact with @DRUG$.	DDI-int
Other concomitant therapy Although specific interaction studies were not performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, @DRUG$, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
INOmax has been administered with tolazoline, @DRUG$, dobutamine, @DRUG$, surfactant, and high-frequency ventilation.	DDI-false
Concurrent administration of drugs possessing nephrotoxic ( e.g. , aminoglycosides , indomethacin ) , myelotoxic ( e.g. , @DRUG$ chemotherapy), cardiotoxic (e.g. doxorubicin) or hepatotoxic (e.g. methotrexate, @DRUG$ ) effects with PROLEUKIN may increase toxicity in these organ systems .	DDI-false
Dose adjustment is not recommended.Levetiracetam had no effect on plasma concentrations of carbamazepine, valproate, @DRUG$, or @DRUG$.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
Injection : @DRUG$ Injection, like other injectable benzodiazepines, produces depression of the central nervous system when used with ethyl alcohol, phenothiazine, barbiturates, MAO inhibitors and other antidepressants. If scopolamine is used simultaneously with injectable @DRUG$ , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .	DDI-false
Example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , @DRUG$ , @DRUG$ , erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
- @DRUG$ (e.g., @DRUG$) or	DDI-false
Other concomitant therapy Although specific interaction studies have not been performed, @DRUG$ Doses of 1 mg or more were used concomitantly in clinical trials with acetaminophene, acetylsalicylic acid, A-blockers, analgesics, angiotensin converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta-blockers, calcium channel blockers, cardiac nitrates, diuretics, H2-antagonists, @DRUG$ , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, @DRUG$, oral @DRUG$, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
- @DRUG$ (e.g., Mexate) Use of methotrexate with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of @DRUG$	DDI-false
Naproxen: The concomitant administration of diflunisal and naproxen in normal volunteers had no effect on the plasma levels of @DRUG$, but significantly decreased the urinary excretion of @DRUG$ and its glucuronide metabolite.	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, @DRUG$, or pentobarbital, the dosage of @DRUG$ needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with pentobarbital.	DDI-effect
Drug-Drug Interactions Between @DRUG$   And Other Antiepileptic Drugs ( AEDs ) Phenytoin Keppra   ( 3000 mg daily ) had no effect on the pharmacokinetic disposition of @DRUG$ In patients with refractory epilepsy.	DDI-false
Plasma @DRUG$ concentration should be monitored when isoniazid and @DRUG$ are co administered, and appropriate dosage adjustments of valproate should be made.	DDI-false
Injection : Lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with @DRUG$ , phenothiazines , barbiturates , @DRUG$ , and other antidepressants . When scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .	DDI-false
Central nervous system depressants : Co-administration of DURAGESIC (Fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, @DRUG$ Anaesthesia (e.g. benzodiazepines), general anaesthesia, @DRUG$ , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	DDI-false
OBJECTIVE: Our objective was to characterize the steady-state pharmacokinetics of everolimus and @DRUG$ (INN, @DRUG$) when coadministered in de novo kidney allograft recipients during the first year after transplantation.	DDI-false
While @DRUG$ Ibogain has similar affinities for kappa opioid and possibly nicotinic acid receptors, @DRUG$ has much lower affinities than ibogaine for NMDA and sigma-2 receptors , sodium channels , and the 5-HT transporter .	DDI-false
- Anabolic steroids (nandrolone [e.g., Anabolin], oxandrolone [e.g., Anavar], oxymetholone [e.g., @DRUG$], @DRUG$ [e.g., Winstrol]) or	DDI-false
It may be necessary to adjust the dosage of oral @DRUG$ upon beginning or stopping disulfiram. since @DRUG$ may prolong prothrombin time.	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, Dapson, disopyramide, quinine, amiodarone, quinidine, @DRUG$ , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with @DRUG$ ;	DDI-mechanism
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, dapsones, @DRUG$ , quinine, amiodarone, quinidine, @DRUG$ Tacrolimus, cyclosporin, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam and triazolam) may exhibit increased plasma concentrations when co-administered with saquinavir;	DDI-false
Since @DRUG$ are potentiated by the @DRUG$, they should be used cautiously in the treatment of convulsions.	DDI-advise
Central nervous system depressants : Concomitant use of DURAGESIC (Fentanyl transdermal system ) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, sedatives (e.g., @DRUG$ ) , general @DRUG$ , phenothiazine, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and deep sedation, or possibly coma or death.	DDI-false
In a clinical pharmacology study, @DRUG$ or @DRUG$ was administered to hypertensive patients receiving VASOTEC.	DDI-false
Note : dissolution of aerosol particles of @DRUG$ in @DRUG$ , a model lung surfactant .	DDI-false
A possible interaction between @DRUG$ and @DRUG$, a fluoroquinolone antibiotic, has been reported, resulting in a potentiation of the hypoglycemic action of glyburide.	DDI-int
Histamine H2-receptor antagonists: @DRUG$ appear to have no significant effect on the bioavailability of @DRUG$.	DDI-false
@DRUG$/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between @DRUG$ and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
These drugs include the thiazides and other diuretics , @DRUG$ , phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel block drugs, and @DRUG$.	DDI-false
The administration of local anesthetic solutions containing epinephrine or @DRUG$ to patients receiving monoamine oxidase inhibitors or @DRUG$ may produce severe, prolonged hypertension.	DDI-effect
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, @DRUG$, nitrates, calcium-blocking agents, hydralazine, prazosin and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Other Drugs:Drugs such as quinidine, disopyramide, @DRUG$, phenothiazines, antihistamines, and @DRUG$ may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen and valproic acid/phenobarbital.	DDI-false
- @DRUG$ ( e.g. , AquaMEPHYTON , @DRUG$ ) Use of sulfapyridine with these medicines may increase the chance of side effects affecting the blood	DDI-false
Patients receiving high doses of @DRUG$ concomitantly with furosemide , as in rheumatic disease , may experience @DRUG$ toxicity at lower doses because of competitive renal excretory sites .	DDI-false
Effect of @DRUG$ on the pharmacokinetics of @DRUG$.	DDI-false
Reciprocal interactions may occur with concomitant use of @DRUG$ and drugs that increase or inhibit the cytochrome P450 system (e.g., phenytoin, carbamazepine, @DRUG$, ketoconazole), though this has not been studied	DDI-mechanism
Ketoconazole ( 200 mg once daily ) produced a 10-fold increase in @DRUG$ AUC and a 4-fold increase in Cmax when co-administered with @DRUG$ 5 mg) in healthy volunteers.	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as @DRUG$, intraconazole, ritonavir, indinavir, saquinavir, erythromycin, etc.) is indicated, reduction of the @DRUG$ dose should be considered.	DDI-advise
In patients with chronic hepatitis C treated with @DRUG$ In combination with COPEGUS, PEGASYS treatment did not affect @DRUG$ Distribution or release.	DDI-false
@DRUG$: The concomitant use of DURAGESIC  (@DRUG$ transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Probenecid: Probenecid affects renal tubular secretion of @DRUG$ and produces an increase in the level of @DRUG$ in serum .	DDI-false
Two groups (SH/DA; SH/FA) were submitted to daily treatment with synthetic hydroalcoholic solutions containing ethanol, @DRUG$, higher @DRUG$ and acetaldehyde in the same proportions as those found in most common distilled and fermented alcoholic beverages;	DDI-false
@DRUG$ Keppra ( 1000 mg twice daily ) did not affect the pharmacokinetics of @DRUG$.	DDI-false
The intensity, uniformity and time course of anticoagulant interference by @DRUG$, @DRUG$, glutethimide, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
acetaminophen/theophylline , lidocaine/quinidine , @DRUG$/acetaminophen , phenobarbital/valproic acid , @DRUG$/lidocaine , theophylline/acetaminophen , and valproic acid/phenobarbital .	DDI-false
The availability of potent non-nucleoside reverse transcriptase inhibitor (NNRTI)-based regimens for @DRUG$ therapy and concerns regarding @DRUG$ (PI)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection .	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, @DRUG$, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and @DRUG$.	DDI-false
Studies in rats have shown that @DRUG$ The application alleviates certain types of adrenocortical steroid dependent hypertension, including @DRUG$ hypertension .	DDI-effect
Because of the increased risk of adverse reactions in patients who have been taking @DRUG$ on a regular basis, it is particularly important that physicians query patients or their guardians carefully about benzodiazepine, alcohol and sedative use as part of the history prior to any procedure in which the use of @DRUG$ is planned.	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, @DRUG$ was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, betablockers, @DRUG$, diuretics, and nonsteroidal anti-inflammatory drugs (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
The similarity of the TYSABRI -associated adverse event profile between Study 1 (without co-administered @DRUG$ ) and Study 2 (with co-administered @DRUG$ ) indicates that this alteration in clearance does not necessitate reduction of the TYSABRI  dose to maintain safety, General).	DDI-false
In addition to the interactions noted above, chronic (  2 weeks) oral Cordarone administration impairs metabolism of @DRUG$, @DRUG$, and methotrexate.	DDI-false
Warfarin @DRUG$ The pharmacokinetics of @DRUG$ were not affected (1000 mg twice daily).	DDI-false
In vitro data suggest that: @DRUG$ , when compared to @DRUG$ , has a less pronounced effect on the biotransformation system responsible for the metabolism of astemizole .	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, betablockers, calcium-channel blockers, diuretics, and @DRUG$ (@DRUG$) without evidence of clinically significant adverse interactions.	DDI-false
The concomitant use of other CYP3A4 inhibitors such as diltiazem and @DRUG$ with transdermal fentanyl may also result in an increase in @DRUG$ plasma concentrations, which could increase or prolong adverse drug effects and may cause serious respiratory depression.	DDI-false
Data from in vitro studies @DRUG$ other than @DRUG$ Ergotamine, cyclosporin, amiodarone, nicardipine and nifedipine.	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as @DRUG$, intraconazole, ritonavir, indinavir, saquinavir, @DRUG$, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
Drugs that may alter @DRUG$ plasma concentrations Drugs that may increase imatinib plasma concentrations : Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family ( e.g. , ketoconazole , itraconazole , erythromycin , @DRUG$ ) .	DDI-false
- Anabolic steroids ( nandrolone [ e.g. , Anabolin ] , oxandrolone [ e.g. , @DRUG$ ] , @DRUG$ [ e.g. , Anadrol ] , stanozolol [ e.g. , Winstrol ] ) or	DDI-false
@DRUG$, @DRUG$ Amphetamines may enhance the activity of tricyclic antidepressants or sympathomimetic agents;	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, Dapson, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporin, ergot derivatives, @DRUG$ , carbamazepine, fentanyl, alfentanyl, @DRUG$ When co-administered with saquinavir, increased plasma concentrations may occur;	DDI-false
acetaminophen/theophylline , lidocaine/quinidine , phenobarbital/acetaminophen , phenobarbital/valproic acid , @DRUG$/@DRUG$ , theophylline/acetaminophen , and valproic acid/phenobarbital .	DDI-false
BACKGROUND: The effects of combined administration of @DRUG$ and verapamil hydrochloride (@DRUG$), a calcium channel blocker, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane (AOM) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
@DRUG$ and retinyl acetate similarly inhibit and stimulate @DRUG$- or insulin-induced proliferation of prostatic epithelium .	DDI-effect
These drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid products , estrogens , oral @DRUG$ , phenytoin , nicotinic acid , sympathomimet-ics , @DRUG$ , and isoniazid .	DDI-false
In addition to this pharmacological interaction , this report describes a novel chemical reaction between @DRUG$ ( a @DRUG$ ) and ethanol under acidic conditions similar to those found in vivo , resulting in a 3-ethoxylated product .	DDI-false
SINCE THE CONCOMITANT ADMINISTRATION OF THESE TWO DRUGS CAN LEAD TO @DRUG$ INTOXICATION , PRIOR TO ADMINISTERING @DRUG$ To a patient on PHENYTOIN THERAPY, A BASELINE PHENYTOIN SERUM LEVEL, ANDIE.	DDI-false
Levosimendan has no clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, @DRUG$ , isosorbide mononitrate, @DRUG$ Ethanol or itraconazole.	DDI-false
( In some patients, the steroid may reduce the diuretic, natriuretic and blood pressure lowering effect of @DRUG-DRUG$.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as @DRUG$ or @DRUG$ antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
@DRUG$ had no significant impact on the Cmax and AUC of zidovudine, although it significantly decreased the @DRUG$ tmax by 44% and increased the intracellular exposure to phosphorylated zidovudine by 110%.	DDI-mechanism
In general, these are drugs that have one or more pharmacologic activities similar to @DRUG$, including anti-arrhythmic agents such as @DRUG$ and procainamide, cardiac glycosides and tricyclic anti-depressants.	DDI-false
Tolazamide : A case of severe hypoglycemia has been reported in a type II diabetic patient maintained on @DRUG$ ( 1 gm/day ) 11 days after the addition of @DRUG$ ( 75 mg/ day ).	DDI-effect
Other strong inhibitors of CYP3A4 (e.g., itraconazole, @DRUG$, nefazodone, troleandomycin, ritonavir, @DRUG$) would be expected to behave similarly.	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (@DRUG$, @DRUG$, cefotetan, cefamandole, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
@DRUG$, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, @DRUG$, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-mechanism
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, @DRUG$, @DRUG$, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, @DRUG$, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as @DRUG$), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , @DRUG$ and @DRUG$ This delays elimination and increases blood levels of these drugs.	DDI-false
Standard monitoring of @DRUG$-related toxicity should be continued if @DRUG$ and methotrexate are administered concomitantly .	DDI-false
@DRUG$: Indinavir (800 mg t.i.d.) co-administered with @DRUG$ 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in vardenafil Cmax and a 2-fold increase in vardenafil half-life.	DDI-false
Previous studies have demonstrated a significant reduction in the oral bioavailability of trovafloxacin and @DRUG$ when administered concomitantly with an intravenous @DRUG$ such as morphine.	DDI-mechanism
No important interactions to date @DRUG$ does not have clinically important pharmacokinetic interactions with captopril , beta-blockers , felodipine , digoxin , warfarin , @DRUG$ , carvedilol , ethanol or itraconazole .	DDI-false
No pharmacokinetic interactions between dexmedetomidine and isoflurane, @DRUG$, @DRUG$, and midazolam have been demonstrated.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, @DRUG$, chlordiazepoxide, diazepam, certain tricyclic antidepressants, @DRUG$, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
@DRUG$: Potentiation of warfarin-type (CYP2C9 and CYP3A4 substrate) anticoagulant response is almost always seen in patients receiving @DRUG$ and can result in serious or fatal bleeding.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, @DRUG$, or @DRUG$ may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
@DRUG$ and Tricyclic Antidepressants: FORADIL should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or @DRUG$ because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-false
@DRUG$ and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving @DRUG$ 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (ACEI/ARB).	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as @DRUG$), and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ , nondepolarizing ( e.g. , @DRUG$ ): possible increased responsiveness to the muscle relaxant .	DDI-false
Serious anticholinergic symptoms (i.e., severe dry mouth, urinary retention and blurred vision) have been associated with elevations in the serum levels of @DRUG$ when @DRUG$ therapy is initiated.	DDI-effect
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, @DRUG$ or beta-adrenergic blocking agents, calcium channel blockers, antihistamines or @DRUG$, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-false
This increase is due to the inhibition of @DRUG$ Metabolism over P450 2C9 by @DRUG$ ( see CLINICAL PHARMACOLOGY - Pharmacokinetics : Metabolism ) .	DDI-mechanism
@DRUG$ Supplements and Potassium-Sparing Diuretics : @DRUG$ can attenuate potassium loss caused by thiazide diuretics .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with @DRUG$ plus bleomycin) without receiving @DRUG$ therapy.	DDI-false
Multivitamins or other products containing iron or zinc, antacids or @DRUG$ should not be administered concomitantly with , or within 2 hours of , the administration of @DRUG$ , because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin .	DDI-advise
@DRUG$: In hypercholesterolemic patients, steady-state @DRUG$ AUC and Cmax increased approximately 50% and 24% respectively after 10 days with co-administration of erythromycin, a known inhibitor of cytochrome P450 3A4.	DDI-false
Central nervous system depressants: the concomitant use of DURAGESIC ( @DRUG$ Transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotic agents, sedatives (e.g., benzodiazepines), general anesthetics, phenothiazines, @DRUG$ , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	DDI-effect
Hydrochlorothiazide : In normal volunteers , concomitant administration of diflunisal and @DRUG$ resulted in significantly increased plasma levels of @DRUG$.	DDI-false
@DRUG$ - prior ingestion of diphenidol may decrease the @DRUG$ Reaction to apomorphine in the treatment of poisoning.	DDI-false
Multivalent Cation-Containing products: Concomitant administration of quinolone, including ciprofloxacin, with multivalent cation-containing products such as @DRUG$ Antacids or antacids of aluminium, sucralfate, @DRUG$ The chewable/buffered tablets or paediatric powders, or products that contain calcium, iron or zinc can significantly reduce the absorption of ciprofloxacin, resulting in serum and urine levels significantly lower than desired.	DDI-false
Non-selective MAO inhibitors including @DRUG$, phenelzine sulfate, and pargyline HC1: Concomitant use of L-tyrosine and non-selective @DRUG$ may cause hypertension.	DDI-false
Both @DRUG$ and nevirapine have been compared to triple therapy with the PI indinavir over 48 weeks as initial therapy, with similar responses being observed with @DRUG$ regimens and superiority observed with efavirenz.	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, Dapson, disopyramide, quinine, amiodarone, @DRUG$ , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , @DRUG$ Concomitant use with saquinavir may result in increased plasma concentrations.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, @DRUG$, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving @DRUG$ therapy.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, @DRUG$, nifedipine, @DRUG$, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Ritonavir and @DRUG$ : Upon concomitant administration of 5 mg of Vardenafil with 600 mg BID @DRUG$ The Cmax and AUC of ritonavir were reduced by approximately 20%.	DDI-false
@DRUG$/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of @DRUG$ 1.5  g/kg/min. over 18 hours).	DDI-false
These results suggest that both @DRUG$ and retinyl acetate, and possibly other @DRUG$ and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF.	DDI-false
@DRUG$: @DRUG$ (800 mg t.i.d.) co-administered with Vardenafil 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in vardenafil Cmax and a 2-fold increase in vardenafil half-life.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, @DRUG$, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
While @DRUG$ and ibogaine have similar affinities for kappa opioid and possibly nicotinic receptors, @DRUG$ has much lower affinities than ibogaine for NMDA and sigma-2 receptors, sodium channels, and the 5-HT transporter.	DDI-false
- Methotrexate (e.g., Mexate) Use of @DRUG$ with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of @DRUG$	DDI-false
Coingestion of acetaminophen with theophylline, @DRUG$ with @DRUG$, and valproic acid with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-effect
Therefore , when @DRUG$ is given to a patient receiving @DRUG$ The dose of warfarin should be reduced to prevent excessive prolongation of prothrombin time.	DDI-advise
@DRUG$ Atorvastatin plasma concentrations decreased by about 25% when colestipol and @DRUG$ were coadministered .	DDI-false
Drug-Drug Interactions Between @DRUG$  And Other Antiepileptic Drugs (@DRUG$) Phenytoin Keppra  (3000 mg daily) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy.	DDI-false
Oral @DRUG$: Pharmacokinetic drug-drug interactions between @DRUG$ and warfarin (7.5 mg single oral dose) have not been demonstrated.	DDI-false
INOmax has been administered with @DRUG$, @DRUG$, dobutamine, steroids, surfactant, and high-frequency ventilation.	DDI-false
@DRUG$ (e.g., spironolactone, triamterene, or @DRUG$), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, @DRUG$, VIDEX chewable/buffered tablets or pediatric powder, or products containing @DRUG$, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Therefore, interactions may occur after concomitant administration of psychotropic medicinal products (e. g. @DRUG$ , @DRUG$ , antiemetics , sedatives , tranquilizers ) .	DDI-false
The hypoglycaemic effect of sulphonylureas can be enhanced by certain medications, including non-steroidal anti-inflammatory drugs and other medicines that are highly protein bound, salicylates, sulphonamides, @DRUG$ , probenecid, coumarine, monoamine oxidase inhibitors and @DRUG$.	DDI-false
Monoamine Oxidase Inhibitors and Tricyclic Antidepressants : FORADIL should be administered with extreme caution in patients being treated with @DRUG$ or @DRUG$ because the action of formoterol on the cardiovascular system may be potentiated by these agents .	DDI-false
@DRUG$-containing therapies should not be combined with @DRUG$ as they may diminish its pharmacologic action .	DDI-advise
- @DRUG$ (e.g., @DRUG$) or	DDI-false
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies (@DRUG$, valproate, oral contraceptive, digoxin, warfarin, @DRUG$) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients.	DDI-false
Lithium: In a study conducted in healthy subjects, mean steady-state lithium plasma levels increased approximately 17% in subjects receiving @DRUG$ 450 mg BID with CELEBREX 200 mg BID as compared to subjects receiving @DRUG$ alone.	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, dapsones, disopyramide, @DRUG$ , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and @DRUG$ Concomitant use with saquinavir may result in increased plasma concentrations.	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase @DRUG$ plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, @DRUG$, erythromycin, clarithromycin).	DDI-false
Moreover , additional interaction studies with @DRUG$ Administration to a patient population receiving chronic digoxin did not cause any difference in the extent of bioavailability of digoxin. @DRUG$ relative to control data .	DDI-false
Drug Interactions : Flupenthixol may interact with some drugs , like Monoamine oxidase inhibitors ( MAOI ): MAOI could theoretically affect flupenthixol pharmacodynamics - @DRUG$ - Eproxindine - Ethanol : Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants : @DRUG$ Increases the effect of tricyclic antidepressants	DDI-false
Benzthiazide may interact with alcohol , blood thinners , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , @DRUG$ , norepinephrine , NSAIDs like @DRUG$ or Ibuprofen , and high blood pressure medications .	DDI-false
In addition, @DRUG$ neither influenced the pharmacodynamics of warfarin, @DRUG$, piroxicam, and digoxin, nor the pharmacokinetics of digoxin at steady state.	DDI-false
* As Amiodarone is a substrate for @DRUG$ , there is the potential that the use of St. John's word in patients who @DRUG$ could result in reduced amiodarone levels .	DDI-false
Clinical studies with celecoxib have identified potentially significant interactions with @DRUG$ and @DRUG$.	DDI-false
@DRUG$ : When multiple doses of atorvastatin and @DRUG$ Plasma digoxin concentrations at steady-state increased by about 20%.	DDI-false
@DRUG$ , or other products containing iron or @DRUG$ , antacids or sucralfate should not be administered concomitantly with , or within 2 hours of , the administration of norfloxacin , because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin .	DDI-false
Serum @DRUG$ levels should be monitored frequently if @DRUG$ It is given concurrently with lithium.	DDI-false
Corticosteroids, Methylxanthines and @DRUG$: Concomitant treatment with xanthine derivatives, @DRUG$, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, @DRUG$ chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or @DRUG$ may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
For these reasons , it is felt that , in most subjects who have had an unsatisfactory lipid response to either drug alone , the possible benefits of combined therapy with @DRUG$ and a @DRUG$ Not outweigh the risks of severe myopathy, rhabdomyolysis and acute renal failure.	DDI-effect
Further, no effects on either warfarin levels or prothrombin times were observed in a study involving concomitant administration of @DRUG$ and @DRUG$.	DDI-false
To evaluate the effects of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL), the authors retrospectively compared a group of 24 patients with HIV-NHL treated with cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$ , doxorubicin , teniposide , and prednisone with vincristine plus bleomycin ) without receiving @DRUG$ therapy .	DDI-false
Other Cardiovascular Agents : @DRUG$ , methyldopa, nitrates, calcium blockers, hydralacin, prazosin and enalapril IV were co-administered with beta-adrenergic blockers, methyldopa, @DRUG$ without evidence of clinically significant adverse interactions .	DDI-false
@DRUG$ : The rate and extent of absorption of ciprofloxacin was bioequivalent when @DRUG$ The dose was given alone or when Proquin XR was administered 2 hours after omeprazole, which suppresses gastric acid secretion maximum.	DDI-false
Reciprocal interactions may occur with concomitant use of antizole and medicinal products that potentiate or inhibit the cytochrome P450 system (e.g. @DRUG$ , @DRUG$ , cimetidine, ketoconazole), although this has not been studied	DDI-false
Other substances : Grapefruit juice given to healthy volunteers increased @DRUG$ AUC by 50 % and Cmax by 84 % , resulting in increased plasma levels of @DRUG$.	DDI-false
@DRUG$ : Increased serum @DRUG$ levels and symptoms of lithium toxicity have been reported in patients receiving concomitant lithium and ACE inhibitor therapy .	DDI-false
Compounds tested in man include @DRUG$ , theophylline , @DRUG$ , diazepam, aminopyrin and antipyrin.	DDI-false
As with other @DRUG$, it should be noted that HALDOL may be capable of potentiating @DRUG$ such as anesthetics, opiates, and alcohol.	DDI-effect
@DRUG$ : The effect of celecoxib on the anti-coagulant effect of @DRUG$ It was studied in a group of healthy subjects who received 2-5 mg of warfarin daily.	DDI-false
No data are available for the coadministration of @DRUG$/ritonavir or @DRUG$/ritonavir and garlic capsules.	DDI-false
Other Cardiovascular Agents : @DRUG$ and enalapril IV have been used concomitantly with beta adrenergic-blocking agents , methyldopa , nitrates , @DRUG$ , hydralazine , prazosin and digoxin without evidence of clinically significant adverse interactions .	DDI-false
@DRUG$: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with @DRUG$, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.	DDI-false
- Anabolic steroids (nandrolone [e.g., Anabolin], oxandrolone [e.g., @DRUG$], oxymetholone [e.g., @DRUG$], stanozolol [e.g., Winstrol]) or	DDI-false
Antiarrhythmia : Other antiarrhythmic drugs such as quinidine, procainamide, @DRUG$ , and phenytoin , have been used concurrently with @DRUG$.	DDI-false
Drug interactions : Flupentixol may interact with some medicines such as monoamine oxidase inhibitors (MAOI): MAOI may theoretically affect flupentixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupentixol and @DRUG$ cause additive CNS depression - Tricyclic antidepressants : Flupenthixol increases the effect of @DRUG$	DDI-false
Tinnitus and decreased hearing have been reported in patients concomitantly receiving @DRUG$ and @DRUG$.	DDI-effect
Potential pharmacokinetic interactions have been reported in clinical pharmacokinetic studies (phenytoin, @DRUG$ , oral contraceptive , digoxin , @DRUG$ , probenecid ) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients .	DDI-false
As the primary effect of @DRUG$ is to decrease conduction through the A-V node , higher degrees of heart block may be produced in the presence of @DRUG$.	DDI-effect
Cyclosporine, Digoxin, Methotrexate Lodine, like other @DRUG$, through effects on renal prostaglandins, may cause changes in the elimination of these drugs leading to elevated serum levels of cyclosporine, digoxin, @DRUG$, and increased toxicity.	DDI-mechanism
Garlic capsules Garlic capsules should not be used during ingestion @DRUG$ ( FORTOVASE ) as the sole protease inhibitor due to the risk of decreased @DRUG$ plasma concentrations .	DDI-false
Acetaminophen/theophylline, @DRUG$/chinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen and @DRUG$/Phenobarbital.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving @DRUG$ therapy.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , @DRUG$ , anticonvulsants, benzodiazepines, beta-blockers, @DRUG$ , cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also known as NSAIDs), and quinolone anti-infections without evidence of clinically significant adverse interactions.	DDI-false
Potassium-sparing diuretics ( e.g. , spironolactone , triamterene , or @DRUG$ ) , @DRUG$ supplements , or potassium-containing salt substitutes may lead to significant increases in serum potassium .	DDI-false
A drug-drug interaction study evaluated the effect of the use of @DRUG$ Gel, 5%, in combination with double strength (160 mg/800 mg) trimethoprim/sulfamethoxazole (@DRUG$/SMX).	DDI-false
These drugs include the thiazides and other @DRUG$ , corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$ , nicotinic acid, sympathomimetics, calcium channel block drugs, and isoniazid.	DDI-false
These results suggest that both @DRUG$ and retinyl acetate, and possibly other glucocorticoids and @DRUG$, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF.	DDI-false
Plasma @DRUG$ concentration should be monitored when isoniazid and @DRUG$ When co-administered, appropriate dose adjustments of valproate should be made.	DDI-false
Glyburide : @DRUG$ No pharmacokinetic interaction is apparent when used with @DRUG$.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, @DRUG$, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as @DRUG$), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
acetaminophen/@DRUG$ , lidocaine/quinidine , phenobarbital/acetaminophen , phenobarbital/valproic acid , quinidine/lidocaine , @DRUG$/acetaminophen , and valproic acid/phenobarbital .	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like @DRUG$ (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - @DRUG$: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Anticoagulants such as coumarin derivatives, indandion derivatives and platelet aggregation inhibitors such as non-steroidal anti-inflammatory drugs (NSAIDs) and @DRUG$ may increase the risk of bleeding when administered concomitantly with @DRUG$.	DDI-effect
It is recommended not to exceed a single 5 mg dose of @DRUG$ In a 24-hour period when used in combination with @DRUG$.	DDI-advise
@DRUG$: Plasma digoxin levels and @DRUG$ clearance at steady-state were not affected by co-administration of 0.2 mg cerivastatin sodium.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including @DRUG$, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, @DRUG$, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies (phenytoin, valproate, oral @DRUG$, @DRUG$, warfarin, probenecid) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients.	DDI-false
Central nervous system depressants : the concomitant use of DURAGESIC (Fentanyl transdermal system ) with other central nervous system depressants, including but not limited to other opioids, @DRUG$ , hypnotics , @DRUG$ ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	DDI-false
Apomorphine - before taking diphenidol, the @DRUG$ response to @DRUG$ in the treatment of poisoning .	DDI-false
Although @DRUG$ The use at both doses had little or no effect on the improvement of intestinal carcinogenesis by @DRUG$ or on the location , histologic type , depth of involvement , labeling index , apoptotic index or tumor vascularity of intestinal cancers , it significantly decreased the incidence of cancer metastasis .	DDI-false
The availability of potent non-nucleoside reverse transcriptase inhibitor (NNRTI)-based regimens for @DRUG$ therapy and concerns regarding protease inhibitor (@DRUG$)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection.	DDI-false
Drugs that cause significant sustained elevation in gastric pH ( histamine H2-receptor antagonists such as ranitidine or @DRUG$ ), the plasma concentration of @DRUG$ and therefore potentially may reduce efficacy .	DDI-mechanism
Coadministration with compounds that are potent inducers of CYP3A4 (eg, phenobarbital, phenytoin, @DRUG$, carbamazepine) may result in decreased plasma levels of @DRUG$.	DDI-mechanism
Clinical studies of @DRUG$ • Alone or in combination with @DRUG$ did not include sufficient numbers of subjects aged 65 or over to determine whether they respond differently from younger subjects .	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine , fibric acid derivatives , @DRUG$ ( nicotinic acid ) , @DRUG$ , azole antifungals .	DDI-false
There is no pharmacokinetic interaction between @DRUG$ and @DRUG$.	DDI-false
Corticosteroids, Methylxanthines and @DRUG$: Concomitant treatment with xanthine derivatives, steroids, or diuretics may potentiate a possible hypokalemic effect of  @DRUG$	DDI-false
METHOD: This study was a multicenter randomized double-blind study of 101 patients who were randomly assigned 1:1:1 to receive @DRUG$ tablets at doses of 0.5 mg, 1 mg, or 2 mg twice daily with cyclosporine and @DRUG$.	DDI-false
Because @DRUG$ Patients who require anticoagulation should receive a low molecular weight or standard @DRUG$.	DDI-false
Particular caution is necessary when using ROMAZICON in cases of mixed drug overdosage since the toxic effects (such as convulsions and cardiac dysrhythmias) of other drugs taken in overdose (especially cyclic antidepressants) may emerge with the reversal of the @DRUG$ effect by @DRUG$.	DDI-false
Multivalent Cation-Containing Products : Simultaneous Application of a @DRUG$ , including @DRUG$ , with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfat, VIDEX chew/buffer tablets or child powder, or products that contain calcium, iron or zinc can significantly reduce the absorption of ciprofloxacin, resulting in serum and urine levels significantly lower than desired.	DDI-false
Corticosteroids, @DRUG$ and Diuretics: Concomitant treatment with xanthine derivatives, steroids, or @DRUG$ may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
Multivalent Cation-Containing Products : Concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as @DRUG$ or aluminum @DRUG$ , Sucralfat, VIDEX chew/buffer tablets or children's powder, or products that contain calcium, iron or zinc can significantly reduce the absorption of ciprofloxacin, resulting in serum and urine levels significantly lower than desired.	DDI-false
Cyclosporine , Digoxin , Methotrexate Lodine , like other NSAIDs , through effects on renal prostaglandins , may cause changes in the elimination of these drugs leading to elevated serum levels of @DRUG$ , digoxin , @DRUG$ , and increased toxicity.	DDI-false
@DRUG$/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
Corticosteroids, Methylxanthines and Diuretics: Concomitant treatment with @DRUG$, steroids, or @DRUG$ may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of @DRUG$, fibric acid derivatives, niacin (nicotinic acid), erythromycin, @DRUG$.	DDI-false
Oral @DRUG$: Coadministration of atorvastatin and an oral contraceptive increased AUC values for @DRUG$ and ethinyl estradiol by approximately 30% and 20%.	DDI-false
METHOD : This study was a multicenter randomized double-blind study of 101 patients who were randomly assigned 1:1:1 to receive @DRUG$ tablets at doses of 0.5 mg , 1 mg , or 2 mg twice daily with @DRUG$ and prednisone .	DDI-false
@DRUG$ @DRUG$, as well as a metabolite of furazolidone, slow amphetamine metabolism.	DDI-false
@DRUG$: Co- administration of warfarin and cerivastatin to healthy volunteers did not result in any changes in prothrombin time or clotting factor VII when compared to co-administration of @DRUG$ and placebo.	DDI-false
- @DRUG$ (e.g., @DRUG$) or	DDI-false
Substances that are potent inhibitors of CYP3A4 activity (eg, @DRUG$ and itraconazole) decrease @DRUG$ metabolism and increase gefitinib plasma concentrations.	DDI-mechanism
The effects of @DRUG$ and L-CCG-1 upon @DRUG$ (PCP)-induced locomotion and behavioral changes in mice .	DDI-false
@DRUG$: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving @DRUG$ or similar agents, since these patients are at an increased risk of bleeding complications.	DDI-false
In clinical studies with fondaparinux, co-administration of @DRUG$ ( warfarin ) , platelet inhibitors ( acetylsalicylic acid ) , NSAIDs ( @DRUG$ ) , and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium .	DDI-false
High-dose cyclosporin A resulting in concentrations above 2000 ng/mL administered with oral etoposide has led to an 80% increase in @DRUG$ exposure with a 38% decrease in total body clearance of @DRUG$ compared to etoposide alone.	DDI-false
@DRUG$ : In a study conducted in healthy subjects , mean steady-state lithium plasma levels increased approximately 17 % in subjects receiving @DRUG$ 450 mg BID with CELEBREX 200 mg BID as compared to subjects receiving lithium alone .	DDI-false
A drug-drug interaction study evaluated the effect of the use of ACZONE Gel, 5%, in combination with double strength (160 mg/800 mg) trimethoprim/@DRUG$ (TMP/@DRUG$).	DDI-false
( In some patients , the steroidal anti-inflammatory agent can reduce the diuretic , natriuretic , and antihypertensive effects of @DRUG-DRUG$.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - @DRUG$: @DRUG$ increases the effect of Tricyclic antidepressants	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, @DRUG$, oral contraceptives, phenytoin, @DRUG$, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, @DRUG$, @DRUG$, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other @DRUG$, amantadine, @DRUG$, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.	DDI-false
- @DRUG$ ( e.g. , @DRUG$ ) or	DDI-false
Both efavirenz and nevirapine have been compared to triple therapy with the PI indinavir over 48 weeks as initial therapy , with similar responses being observed with @DRUG$ regimens and superiority observed with @DRUG$.	DDI-false
Oral anticoagulant agents : Pharmacokinetic drug-drug interactions between @DRUG$ and @DRUG$ 7.5 mg oral single dose) has not been established.	DDI-false
, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen and valproic acid/phenobarbital.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ACE ) inhibitors , anticonvulsants , @DRUG$ , beta blockers , @DRUG$ , cardiac nitrates , diuretics , H2 antagonists , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
@DRUG$ may interact with @DRUG$ , blood thinners , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , NSAIDs like Aleve or Ibuprofen , and high blood pressure medications .	DDI-int
Therefore, patients under @DRUG$ therapy should be carefully monitored when concomitant @DRUG$ therapy is indicated.	DDI-advise
ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving @DRUG$ 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (@DRUG$/ARB).	DDI-false
For example, inhibitors are azole antimycotics, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazide, @DRUG$ , nicardipine, propofol, protease inhibitors, quinidine and @DRUG$.	DDI-false
In addition, we have shown that @DRUG$ is a useful pharmacological tool with which to examine the @DRUG$-mediated responses of megakaryocytes.	DDI-false
@DRUG$ : @DRUG$ CONTRAINDICATED since the coadministration of this product with saquinavir in an antiretroviral regimen reduces the plasma concentrations of saquinavir .	DDI-false
Use with @DRUG$: The use of angiotensin converting enzyme inhibitors to control hypertension in patients on @DRUG$ has been reported to induce severe leukopenia.	DDI-false
Nephrotoxicity has been reported following concomitant administration of @DRUG$ with aminoglycoside antibiotics or potent @DRUG$ such as furosemide.	DDI-effect
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or @DRUG$ antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or @DRUG$ may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
ACE-inhibitors Reports suggest that @DRUG$ may diminish the antihypertensive effect of @DRUG$.	DDI-effect
Example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , @DRUG$ , erythromycin , @DRUG$ , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , @DRUG$ , dapsone , disopyramide , quinine , @DRUG$ , quinidine, warfarin, tacrolimus, cyclosporin, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have increased plasma concentrations when co-administered with saquinavir;	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, @DRUG$, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as @DRUG$), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, @DRUG$, monoamine oxidase inhibitors, and @DRUG$.	DDI-false
@DRUG$ The plasma concentration of other CYP3A4 metabolised medicinal products is increased (e.g. triazolo-@DRUG$, dihydropyridine calcium channel blockers, certain HMG-CoA reductase inhibitors, etc.).	DDI-mechanism
Valproate @DRUG$  (1500 mg twice daily) did not alter the pharmacokinetics of @DRUG$ in healthy volunteers.	DDI-false
The administration of local anesthetic solutions containing epinephrine or @DRUG$ to patients receiving @DRUG$ Or tricyclic antidepressants can cause severe, prolonged hypertension.	DDI-effect
Concomitant use of LEVSIN with other antimuscarinic agents, amantadine, may lead to additive side effects due to cholinergic blockade. @DRUG$ , phenothiazines , monoamine oxidase ( MAO ) inhibitors , tricyclic antidepressants or some @DRUG$.	DDI-false
@DRUG$ : @DRUG$ No pharmacokinetic interaction is apparent when co-administered with phenytoin.	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with @DRUG$ may reduce the antitumor effectiveness of @DRUG$ and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-false
Lithium : Increased serum @DRUG$ levels and symptoms of lithium toxicity have been reported in patients receiving concomitant lithium and @DRUG$ therapy .	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, @DRUG$, @DRUG$, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
@DRUG$ : Concomitant treatment with @DRUG$ and tetracyclines should be avoided because Accutane use has been associated with a number of cases of pseudotumor cerebri ( benign intracranial hypertension ) , some of which involved concomitant use of tetracyclines	DDI-false
Additional drugs that are not recommended for coadministration with @DRUG$ and @DRUG$ are included below .	DDI-false
Carbamazepine: @DRUG$ is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of @DRUG$ toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.	DDI-false
Then, the effects of metabotropic glutamate receptor (mGluR) agonists, @DRUG$ and L-CCG-1, on the above behavioral changes induced by @DRUG$ were found.	DDI-false
Other strong inhibitors of CYP3A4 ( e.g. , @DRUG$ , clarithromycin , @DRUG$ , troleandomycin , ritonavir , nelfinavir ) would be expected to behave similarly .	DDI-false
- Anabolic steroids (@DRUG$ [e.g., Anabolin], oxandrolone [e.g., Anavar], oxymetholone [e.g., @DRUG$], stanozolol [e.g., Winstrol]) or	DDI-false
Therefore, interactions could occur following concomitant administration of @DRUG$ (e.g., narcotics, @DRUG$, antiemetics, sedatives, tranquilizers).	DDI-false
@DRUG$ Co-administration of diflunisal and naproxene in normal subjects had no effect on the plasma levels of naproxene, but significantly reduced urinary excretion of naproxene. @DRUG$ And his glucuronide metabolite.	DDI-false
Because @DRUG$ has not been shown to produce any additional effect beyond that obtained with @DRUG$ alone and because aspirin increases the rate of excretion of Nalfon, the concomitant use of Nalfon and salicylates is not recommended.	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , @DRUG$ , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and @DRUG$ Concomitant use with saquinavir may result in increased plasma concentrations.	DDI-false
It has been reported that @DRUG$-related adverse reactions in patients are due to concomitant therapy with norfloxacin and @DRUG$.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , @DRUG$ , Dapson, disopyramide, quinine, amiodarone, quinidine, @DRUG$ Tacrolimus, cyclosporin, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam and triazolam) may exhibit increased plasma concentrations when co-administered with saquinavir;	DDI-false
Cefmenoxime, cefoperazone, @DRUG$ , cefamandole , latamoxef ) or methylthiadiazole ( cefazolin ) can cause vitamin K deficiency and hypoprothrombinemia .	DDI-false
Drug-drug interactions have not been observed between @DRUG$ and digoxin or @DRUG$.	DDI-false
In addition to this pharmacological interaction , this report describes a novel chemical reaction between @DRUG$ ( a benzodiazepine ) and @DRUG$ under acidic conditions similar to those found in vivo , resulting in a 3-ethoxylated product .	DDI-mechanism
@DRUG$: NSAIDs have produced an elevation of plasma lithium levels and a reduction in renal @DRUG$ clearance.	DDI-false
In addition to the above mentioned interactions, chronic ( 2 weeks ) oral @DRUG$ administration impairs metabolism of phenytoin , @DRUG$ , and methotrexate .	DDI-false
Another oral @DRUG$, @DRUG$, inhibits the metabolism of astemizole, resulting in elevated plasma concentrations of astemizole and its active metabolite desmethylastermizole which may prolong QT intervals.	DDI-false
Example inhibitors include @DRUG$ , ciprofloxacin, clarithromycin, diclofenac, doxycycline, @DRUG$ , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .	DDI-false
Warfarin: @DRUG$ enhances the effect of @DRUG$.	DDI-false
No data from prospective clinical trials currently exist comparing the 3 approved agents (efavirenz, @DRUG$ or @DRUG$).	DDI-false
- @DRUG$ ( e.g. , @DRUG$ ) or	DDI-false
Dose adjustment is not recommended.@DRUG$ had no effect on plasma concentrations of @DRUG$ , valproate , topiramate , or lamotrigine .	DDI-false
Intravenous Adenocard (@DRUG$) has been effectively administered in the presence of other cardioactive drugs, such as quinidine, @DRUG$, calcium channel blocking agents, and angiotensin converting enzyme inhibitors, without any change in the adverse reaction profile.	DDI-false
@DRUG$-@DRUG$ can antagonize the effect of warfarin	DDI-false
Clinical studies with celecoxib have identified potentially significant interactions with @DRUG$ and @DRUG$.	DDI-false
- @DRUG$ ( nandrolone [ e.g. , Anabolin ] , oxandrolone [ e.g. , Anavar ] , oxymetholone [ e.g. , Anadrol ] , stanozolol [ e.g. , @DRUG$ ] ) or	DDI-false
Amiodarone may suppress certain CYP450 enzymes, including: @DRUG$ , CYP2C9 , @DRUG$ , and CYP3A4.	DDI-false
Other Drug Interactions Oral Contraceptives Keppra  (500 mg twice daily) did not influence the pharmacokinetics of an oral contraceptive containing 0.03 mg @DRUG$ and 0.15 mg @DRUG$, or of the luteinizing hormone and progesterone levels, indicating that impairment of contraceptive efficacy is unlikely.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, @DRUG$, HMG-CoA reductase inhibitors, @DRUG$ (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
These results suggest that both dexamethasone and retinyl acetate, and possibly other glucocorticoids and @DRUG$ , the proliferation of prostate epithelium can be regulated by a dose-dependent change in the activity of @DRUG$ and EGF .	DDI-effect
Suppression by @DRUG$ By @DRUG$-enhanced peritoneal metastases of intestinal adenocarcinoma induced by azoxymethane in Wistar rats.	DDI-effect
In EM patients treated with paroxetine, or @DRUG$ , the AUC of @DRUG$ The maximum is about 3- to 4-fold greater than atomoxetine alone.	DDI-mechanism
Results of studies in multiple sclerosis patients taking TYSABRI   and concomitant interferon beta-1a ( @DRUG$   30 mcg IM once weekly ) or glatiramer acetate were inconclusive with regard to the need for dose adjustment of the @DRUG$ or glatiramer acetate .	DDI-false
No pharmacokinetic interactions between dexmedetomidine and isoflurane, propofol, @DRUG$ , and @DRUG$ have been demonstrated .	DDI-false
Central Nervous System Depressants : The concomitant use of DURAGESIC   ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , @DRUG$ , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and @DRUG$ , respiratory depression, hypotension, and deep sedation, or possibly lead to coma or death.	DDI-false
Although @DRUG$ administered at either dose had little or no effect on the enhancement of intestinal carcinogenesis by @DRUG$ or on the location, histologic type, depth of involvement, labeling index, apoptotic index or tumor vascularity of intestinal cancers, it significantly decreased the incidence of cancer metastasis.	DDI-false
In order to evaluate the effects of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL ), the authors retrospectively compared a group of 24 patients with HIV-NHL who had been treated with the @DRUG$ , doxorubicin , vincristine , and prednisone ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , doxorubicin , @DRUG$ , and prednisone with vincristine plus bleomycin ) without receiving antiretroviral therapy .	DDI-false
Example inhibitors include @DRUG$, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, @DRUG$, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
* Delayed side effects on @DRUG$ A review of the literature showed that 12.6% ( range 11 - 28% ) of 501 patients treated with different interleukin-2-containing regimens were subsequently administered @DRUG$ experienced acute , atypical adverse reactions .	DDI-false
Therefore, interactions could occur following concomitant administration of @DRUG$ (e.g., narcotics, analgesics, antiemetics, @DRUG$, tranquilizers).	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , @DRUG$ , @DRUG$ , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
Like ibogaine ( 40 mg/kg ) , 18-MC ( 40 mg/kg ) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of @DRUG$ and @DRUG$ in rats ;	DDI-false
Like @DRUG$ (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of @DRUG$ and nicotine in rats;	DDI-false
Effects of @DRUG$ on Drug Metabolizing Enzymes and Drug Transport Systems @DRUG$ inhibits CYP3A4 and CYP2C8 in vitro at clinically relevant concentrations.	DDI-false
By contrast, @DRUG$ (1 mM) and @DRUG$ (1 mM) had no significant effect on the translocation when added alone.	DDI-false
Another oral azole antimycotics, ketoconazole, inhibits the metabolism of @DRUG$ , resulting in elevated plasma concentrations of astemizole and its active metabolite @DRUG$ which may prolong QT intervals .	DDI-false
BACKGROUND: The effects of combined administration of @DRUG$ and verapamil hydrochloride (verapamil), a calcium channel blocker, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane (@DRUG$) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
@DRUG$ is the first @DRUG$ to be approved for clinical use , and has been studied extensively in humans since 1986 .	DDI-false
Both efavirenz and @DRUG$ have been compared to triple therapy with the @DRUG$ Indinavir for 48 weeks as initial therapy, with similar response observed with nevirapine regimens and superiority observed with efavirenz.	DDI-false
@DRUG$-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, cefotetan, @DRUG$, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Therophylline: A recent study has shown that concomitan administration of @DRUG$ and theophylline may cause elevated plasma levels of @DRUG$, and in some instances a slight decrease in the elimination of isoniazid.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., @DRUG$ chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, asparaginase) effects with @DRUG$ may increase toxicity in these organ systems.	DDI-effect
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, @DRUG$, @DRUG$, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.	DDI-false
Chlorpromazine : Chlorpromazine blocks dopamine and norepinephrine receptors , thus inhibiting the central stimulant effects of @DRUG$ And can be used to treat @DRUG$ poisoning .	DDI-false
Ritonavir and indinavir: Upon concomitant administration of 5 mg of @DRUG$ with 600 mg BID ritonavir, the Cmax and AUC of @DRUG$ were reduced by approximately 20%.	DDI-false
@DRUG$: The rate and extent of absorption of ciprofloxacin was bioequivalent when Proquin XR was given alone or when @DRUG$ was given 2 hours after omeprazole at the dose that maximally suppresses gastric acid secretion.	DDI-false
Results of studies in multiple sclerosis patients taking TYSABRI  and concomitant interferon beta-1a (AVONEX  30 mcg IM once weekly) or @DRUG$ were inconclusive with regard to the need for dose adjustment of the @DRUG$ or glatiramer acetate.	DDI-false
Imipramine (5 mg/kg), moclobemide (30 mg/kg), clonazepam (0.25 mg/kg), @DRUG$ (20 mg/kg) @DRUG$ (30 mg/kg) or vehicle was administered.	DDI-false
@DRUG$ , tricyclic @DRUG$ may enhance the activity of tricyclic antidepressants or sympathomimetic agents ;	DDI-false
Hypotension patients receiving diuretic therapy: @DRUG$ and especially those in whom diuretic therapy was recently instituted , as well as those on severe dietary salt restriction or dialysis , may occasionally experience a precipitous reduction of blood pressure usually within the first hour after receiving the initial dose of @DRUG$.	DDI-effect
Patients receiving @DRUG$ If allopurinol is co-administered, a dose reduction of @DRUG$ , to approximately 1/3 to 1/4 the usual dose .	DDI-false
Dose adjustment is not recommended.Levetiracetam had no effect on plasma concentrations of carbamazepine, @DRUG$, @DRUG$, or lamotrigine.	DDI-false
Acetaminophene/theophylline, lidocaine/chinidine, @DRUG$/@DRUG$ , phenobarbital/valproic acid , quinidine/lidocaine , theophylline/acetaminophen , and valproic acid/phenobarbital .	DDI-false
Tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , @DRUG$ , @DRUG$ , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as @DRUG$, intraconazole, ritonavir, @DRUG$, saquinavir, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
Administration of @DRUG$ The serum concentrations of amiodarone and @DRUG$ with oral amiodarone have been shown to decrease.	DDI-false
Reciprocal interactions may occur with concomitant use of Antizol and drugs that increase or inhibit the cytochrome P450 system ( e.g. , phenytoin , carbamazepine , @DRUG$ , @DRUG$ ) , though this has not been studied	DDI-false
In rats, co-administration of @DRUG$ and @DRUG$ in the diet for 78 weeks has been reported to cause tumors , and it has been suggested that disulfiram may react with nitrites in the rat stomach to form a nitrosamine , which is tumorigenic .	DDI-effect
Further, no effects on either @DRUG$ levels or prothrombin times were observed in a study involving concomitant administration of warfarin and @DRUG$.	DDI-false
Since the therapeutic field of @DRUG$ is narrow @DRUG$ serum levels should be monitored closely , and appropriate dosage adjustments of theophylline should be made .	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and @DRUG$) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of @DRUG$.	DDI-false
Lithium generally should not be given with diuretics because they reduce @DRUG$s renal clearance and add a high risk of @DRUG$ toxicity.	DDI-false
Cholestyramine and colestipol resins : Absorption of @DRUG$ This is affected in the presence of @DRUG$.	DDI-mechanism
Other Cardiovascular Agents: @DRUG$ and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, hydralazine, @DRUG$ and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Tagamet, apparently due to an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, @DRUG$ , propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, @DRUG$ , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .	DDI-false
Potential drug interactions between Keppra  and other AEDs (@DRUG$, @DRUG$, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
acetaminophen/theophylline , lidocaine/quinidine , phenobarbital/acetaminophen , phenobarbital/@DRUG$ , quinidine/@DRUG$ , theophylline/acetaminophen , and valproic acid/phenobarbital .	DDI-false
In EM-persons treated with @DRUG$ or @DRUG$ The AUC of atomoxetine is about 6- to 8-fold and Css, max is about 3- to 4-fold greater than atomoxetine alone.	DDI-false
Coadministration of @DRUG$ and cyclosporine, @DRUG$ or digoxin has led to increased plasma concentrations of the latter three drugs.	DDI-mechanism
Since the therapeutic field of @DRUG$ is narrow theophylline serum levels should be monitored closely , and appropriate dosage adjustments of @DRUG$ should be made .	DDI-false
Coadministration with compounds that are potent inducers of CYP3A4 ( eg , phenobarbital , @DRUG$ , dexamethasone , @DRUG$ This may lead to decreased plasma levels of saquinavir.	DDI-false
In clinical studies with fondaparinux, concomitant use of oral anticoagulants ( warfarin), platelet inhibitors (acetylsalicylic acid) and NSAIDs ( @DRUG$ ) , and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of @DRUG$.	DDI-false
Careful observation is required when @DRUG$ is administered concurrently with @DRUG$.	DDI-advise
Acetaminophene, lidocaine, phenobarbital, quinidine, @DRUG$ , and @DRUG$ were added to pooled human serum at therapeutic concentrations .	DDI-false
@DRUG$ may enhance the effects of alcohol, barbiturates, and other @DRUG$.	DDI-effect
There is a significant increase in exposure to @DRUG$ when @DRUG$ is coadministered with ketoconazole ( CYP3A4 inhibitor ) .	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with @DRUG$, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with @DRUG$ or Innovar than with pentobarbital.	DDI-false
There have been greater than 2-fold increases in previously stable plasma levels of other antidepressants, including @DRUG$, when @DRUG$ has been administered in combination with these agents.	DDI-mechanism
@DRUG$ : Caution should be used if @DRUG$ is administered concomitantly with methotrexate .	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, @DRUG$, oral @DRUG$, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Concomitant cyclophosphamide, doxorubicin, @DRUG$, and prednisone chemotherapy plus @DRUG$ therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
@DRUG$ and Zidovudine @DRUG$ can antagonize the in vitro antiviral activity of stavudine and zidovudine against HIV.	DDI-false
Elevated serum levels of cyclosporine have been reported with concomitant use of @DRUG$ with @DRUG$.	DDI-mechanism
For example, inhibitors are azole antimycotics, ciprofloxacin, @DRUG$ , diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, @DRUG$ , protease inhibitors, quinidine, and verapamil.	DDI-false
Concurrent administration of @DRUG$ (for the treatment of hypotension related to obstetric blocks) and @DRUG$ may cause severe, persistent hypertension or cerebrovascular accidents.	DDI-effect
@DRUG$ : Because of the relationship of Accutane to vitamin A , patients should be advised against taking vitamin supplements containing @DRUG$ To avoid additive toxic effects	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus @DRUG$) without receiving @DRUG$ therapy.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, @DRUG$, nefazodone, nicardipine, propofol, protease inhibitors, @DRUG$, and verapamil.	DDI-false
Since @DRUG$ are potentiated by the @DRUG$ , they should be used cautiously in the treatment of convulsions .	DDI-advise
@DRUG$ : DURAGESIC   is not recommended for use in patients who have received MAOI within 14 days because severe and unpredictable potentiation by MAO inhibitors has been reported with @DRUG$	DDI-false
@DRUG$ ( 600 mg b.i.d . ) co-administered with Vardenafil 5 mg resulted in a 49-fold increase in vardenafil AUC and a 13-fold increase in @DRUG$ Cmax .	DDI-false
Because of the increased risk of adverse reactions in patients who have been taking benzodiazepines on a regular basis, it is particularly important that physicians query patients or their guardians carefully about benzodiazepine, alcohol and @DRUG$ use as part of the history prior to any procedure in which the use of @DRUG$ is planned.	DDI-false
Particular caution is necessary when using @DRUG$ in cases of mixed drug overdosage since the toxic effects (such as convulsions and cardiac dysrhythmias) of other drugs taken in overdose (especially cyclic antidepressants) may emerge with the reversal of the @DRUG$ effect by flumazenil.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., @DRUG$, @DRUG$) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, @DRUG$, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and @DRUG$, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
This appears to be the only clinically relevant interaction of this species with mefloquines, although theoretically the concomitant use of other medicinal products is known to alter the heart conduction (e.g. anti-arrhythmic or @DRUG$ - calcium channel blockers, antihistamines or H1-blockers, @DRUG$ and phenothiazines ) might also contribute to a prolongation of the QTc interval .	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine , although theoretically , coadministration of other drugs known to alter cardiac conduction ( eg , anti-arrhythmic or beta-adrenergic blocking agents , calcium channel blockers , @DRUG$ or H1-blocking agents , tricyclic antidepressants and @DRUG$ ) could also contribute to an extension of the QTc interval.	DDI-false
The coingestion of acetaminophen with theophylline, @DRUG$ with @DRUG$ Valproic acid with phenobarbital in high to toxic concentrations decreases the binding of the target drug.	DDI-effect
for adult-onset diabetics, dosage adjustment of @DRUG$ may be necessary during and after @DRUG$ therapy;	DDI-advise
Because @DRUG$ is metabolized by CYP2C9 and CYP3A4, patients who require anticoagulation should receive low-molecular weight or standard @DRUG$.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, @DRUG$, nitrates, @DRUG$, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Patients receiving high doses of salicylates concomitantly with @DRUG$ , as in rheumatic diseases, can experience @DRUG$ toxicity at lower doses because of competitive renal excretory sites .	DDI-false
Similarly dialyzed were phenobarbital, @DRUG$, and theophylline, both alone at therapeutic concentrations in serum and with @DRUG$ at three different concentrations in serum.	DDI-false
Although the specific drug interaction was not studied in a clinical trial, there have been more than 50 episodes of concomitant use of antifibrinolytic therapies (i.e., @DRUG$, @DRUG$) and NovoSeven.	DDI-false
These drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , @DRUG$ , sympathomimetics , @DRUG$ , and isoniazid .	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, @DRUG$ (e.g., benzodiazepines), general anesthetics, phenothiazines, @DRUG$, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Potential drug interactions between Keppra   and other AEDs ( carbamazepine , gabapentin , @DRUG$ , phenobarbital , phenytoin , primidone and @DRUG$ ) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies .	DDI-false
Like @DRUG$ ( 40 mg/ kg ), @DRUG$ 40 mg/kg) decreases intravenous self-administration of morphine and cocaine and oral self-administration of ethanol and nicotine in rats;	DDI-false
@DRUG$: A case of severe hypoglycemia has been reported in a type II diabetic patient maintained on tolazamide (1 gm/day) 11 days after the addition of @DRUG$ (75 mg/day).	DDI-false
The concomitant use of naltrexone with @DRUG$ The result was a 25% increase in AUC and a 33% increase in Cmax of @DRUG$.	DDI-false
Drug/Laboratory Test Interaction Fosinopril may cause a false low measurement of serum @DRUG$ levels with the Digi- Tab  RIA Kit for @DRUG$.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril , beta-blockers , @DRUG$ , digoxin , @DRUG$ , isosorbide mononitrate, knitztilol, ethanol or itraconazole.	DDI-false
Results of studies in multiple sclerosis patients taking TYSABRI  and concomitant @DRUG$ (AVONEX  30 mcg IM once weekly) or @DRUG$ were inconclusive with regard to the need for dose adjustment of the beta-interferon or glatiramer acetate.	DDI-false
Other concomitant therapy Although specific interaction studies have not been performed, 1 mg or more of finasteride doses have been co-administered in clinical trials with acetaminophen, acetylsalicylic acid, A-blockers, analgesics, angiotensin converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta-blockers, calcium channel blockers, heart @DRUG$ , diuretics , H2 antagonists , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as @DRUG$ In addition, quinolones anti-infections with no evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ and @DRUG$ ( Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS , 3020 ( 91 % ) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists ( ACEI/ARB ) .	DDI-false
Injection : @DRUG$ Injection, such as other injectable benzodiazepines, produces depression of the central nervous system when with @DRUG$ , phenothiazines, barbiturates, MAO inhibitors, and other antidepressants. If scopolamine is associated with injectable lorazepam, an increased incidence of sedation, hallucinations and irrational behaviour has been observed.	DDI-effect
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other @DRUG$, including but not limited to other opioids, @DRUG$, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Concomitant administration of other @DRUG$ may potentiate the undesirable effects of @DRUG$.	DDI-effect
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including @DRUG$ and other drugs that are highly protein bound, salicylates, @DRUG$, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
@DRUG$ : Patients on diuretics , especially those with intravascular volume depletion , may occasionally experience an excessive reduction of blood pressure after initiation of therapy with @DRUG$.	DDI-false
In patients with chronic hepatitis C treated with @DRUG$ in combination with COPEGUS, PEGASYS treatment did not affect @DRUG$ distribution or clearance.	DDI-false
These drugs include thiazides and other @DRUG$ , corticosteroids , phe-nothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimet-ics , calcium channel blocking drugs , and @DRUG$.	DDI-false
The effect of rifampin on the @DRUG$ The need of our patient seemed to be maximum 5 to 7 days after the induction of rifampin and extended a similar length of time after @DRUG$ withdrawal .	DDI-false
Haloperidol : @DRUG$ • Impairs dopamine receptors and thus inhibits the central stimulating effects of @DRUG$.	DDI-effect
acetaminophen/theophylline , @DRUG$/quinidine , phenobarbital/acetaminophen , phenobarbital/valproic acid , quinidine/lidocaine , theophylline/acetaminophen , and valproic acid/@DRUG$.	DDI-false
The hypoglycaemic effect of sulphonylureas can be enhanced by certain medications, including non-steroidal anti-inflammatory drugs and other medicines that are highly protein bound, salicylates, sulphonamides, @DRUG$ , @DRUG$ , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .	DDI-false
HMG-CoA Reductase Inhibitors : @DRUG$ ( CYP3A4 substrate ) in combination with @DRUG$ has been associated with reports of myopathy/rhabdomyolysis .	DDI-false
Concurrent administration of @DRUG$ and androgens may result in elevated serum levels of @DRUG$.	DDI-false
Therefore, interactions following concomitant administration of psychotropic medicinal products (e.g. narcotics, analgesics, @DRUG$ , @DRUG$ , sedatives).	DDI-false
Antihistamines: @DRUG$ may counteract the sedative effect of @DRUG$.	DDI-effect
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, Dapson, disopyramide, quinine, @DRUG$ , quinidine , @DRUG$ , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
Cephalosporine-@DRUG$ containing side chains of N-methylthiotetrazole (cefmenoxime, cefooperazone, cefotetan, cefamandol), @DRUG$ ) or methylthiadiazole ( cefazolin ) can cause vitamin K deficiency and hypoprothrombinemia .	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations : Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family ( e.g. , ketoconazole , @DRUG$ , erythromycin , @DRUG$ ) .	DDI-false
Further, no effects on either @DRUG$ levels or prothrombin times were observed in a study involving concomitant administration of @DRUG$ and fluvastatin.	DDI-false
Olanzapine: concomitant use of @DRUG$ 3 mg and @DRUG$ 10 mg produced a decrease in DSST scores.	DDI-effect
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and @DRUG$.	DDI-false
The concomitant use of @DRUG$ tablets and other @DRUG$ is not recommended due to the increased possibility of gastrointestinal toxicity , with little or no increase in efficacy .	DDI-effect
Co-medications that induce CYP3A4 (e.g., @DRUG$, phenytoin, carbamazepine, @DRUG$, phenobarbital or St.	DDI-false
Other @DRUG$ ( e.g. , @DRUG$ ==References====External links==	DDI-false
Similarly dialyzed were @DRUG$, quinidine, and @DRUG$, both alone at therapeutic concentrations in serum and with ethanol at three different concentrations in serum.	DDI-false
Standard monitoring of methotrexate-related toxicity should be continued if @DRUG$ and @DRUG$ are administered concomitantly .	DDI-advise
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect @DRUG$ pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and @DRUG$ cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
@DRUG$: Other antiarrhythmic drugs, such as quinidine, @DRUG$, disopyramide, and phenytoin, have been used concurrently with amiodarone.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, @DRUG$, calcium channel blocking drugs, and @DRUG$.	DDI-false
In general , these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride , including anti-arrhythmic agents such as @DRUG$ and procainamide , @DRUG$ And tricyclic antidepressants.	DDI-false
Administration of @DRUG$ concomitantly with oral amiodarone has been shown to result in decreases in serum concentrations of amiodarone and @DRUG$.	DDI-false
Tolbutamide : In diabetic patients who @DRUG$ There were no significant effects on the @DRUG$ Plasma levels or fasting blood sugar.	DDI-false
Other cardiovascular agents: Enalapril and Enalapril IV were co-administered with beta-adrenergic blockers, methyldopa, @DRUG$ , calcium-blocking agents , hydralazine , prazosin and @DRUG$ without evidence of clinically significant adverse interactions .	DDI-false
@DRUG$ MAOI antidepressants, as well as a metabolite of @DRUG$, slow amphetamine metabolism.	DDI-false
@DRUG$ and butyrophenones may reduce or reverse the pressor effect of @DRUG$.	DDI-effect
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, @DRUG$, @DRUG$, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
- Anabolic steroids ( nandrolone [ e.g. , Anabolin ] , oxandrolone [ e.g. , Anavar ] , @DRUG$ [e.g. Anadrol ], stanozole [e.g., @DRUG$ ] ) or	DDI-false
Potential drug interactions between Keppra  and other AEDs (@DRUG$, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these @DRUG$ during placebo-controlled clinical studies.	DDI-false
These drugs include the thiazides and other diuretics, @DRUG$, @DRUG$, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
These results suggest that both dexamethasone and @DRUG$, and possibly other @DRUG$ and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF.	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as @DRUG$, @DRUG$, ritonavir, indinavir, saquinavir, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
Results of studies in multiple sclerosis patients taking TYSABRI  and concomitant interferon beta-1a (@DRUG$  30 mcg IM once weekly) or @DRUG$ were inconclusive with regard to the need for dose adjustment of the beta-interferon or glatiramer acetate.	DDI-false
Other Drugs : Drugs such as quinidine , @DRUG$ , procainamide , phenothiazines , antihistamines , and @DRUG$ It may be associated with QT interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
@DRUG$: In healthy individuals, plasma concentrations of atorvastatin increased approximately 40% with coadministration of @DRUG$ and erythromycin, a known inhibitor of cytochrome P450 3A4.	DDI-false
Concurrent administration of @DRUG$ and @DRUG$ may result in elevated serum levels of oxyphenbutazone.	DDI-mechanism
Benzthiazide may interact with @DRUG$, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, @DRUG$ like Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
Drug Interactions : Flupenthixol may interact with some drugs , like @DRUG$ ( MAOI ): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol : Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants : Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, @DRUG$, @DRUG$, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
BACKGROUND: The effects of combined administration of bombesin and @DRUG$ (@DRUG$), a calcium channel blocker, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane (AOM) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
There have been case reports of increased steady-state levels of quinidine, procainamide, and @DRUG$ during concomitant therapy with @DRUG$.	DDI-false
Nursing Mothers It is not known whether @DRUG$ or @DRUG$ The ingredients are excreted in breast milk.	DDI-false
Furosemide : Clinical studies , as well as post marketing observations , have shown that @DRUG$ The natriuretic effect of @DRUG$ and thiazides in some patients .	DDI-effect
@DRUG$, such as verapamil, diltiazem and @DRUG$, inhibit platelet activation in vitro, and decrease platelet adhesion intravascularly.	DDI-false
Nonsteroidal Anti-Inflammatory Drugs : The administration of @DRUG$ In normal subjects receiving indomethacin, they decreased renal clearance and significantly increased plasma levels of @DRUG$.	DDI-false
@DRUG$: In an interaction study of rheumatoid arthritis patients taking methotrexate, @DRUG$ did not have a significant effect on the pharmacokinetics of methotrexate.	DDI-false
Single doses of any of the following doses: @DRUG$ or colestipol @DRUG$ bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent , respectively .	DDI-false
The availability of potent non-nucleoside reverse transcriptase inhibitor (NNRTI)-based regimens for @DRUG$ therapy and concerns regarding protease inhibitor (@DRUG$)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection .	DDI-false
Since higher doses of @DRUG$ (400 mg daily) may result in higher increases in Cmax and AUC, a single 2.5 mg dose of Vardenafil should not be exceeded in a 24-hour period when used in combination with @DRUG$ 400 mg daily.	DDI-false
Hemodynamic and electrophysiologic interactions have also been observed after concomitant administration with @DRUG$, diltiazem, and @DRUG$.	DDI-false
@DRUG$ The simultaneous use of @DRUG$ Good tolerability was achieved in patients with stable angina pectoris and beta-blockers.	DDI-false
@DRUG$ (600 mg b.i.d.) co-administered with Vardenafil 5 mg resulted in a 49-fold increase in vardenafil AUC and a 13-fold increase in @DRUG$ Cmax.	DDI-false
@DRUG$/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
Omeprazole: The rate and extent of absorption of ciprofloxacin was bioequivalent when @DRUG$ was given alone or when Proquin XR was given 2 hours after @DRUG$ at the dose that maximally suppresses gastric acid secretion.	DDI-false
Tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , @DRUG$ , @DRUG$ And metronidazole, which delays the elimination and increase in blood levels of these drugs.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
These results suggest that both @DRUG$ and retinyl acetate, and possibly other glucocorticoids and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and @DRUG$.	DDI-effect
In clinical studies conducted with fondaparinux, concomitant use of oral anticoagulants ( warfarin), platelet inhibitors ( @DRUG$ ) , @DRUG$ ( piroxicam ) , and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium .	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a @DRUG$, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, @DRUG$, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
Isocarboxazid should be used with caution in patients who: @DRUG$ ( @DRUG$ , Wyeth-Ayerst Laboratories ) .	DDI-false
( In some patients @DRUG$ can reduce the diuretic , natriuretic , and antihypertensive effects of loop , @DRUG$.	DDI-effect
Patients receiving @DRUG$, @DRUG$, or sulfonylureas should be observed for increased activity of these drugs and, therefore, signs of toxicity from these drugs.	DDI-false
These drugs include the thiazides and other diuretics, @DRUG$, phenothiazines, thyroid products, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
This medicine can be used with @DRUG$ or other CNS depressants ( may potentiate the CNS depressant effects of either these medications or antihistamines ) , @DRUG$ • or other medicines with anticholinergic activity (anticholinergic effects can be intensified if these drugs are used simultaneously with antihistamines), and monoamine oxidase (MAO) inhibitors ( concomitant use with antihistamines can prolong and increase the anticholinergic and CNS depressive effects of antihistamines.	DDI-false
In vitro data suggest that @DRUG$, when compared to @DRUG$, has a less pronounced effect on the biotransformation system responsible for the metabolism of astemizole.	DDI-false
These results suggest that both dexamethasone and retinyl acetate, and possibly other glucocorticoids and @DRUG$, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of @DRUG$ and EGF.	DDI-effect
Potassium-sparing diuretics (e.g., spironolactone, triamterene, or amiloride), @DRUG$ supplements, or @DRUG$-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
Other strong inhibitors of CYP3A4 (e.g., itraconazole, @DRUG$, nefazodone, @DRUG$, ritonavir, nelfinavir) would be expected to behave similarly.	DDI-false
Digoxin : When multiple doses of atorvastatin and @DRUG$ were coadministered , steady-state plasma @DRUG$ concentrations increased by approximately 20 % .	DDI-false
Reciprocal interactions may occur with concomitant use of Antizol and drugs that increase or inhibit the cytochrome P450 system (e.g., phenytoin, @DRUG$, cimetidine, @DRUG$), though this has not been studied	DDI-false
Drugs With A Narrow Therapeutic Index Digoxin A single dose of @DRUG$ 3 mg did not affect the pharmacokinetics of @DRUG$ measured at steady state following dosing of 0.5 mg twice daily for one day and 0.25 mg daily for the next 6 days.	DDI-false
Also, phenobarbital, @DRUG$ , and theophylline , both alone at therapeutic concentrations in serum and with @DRUG$ At three different serum concentrations.	DDI-false
Effect of @DRUG$ in Pediatric Patients There was about a 22 % increase of apparent total body clearance of @DRUG$ when it was co-administered with enzyme-inducing AEDs .	DDI-false
The authors investigated the possibility of a similar interaction between @DRUG$ and @DRUG$.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, @DRUG$, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with @DRUG$ administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, @DRUG$, and @DRUG$.	DDI-false
- anabolic steroids (Nandrolone [e.g. Anaboline], Oxandrolone [e.g., Anavar], Oxymetholone [e.g., @DRUG$ ] , @DRUG$ [ e.g. , Winstrol ] ) or	DDI-false
Specific studies have these effects with: @DRUG$ , isoflurane , propofol , alfentanil , and @DRUG$.	DDI-false
These drugs include the thiazides and other @DRUG$ , corticosteroids , phe-nothiazines , thyroid products , @DRUG$ , oral contraceptives , phenytoin , nicotinic acid , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .	DDI-false
The possibility of hypotensive effects with enalapril or enalaprilat can be minimized by either discontinuing the @DRUG$ or increasing the salt intake prior to initiation of treatment with @DRUG$ or enalaprilat .	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride, including @DRUG$ such as quinidine and procainamide, @DRUG$ and tricyclic anti-depressants.	DDI-false
Elevated serum levels of cyclosporine have been reported with concomitant use of @DRUG$ with @DRUG$.	DDI-mechanism
Like ibogaine (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of @DRUG$ and @DRUG$ and the oral self-administration of ethanol and nicotine in rats;	DDI-false
Because @DRUG$ It has not been shown to produce an additional effect beyond that obtained with aspirin alone, and because aspirin increases the rate of excretion of @DRUG$ , the concomitant use of Nalfon and salicylates is not recommended .	DDI-false
Intravenous adenocard (adenosine) has been effective in the presence of other cardiovascular drugs such as @DRUG$ , beta-adrenergic blocking agents , @DRUG$ , and angiotensin converting enzyme inhibitors , without any change in the adverse reaction profile .	DDI-false
Digoxin and @DRUG$ The application may rarely be associated with ventricular fibrillation when combined with @DRUG$.	DDI-effect
Observations from drug interaction studies with @DRUG$ may not be predictive for @DRUG$.	DDI-false
The management of others @DRUG$ with @DRUG$ has been shown to reduce the antihypertensive effect in some patients and result in severe hyperkalemia in patients with impaired renal function .	DDI-effect
@DRUG$ Potassium supplements (e.g. spironolactone, triamterene or amiloride), potassium supplements or salt substitutes containing @DRUG$ may lead to a significant increase in serum potassium.	DDI-false
@DRUG$, including norfloxacin, may enhance the effects of oral anticoagulants, including @DRUG$ or its derivatives or similar agents.	DDI-effect
Lithium: Lithium toxicity has been reported in patients receiving @DRUG$ concomitantly with drugs which cause elimination of sodium, including @DRUG$.	DDI-effect
Vitamin A : Because of the relationship between Accutane and @DRUG$ , patients should be advised against taking vitamin supplements containing @DRUG$ To avoid additive toxic effects	DDI-false
Cardiovasculars : @DRUG$ In patients who: @DRUG$ The oral administration of amiodarone regularly leads to an increase in serum digoxin concentration, which can reach toxic concentrations with resulting clinical toxicity.	DDI-false
Since @DRUG$ is a substrate for CYP3A4 and CYP2C8 , drugs/substances that inhibit these isoenzymes may decrease the metabolism and increase serum concentration of @DRUG$.	DDI-false
However, high doses of @DRUG$ The effectiveness of @DRUG$ administered intrathecally may be reduced.	DDI-effect
The availability of potent non-nucleoside reverse transcriptase inhibitors (@DRUG$)-based antiretroviral therapy and concerns about @DRUG$ (PI)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection .	DDI-false
@DRUG$: Simvastatin (@DRUG$ substrate) in combination with amiodarone has been associated with reports of myopathy/rhabdomyolysis.	DDI-false
Although this effect was noted even when @DRUG$ was given 4 hours prior to @DRUG$, this regimen did not result in diminished efficacy.	DDI-effect
@DRUG$ In diabetics, the diflunisal and @DRUG$ No significant effects on tolbutamide plasma levels or fasting blood sugar were observed.	DDI-false
Other concomitant therapy Although no specific interaction studies have been conducted, 1 mg or more of fissteride doses have been co-administered in clinical trials with acetaminophen, @DRUG$ , a-blockers , analgesics , angiotensin-converting enzyme ( ACE ) inhibitors , @DRUG$ , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , H2 antagonists , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
Possible interactions between Keppra and other medicinal products @DRUG$ ( carbamazepine , gabapentin , lamotrigine , phenobarbital , @DRUG$ In placebo-controlled clinical trials, serum concentrations of levetiracetam and these AEDs have also been studied.	DDI-false
These drugs include the @DRUG$ and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with @DRUG$ plus @DRUG$) without receiving antiretroviral therapy.	DDI-false
Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving @DRUG$ (caution is recommended during coadministration with @DRUG$): Coadministration of fluoxetine with alprazolam increased the maximum plasma concentration of alprazolam by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance.	DDI-false
Ergot Derivatives: Dihydroergotamine, ergonovine, ergotamine, @DRUG$ CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute @DRUG$ toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
Levosimendan has no clinically important pharmacokinetic interactions with @DRUG$ , @DRUG$ , felodipine, digoxin, warfarin, isosorbide mononitrate, schnitztilol, ethanol or itraconazole.	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , @DRUG$ , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with @DRUG$ ;	DDI-mechanism
While all the selective serotonin reuptake inhibitors ( SSRIs ) , e.g. , citalopram , escitalopram , @DRUG$ , sertraline , and @DRUG$ , inhibit P450 2D6 , they may vary in the extent of inhibition .	DDI-false
Other Cardiovascular Agents : Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents , methyldopa , nitrates , calcium-blocking agents , @DRUG$ , @DRUG$ And digoxin without evidence of clinically significant adverse interactions.	DDI-false
Other Cardiovascular Agents: @DRUG$ and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, @DRUG$, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Although @DRUG$ have been shown to reduce PROLEUKIN-induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided . 12 Beta-blockers and other @DRUG$ may potentiate the hypotension seen with PROLEUKIN .	DDI-false
Other Drugs : Drugs such as quinidine , disopyramide , procainamide , phenothiazines , @DRUG$ , and @DRUG$ may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia .	DDI-false
Benzthiazide may interact with alcohol , blood thinners , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , NSAIDs like @DRUG$ or @DRUG$ , and high blood pressure medications.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as @DRUG$ or aluminum antacids, sucralfate, @DRUG$ chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
Moreover , additional interaction studies with @DRUG$ The use of fluvastatin and propranolol showed no effect on plasma fluvastatin levels and chronic use in a patient population that: @DRUG$ The bioavailability of digoxin compared to control data was not different.	DDI-false
Aspirin/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered @DRUG$ (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or @DRUG$ (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
@DRUG$ - prior ingestion of diphenidol may decrease the @DRUG$ response to apomorphine in the treatment of poisoning.	DDI-false
Compounds tested in man include warfarin , theophylline , phenytoin , @DRUG$ , aminopyrine and @DRUG$.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, @DRUG$, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Central nervous system depressants : Co-administration of @DRUG$   ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general @DRUG$ , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	DDI-effect
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other @DRUG$, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., @DRUG$), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
The similarity of the @DRUG$ -associated adverse event profile between Study 1 ( without co-administered AVONEX ) and Study 2 ( with co-administered @DRUG$ ) indicates that this change in clearance is not required to reduce the TYSABRI dose to maintain safety.	DDI-false
In order to evaluate the effects of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL ), the authors retrospectively compared a group of 24 patients with HIV-NHL who had been treated with the @DRUG$ , doxorubicin , vincristine , and prednisone ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , doxorubicin , teniposide , and prednisone with vincristine plus bleomycin ) without receiving @DRUG$ therapy .	DDI-false
Drug-Drug Interactions Between Keppra   And Other Antiepileptic Drugs ( @DRUG$ ) Phenytoin @DRUG$   ( 3000 mg daily ) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy .	DDI-false
Amiodarone taken concomitantly with @DRUG$ for less than seven days increases plasma concentrations of procainamide and n-acetyl @DRUG$ by 55 % and 33 % , respectively .	DDI-false
Sedatives/Hypnotics : @DRUG$ , @DRUG$ CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as prolonged or increased sedation or respiratory depression .	DDI-false
Co-administration of warfarin and @DRUG$ did not alter the pharmacokinetics of @DRUG$.	DDI-false
The intensity, uniformity and time course of the anticoagulant interference by phenobarbital, @DRUG$ , glutethimide , @DRUG$ In 16 patients receiving coumarin therapy, methaqualone and methaqualone were systematically studied.	DDI-false
- Anabolic steroids ( @DRUG$ [ e.g. Anaboline ], Oxandrolone [ e.g. Anavar ], @DRUG$ [ e.g. Anadrol ], stanozozole [ e.g. Winstrol ] or	DDI-false
Data from in vitro studies of @DRUG$ Other than alprazolem propose a possible interaction for the following drugs: @DRUG$ , cyclosporine , amiodarone , nicardipine , and nifedipine .	DDI-int
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, @DRUG$, protease inhibitors, @DRUG$, and verapamil.	DDI-false
Stavudine and Zidovudine Ribavirin can antagonize the in vitro antiviral activity of @DRUG$ and @DRUG$ against HIV.	DDI-false
Example inhibitors include @DRUG$, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, @DRUG$, quinidine, and verapamil.	DDI-false
Drug-Drug Interactions Between Keppra   And Other Antiepileptic Drugs ( @DRUG$ ) @DRUG$ Keppra   ( 3000 mg daily ) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy .	DDI-false
@DRUG$ Amphetamines can antagonistize the blood pressure lowering effects of @DRUG$.	DDI-false
♪ Drugs that can change ♪ @DRUG$ Plasma concentrations Medicines that may increase the plasma concentration of imatinib: Caution should be exercised when gleevec is administered with CYP3A4 inhibitors (e.g. ketoconazole, @DRUG$ , erythromycin , clarithromycin ) .	DDI-false
The compounds tested in humans include warfarin, @DRUG$ , phenytoin , diazepam , @DRUG$ and antipyrine .	DDI-false
To assess the effect of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL), the authors retrospectively compared a group of 24 patients with HIV-NHL treated with cyclophosphamide, doxorubicin, vincristine, and @DRUG$ ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , doxorubicin , teniposide , and prednisone with @DRUG$ plus bleomycin ) without receiving antiretroviral therapy .	DDI-false
The concomitant use of these oral @DRUG$ The pharmacokinetics of @DRUG$ have not been affected.	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , @DRUG$ , sulphonamides, chloramphenicol, @DRUG$ , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .	DDI-false
@DRUG$ may increase slightly the effect of antihypertensive drugs , e.g. , guanethidine , @DRUG$ , reserpine .	DDI-effect
Aspirin : When @DRUG$ is administered with @DRUG$ His protein binding is reduced, although the clearance of free etodolac is not altered.	DDI-mechanism
The @DRUG$ Study participants with 1200 mg/day azithromycin ( n = 7 ) ( subsequently changed to 600 mg/day [ n = 5 ]) for days 8 to 21 of a 21-day course of 100 mg, five times/day @DRUG$.	DDI-false
Multivalent Cation-Containing Products : Concurrent administration of a @DRUG$ , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , @DRUG$ chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .	DDI-mechanism
Prostatic epithelium proliferates in a defined medium consisting of basal medium RPMI1640 containing @DRUG$ ( 1 microgram/ml ) , @DRUG$ ( 10 ng/ml ) , and insulin ( 3.7 micrograms/ml or 0.1 IU/ml ) .	DDI-false
Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving @DRUG$ (caution is recommended during coadministration with alprazolam): Coadministration of @DRUG$ with alprazolam increased the maximum plasma concentration of alprazolam by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance.	DDI-false
acetaminophen/theophylline , lidocaine/quinidine , phenobarbital/@DRUG$ , phenobarbital/valproic acid , @DRUG$/lidocaine , theophylline/acetaminophen , and valproic acid/phenobarbital .	DDI-false
Multivitamins, or other products containing iron or zinc, @DRUG$ or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of @DRUG$, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.	DDI-advise
@DRUG$ Renal tubular transport of methotrexate may be inhibited by concomitant administration of @DRUG$, potentially leading to increased plasma levels of methotrexate.	DDI-false
@DRUG$ : NSAIDs have produced an elevation of plasma lithium levels and a reduction in renal @DRUG$ clearance .	DDI-false
@DRUG$ (5 mg/kg), @DRUG$ (30 mg/kg), clonazepam (0.25 mg/kg), fluoxetine (20 mg/kg) sertraline (30 mg/kg) or vehicle was administered.	DDI-false
Caution should be exercised when @DRUG$ It is specified in connection with @DRUG$.	DDI-advise
No drug interactions between argatroban and argatroban have been observed. @DRUG$ or @DRUG$.	DDI-false
Specific studies have confirmed these effects with @DRUG$ , isoflurane , @DRUG$ , alfentanil, and midazolam.	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , @DRUG$ , Dapson, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$ , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
acetaminophen/@DRUG$, @DRUG$/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
In patients receiving @DRUG$ and a @DRUG$ At the same time, any reduction in steroid dose should be done gradually to avoid possible complications of sudden steroid withdrawal.	DDI-advise
however, no deleterious interactions were seen when ROMAZICON was administered after @DRUG$, inhalational anesthetics, @DRUG$ and muscle relaxant antagonists administered in conjunction with sedation or anesthesia.	DDI-false
INOmax has been administered with @DRUG$, dopamine, dobutamine, @DRUG$, surfactant, and high-frequency ventilation.	DDI-false
The concomitant intake of @DRUG$ and Acamprosate does not affect the pharmacokinetics of either @DRUG$ or acamprosate.	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, @DRUG$, cefotetan, cefamandole, latamoxef) or methylthiadiazole (@DRUG$) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
• Concomitant administration of medicinal products that are nephrotoxic (e.g. aminoglycosides, indomethacin), myelotoxic (e.g. cytotoxic chemotherapy), cardiotoxic (e.g. @DRUG$ Hepatotoxic effects (e.g. methotrexate, asparaginase) @DRUG$ The toxicity in these organ systems can be increased.	DDI-effect
@DRUG$: In some patients, the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of @DRUG$.	DDI-false
Potassium-sparing diuretics (e.g. @DRUG$ , triamterene , or amiloride ) , potassium supplements , or @DRUG$-containing salt substitutes may lead to significant increases in serum potassium .	DDI-false
Refer to the package insert for @DRUG$ preparations before use of such preparations with @DRUG$.	DDI-advise
Plasma levels of @DRUG$ may become subtherapeutic during @DRUG$ therapy.	DDI-mechanism
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, @DRUG$, a-blockers, analgesics, @DRUG$, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Other concomitant therapy Although specific interaction studies have not been performed, 1 mg or more of finasteride doses have been co-administered in clinical trials with acetaminophen, acetylsalicylic acid, A-blockers, analgesics, angiotensin converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta-blockers, calcium channel blockers, cardiac nitrates, diuretics, H2-antagonists, @DRUG$ , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and @DRUG$ Without evidence of clinically significant adverse interactions.	DDI-false
As with other antipsychotic agents , it should be noted that HALDOL may be capable of potentiating @DRUG$ Like anesthetics, opiates, and @DRUG$.	DDI-false
Example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , @DRUG$ , imatinib , isoniazid , nefazodone , nicardipine , propofol , @DRUG$ , quinidine, and verapamil.	DDI-false
Therefore , @DRUG$ serum levels should be monitored and appropriate @DRUG$ Dose adjustments are made when these medicines are used at the same time.	DDI-false
Refer to the package insert for @DRUG$ preparations before use of such preparations with @DRUG$.	DDI-advise
Cephalosporine cephalosporine containing side chains of N-methylthiotetrazole ( @DRUG$ , @DRUG$ , cefotetan , cefamandole , latamoxef ) or methylthiadiazole ( cefazolin ) can cause vitamin K deficiency and hypoprothrombinemia .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac @DRUG$, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ ( Neostgmin, Physostigmin), lignocaine, quinine, @DRUG$ The toxicity can be increased and lead to heart respiratory depression.	DDI-false
The effects of @DRUG$ and @DRUG$ upon phencyclidine (PCP)-induced locomotion and behavioral changes in mice .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral @DRUG$, phenytoin, @DRUG$, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Other Drugs:Drugs such as quinidine, @DRUG$, @DRUG$, phenothiazines, antihistamines, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
Drugs that may alter @DRUG$ plasma concentrations Drugs that may increase @DRUG$ plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, erythromycin, clarithromycin).	DDI-false
Anticoagulants: Potentiation of warfarin-type (@DRUG$ and CYP3A4 substrate) @DRUG$ response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding.	DDI-false
When @DRUG$ , was associated with Phenytoin, @DRUG$ Itraconazole decreased plasma concentrations have been reported.	DDI-mechanism
Because @DRUG$ It has not been shown to produce an additional effect beyond that obtained with aspirin alone and because aspirin increases the rate of excretion of nalfon, concomitant use of @DRUG$ and salicylates is not recommended .	DDI-false
@DRUG$ (@DRUG$)-A drug interaction study of eplerenone with an NSAID has not been conducted.	DDI-false
Urinary acidifying agents These agents (@DRUG$, @DRUG$, etc.) increase the concentration of the ionized species of the amphetamine molecule, thereby increasing urinary excretion.	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of the magnesium deficiency and to discriminate between magnesium deficiency due to insufficient @DRUG$ Ingestion that requires only oral physiological supplement and magnesium deficiency, which is accompanied by a dysregulation of the control mechanisms of @DRUG$ Status that requires more or less specific regulation of its causal dysregulation.	DDI-false
Adequate monitoring of @DRUG$ plasma concentrations should be considered when therapy with VIOXX is initiated or changed in patients receiving @DRUG$.	DDI-false
@DRUG$, lidocaine, phenobarbital, quinidine, theophylline, and @DRUG$ were added to pooled human serum at therapeutic concentrations.	DDI-false
The concomitant use of other CYP3A4 inhibitors such as diltiazem and erythromycin with transdermal @DRUG$ may also result in an increase in @DRUG$ plasma concentrations, which could increase or prolong adverse drug effects and may cause serious respiratory depression.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of @DRUG$, phenytoin, @DRUG$, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Pharmacokinetic or pharmacodynamic drug interactions between argatroban and co-administered aspirin (administered 162.5 mg orally 26 and 2 hours before starting treatment with aspirin/acetaminophen) have not been demonstrated. @DRUG$ 1   g/kg/min . over 4 hours ) or acetaminophen ( 1000 mg orally given 12 , 6 and 0 hours prior to , and 6 and 12 hours subsequent to , initiation of @DRUG$ 1.5 g/kg/min over 18 hours).	DDI-false
Short-term pharmacokinetic studies have shown that concomitant use of warfarin and @DRUG$   ( @DRUG$ However, there was no change in the clearance of free warfarin.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ has been administered with @DRUG$ , dopamine, dobutamine, steroids, surfactant, and high-frequency ventilation.	DDI-false
Multivitamins , or other products containing iron or @DRUG$ Antacids or sucralfate should not be administered concomitantly with or within 2 hours of Norfloxacin administration as they may impair absorption, resulting in lower serum and urine levels of @DRUG$.	DDI-false
In clinical studies performed with Fondaparinux , the concomitant use of oral anticoagulants ( warfarin ) , platelet inhibitors ( acetylsalicylic acid ) , @DRUG$ ( Piroxicam ) and @DRUG$ The pharmacokinetics/pharmacodynamics of fondaparinux sodium were not significantly affected.	DDI-false
Methotrexate: Caution should be exercised if: @DRUG$ is administered concomitantly with @DRUG$.	DDI-advise
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, @DRUG$, glutethimide, @DRUG$ and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
Notably , systemic exposure ( AUC0 - 12 ) of dapsone hydroxylamine ( @DRUG$ ) was more than doubled in the presence of TMP/@DRUG$.	DDI-false
The availability of potent non-nucleoside reverse transcriptase inhibitor (@DRUG$)-based regimens for antiretroviral therapy and concerns regarding @DRUG$ (PI)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ACE ) inhibitors , anticonvulsants , benzodiazepines , @DRUG$ , @DRUG$ , cardiac nitrates , diuretics , H2 antagonists , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
Possible interactions between Keppra and other medicinal products @DRUG$ ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of @DRUG$ and these AEDs during placebo-controlled clinical studies .	DDI-false
Injection: Lorazepam injection, like other injectable @DRUG$, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, @DRUG$, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-effect
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (alcohol, @DRUG$, opiates, sedatives, @DRUG$) should be considered.	DDI-false
No pharmacokinetic interactions between dexmedetomidine and @DRUG$, propofol, @DRUG$, and midazolam have been demonstrated.	DDI-false
Serum @DRUG$ levels should be monitored frequently if INSPRA is administered concomitantly with @DRUG$.	DDI-false
@DRUG$ : @DRUG$ The pharmacokinetics of levetiracetam 1000 mg twice daily have not been altered.	DDI-false
Cyclosporin, digoxin, methotrexate @DRUG$ , like other @DRUG$ By effects on renal prostaglandins, changes in the elimination of these drugs can lead to increased serum levels of cyclosporin, digoxin, methotrexate, and increased toxicity.	DDI-false
Antihypertensives: @DRUG$ should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a @DRUG$ inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
In general, lithium should not be co-administered with @DRUG$ because they reduce lithiums renal clearance and add a high risk of @DRUG$ toxicity .	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with @DRUG$, betablockers, calcium-channel blockers, @DRUG$, and nonsteroidal anti-inflammatory drugs (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
Example inhibitors include azole antifungals, @DRUG$, clarithromycin, diclofenac, doxycycline, erythromycin, @DRUG$, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
However, since there is an increased risk of bleeding with @DRUG$, caution should be employed when @DRUG$ is used with other drugs that affect hemostasis.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., @DRUG$, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., @DRUG$, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Benzthiazide may interact with alcohol , blood thinners , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , @DRUG$ , NSAIDs like @DRUG$ or Ibuprofen , and high blood pressure medications .	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of @DRUG$ deficit and to discriminate between @DRUG$ deficiency due to an insufficient magnesium intake which only requires oral physiological supplementation and magnesium depletion related to a dysregulation of the control mechanisms of magnesium status which requires more or less specific regulation of its causal dysregulation.	DDI-false
@DRUG$ may decrease the amount of @DRUG$ ( Lanoxin , Lanoxicaps ) that gets absorbed into your body .	DDI-mechanism
Combinations of @DRUG$ and @DRUG$: effects on drug discrimination and behavioral inhibition in rats.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ : When Vardenafil 10 or 20 mg was given to healthy volunteers either simultaneously or 6 hours after a 10 mg dose of @DRUG$ Significant hypotension develops in a significant number of subjects.	DDI-false
@DRUG$ will increase plasmaconcentration of other CYP3A4 metabolized drugs (e.g., triazolo-benzodiazepines, @DRUG$, certain HMG-CoA reductase inhibitors, etc.).	DDI-mechanism
A drug-drug interaction study evaluated the effect of the use of @DRUG$ Gel , 5 % , in combination with double strength ( 160 mg/800 mg ) trimethoprim/@DRUG$ ( TMP/SMX ) .	DDI-false
Other Cardiovascular Agents : @DRUG$ and enalapril IV have been used concomitantly with @DRUG$ , methyldopa , nitrates , calcium-blocking agents , hydralazine , prazosin and digoxin without evidence of clinically significant adverse interactions .	DDI-false
@DRUG$: Etodolac has no apparent pharmacokinetic interaction when administered with @DRUG$.	DDI-false
There was not a significant difference ( p > 0.05 ) in AUC ( 48.59 + /- 8.52 vs. 49.9 + /- 9.93 ) , Cmax ( 7.73 + /- 2.6 vs. 6.6 + /- 2.0 ) , and tmax ( 1.1 + /- 0.6 vs. 1.6 + /- 1.1 ) for @DRUG$ versus @DRUG$/oxycodone regimens .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, @DRUG$ (also referred to as @DRUG$), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Coadministration of @DRUG$ with Itraconazole has led to elevated plasma concentrations of @DRUG$, resulting in rare instances of life- threatening cardiac dysrhythmias and one death.	DDI-false
however, no deleterious interactions were seen when ROMAZICON was administered after narcotics, inhalational @DRUG$, @DRUG$ and muscle relaxant antagonists administered in conjunction with sedation or anesthesia.	DDI-false
@DRUG$ administration to three cancer patients over a dose range of 0.025 mg to 2.2 mg led to a dose-dependent inhibition of @DRUG$ elimination.14 The effect of alternate-day administration of 0.25 mg of Betaseron on drug metabolism in MS patients is unknown.	DDI-mechanism
Tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , @DRUG$ , diazepam , certain @DRUG$ , lidocaine, theophylline and metronidazole, delaying the elimination and increase in blood levels of these drugs.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Drug/Laboratory Test Interaction @DRUG$ ♪ Can cause a false, low measurement of the serum ♪ @DRUG$ levels with the Digi- Tab   RIA Kit for Digoxin .	DDI-false
Coadministration with compounds that are potent inducers of CYP3A4 ( eg , phenobarbital , @DRUG$ , @DRUG$ , carbamazepine ) may result in decreased plasma levels of saquinavir .	DDI-false
Because Nalfon has not been shown to produce any additional effect beyond that obtained with aspirin alone and because @DRUG$ increases the rate of excretion of Nalfon , the concomitant use of @DRUG$ and salicylates is not recommended .	DDI-false
@DRUG$ and retinyl acetate similarly inhibit and stimulate EGF- or @DRUG$-induced proliferation of prostatic epithelium.	DDI-effect
Caution should be exercised when @DRUG$ are given in conjunction with @DRUG$.	DDI-advise
Coadministration with compounds that are potent inducers of CYP3A4 (eg, phenobarbital, @DRUG$, @DRUG$, carbamazepine) may result in decreased plasma levels of saquinavir.	DDI-false
The intensity , uniformity and time course of anticoagulant interference by phenobarbital , secobarbital , glutethimide , chloral hydrate and @DRUG$ It has been systematically studied in 16 patients who: @DRUG$ therapy .	DDI-false
ACE inhibitors and angiotensin II receptor antagonists (congestive heart failure after myocardial infarction)- In EPHESUS, 3020 (91%) patients also received INSPRA 25-50 mg. @DRUG$ Angiotensin II receptor antagonists ( @DRUG$/ARB ).	DDI-false
While 18-MC and ibogain have similar affinities for kappa opioid and possibly nicotinic acid receptors, @DRUG$ has much lower affinities than @DRUG$ for NMDA and sigma-2 receptors , sodium channels , and the 5-HT transporter .	DDI-false
Probenecid : @DRUG$ • Impairs renal tubular secretion of ciprofloxacin and leads to an increase in renal tubular secretion of ciprofloxacin. @DRUG$ in serum .	DDI-mechanism
Like ibogaine ( 40 mg/kg ) , 18-MC ( 40 mg/kg ) decreases the intravenous self-administration of morphine and @DRUG$ and the oral self-administration of @DRUG$ and nicotine in rats ;	DDI-false
This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and @DRUG$ (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of @DRUG$).	DDI-false
@DRUG$: In diabetic patients receiving diflunisal and tolbutamide, no significant effects were seen on @DRUG$ plasma levels or fasting blood glucose.	DDI-false
Again, @DRUG$ neutralized the increase in glycemia after @DRUG$ overload both in diabetic and non-diabetic rats.	DDI-false
In addition to this pharmacological interaction, this report describes a novel chemical reaction between @DRUG$ (a benzodiazepine) and @DRUG$ under acidic conditions similar to those found in vivo, resulting in a 3-ethoxylated product.	DDI-mechanism
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, betablockers, calcium-channel blockers, @DRUG$, and @DRUG$ (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
- Anabolic steroids (nandrolone [e.g., Anabolin], oxandrolone [e.g., Anavar], @DRUG$ [e.g., Anadrol], stanozolol [e.g., @DRUG$]) or	DDI-false
These drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , @DRUG$ , estrogens , oral contraceptives , @DRUG$ , nicotinic acid, sympathomimetics, calcium channel block drugs, and isoniazid.	DDI-false
Lithium : @DRUG$ Toxicity has been reported in patients receiving lithium concomitantly with medicinal products that cause sodium excretion, including @DRUG$.	DDI-false
In a 12-week endoscopy study in OA patients, there was no difference in the cumulative incidence of endoscopic gastrointestinal ulcers in patients receiving a low dose ( 81 mg ) @DRUG$ • plus VIOXX 25 mg daily, compared to those who @DRUG$ 2400 mg daily alone .	DDI-false
Concomitant oral administration of @DRUG$ (a known inhibitor of CYP3A4 activity in the liver and in the intestinal mucosa) caused an eight-fold increase of the systemic exposure to oral @DRUG$.	DDI-mechanism
- Mineral oil compositional intake of @DRUG$ and @DRUG$ The absorption of vitamin K can be reduced.	DDI-mechanism
Lithium: Increased serum lithium levels and symptoms of @DRUG$ toxicity have been reported in patients receiving concomitant @DRUG$ and ACE inhibitor therapy.	DDI-false
Corticosteroids, Methylxanthines and Diuretics: Concomitant treatment with xanthine derivatives, @DRUG$, or diuretics may potentiate a possible hypokalemic effect of  @DRUG$	DDI-effect
@DRUG$ , lidocaine , @DRUG$ , quinidine, theophylline, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
Anticholinesterases (neostgmine, physostigmine), @DRUG$, quinine, @DRUG$ can enhance toxicity and cause cardio respiratory depression.	DDI-false
For example, inhibitors are azole antimycotics, @DRUG$ , clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodon, @DRUG$ , propofol , protease inhibitors , quinidine , and verapamil .	DDI-false
Multivalent Cation-Containing Products : Simultaneous Application of a @DRUG$ , including ciprofloxacin, containing multivalent cationic products such as magnesium or aluminium antacids, sucralfat, VIDEX chewable/buffer tablets or pediatric powder or products containing calcium, @DRUG$ Zinc can significantly reduce the absorption of ciprofloxacin, resulting in serum and urine levels significantly lower than desired.	DDI-mechanism
Carbamazepine : @DRUG$ It is known that the metabolism of carbamazepine slows and increases its serum levels Carbamazepine should be determined prior to co-administration with isoniazide, signs and symptoms of carbamazepine. @DRUG$ The toxicity should be closely monitored and an appropriate dose adjustment of the anticonvulsant should be made.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , doxorubicin , vincristine , and prednisone ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , doxorubicin , @DRUG$ , and prednisone with @DRUG$ Bleomycin) without antiretroviral therapy.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or @DRUG$ may substantially decrease the absorption of @DRUG$, resulting in serum and urine levels considerably lower than desired.	DDI-false
Concomitant administration of Mefloquine and other related compounds ( eg , @DRUG$ , quinidine and @DRUG$ ) may cause electrocardiographic abnormalities and increase the risk of convulsions.	DDI-false
Multivalent Cation-Containing Products : Concomitant administration of a quinolone, including @DRUG$ With multivalent cation-containing products such as magnesium or aluminium antacids, sucralfate, @DRUG$ chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .	DDI-mechanism
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, @DRUG$, calcium-channel blockers, cardiac @DRUG$, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Example inhibitors include azole antifungals, @DRUG$, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, @DRUG$, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
@DRUG$ may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like @DRUG$ or Ibuprofen, and high blood pressure medications.	DDI-int
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Intravenous adenocard (adenosine) has been effective in the presence of other cardiovascular drugs such as @DRUG$ , beta-adrenergic blocking agents , calcium channel blocking agents , and @DRUG$ , without changing the adverse reaction profile.	DDI-false
Central nervous system depressants: Concomitant use of DURAGESIC (Fentanyl transdermal system) with others @DRUG$ , including but not limited to other opioids , sedatives , @DRUG$ Anaesthetics (e.g. benzodiazepines), general anaesthetics, phenothiazines, skeletal muscle relaxants and alcohol can cause respiratory depression, hypotension and deep sedation, or possibly lead to coma or death.	DDI-false
@DRUG$ may decrease arterial responsiveness to @DRUG$.	DDI-effect
@DRUG$-Concomitant intake of @DRUG$ The absorption of vitamin K can be reduced.	DDI-false
Amiodarone may suppress certain CYP450 enzymes, including CYP1A2. @DRUG$ , CYP2D6 , and @DRUG$.	DDI-false
acetaminophen/theophylline , lidocaine/quinidine , phenobarbital/acetaminophen , phenobarbital/valproic acid , quinidine/@DRUG$ , theophylline/acetaminophen , and valproic acid/@DRUG$.	DDI-false
Other medicinal products Interactions: No pharmacokinetic interactions between vardenafil and the following medicinal products have been observed: @DRUG$ , warfarin , @DRUG$ ==References====External links==	DDI-false
Based on the chemical resemblance of @DRUG$ and @DRUG$ , coadministration of astemizole with itraconazole is contraindicated .	DDI-false
In clinical studies performed with @DRUG$ , the concomitant use of oral anticoagulants ( warfarin ) , platelet inhibitors ( acetylsalicylic acid ) , NSAIDs ( piroxicam ) , and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of @DRUG$.	DDI-false
To determine whether injection of @DRUG$ would permit larger doses of cisplatin to be administered , a fixed 9.9-g/m2 dose of thiosulfate was given intravenously over three hours concurrently with escalating doses of @DRUG$.	DDI-false
To determine whether injection of thiosulfate would permit larger doses of @DRUG$ to be administered, a fixed 9.9-g/m2 dose of thiosulfate was given intravenously over three hours concurrently with escalating doses of @DRUG$.	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with @DRUG$, hypnotics and sedatives (including benzodiazepines), or @DRUG$ was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
It is assumed that the toxicity is caused by an unprecedented interaction between: @DRUG$ and @DRUG$ A molecular basis for this interaction was proposed.	DDI-effect
Other drugs : Drugs like @DRUG$ , disopyramide , procainamide , phenothiazines , @DRUG$ , and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
Cyclosporine, Digoxin, Methotrexate Lodine, like other @DRUG$, through effects on renal prostaglandins, may cause changes in the elimination of these drugs leading to elevated serum levels of @DRUG$, digoxin, methotrexate, and increased toxicity.	DDI-mechanism
@DRUG$ may add to or potentiate the therapeutic effect of other @DRUG$.	DDI-effect
The results of the studies in patients with multiple sclerosis who: @DRUG$   and concomitant @DRUG$ ( AVONEX   30 mcg IM once weekly ) or glatiramer acetate were inconclusive with regard to the need for dose adjustment of the beta-interferon or glatiramer acetate .	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, @DRUG$, isoniazid, nefazodone, nicardipine, @DRUG$, protease inhibitors, quinidine, and verapamil.	DDI-false
Glyburide : The concomitant administration of ciprofloxacin with the @DRUG$ @DRUG$ Rare cases have led to severe hypoglycaemia.	DDI-false
In clinical studies performed with Fondaparinux , the concomitant use of oral anticoagulants ( warfarin ) , platelet inhibitors ( @DRUG$ , NSAIDs (piroxicam) and digoxin did not significantly affect @DRUG$ pharmacokinetics/pharmacodynamics.	DDI-false
Theophylline: As with some other quinolones, concurrent administration of ciprofloxacin with @DRUG$ may lead to elevated serum concentrations of @DRUG$ and prolongation of its elimination half-life.	DDI-false
Micro-dosed @DRUG$ Preparations: Micro-dosed progesterone preparations (minipills not containing estrogen) may provide an inadequate method of contraception during pregnancy. @DRUG$ therapy .	DDI-false
However, in the second study, administration of 12 g cholestyramine 1 hour before the evening meal and 0.3 mg cerivastatin sodium approximately 4 hours after the same evening meal resulted in a decrease in the @DRUG$ AUC of less than 8%, and a decrease in Cmax of about 30% when compared to dosing @DRUG$ alone.	DDI-false
Corticosteroids , Methylxanthines and Diuretics : Concomitant treatment with @DRUG$ , steroids , or @DRUG$ may potentiate a possible hypokalemic effect of   beta2-agonists .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, @DRUG$, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and @DRUG$ with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of @DRUG$ and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with @DRUG$.	DDI-false
HIV Protease Inhibitors : Indinavir ( 800 mg t.i.d . ) co-administered with @DRUG$ 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in @DRUG$ Cmax and a 2-fold increase in vardenafil half-life .	DDI-false
The use of acetaminophene with acetaminophene @DRUG$ , @DRUG$ with acetaminophen , and valproic acid with phenobarbital at high to toxic concentrations decreases the binding of the target drug .	DDI-false
Warfarin: @DRUG$ 3 mg administered daily for 5 days did not affect the pharmacokinetics of (R)- or (S)-warfarin, nor were there any changes in the pharmacodynamic profile (prothrombin time) following a single 25 mg oral dose of @DRUG$	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, @DRUG$, and isoniazid.	DDI-false
Intravenous @DRUG$ Adenosine was effectively administered in the presence of other cardiovascular drugs such as quinidine, beta-adrenergic agents, @DRUG$ , and angiotensin converting enzyme inhibitors , without any change in the adverse reaction profile .	DDI-false
Phenytoin : @DRUG$ may delay intestinal absorption of @DRUG$ ;	DDI-mechanism
- @DRUG$ ( e.g. , @DRUG$ The use of sulfapyridin with these medicines may increase the likelihood of side effects that affect the blood.	DDI-false
@DRUG$ diminished binding of @DRUG$ by a net change of 9.9 % ( percentage increase in FDF , 21.2 % ) at 1732 micromol/L.	DDI-mechanism
In addition to this pharmacological interaction, this report describes a novel chemical reaction between temazepam ( @DRUG$ ) and @DRUG$ under acidic conditions similar to those found in vivo , resulting in a 3-ethoxylated product .	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or @DRUG$ antagonists (e.g., verapamil, a CYP3A4 substrate, and @DRUG$, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Potential drug interactions between Keppra  and other @DRUG$ (carbamazepine, gabapentin, lamotrigine, phenobarbital, @DRUG$, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
• Lack of an effect of @DRUG$ on the disposition of @DRUG$ and dideoxyinosine in HIV-infected patients .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, @DRUG$, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus @DRUG$) without receiving antiretroviral therapy.	DDI-false
The effects of @DRUG$ (RR) on @DRUG$ (InsP(3))-induced responses were studied in rat bone marrow megakaryocytes with the patch-clamp whole-cell recording technique in combination with fura-2 microfluorometry.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ The co-administration of DURAGESIC (Fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), generally @DRUG$ , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	DDI-false
@DRUG$ and @DRUG$ Similarly, EGF or insulin-induced proliferation of prostate epithelium is inhibited and stimulated.	DDI-false
The pressor effects of catecholamines such as @DRUG$ or norepinephrine are enhanced by @DRUG$.	DDI-effect
Lithium : In a study conducted in healthy subjects, mean steady state @DRUG$ plasma levels increased approximately 17 % in subjects receiving lithium 450 mg BID with @DRUG$ 200 mg twice daily compared to people who only receive lithium.	DDI-false
• Methenamin therapy Urinary excretion of @DRUG$ is increased , and efficacy is reduced by acidifying agents used in @DRUG$ therapy .	DDI-mechanism
In general, these are drugs that have one or more pharmacological activities such as bepridil hydrochloride, including antiarrhythmics such as e.g. @DRUG$ and @DRUG$ , cardiac glycosides and tricyclic antidepressants.	DDI-false
High-dose @DRUG$ resulting in concentrations above 2000 ng/mL administered with oral @DRUG$ has led to an 80% increase in etoposide exposure with a 38% decrease in total body clearance of etoposide compared to etoposide alone.	DDI-mechanism
Antiarrhythmics : Amiodarone , @DRUG$ , flecainide , propafenone , @DRUG$ CONTRAINDICATED due to potential for serious and/or life-threatening reactions .	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (@DRUG$), platelet inhibitors (@DRUG$), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ACE ) inhibitors , @DRUG$ , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , H2 antagonists , HMG-CoA reductase inhibitors , @DRUG$ ==See also==*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID==References==	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - @DRUG$ - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - @DRUG$: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
omeprazole : The rate and extent of absorption of @DRUG$ was bioequivalent when @DRUG$ The dose was given alone or when Proquin XR was administered 2 hours after omeprazole, which suppresses gastric acid secretion maximum.	DDI-false
@DRUG$ The hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, has been reported, apparently due to an effect on certain microsomal enzyme systems, @DRUG$ , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .	DDI-mechanism
Short-term pharmacokinetic studies have demonstrated that concomitant administration of warfarin and Lodine  (@DRUG$ capsules and tablets) results in reduced protein binding of warfarin, but there was no change in the clearance of free @DRUG$.	DDI-false
Antacids : In a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium hydroxide , and @DRUG$ (iv) with fosinopril reduced serum levels and urinary excretion of @DRUG$ as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .	DDI-false
The possibility of hypotensive effects with @DRUG$ can be minimized by either discontinuing the @DRUG$ or increasing the salt intake approximately one week prior to initiation of treatment with captopril (captopril tablets, USP) or initiating therapy with small doses (6.25 or 12.5 mg).	DDI-effect
Another oral @DRUG$, ketoconazole, inhibits the metabolism of @DRUG$, resulting in elevated plasma concentrations of astemizole and its active metabolite desmethylastermizole which may prolong QT intervals.	DDI-false
@DRUG$ @DRUG$  (1000 mg twice daily) did not influence the pharmacokinetics of R and S warfarin.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Drug-Drug Interactions Between @DRUG$   And Other Antiepileptic Drugs ( AEDs ) @DRUG$ Keppra   ( 3000 mg daily ) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy .	DDI-false
Like @DRUG$ (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of morphine and @DRUG$ and the oral self-administration of ethanol and nicotine in rats;	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, @DRUG$, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and @DRUG$, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with @DRUG$ reduced serum levels and urinary excretion of @DRUG$ as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
@DRUG$, @DRUG$, or narcotics: potentiation of orthostatic hypotension may occur.	DDI-false
Moreover, additional interaction studies with @DRUG$ and @DRUG$ have not demonstrated any effect on fluvastatin plasma levels, and administration to a patient population chronically receiving digoxin resulted in no difference in the extent of bioavailability of digoxin relative to control data.	DDI-false
Other Drug Interactions: No pharmacokinetic interactions were observed between vardenafil and the following drugs: glyburide, @DRUG$, digoxin, Maalox, and @DRUG$.	DDI-false
@DRUG$: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., @DRUG$), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Multivitamins or other products which: @DRUG$ Zinc, antacids or sucralfate should not be administered simultaneously with or within 2 hours of administration of norfloxacin as they may impair absorption, resulting in lower serum and urine levels of @DRUG$.	DDI-false
Both efavirenz and nevirapine have been compared to triple therapy with the PI indinavir over 48 weeks as initial therapy, with similar responses being observed with @DRUG$ regimens and superiority observed with @DRUG$.	DDI-false
@DRUG$: Clinical studies, as well as post marketing observations, have shown that NSAIDs can reduce the natriuretic effect of furosemide and @DRUG$ in some patients.	DDI-false
It is structurally distinct from the other currently available HMGCoA reductase inhibitors ( @DRUG$ , simvastatin , and @DRUG$ This leads to unique biopharmaceutical properties compared to other active substances in this class.	DDI-false
Caution should be exercised if an @DRUG$ is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones , such as ketoconazole , spironolactone , and @DRUG$.	DDI-advise
Patients receiving both @DRUG$ and @DRUG$ It should be closely observed to determine whether the desired diuretic and/ or blood pressure lowering effect of furosemide is achieved.	DDI-advise
Coingestion of @DRUG$ With theophylline, phenobarbital with @DRUG$ Valproic acid with phenobarbital in high to toxic concentrations decreases the binding of the target drug.	DDI-false
@DRUG$ @DRUG$  (1500 mg twice daily) did not alter the pharmacokinetics of valproate in healthy volunteers.	DDI-false
The effect of @DRUG$ on the warfarin requirement of our patient appeared to be maximal 5 to 7 days after the initiation of rifampin and extended a similar length of time after @DRUG$ withdrawal.	DDI-false
MAO Inhibitors: DURAGESIC  is not recommended for use in patients who have received MAOI within 14 days because severe and unpredictable potentiation by @DRUG$ has been reported with @DRUG$	DDI-advise
For example, when @DRUG$ are administered concomitantly with nilutamide, prothrombin time should be carefully monitored and if necessary, the dosage of @DRUG$ should be reduced.	DDI-false
Coingestion of acetaminophen with @DRUG$, phenobarbital with acetaminophen, and @DRUG$ with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-false
Potential differences in @DRUG$ dosing and pharmacokinetics at different levels of @DRUG$ The exposure was assessed by ANOVA.	DDI-false
The zidovudine study dosed subjects with 1200 mg/day of @DRUG$ (n = 7) (later changed to 600 mg/day [n = 5]) for Days 8 to 21 of a 21-day course of 100 mg, five times/day of @DRUG$.	DDI-false
- Non-selective MAO inhibitors including tranylcypromin sulfate, @DRUG$ , and @DRUG$ HC1 : Concomitant use of L-tyrosine and non-selective MAO inhibitors may cause hypertension .	DDI-false
No Important Interactions To Date @DRUG$ does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, @DRUG$, digoxin, warfarin, isosorbide mononitrate, carvedilol, ethanol or itraconazole.	DDI-false
• Rifampin: co-administration of VIOXX with @DRUG$ 600 mg daily , a potent inducer of hepatic metabolism , produced an approximate 50 % decrease in @DRUG$ plasma concentrations .	DDI-false
@DRUG$ Renal tubular transport of @DRUG$ may be inhibited by concomitant administration of ciprofloxacin, potentially leading to increased plasma levels of methotrexate.	DDI-false
MAO Inhibitors: @DRUG$  is not recommended for use in patients who have received MAOI within 14 days because severe and unpredictable potentiation by @DRUG$ has been reported with opioid analgesics	DDI-false
@DRUG$ ( 400 mg b.i.d . ) had no effect on vardenafil bioavailability ( AUC ) and maximum concentration ( Cmax ) of vardenafil when co-administered with 20 mg @DRUG$ For healthy volunteers.	DDI-false
ANTACID (@DRUG$): @DRUG$ plasma concentrations were not affected by co-administration of antacid.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and @DRUG$ with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
@DRUG$ has been shown to be antagonistic to beta-lactam antibiotics, including @DRUG$, based on in vitro studies and time kill curves with enteric gram-negative bacilli.	DDI-effect
@DRUG$ It has a tendency to antagonize the skeletal muscle relaxing effect of tubocurarin and can enhance the effect of @DRUG$.	DDI-effect
Other concomitant therapy Although specific interaction studies have not been performed, 1 mg or more of finasteride doses have been co-administered in clinical trials with acetaminophen, acetylsalicylic acid, A-blockers, analgesics, angiotensin converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta-blockers, calcium channel blockers, heart @DRUG$ , diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also known as NSAIDs) and @DRUG$ without evidence of clinically significant adverse interactions .	DDI-false
This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), @DRUG$ or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with @DRUG$), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
Levosimendan has no clinically important pharmacokinetic interactions with @DRUG$ , beta-blockers , felodipine , digoxin , warfarin , isosorbide mononitrate , @DRUG$ Ethanol or itraconazole.	DDI-false
Ketoconazole: In healthy subjects receiving @DRUG$, a CYP3A4 inhibitor, at 200 mg twice daily for 7 days, systemic exposure (AUC) to @DRUG$ was increased to approximately 3.6-fold of control and half-life increased to 1.7-fold of control.	DDI-mechanism
Methotrexate: In an interaction study of rheumatoid arthritis patients taking methotrexate, @DRUG$ did not have a significant effect on the pharmacokinetics of @DRUG$.	DDI-false
@DRUG$ : In a study conducted in healthy subjects , mean steady-state lithium plasma levels increased approximately 17 % in subjects receiving lithium 450 mg BID with @DRUG$ 200 mg BID as compared to subjects receiving lithium alone .	DDI-false
Other Cardiovascular Agents: Enalapril and @DRUG$ IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, @DRUG$, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ and colestipol resins: Absorption of @DRUG$ is impaired in the presence of anionic exchange resins.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, @DRUG$, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, @DRUG$, and verapamil.	DDI-false
The compounds that have been tested in humans include: @DRUG$ , digoxin, propranolol, @DRUG$ No clinically significant interactions and warfarin were found.	DDI-false
Drug/Laboratory Test Interaction @DRUG$ may cause a false low measurement of serum @DRUG$ levels with the Digi- Tab  RIA Kit for Digoxin.	DDI-false
Theophylline : As with some others @DRUG$ Co-administration of ciprofloxacin and theophylline may lead to increased serum concentrations. @DRUG$ Elongation of elimination half-life.	DDI-false
These drugs include the thiazides and other diuretics , @DRUG$ , phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, @DRUG$ , and isoniazid .	DDI-false
No Important Interactions To Date @DRUG$ There are no clinically important pharmacokinetic interactions with captopril, beta-blockers, @DRUG$ , digoxin, warfarin, isosorbide mononitrate, schnitztilol, ethanol or itraconazole.	DDI-false
Drug-Drug Interactions Between Keppra  And Other Antiepileptic Drugs (AEDs) @DRUG$ @DRUG$  (3000 mg daily) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy.	DDI-false
Example inhibitors include @DRUG$ , ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and @DRUG$.	DDI-false
Data from in vitro studies of benzodiazepines other than @DRUG$ suggest a possible drug interaction for the following: ergotamine, cyclosporine, @DRUG$, nicardipine, and nifedipine.	DDI-int
@DRUG$ : Co-administration of VIOXX with @DRUG$ 600 mg daily , a potent inducer of hepatic metabolism , produced an approximate 50 % decrease in rofecoxib plasma concentrations .	DDI-false
Aspirin : Concurrent administration of @DRUG$ may lower @DRUG$ Plasma levels, possibly through competition for protein-binding sites.	DDI-mechanism
The coingestion of acetaminophen with theophylline, @DRUG$ with acetaminophen , and @DRUG$ with phenobarbital at high to toxic concentrations decreases the binding of the target drug .	DDI-false
Levosimendan has no clinically important pharmacokinetic interactions with @DRUG$ , beta-blockers , felodipine , digoxin , warfarin , @DRUG$ , carvedilol , ethanol or itraconazole .	DDI-false
While all the selective serotonin reuptake inhibitors (@DRUG$), e.g., citalopram, @DRUG$, fluoxetine, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
@DRUG$: Reports suggest that NSAIDs may diminish the antihypertensive effect of @DRUG$.	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, @DRUG$ , barbiturates , @DRUG$ , and other antidepressants . When scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .	DDI-false
@DRUG$ , or other products containing iron or zinc , antacids or sucralfate should not be administered concomitantly with , or within 2 hours of , the administration of @DRUG$ Because they may impair absorption, resulting in lower serum and urine levels of norfloxacin.	DDI-advise
Drug Interactions : Flupenthixol may interact with some drugs , like Monoamine oxidase inhibitors ( MAOI ): MAOI could theoretically affect @DRUG$ pharmacodynamics - Arecoline - Eproxindine - Ethanol : Flupenthixol and @DRUG$ Cause additive CNS depression - Tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants	DDI-false
Garlic Capsules Garlic capsules should not be used while taking @DRUG$ (FORTOVASE) as the sole @DRUG$ due to the risk of decreased saquinavir plasma concentrations.	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase @DRUG$ plasma concentrations: Caution is recommended when administering @DRUG$ with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, erythromycin, clarithromycin).	DDI-false
Data from in vitro studies @DRUG$ suggest a possible drug interaction with @DRUG$ for the following : sertraline and paroxetine .	DDI-false
Oral Contraceptives: Coadministration of @DRUG$ and an oral contraceptive increased AUC values for @DRUG$ and ethinyl estradiol by approximately 30% and 20%.	DDI-mechanism
@DRUG$: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing @DRUG$ therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -@DRUG$ blocking agents (e.g., propranolol, a @DRUG$ inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, @DRUG$, imatinib, isoniazid, nefazodone, nicardipine, propofol, @DRUG$, quinidine, and verapamil.	DDI-false
These medicines include thiazides and other diuretics, corticosteroids, phenothiazines, @DRUG$ , estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel block drugs, and @DRUG$.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other @DRUG$, amantadine, haloperidol, phenothiazines, @DRUG$, tricyclic antidepressants or some antihistamines.	DDI-false
Example inhibitors include @DRUG$, ciprofloxacin, clarithromycin, diclofenac, doxycycline, @DRUG$, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
@DRUG$: Because atorvastatin does not affect the pharmacokinetics of @DRUG$, interactions with other drugs metabolized via the same cytochrome isozymes are not expected.	DDI-false
Intravenous @DRUG$ ( adenosine ) has been effectively administered in the presence of other cardioactive drugs , such as @DRUG$ , beta-adrenergic blocking agents , calcium channel blocking agents , and angiotensin converting enzyme inhibitors , without any change in the adverse reaction profile .	DDI-false
The management of the local @DRUG$ containing epinephrine or @DRUG$ Patients receiving monoamine oxidase inhibitors, tricyclic antidepressants or phenothiazine may experience severe, prolonged hypotension or hypertension.	DDI-false
In patients with chronic hepatitis C treated with PEGASYS in combination with @DRUG$, PEGASYS treatment did not affect @DRUG$ distribution or clearance.	DDI-false
@DRUG$ and @DRUG$ increased blood glucose at different times after the glucose overload.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other @DRUG$, including but not limited to other opioids, sedatives, @DRUG$, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Hypotension Patients on diuretic therapy : patients on diuretics and especially those in which @DRUG$ The therapy has recently been initiated, as well as those with severe dietary salt restrictions or dialysis, may occasionally abruptly decrease blood pressure usually within the first hour after receiving the initial dose of @DRUG$.	DDI-false
@DRUG$: When @DRUG$ 10 or 20 mg was given to healthy volunteers either simultaneously or 6 hours after a 10 mg dose of terazosin, significant hypotension developed in a substantial number of subjects.	DDI-false
@DRUG$ and glutethimide should not be administered to patients receiving @DRUG$.	DDI-advise
Short-term pharmacokinetic studies have demonstrated that concomitant administration of warfarin and @DRUG$   ( etodolac capsules and tablets ) results in reduced protein binding of @DRUG$ However, there was no change in the release of free warfarin.	DDI-false
BACKGROUND: The effects of combined administration of bombesin and @DRUG$ (verapamil), a calcium channel blocker, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by @DRUG$ (AOM) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
In patients with mild to moderate hypertension , administration of 25 mg daily of @DRUG$ With the ACE inhibitor @DRUG$ , 10 to 40 mg for 4 weeks , was associated with an average increase in mean arterial pressure of about 3 mm Hg compared to ACE inhibitor alone .	DDI-effect
Compounds tested in man include warfarin, @DRUG$, @DRUG$, diazepam, aminopyrine and antipyrine.	DDI-false
Although there is no study data to evaluate the possibility of nitric oxide donor compounds, including @DRUG$ ug and nitroglycerin, may have an additive effect with @DRUG$ on the risk of developing methemoglobinemia .	DDI-effect
Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following : ergotamine , @DRUG$ , @DRUG$ , nicardipine, and nifedipine.	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, @DRUG$, @DRUG$).	DDI-false
Drug-Drug Interactions Between Keppra  And Other Antiepileptic Drugs (AEDs) Phenytoin @DRUG$  (3000 mg daily) had no effect on the pharmacokinetic disposition of @DRUG$ in patients with refractory epilepsy.	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, @DRUG$, indinavir, saquinavir, @DRUG$, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
@DRUG$ Etodolac has no apparent pharmacokinetic interaction if: @DRUG$ or hydrochlorothiazide .	DDI-false
Patients taking @DRUG$ concomitantly with @DRUG$ more commonly reported both weight gain and weight loss , compared with patients taking either medication alone .	DDI-effect
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, @DRUG$, niacin (@DRUG$), erythromycin, azole antifungals.	DDI-false
Ergot Derivatives: @DRUG$, ergonovine, ergotamine, @DRUG$ CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
Other concomitant therapy Although specific interaction studies have not been performed, 1 mg or more of finasteride doses have been co-administered in clinical trials with acetaminophen, acetylsalicylic acid, A-blockers, analgesics, angiotensin converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta-blockers, calcium channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, @DRUG$ (also referred to as @DRUG$ ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
@DRUG$/@DRUG$ Triazolam, midazolam CONTRAINDICATES due to the potential for serious and/or life-threatening reactions such as prolonged or increased sedation or respiratory depression.	DDI-false
@DRUG$ has been shown to be antagonistic to @DRUG$, including ceftazidime, based on in vitro studies and time kill curves with enteric gram-negative bacilli.	DDI-effect
There have been greater than 2-fold increases in previously stable plasma levels of other @DRUG$, including @DRUG$, when fluoxetine hydrochloride has been administered in combination with these agents.	DDI-false
Furosemide: Clinical studies, as well as post marketing observations, have shown that NSAIDs can reduce the natriuretic effect of @DRUG$ and @DRUG$ in some patients.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, haloperidol, @DRUG$, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some @DRUG$.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, @DRUG$, @DRUG$, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , @DRUG$ , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , @DRUG$ And metronidazole, which delays the elimination and increase in blood levels of these drugs.	DDI-false
Acid-catalyzed ethanolysis of @DRUG$ in anhydrous and aqueous @DRUG$ solutions.	DDI-mechanism
@DRUG$ including @DRUG$ , phenelzine sulfate , and pargyline HC1 : Concomitant use of L-tyrosine and non-selective MAO inhibitors may cause hypertension .	DDI-false
@DRUG$ could exaggerate the depression of AV nodal conduction observed with @DRUG$.	DDI-effect
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or @DRUG$, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with @DRUG$ or Innovar than with pentobarbital.	DDI-false
Concomitant use of @DRUG$ with drugs that can inhibit cytochrome P450 2D6 may require lower doses than usually prescribed for either the @DRUG$ or the other drug.	DDI-false
Other interactions: no pharmacokinetic interactions between: @DRUG$ and the following drugs : glyburide , warfarin , @DRUG$ ==References====External links==	DDI-false
Monoamine oxidase inhibitors and tricyclic antidepressants : @DRUG$ In patients treated with @DRUG$ or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents .	DDI-advise
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, @DRUG$ (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
The results raise the possibility that the ethanolysis reaction may occur in the stomach of people who consume @DRUG$ and @DRUG$ on a regular basis.	DDI-mechanism
Therefore, it would be expected that a dosing schedule of @DRUG$ given at bedtime and @DRUG$ given before the evening meal would not result in a significant decrease in the clinical effect of cerivastatin sodium.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen, and valproic acid/@DRUG$.	DDI-false
In single and multiple dose studies in healthy subjects receiving both @DRUG$ and @DRUG$, prothrombin time (measured as INR) was increased by approximately 8% to 11%.	DDI-effect
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with @DRUG$, @DRUG$, calcium-channel blockers, diuretics, and nonsteroidal anti-inflammatory drugs (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
- anabolic steroids (Nandrolone [e.g. Anaboline ], Oxandrolone [e.g., @DRUG$ ], oxymetholone [e.g. Anadrol ], stanozool [e.g., @DRUG$ ] ) or	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, @DRUG$, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, @DRUG$ (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$-Broad-Spectrum Antibiotics can sterilize the intestine and reduce the @DRUG$ contribution to the body by the intestinal microflora .	DDI-false
@DRUG$ : Etodolac has no apparent pharmacokinetic interaction when administered with furosemide or @DRUG$.	DDI-false
Potassium-sparing diuretics (e.g. @DRUG$ , Triamteren or @DRUG$ ) , potassium supplements , or potassium-containing salt substitutes may lead to significant increases in serum potassium .	DDI-false
Imipramine (5 mg/kg), moclobemide (30 mg/kg), @DRUG$ (0.25 mg/kg), fluoxetine (20 mg/kg) @DRUG$ (30 mg/kg) or vehicle was administered.	DDI-false
Anticoagulants including coumarin derivatives, indandion derivatives and @DRUG$ such as nonsteroidal anti-inflammatory drugs ( NSAIDs ) , and @DRUG$ may increase the risk of bleeding when administered concomitantly with ardeparin .	DDI-false
@DRUG$: Coadministration of single doses of eszopiclone 3 mg and @DRUG$ 2 mg did not have clinically relevant effects on the pharmacodynamics or pharmacokinetics of either drug.	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, @DRUG$ , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , @DRUG$ When co-administered with saquinavir, carbamazepine, fentanyl, alfentanyl, alprazolam and triazolam may exhibit increased plasma concentrations;	DDI-false
Tagamet, apparently due to an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, @DRUG$ , nifedipine, chlordiazepoxide, diazepam, certain @DRUG$ , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .	DDI-false
No important interactions to date @DRUG$ does not have clinically important pharmacokinetic interactions with captopril , @DRUG$ , felodipine, digoxin, warfarin, isosorbide mononitrate, schnitztilol, ethanol or itraconazole.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, @DRUG$, cardiac nitrates, @DRUG$, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Interaction with @DRUG$ , lidocaine and @DRUG$ has also been reported to produce adverse clinical effects .	DDI-false
Multivalent Cation-Containing Products : Concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , @DRUG$ , VIDEX chewable/buffer tablets or paediatric powders or products containing calcium, iron or zinc may cause absorption of @DRUG$ , which leads to serum and urine levels significantly lower than desired.	DDI-false
Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: ergotamine, cyclosporine, @DRUG$, @DRUG$, and nifedipine.	DDI-false
Other oral interactions @DRUG$ Keppra   ( 500 mg twice daily ) did not influence the pharmacokinetics of an oral @DRUG$ Includes 0.03 mg ethinylestradiol and 0.15 mg levonorgestrel or luteinising hormone and progesterone levels, indicating that impairment of antibetic efficacy is unlikely.	DDI-false
Diuretics : Patients on @DRUG$ In particular, patients with intravascular volume depletion may occasionally experience an excessive reduction in blood pressure after initiation of @DRUG$ therapy.	DDI-effect
It is recommended that the concomitant use of ethambutol with @DRUG$ containing @DRUG$ At least 4 hours after administration of ethambutol.	DDI-false
Since the concomitant use of @DRUG$ with amiodarone increases the prothrombin time by 100 % after 3 to 4 days , the dose of the @DRUG$ should be reduced by one-third to one-half , and prothrombin times should be monitored closely .	DDI-false
acetaminophen/@DRUG$, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
In clinical trials , the concomitant administration of @DRUG$ and @DRUG$ did not alter the adverse reaction profile .	DDI-false
There have been case reports of increased steady-state levels of @DRUG$, procainamide, and phenytoin during concomitant therapy with @DRUG$.	DDI-false
Cyclosporine, Digoxin, Methotrexate Lodine, like other NSAIDs, through effects on renal prostaglandins, may cause changes in the elimination of these drugs leading to elevated serum levels of cyclosporine, @DRUG$, @DRUG$, and increased toxicity.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$ , doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and @DRUG$ • with vincristine plus bleomycin) without antiretroviral therapy.	DDI-false
Potential drug interactions between: @DRUG$   and other AEDs ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and @DRUG$ The serum concentrations of levetiracetam and these AEDs were also evaluated in placebo-controlled clinical trials.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and @DRUG$, specifically, dacarbazine, cis-platinum, tamoxifen and @DRUG$.	DDI-false
@DRUG$ also significantly decreased the incidence of lymphatic invasion of adenocarcinomas , which was enhanced by @DRUG$.	DDI-effect
In the first study , concomitant administration of 0.2 mg cerivastatin sodium and 12 g @DRUG$ resulted in decreases of more than 22 % for AUC and 40 % for Cmax when compared to dosing @DRUG$ alone .	DDI-false
Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving Alprazolam ( caution is recommended during coadministration with alprazolam ): Coadministration of @DRUG$ The maximum plasma concentration of alprazoleam increased by @DRUG$ by 46 % , decreased clearance by 21 % , increased half-life by 17 % , and decreased measured psychomotor performance .	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , @DRUG$ , coumarins , monoamine oxidase inhibitors , and @DRUG$.	DDI-false
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies (phenytoin, valproate, oral contraceptive, digoxin, @DRUG$, @DRUG$) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients.	DDI-false
@DRUG$: Co- administration of warfarin and @DRUG$ to healthy volunteers did not result in any changes in prothrombin time or clotting factor VII when compared to co-administration of warfarin and placebo.	DDI-false
An interaction study with warfarin showed no clinically significant effect of @DRUG$ on @DRUG$ pharmacokinetics or anticoagulant activity.	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with @DRUG$ (alcohol, barbiturates, opiates, sedatives, @DRUG$) should be considered.	DDI-false
Tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , @DRUG$ , propranolol, nifedipine, chlordiazepoxide, @DRUG$ , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .	DDI-false
Oral @DRUG$: Coadministration of atorvastatin and an oral contraceptive increased AUC values for norethindrone and @DRUG$ by approximately 30% and 20%.	DDI-false
Benzthiazide can be used with @DRUG$ , @DRUG$s, decongestant medications (allergy, cold, and sinus drugs), diabetes medications, lithium, norepinephrine, NSAIDs such as aleve or ibuprofen, and high blood pressure medications.	DDI-false
Compounds tested in man include warfarin, theophylline, @DRUG$, diazepam, @DRUG$ and antipyrine.	DDI-false
Short-term pharmacokinetic studies have demonstrated that concomitant administration of warfarin and Lodine   ( @DRUG$ • Capsules and tablets) leads to reduced protein binding of @DRUG$ , but there was no change in the clearance of free warfarin .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, @DRUG$, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, @DRUG$, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, @DRUG$, @DRUG$, quinidine, and verapamil.	DDI-false
Moreover , additional interaction studies with niacin and @DRUG$ have not demonstrated any effect on fluvastatin plasma levels , and administration to a patient population chronically receiving digoxin resulted in no difference in the extent of bioavailability of @DRUG$ relative to control data .	DDI-false
Oral Contraceptives : Coadministration of atorvastatin and an oral @DRUG$ increased AUC values for norethindrone and @DRUG$ - about 30% and 20%.	DDI-false
Non-steroidal anti-inflammatory drugs (but not @DRUG$): These drugs in combination with very high doses of @DRUG$ have been shown to provoke convulsions in pre-clinical studies.	DDI-false
Quinolones, including norfloxacin, may enhance the effects of oral @DRUG$, including @DRUG$ or its derivatives or similar agents.	DDI-false
Hypotension: Patients on Diuretic Therapy: Patients on @DRUG$ and especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with enalapril or @DRUG$.	DDI-effect
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations : Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family ( e.g. , @DRUG$ , itraconazole, erythromycin, @DRUG$ ) .	DDI-false
@DRUG$ SHOULD BE USED WITH CAUTION IN THOSE PATIENTS REVEIVING @DRUG$ AND ITS CONGENERS .	DDI-advise
@DRUG$ The plasma levels of @DRUG$ When taken in combination.	DDI-false
Previous studies have demonstrated a significant reduction in the oral bioavailability of @DRUG$ and @DRUG$ When co-administered with an intravenous opiate such as morphine.	DDI-false
There is thus an enhancement effect of @DRUG$ upon the reaction of placental vessels to @DRUG$ in vitro.	DDI-effect
Adrenergic blockers @DRUG$ are inhibited by @DRUG$.	DDI-effect
Imipramine (5 mg/kg), @DRUG$ (30 mg/kg), @DRUG$ (0.25 mg/kg), fluoxetine (20 mg/kg) sertraline (30 mg/kg) or vehicle was administered.	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with @DRUG$, phenothiazines, barbiturates, @DRUG$, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
@DRUG$ : Clinical studies , as well as post marketing observations , have shown that NSAIDs can reduce the natriuretic effect of furosemide and @DRUG$ In some patients.	DDI-false
Although the specific drug interaction was not studied in a clinical trial , there have been more than 50 episodes of concomitant use of antifibrinolytic therapies ( i.e. , @DRUG$ , @DRUG$ ) and NovoSeven .	DDI-false
How ibogain ( 40 mg/kg ) reduces intravenous self-injection of 18-MC ( 40 mg/kg ) @DRUG$ • Cocaine and oral self-administration of ethanol and @DRUG$ in rats ;	DDI-false
Aspirin : @DRUG$ ( 10 mg and 20 mg ) did not potentiate the increase in bleeding time caused by @DRUG$ Two 81 mg tablets).	DDI-false
Potential drug interactions between Keppra   and other AEDs ( carbamazepine , gabapentin , lamotrigine , @DRUG$ , phenytoin , primidone and @DRUG$ ) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies .	DDI-false
Injection : @DRUG$ Injection, like other injectable benzodiazepines, produces depression of the central nervous system when with ethyl alcohol, phenothiazine, barbiturates, @DRUG$ , and other antidepressants . When scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .	DDI-effect
Antidepressants , tricyclic @DRUG$ The effect of tricyclic antidepressants may be increased or @DRUG$ ;	DDI-effect
Antihypertensive agents: amiodarone should be used with caution in patients receiving -@DRUG$ blockers (e.g. propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g. verapamil, a CYP3A4 substrate), and @DRUG$ , a CYP3A4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and AV block ;	DDI-false
Cholestyramine and colestipol @DRUG$ : Absorption of hydrochlorothiazide is impaired in the presence of @DRUG$.	DDI-false
- Anabolic steroids ( nandrolone [ e.g. , Anabolin ] , @DRUG$ [ e.g. Anavar ], Oxymetholone [ e.g. Anadrol ], Stanozolol [ e.g., @DRUG$ ] ) or	DDI-false
ACE Inhibitors and @DRUG$ (Hypertension)- In clinical studies of patients with hypertension, the addition of @DRUG$ 50 to 100 mg to ACE inhibitors and angiotensin II receptor antagonists increased mean serum potassium slightly (about 0.09-0.13 mEq/L).	DDI-false
@DRUG$ , and to a lesser extent, @DRUG$ , enhanced the translocating effect of oleate and increased its effectiveness in the transfer of phosphohydrolase from soluble to microsomal fraction.	DDI-false
Based on the chemical resemblance of @DRUG$ and ketoconazole , coadministration of astemizole with @DRUG$ is contraindicated .	DDI-false
@DRUG$-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, cefotetan, cefamandole, @DRUG$) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
FLEXERIL may enhance the effects of alcohol, @DRUG$, and other @DRUG$.	DDI-false
On administration of oral @DRUG$, the need for @DRUG$ therapy should be reviewed and the dose reduced by approximately 50% or discontinued.	DDI-advise
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, @DRUG$, erythromycin, @DRUG$, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
• Co-administration of a single dose of 25 mg @DRUG$ The pharmacokinetics of @DRUG$ have not been affected.	DDI-false
@DRUG$ ", apparently due to an effect on certain microsomal enzyme systems, has been reported to reduce hepatic metabolism @DRUG$ , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .	DDI-mechanism
Central nervous system depressants: Concomitant use of DURAGESIC (Fentanyl transdermal system) with others @DRUG$ , including but not limited to other opioids, sedatives, hypnotic, sedatives (e.g. benzodiazepines), general anesthetics, @DRUG$ , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics , amantadine , haloperidol , phenothiazines , @DRUG$ , @DRUG$ Or some antihistamines.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
In a comparison of digitalis tolerance in dogs anesthetized with @DRUG$ , Innovar Vet , or pentobarbital , the dosage of ouabain needed to cause ventricular tachycardia was significantly higher , as was the LD50 of @DRUG$ , with ketamine or Innovar than with pentobarbital .	DDI-false
Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving @DRUG$ (caution is recommended during coadministration with alprazolam): Coadministration of fluoxetine with @DRUG$ increased the maximum plasma concentration of alprazolam by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance.	DDI-false
In addition, Fondaparinux neither influenced the pharmacodynamics of @DRUG$, @DRUG$, piroxicam, and digoxin, nor the pharmacokinetics of digoxin at steady state.	DDI-false
Probenecid: May decrease renal tubular secretion of @DRUG$ resulting in increased blood levels and/or @DRUG$ toxicity.	DDI-false
HIV Protease Inhibitors: Indinavir (800 mg t.i.d.) co-administered with @DRUG$ 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in vardenafil Cmax and a 2-fold increase in @DRUG$ half-life.	DDI-false
- Vitamin K (e.g., @DRUG$, @DRUG$) Use of sulfapyridine with these medicines may increase the chance of side effects affecting the blood	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., @DRUG$, itraconazole, @DRUG$, clarithromycin).	DDI-false
@DRUG$ and Zidovudine @DRUG$ In vitro, the antiviral activity of stavudine and zidovudine against HIV can be antagonistic.	DDI-false
While all selective serotonin reuptake inhibitors ( @DRUG$ ) , e.g. , citalopram , escitalopram , fluoxetine , @DRUG$ , and paroxetine , inhibit P450 2D6 , they may vary in the extent of inhibition .	DDI-false
In patients receiving Nalfon and a @DRUG$ concomitantly, any reduction in steroid dosage should be gradual in order to avoid the possible complications of sudden @DRUG$ withdrawal.	DDI-false
@DRUG$: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., @DRUG$, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Warfarin : @DRUG$ 3 mg daily for 5 days, affected the pharmacokinetics of (R)- or @DRUG$ , nor were there any changes in the pharmacodynamic profile ( prothrombin time ) following a single 25 mg oral dose of warfarin	DDI-false
@DRUG$ Probenecid affects renal tubular secretion of ciprofloxacin and leads to an increase in the @DRUG$ in serum .	DDI-false
Both ibogaine and @DRUG$ • Reduction of extracellular dopamine levels in the nucleus accumbens, but only @DRUG$ Elevates extracellular serotonin levels in the nucleus accumbens.	DDI-false
Slow-channel calcium blockers, such as @DRUG$, @DRUG$ and nifedipine, inhibit platelet activation in vitro, and decrease platelet adhesion intravascularly.	DDI-false
Example inhibitors include azole antifungals, @DRUG$, clarithromycin, diclofenac, doxycycline, @DRUG$, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, @DRUG$, phenothiazines, monoamine oxidase (MAO) inhibitors, @DRUG$ or some antihistamines.	DDI-false
No data are available for the coadministration of @DRUG$/@DRUG$ or FORTOVASE/ritonavir and garlic capsules.	DDI-false
Hypotension   Patients on Diuretic Therapy: Patients on @DRUG$ and especially those in whom diuretic therapy was recently instituted, as well as those on severe dietary salt restriction or dialysis, may occasionally experience a precipitous reduction of blood pressure usually within the first hour after receiving the initial dose of @DRUG$.	DDI-effect
- anabolic steroids (Nandrolone [e.g., @DRUG$ ], Oxandrolone [e.g., Anavar], Oxymetholone [e.g., Anadrol], Stanozolol [e.g., @DRUG$ ] ) or	DDI-false
@DRUG$ A small decrease in diflunisal levels was observed in normal subjects when multiple doses of @DRUG$ Aspirin and aspirin were co-administered.	DDI-false
Like @DRUG$ (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of ethanol and @DRUG$ in rats;	DDI-false
Compounds tested in man include @DRUG$, theophylline, phenytoin, @DRUG$, aminopyrine and antipyrine.	DDI-false
Coadministration of @DRUG$ Itraconazole has increased plasma concentrations of @DRUG$ In rare cases of life-threatening cardiac dysrrhythmias and a death.	DDI-false
The administration of local @DRUG$ containing epinephrine or norepinephrine to patients receiving @DRUG$ , tricyclic antidepressants or phenothiazines may produce severe , prolonged hypotension or hypertension .	DDI-false
INOmax has been administered with @DRUG$, dopamine, @DRUG$, steroids, surfactant, and high-frequency ventilation.	DDI-false
Warfarin @DRUG$  (1000 mg twice daily) did not influence the pharmacokinetics of @DRUG$.	DDI-false
Other concomitant therapy Although no specific interaction studies have been conducted, 1 mg or more of finasteride doses have been used in clinical trials with acetaminophen, acetylsalicylic acid, A-blockers, @DRUG$ Angiotensin converting enzymes ( ACE) inhibitors, anticonvulsants, @DRUG$ Beta blockers, calcium channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also known as NSAIDs) and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
# pollination, associated with increased @DRUG$ Co-administration of intravenous @DRUG$ has been reported.	DDI-false
@DRUG$ had no significant impact on the Cmax and AUC of zidovudine, although it significantly decreased the zidovudine tmax by 44% and increased the intracellular exposure to phosphorylated @DRUG$ by 110%.	DDI-mechanism
Effect of AEDs in Pediatric Patients There was about a 22% increase of apparent total body clearance of @DRUG$ when it was co-administered with enzyme-inducing @DRUG$.	DDI-mechanism
@DRUG$ The resolution rate also increased, similar to @DRUG$.	DDI-false
Interaction on the antinociceptive effect between @DRUG$ and @DRUG$ or tuftsin .	DDI-effect
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
The successive application of @DRUG$ (5 or 10 mg/kg egg weight (e.w.) and glutamate (15 mg/kg e.w.) in a 10 min interval significantly increased the activation of spontaneous motility of 17-day-old chick embryos in comparison with the effect of @DRUG$ alone.	DDI-false
Hemodynamic and electrophysiologic interactions have also been observed after concomitant administration with propranolol, @DRUG$, and @DRUG$.	DDI-false
@DRUG$ : The concomitant use of DURAGESIC   ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , @DRUG$ Hypnosis, sedatives (e.g., benzodiazepines), general anaesthetics, phenothiazines, skeletal muscle relaxants and alcohol, can cause respiratory depression, hypotension and deep sedation, or possibly lead to coma or death.	DDI-false
@DRUG$ : @DRUG$ have produced an elevation of plasma lithium levels and a reduction in renal lithium clearance .	DDI-false
These results suggest that both @DRUG$ Prostate epithelium proliferation can be regulated by dose-dependent changes in insulin and @DRUG$ activity.	DDI-effect
Aspirin: In normal volunteers, a small decrease in diflunisal levels was observed when multiple doses of @DRUG$ and @DRUG$ were administered concomitantly.	DDI-mechanism
Levosimendan has no clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, @DRUG$ , isosorbide mononitrate, schnitztilol, ethanol or @DRUG$.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that @DRUG$ may impair absorption of @DRUG$.	DDI-mechanism
@DRUG$/theophylline, lidocaine/quinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
This appears to be the only clinically relevant interaction of this kind with @DRUG$ Although theoretically, the concomitant use of other drugs is known to alter the heart conduction (e.g., anti-arrhythmic or beta-adrenergic blockers, calcium channel blockers, antihistamines or H1 blockers, @DRUG$ ) could also contribute to an extension of the QTc interval.	DDI-effect
While all the selective serotonin reuptake inhibitors (SSRIs), e.g., citalopram, escitalopram, @DRUG$, @DRUG$, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
@DRUG$: In healthy individuals, plasma concentrations of @DRUG$ increased approximately 40% with coadministration of atorvastatin and erythromycin, a known inhibitor of cytochrome P450 3A4.	DDI-false
This drug may interact with alcohol or other @DRUG$ (may increase the CNS-depressive effect of these drugs or @DRUG$ ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( MAO ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines ) .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, @DRUG$, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, @DRUG$, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, @DRUG$, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with @DRUG$ or Innovar than with pentobarbital.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, @DRUG$, certain tricyclic antidepressants, lidocaine, theophylline and @DRUG$, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
For example , when @DRUG$ Prothrombin time should be carefully monitored and, if necessary, the dose of nilutamide should be administered with nilutamide. @DRUG$ , should be reduced.	DDI-false
Potassium-sparing diuretics (e.g., @DRUG$, triamterene, or amiloride), @DRUG$ supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
However , the absolute number of @DRUG$-related deaths is far greater than the number of deaths in amphetamine or @DRUG$ users .	DDI-false
@DRUG$ Other antiarrhythmic drugs, such as quinidine, procainamide, disopyramide, and @DRUG$ , were used simultaneously with amiodarone.	DDI-false
Other concomitant therapy Although no specific interaction studies have been conducted, 1 mg or more of fissteride doses have been co-administered in clinical trials with acetaminophen, @DRUG$ , a-blockers , analgesics , angiotensin-converting enzyme ( ACE ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , @DRUG$ , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, betablockers, @DRUG$, @DRUG$, and nonsteroidal anti-inflammatory drugs (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
Furosemide: Clinical studies, as well as post marketing observations, have shown that @DRUG$ can reduce the natriuretic effect of @DRUG$ and thiazides in some patients.	DDI-effect
ACE inhibitors : Reports suggest that @DRUG$ may diminish the antihypertensive effect of @DRUG$.	DDI-effect
Two groups (SH/DA; SH/FA) were submitted to daily treatment with synthetic hydroalcoholic solutions containing ethanol, methanol, higher @DRUG$ and @DRUG$ in the same proportions as those found in most common distilled and fermented alcoholic beverages;	DDI-false
@DRUG$ To reduce the hepatic metabolism of warfarin-type anticoagulants, apparently due to an effect on certain microsomal enzyme systems, @DRUG$ , propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, delaying the elimination and increase in blood levels of these drugs.	DDI-mechanism
These results suggest that the hepatoxicity of @DRUG$ in alcoholic beverages is enhanced by interaction with its congeners and @DRUG$;	DDI-effect
Levosimendan has no clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, @DRUG$ , warfarin, isosorbide mononitrate, knitztilol, @DRUG$ or itraconazole .	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, @DRUG$, antihistamines or @DRUG$, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-false
Patients receiving hydantoins, @DRUG$ , or @DRUG$ In case of increased activity of these drugs should be observed and therefore signs of toxicity by these drugs.	DDI-false
Data suggest that coadministration of oral @DRUG$ and @DRUG$ can result in prolongation of the QT interval on the ECG.	DDI-effect
There have been case reports of increased steady-state levels of quinidine, @DRUG$ , and @DRUG$ during concomitant therapy with amiodarone .	DDI-false
Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving concomitant @DRUG$ and @DRUG$ therapy.	DDI-effect
Warfarin: Eszopiclone 3 mg administered daily for 5 days had no effect on the pharmacokinetics of@DRUG$n, nor were there any changes in the pharmacodynamic profile (prothrombin time) after a single 25 mg oral dose of @DRUG$	DDI-false
Chloramphenicol has been shown to be antagonistic to @DRUG$, including @DRUG$, based on in vitro studies and time kill curves with enteric gram-negative bacilli.	DDI-false
@DRUG$ may block the antihypertensive action of @DRUG$ and similarly acting compounds .	DDI-effect
Nevertheless, caution is indicated in the co-administration of @DRUG$ with any of the @DRUG$ and also in switching from one class to the other.	DDI-advise
The administration of local anesthetic solutions containing @DRUG$ or @DRUG$ to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.	DDI-false
- Anabolic steroids (nandrolone [e.g., Anabolin], oxandrolone [e.g., Anavar], @DRUG$ [e.g., @DRUG$], stanozolol [e.g., Winstrol]) or	DDI-false
Although glucocorticoids have been shown to reduce @DRUG$-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with @DRUG$ may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-false
These drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , @DRUG$ , estrogens, oral contraceptives, phenytoin, nicotinic acid, @DRUG$ , calcium channel block drugs, and isoniazid.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ACE ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , H2 antagonists , @DRUG$ Prostaglandin synthetase inhibitors (also known as prostaglandin synthetase inhibitors) @DRUG$ In addition, quinolones anti-infections with no evidence of clinically significant adverse interactions.	DDI-false
Slow-channel calcium blockers, such as @DRUG$, diltiazem and @DRUG$, inhibit platelet activation in vitro, and decrease platelet adhesion intravascularly.	DDI-false
@DRUG$ It was given with tolazolin, @DRUG$ , dobutamine , steroids , surfactant , and high-frequency ventilation .	DDI-false
bacteriostatic antibiotics: chloramphenicol, erythromycins, sulphonamides or @DRUG$ The bactericidal effect of @DRUG$ may be impaired.	DDI-effect
Both efavirenz and nevirapine have been compared to triple therapy with the PI @DRUG$ For 48 weeks as initial therapy, with similar response observed with nevirapine therapies and superiority with @DRUG$.	DDI-false
Coingestion of @DRUG$ with theophylline, phenobarbital with acetaminophen, and @DRUG$ with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-false
@DRUG$ is a substrate for both CYP2D6 and @DRUG$.	DDI-false
In chronic hepatitis C patients treated with @DRUG$ In combination with COPEGUS, @DRUG$ treatment did not affect ribavirin distribution or clearance .	DDI-false
@DRUG$ may decrease the amount of @DRUG$ (Lanoxin, Lanoxicaps) that gets absorbed into your body.	DDI-mechanism
@DRUG$ , lidocaine , phenobarbital , @DRUG$ , theophylline , and valproic acid were added to pooled human serum at therapeutic concentrations .	DDI-false
Concomitant administration of alcohol and acamprosate does not affect the pharmacokinetics of @DRUG$ or @DRUG$.	DDI-false
An interaction study with warfarin showed no clinically significant effect of @DRUG$ on @DRUG$ Pharmacokinetics or anticoagulant activity.	DDI-false
In vitro binding studies with human serum proteins indicate that glipizide binds differently than @DRUG$ ♪ And don't interact with me ♪ @DRUG$ or dicumarol .	DDI-false
Potential drug interactions between @DRUG$  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of @DRUG$ and these AEDs during placebo-controlled clinical studies.	DDI-false
In vitro data suggest that itraconazole , when compared to @DRUG$ It has a less pronounced effect on the biotransformation system responsible for the metabolism of @DRUG$.	DDI-false
There are 3 types of indications: specific (for the treatment of some forms of @DRUG$ deficit i.e. acute), pharmacological (i.e. without alterations of @DRUG$ status) and mixed--pharmacological and aetiopathogenic--(for example complications of chronic alcoholism).	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5 % Ophthalmic Solution , the possibility of an additive or potentiating effect with CNS depressants ( @DRUG$ , barbiturates, opiates, sedatives, @DRUG$ ) should be considered.	DDI-false
Fenfluramine may increase slightly the effect of @DRUG$, e.g., guanethidine, methyldopa, @DRUG$.	DDI-false
@DRUG$ A report of severe acetaminophen toxicity was reported in a patient receiving @DRUG$.	DDI-false
No pharmacokinetic interactions between @DRUG$ and isoflurane, propofol, alfentanil, and @DRUG$ have been demonstrated.	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other @DRUG$ may potentiate the hypotension seen with @DRUG$.	DDI-effect
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, @DRUG$, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that @DRUG$ may impair absorption of fosinopril.	DDI-false
A crossover study in healthy subjects that either @DRUG$ 300 mg q.i.d. or 800 mg h.s. with a dose of 300 mg b.i.d. theophylline ( @DRUG$ , Key Pharmaceuticals , Inc. ) demonstrated less alteration in steady-state theophylline peak serum levels with the 800 mg h.s . regimen , particularly in subjects aged 54 years and older .	DDI-mechanism
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , @DRUG$ , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , @DRUG$ Concomitant use with saquinavir may result in increased plasma concentrations.	DDI-false
Administration of rifampin with oral @DRUG$ It has been shown that serum concentrations of @DRUG$ and desethylamiodarone .	DDI-false
Particular caution is necessary when using @DRUG$ In cases of mixed medication overdose, since the toxic effects (such as cramps and cardiac arrhythmias) of other medicines taken during overdose (especially cyclic antidepressants) may occur with the reversal of the benzodiazepine effect by @DRUG$.	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with @DRUG$ concomitantly with anxiolytics, hypnotics and sedatives (including @DRUG$), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
@DRUG$ Reports suggest that @DRUG$ may diminish the antihypertensive effect of ACE-inhibitors.	DDI-false
Furosemide: Clinical studies, as well as post marketing observations, have shown that @DRUG$ can reduce the natriuretic effect of furosemide and @DRUG$ in some patients.	DDI-effect
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
Therefore, when hydroflumethiazide and @DRUG$ are used concomitantly, the patient should be observed closely to determine if the desired effect of the @DRUG$ is obtained.)	DDI-false
Similarly dialyzed were @DRUG$, @DRUG$, and theophylline, both alone at therapeutic concentrations in serum and with ethanol at three different concentrations in serum.	DDI-false
The use of acetaminophene with acetaminophene @DRUG$ , phenobarbital with acetaminophene and valproic acid with @DRUG$ at high to toxic concentrations decreases the binding of the target drug .	DDI-false
@DRUG$: Quinolones have been reported to enhance the effects of the oral anticoagulant @DRUG$ or its derivatives.	DDI-false
Lithium: Increased serum @DRUG$ levels and symptoms of lithium toxicity have been reported in patients receiving concomitant lithium and @DRUG$ therapy.	DDI-false
Other concomitant therapies : In clinical trials , the safety profile in subjects treated with Acamprosate concomitantly with @DRUG$ , @DRUG$ and sedatives ( including benzodiazepines ) , or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications .	DDI-false
Because of the increased risk of adverse reactions in patients who have been taking @DRUG$ on a regular basis, it is particularly important that physicians query patients or their guardians carefully about @DRUG$, alcohol and sedative use as part of the history prior to any procedure in which the use of ROMAZICON is planned.	DDI-false
@DRUG$: Concurrent administration of @DRUG$ may lower meclofenamate sodium plasma levels, possibly by competing for protein-binding sites.	DDI-false
@DRUG$: In some patients, the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and @DRUG$.	DDI-false
To evaluate the effects of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL), the authors retrospectively compared a group of 24 patients with HIV-NHL treated with cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$ , doxorubicin , @DRUG$ , and prednisone with vincristine plus bleomycin) without antiretroviral therapy.	DDI-false
Five days of @DRUG$ treatment did not significantly affect steady-state pharmacokinetic variables of @DRUG$ compared with placebo;	DDI-false
Ergot Derivatives: Dihydroergotamine, @DRUG$, ergotamine, methylergonovine CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute @DRUG$ toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
@DRUG$ may increase slightly the effect of antihypertensive drugs, e.g., @DRUG$, methyldopa, reserpine.	DDI-effect
The effects of DCG-IV and L-CCG-1 upon @DRUG$ (@DRUG$)-induced locomotion and behavioral changes in mice.	DDI-false
Gleevec will increase plasmaconcentration of other CYP3A4 metabolized drugs (e.g., triazolo-@DRUG$, @DRUG$, certain HMG-CoA reductase inhibitors, etc.).	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , @DRUG$ , warfarin, tacrolimus, cyclosporin, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$ When co-administered with saquinavir, increased plasma concentrations may occur;	DDI-false
Tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , @DRUG$ , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and @DRUG$ , thereby delaying elimination and increasing blood levels of these drugs .	DDI-false
Specific studies have confirmed these effects with @DRUG$ , @DRUG$ , propofol , alfentanil , and midazolam .	DDI-false
Tagamet, apparently due to an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, @DRUG$ , theophylline and @DRUG$ This delays elimination and increases blood levels of these drugs.	DDI-false
Clinical interaction studies with cimetidine and @DRUG$ The concomitant use of @DRUG$ with these drugs does not result in clinically- significant drug interactions .	DDI-false
In patients with mild to moderate hypertension, administration of 25 mg daily of @DRUG$ with the ACE inhibitor @DRUG$, 10 to 40 mg for 4 weeks, was associated with an average increase in mean arterial pressure of about 3 mm Hg compared to ACE inhibitor alone.	DDI-effect
Although studies designed to examine drug interactions have not been done , it was noted that @DRUG$ or ACTH treatment of relapses for periods of up to 28 days has been administered to patients ( N=180 ) receiving @DRUG$.	DDI-false
These drugs include the thiazides and other diuretics , @DRUG$ , phenothiazines , thyroid products , @DRUG$ , oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel block drugs, and isoniazide.	DDI-false
These medicines include thiazides and other diuretics, corticosteroids, phe-nothiazines, @DRUG$ , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimet-ics , @DRUG$ , and isoniazid .	DDI-false
Multivitamins, or other products containing iron or @DRUG$, antacids or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of @DRUG$.	DDI-false
@DRUG$ have been reported to blunt the hypotensive effect of systemic clonidine.It is not known whether the concurrent use of these agents with @DRUG$ in humans can lead to resulting interference with the IOP lowering effect.	DDI-false
The hypoglycaemic effect of sulphonylureas may be due to certain medications, including: @DRUG$ And other medicines that are highly protein bound, salicylates, sulphonamides, chloramphenicol, probenecid, coumarin, @DRUG$ , and beta adrenergic blocking agents .	DDI-false
After multiple dosing, @DRUG$ (@DRUG$  30 mcg IM once weekly) reduced TYSABRI  clearance by approximately 30%.	DDI-false
Possible drug interactions of: @DRUG$ with @DRUG$ or with other anticholinesterase agents .	DDI-int
Like ibogaine (40 mg/kg), @DRUG$ (40 mg/kg) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of @DRUG$ and nicotine in rats;	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, @DRUG$, haloperidol, @DRUG$, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, @DRUG$, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, @DRUG$, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (@DRUG$ transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, @DRUG$, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
@DRUG$ : Alcohol ( 0.5 g/kg body weight : approximately 40 mL of absolute alcohol in a 70 kg person ) and @DRUG$ plasma levels were not altered when dosed simultaneously .	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with @DRUG$, methyldopa, nitrates, calcium-blocking agents, hydralazine, @DRUG$ and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$ , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ACE ) inhibitors , @DRUG$ , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , H2 antagonists , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
In the @DRUG$ study , @DRUG$ The prothrombin time or other pharmacodynamic parameters have not been affected.	DDI-false
Specific studies have confirmed these effects with sevoflurane, isoflurane, @DRUG$, alfentanil, and @DRUG$.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect @DRUG$ pharmacodynamics - Arecoline - Eproxindine - @DRUG$: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
This drug may interact with alcohol or other CNS depressants ( may potentiate the CNS depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and @DRUG$ ( concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of @DRUG$ ) .	DDI-false
@DRUG$ including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as nonsteroidal anti-inflammatory drugs (NSAIDs), and @DRUG$ may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
Other Drugs:Drugs such as @DRUG$, @DRUG$, procainamide, phenothiazines, antihistamines, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
@DRUG$ and verapamil use may be rarely associated with ventricular fibrillation when combined with @DRUG$.	DDI-effect
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with @DRUG$, methyldopa, nitrates, calcium-blocking agents, @DRUG$, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Multivalent Cation-Containing Products : Concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or @DRUG$ antacids , sucralfate , @DRUG$ chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .	DDI-false
Prednisone/@DRUG$: Rofecoxib did not have any clinically important effect on the pharmacokinetics of prednisolone or @DRUG$.	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of magnesium deficit and to discriminate between magnesium deficiency due to an insufficient magnesium intake which only requires oral physiological supplementation and @DRUG$ • Reduction of dysregulation of control mechanisms @DRUG$ Status that requires more or less specific regulation of its causal dysregulation.	DDI-false
For example, inhibitors are azole antimycotics, @DRUG$ , clarithromycin , @DRUG$ , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .	DDI-false
@DRUG$ NSAIDs have an increase in plasma lithium levels and a decrease in renal @DRUG$ clearance .	DDI-false
Single doses of either cholestyramine or @DRUG$ resins bind the @DRUG$ and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent , respectively .	DDI-mechanism
There was not a significant difference (p > 0.05) in AUC (48.59 +/- 8.52 vs. 49.9 +/- 9.93), Cmax (7.73 +/- 2.6 vs. 6.6 +/- 2.0), and tmax (1.1 +/- 0.6 vs. 1.6 +/- 1.1) for levofloxacin versus @DRUG$/@DRUG$ regimens.	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, @DRUG$, phenobarbital, phenytoin, @DRUG$ and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
In patients with chronic hepatitis C treated with PEGASYS in combination with COPEGUS, @DRUG$ treatment did not affect @DRUG$ Distribution or release.	DDI-false
Because Nalfon has not been shown to produce any additional effect beyond that obtained with @DRUG$ alone and because @DRUG$ increases the rate of excretion of Nalfon, the concomitant use of Nalfon and salicylates is not recommended.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, @DRUG$, thyroid products, estrogens, oral contraceptives, @DRUG$, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
@DRUG$ : Chloramphenicol , @DRUG$ The bactericidal effect of penicillins may be affected by sulfonamides or tetracyclines.	DDI-false
These drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , @DRUG$ , oral @DRUG$ , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, @DRUG$, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and @DRUG$.	DDI-false
Drug-Drug Interactions Between Keppra   And Other @DRUG$ Phenytoin @DRUG$   ( 3000 mg daily ) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy .	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with @DRUG$, @DRUG$ and sedatives (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
Potential drug interactions between Keppra  and other @DRUG$ (carbamazepine, gabapentin, lamotrigine, @DRUG$, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Antiarrhythmics: Amiodarone, @DRUG$, @DRUG$, propafenone, quinidine CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering @DRUG$ with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, @DRUG$, clarithromycin).	DDI-advise
Central Nervous System Depressants: The concomitant use of @DRUG$  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general @DRUG$, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and @DRUG$ cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
DIGOXIN: Plasma @DRUG$ levels and digoxin clearance at steady-state were not affected by co-administration of 0.2 mg @DRUG$.	DDI-false
The intensity, uniformity and time course of @DRUG$ interference by phenobarbital, @DRUG$, glutethimide, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
@DRUG$ In large quantities, the antiepileptic effect of @DRUG$ , phenytoin and primidone, and increase the frequency of seizures in susceptible paediatric patients.	DDI-effect
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving @DRUG$ therapy.	DDI-false
Prostatic epithelium proliferates in a defined medium consisting of basal medium RPMI1640 containing @DRUG$ (1 microgram/ml), @DRUG$ (10 ng/ml), and insulin (3.7 micrograms/ml or 0.1 IU/ml).	DDI-false
Fluconazole: Concomitant administration of @DRUG$ at 200 mg QD resulted in a two-fold increase in @DRUG$ plasma concentration.	DDI-mechanism
Probenecid: @DRUG$ interferes with renal tubular secretion of @DRUG$ and produces an increase in the level of ciprofloxacin in serum.	DDI-mechanism
These results suggest that both @DRUG$ and retinyl acetate , and possibly other glucocorticoids and @DRUG$ , may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF .	DDI-false
When @DRUG$ was coadministered with phenytoin, rifampin, or H2antagonists, reduced plasma concentrations of @DRUG$ were reported.	DDI-false
Aspirin: Concomitant administration of low-dose @DRUG$ with @DRUG$ may result in an increased rate of GI ulceration or other complications, compared to use of VIOXX alone.	DDI-effect
Another oral azole antimycotics, ketoconazole, inhibits the metabolism of astemizole, resulting in increased plasma concentrations of @DRUG$ and its active metabolite @DRUG$ , which can prolong QT intervals.	DDI-false
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., @DRUG$, @DRUG$, antiemetics, sedatives, tranquilizers).	DDI-false
Slow-channel calcium blockers , such as @DRUG$ , @DRUG$ and nifedipine , inhibit platelet activation in vitro , and decrease platelet adhesion intravascularly .	DDI-false
Other Cardiovascular Agents : Enalapril and @DRUG$ IV were co-administered with beta-adrenerg blockers, methyldopa, nitrates, calcium blockers, hydralazine, @DRUG$ And digoxin without evidence of clinically significant adverse interactions.	DDI-false
- Methotrexate ( e.g. , Mexate ) Use of methotrexate with @DRUG$ may increase the chance of side effects affecting the liver and/or the side effects of @DRUG$	DDI-false
Simultaneous use of @DRUG$ - with antiplatelet agents, @DRUG$ , and other anticoagulants may increase the risk of bleeding .	DDI-effect
Example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , @DRUG$ , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , @DRUG$ , protease inhibitors , quinidine , and verapamil .	DDI-false
bacteriostatic antibiotics : chloramphenicol, @DRUG$ , @DRUG$ , or tetracyclines may interfere with the bactericidal effect of penicillins .	DDI-false
@DRUG$ and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (@DRUG$/ARB).	DDI-false
@DRUG$ or iodine excess may decrease the effect of Carbimazole, and an iodine deficiency can increase the effect of @DRUG$.	DDI-false
@DRUG$     @DRUG$ antagonism	DDI-false
@DRUG$ In some patients with renal impairment treated with nonsteroidal anti-inflammatory medicinal products, concomitant use of @DRUG$ may result in a further deterioration of renal function .	DDI-false
Aspirin/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of @DRUG$ 1  g/kg/min. over 4 hours) or @DRUG$ (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
For treatment with CYP3A4 inhibitors (such as ketoconazole, intraconazole, @DRUG$ , indinavir , @DRUG$ , erythromycin, etc.) is indicated, reduction of budesonide dose should be considered.	DDI-false
When antizole is used concomitantly with medicinal products that increase or inhibit the cytochrome P450 system, reciprocal interactions may occur (e.g. phenytoin, @DRUG$ , cimetidine , @DRUG$ ) , though this has not been studied	DDI-false
Other strong inhibitors of CYP3A4 (e.g., itraconazole, @DRUG$, nefazodone, troleandomycin, @DRUG$, nelfinavir) would be expected to behave similarly.	DDI-false
@DRUG$ : Concurrent administration of aspirin may lower @DRUG$ plasma levels , possibly by competing for protein-binding sites .	DDI-false
No pharmacokinetic interactions between @DRUG$ and @DRUG$, propofol, alfentanil, and midazolam have been demonstrated.	DDI-false
Acid-catalyzed ethanolysis of @DRUG$ in anhydrous and aqueous @DRUG$ solutions .	DDI-mechanism
High-dose cyclosporin A resulting in concentrations above 2000 ng/mL administered with oral @DRUG$ has led to an 80% increase in @DRUG$ exposure with a 38% decrease in total body clearance of etoposide compared to etoposide alone.	DDI-false
The administration of local @DRUG$ containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors, tricyclic antidepressants or @DRUG$ may produce severe, prolonged hypotension or hypertension.	DDI-effect
Coingestion of acetaminophen with theophylline, @DRUG$ with acetaminophen, and @DRUG$ with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-false
Imipramine ( 5 mg/kg), moclobemid ( 30 mg/kg), @DRUG$ [ 0.25 mg/kg], @DRUG$ Sertraline ( 30 mg/kg) or vehicle was administered.	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of magnesium deficit and to discriminate between magnesium deficiency due to an insufficient magnesium intake which only requires oral physiological supplementation and @DRUG$ depletion related to a dysregulation of the control mechanisms of @DRUG$ status which requires more or less specific regulation of its causal dysregulation.	DDI-false
By contrast , @DRUG$ ( 1 mM ) and @DRUG$ 1 mM) had no significant effect on translocation when added alone.	DDI-false
The co-administration of medicinal products which are nephrotoxic (e. g. @DRUG$ , @DRUG$ ) , myelotoxic ( e.g. , cytotoxic chemotherapy ) , cardiotoxic ( e.g. , doxorubicin ) or hepatotoxic ( e.g. , methotrexate , asparaginase ) effects with PROLEUKIN may increase toxicity in these organ systems .	DDI-false
@DRUG$ Chloramphenicol, erythromycines, sulphonamides or tetracyclines may affect the bactericidal effect of @DRUG$.	DDI-false
@DRUG$ and Angiotensin II Receptor Antagonists ( Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS , 3020 ( 91 % ) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists ( ACEI/@DRUG$ ) .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with @DRUG$ plus bleomycin) without receiving antiretroviral therapy.	DDI-false
The administration of local anesthetic solutions containing @DRUG$ or norepinephrine to patients receiving monoamine oxidase inhibitors, tricyclic antidepressants or @DRUG$ may produce severe, prolonged hypotension or hypertension.	DDI-effect
Bacteriostatic Antibiotics : @DRUG$ , erythromycines, sulphonamides or tetracyclines may affect the bactericidal effect of @DRUG$.	DDI-effect
[Quantitative approach to treatment with incisive @DRUG$ by therapeutic monitoring]; The problems encountered during the longterm treatment of psychotic patients with @DRUG$ are illustrated by six typical case reports.	DDI-false
Drug Interactions : @DRUG$ may interact with some drugs , like Monoamine oxidase inhibitors ( @DRUG$ ): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol : Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants : Flupenthixol increases the effect of Tricyclic antidepressants	DDI-int
Benzthiazide may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, @DRUG$, norepinephrine, NSAIDs like Aleve or @DRUG$, and high blood pressure medications.	DDI-false
No formal clinical studies have been conducted to assess if there is an interactive effect on bone loss between @DRUG$ and @DRUG$.	DDI-false
however, no deleterious interactions were seen when @DRUG$ was administered after narcotics, inhalational anesthetics, @DRUG$ and muscle relaxant antagonists administered in conjunction with sedation or anesthesia.	DDI-false
@DRUG$ Atorvastatin plasma concentrations increased in healthy subjects when co-administered with atorvastatin. @DRUG$ Erythromycin, a known inhibitor of cytochrome P450 3A4.	DDI-false
A possible interaction between glyburide and @DRUG$, a fluoroquinolone antibiotic, has been reported, resulting in a potentiation of the hypoglycemic action of @DRUG$.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other @DRUG$, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general @DRUG$, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Co-medications that induce CYP3A4 ( e.g. , dexamethasone , phenytoin , @DRUG$ , rifampin , @DRUG$ or St.	DDI-false
In the presence of these @DRUG$, larger doses of adenosine may be required or @DRUG$ may not be effective.	DDI-advise
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and @DRUG$) with @DRUG$ reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-mechanism
* Drug interactions : Flupentixol may interact with some drugs, such as @DRUG$ ( @DRUG$ ): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol : Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants : Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
ACE Inhibitors and @DRUG$ ( Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS , 3020 ( 91 % ) patients receiving @DRUG$ ACE inhibitors or angiotensin II receptor antagonists (ACEI/ ARB) were also administered 25 to 50 mg.	DDI-false
Tetracycline : Concomitant treatment with Accutane and Tetracycline should be avoided as: @DRUG$ use has been associated with a number of cases of pseudotumor cerebri ( benign intracranial hypertension ) , some of which involved concomitant use of @DRUG$	DDI-effect
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$: The concomitant administration of ciprofloxacin with the @DRUG$ glyburide has, on rare occasions, resulted in severe hypoglycemia.	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , @DRUG$ , @DRUG$ Tacrolimus, cyclosporin, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam and triazolam) may exhibit increased plasma concentrations when co-administered with saquinavir;	DDI-false
This appears to be the only clinically relevant interaction of this kind with @DRUG$, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or @DRUG$, calcium channel blockers, antihistamines or H1-blocking agents, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-effect
Longitudinal assessment of @DRUG$ in de novo renal transplant recipients over the first post-transplant year: pharmacokinetics, exposure-response relationships, and influence on @DRUG$.	DDI-false
This drug may interact with @DRUG$ or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), @DRUG$ or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
@DRUG$ as potent @DRUG$ of glucocorticoid-induced mouse mammary tumor virus gene expression.	DDI-false
Amiodarone taken concomitantly with @DRUG$ increases @DRUG$ serum concentration by 33% after two days.	DDI-false
Also, phenobarbital, quinidine, and @DRUG$ , both alone at therapeutic concentrations in serum and with @DRUG$ at three different concentrations in serum .	DDI-false
Lithium-A drug interaction study of @DRUG$ with @DRUG$ has not been conducted.	DDI-false
Reciprocal interactions may occur with concomitant use of Antizol and drugs that increase or inhibit the cytochrome P450 system (e.g., @DRUG$, @DRUG$, cimetidine, ketoconazole), though this has not been studied	DDI-false
Patients receiving both @DRUG$ It should be closely observed to determine whether the desired diuretic and/ or antihypertensive effect of @DRUG$ is achieved .	DDI-false
In general , these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride , including @DRUG$ Like quinidine and procainamide, @DRUG$ and tricyclic anti-depressants .	DDI-false
Multivitamins, or other products containing iron or zinc, @DRUG$ or @DRUG$ should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.	DDI-false
@DRUG$: Amiodarone, bepridil, flecainide, @DRUG$, quinidine CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
These drugs include the thiazides and other diuretics, @DRUG$, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, @DRUG$, and isoniazid.	DDI-false
Administration of @DRUG$ concomitantly with oral amiodarone has been shown to result in decreases in serum concentrations of @DRUG$ and desethylamiodarone .	DDI-false
Because of the increased risk of adverse reactions in patients who have been taking benzodiazepines on a regular basis , it is particularly important that physicians query patients or their guardians carefully about @DRUG$ , alcohol and sedative use as part of the story before any procedure in which the use of @DRUG$ is planned .	DDI-false
@DRUG$/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$ and colestipol @DRUG$: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.	DDI-false
MAO Inhibitors: @DRUG$  is not recommended for use in patients who have received MAOI within 14 days because severe and unpredictable potentiation by MAO inhibitors has been reported with @DRUG$	DDI-false
In addition , @DRUG$ neither influenced the pharmacodynamics of warfarin , @DRUG$ , piroxicam , and digoxin , nor the pharmacokinetics of digoxin at steady state .	DDI-false
@DRUG$: Chloramphenicol, @DRUG$, sulfonamides, or tetracyclines may interfere with the bactericidal effect of penicillins.	DDI-false
hypersensitivity reactions have been reported in patients receiving combination regimens with sequentially high-dose PROLEUKIN and @DRUG$ , specifically , dacarbazine , cis-platinum , tamoxifen and @DRUG$.	DDI-false
acetaminophen/theophylline , @DRUG$/quinidine , phenobarbital/acetaminophen , phenobarbital/valproic acid , quinidine/lidocaine , theophylline/@DRUG$ , and valproic acid/phenobarbital .	DDI-false
Azithromycin had no significant impact on the Cmax and AUC of zidovudine, although it significantly decreased the @DRUG$ tmax by 44% and increased the intracellular exposure to phosphorylated @DRUG$ by 110%.	DDI-false
therefore, @DRUG$ or other @DRUG$ (as used for management of angina) or other drugs having vasodilator activity should, if possible, be discontinued before starting captopril.	DDI-false
Patients receiving these drugs who are given @DRUG$, or any other @DRUG$, and particularly those patients with altered renal function, should be observed for the development of the specific toxicities of these drugs.	DDI-false
Therefore, patients with @DRUG$ Treatment should be carefully monitored if: @DRUG$ therapy is indicated .	DDI-advise
The effects of @DRUG$ They are antagonized by methylxanthine such as caffeine and @DRUG$.	DDI-effect
Therefore, the use of @DRUG$ Not required is an adjustment in @DRUG$ dose to maintain therapeutic digoxin levels .	DDI-false
Previous studies have demonstrated a significant reduction in the oral bioavailability of @DRUG$ and ciprofloxacin when administered concomitantly with an intravenous opiate such as @DRUG$.	DDI-mechanism
These drugs include the thiazides and other diuretics, @DRUG$, phe-nothiazines, thyroid products, estrogens, oral @DRUG$, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Drug Interactions : Flupenthixol may interact with some drugs , like @DRUG$ ( MAOI ): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol : Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants : @DRUG$ Increases the effect of tricyclic antidepressants	DDI-false
Because Nalfon has not been shown to produce any additional effect beyond that obtained with aspirin alone and because @DRUG$ increases the rate of excretion of Nalfon, the concomitant use of Nalfon and @DRUG$ is not recommended.	DDI-false
Central nervous system depressants : the concomitant use of DURAGESIC (Fentanyl transdermal system ) with other central nervous system depressants, including but not limited to other opioids, @DRUG$ Hypnotics, sedatives (e.g. benzodiazepines), general @DRUG$ , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	DDI-false
acetaminophen/theophylline , lidocaine/quinidine , phenobarbital/@DRUG$ , phenobarbital/@DRUG$ , quinidine/lidocaine , theophylline/acetaminophen , and valproic acid/phenobarbital .	DDI-false
Two groups (SH/DA; SH/FA) were treated daily with synthetic hydroalcoholic solutions containing ethanol. @DRUG$ , higher @DRUG$ acetaldehyde and acetaldehyde in the same proportions as in the most common distilled and fermented alcoholic beverages;	DDI-false
There is a significant increase in exposure to imatinib when @DRUG$ is coadministered with @DRUG$ (CYP3A4 inhibitor).	DDI-mechanism
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
In addition , @DRUG$ The pharmacodynamics of @DRUG$ Acetylsalicylic acid, piroxicam and digoxin, and the pharmacokinetics of digoxin in steady state.	DDI-false
Combinations of @DRUG$ and @DRUG$ : effects on drug discrimination and behavioral inhibition in rats .	DDI-false
While all the selective serotonin reuptake inhibitors (@DRUG$), e.g., citalopram, escitalopram, fluoxetine, sertraline, and @DRUG$, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
Antiarrhythmics: Other antiarrhythmic drugs, such as quinidine, @DRUG$, disopyramide, and phenytoin, have been used concurrently with @DRUG$.	DDI-false
Co-administration of @DRUG$ and cerivastatin did not alter the pharmacokinetics of @DRUG$.	DDI-false
METHOD: This study was a multicenter randomized double-blind study of 101 patients who were randomly assigned 1:1:1 to receive @DRUG$ tablets at doses of 0.5 mg, 1 mg, or 2 mg twice daily with @DRUG$ and prednisone.	DDI-false
HIV protease inhibitors : @DRUG$ Co-administration of vardenafil 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in vardenafil Cmax and a 2-fold increase in vardenafil Cmax. @DRUG$ half-life .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, @DRUG$, @DRUG$, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
These results suggest that both dexamethasone and retinyl acetate, and possibly other @DRUG$ and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of @DRUG$ and EGF.	DDI-effect
Intravenous Adenocard ( @DRUG$ ) has been effectively administered in the presence of other cardioactive drugs , such as quinidine , beta-adrenergic blocking agents , @DRUG$ , and angiotensin converting enzyme inhibitors , without any change in the adverse reaction profile .	DDI-false
These results would seem to dictate against the clinical use of @DRUG$ with ELSPAR , or during the period following @DRUG$ Treatment if plasma asparagine levels are below normal.	DDI-false
ACE Inhibitors and Angiotensin II Receptor Antagonists (Hypertension)- In clinical studies of patients with hypertension, the addition of @DRUG$ 50 to 100 mg to ACE inhibitors and @DRUG$ increased mean serum potassium slightly (about 0.09-0.13 mEq/L).	DDI-effect
@DRUG$ and retinyl acetate similarly inhibit and stimulate @DRUG$- or insulin-induced proliferation of prostatic epithelium.	DDI-effect
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, @DRUG$ , disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$ When co-administered with saquinavir, increased plasma concentrations may occur when it contains its derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam and triazolam.	DDI-false
Corticosteroids , @DRUG$ Abs and diuretics: Concomitant treatment with xanthine derivatives, steroids or diuretics may potentiate a possible hypocalemic effect @DRUG$	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, @DRUG$, @DRUG$, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Dose adjustment is not recommended.Levetiracetam had no effect on plasma concentrations of carbamazepine, @DRUG$, topiramate, or @DRUG$.	DDI-false
Haemodynamic effects of @DRUG$ Insulins were additive if: @DRUG$ The administration was performed simultaneously, but not under basal conditions.	DDI-false
Other Drug Interactions: No pharmacokinetic interactions were observed between @DRUG$ and the following drugs: glyburide, warfarin, digoxin, Maalox, and @DRUG$.	DDI-false
Example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , @DRUG$ , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , @DRUG$ , quinidine, and verapamil.	DDI-false
Tagamet, apparently due to an effect on certain microsomal enzyme systems, has been reported to reduce hepatic metabolism @DRUG$ , @DRUG$ , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, @DRUG$, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, @DRUG$, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Drug Interactions : Flupenthixol may interact with some drugs , like Monoamine oxidase inhibitors ( MAOI ): MAOI could theoretically affect @DRUG$ pharmacodynamics - Arecoline - Eproxindine - Ethanol : @DRUG$ - Tricyclic antidepressants : Flupentixol increases the effect of tricyclic antidepressants	DDI-false
The possibility of hypotensive effects with enalapril or @DRUG$ can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with enalapril or @DRUG$.	DDI-false
Like ibogaine (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of @DRUG$ and cocaine and the oral self-administration of @DRUG$ and nicotine in rats;	DDI-false
Data from in vitro studies of @DRUG$ suggest a possible drug interaction with @DRUG$ for the following: sertraline and paroxetine.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, @DRUG$, isosorbide mononitrate, carvedilol, @DRUG$ or itraconazole.	DDI-false
Patients treated with @DRUG$ may be resistant to the effects of @DRUG$.	DDI-effect
Benzthiazide may interact with alcohol , blood thinners , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , @DRUG$ , NSAIDs like Aleve or @DRUG$ , and high blood pressure medications.	DDI-false
The intensity , uniformity and time course of anticoagulant interference by phenobarbital , secobarbital , glutethimide , @DRUG$ and @DRUG$ The treatment was systematically studied in 16 patients receiving coumarin therapy.	DDI-false
acetaminophen/theophylline , lidocaine/quinidine , phenobarbital/acetaminophen , phenobarbital/valproic acid , quinidine/lidocaine , theophylline/acetaminophen , and @DRUG$/@DRUG$.	DDI-false
Monitoring for amiodarone toxicity and serial measurement of @DRUG$ serum concentration during concomitant @DRUG$ therapy should be considered.	DDI-advise
- anabolic steroids (Nandrolone [e.g. Anaboline ], @DRUG$ [ e.g. , Anavar ] , @DRUG$ [ e.g. , Anadrol ] , stanozolol [ e.g. , Winstrol ] ) or	DDI-false
Anticoagulants including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as nonsteroidal anti-inflammatory drugs (NSAIDs), and @DRUG$ may increase the risk of bleeding when administered concomitantly with @DRUG$.	DDI-effect
The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving @DRUG$, @DRUG$ or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-false
Dosage adjustment of STRATTERA may be necessary when coadministered with CYP2D6 inhibitors, e.g., @DRUG$, @DRUG$, and quinidine.	DDI-false
@DRUG$ In some patients, the administration of a non-steroidal anti-inflammatory agent may reduce the diuretic, natriuretic and blood pressure lowering effect of @DRUG$.	DDI-false
The possibility of hypotensive effects with @DRUG$ Treatment with Enalapril or @DRUG$ can be minimized by stopping the diuretic or increasing salt intake before starting treatment.	DDI-false
Antipyrine : Because atorvastatin does not affect the pharmacokinetics of @DRUG$ Interactions with others @DRUG$ Metabolism via the same cytochrome isozymes is not expected.	DDI-false
Drugs that cause significant sustained elevation in gastric pH (@DRUG$ such as @DRUG$ or cimetidine) may reduce plasma concentrations of IRESSA and therefore potentially may reduce efficacy.	DDI-false
Carbamazepine: Isoniazid is known to slow the metabolism of @DRUG$ and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with @DRUG$, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.	DDI-false
Potassium-sparing diuretics (e.g., spironolactone, @DRUG$, or @DRUG$), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
However, in the second study, administration of 12 g cholestyramine 1 hour before the evening meal and 0.3 mg @DRUG$ approximately 4 hours after the same evening meal resulted in a decrease in the @DRUG$ AUC of less than 8%, and a decrease in Cmax of about 30% when compared to dosing cerivastatin sodium alone.	DDI-false
Antacids : In a clinical pharmacology study, concomitant administration of antacids (aluminium hydroxide, magnesium hydroxide and simethicone) with @DRUG$ • Decreased serum levels and urinary excretion of @DRUG$ In comparison to Fosinopril alone, which suggests that antacids may affect the absorption of Fosinopril.	DDI-false
Other strong inhibitors of CYP3A4 ( e.g. , itraconazole , clarithromycin , nefazodone , @DRUG$ , ritonavir , @DRUG$ It would be expected that it would behave in a similar way.	DDI-false
Drug Interactions: @DRUG$ may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
As with other antipsychotic agents, it should be noted that HALDOL may be capable of potentiating CNS depressants such as @DRUG$, opiates, and @DRUG$.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
Although there are no study data to evaluate the possibility, nitric oxide donor compounds, including @DRUG$ and nitroglycerin, may have an additive effect with @DRUG$ on the risk of developing methemoglobinemia.	DDI-effect
These drugs include the thiazides and other diuretics , corticosteroids , @DRUG$ , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , @DRUG$ , and isoniazid .	DDI-false
Multivalent Cation-Containing Products : Simultaneous Application of a @DRUG$ , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , VIDEX chewable/buffered tablets or pediatric powder , or products containing @DRUG$ , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .	DDI-mechanism
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, @DRUG$, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, @DRUG$, protease inhibitors, quinidine, and verapamil.	DDI-false
Co-medications that induce CYP3A4 (e.g., @DRUG$, phenytoin, carbamazepine, rifampin, @DRUG$ or St.	DDI-false
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, secobarbital, @DRUG$, chloral hydrate and @DRUG$ were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like @DRUG$ (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and @DRUG$ cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
In vitro binding studies with human serum proteins indicate that @DRUG$ binds differently than @DRUG$ And don't interact with salicylate or dicumarol.	DDI-false
These drugs include thiazides and other @DRUG$ , corticosteroids , phenothiazines , thyroid products , estrogens , oral @DRUG$ , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .	DDI-false
@DRUG$ In a clinical pharmacology study, concomitant use of @DRUG$ ( aluminum hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .	DDI-false
Other Drugs:Drugs such as quinidine, disopyramide, procainamide, @DRUG$, @DRUG$, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
The application of local anaesthetic solutions that @DRUG$ or norepinephrine to patients receiving @DRUG$ , tricyclic antidepressants or phenothiazines may produce severe , prolonged hypotension or hypertension .	DDI-effect
Nevertheless, clinical trials and post-marketing observations have shown that: @DRUG$ The natriuretic effect of furosemide and @DRUG$ in some patients .	DDI-effect
Antihypertensives : Amiodarone should be used with caution in patients receiving   -receptor blocking agents ( e.g. , propranolol , a CYP3A4 inhibitor ) or calcium channel antagonists ( e.g. , @DRUG$ , a @DRUG$ Substrate, and diltiazem, an inhibitor of CYP3A4) due to the potential for bradycardia, sinus arrest, and AV block;	DDI-false
These drugs include the thiazides and other diuretics , @DRUG$ , phenothiazines , @DRUG$ , estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel block drugs, and isoniazide.	DDI-false
Carbamazepine : @DRUG$ is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with @DRUG$ The signs and symptoms of carbamazepine toxicity should be closely monitored and the anticonvulsant dose adjusted accordingly.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$, acetylsalicylic acid, a-blockers, @DRUG$, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Certain endocrine and liver function tests may be affected by @DRUG$-containing oral @DRUG$.	DDI-false
Other Drugs : Drugs such as @DRUG$ , @DRUG$ , procainamide , phenothiazines , antihistamines , and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia .	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When @DRUG$ is used concomitantly with injectable @DRUG$, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-effect
Injection : @DRUG$ injection , like other injectable @DRUG$ , produces depression of the central nervous system when administered with ethyl alcohol, phenothiazine, barbiturates, MAO inhibitors and other antidepressants. When scopolamine is simultaneously observed with injectable lorazepam, an increased incidence of sedation, hallucinations and irrational behaviour.	DDI-false
@DRUG$ : Dihydroergotamine , @DRUG$ , ergotamine, methylergonovine CONTRAINDICATED due to the potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasms and ischaemia of extremities and other tissues.	DDI-false
Other Drug Interactions: No pharmacokinetic interactions were observed between @DRUG$ and the following drugs: glyburide, warfarin, digoxin, @DRUG$, and ranitidine.	DDI-false
These drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid products , @DRUG$ , oral contraceptives , phenytoin , nicotinic acid , sympathomimet-ics , @DRUG$ , and isoniazid .	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, @DRUG$, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and @DRUG$, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , @DRUG$ , chlordiazepoxide , diazepam , certain @DRUG$ , lidocaine, theophylline and metronidazole, delaying the elimination and increase in blood levels of these drugs.	DDI-false
The concomitant intake of @DRUG$ and Acamprosate does not affect the pharmacokinetics of either alcohol or @DRUG$.	DDI-false
When @DRUG$ The dose is added to or withdrawn from treatment. @DRUG$ may be required .	DDI-advise
The similarity of the @DRUG$ Study 1 (without concomitant use of AVONEX ) and Study 2 ( with concomitant use of AVONEX ) show that this change in clearance does not reduce the @DRUG$ Dose to maintain safety, general).	DDI-false
These drugs include the thiazides and other diuretics , @DRUG$ , phe-nothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$ , nicotinic acid , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .	DDI-false
Levosimendan has no clinically important pharmacokinetic interactions with captopril, @DRUG$ , felodipine, digoxin, warfarin, isosorbide mononitrate, knitztilol, @DRUG$ or itraconazole .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Aspirin : Concomitant administration of low-dose aspirin with @DRUG$ This may lead to an increased rate of GI ulceration or other complications compared to the use of @DRUG$ alone .	DDI-false
HIV Protease Inhibitors: Indinavir (800 mg t.i.d.) co-administered with Vardenafil 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in @DRUG$ Cmax and a 2-fold increase in @DRUG$ half-life.	DDI-false
The effects of concomitant @DRUG$ @DRUG$ steady-state pharmacokinetic application.	DDI-false
If treatment with inhibitors of CYP3A4 activity ( such as ketoconazole , intraconazole , ritonavir , @DRUG$ , @DRUG$ , erythromycin , etc . ) is indicated , reduction of the budesonide dose should be considered .	DDI-false
Rhabdomyolysis has been observed in patients receiving @DRUG$ administered alone (at recommended dosages) or concomitantly with immunosuppressive drugs including @DRUG$.	DDI-effect
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, @DRUG$, propranolol, @DRUG$, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Both efavirenz and @DRUG$ have been compared to triple therapy with the PI @DRUG$ over 48 weeks as initial therapy , with similar responses being observed with nevirapine regimens and superiority observed with efavirenz .	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including @DRUG$ And other medicines that are highly protein-bound, @DRUG$ , sulphonamides, chloramphenicol, probenecid, coumarine, monoamine oxidase inhibitors, and beta-adrenergic blockers.	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with @DRUG$, Innovar Vet, or pentobarbital, the dosage of @DRUG$ needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with pentobarbital.	DDI-effect
@DRUG$ A case of severe hypoglycaemia has been reported in a type II diabetic who continues to @DRUG$ ( 1 gm/day ) 11 days after the addition of doxepin ( 75 mg/day ) .	DDI-false
There are case reports of patients who developed increased BUN, serum creatinine and serum potassium levels, and weight gain when @DRUG$ was used in conjunction with @DRUG$.	DDI-effect
In general, these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride, including anti-arrhythmic agents such as @DRUG$ and @DRUG$, cardiac glycosides and tricyclic anti-depressants.	DDI-false
Tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of @DRUG$ , phenytoin , propranolol , nifedipine , @DRUG$ , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .	DDI-false
Specific studies have confirmed these effects with @DRUG$, @DRUG$, propofol, alfentanil, and midazolam.	DDI-false
Short-term pharmacokinetic studies have demonstrated that concomitant administration of warfarin and @DRUG$  (etodolac capsules and tablets) results in reduced protein binding of warfarin, but there was no change in the clearance of free @DRUG$.	DDI-false
Stavudine and @DRUG$ Ribavirin can antagonize the in vitro antiviral activity of @DRUG$ and zidovudine against HIV .	DDI-false
@DRUG$ Keppra  (1000 mg twice daily) did not influence the pharmacokinetics and pharmacodynamics (ECG) of @DRUG$ given as a 0.25 mg dose every day.	DDI-false
@DRUG$ may interact with alcohol, blood thinners, @DRUG$ (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.	DDI-int
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or @DRUG$ antagonists (e.g., @DRUG$, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
It is not known if @DRUG$ When used with @DRUG$, their effectiveness varies.	DDI-false
Medicines that may alter the plasma concentration of imatinib Medicines that may increase the plasma concentration of imatinib: Caution should be exercised when administering imatinib @DRUG$ with inhibitors of the CYP3A4 family ( e.g. , ketoconazole , itraconazole , @DRUG$ , clarithromycin ) .	DDI-advise
Anticholinesterases ( neostgmine , physostigmine ) , @DRUG$ , @DRUG$ , procainamide can enhance toxicity and cause cardio respiratory depression .	DDI-false
This study demonstrates that concurrent administration of @DRUG$ permits at least a twofold increase in dose and total exposure to @DRUG$.	DDI-mechanism
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and antineoplastic agents, specifically, @DRUG$, @DRUG$, tamoxifen and interferon-alfa.	DDI-false
@DRUG$ is inhibited by @DRUG$.	DDI-mechanism
In order to evaluate the effects of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL ), the authors retrospectively compared a group of 24 patients with HIV-NHL who had been treated with the @DRUG$ , doxorubicin , vincristine , and prednisone ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , @DRUG$ , doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without antiretroviral therapy.	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided . 12 @DRUG$ and other @DRUG$ Hypotension observed with PROLEUKIN may be increased.	DDI-false
@DRUG$ also significantly decreased the incidence of lymphatic invasion of adenocarcinomas, which was enhanced by @DRUG$.	DDI-effect
Although there are no study data to evaluate the possibility, nitric oxide donor compounds, including sodium nitroprusside and @DRUG$, may have an additive effect with @DRUG$ on the risk of developing methemoglobinemia.	DDI-effect
@DRUG$ ( 20 mg ) did not potentiate the hypotensive effects of alcohol during the 4-hour observation period in healthy volunteers when administered with @DRUG$ ( 0.5 g/kg body weight ) .	DDI-false
@DRUG$ , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , @DRUG$ , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .	DDI-mechanism
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, @DRUG$, @DRUG$, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
In vitro studies have shown that precipitation occurs when eye drops containing @DRUG$ are mixed with @DRUG$.	DDI-false
@DRUG$ : In normal volunteers , concomitant administration of diflunisal and @DRUG$ This resulted in significantly increased plasma levels of hydrochlorothiazide.	DDI-false
These data indicate that @DRUG$ does not influence the plasma concentration of other AEDs and that these AEDs do not influence the pharmacokinetics of @DRUG$.	DDI-false
@DRUG$ in large amounts may counteract the antiepileptic effect of @DRUG$, phenytoin and primidone, and increase the frequency of seizures in susceptible pediatric patients.	DDI-effect
Warfarin: The effect of @DRUG$ on the anti-coagulant effect of warfarin was studied in a group of healthy subjects receiving daily doses of 2-5 mg of @DRUG$.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, @DRUG$, quinidine, and @DRUG$.	DDI-false
@DRUG$: May decrease renal tubular secretion of @DRUG$ resulting in increased blood levels and/or ampicillin toxicity.	DDI-mechanism
Acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen and valproic acid/phenobarbital.	DDI-false
Interaction with phenytoin , @DRUG$ and @DRUG$ has also been reported to produce adverse clinical effects .	DDI-false
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., narcotics, @DRUG$, antiemetics, @DRUG$, tranquilizers).	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, @DRUG$, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, @DRUG$ (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ In some patients, the administration of a non-steroidal anti-inflammatory agent may reduce the diuretic, natriuretic and blood pressure lowering effect of Loop, @DRUG$.	DDI-false
Possible interactions between Keppra and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, @DRUG$ , @DRUG$ and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies .	DDI-false
@DRUG$: Amphetamines inhibit the hypotensive effect of @DRUG$.	DDI-false
While all the selective serotonin reuptake inhibitors ( SSRIs ) , e.g. , @DRUG$ , @DRUG$ , fluoxetine , sertraline , and paroxetine , inhibit P450 2D6 , they may vary in the extent of inhibition .	DDI-false
Dosage adjustment of STRATTERA may be necessary when coadministered with CYP2D6 inhibitors , e.g. , paroxetine , @DRUG$ , and @DRUG$.	DDI-false
Because @DRUG$ has not been shown to produce any additional effect beyond that obtained with aspirin alone and because aspirin increases the rate of excretion of @DRUG$, the concomitant use of Nalfon and salicylates is not recommended.	DDI-false
@DRUG$: Chloramphenicol, erythromycins, sulfonamides, or @DRUG$ may interfere with the bactericidal effect of penicillins.	DDI-false
At higher than recommended doses, @DRUG$ 75 mg administered once daily for 10 days increased plasma concentrations by 23% as measured by AUC0-24hr in patients receiving @DRUG$ 7.5 to 15 mg/week for rheumatoid arthritis.	DDI-mechanism
Dosage adjustment of @DRUG$ Paroxetine may be necessary when co-administered with CYP2D6 inhibitors, e.g. @DRUG$ , and quinidine .	DDI-advise
Tagamet, apparently due to an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, @DRUG$ , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and @DRUG$ This delays elimination and increases blood levels of these drugs.	DDI-false
Co-administration of BOTOX and aminoglycosides or other agents interfering with neuromuscular transmission (e.g., @DRUG$) should only be performed with caution as the effect of the @DRUG$ may be potentiated.	DDI-false
HIV Protease Inhibitors : Indinavir ( 800 mg t.i.d . ) co-administered with Vardenafil 10 mg resulted in a 16-fold increase in @DRUG$ AUC, a 7-fold increase in AUC @DRUG$ Cmax and a 2-fold increase in vardenafil half-life.	DDI-false
Multivalent Cation-Containing products: Concomitant administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminium antacids, sucralfate, VIDEX chewable tablets or pediatric powder or products which: @DRUG$ Iron or iron @DRUG$ The absorption of ciprofloxacin can be significantly reduced, resulting in significantly lower serum and urine levels than desired.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a @DRUG$, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of @DRUG$, resulting in serum and urine levels considerably lower than desired.	DDI-false
- @DRUG$ (nandrolone [e.g., Anabolin], oxandrolone [e.g., Anavar], oxymetholone [e.g., Anadrol], stanozolol [e.g., @DRUG$]) or	DDI-false
@DRUG$ : Reports suggest that NSAIDs may diminish the antihypertensive effect of @DRUG$.	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (@DRUG$, barbiturates, opiates, sedatives, @DRUG$) should be considered.	DDI-false
WARFARIN: Co- administration of warfarin and @DRUG$ to healthy volunteers did not result in any changes in prothrombin time or clotting factor VII when compared to co-administration of @DRUG$ and placebo.	DDI-false
Ritonavir and @DRUG$: Upon concomitant administration of 5 mg of Vardenafil with 600 mg BID ritonavir, the Cmax and AUC of @DRUG$ were reduced by approximately 20%.	DDI-false
Anticoagulants : Potentiation of warfarin-type ( CYP2C9 and @DRUG$ substrate ) @DRUG$ The response is almost always observed in patients receiving amiodarone and can lead to severe or fatal bleeding.	DDI-false
In patients receiving Nalfon and a @DRUG$ concomitantly , any reduction in steroid dosage should be gradual in order to avoid the possible complications of sudden @DRUG$ withdrawal .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, @DRUG$ (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
This may occur because @DRUG$ competitively displaces @DRUG$ from protein binding sites.	DDI-mechanism
Aspirin/Acetaminophen : Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered @DRUG$ ( 162.5 mg orally administered 26 and 2 hours before starting argatroban 1 g/kg/min for 4 hours) or acetaminophen ( 1000 mg orally administered 12, 6 and 0 hours before and 6 and 12 hours after starting argatroban). @DRUG$ 1.5   g/kg/min . over 18 hours ) .	DDI-false
@DRUG$ : @DRUG$ Plasma concentrations and LDL-C reduction were not altered by co-administration of cimetidine.	DDI-false
Antihypertensive agents: amiodarone should be used with caution in patients who block -@DRUG$ (e.g. @DRUG$ , a CYP3A4 inhibitor ) or calcium channel antagonists (e.g. verapamil, a CYP3A4 substrate and diltiazem, a CYP3A4 inhibitor ) because of the potential for bradycardia, sinus arrest and AV block;	DDI-false
The effects of adenosine are caused by methylxanthine, e.g. @DRUG$ and @DRUG$.	DDI-false
Other CONCOMITANT THERAPY: Although no specific interaction studies have been conducted, cerivastatin sodium was co-administered with @DRUG$ , betablockers , calcium-channel blockers , diuretics , and @DRUG$ NSAIDs without evidence of clinically significant adverse interactions.	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, @DRUG$, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with @DRUG$.	DDI-false
Other Drugs:Drugs such as @DRUG$, disopyramide, procainamide, @DRUG$, antihistamines, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
@DRUG$ : @DRUG$ may counteract the sedative effect of antihistamines .	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$ : @DRUG$ blocks dopamine and norepinephrine receptors , thus inhibiting the central stimulant effects of amphetamines and can be used to treat amphetamine poisoning .	DDI-false
@DRUG$ and @DRUG$ FORADIL should be used with extreme caution in patients treated with monoamine oxidase inhibitors or tricyclic antidepressants, as the effect of formoterol on the cardiovascular system may be enhanced by these agents.	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, Dapson, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporin, ergot derivatives, @DRUG$ , carbamazepine, fentanyl, alfentanyl, alprazolem, and @DRUG$ ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
Other oral interactions @DRUG$ Keppra ( 500 mg twice daily ) did not affect the pharmacokinetics of an oral contraceptive of 0.03 mg @DRUG$ and 0.15 mg levonorgestrel , or of the luteinizing hormone and progesterone levels , indicating that impairment of contraceptive efficacy is unlikely .	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or @DRUG$, calcium channel blockers, antihistamines or H1-blocking agents, @DRUG$ and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-false
The @DRUG$ are a family of @DRUG$ and hypnotic drugs.	DDI-false
Phenytoin: Altered serum levels of @DRUG$ (increased and decreased) have been reported in patients receiving concomitant @DRUG$.	DDI-mechanism
Levosimendan has no clinically important pharmacokinetic interactions with captopril, @DRUG$ , felodipine , @DRUG$ , warfarin, isosorbide mononitrate, knitztilol, ethanol or itraconazole.	DDI-false
No pharmacokinetic interactions between @DRUG$ and isoflurane, @DRUG$, alfentanil, and midazolam have been demonstrated.	DDI-false
Co-medications that induce CYP3A4 ( e.g. , @DRUG$ , phenytoin , @DRUG$ , rifampin , phenobarbital or St.	DDI-false
The hypoglycaemic effect of sulphonylureas can be enhanced by certain medications, including non-steroidal anti-inflammatory drugs and other medicines that are highly protein-bound, @DRUG$ , sulfonamides , @DRUG$ , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .	DDI-false
For example, when vitamin K antagonists are administered concomitantly with @DRUG$, prothrombin time should be carefully monitored and if necessary, the dosage of @DRUG$ should be reduced.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ NSAIDs have caused an increase in plasma @DRUG$ The concentrations and a reduction in renal lithium clearance.	DDI-false
These drugs include thiazides and other @DRUG$ , corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$ , nicotinic acid, sympathomimetics, calcium channel block drugs, and isoniazid.	DDI-false
Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving Alprazolam ( caution is recommended during coadministration with @DRUG$ ): Coadministration of fluoxetine with alprazolam increased the maximum plasma concentration of @DRUG$ by 46 % , decreased clearance by 21 % , increased half-life by 17 % , and decreased measured psychomotor performance .	DDI-false
@DRUG$: As with some other @DRUG$, concurrent administration of ciprofloxacin with theophylline may lead to elevated serum concentrations of theophylline and prolongation of its elimination half-life.	DDI-false
No pharmacokinetic interactions between: @DRUG$ and isoflurane , @DRUG$ , alfentanil, and midazolam have been detected.	DDI-false
Possible drug interactions between Keppra and other AEDs (carbamazepine, gabapentin, lamotrigine, @DRUG$ , @DRUG$ In placebo-controlled clinical trials, serum concentrations of levetiracetam and these AEDs have also been studied.	DDI-false
Potential differences in @DRUG$ dosing and pharmacokinetics at different levels of @DRUG$ exposure were assessed in the context of ANOVA.	DDI-false
Anticoagulants including coumarin derivatives , indandione derivatives , and platelet aggregation inhibitors such as @DRUG$ ( NSAIDs ) , and @DRUG$ The risk of bleeding may be increased when co-administered with ardeparin.	DDI-false
Another oral azole antifungal , @DRUG$ , inhibits the metabolism of astemizole , resulting in elevated plasma concentrations of @DRUG$ The active metabolite desmethylastermizole may prolong the QT interval.	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with @DRUG$ , @DRUG$ , or pentobarbital , the dosage of ouabain needed to cause ventricular tachycardia was significantly higher , as was the LD50 of ouabain , with ketamine or Innovar than with pentobarbital .	DDI-false
@DRUG$ (200 mg once daily) produced a 10-fold increase in vardenafil AUC and a 4-fold increase in Cmax when co-administered with @DRUG$ (5 mg) in healthy volunteers.	DDI-false
- Methotrexate (e.g., @DRUG$) Use of methotrexate with @DRUG$ may increase the chance of side effects affecting the liver and/or the side effects of methotrexate	DDI-false
Multivalent Cation-Containing Products : Concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum @DRUG$ , Sucralfat, VIDEX chewable/buffer tablets or children's powder, or products containing calcium, iron, or @DRUG$ may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .	DDI-false
Adequate monitoring of @DRUG$ plasma concentrations should be considered when therapy with VIOXX is initiated or changed in patients receiving @DRUG$.	DDI-false
The concomitant use of other CYP3A4 inhibitors such as diltiazem and @DRUG$ with transdermal @DRUG$ may also result in an increase in fentanyl plasma concentrations , which could increase or prolong adverse drug effects and may cause serious respiratory depression .	DDI-mechanism
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Other concomitant therapy Although no specific interaction studies have been conducted, 1 mg or more of fissteride doses have been co-administered in clinical trials with acetaminophen, @DRUG$ , a-blockers , analgesics , angiotensin-converting enzyme ( ACE ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , @DRUG$ , cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also known as NSAIDs), and quinolone anti-infections without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ may suppress certain CYP450 enzymes, including CYP1A2, CYP2C9, @DRUG$, and CYP3A4.	DDI-false
@DRUG$: Clinical studies, as well as post marketing observations, have shown that NSAIDs can reduce the natriuretic effect of @DRUG$ and thiazides in some patients.	DDI-false
Theophylline: As with some other quinolones, concurrent administration of @DRUG$ with theophylline may lead to elevated serum concentrations of @DRUG$ and prolongation of its elimination half-life.	DDI-false
Other cardiovascular agents: Enalapril and Enalapril IV were co-administered with beta-adrenergic blockers, @DRUG$ , nitrates , calcium-blocking agents , @DRUG$ , prazosin and digoxin without evidence of clinically significant adverse interactions .	DDI-false
Tolbutamide : In diabetic patients who @DRUG$ and @DRUG$ , no significant effects were seen on tolbutamide plasma levels or fasting blood glucose .	DDI-false
Consequently, drugs with a low therapeutic margin, such as @DRUG$, phenytoin, and @DRUG$, could have a delayed elimination and increases in their serum half-life leading to a toxic level.	DDI-false
In a clinical pharmacology study, indomethacin or @DRUG$ was administered to hypertensive patients receiving @DRUG$.	DDI-false
METHODS: From the beginning of the experiment, rats were given 10 weekly subcutaneous injections of @DRUG$ (7.4 mg/kg body weight) and subcutaneous injections of bombesin (40 microg/kg body weight) every other day, and from week 16, intraperitoneal injections of @DRUG$ (10 or 20 mg/kg body weight) every other day until the end fo the experiment in week 45.	DDI-false
Concomitant cyclophosphamide , doxorubicin , vincristine , and @DRUG$ chemotherapy plus @DRUG$ therapy in patients with human immunodeficiency virus-related , non-Hodgkin lymphoma .	DDI-false
ACE Inhibitors and Angiotensin II Receptor Antagonists (Hypertension)- In clinical studies of patients with hypertension , the addition of INSPRA 50 to 100 mg to @DRUG$ and @DRUG$ increased mean serum potassium slightly ( about 0.09 - 0.13 mEq/L ) .	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, @DRUG$, calcium-channel blockers, @DRUG$, and nonsteroidal anti-inflammatory drugs (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
hypersensitivity reactions have been reported in patients receiving combination regimens with sequentially high-dose PROLEUKIN and @DRUG$ , in particular, dacarbazine, @DRUG$ , tamoxifen and interferon-alfa .	DDI-false
Tetracyclines : Concomitant treatment with @DRUG$ and tetracyclines should be avoided because @DRUG$ use has been associated with a number of cases of pseudotumor cerebri ( benign intracranial hypertension ) , some of which involved concomitant use of tetracyclines	DDI-false
Coingestion of acetaminophen with @DRUG$, phenobarbital with @DRUG$, and valproic acid with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-false
Bacteriostatic Antibiotics: Chloramphenicol, @DRUG$, sulfonamides, or @DRUG$ may interfere with the bactericidal effect of penicillins.	DDI-false
Antacids : In a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of @DRUG$ Compared to Fosinopril alone, which suggests that antacids may affect the absorption of @DRUG$.	DDI-false
Other strong inhibitors of CYP3A4 ( e.g. , itraconazole , clarithromycin , @DRUG$ , troleandomycin , ritonavir , @DRUG$ ) would be expected to behave similarly .	DDI-false
The effects of @DRUG$ are antagonized by @DRUG$ Like caffeine and theophylline.	DDI-effect
Single doses of either cholestyramine or @DRUG$ resins bind the @DRUG$ and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.	DDI-mechanism
This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or @DRUG$), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of @DRUG$).	DDI-false
@DRUG$ potentiates the muscle relaxant effect of all @DRUG$, most notably nondepolarizing muscle relaxants, and MAC (minimum alveolar concentration) is reduced by concomitant administration of N 2O.	DDI-effect
The intensity, uniformity and time course of @DRUG$ The interference with phenobarbital, secobarbital, glutethimide, chloral hydrate and methaqualone has been systematically studied in 16 patients who: @DRUG$ therapy .	DDI-false
Cephalosporine cephalosporine containing side chains of N-methylthiotetrazole ( @DRUG$ , cefoperazone , cefotetan , cefamandole , @DRUG$ Methylthiadiazole (Cefazolin) may cause vitamin K deficiency and hypoprothrombinaemia.	DDI-false
Antiarrhythmics : Other @DRUG$ ==References== @DRUG$ , procainamide , disopyramide , and phenytoin , have been used concurrently with amiodarone .	DDI-false
Intravenous Adenocard ( @DRUG$ ) was effective in the presence of other cardiovascular drugs such as quinidine, beta-adrenergic blockers, calcium channel blockers, and @DRUG$ , without any change in the adverse reaction profile .	DDI-false
Multivalent Cation-Containing Products : Concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , @DRUG$ - chewable/buffered tablets or paediatric powders, or products that can significantly reduce the absorption of calcium, iron or zinc @DRUG$ , which leads to serum and urine levels significantly lower than desired.	DDI-false
Combination of @DRUG$ with other @DRUG$ therapy should be reserved for patients with life-threatening ventricular arrhythmias who are incompletely responsive to a single agent or incompletely responsive to amiodarone .	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, Dapson, disopyramide, quinine, @DRUG$ , quinidine, warfarin, tacrolimus, @DRUG$ , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
Drugs that may alter @DRUG$ plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering @DRUG$ with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, erythromycin, clarithromycin).	DDI-false
Patients receiving both @DRUG$ and @DRUG$ should be observed closely to determine if the desired diuretic and/or antihypertensive effect of furosemide is achieved.	DDI-advise
Additive adverse effects resulting from cholinergic blockade may occur when @DRUG$ is administered concomitantly with other antimuscarinics, amantadine, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, @DRUG$ or some antihistamines.	DDI-effect
Chlorpromazine: @DRUG$ blocks dopamine and norepinephrine receptors, thus inhibiting the central stimulant effects of @DRUG$ and can be used to treat amphetamine poisoning.	DDI-effect
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, @DRUG$, propofol, @DRUG$, quinidine, and verapamil.	DDI-false
Acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen and valproic acid/phenobarbital.	DDI-false
Analysis of the concentration of budesonide following ultracentrifugation indicated that there is rapid equilibration of @DRUG$ between the @DRUG$ and aqueous phase.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with @DRUG$, beta-blockers, felodipine, digoxin, warfarin, @DRUG$, carvedilol, ethanol or itraconazole.	DDI-false
In patients receiving @DRUG$ A reduction in the steroid dose should be done step by step and at the same time with a steroid to avoid possible complications in case of sudden ingestion. @DRUG$ withdrawal .	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., @DRUG$, a CYP3A4 substrate, and @DRUG$, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Pregnancy : Category X : Use with @DRUG$ Considerable teratogenic and/or embryonic effects have been demonstrated in all species exposed to @DRUG$.	DDI-false
Injection : Lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , MAO inhibitors , and other @DRUG$.When scopolamine is used concomitantly with injectable @DRUG$ An increased incidence of sedation, hallucinations, and irrational behaviour has been observed.	DDI-false
HMG-CoA reductase inhibitors: simvastatin ( @DRUG$ substrate ) in combination with @DRUG$ has been associated with reports of myopathy/rhabdomyolysis .	DDI-false
Intravenous @DRUG$ (adenosine) has been effectively administered in the presence of other cardioactive drugs, such as quinidine, beta-adrenergic blocking agents, @DRUG$, and angiotensin converting enzyme inhibitors, without any change in the adverse reaction profile.	DDI-false
Example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , @DRUG$ , @DRUG$ , quinidine, and verapamil.	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine , fibric acid derivatives , @DRUG$ (nicotinic acid), erythromycin, @DRUG$.	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to @DRUG$, including @DRUG$ such as quinidine and procainamide, cardiac glycosides and tricyclic anti-depressants.	DDI-false
Gleevec will increase plasmaconcentration of other CYP3A4 metabolized drugs (e.g., triazolo-benzodiazepines, @DRUG$, certain @DRUG$, etc.).	DDI-false
Tagamet, apparently due to an effect on certain microsomal enzyme systems, has been reported to reduce hepatic metabolism @DRUG$ , phenytoin, propranolol, @DRUG$ , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .	DDI-false
In the second experiment, non-diabetic and streptozotocin-induced diabetic rats were fasted, and the same procedures were followed for estimation of @DRUG$ tolerance 30 min after @DRUG$ overload.	DDI-false
- Warfarin : The effect of celecoxib on the anticoagulant effect of @DRUG$ was studied in a group of healthy subjects receiving daily doses of 2 - 5 mg of @DRUG$.	DDI-false
Digoxin @DRUG$ • ( 1000 mg twice daily ) did not affect pharmacokinetics and pharmacodynamics ( ECG) @DRUG$ given as a 0.25 mg dose every day .	DDI-false
Hydrochlorothiazide: In normal subjects, concomitant use of @DRUG$ and hydrochlorothiazide resulted in significantly increased plasma levels of @DRUG$.	DDI-false
The effect of orally ingested @DRUG$ or @DRUG$ from breast milk on the nursing infant has not been evaluated .	DDI-false
No data are available for the coadministration of @DRUG$/@DRUG$ FORTOVASE/ritonavir and garlic capsules.	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, @DRUG$ or beta-adrenergic blocking agents, @DRUG$, antihistamines or H1-blocking agents, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-false
For example, if @DRUG$ are administered concomitantly with @DRUG$ , prothrombin time should be carefully monitored and if necessary , the dosage of vitamin K antagonists should be reduced .	DDI-advise
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other @DRUG$.When @DRUG$ is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
Anticoagulants including coumarin derivatives , indandione derivatives , and platelet aggregation inhibitors such as @DRUG$ ( @DRUG$ ) , and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin .	DDI-false
High-dose @DRUG$ resulting in concentrations above 2000 ng/mL administered with oral @DRUG$ Etoposide exposure has increased by 80%, with total body clearance of etoposide falling by 38% compared to etoposide alone.	DDI-mechanism
In a comparison of digitalis tolerance in dogs anesthetized with ketamine , Innovar Vet , or @DRUG$ , the dosage of ouabain needed to cause ventricular tachycardia was significantly higher , as was the LD50 of ouabain , with ketamine or Innovar than with @DRUG$.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
The risk of myopathy during treatment with medicines in this class is increased when cyclosporin is co-administered. @DRUG$ , niacin ( nicotinic acid ) , @DRUG$ , azole antifungals .	DDI-false
• Anabolic steroids ( @DRUG$ [ e.g. , Anabolin ] , oxandrolone [ e.g. , @DRUG$ ] , oxymetholone [ e.g. , Anadrol ] , stanozolol [ e.g. , Winstrol ] ) or	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, @DRUG$, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, @DRUG$, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
In a comparison of digital tolerance in dogs stunned with ketamine, Innovar Vet, or pentobarbital, the dosage of @DRUG$ needed to cause ventricular tachycardia was significantly higher , as was the LD50 of @DRUG$ , with ketamine or Innovar than with pentobarbital .	DDI-false
• Furosemid : Clinical studies, as well as post-marketing observations, have shown that @DRUG$ The natriuretic effect of furosemide and @DRUG$ In some patients.	DDI-effect
The use of @DRUG$ in patients receiving @DRUG$ may be rarely associated with ventricular fibrillation .	DDI-effect
@DRUG$ : Other antiarrhythmic drugs , such as quinidine , procainamide , @DRUG$ , and phenytoin , have been used concurrently with amiodarone .	DDI-false
In clinical studies performed with Fondaparinux , the concomitant use of oral @DRUG$ ( Warfarin ), @DRUG$ ( acetylsalicylic acid ) , NSAIDs ( piroxicam ) , and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium .	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, ritonavir, @DRUG$, saquinavir, erythromycin, etc.) is indicated, reduction of the @DRUG$ dose should be considered.	DDI-advise
Concurrent administration of @DRUG$ and @DRUG$ may cause severe orthostatic hypotension.Cimetidine, an inhibitor of microsomal drug metabolism, increased altretamines half-life and toxicity in a rat model.	DDI-effect
Other potent inhibitors of CYP3A4 (e.g. @DRUG$ , clarithromycin , nefazodone , troleandomycin , ritonavir , @DRUG$ ) would be expected to behave similarly .	DDI-false
@DRUG$ : Amphetamines may delay intestinal absorption of @DRUG$.	DDI-false
In clinical trials, the concomitant administration of @DRUG$ and @DRUG$ did not alter the adverse reaction profile.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens with sequentially high-dose PROLEUKIN and antineoplastic agents, especially dacarbazine. @DRUG$ , @DRUG$ and interferon-alfa .	DDI-false
The possibility of hypotensive effects with enalapril or @DRUG$ It can be minimized by stopping the diuretic or increasing salt intake before starting Enalapril or @DRUG$ treatment.	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, Dapson, disopyramide, quinine, @DRUG$ , quinidine, warfarin, tacrolimus, cyclosporin, ergot derivatives, @DRUG$ , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , doxorubicin , @DRUG$ , and @DRUG$ ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , doxorubicin , teniposide , and prednisone with vincristine plus bleomycin ) without receiving antiretroviral therapy .	DDI-false
@DRUG$ has been administered with @DRUG$, dopamine, dobutamine, steroids, surfactant, and high-frequency ventilation.	DDI-false
Coadministration of @DRUG$ with 40 mg @DRUG$ tablets in epileptic patients lowered the nisoldipine plasma concentrations to undetectable levels.	DDI-mechanism
Antidepressants, @DRUG$ Amphetamines may enhance the activity of @DRUG$ or sympathomimetic agents;	DDI-false
Other reported interactions with amiodarone: @DRUG$ ( @DRUG$ The substrate) in combination with amiodarone may cause hypotension, bradycardia, and reduced cardiac output.	DDI-false
The immediate release, but not the coat-core formulation of @DRUG$ increased plasma @DRUG$ concentrations by about 20%.	DDI-mechanism
Potassium Supplements and @DRUG$: Fosinopril sodium can attenuate potassium loss caused by @DRUG$.	DDI-false
The aim of this paper was to establish the interaction between @DRUG$ and both enkephalins or its synthetic analogue D-Ala2-metenkephalinamide , or @DRUG$ , on the antinonciceptive effect of these peptides in mice after intracisternal injection .	DDI-false
Antidepressants , @DRUG$ @DRUG$ may enhance the activity of tricyclic antidepressants or sympathomimetic agents ;	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, @DRUG$, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable @DRUG$, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , @DRUG$ , pimozide, carbamazepine, fentanyl, @DRUG$ , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
In a comparison of @DRUG$ The tolerance in dogs anaesthetized with ketamine, Innovar-Vet or pentobarbital was the dose of Ouabain required to cause ventricular tachycardia significantly higher than the LD50 of Ouabain, with ketamine or Innovar than with @DRUG$.	DDI-false
Acetaminophen/theophylline, @DRUG$/chinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen and valproic acid/phenobarbital.	DDI-false
Compounds that have been tested in man include @DRUG$, @DRUG$, propranolol, theophylline, and warfarin and no clinically meaningful interactions were found.	DDI-false
Stavudine and Zidovudine @DRUG$ can antagonize the in vitro antiviral activity of stavudine and @DRUG$ against HIV.	DDI-effect
Antihypertensive agents: amiodarone should be used with caution in patients receiving antihypertensive agents (e.g. @DRUG$ , a @DRUG$ Inhibitor) or calcium channel antagonists (e.g. verapamil, a CYP3A4 substrate and diltiazem, a CYP3A4 inhibitor ) because of the potential for bradycardia, sinus arrest and AV block;	DDI-false
A possible interaction between glyburide and ciprofloxacin, @DRUG$ , has been reported , resulting in a potentiation of the hypoglycemic action of @DRUG$.	DDI-false
Other concomitant therapy Although no specific interaction studies have been conducted, 1 mg or more finasteride doses have been reported in clinical trials with acetaminophen, acetylsalicylic acid, A-blockers, analgesics, angiotensin converting enzyme (ACE) inhibitors, @DRUG$ , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , H2 antagonists , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as @DRUG$ In addition, quinolones anti-infections with no evidence of clinically significant adverse interactions.	DDI-false
Adrenergic blockers @DRUG$ are inhibited by @DRUG$.	DDI-effect
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , @DRUG$ , @DRUG$ , and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide and prednisone with vincristine plus bleomycin) without antiretroviral therapy.	DDI-false
Anticoagulants including coumarin derivatives , indandione derivatives , and platelet aggregation inhibitors such as nonsteroidal anti-inflammatory drugs ( @DRUG$ Aspirin may increase the risk of bleeding if it is administered at the same time as @DRUG$.	DDI-effect
acetaminophen/theophylline , lidocaine/quinidine , phenobarbital/acetaminophen , @DRUG$/@DRUG$ , quinidine/lidocaine, theophylline/acetaminophene and valproic acid/phenobarbital.	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, @DRUG$, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of @DRUG$ and these AEDs during placebo-controlled clinical studies.	DDI-false
In addition , Fondaparinux neither influenced the pharmacodynamics of @DRUG$ - acetylsalicylic acid, @DRUG$ The pharmacokinetics of digoxin in steady state.	DDI-false
Similarly dialyzed were @DRUG$ , @DRUG$ Theophylline and theophylline, both in therapeutic concentrations in serum and with ethanol in three different concentrations in serum.	DDI-false
Patients receiving @DRUG$ , sulphonamides or @DRUG$ In case of increased activity of these drugs should be observed and therefore signs of toxicity by these drugs.	DDI-false
While all the selective serotonin reuptake inhibitors (SSRIs), e.g., @DRUG$, escitalopram, fluoxetine, @DRUG$, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
Sedatives/Hypnotics: @DRUG$, @DRUG$ CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as prolonged or increased sedation or respiratory depression.	DDI-false
Tagamet, apparently due to an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, @DRUG$ , nifedipine , @DRUG$ , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .	DDI-false
Non-selective MAO inhibitors including tranylcypromine sulfate, @DRUG$, and pargyline HC1: Concomitant use of L-tyrosine and non-selective @DRUG$ may cause hypertension.	DDI-false
DIGOXIN: plasma digoxin levels and @DRUG$ The steady-state clearance was not affected by concomitant administration of 0.2 mg @DRUG$.	DDI-false
@DRUG$ Cimetidine has been reported to produce clinically significant fluctuations in steady-state serum concentrations of different @DRUG$.	DDI-false
However, a crossover study in healthy subjects receiving either @DRUG$ 300 mg q.i.d. or 800 mg h.s. concomitantly with a 300 mg b.i.d. dosage of @DRUG$ (Theo-Dur , Key Pharmaceuticals, Inc.) demonstrated less alteration in steady-state theophylline peak serum levels with the 800 mg h.s. regimen, particularly in subjects aged 54 years and older.	DDI-mechanism
- Anabolic steroids ( nandrolone [ e.g. , Anabolin ] , @DRUG$ [ e.g. , @DRUG$ ], oxymethol [ e.g. Anadrol ], stanozole [ e.g. Winstrol ] or	DDI-false
Injection: Lorazepam injection, like other injectable @DRUG$, produces depression of the central nervous system when administered with ethyl alcohol, @DRUG$, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-effect
Ritonavir ( 600 mg b.i.d . ) co-administered with Vardenafil 5 mg resulted in a 49-fold increase in @DRUG$ AUC and a 13-fold increase in @DRUG$ Cmax .	DDI-false
@DRUG$: Because of the relationship of Accutane to @DRUG$, patients should be advised against taking vitamin supplements containing vitamin A to avoid additive toxic effects	DDI-false
Other substances: Grapefruit juice given to healthy volunteers increased @DRUG$ AUC by 50% and Cmax by 84%, resulting in increased plasma levels of @DRUG$.	DDI-false
Compounds tested in man include @DRUG$ , theophylline , phenytoin , diazepam , @DRUG$ and antipyrine .	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/@DRUG$, and valproic acid/phenobarbital.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -@DRUG$ blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or @DRUG$ antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine , @DRUG$ , niacin (nicotinic acid), erythromycin, @DRUG$.	DDI-false
@DRUG$ : Amphetamines may delay intestinal absorption of @DRUG$ ;	DDI-false
@DRUG$ , lidocaine , phenobarbital , quinidine , theophylline , and @DRUG$ The pooled human serum was added at therapeutic concentrations.	DDI-false
omeprazole: The rate and extent of absorption of ciprofloxacin was bioequivalent if @DRUG$ It was given alone or if @DRUG$ 2 hours after administration of omeprazole at the dose that suppresses gastric acid secretion maximum.	DDI-false
@DRUG$ (Magnesium-Aluminum Hydroxide): Cerivastatin plasma concentrations were not affected by co-administration of @DRUG$.	DDI-false
Single doses of either cholestyramine or @DRUG$ @DRUG$ bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.	DDI-false
ANTACID ( @DRUG$ Cerivastatin plasma concentrations were not affected by the concomitant use of @DRUG$.	DDI-false
@DRUG$/prednisolone: Rofecoxib did not have any clinically important effect on the pharmacokinetics of @DRUG$ or prednisone.	DDI-false
It is therefore necessary to be familiar with the clinical and paraclinical pattern @DRUG$ deficit and to discriminate between @DRUG$ Deficiency due to insufficient magnesium uptake, which requires only oral physiological supplement and magnesium deficiency associated with a dysregulation of the control mechanisms of magnesium status, which requires more or less specific regulation of its causal dysregulation.	DDI-false
Coadministration with compounds that are potent inducers of CYP3A4 (eg, phenobarbital, phenytoin, @DRUG$, @DRUG$) may result in decreased plasma levels of saquinavir.	DDI-false
Nephrotoxicity has been reported following concomitant administration of cephalosporins with aminoglycoside antibiotics or potent @DRUG$ such as @DRUG$.	DDI-false
Drug/Laboratory Test Interactions The urine of patients who take @DRUG$ can give a false-positive reaction for urinary bilirubin (urobilin) due to the presence of phenolic metabolites of @DRUG$.	DDI-false
Compounds that have been tested in man include antipyrine , @DRUG$ , propranolol , @DRUG$ , and warfarin and no clinically meaningful interactions were found .	DDI-false
Gleevec will increase plasmaconcentration of other CYP3A4 metabolized drugs ( e.g. , triazolo-@DRUG$ , @DRUG$ , certain HMG-CoA reductase inhibitors , etc . ) .	DDI-false
The application of local anaesthetic solutions that @DRUG$ or norepinephrine to patients receiving monoamine oxidase inhibitors or @DRUG$ For this reason, severe, prolonged hypertension can arise.	DDI-effect
@DRUG$ : In healthy subjects receiving the CYP3A4 inducer , @DRUG$ , at 100 mg twice daily for 3 days and 200 mg twice daily for 17 days , systemic exposure ( AUC ) to lapatinib was decreased approximately 72 % .	DDI-false
Antihypertensives : @DRUG$ should be used with caution in patients receiving   -receptor blocking agents ( e.g. , propranolol , a CYP3A4 inhibitor ) or @DRUG$ • antagonists (e.g. verapamil, a CYP3A4 substrate and diltiazem, a CYP3A4 inhibitor) because of the potential for bradycardia, sinus arrest and AV block;	DDI-false
Cyclosporin : Management of @DRUG$ concomitantly with cyclosporine has been associated with an increase in @DRUG$-induced toxicity , possibly due to decreased synthesis of renal prostacyclin .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
acetaminophen/theophylline , @DRUG$/@DRUG$ , phenobarbital/acetaminophen, phenobarbital/ valproic acid, quinidine/ lidocaine, theophylline/acetaminophen and valproic acid/phenobarbital.	DDI-false
@DRUG$ have been reported to decrease the tubular secretion of @DRUG$ and to potentiate its toxicity .	DDI-mechanism
The effects of ketamine and @DRUG$ anesthesia on @DRUG$ tolerance in dogs .	DDI-false
Short-term pharmacokinetic studies have demonstrated that concomitant administration of warfarin and Lodine  (etodolac capsules and tablets) results in reduced protein binding of @DRUG$, but there was no change in the clearance of free @DRUG$.	DDI-false
@DRUG$ should not be used in patients receiving @DRUG$..	DDI-advise
However, in the second study, administration of 12 g cholestyramine 1 hour before the evening meal and 0.3 mg @DRUG$ approximately 4 hours after the same evening meal resulted in a decrease in the cerivastatin AUC of less than 8%, and a decrease in Cmax of about 30% when compared to dosing @DRUG$ alone.	DDI-false
Interaction with @DRUG$ other than @DRUG$ has not been specifically studied;	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like @DRUG$ (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: @DRUG$ increases the effect of Tricyclic antidepressants	DDI-false
In patients with chronic hepatitis C treated with PEGASYS in combination with @DRUG$ , PEGASYS treatment does not affect @DRUG$ distribution or clearance .	DDI-false
These drugs include thiazides and other @DRUG$ , corticosteroids, phenothiazines, @DRUG$ , estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel block drugs, and isoniazide.	DDI-false
, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, valproic acid/@DRUG$.	DDI-false
Co-administration of @DRUG$ with @DRUG$ It has been shown that the mean half-life and area under the concentration-time curve increase.	DDI-mechanism
These results suggest that acute dosing with @DRUG$ would not affect behaviors most closely associated with @DRUG$ intoxication.	DDI-false
Both @DRUG$ and @DRUG$ decrease extracellular levels of dopamine in the nucleus accumbens, but only ibogaine increases extracellular levels of serotonin in the nucleus accumbens.	DDI-false
Two of 16 subjects dosed simultaneously with @DRUG$ 10 mg and @DRUG$ 0.4 mg experienced a standing systolic blood pressure below 85 mm Hg .	DDI-effect
No important interactions to date @DRUG$ No clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, warfarin, isosorbide mononitrate, @DRUG$ Ethanol or itraconazole.	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including @DRUG$ and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and @DRUG$.	DDI-false
Drug Interactions : @DRUG$ may interact with some drugs , like Monoamine oxidase inhibitors ( MAOI ): MAOI could theoretically affect flupenthixol pharmacodynamics - @DRUG$ - Eproxindine - Ethanol : Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants : Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
The mean percentage increase in the @DRUG$ AUC after @DRUG$ administration was 56.9 % ( range : 35 to 81 ) .	DDI-mechanism
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , @DRUG$ , angiotensin-converting enzyme ( ACE ) inhibitors , @DRUG$ , benzodiazepines, beta-blockers, calcium channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also known as NSAIDs), and quinolone anti-infections without evidence of clinically significant adverse interactions.	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5 % Ophthalmic Solution , the possibility of an additive or potentiating effect with @DRUG$ ( alcohol , barbiturates , @DRUG$ , sedatives, anaesthetics) should be considered.	DDI-false
Fenfluramine may increase slightly the effect of @DRUG$ , e.g. , @DRUG$ , methyldopa, reserpine.	DDI-false
Antiarrhythmics : Other antiarrhythmic drugs , such as quinidine , @DRUG$ , disopyramide , and @DRUG$ , were used simultaneously with amiodarone.	DDI-false
Other concomitant therapy Although specific interaction studies have not been performed, 1 mg or more finasteride doses have been reported in clinical trials with acetaminophen, acetylsalicylic acid, A-blockers, analgesics, angiotensin converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta-blockers, calcium channel blockers, heart nitrates, @DRUG$ , H2 antagonists, @DRUG$ , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
@DRUG$ diminished the binding of @DRUG$ 11.0 % for 662 micromol/L and 7.1% for 1324 micromol/L (percentage increase for FDF, 13.7%).	DDI-mechanism
@DRUG$-Concomitant intake of @DRUG$ and vitamin K may reduce the absorption of vitamin K.	DDI-false
Antimycobacterial Agents: rifampin CONTRAINDICATED since the coadministration of this product with @DRUG$ in an @DRUG$ regimen reduces the plasma concentrations of saquinavir.	DDI-false
Quinolones , including norfloxacin , may enhance the effects of oral @DRUG$ , including @DRUG$ or its derivatives or similar agents .	DDI-false
@DRUG$: The effect of @DRUG$ on the anti-coagulant effect of warfarin was studied in a group of healthy subjects receiving daily doses of 2-5 mg of warfarin.	DDI-false
Since the concomitant administration of @DRUG$ with amiodarone increases the prothrombin time by 100% after 3 to 4 days, the dose of the @DRUG$ should be reduced by one-third to one-half, and prothrombin times should be monitored closely.	DDI-false
The possibility of hypotensive effects with enalapril or enalaprilat can be minimized by either discontinuing the @DRUG$ or increasing the salt intake prior to initiation of treatment with enalapril or @DRUG$.	DDI-false
Central nervous system depressants: Concomitant use of DURAGESIC (Fentanyl transdermal system) with others @DRUG$ , including but not limited to other opioids, sedatives, hypnotics, sedatives (e.g. benzodiazepines), general anesthetics, phenothiazines, @DRUG$ , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	DDI-false
Micro-dosed Progesterone Preparations: Micro-dosed @DRUG$ preparations (minipills that do not contain an @DRUG$) may be an inadequate method of contraception during Accutane therapy.	DDI-false
Potassium-sparing diuretics ( e.g. , spironolactone , triamterene , or @DRUG$ ) , potassium supplements , or @DRUG$-containing salt substitutes may lead to significant increases in serum potassium .	DDI-false
Central Nervous System Depressants : The concomitant use of DURAGESIC   ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other @DRUG$ , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general @DRUG$ , phenothiazine, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and deep sedation, or possibly coma or death.	DDI-false
These drugs include the thiazides and other diuretics , corticosteroids , @DRUG$ , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and @DRUG$.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics , amantadine , haloperidol , phenothiazines , @DRUG$ , tricyclic antidepressants or something @DRUG$.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Other concomitant therapy Although no specific interaction studies have been conducted, 1 mg or more of fissteride doses have been co-administered in clinical trials with acetaminophen, @DRUG$ , A-blockers, analgesics, angiotensin converting enzyme ( ACE) inhibitors, anticonvulsants, benzodiazepines, beta-blockers, calcium channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, @DRUG$ ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
@DRUG$ and @DRUG$ use may be rarely associated with ventricular fibrillation when combined with Adenocard.	DDI-false
However , since there is an increased risk of bleeding with @DRUG$ , caution should be employed when @DRUG$ The drug is used together with other medicines that affect haemostasis.	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering @DRUG$ with inhibitors of the CYP3A4 family (e.g., @DRUG$, itraconazole, erythromycin, clarithromycin).	DDI-advise
During the transition to oral @DRUG$ , the dose levels of previously administered agents should be reduced by 30 to 50 % several days after the addition of oral @DRUG$.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , @DRUG$ , A-blockers, analgesics, angiotensin converting enzyme ( ACE) inhibitors, anticonvulsants, benzodiazepines, beta-blockers, calcium channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA-reductase inhibitors, prostaglandin synthetase inhibitors (also known as @DRUG$ ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
Antidepressants, tricyclic Amphetamines may enhance the activity of @DRUG$ or @DRUG$;	DDI-false
Atromid-S may displace acidic drugs such as @DRUG$ or @DRUG$ from their binding sites.	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole ( cefmenoxime , @DRUG$ , cefotetan , cefamandole , latamoxef ) or methylthiadiazole ( @DRUG$ ) can cause vitamin K deficiency and hypoprothrombinemia .	DDI-false
The aim of this paper was to study the interaction between @DRUG$ and both enkephalins or its synthetic analogue D-Ala2-metenkephalinamide, or @DRUG$, on the antinonciceptive effect of these peptides in mice after intracisternal injection.	DDI-false
Non-steroidal Anti-inflammatory Drugs: In some patients, the administration of a @DRUG$ can reduce the diuretic, natriuretic, and antihypertensive effects of loop, @DRUG$.	DDI-effect
acetaminophen/@DRUG$, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
The effects of @DRUG$ and @DRUG$ upon phencyclidine (PCP)-induced locomotion and behavioral changes in mice.	DDI-false
acetaminophen/theophylline , lidocaine/quinidine , phenobarbital/acetaminophen , phenobarbital/valproic acid , @DRUG$/lidocaine , @DRUG$/acetaminophen , and valproic acid/phenobarbital .	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing a high sequential dose. @DRUG$ and antineoplastic agents, in particular: @DRUG$ , cis-platinum, tamoxifen and interferon alpha.	DDI-effect
Like @DRUG$ ( 40 mg/kg ) , 18-MC ( 40 mg/kg ) decreases the intravenous self-administration of @DRUG$ • cocaine and oral self-administration of ethanol and nicotine in rats;	DDI-false
@DRUG$-Concomitant intake of colestipol and vitamin K may reduce the absorption of @DRUG$.	DDI-false
Data from in vitro studies of alprazolam suggest a possible drug interaction with @DRUG$ for the following: sertraline and @DRUG$.	DDI-int
Example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , @DRUG$ , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and @DRUG$.	DDI-false
These drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , @DRUG$ , sympathomimet-ics , @DRUG$ ==References====External links==	DDI-false
In addition to the interactions noted above, chronic (  2 weeks) oral @DRUG$ administration impairs metabolism of phenytoin, dextromethorphan, and @DRUG$.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, @DRUG$, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, @DRUG$, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Cardiovasculars : @DRUG$ In patients receiving digoxin therapy, @DRUG$ This regularly leads to an increase in digoxin serum concentration, which can reach toxic concentrations with resulting clinical toxicity.	DDI-false
These drugs include the thiazides and other diuretics, @DRUG$, phe-nothiazines, thyroid products, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , @DRUG$ , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , @DRUG$ , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
The administration of local anesthetic solutions containing @DRUG$ or norepinephrine to patients receiving @DRUG$ or tricyclic antidepressants may produce severe, prolonged hypertension.	DDI-effect
@DRUG$ may also decrease the absorption of @DRUG$, which can lead to a deficiency.	DDI-mechanism
Central nervous system depressants: the concomitant use of DURAGESIC ( @DRUG$ transdermal system ) with other central nervous system depressants , including but not limited to other @DRUG$ Anaesthetics, hypnosis, tranquilizers (e.g. benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants and alcohol may cause respiratory depression, hypotension and deep sedation, or possibly lead to coma or death.	DDI-effect
Lithium : Increased serum @DRUG$ * Concentrations and symptoms of @DRUG$ Toxicity has been reported in patients receiving concomitant lithium and ACE inhibitor therapy.	DDI-false
@DRUG$: Other antiarrhythmic drugs, such as quinidine, procainamide, disopyramide, and @DRUG$, have been used concurrently with amiodarone.	DDI-false
Specific studies have confirmed these effects with sevoflurane, @DRUG$, propofol, @DRUG$, and midazolam.	DDI-false
Tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , @DRUG$ , @DRUG$ , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .	DDI-false
While 18-MC and ibogaine have similar affinities for kappa opioid and possibly nicotinic receptors, @DRUG$ has much lower affinities than @DRUG$ for NMDA and sigma-2 receptors, sodium channels, and the 5-HT transporter.	DDI-false
Other Cardiovascular Agents: Enalapril and @DRUG$ IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, @DRUG$, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
These drugs include the @DRUG$ and other diuretics, corticosteroids, phe-nothiazines, thyroid products, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, @DRUG$, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
The pharmacokinetics of @DRUG$ ♪ And his main metabolite ♪ @DRUG$ were unaffected following co-administration with Acamprosate .	DDI-false
Using Angiotensin Converting Enzymes Inhibitors : The Use of @DRUG$ to control hypertension in patients on @DRUG$ has been reported to induce severe leukopenia .	DDI-effect
These medicines include thiazides and other diuretics, corticosteroids, phe-nothiazines, @DRUG$ , estrogens , oral @DRUG$ , phenytoin , nicotinic acid , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .	DDI-false
Lithium carbonate: The anorectic and stimulatory effects of @DRUG$ may be inhibited by @DRUG$.	DDI-effect
Concomitant use of LEVSIN with other antimuscarinic agents may lead to additive side effects due to cholinergic blockade. @DRUG$ , haloperidol, phenothiazine, monoamine oxidase (MAO) inhibitors, @DRUG$ or some antihistamines .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, @DRUG$, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac @DRUG$, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
- @DRUG$ (e.g., Mexate) Use of @DRUG$ with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of methotrexate	DDI-false
These data indicate that @DRUG$ does not influence the plasma concentration of other AEDs and that these @DRUG$ do not influence the pharmacokinetics of levetiracetam.	DDI-false
Multivitamins, or other products containing @DRUG$ or zinc, antacids or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of @DRUG$, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.	DDI-advise
Antiarrhythmics: Amiodarone, @DRUG$, flecainide, propafenone, @DRUG$ CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
In addition to the above interactions, the chronic (2 weeks) oral administration of Cordaron affects the metabolism of @DRUG$ , @DRUG$ , and methotrexate .	DDI-false
A possible interaction between glyburide and @DRUG$, a @DRUG$, has been reported, resulting in a potentiation of the hypoglycemic action of glyburide.	DDI-false
There was no significant difference in the pharmacodynamic effect of @DRUG$ administered alone and @DRUG$ When used with Lodin, measured by prothrombin time.	DDI-false
Antiarrhythmics: Amiodarone, @DRUG$, flecainide, @DRUG$, quinidine CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
@DRUG$: The effect of celecoxib on the anti-coagulant effect of warfarin was studied in a group of healthy subjects receiving daily doses of 2-5 mg of @DRUG$.	DDI-false
@DRUG$ : Concomitant administration of antacids may reduce plasma levels of @DRUG$.	DDI-false
These drugs include thiazides and other @DRUG$ , corticosteroids , phe-nothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimet-ics , @DRUG$ , and isoniazid .	DDI-false
As with other antipsychotic agents, it should be noted that HALDOL may be capable of potentiating @DRUG$ such as anesthetics, opiates, and @DRUG$.	DDI-false
(In some patients, the steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of @DRUG-DRUG$.	DDI-false
Multivitamins, or other products containing @DRUG$ or zinc, antacids or @DRUG$ should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.	DDI-false
@DRUG$ Elevated serum lithium levels and symptoms of @DRUG$ Toxicity has been reported in patients receiving concomitant lithium and ACE inhibitor therapy.	DDI-false
Compounds tested in man include warfarin , theophylline , @DRUG$ , Diazepam, Aminopyrin and @DRUG$.	DDI-false
The high dose of cyclosporin A, which resulted in concentrations above 2000 ng/ml administered with oral etoposide, resulted in an 80% increase in @DRUG$ Exposure with a decrease in total body clearance of etoposide by 38% compared to @DRUG$ alone .	DDI-false
These results suggest that both dexamethasone and @DRUG$ , and possibly other glucocorticoids and retinoids, the proliferation of prostate epithelium can be regulated by a dose-dependent change in activity of @DRUG$ and EGF .	DDI-effect
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., @DRUG$), general anesthetics, @DRUG$, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), @DRUG$ (acetylsalicylic acid), NSAIDs (@DRUG$), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
@DRUG$: The concomitant administration of diflunisal and naproxen in normal volunteers had no effect on the plasma levels of naproxen, but significantly decreased the urinary excretion of @DRUG$ and its glucuronide metabolite.	DDI-false
The blood pressure lowering effect of vardenafil ( 20 mg ) @DRUG$ during the 4-hour observation period in healthy volunteers when administered with @DRUG$ ( 0.5 g/kg body weight ) .	DDI-false
@DRUG$ To reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, @DRUG$ , chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, which delays the elimination and increase in blood levels of these drugs.	DDI-mechanism
Non-steroidal Anti-inflammatory Drugs: In some patients, the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of loop, @DRUG-DRUG$.	DDI-false
@DRUG$: Other antiarrhythmic drugs, such as @DRUG$, procainamide, disopyramide, and phenytoin, have been used concurrently with amiodarone.	DDI-false
Short-term pharmacokinetic studies have demonstrated that concomitant administration of warfarin and Lodine  (@DRUG$ capsules and tablets) results in reduced protein binding of @DRUG$, but there was no change in the clearance of free warfarin.	DDI-false
Probenecid : @DRUG$ , a renal tubular secretion blocking agent, administered at a dose of 500 mg four times a day, did not alter the pharmacokinetics of @DRUG$ 1000 mg twice daily.	DDI-false
Colestipol : Plasma concentrations of @DRUG$ 25 % if Colestipol and @DRUG$ were coadministered .	DDI-false
Coadministration of terfenadine with @DRUG$ This resulted in increased plasma concentrations of @DRUG$ , resulting in rare instances of life- threatening cardiac dysrhythmias and one death .	DDI-false
In patients with nalfon and @DRUG$ concomitantly , any reduction in @DRUG$ dosage should be gradual in order to avoid the possible complications of sudden steroid withdrawal .	DDI-false
Tagamet, apparently due to an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, @DRUG$ , propranolol , nifedipine , @DRUG$ , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .	DDI-false
Anticholinesterases ( neostgmine, physostigmine), lignocaine, @DRUG$ , @DRUG$ The toxicity can be increased and lead to heart respiratory depression.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, @DRUG$, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ The blood pressure lowering effect of systemic @DRUG$ has been reported to dull.	DDI-effect
@DRUG$: @DRUG$ blocks dopamine and norepinephrine receptors, thus inhibiting the central stimulant effects of amphetamines and can be used to treat amphetamine poisoning.	DDI-false
@DRUG$: The concomitant administration of ciprofloxacin with the sulfonylurea @DRUG$ has, on rare occasions, resulted in severe hypoglycemia.	DDI-false
Preliminary animal and human studies have shown that small amounts of systemic @DRUG$ In the CSF mainly as 5-methyltetrahydrofolate and, in humans, 1 to 3 orders of magnitude remain lower than the usual. @DRUG$ Concentrations after intrathecal administration.	DDI-false
@DRUG$ - before taking @DRUG$ may decrease the emetic response to apomorphine in the treatment of poisoning .	DDI-false
Ritonavir and indinavir: When vardenafil 5 mg is co-administered with 600 mg twice daily @DRUG$ , the Cmax and AUC of @DRUG$ Production was reduced by around 20%.	DDI-false
Numerous drug interactions are possible with some @DRUG$, such as @DRUG$ and phenytoin, which affect hepatic microsomal enzyme systems.	DDI-false
Based on the results of these studies , it is concluded that @DRUG$ may be safely coadministered with both zidovudine and @DRUG$.	DDI-false
Coadministration of @DRUG$ with @DRUG$ has led to elevated plasma concentrations of terfenadine , resulting in rare instances of life- threatening cardiac dysrhythmias and one death .	DDI-mechanism
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with @DRUG$, beta-blockers, felodipine, digoxin, warfarin, isosorbide mononitrate, carvedilol, @DRUG$ or itraconazole.	DDI-false
Potential drug interactions between Keppra   and other AEDs ( @DRUG$ , gabapentin , lamotrigine , @DRUG$ , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies .	DDI-false
Another oral azole antifungal, @DRUG$, inhibits the metabolism of astemizole, resulting in elevated plasma concentrations of @DRUG$ and its active metabolite desmethylastermizole which may prolong QT intervals.	DDI-false
@DRUG$: Because @DRUG$ does not affect the pharmacokinetics of antipyrine, interactions with other drugs metabolized via the same cytochrome isozymes are not expected.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed , @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ACE ) inhibitors , anticonvulsants , benzodiazepines , @DRUG$ , calcium channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also known as NSAIDs), and quinolone anti-infections without evidence of clinically significant adverse interactions.	DDI-false
Glyburide: The concomitant administration of ciprofloxacin with the @DRUG$ @DRUG$ has, on rare occasions, resulted in severe hypoglycemia.	DDI-false
Two groups (SH/DA; SH/FA) were submitted to daily treatment with synthetic hydroalcoholic solutions containing ethanol, @DRUG$, higher alcohols and @DRUG$ in the same proportions as those found in most common distilled and fermented alcoholic beverages;	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, @DRUG$, @DRUG$, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Note : dissolution of aerosol particles of budesonide in @DRUG$ A model @DRUG$.	DDI-false
Multivitamins or other products which: @DRUG$ Zinc, antacids or sucralfate should not be administered concomitantly with or within 2 hours after administration of @DRUG$ Because they may impair absorption, resulting in lower serum and urine levels of norfloxacin.	DDI-advise
Drug Interactions : Flupenthixol may interact with some drugs , like Monoamine oxidase inhibitors ( MAOI ): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol : Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants : @DRUG$ increases the effect of @DRUG$	DDI-effect
Multivalent Cation-Containing Products : Concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , VIDEX chewable/buffered tablets or pediatric powder , or products containing calcium , @DRUG$ , or zinc may substantially decrease the absorption of @DRUG$ , resulting in serum and urine levels considerably lower than desired .	DDI-false
1 hour after starting the @DRUG$ or @DRUG$ 500 mg p.o.	DDI-false
@DRUG$ ( 5 mg/kg ) , @DRUG$ ( 30 mg/kg ) , clonazepam ( 0.25 mg/kg ) , fluoxetine ( 20 mg/kg ) sertraline ( 30 mg/kg ) or vehicle was administered .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
In patients with mild to moderate hypertension, administration of 25 mg daily of VIOXX with the ACE inhibitor @DRUG$, 10 to 40 mg for 4 weeks, was associated with an average increase in mean arterial pressure of about 3 mm Hg compared to @DRUG$ alone.	DDI-false
Levosimendan has no clinically important pharmacokinetic interactions with @DRUG$ , beta-blockers , @DRUG$ , digoxin, warfarin, isosorbide mononitrate, schnitztilol, ethanol or itraconazole.	DDI-false
Therefore , the combined use of @DRUG$ with @DRUG$ In general, it should be avoided.	DDI-advise
Therefore, it would be expected that a dosage regimen of cerivastatin sodium at the time of sleep and @DRUG$ Given before the Lord's Supper would not lead to a significant decrease in the clinical effect of @DRUG$.	DDI-false
@DRUG$/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of @DRUG$ 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
In clinical studies performed with @DRUG$, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and @DRUG$ did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
If @DRUG$ is administered with drugs that inhibit Pgp, increased concentrations of @DRUG$ are likely, and caution should be exercised.	DDI-false
@DRUG$: In a study conducted in healthy subjects, mean steady-state lithium plasma levels increased approximately 17% in subjects receiving @DRUG$ 450 mg BID with CELEBREX 200 mg BID as compared to subjects receiving lithium alone.	DDI-false
Limited clinical data in angina patients receiving concomitant @DRUG$ and @DRUG$ therapy indicate no discernible changes in serum digoxin levels.	DDI-false
In clinical studies performed with Fondaparinux , the concomitant use of oral anticoagulants ( warfarin ) , platelet inhibitors ( acetylsalicylic acid ) , @DRUG$ Piroxicam and digoxin did not significantly affect @DRUG$ pharmacokinetics/pharmacodynamics.	DDI-false
In these patients whose hypertension is associated with @DRUG$ , @DRUG$ 20 mg produced mean additional supine systolic/diastolic blood pressure reductions of 6/5 mm Hg compared to placebo .	DDI-effect
@DRUG$: @DRUG$ CONTRAINDICATED since the coadministration of this product with saquinavir in an antiretroviral regimen reduces the plasma concentrations of saquinavir.	DDI-false
Other Drug Interactions Oral @DRUG$ Keppra  (500 mg twice daily) did not influence the pharmacokinetics of an oral contraceptive containing 0.03 mg @DRUG$ and 0.15 mg levonorgestrel, or of the luteinizing hormone and progesterone levels, indicating that impairment of contraceptive efficacy is unlikely.	DDI-false
Based on the chemical resemblance of @DRUG$ and ketoconazole, coadministration of @DRUG$ with itraconazole is contraindicated.	DDI-false
Nephrotoxicity has been reported following concomitant administration of cephalosporins with @DRUG$ or potent diuretics such as @DRUG$.	DDI-false
Standard monitoring of @DRUG$-related toxicity should be continued if VIOXX and @DRUG$ The medicine is given at the same time.	DDI-false
Amiodarone may suppress certain CYP450 enzymes, including @DRUG$, @DRUG$, CYP2D6, and CYP3A4.	DDI-false
Multivalent Cation-Containing products: Concomitant administration of quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminium antacids, sucralfate, @DRUG$ chewable/buffered tablets or pediatric powder , or products containing @DRUG$ , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .	DDI-false
This drug may interact with @DRUG$ CNS depressants (may increase the CNS depressive effect of either these drugs or @DRUG$ ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( MAO ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines ) .	DDI-false
Tetracyclines : Concomitant treatment with Accutane and @DRUG$ The use of Accutane should be avoided as the use of Accutane has been associated with a number of cases of pseudotumour cerebri (benign intracranial hypertension), some of which are associated with concomitant use of @DRUG$	DDI-false
@DRUG$ ( Neostgmin, Physostigmin), lignocaine, @DRUG$ Procainamide can increase toxicity and lead to heart respiratory depression.	DDI-false
@DRUG$ and @DRUG$ should not be administered to patients receiving coumarin drugs.	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, @DRUG$ , disopyramide , quinine , amiodarone , quinidine , warfarin , @DRUG$ (e. g. cyclosporin, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam and triazolam) may exhibit increased plasma concentrations when co-administered with saquinavir;	DDI-false
@DRUG$ The efficacy of the warfarin type ( CYP2C9 and CYP3A4 substrate) is almost always observed in patients who: @DRUG$ and can result in serious or fatal bleeding .	DDI-false
Cephalosporins-@DRUG$ containing side chains of N-methylthiotetrazole (@DRUG$, cefoperazone, cefotetan, cefamandole, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
No pharmacokinetic interactions between: @DRUG$ and isoflurane , propofol , @DRUG$ ==References====External links==	DDI-false
@DRUG$: @DRUG$ may delay intestinal absorption of phenytoin;	DDI-false
Therefore, when Hydrochlorothiazide and @DRUG$ are used concomitantly, the patient should be observed closely to determine if the desired effect of the @DRUG$ is obtained.	DDI-false
Intravenous Adenocard (adenosine) has been effectively administered in the presence of other cardioactive drugs, such as quinidine, @DRUG$, @DRUG$, and angiotensin converting enzyme inhibitors, without any change in the adverse reaction profile.	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , disopyramide , @DRUG$ , @DRUG$ , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
Other Drug Interactions Oral Contraceptives @DRUG$  (500 mg twice daily) did not influence the pharmacokinetics of an oral contraceptive containing 0.03 mg @DRUG$ and 0.15 mg levonorgestrel, or of the luteinizing hormone and progesterone levels, indicating that impairment of contraceptive efficacy is unlikely.	DDI-false
Notably , systemic exposure ( AUC0 - 12 ) of dapsone hydroxylamine ( @DRUG$ @DRUG$/SMX was more than doubled in the presence of @DRUG$/SMX.	DDI-false
@DRUG$ : Vardenafil 20 mg , when co-administered with slow-release @DRUG$ 30 mg or 60 mg once daily , did not affect the relative bioavailability ( AUC ) or maximum concentration ( Cmax ) of nifedipine , a drug that is metabolized via CYP3A4 .	DDI-false
- methotrexate (e.g. mexate) use of @DRUG$ Sulfapyridine may increase the likelihood of side effects affecting the liver and/ or side effects of sulfapyridine. @DRUG$	DDI-false
Ergot Derivatives: Dihydroergotamine, @DRUG$, ergotamine, @DRUG$ CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
@DRUG$ ( but not @DRUG$ ): These drugs in combination with very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies .	DDI-false
@DRUG$ did not alter the pharmacokinetics of @DRUG$.	DDI-false
Both @DRUG$ and @DRUG$ block morphine-induced and nicotine-induced dopamine release in the nucleus accumbens;	DDI-false
Both @DRUG$ and @DRUG$ block morphine-induced and nicotine-induced dopamine release in the nucleus accumbens ;	DDI-false
Since the therapeutic area of theophylline is narrow @DRUG$ Serum levels should be closely monitored and appropriate dose adjustments made. @DRUG$ It should be done.	DDI-false
@DRUG$ ( oral and @DRUG$ ) - dosage adjustment of the antidiabetic drug may be required .	DDI-false
Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: @DRUG$, cyclosporine, @DRUG$, nicardipine, and nifedipine.	DDI-false
Compounds tested in man include @DRUG$, theophylline, phenytoin, diazepam, @DRUG$ and antipyrine.	DDI-false
@DRUG$ and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (ACEI/@DRUG$).	DDI-false
@DRUG$/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Prednisone/prednisolone: Rofecoxib did not have any clinically important effect on the pharmacokinetics of @DRUG$ or @DRUG$.	DDI-false
For example, when @DRUG$ are administered concomitantly with @DRUG$, prothrombin time should be carefully monitored and if necessary, the dosage of vitamin K antagonists should be reduced.	DDI-advise
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, @DRUG$, propofol, protease inhibitors, quinidine, and @DRUG$.	DDI-false
As with other antipsychotic agents, it should be noted that @DRUG$ may be capable of potentiating @DRUG$ such as anesthetics, opiates, and alcohol.	DDI-effect
@DRUG$: The administration of diflunisal to normal volunteers receiving @DRUG$ decreased the renal clearance and significantly increased the plasma levels of indomethacin.	DDI-false
These drugs include: @DRUG$ and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , @DRUG$ ==References====External links==	DDI-false
@DRUG$ : The concomitant administration of ciprofloxacin with the @DRUG$ Glyburide has, in rare cases, led to severe hypoglycaemia.	DDI-false
Antiarrhythmics: @DRUG$, bepridil, flecainide, @DRUG$, quinidine CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
Intravenous Adenocard ( @DRUG$ ) was effective in the presence of other cardiovascular medications, e.g. @DRUG$ , beta-adrenergic blocking agents , calcium channel blocking agents , and angiotensin converting enzyme inhibitors , without any change in the adverse reaction profile .	DDI-false
Example inhibitors include azole antifungals, @DRUG$, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and @DRUG$.	DDI-false
Warfarin @DRUG$  (1000 mg twice daily) did not influence the pharmacokinetics of R and @DRUG$.	DDI-false
The availability of potent @DRUG$ (@DRUG$)-based regimens for antiretroviral therapy and concerns regarding protease inhibitor (PI)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection .	DDI-false
There is a significant increase in exposure to @DRUG$ when Gleevec is coadministered with @DRUG$ (CYP3A4 inhibitor).	DDI-false
There was no evidence of any pharmacokinetic interactions between @DRUG$ and @DRUG$.	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, @DRUG$, calcium-channel blockers, diuretics, and @DRUG$ (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
These drugs include the thiazides and other diuretics, @DRUG$, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and @DRUG$.	DDI-false
Lithium : Increased serum @DRUG$ The concentrations and symptoms of lithium toxicity have been reported in patients who are at the same time: @DRUG$ and ACE inhibitor therapy .	DDI-false
The physician is advised to monitor the plasma concentrations of @DRUG$ when any of these drugs is taken concurrently, and to increase the dose of @DRUG$ if necessary.	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced adverse reactions such as fever, renal failure, hyperbilirubinaemia, confusion and dyspnoea, concomitant administration of these agents with PROLEUKIN may reduce the efficacy of antitumours. @DRUG$ 12 and should therefore be avoided. @DRUG$ and other antihypertensives may potentiate the hypotension seen with PROLEUKIN .	DDI-false
Oral @DRUG$ Co-administration of atorvastatin and oral @DRUG$ AUC values for norethindron and ethinylestradiol were increased by approximately 30% and 20%.	DDI-false
@DRUG$-based regimens may have several advantages over @DRUG$-based therapy for initial or prolonged therapy, including more convenient administration regimens, lower tablet volume, fewer drug interactions, and central nervous system penetration.	DDI-false
Possible drug interactions of @DRUG$ with @DRUG$ or with other anticholinesterase agents.	DDI-int
Stavudine and Zidovudine @DRUG$ In vitro, the antiviral activity of @DRUG$ And zidovudine against HIV.	DDI-effect
Drugs that Inhibit or Induce Cytochrome P450 3A4 Enzymes @DRUG$ undergoes extensive metabolism by CYP3A4, and concomitant administration of strong inhibitors or inducers of CYP3A4 alter @DRUG$ concentrations significantly.	DDI-false
Other Drug Interactions Oral @DRUG$ Keppra  (500 mg twice daily) did not influence the pharmacokinetics of an oral @DRUG$ containing 0.03 mg ethinyl estradiol and 0.15 mg levonorgestrel, or of the luteinizing hormone and progesterone levels, indicating that impairment of contraceptive efficacy is unlikely.	DDI-false
How ibogain ( 40 mg/kg ) reduces intravenous self-injection of 18-MC ( 40 mg/kg ) @DRUG$ and cocaine and the oral self-administration of @DRUG$ nicotine in rats;	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, @DRUG$, cardiac @DRUG$, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced adverse reactions including fever, renal failure, hyperbilirubinaemia, confusion and dyspnoea, concomitant use of these active substances with @DRUG$ The effectiveness of antitumours can be reduced. @DRUG$ and thus should be avoided . 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN .	DDI-false
The safety and efficacy of @DRUG$ in combination with any @DRUG$ It wasn't detected.	DDI-false
SINCE THE CONCOMPITANT MANAGEMENT OF THIS TWO THROUGH @DRUG$ INTOXICATION BEFORE THE DEVELOPMENT OF DISCULFIRAM TO A PATIENT @DRUG$ THERAPY, A BASELINE PHENYTOIN SERUM SERUM LEVEL ANDIE.	DDI-false
Reciprocal interactions may occur with concomitant use of Antizol and drugs that increase or inhibit the cytochrome P450 system (e.g., @DRUG$, carbamazepine, cimetidine, @DRUG$), though this has not been studied	DDI-false
Aspirin : When @DRUG$ The protein binding is reduced with aspirin, although the clearance of free @DRUG$ is not altered .	DDI-false
@DRUG$ : Other @DRUG$ Medicines such as quinidine, procainamide, disopyramide and phenytoin have been used concomitantly with amiodarone.	DDI-false
Injection: Lorazepam injection, like other injectable @DRUG$, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, @DRUG$, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-effect
This drug may interact with @DRUG$ or other CNS depressants (may enhance the CNS depressive effect of either these drugs or antihistamines), anticholinergics or other anticholinergic drugs (anticholinergic effects may be intensified if these drugs are used at the same time as antihistamines), and @DRUG$ Concomitant use of antihistamines may prolong and increase the anticholinergic and CNS depressive effects of antihistamines.	DDI-false
- anabolic steroids (Nandrolone [e.g., @DRUG$ ] , oxandrolone [ e.g. , @DRUG$ ], oxymethol [ e.g. Anadrol ], stanozole [ e.g. Winstrol ] or	DDI-false
As with other antipsychotic agents , it should be noted that HALDOL may be capable of potentiating CNS depressants such as @DRUG$ , opiates , and @DRUG$.	DDI-false
@DRUG$: rifampin CONTRAINDICATED since the coadministration of this product with saquinavir in an antiretroviral regimen reduces the plasma concentrations of @DRUG$.	DDI-false
Thus, smaller doses of @DRUG$ may be effective in the presence of @DRUG$.	DDI-effect
@DRUG$ or @DRUG$ Surplus may reduce the effect of carbimazole, and a lack of iodine may increase the effect of carbimazole.	DDI-false
@DRUG$ : The concomitant use of @DRUG$ with long- and short-acting nitrates has been safely tolerated in patients with stable angina pectoris .	DDI-false
Benzthiazide may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like @DRUG$ or @DRUG$, and high blood pressure medications.	DDI-false
@DRUG$ 500 mg twice daily did not modify the rate or extent of @DRUG$ absorption or its plasma clearance or urinary excretion.	DDI-false
Phenytoin: @DRUG$ has no apparent pharmacokinetic interaction when administered with @DRUG$.	DDI-false
- @DRUG$ ( e.g. , @DRUG$ ) or	DDI-false
Drugs Interactions between Keppra and other antiepileptics ( AEDs ) @DRUG$ Keppra   ( 3000 mg daily ) had no effect on the pharmacokinetic disposition of @DRUG$ in patients with refractory epilepsy .	DDI-false
Co-medicines that induce CYP3A4 (e.g. @DRUG$ , @DRUG$ , carbamazepine , rifampin , phenobarbital or St.	DDI-false
@DRUG$, barbiturates, or @DRUG$: potentiation of orthostatic hypotension may occur.	DDI-false
Hypotension    Patients on @DRUG$ Therapy : Patients on diuretics and especially those in whom diuretic therapy was recently instituted , as well as those on severe dietary salt restriction or dialysis , may occasionally experience a precipitous reduction of blood pressure usually within the first hour after receiving the initial dose of @DRUG$.	DDI-false
Potassium-sparing diuretics (e.g., spironolactone, triamterene, or @DRUG$), @DRUG$ supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
Other concomitant therapy Although no specific interaction studies have been conducted, 1 mg or more of finasteride doses have been used in clinical trials with acetaminophen, acetylsalicylic acid, A-blockers, analgesics, @DRUG$ , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac @DRUG$ , diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also known as NSAIDs), and quinolones anti-infections without evidence of clinically significant adverse interactions.	DDI-false
Central Nervous System Depressants : The concomitant use of @DRUG$   ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and @DRUG$ , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	DDI-effect
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, @DRUG$, @DRUG$, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
- anabolic steroids (Nandrolone [e.g. Anaboline], Oxandrolone [e.g., Anavar], Oxymetholone [e.g., @DRUG$ ], stanozolol [e.g., @DRUG$ ] ) or	DDI-false
For example, inhibitors are azole antimycotics, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, @DRUG$ , protease inhibitors , quinidine , and @DRUG$.	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, @DRUG$, and other antidepressants.When scopolamine is used concomitantly with injectable @DRUG$, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
Particular caution is recommended when administering @DRUG$ with CYP3A4 substrates that have a narrow therapeutic window (e.g., @DRUG$ or pimozide).	DDI-advise
Specific studies have confirmed these effects with sevoflurane, @DRUG$, @DRUG$, alfentanil, and midazolam.	DDI-false
* Drug interactions : Flupentixol may interact with some drugs, such as @DRUG$ MAOI could theoretically influence the pharmacodynamics of flupenthixol - Arecolin - eproxindine - @DRUG$ : Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants : Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Plasma @DRUG$ concentration should be monitored when isoniazid and valproate are co administered, and appropriate dosage adjustments of @DRUG$ should be made.	DDI-false
Theophylline: As with some other quinolones, concomitant use of @DRUG$ with @DRUG$ may lead to elevated serum concentrations of theophylline and prolongation of its elimination half-life .	DDI-mechanism
Possible interactions between Keppra and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, @DRUG$ Serum concentrations of levetiracetam and valproate have also been studied by @DRUG$ • during placebo-controlled clinical trials.	DDI-false
Concurrent administration of HEXALEN and antidepressants of the MAO inhibitor class may cause severe orthostatic hypotension.@DRUG$ , an inhibitor of microsomal drug metabolism , increased @DRUG$s half-life and toxicity in a rat model .	DDI-mechanism
In a 12-week endoscopy study conducted in OA patients there was no difference in the cumulative incidence of endoscopic gastroduodenal ulcers in patients taking low-dose ( 81 mg ) enteric coated @DRUG$ plus @DRUG$ 25 mg daily, compared to the ibuprofen 2400 mg daily alone.	DDI-false
@DRUG$: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, @DRUG$, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
Both @DRUG$ and nevirapine have been compared to triple therapy with the @DRUG$ Indinavir for 48 weeks as initial therapy, with similar response observed with nevirapine regimens and superiority observed with efavirenz.	DDI-false
While all selective serotonin reuptake inhibitors ( @DRUG$ ) , e.g. , citalopram , escitalopram , fluoxetine , sertraline , and @DRUG$ , inhibit P450 2D6 , they may vary in the extent of inhibition .	DDI-false
Central Nervous System Depressants: The concomitant use of @DRUG$  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, @DRUG$, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
Cephalosporine cephalosporine containing side chains of N-methylthiotetrazole (Cefmenoxime, cefoperazone, cefotetan), @DRUG$ , latamoxef ) or methylthiadiazole ( @DRUG$ ) can cause vitamin K deficiency and hypoprothrombinemia .	DDI-false
@DRUG$ In a single dose interaction study in patients with NIDDM, the @DRUG$ AUC and Cmax were observed , but were highly variable .	DDI-false
Other strong inhibitors of CYP3A4 (e.g., @DRUG$, clarithromycin, @DRUG$, troleandomycin, ritonavir, nelfinavir) would be expected to behave similarly.	DDI-false
Bacteriostatic Antibiotics: @DRUG$, erythromycins, sulfonamides, or @DRUG$ may interfere with the bactericidal effect of penicillins.	DDI-false
@DRUG$, such as @DRUG$, diltiazem and nifedipine, inhibit platelet activation in vitro, and decrease platelet adhesion intravascularly.	DDI-false
* As Amiodarone is a substrate for @DRUG$ , there is the potential that the use of St. John s Wort in patients receiving amiodarone could result in reduced @DRUG$ levels .	DDI-false
ACE Inhibitors and Angiotensin II Receptor Antagonists ( Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS , 3020 ( 91 % ) patients receiving @DRUG$ 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists ( @DRUG$/ARB ) .	DDI-false
The continued need for the other @DRUG$ agent should be reviewed after the effects of @DRUG$ have been established, and discontinuation ordinarily should be attempted.	DDI-false
In addition, certain drugs that are metabolised by this isoenzyme, including many @DRUG$ ( @DRUG$ Selective serotonin reuptake inhibitors, and others), can inhibit the activity of this isoenzyme, and so normal metab olisators such as poor metabolisers can metabolize in relation to concomitant therapy with other drugs through this enzyme system, resulting in drug interactions.	DDI-false
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies ( phenytoin , @DRUG$ , oral contraceptive , digoxin , warfarin , @DRUG$ ) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients .	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
Particular caution is necessary when using @DRUG$ In cases of mixed drug overdose, as the toxic effects (such as cramps and cardiac arrhythmias) of other medicinal products taken during overdose (especially cyclic antidepressants) with the reversal of the @DRUG$ Effect by flumazenil.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ACE ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , @DRUG$ HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also known as @DRUG$ ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
If cholinergic blockades occur, additive undesirable effects may occur if: @DRUG$ It is administered concomitantly with other antimuscarinics, amantadine, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some @DRUG$.	DDI-effect
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and @DRUG$, specifically, dacarbazine, cis-platinum, @DRUG$ and interferon-alfa.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, @DRUG$, doxycycline, @DRUG$, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Azithromycin had no significant effect on Cmax and AUC of @DRUG$ However, although it significantly reduced the @DRUG$ Tmax increased by 44% and intracellular exposure to phosphorylated zidovudine by 110%.	DDI-false
Bacteriostatic Antibiotics : @DRUG$ , @DRUG$ , sulfonamides , or tetracyclines may interfere with the bactericidal effect of penicillins .	DDI-false
Other Chemotherapy Agents In a separate study, concomitant administration of @DRUG$ with capecitabine did not meaningfully alter the pharmacokinetics of either agent (or the metabolites of @DRUG$).	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, Dapson, disopyramide, quinine, amiodarone, quinidine, @DRUG$ , tacrolimus, cyclosporin, ergot derivatives, @DRUG$ , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
@DRUG$ "Seroquel" is a newly introduced @DRUG$ With proven efficacy in the treatment of positive and negative symptoms of schizophrenia.	DDI-false
Central nervous system depressants : Concomitant use of DURAGESIC (Fentanyl transdermal system ) with other central nervous system depressants, including but not limited to others @DRUG$ , sedatives , @DRUG$ Anaesthetics (e.g. benzodiazepines), general anaesthetics, phenothiazines, skeletal muscle relaxants and alcohol can cause respiratory depression, hypotension and deep sedation, or possibly lead to coma or death.	DDI-false
Compounds tested in man include warfarin, theophylline, phenytoin, diazepam, @DRUG$ and @DRUG$.	DDI-false
Potassium Supplements and Potassium-Sparing Diuretics: @DRUG$ can attenuate potassium loss caused by @DRUG$.	DDI-effect
@DRUG$: In normal volunteers, concomitant administration of @DRUG$ and acetaminophen resulted in an approximate 50% increase in plasma levels of acetaminophen.	DDI-false
Folic acid in large amounts may counteract the antiepileptic effect of @DRUG$, @DRUG$ and primidone, and increase the frequency of seizures in susceptible pediatric patients.	DDI-false
Prednisone/@DRUG$ : Rofecoxib did not have any clinically important effect on the pharmacokinetics of @DRUG$ or prednisone .	DDI-false
Tolbutamide : In diabetic patients receiving diflunisal and @DRUG$ , no significant effects were seen on @DRUG$ plasma levels or fasting blood glucose .	DDI-false
Sedatives/@DRUG$: triazolam, @DRUG$ CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as prolonged or increased sedation or respiratory depression .	DDI-false
@DRUG$ Patients receiving Antabuse should be used with caution ( @DRUG$ , Wyeth-Ayerst Laboratories ) .	DDI-advise
The possibility of hypotensive effects with @DRUG$ can be minimized by either discontinuing the diuretic or increasing the salt intake approximately one week prior to initiation of treatment with captopril (@DRUG$ tablets, USP) or initiating therapy with small doses (6.25 or 12.5 mg).	DDI-false
Drug Interactions: @DRUG$ may interact with some drugs, like @DRUG$ (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-int
@DRUG$ Etodolac does not have an apparent pharmacokinetic interaction when given with @DRUG$.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, @DRUG$, warfarin, isosorbide mononitrate, carvedilol, @DRUG$ or itraconazole.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, @DRUG$, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac @DRUG$, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
MAO inhibitors: DURAGESIC is not recommended for use in patients who: @DRUG$ within 14 days because severe and unpredictable potentiation by MAO inhibitors has been reported with @DRUG$	DDI-false
The intensity , uniformity and time course of @DRUG$ interference by phenobarbital , @DRUG$ , glutethimide , chloral hydrate and methaqualone were systematically investigated in 16 patients receiving coumarin therapy .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , doxorubicin , vincristine , and @DRUG$ chemotherapy therapy plus HAART with a group of 80 patients treated with CHOP chemotherapy or with a CHOP-like regimen (e.g. cyclophosphamide, doxorubicin, tenipide), and @DRUG$ with vincristine plus bleomycin ) without receiving antiretroviral therapy .	DDI-false
For treatment with CYP3A4 inhibitors (such as ketoconazole, intraconazole, ritonavir, @DRUG$ , saquinavir , @DRUG$ , etc . ) is indicated , reduction of the budesonide dose should be considered .	DDI-false
Cyclosporine, Digoxin, Methotrexate Lodine, like other @DRUG$, through effects on renal prostaglandins, may cause changes in the elimination of these drugs leading to elevated serum levels of cyclosporine, @DRUG$, methotrexate, and increased toxicity.	DDI-mechanism
Physiological oral @DRUG$ supplementation ( 5 mg/kg/day ) is easy and can be carried out in the diet or with @DRUG$s , with practically only one contra-indication : overt renal failure .	DDI-false
Carbamazepine : Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid , signs and symptoms of @DRUG$ toxicity should be monitored closely , and appropriate dosage adjustment of the @DRUG$ It should be done.	DDI-false
@DRUG$ : @DRUG$ have produced an elevation of plasma lithium levels and a reduction in renal lithium clearance .	DDI-false
Other strong inhibitors of CYP3A4 (e.g., itraconazole, clarithromycin, @DRUG$, @DRUG$, ritonavir, nelfinavir) would be expected to behave similarly.	DDI-false
However , concomitant administration of @DRUG$ with @DRUG$ may result in an increased rate of GI ulceration or other complications , compared to use of CELEBREX alone .	DDI-effect
In view of the long and variable half-life of @DRUG$, potential for drug interactions exists not only with concomitant medication but also with drugs administered after discontinuation of @DRUG$.	DDI-false
Clinical interaction studies with: @DRUG$ and @DRUG$ Co-administration of femara with these medicinal products does not result in clinically significant drug interactions.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, @DRUG$, @DRUG$, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
acetaminophen/theophylline , lidocaine/quinidine , phenobarbital/acetaminophen , @DRUG$/valproic acid , quinidine/lidocaine , theophylline/acetaminophen , and valproic acid/@DRUG$.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , @DRUG$ , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , @DRUG$ , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
Limited clinical data in angina patients @DRUG$ and @DRUG$ The therapy does not indicate any apparent changes in serum digoxin levels.	DDI-false
Because of the increased risk of adverse reactions in patients who have been taking benzodiazepines on a regular basis , it is particularly important that physicians query patients or their guardians carefully about benzodiazepine , alcohol and @DRUG$ "Use as part of the story before any process in which the use of @DRUG$ is planned .	DDI-false
Results of studies in multiple sclerosis patients taking @DRUG$  and concomitant interferon beta-1a (@DRUG$  30 mcg IM once weekly) or glatiramer acetate were inconclusive with regard to the need for dose adjustment of the beta-interferon or glatiramer acetate.	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, @DRUG$, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and @DRUG$.	DDI-false
@DRUG$ should be administered with caution to patients receiving Antabuse (@DRUG$, Wyeth-Ayerst Laboratories).	DDI-advise
This appears to be the only clinically relevant interaction of this kind with @DRUG$, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, @DRUG$ or beta-adrenergic blocking agents, calcium channel blockers, antihistamines or H1-blocking agents, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-effect
Therefore, when @DRUG$ and nonsteroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the @DRUG$ is obtained.)	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 @DRUG$ and other @DRUG$ may potentiate the hypotension seen with PROLEUKIN.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ACE ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , H2 antagonists , @DRUG$ , @DRUG$ ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
It is structurally distinct from the other currently available @DRUG$ (lovastatin, @DRUG$, and pravastatin), leading to unique biopharmaceutical properties relative to the other agents of this class.	DDI-false
The coadministration of @DRUG$ • reduces the biological half-life of @DRUG$ Because of an increase in metabolic clearance leading to a greater amount of hydroxylated femoprofen in urine.	DDI-mechanism
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, @DRUG$, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, secobarbital, @DRUG$, @DRUG$ and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
In the present study, the @DRUG$ clozapine was tested in combination with an active dose of @DRUG$ in two-lever drug discrimination and mixed signalled-unsignalled differential-reinforcement-of-low-rates (DRL) procedures.	DDI-false
Methotrexate Renal tubular transport of @DRUG$ The concomitant use of @DRUG$ This may lead to increased plasma levels of methotrexate.	DDI-mechanism
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, Dapson, disopyramide, quinine, @DRUG$ , quinidine , warfarin , tacrolimus , cyclosporine , @DRUG$ When co-administered with saquinavir, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam and triazolam may exhibit increased plasma concentrations;	DDI-false
Nevertheless, clinical trials and post-marketing observations have shown that: @DRUG$ The natriuretic effect of @DRUG$ and thiazides in some patients .	DDI-effect
A drug-drug interaction study evaluated the effect of the use of ACZONE Gel, 5%, in combination with double strength (160 mg/800 mg) trimethoprim/sulfamethoxazole (@DRUG$/@DRUG$).	DDI-false
These drugs include the @DRUG$ and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral @DRUG$, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
In a clinical pharmacology study, indomethacin or @DRUG$ was administered to hypertensive patients receiving @DRUG$.	DDI-false
Since @DRUG$ There is the potential that the use of St. John's word in patients who @DRUG$ could result in reduced amiodarone levels .	DDI-false
Special care should be taken when using Gleevec with CYP3A4 substrates with a narrow therapeutic window (e. g. @DRUG$ or @DRUG$ ) .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , @DRUG$ , @DRUG$ , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
The concomitant administration of medicinal products that are nephrotoxic (e.g. aminoglycosides, @DRUG$ ), myelotoxic (e.g., @DRUG$ Chemotherapy), cardiotoxic (e.g. doxorubicin) or hepatotoxic (e.g. methotrexate, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Because Nalfon has not been shown to produce any additional effect beyond that obtained with aspirin alone and because aspirin increases the rate of excretion of Nalfon , the concomitant use of @DRUG$ and @DRUG$ It's not recommended.	DDI-advise
The intensity, uniformity and time course of @DRUG$ interference by @DRUG$, secobarbital, glutethimide, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , doxorubicin , vincristine , and prednisone ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , @DRUG$ , teniposide, and @DRUG$ • with vincristine plus bleomycin) without antiretroviral therapy.	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, @DRUG$, coumarins, @DRUG$, and beta adrenergic blocking agents.	DDI-false
It is recommended not to exceed a single 5 mg dose of @DRUG$ in a 24-hour period when used in combination with @DRUG$.	DDI-advise
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, @DRUG$, calcium-blocking agents, @DRUG$, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$: Etodolac has no apparent pharmacokinetic interaction when administered with furosemide or @DRUG$.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, @DRUG$, nefazodone, nicardipine, propofol, @DRUG$, quinidine, and verapamil.	DDI-false
Central Nervous System Depressants : The concomitant use of DURAGESIC   ( @DRUG$ transdermal system ) with other @DRUG$ , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	DDI-effect
Data from in vitro studies of benzodiazepines other than @DRUG$ suggest a possible drug interaction for the following: ergotamine, @DRUG$, amiodarone, nicardipine, and nifedipine.	DDI-int
Example inhibitors include @DRUG$, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, @DRUG$, and verapamil.	DDI-false
Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, warfarin, isosorbide mononitrate, schnitztilol, @DRUG$ or @DRUG$.	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, @DRUG$ , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , @DRUG$ , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
and ( ii ) the effects of @DRUG$ were more efficiently inhibited by added cholesterol , the major membrane sterol in human cells , whereas the effects of @DRUG$ The main membrane sterol in the yeast was more efficiently affected by ergosterol.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Central nervous system depressants : Concomitant use of DURAGESIC (Fentanyl transdermal system ) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, sedatives (e.g., @DRUG$ ), general anaesthetics, @DRUG$ , skeletal muscle relaxants, and alcohol, may result in respiratory depression, hypotension, and deep sedation, or possibly in coma or death.	DDI-false
@DRUG$ : The concomitant use of DURAGESIC   ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , @DRUG$ ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	DDI-false
@DRUG$ The skeletal musculature has a tendency to antagonize the relaxing effect of @DRUG$ And can enhance the effect of succinylcholine.	DDI-effect
In a comparison of digitalis tolerance in dogs anesthetized with ketamine , @DRUG$ , or pentobarbital , the dosage of ouabain needed to cause ventricular tachycardia was significantly higher , as was the LD50 of ouabain , with @DRUG$ Or Innovar as with Pentobarbital.	DDI-false
Substances that are potent inhibitors of CYP3A4 activity (e.g. @DRUG$ - decrease in itraconazole and itraconazole @DRUG$ metabolism and increase gefitinib plasma concentrations .	DDI-mechanism
Both efavirenz and nevirapine have been compared to triple therapy with the PI @DRUG$ over 48 weeks as initial therapy, with similar responses being observed with @DRUG$ regimens and superiority observed with efavirenz.	DDI-false
Prednisone/prednisolone: @DRUG$ did not have any clinically important effect on the pharmacokinetics of prednisolone or @DRUG$.	DDI-false
- @DRUG$ (e.g., @DRUG$, Synkayvite) Use of sulfapyridine with these medicines may increase the chance of side effects affecting the blood	DDI-false
Molecular basis for the selective toxicity of @DRUG$ for yeast and @DRUG$ for animal cells .	DDI-false
Corticosteroids , Methylxanthines and @DRUG$ : Accompanying treatment with xanthine derivatives, @DRUG$ , or diuretics may potentiate a possible hypokalemic effect of   beta2-agonists .	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., @DRUG$, a CYP3A4 inhibitor) or @DRUG$ antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
While all the @DRUG$ (SSRIs), e.g., citalopram, escitalopram, fluoxetine, sertraline, and @DRUG$, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
@DRUG$ including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as @DRUG$ (NSAIDs), and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
The effects of ruthenium red ( @DRUG$ ) on inositol 1,4,5-trisphosphate (@DRUG$)-induced responses were studied in rat bone marrow megakaryocytes with the patch-clamp whole-cell recording technique in combination with fura-2 microfluorometry .	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing a high sequential dose. @DRUG$ And antineoplastic agents, especially dacarbazine, cis-platinum, @DRUG$ and interferon-alfa .	DDI-effect
Results of studies in multiple sclerosis patients taking TYSABRI  and concomitant @DRUG$ (AVONEX  30 mcg IM once weekly) or glatiramer acetate were inconclusive with regard to the need for dose adjustment of the @DRUG$ or glatiramer acetate.	DDI-false
Although in clinical studies with IOPIDINE 0.5 % ophthalmic solution no specific drug interactions with topical glaucoma or systemic drugs have been identified, there is a possibility of additive or potentiating effects with: @DRUG$ ( alcohol , @DRUG$ , opiates, sedatives, anaesthetics) should be considered.	DDI-false
Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving Alprazolam (caution is recommended during coadministration with @DRUG$): Coadministration of fluoxetine with @DRUG$ increased the maximum plasma concentration of alprazolam by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance.	DDI-false
Potential pharmacokinetic interactions have been reported in clinical pharmacokinetic studies (phenytoin, valproate, oral contraceptive drug, @DRUG$ , @DRUG$ , probenecid ) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients .	DDI-false
Anticoagulant inhibition was observed during the administration of @DRUG$, secobarbital and @DRUG$;	DDI-false
Therefore, it would be expected that a dosage regimen of @DRUG$ given at bedtime and @DRUG$ Administration prior to supper would not result in a significant decrease in the clinical effect of cerivastatin sodium.	DDI-false
Garlic capsules Garlic capsules should not be used while taking saquinavir ( @DRUG$ ) as the sole protease inhibitor due to the risk of decreased @DRUG$ plasma concentrations .	DDI-false
Injection : Lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with @DRUG$ , @DRUG$ , barbiturates , MAO inhibitors , and other antidepressants . When scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .	DDI-false
Lithium: In a study conducted in healthy subjects, mean steady-state @DRUG$ plasma levels increased approximately 17% in subjects receiving lithium 450 mg BID with CELEBREX 200 mg BID as compared to subjects receiving @DRUG$ alone.	DDI-false
MAO inhibitors @DRUG$, as well as a metabolite of furazolidone, slow @DRUG$ metabolism.	DDI-mechanism
These results suggest that both @DRUG$ and retinyl acetate, and possibly other glucocorticoids and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of @DRUG$ and EGF.	DDI-effect
It is structurally distinct from the other currently available @DRUG$ (lovastatin, simvastatin, and @DRUG$), leading to unique biopharmaceutical properties relative to the other agents of this class.	DDI-false
@DRUG$ It was used with tolazolin, dopamine, dobutamine, steroids, @DRUG$ And high-frequency ventilation.	DDI-false
Bacteriostatic Antibiotics : @DRUG$ , erythromycins , @DRUG$ Tetracyclines may interfere with the bactericidal effect of penicillins.	DDI-false
Sedatives/@DRUG$ : @DRUG$ , Midazolam CONTRAINDICATES due to the potential for serious and/ or life-threatening reactions such as prolonged or increased sedation or respiratory depression.	DDI-false
These drugs include the thiazides and other diuretics , @DRUG$ , phenothiazine, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$ , sympathomimetics, calcium channel block drugs, and isoniazid.	DDI-false
Both efavirenz and nevirapine have been compared to triple therapy with the @DRUG$ indinavir over 48 weeks as initial therapy, with similar responses being observed with nevirapine regimens and superiority observed with @DRUG$.	DDI-false
@DRUG$ Indinavir (800 mg t.i.d.) with vardenafil 10 mg resulted in a 16-fold increase in @DRUG$ AUC, a 7-fold increase in vardenafil Cmax and a 2-fold increase in vardenafil half-life.	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , disopyramide , @DRUG$ , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , @DRUG$ Concomitant use with saquinavir may result in increased plasma concentrations.	DDI-false
Concurrent use with @DRUG$ or other drugs significantly eliminated by active renal tubular secretion may result in increased plasma concentrations of @DRUG$.	DDI-mechanism
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, secobarbital, glutethimide, @DRUG$ and methaqualone were systematically investigated in 16 patients receiving @DRUG$ therapy.	DDI-false
@DRUG$ Simvastatin ( CYP3A4 substrate) in combination with @DRUG$ It has been associated with reports of myopathy/rhabdomyolysis.	DDI-false
Drug interactions : Flupentixol may interact with some medicines, such as monoamine oxidase inhibitors (MAOI): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol : @DRUG$ - Tricyclic antidepressants : Flupentixol increases the effect of tricyclic antidepressants	DDI-false
Drug Interactions : Flupenthixol may interact with some drugs , like Monoamine oxidase inhibitors ( MAOI ): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol : @DRUG$ - Tricyclic antidepressants : @DRUG$ Increases the effect of tricyclic antidepressants	DDI-false
Based on the results of these studies, it is concluded that azithromycin can be safely administered with both. @DRUG$ and @DRUG$.	DDI-false
Non-steroidal anti-inflammatory drugs : In some patients, the administration of a @DRUG$ The diuretic, natriuretic and antihypertensive effects of Loop, @DRUG$ can be reduced.	DDI-effect
@DRUG$ and @DRUG$ could exaggerate the prolongation of the QT interval observed with bepridil hydrochloride.	DDI-false
Intravenous adenocard (adenosine) has been effective in the presence of other cardiovascular drugs such as @DRUG$ , @DRUG$ , calcium channel blocking agents , and angiotensin converting enzyme inhibitors , without any change in the adverse reaction profile .	DDI-false
Antihypertensives : @DRUG$ Propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g. verapamil, a CYP3A4 substrate and @DRUG$ , a CYP3A4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and AV block ;	DDI-false
This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or @DRUG$), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and @DRUG$ (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
While all the selective serotonin reuptake inhibitors (SSRIs), e.g., citalopram, escitalopram, fluoxetine, @DRUG$, and @DRUG$, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
Other concomitant therapies : In clinical trials, the safety profile in patients with @DRUG$ concomitantly with @DRUG$ Hypnotics and sedatives (including benzodiazepines) or non-opioid analgesics were similar to those in patients receiving placebo with these concomitant drugs.	DDI-false
ACE Inhibitors and @DRUG$ (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving @DRUG$ 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (ACEI/ARB).	DDI-false
Although no specific drug interactions with topical glaucoma or systemic medications have been identified in clinical studies, there has been an increase in the incidence of adverse drug reactions. @DRUG$ 0.5 % Ophthalmic Solution , the possibility of an additive or potentiating effect with CNS depressants ( @DRUG$ , barbiturates, opiates, sedatives, anaesthetics) should be considered.	DDI-advise
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , @DRUG$ , @DRUG$ , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine , although theoretically , coadministration of other drugs known to alter cardiac conduction ( eg , anti-arrhythmic or beta-adrenergic blocking agents , calcium channel blockers , antihistamines or H1-blocking agents , @DRUG$ and @DRUG$ ) could also contribute to an extension of the QTc interval.	DDI-false
- Anabolic steroids (nandrolone [e.g., @DRUG$], @DRUG$ [e.g., Anavar], oxymetholone [e.g., Anadrol], stanozolol [e.g., Winstrol]) or	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a @DRUG$ substrate, and @DRUG$, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
These drugs include: @DRUG$ Other diuretics, corticosteroids, phenothiazines, @DRUG$ , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .	DDI-false
@DRUG$ and Angiotensin II Receptor Antagonists (Hypertension)- In clinical studies of patients with hypertension, the addition of INSPRA 50 to 100 mg to @DRUG$ and angiotensin II receptor antagonists increased mean serum potassium slightly (about 0.09-0.13 mEq/L).	DDI-false
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$ , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ACE ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , @DRUG$ H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also known as NSAIDs) and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
These drugs include thiazides and other diuretics, @DRUG$ , phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel block drugs, and @DRUG$.	DDI-false
Plasma @DRUG$ concentration should be monitored when isoniazid and valproate are co administered , and appropriate dosage adjustments of @DRUG$ should be made .	DDI-false
Based on the chemical resemblance of itraconazole and @DRUG$ , coadministration of astemizole with @DRUG$ is contraindicated .	DDI-false
Other Drug Interactions Oral Contraceptives Keppra  (500 mg twice daily) did not influence the pharmacokinetics of an oral @DRUG$ containing 0.03 mg @DRUG$ and 0.15 mg levonorgestrel, or of the luteinizing hormone and progesterone levels, indicating that impairment of contraceptive efficacy is unlikely.	DDI-false
@DRUG$ The effect of @DRUG$ on the anti-coagulant effect of warfarin was studied in a group of healthy subjects receiving daily doses of 2 - 5 mg of warfarin .	DDI-false
Digoxin: When multiple doses of @DRUG$ and digoxin were coadministered, steady-state plasma @DRUG$ concentrations increased by approximately 20%.	DDI-false
Antacids : In a clinical pharmacology study, the concomitant use of a @DRUG$ ( aluminum hydroxide , magnesium hydroxide , and @DRUG$ ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, @DRUG$, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with @DRUG$ plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Acetaminophen/@DRUG$, Lidocain/@DRUG$, Phenobarbital/Acetaminophen, Phenobarbital/Valproic acid, Chinidine/Lidocain, Theophylline/Acetaminophen and Valproic acid/Phenobarbital.	DDI-false
Another oral azole antifungal, @DRUG$, inhibits the metabolism of @DRUG$, resulting in elevated plasma concentrations of astemizole and its active metabolite desmethylastermizole which may prolong QT intervals.	DDI-mechanism
The successive application of glycine ( 5 or 10 mg/kg egg weight ( e.w . ) and @DRUG$ 15 mg/kg E.w.) in a 10-minute interval, significantly the activation of spontaneous mobility of 17-day-old chick embryos compared to the effect of @DRUG$ alone .	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, calcium channel blockers, @DRUG$ or H1-blocking agents, tricyclic antidepressants and @DRUG$) might also contribute to a prolongation of the QTc interval.	DDI-false
Benzthiazide may interact with alcohol , blood thinners , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , @DRUG$ , @DRUG$ like Aleve or Ibuprofen , and high blood pressure medications .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$ , doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, tenipide, and prednisone with vincristine plus). @DRUG$ ) without antiretroviral therapy.	DDI-false
Although no specific studies have been performed, co-administration with medicinal products primarily metabolised by CYP3A4 (e. g. @DRUG$ , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with @DRUG$ ;	DDI-mechanism
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)-A drug interaction study of @DRUG$ with an @DRUG$ It wasn't done.	DDI-false
These results suggest that both dexamethasone and @DRUG$ , and possibly other glucocorticoids and @DRUG$ Prostate epithelium proliferation can be controlled by dose-dependent changes in insulin and EGF activity.	DDI-false
Ergot Derivatives: Dihydroergotamine, ergonovine, @DRUG$, @DRUG$ CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
Use With @DRUG$ @DRUG$ is genotoxic and mutagenic.	DDI-false
Central nervous system depressants : the concomitant use of DURAGESIC (Fentanyl transdermal system ) with other central nervous system depressants, including but not limited to other opioids, @DRUG$ , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , @DRUG$ And alcohol, can cause respiratory depression, hypotension, and deep sedation, or possibly lead to coma or death.	DDI-false
Iodine or @DRUG$ excess may decrease the effect of @DRUG$, and an iodine deficiency can increase the effect of Carbimazole.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with @DRUG$ , beta-blockers , felodipine , @DRUG$ , warfarin, isosorbide mononitrate, knitztilol, ethanol or itraconazole.	DDI-false
- @DRUG$, oral (diabetes medicine you take by mouth) Use of oral antidiabetics with sulfapyridine may increase the chance of side effects affecting the blood and/or the side effects or oral @DRUG$	DDI-false
Coadministration of @DRUG$ decreased the maximum plasma concentration of @DRUG$ by 6%, decreased clearance by 38%, and increased half-life by 58%.	DDI-mechanism
Antihypertensives: @DRUG$ should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a @DRUG$ inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including @DRUG$, with multivalent cation-containing products such as magnesium or aluminum antacids, @DRUG$, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, @DRUG$, digoxin, warfarin, @DRUG$, carvedilol, ethanol or itraconazole.	DDI-false
@DRUG$: In a study conducted in healthy subjects, mean steady-state @DRUG$ plasma levels increased approximately 17% in subjects receiving lithium 450 mg BID with CELEBREX 200 mg BID as compared to subjects receiving lithium alone.	DDI-false
Results of studies in multiple sclerosis patients taking @DRUG$  and concomitant @DRUG$ (AVONEX  30 mcg IM once weekly) or glatiramer acetate were inconclusive with regard to the need for dose adjustment of the beta-interferon or glatiramer acetate.	DDI-false
The effects of ruthenium red (@DRUG$) on @DRUG$ (InsP(3))-induced responses were studied in rat bone marrow megakaryocytes with the patch-clamp whole-cell recording technique in combination with fura-2 microfluorometry.	DDI-false
Combination of @DRUG$ with other @DRUG$ therapy should be reserved for patients with life-threatening ventricular arrhythmias who are incompletely responsive to a single agent or incompletely responsive to amiodarone.	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of magnesium deficit and to discriminate between @DRUG$ deficiency due to an insufficient @DRUG$ intake which only requires oral physiological supplementation and magnesium depletion related to a dysregulation of the control mechanisms of magnesium status which requires more or less specific regulation of its causal dysregulation.	DDI-false
Although glucocorticoids have been shown to reduce @DRUG$-induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided . 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with @DRUG$.	DDI-false
Anticoagulants including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as nonsteroidal anti-inflammatory drugs (@DRUG$), and @DRUG$ may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
In rats, simultaneous ingestion of @DRUG$ and @DRUG$ in the diet for 78 weeks has been reported to cause tumors, and it has been suggested that disulfiram may react with nitrites in the rat stomach to form a nitrosamine, which is tumorigenic.	DDI-effect
Higher concentrations of @DRUG$ ( 10(-8 ) - 10(-6 ) M ) or @DRUG$ ( 3 X 10(-8 ) - 10(-7 ) M ) enhance the mitogenic activity of EGF .	DDI-false
Fenfluramine may increase slightly the effect of @DRUG$ , e.g. , guanethidine , @DRUG$ , reserpine .	DDI-false
Intravenous Adenocard (adenosine) has been effectively administered in the presence of other cardioactive drugs, such as @DRUG$, beta-adrenergic blocking agents, @DRUG$, and angiotensin converting enzyme inhibitors, without any change in the adverse reaction profile.	DDI-false
These drugs include the @DRUG$ And other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$ , sympathomimetics , calcium channel blocking drugs , and isoniazid .	DDI-false
Antacids : In a clinical pharmacology study, the concomitant use of antacids ( @DRUG$ In patients with renal failure (e. g., magnesium hydroxide and simethicone) with fosinopril reduced serum levels and urinary excretion of @DRUG$ as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of @DRUG$ , fibrous acid derivatives, @DRUG$ ( nicotinic acid ) , erythromycin , azole antifungals .	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations : Caution is recommended when administering @DRUG$ Inhibitors of the CYP3A4 family (e.g. @DRUG$ Itraconazole, erythromycin, clarithromycin).	DDI-advise
Although neither @DRUG$ The proliferation of the prostate epithelium in RPMI1640, which contains transferrin alone, was not influenced by retinyl acetate, they modify the mitogenic effect of @DRUG$ and insulin .	DDI-effect
Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following : @DRUG$ , cyclosporine , @DRUG$ , nicardipine , and nifedipine .	DDI-false
@DRUG$: Co-administration of @DRUG$ with rifampin 600 mg daily, a potent inducer of hepatic metabolism, produced an approximate 50% decrease in rofecoxib plasma concentrations.	DDI-false
Cephalosporins-@DRUG$ containing side chains of N-methylthiotetrazole ( cefmenoxime , cefoperazone , cefotetan , @DRUG$ Methylthiadiazole (cefazolin) may cause vitamin K deficiency and hypoprothrombinaemia.	DDI-false
Other concomitant therapy Although specific interaction studies have not been performed, @DRUG$ Doses of 1 mg or more have been associated with acetaminophene, acetylsalicylic acid, A-blockers, analgesics, angiotensin converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta-blockers, @DRUG$ , cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also known as NSAIDs), and quinolone anti-infections without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, @DRUG$, cefotetan, cefamandole, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Drug Interactions : Flupenthixol may interact with some drugs , like @DRUG$ MAOI could theoretically influence the pharmacodynamics of flupentixol - Arecoline - Eproxindine - Ethanol : Flupentixol and @DRUG$ Cause additive CNS depression - Tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like @DRUG$ (@DRUG$): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, warfarin, isosorbide mononitrate, @DRUG$, ethanol or @DRUG$.	DDI-false
Non-selective MAO inhibitors including @DRUG$, phenelzine sulfate, and pargyline HC1: Concomitant use of @DRUG$ and non-selective MAO inhibitors may cause hypertension.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Simultaneous absorption of mineral oil and vitamin K may reduce the absorption of @DRUG$.	DDI-false
Examples of inhibitors are azole antimycotics, ciprofloxacin, clarithromycin, @DRUG$ , doxycycline , @DRUG$ , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .	DDI-false
Non-selective MAO inhibitors including @DRUG$ , phenelzine sulfate , and pargyline HC1 : Concomitant use of @DRUG$ Non-selective MAO inhibitors can lead to hypertension.	DDI-false
Non-steroidal Anti-inflammatory Drugs: In some patients, the administration of a @DRUG$ can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and @DRUG$.	DDI-effect
@DRUG$ Reports suggest that @DRUG$ The antihypertensive effect of ACE inhibitors can be reduced.	DDI-false
FLEXERIL may enhance the effects of @DRUG$ , @DRUG$ And other CNS depressants.	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, calcium channel blockers, antihistamines or @DRUG$, tricyclic antidepressants and @DRUG$) might also contribute to a prolongation of the QTc interval.	DDI-false
These drugs include the thiazides and other diuretics, @DRUG$, phe-nothiazines, @DRUG$, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
A possible interaction between @DRUG$ , and ciprofloxacin, a @DRUG$ , has been reported , resulting in a potentiation of the hypoglycemic action of glyburide .	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including @DRUG$ And other drugs that are highly protein bound, salicylates, sulfonamides, @DRUG$ , probenecid, coumarine, monoamine oxidase inhibitors, and beta-adrenergic blockers.	DDI-false
@DRUG$ : Indinavir ( 800 mg t.i.d . ) co-administered with @DRUG$ 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in vardenafil Cmax and a 2-fold increase in vardenafil half-life.	DDI-false
Antimycobacterial Agents : @DRUG$ CONTRAINDICATED since the coadministration of this product with @DRUG$ In an antiretroviral regimen, this reduces the plasma concentrations of saquinavir.	DDI-false
Administration of @DRUG$ concomitantly with oral @DRUG$ has been shown to result in decreases in serum concentrations of amiodarone and desethylamiodarone.	DDI-false
Sulfapyridine may interact with any of the following: @DRUG$ ( e.g. , @DRUG$ ) ( with long-term , high-dose use ) or	DDI-false
Benzthiazide may interact with @DRUG$, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, @DRUG$, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
injection of @DRUG$ (@DRUG$) were observed by measuring locomotor activity and stereotyped behavior.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with @DRUG$ plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Notably, systemic exposure (AUC0-12) of dapsone hydroxylamine (DHA) was more than doubled in the presence of @DRUG$/@DRUG$.	DDI-false
If treatment with inhibitors of CYP3A4 activity ( such as ketoconazole , intraconazole , @DRUG$ , @DRUG$ , saquinavir, erythromycin, etc.) is indicated, reduction of budesonide dose should be considered.	DDI-false
Although the specific drug interaction was not studied in a clinical trial, there have been more than 50 episodes of concomitant use of antifibrinolytic therapies (i.e., tranexamic acid, @DRUG$) and @DRUG$.	DDI-false
There have been case reports of increased steady-state levels of @DRUG$, @DRUG$, and phenytoin during concomitant therapy with amiodarone.	DDI-false
In addition, Fondaparinux neither influenced the pharmacodynamics of @DRUG$, acetylsalicylic acid, piroxicam, and @DRUG$, nor the pharmacokinetics of digoxin at steady state.	DDI-false
@DRUG$ : Amiodarone , @DRUG$ , flecainide, propafenone, quinidine CONTRAINDICATES due to the potential for serious and/or life-threatening reactions.	DDI-false
Drug Interactions : Flupenthixol may interact with some drugs , like Monoamine oxidase inhibitors ( MAOI ): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol : @DRUG$ - and ethanol cause additive CNS depression - @DRUG$ : Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
The intensity, uniformity and time course of the anticoagulant interference by @DRUG$ , sekobarbital, glutethimide, @DRUG$ In 16 patients receiving coumarin therapy, methaqualone and methaqualone were systematically studied.	DDI-false
Drugs That Inhibit @DRUG$ Metabolism Via Cytochrome P450 3A : The first step in @DRUG$ metabolism is hydroxylation catalyzed by cytochrome P450 3A ( CYP 3A ) .	DDI-false
@DRUG$: Vardenafil 20 mg, when co-administered with slow-release @DRUG$ 30 mg or 60 mg once daily, did not affect the relative bioavailability (AUC) or maximum concentration (Cmax) of nifedipine, a drug that is metabolized via CYP3A4.	DDI-false
Oral @DRUG$ : Pharmacokinetic interactions between argatroban and @DRUG$ 7.5 mg oral single dose) has not been established.	DDI-false
Aspirin: When @DRUG$ is administered with aspirin, its protein binding is reduced, although the clearance of free @DRUG$ is not altered.	DDI-false
Therophylline: A recent study has shown that concomitan administration of isoniazid and @DRUG$ may cause elevated plasma levels of @DRUG$, and in some instances a slight decrease in the elimination of isoniazid.	DDI-false
ACE Inhibitors and @DRUG$ (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (@DRUG$/ARB).	DDI-false
Cephalosporins-@DRUG$ containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, @DRUG$, cefamandole, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
These drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral @DRUG$ , phenytoin , @DRUG$ , sympathomimetics , calcium channel blocking drugs , and isoniazid .	DDI-false
@DRUG$ generally should not be given with diuretics because they reduce @DRUG$s renal clearance and add a high risk of lithium toxicity .	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, @DRUG$, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, @DRUG$ and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
In a comparison of @DRUG$ tolerance in dogs anesthetized with @DRUG$, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with pentobarbital.	DDI-false
Central Nervous System Depressants : The concomitant use of DURAGESIC   ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other @DRUG$ , sedatives , hypnotics , @DRUG$ • (e.g. benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants and alcohol, may cause respiratory depression, hypotension and deep sedation, or may lead to coma or death.	DDI-false
Coingestion of @DRUG$ with @DRUG$, phenobarbital with acetaminophen, and valproic acid with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-effect
In a comparison of @DRUG$ tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or @DRUG$ than with pentobarbital.	DDI-false
Possible drug interactions of @DRUG$ with succinylcholine or with other @DRUG$.	DDI-int
BACKGROUND: The effects of combined administration of bombesin and verapamil hydrochloride (verapamil), a @DRUG$, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane (@DRUG$) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, @DRUG$, cefamandole, @DRUG$) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
In vitro binding studies with human serum proteins indicate that glipizide binds differently than tolbutamide and does not interact with @DRUG$ or @DRUG$.	DDI-false
These drugs include the @DRUG$ and other @DRUG$ , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, @DRUG$, indinavir, saquinavir, erythromycin, etc.) is indicated, reduction of the @DRUG$ dose should be considered.	DDI-advise
In clinical studies performed with Fondaparinux , the concomitant use of oral @DRUG$ ( Warfarin), platelet inhibitors ( @DRUG$ ) , NSAIDs ( piroxicam ) , and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium .	DDI-false
@DRUG$-A drug interaction study of eplerenone with @DRUG$ has not been conducted.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics , amantadine , @DRUG$ , phenothiazines , @DRUG$ , tricyclic antidepressants or some antihistamines.	DDI-false
@DRUG$ - May reduce renal tubular secretion of ampicillin resulting in increased blood levels and/or @DRUG$ toxicity .	DDI-false
BACKGROUND : The effects of combined administration of @DRUG$ and verapamil hydrochloride ( verapamil ) , a @DRUG$ , on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane ( AOM ) and the labeling index of intestinal cancers were investigated in male Wistar rats .	DDI-false
In the second study, however, the administration of 12 g cholestyramine 1 hour before the evening meal and 0.3 mg cerivastatin sodium approximately 4 hours after the same evening meal resulted in a decrease in @DRUG$ AUC of less than 8 % , and a decrease in Cmax of about 30 % when compared to dosing @DRUG$ alone .	DDI-false
Lithium carbonate : The anorectic and stimulating effects of @DRUG$ may be inhibited by @DRUG$.	DDI-effect
Antihypertensives : @DRUG$ may antagonize the hypotensive effects of @DRUG$.	DDI-effect
No data from prospective clinical trials currently exist comparing the 3 approved agents (@DRUG$, nevirapine or @DRUG$).	DDI-false
In EM individuals treated with @DRUG$ or @DRUG$, the AUC of atomoxetine is approximately 6- to 8-fold and Css,max is about 3- to 4-fold greater than atomoxetine alone.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum @DRUG$, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of @DRUG$, resulting in serum and urine levels considerably lower than desired.	DDI-false
The concomitant intake of alcohol and @DRUG$ does not affect the pharmacokinetics of either @DRUG$ or acamprosate.	DDI-false
These drugs include thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, @DRUG$ , oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel block drugs, and @DRUG$.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Previous studies have demonstrated a significant reduction in the oral bioavailability of trovafloxacin and ciprofloxacin when administered concomitantly with an intravenous @DRUG$ such as @DRUG$.	DDI-false
Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: ergotamine, cyclosporine, @DRUG$, nicardipine, and @DRUG$.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a @DRUG$ inhibitor) or calcium channel antagonists (e.g., verapamil, a @DRUG$ substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
SINCE THE CONCOMPITANT MANAGEMENT OF THIS TWO THROUGH @DRUG$ INTOXICATION BEFORE THE DEVELOPMENT OF THE DISCULFIRAM OF A PATIENT ON PHENYTOIN THERAPY, A BASELINE @DRUG$ ....................................................................................................................................................................................................................................................................	DDI-false
Theophylline : As with some others @DRUG$ , concurrent administration of @DRUG$ with theophylline may lead to elevated serum concentrations of theophylline and prolongation of its elimination half-life .	DDI-false
Possible drug interactions between Keppra and other AEDs (carbamazepine, gabapentin, @DRUG$ , phenobarbital , phenytoin , @DRUG$ In placebo-controlled clinical trials, serum concentrations of levetiracetam and these AEDs have also been studied.	DDI-false
The similarity of the TYSABRI -associated adverse event profile between Study 1 ( without co-administered AVONEX ) and Study 2 ( with co-administered @DRUG$ ) points out that this change in clearance does not require a reduction in clearance. @DRUG$ Dose to maintain safety, general).	DDI-false
Other concomitant therapy Although specific interaction studies have not been performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , @DRUG$ , a-blockers , analgesics , angiotensin-converting enzyme ( ACE ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , H2 antagonists , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
@DRUG$ and procainamide doses should be reduced by one-third when either is administered with @DRUG$.	DDI-false
Consequently , drugs with a low therapeutic margin , such as @DRUG$ , @DRUG$ Theophylline, and theophylline, could lead to delayed elimination and increase in serum half-life leading to toxic levels.	DDI-false
@DRUG$-Cephalosporins containing side chains of N-methylthiotetrazole ( cefmenoxime , cefoperazone , cefotetan , cefamandole , latamoxef ) or methylthiadiazole ( @DRUG$ ) may cause vitamin K deficiency and hypoprothrombinaemia.	DDI-false
@DRUG$ : @DRUG$ The antihypertensive effect of antihypertensive agents may be antagonistic.	DDI-false
Two groups (SH/DA; SH/FA) were submitted to daily treatment with synthetic hydroalcoholic solutions containing @DRUG$, methanol, higher alcohols and @DRUG$ in the same proportions as those found in most common distilled and fermented alcoholic beverages;	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of @DRUG$, phenytoin, propranolol, @DRUG$, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
@DRUG$ : Plasma digoxin levels and digoxin clearance at steady-state were not affected by co-administration of 0.2 mg @DRUG$.	DDI-false
@DRUG$ : The concomitant administration of diflunisal and @DRUG$ in normal volunteers resulted in lowering of the plasma levels of the active sulindac sulfide metabolite by approximately one-third .	DDI-false
The concomitant use of other CYP3A4 inhibitors such as @DRUG$ and erythromycin with transdermal @DRUG$ may also result in an increase in fentanyl plasma concentrations , which could increase or prolong adverse drug effects and may cause serious respiratory depression .	DDI-mechanism
Other chemotherapy agents In a separate study, concomitant use of @DRUG$ with capecitabine did not meaningfully alter the pharmacokinetics of either agent ( or the metabolites of @DRUG$ ) .	DDI-false
In addition, additional interaction studies with: @DRUG$ and @DRUG$ have not demonstrated any effect on fluvastatin plasma levels , and administration to a patient population chronically receiving digoxin resulted in no difference in the extent of bioavailability of digoxin relative to control data .	DDI-false
Valproate @DRUG$ The pharmacokinetics of ( 1500 mg twice daily) @DRUG$ For healthy volunteers.	DDI-false
- Antidiabetics, oral (diabetes medicine you take by mouth) Use of oral antidiabetics with @DRUG$ may increase the chance of side effects affecting the blood and/or the side effects or oral @DRUG$	DDI-false
@DRUG$ : Caution should be used if diflunisal is administered concomitantly with @DRUG$.	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine , @DRUG$ , or pentobarbital , the dosage of ouabain needed to cause ventricular tachycardia was significantly higher , as was the LD50 of ouabain , with ketamine or @DRUG$ As with Pentobarbital.	DDI-false
SINCE THE CONCOMITANT ADMINISTRATION OF THESE TWO DRUGS CAN LEAD TO @DRUG$ INTOXICATION, PRIOR TO ADMINISTERING @DRUG$ TO A PATIENT ON PHENYTOIN THERAPY, A BASELINE PHENYTOIN SERUM LEVEL SHOULD BE OBTAINED.	DDI-false
This interaction should be given consideration in patients taking @DRUG$ concomitantly with @DRUG$.	DDI-advise
Imipramine ( 5 mg/kg), moclobemid ( 30 mg/kg), clonazepam ( 0.25 mg/kg), @DRUG$ [ 20 mg/kg] @DRUG$ 30 mg/ kg) or vehicle.	DDI-false
@DRUG$ has been administered with tolazoline, @DRUG$, dobutamine, steroids, surfactant, and high-frequency ventilation.	DDI-false
In a median follow-up of 33 months, the combination of ARIMIDEX and @DRUG$ did not demonstrate any efficacy benefit when compared with @DRUG$ In all patients as well as in the hormone receptor-positive subpopulation.	DDI-false
Interaction on the antinociceptive effect between neurotensin and @DRUG$ or @DRUG$.	DDI-false
@DRUG$: The effects of @DRUG$ and NSAIDs on GI bleeding are synergistic, such that users of both drugs together have a risk of serious GI bleeding higher than that of users of either drug alone.	DDI-false
Use with @DRUG$ The most important way to detoxify @DRUG$ Is inhibited by allopurinol.	DDI-false
Preliminary animal and human studies have shown that small quantities of systemically administered @DRUG$ enter the CSF primarily as 5-methyltetrahydro-folate and, in humans, remain 1 to 3 orders of magnitude lower than the usual @DRUG$ concentrations following intrathecal administration.	DDI-false
Antiarrhythmia: amiodarone, @DRUG$ , @DRUG$ , propafenone, quinidine CONTRAINDICATES due to the potential for serious and/or life-threatening reactions.	DDI-false
@DRUG$ It has been shown that it is an antagonistic @DRUG$ , including ceftazidime, based on in vitro studies and time kill curves with enteric gram-negative bacilli.	DDI-effect
@DRUG$ Including coumarin derivatives, indandion derivatives and platelet aggregation inhibitors such as non-steroidal anti-inflammatory drugs (NSAIDs) and @DRUG$ The risk of bleeding may be increased when co-administered with ardeparin.	DDI-false
@DRUG$ showed the most potent inhibition ( 66 % inhibition at 10 microM ) , which was far more potent than that of crude @DRUG$.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac @DRUG$, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
As with other antipsychotic agents , it should be noted that @DRUG$ ==References====External links== @DRUG$ , opiates , and alcohol .	DDI-effect
Response to @DRUG$ It can be extended by @DRUG$.	DDI-effect
Clinical studies with @DRUG$ have identified potentially significant interactions with fluconazole and @DRUG$.	DDI-int
@DRUG$ and @DRUG$ may reduce or reverse the pressor effect of epinephrine.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like @DRUG$ (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - @DRUG$: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies ( phenytoin , valproate , oral @DRUG$ , digoxin , @DRUG$ , probenecid) and by pharmacokinetic screening in placebo-controlled clinical trials in epilepsy patients.	DDI-false
Sinus bradycardia has been reported with oral amiodarone in combination with @DRUG$ (CYP3A4 substrate) given for local @DRUG$.	DDI-false
Concurrent administration of drugs possessing nephrotoxic ( e.g. , aminoglycosides , indomethacin ) , myelotoxic ( e.g. , cytotoxic chemotherapy ) , cardiotoxic ( e.g. , @DRUG$ ) or hepatotoxic ( e.g. , methotrexate , @DRUG$ Effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Interaction with @DRUG$ , @DRUG$ Theophylline has also been reported to cause adverse clinical effects.	DDI-false
Cholestyramine and @DRUG$ @DRUG$: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
This drug may interact with @DRUG$ or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and @DRUG$ (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including @DRUG$ and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , @DRUG$ , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .	DDI-false
Therefore , interactions could occur following concomitant administration of @DRUG$ ( e.g. , narcotics , analgesics , antiemetics , sedatives , @DRUG$ ) .	DDI-false
@DRUG$ , @DRUG$ , or narcotics: potentiation of orthostatic hypotension may occur.	DDI-false
Cholestyramine and @DRUG$ resins : Absorption of @DRUG$ In the presence of anionic exchange resins the effect is impaired.	DDI-false
The similarity of the @DRUG$ -associated adverse event profile between Study 1 (without co-administered @DRUG$ ) and Study 2 (with co-administered AVONEX ) indicates that this alteration in clearance does not necessitate reduction of the TYSABRI  dose to maintain safety, General).	DDI-false
In a comparison of @DRUG$ tolerance in dogs anesthetized with ketamine, Innovar Vet, or @DRUG$, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with pentobarbital.	DDI-false
The following precautions should be kept in mind in the treatment of anticholinesterase poisoning although they do not bear directly on the use of @DRUG$ and @DRUG$.	DDI-advise
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, @DRUG$, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of @DRUG$, fibric acid derivatives, niacin (nicotinic acid), @DRUG$, azole antifungals.	DDI-false
Other interactions: no pharmacokinetic interactions between: @DRUG$ And the following medications: glyburide, warfarin, digoxin, @DRUG$ , and ranitidine .	DDI-false
International Normalized Ratio (INR) elevations and/or bleeding events have been reported in some patients taking @DRUG$ while on @DRUG$ therapy.	DDI-effect
Because Nalfon has not been shown to produce any additional effect beyond that obtained with aspirin alone and because aspirin increases the rate of excretion of Nalfon, the concomitant use of @DRUG$ and @DRUG$ is not recommended.	DDI-advise
The possibility of hypotensive effects with @DRUG$ or @DRUG$ can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with enalapril or enalaprilat.	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with @DRUG$, betablockers, calcium-channel blockers, diuretics, and @DRUG$ (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
Cimetidine ( 400 mg b.i.d . ) had no effect on vardenafil bioavailability ( AUC ) and maximum concentration ( Cmax ) of @DRUG$ when co-administered with 20 mg @DRUG$ For healthy volunteers.	DDI-false
FLEXERIL may enhance the effects of alcohol , @DRUG$ And others @DRUG$.	DDI-false
Other CONCOMITANT THERAPY: Although specific interaction studies have not been performed, in clinical studies cerivastatin sodium was used together with angiotensin converting enzyme ( ACE) inhibitors, beta-blockers, @DRUG$ , diuretics and nonsteroidal anti-inflammatory drugs ( @DRUG$ ) without evidence of clinically significant adverse interactions.	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with @DRUG$ (@DRUG$, barbiturates, opiates, sedatives, anesthetics) should be considered.	DDI-false
While @DRUG$ and @DRUG$ have similar affinities for kappa opioid and possibly nicotinic receptors , 18-MC has much lower affinities than ibogaine for NMDA and sigma-2 receptors , sodium channels , and the 5-HT transporter .	DDI-false
Other cardiovascular agents : enalapril and @DRUG$ IV have been used concomitantly with beta adrenergic-blocking agents , methyldopa , nitrates , calcium-blocking agents , @DRUG$ , prazosin and digoxin without evidence of clinically significant adverse interactions .	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when @DRUG$ is administered concomitantly with other antimuscarinics, amantadine, @DRUG$, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.	DDI-effect
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as @DRUG$), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$: Concomitant treatment with Accutane and tetracyclines should be avoided because Accutane use has been associated with a number of cases of pseudotumor cerebri (benign intracranial hypertension), some of which involved concomitant use of @DRUG$	DDI-false
Coingestion of acetaminophen with @DRUG$, @DRUG$ with acetaminophen, and valproic acid with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-false
Possible interactions between Keppra and other medicinal products @DRUG$ The evaluation of levetiracetam serum concentrations (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) was also performed. @DRUG$ • during placebo-controlled clinical trials.	DDI-false
@DRUG$ may interact with any of the following: - @DRUG$ (e.g., Tylenol) (with long-term, high-dose use) or	DDI-int
Tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain @DRUG$ , @DRUG$ , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .	DDI-false
Antiarrhythmics: Amiodarone, bepridil, flecainide, @DRUG$, @DRUG$ CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with @DRUG$), and @DRUG$ (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like @DRUG$ (MAOI): MAOI could theoretically affect @DRUG$ pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, @DRUG$, sulfonamides, chloramphenicol, @DRUG$, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
The potentiation is done with @DRUG-DRUG$.	DDI-false
@DRUG$: In a clinical pharmacology study, coadministration of an @DRUG$ (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
Potential drug interactions between Keppra  and other @DRUG$ (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and @DRUG$) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
@DRUG$ increases enterohepatic elimination of amiodarone and may reduce its serum levels and @DRUG$/2.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, @DRUG$, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, @DRUG$, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, @DRUG$, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
@DRUG$/Hypnotics: @DRUG$, midazolam CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as prolonged or increased sedation or respiratory depression.	DDI-false
Effects of @DRUG$ on Drug Metabolizing Enzymes and Drug Transport Systems @DRUG$ inhibits CYP3A4 and CYP2C8 in vitro at clinically relevant concentrations .	DDI-false
@DRUG$-@DRUG$ In large doses, vitamin K-epoxide reductase can inhibit, leading to vitamin K deficiency.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, @DRUG$), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., @DRUG$) or hepatotoxic (e.g., methotrexate, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Effect of AEDs in Pediatric Patients There was about a 22 % increase of apparent total body clearance of @DRUG$ when it was co-administered with enzyme-inducing @DRUG$.	DDI-mechanism
Moreover, additional interaction studies with niacin and propranolol have not demonstrated any effect on @DRUG$ plasma levels, and administration to a patient population chronically receiving @DRUG$ resulted in no difference in the extent of bioavailability of digoxin relative to control data.	DDI-false
@DRUG$/theophylline , @DRUG$/quinidine , phenobarbital/acetaminophen , phenobarbital/valproic acid , quinidine/lidocaine , theophylline/acetaminophen , and valproic acid/phenobarbital .	DDI-false
@DRUG$ In vitro, the antiviral activity of stavudine and zidovudine ribavirin may be antagonistic. @DRUG$ against HIV .	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with @DRUG$, methyldopa, nitrates, calcium-blocking agents, hydralazine, prazosin and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Antacids : In a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that @DRUG$ may impair absorption of @DRUG$.	DDI-mechanism
Although glucocorticoids have been shown to reduce @DRUG$-induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided . 12 Beta-blockers and other @DRUG$ Hypotension observed with PROLEUKIN may be increased.	DDI-false
Both @DRUG$ and 18-MC decrease extracellular levels of dopamine in the nucleus accumbens , but only @DRUG$ increases extracellular levels of serotonin in the nucleus accumbens .	DDI-false
Antidepressants, tricyclic @DRUG$ may enhance the activity of @DRUG$ or sympathomimetic agents;	DDI-effect
Although no specific studies have been performed, co-administration with medicinal products primarily metabolised by CYP3A4 (e. g. @DRUG$ , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , @DRUG$ , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
Although @DRUG$ have been shown to reduce @DRUG$-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-effect
Drug interactions : Flupentixol may interact with some medicines such as monoamine oxidase inhibitors (MAOI): MAOI may theoretically affect flupentixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: @DRUG$ - Tricyclic antidepressants : flupenthixol increases the effect of @DRUG$	DDI-false
Potential pharmacokinetic interactions have been studied in clinical pharmacokinetic studies ( @DRUG$ , valproate, oral contraceptives, digoxin, @DRUG$ , probenecid) and by pharmacokinetic screening in placebo-controlled clinical trials in epilepsy patients.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, @DRUG$, propranolol, nifedipine, @DRUG$, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
@DRUG$ , methylxanthine and diuretics: Concomitant treatment with xanthine derivatives, steroids or diuretics may potentiate a possible hypocalemic effect @DRUG$	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain @DRUG$, @DRUG$, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Aspirin: When @DRUG$ is administered with @DRUG$, its protein binding is reduced, although the clearance of free etodolac is not altered.	DDI-mechanism
Effect of @DRUG$ on the pharmacokinetics of @DRUG$.	DDI-false
The blood pressure effect of @DRUG$ tended to be greater in patients on @DRUG$ than in patients on no other antihypertensive therapy.	DDI-effect
This drug may interact with alcohol or other CNS depressants ( may potentiate the CNS depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with @DRUG$ Concomitant use with antihistamines may have the anticholinergic and CNS depressive effects of @DRUG$ ) .	DDI-false
The pharmacokinetics of @DRUG$ The main metabolite 6-beta-naltrexol and its main metabolite were not affected after co-administration with @DRUG$.	DDI-false
Because Nalfon has not been shown to produce any additional effect beyond that obtained with @DRUG$ alone and because aspirin increases the rate of excretion of Nalfon, the concomitant use of @DRUG$ and salicylates is not recommended.	DDI-false
In a 12-week endoscopy study in OA patients, there was no difference in the cumulative incidence of endoscopic gastrointestinal ulcers in patients with low-dose ( 81 mg) enteric-coated aspirin plus @DRUG$ 25 mg daily, compared to those who @DRUG$ 2400 mg daily alone .	DDI-false
@DRUG$ In a clinical pharmacology study, concomitant administration of antazide (aluminium hydroxide, magnesium hydroxide and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat compared to fosinopril alone, suggesting that antacids may affect the absorption of @DRUG$.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
@DRUG$ : Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with @DRUG$ The signs and symptoms of carbamazepine toxicity should be closely monitored and the anticonvulsant dose adjusted accordingly.	DDI-false
High-dose cyclosporin A resulting in concentrations above 2000 ng/mL administered with oral @DRUG$ has led to an 80% increase in etoposide exposure with a 38% decrease in total body clearance of etoposide compared to @DRUG$ alone.	DDI-false
Standard monitoring of methotrexate-related toxicity should be continued if @DRUG$ and @DRUG$ are administered concomitantly.	DDI-advise
The effects of @DRUG$ are antagonized by methylxanthines such as caffeine and @DRUG$.	DDI-effect
Warfarin: Quinolones have been reported to enhance the effects of the oral @DRUG$ @DRUG$ or its derivatives.	DDI-false
Co-administration of BOTOX and @DRUG$ or other agents interfering with neuromuscular transmission (e.g., @DRUG$) should only be performed with caution as the effect of the toxin may be potentiated.	DDI-false
Vitamin K (e.g. @DRUG$ , @DRUG$ ) Use of sulfapyridine with these medicines may increase the chance of side effects affecting the blood	DDI-false
Pre-treatment of healthy volunteers with multiple doses @DRUG$ followed by a single dose of @DRUG$ Gleevec increased oral dose clearance by 3.8-fold, significantly reducing mean cmax and AUC (0-8) (p 0.05).	DDI-mechanism
A possible interaction between glyburide and ciprofloxacin, a @DRUG$, has been reported, resulting in a potentiation of the hypoglycemic action of @DRUG$.	DDI-false
@DRUG$ (600 mg b.i.d.) co-administered with @DRUG$ 5 mg resulted in a 49-fold increase in vardenafil AUC and a 13-fold increase in vardenafil Cmax.	DDI-mechanism
In addition, the mechanisms that can be similar to the development of dependency may be similar for @DRUG$ and @DRUG$.	DDI-false
Tinnitus and decreased hearing have been reported in patients with concomitant @DRUG$ and @DRUG$.	DDI-effect
Both ibogaine and @DRUG$ decrease extracellular levels of dopamine in the nucleus accumbens, but only @DRUG$ increases extracellular levels of serotonin in the nucleus accumbens.	DDI-false
Therefore, interactions could occur following concomitant administration of @DRUG$ (e.g., @DRUG$, analgesics, antiemetics, sedatives, tranquilizers).	DDI-false
@DRUG$ and Tricyclic Antidepressants: FORADIL should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants because the action of @DRUG$ on the cardiovascular system may be potentiated by these agents.	DDI-false
Injection: @DRUG$ injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, @DRUG$, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-effect
Lithium : Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving concomitant @DRUG$ and @DRUG$ therapy .	DDI-effect
Example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , @DRUG$ - propofol, protease inhibitors, @DRUG$ ==References====External links==	DDI-false
- skeletal muscle relaxants, not depolarising (e.g., @DRUG$ ): possible increased responsiveness to the @DRUG$.	DDI-false
@DRUG$, such as verapamil, @DRUG$ and nifedipine, inhibit platelet activation in vitro, and decrease platelet adhesion intravascularly.	DDI-false
There are no data for the concomitant use of INVIRASE/@DRUG$ or FORTOVASE/@DRUG$ and garlic capsules.	DDI-false
@DRUG$ Magnesium-aluminium hydroxide: @DRUG$ plasma concentrations were not affected by co-administration of antacid .	DDI-false
@DRUG$ , but not @DRUG$ , lowers the heart rate at high doses.	DDI-false
Acetaminophen/@DRUG$, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen and valproic acid/phenobarbital.	DDI-false
Acetaminophen: A report of severe @DRUG$ toxicity was reported in a patient receiving @DRUG$.	DDI-effect
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, @DRUG$, beta blockers, calcium-channel blockers, cardiac @DRUG$, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, @DRUG$, chlordiazepoxide, diazepam, certain @DRUG$, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Corticosteroids, Methylxanthines and Diuretics: Concomitant treatment with @DRUG$, steroids, or diuretics may potentiate a possible hypokalemic effect of  @DRUG$	DDI-effect
Specific studies have confirmed these effects with @DRUG$, isoflurane, propofol, @DRUG$, and midazolam.	DDI-false
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies (phenytoin, @DRUG$, oral contraceptive, digoxin, warfarin, @DRUG$) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients.	DDI-false
- Vitamin K (e.g., @DRUG$, Synkayvite) Use of @DRUG$ with these medicines may increase the chance of side effects affecting the blood	DDI-false
@DRUG$ may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like Aleve or @DRUG$, and high blood pressure medications.	DDI-int
However, caution should be used when administering @DRUG$ with @DRUG$ since these patients are at increased risk of bleeding complications.	DDI-advise
Both efavirenz and nevirapine have been compared to triple therapy with the @DRUG$ @DRUG$ over 48 weeks as initial therapy, with similar responses being observed with nevirapine regimens and superiority observed with efavirenz.	DDI-false
@DRUG$: Coadministration of @DRUG$ 3 mg and olanzapine 10 mg produced a decrease in DSST scores.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac @DRUG$, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, @DRUG$ (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
The intensity , uniformity and time course of anticoagulant interference by @DRUG$ , secobarbital , @DRUG$ In 16 patients receiving coumarin therapy, chloral hydrate and methaqualone were systematically studied.	DDI-false
Central nervous system depressants : Concomitant use of DURAGESIC (Fentanyl transdermal system ) with other central nervous system depressants, including but not limited to others @DRUG$ , @DRUG$ Hypnosis, sedatives (e.g., benzodiazepines), general anaesthetics, phenothiazines, skeletal muscle relaxants and alcohol, can cause respiratory depression, hypotension and deep sedation, or possibly lead to coma or death.	DDI-false
Anticoagulants including coumarin derivatives , indandione derivatives , and @DRUG$ such as @DRUG$ NSAIDs and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
Multivalent Cation-Containing Products : Concurrent administration of a quinolone , including @DRUG$ , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , VIDEX chewable/buffered tablets or pediatric powder , or products containing @DRUG$ Iron or zinc can significantly reduce the absorption of ciprofloxacin, resulting in significantly lower serum and urine levels than desired.	DDI-mechanism
Delayed Adverse Reactions to Iodinated Contrast Media: A review of the literature revealed that 12.6% (range 11-28%) of 501 patients treated with various @DRUG$ containing regimens who were subsequently administered @DRUG$ experienced acute, atypical adverse reactions.	DDI-effect
Antimycobacterial Agents: rifampin CONTRAINDICATED since the coadministration of this product with @DRUG$ in an antiretroviral regimen reduces the plasma concentrations of @DRUG$.	DDI-false
Drug Interaction During Pregnancy : @DRUG$ and @DRUG$ were studied following subcutaneous injections in pregnant mice .	DDI-false
@DRUG$: The anorectic and stimulatory effects of amphetamines may be inhibited by @DRUG$.	DDI-false
Vitamin A: Because of the relationship of Accutane to @DRUG$, patients should be advised against taking vitamin supplements containing @DRUG$ to avoid additive toxic effects	DDI-false
Other concomitant therapy Although specific interaction studies have not been performed, 1 mg or more of finasteride doses have been co-administered in clinical trials with acetaminophen, acetylsalicylic acid, A-blockers, analgesics, angiotensin converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta-blockers, calcium channel blockers, heart @DRUG$ , @DRUG$ H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also known as NSAIDs) and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
No data are available for the coadministration of INVIRASE/ritonavir or @DRUG$/@DRUG$ and garlic capsules .	DDI-false
If treatment with inhibitors of CYP3A4 activity ( such as @DRUG$ , @DRUG$ , ritonavir, indinavir, saquinavir, erythromycin, etc.) is indicated and Budesonide dose reduction should be considered.	DDI-false
There have been case reports of increased steady-state levels of @DRUG$, procainamide, and @DRUG$ during concomitant therapy with amiodarone.	DDI-false
In comparison of digitalis tolerance in dogs anaesthetized with ketamine, Innovar Vet or pentobarbital, the dose of Ouabain required to cause ventricular tachycardia was significantly higher than the LD50 of @DRUG$ , with ketamine or @DRUG$ than with pentobarbital .	DDI-false
Cyclosporine , Digoxin , Methotrexate Lodine , like other NSAIDs , through effects on renal prostaglandins , may cause changes in the elimination of these drugs leading to elevated serum levels of @DRUG$ , @DRUG$ , methotrexate , and increased toxicity .	DDI-false
Examples of inhibitors are azole antimycotics, ciprofloxacin, clarithromycin, diclofenac, @DRUG$ , erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, @DRUG$ ==References====External links==	DDI-false
iodine or iodine surplus may have the effect of @DRUG$ , and an @DRUG$ Deficiency can increase the effect of carbimazole.	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , @DRUG$ , warfarin, tacrolimus, cyclosporin, @DRUG$ , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
When administered orally @DRUG$ , the need for @DRUG$ therapy should be reviewed and the dose reduced by approximately 50 % or discontinued .	DDI-advise
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Therefore, interactions following concomitant administration of psychotropic medicinal products (e.g. narcotics, @DRUG$ , @DRUG$ , sedatives , tranquilizers ) .	DDI-false
@DRUG$, an anionic-binding resin, has a considerable effect in lowering the rate and extent of @DRUG$ bioavailability.	DDI-mechanism
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, @DRUG$, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and @DRUG$.	DDI-false
Acetaminophen, lidocaine, phenobarbital, quinidine, @DRUG$, and @DRUG$ were added to pooled human serum at therapeutic concentrations.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - @DRUG$ - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of @DRUG$	DDI-false
To determine whether injection of thiosulfate would permit larger doses of cisplatin to be administered, a fixed 9.9-g/m2 dose of @DRUG$ was given intravenously over three hours concurrently with escalating doses of @DRUG$.	DDI-false
Pre-treatment of healthy volunteers with multiple doses @DRUG$ followed by a single dose of Gleevec , increased @DRUG$ Oral dose clearance was reduced by 3.8-fold, significantly reducing the mean cmax and AUC(0-8) (p 0.05).	DDI-false
Glyburide : The concomitant administration of @DRUG$ with the sulfonylurea @DRUG$ Rare cases have led to severe hypoglycaemia.	DDI-effect
HIV protease inhibitors : @DRUG$ ( 800 mg t.i.d . ) co-administered with @DRUG$ 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in vardenafil Cmax and a 2-fold increase in vardenafil half-life.	DDI-mechanism
OTHER CONCOMITANT THERAPY : Although specific interaction studies were not performed , in clinical studies , cerivastatin sodium was used concomitantly with @DRUG$ , beta blockers, calcium channel blockers, @DRUG$ , and nonsteroidal anti-inflammatory drugs ( NSAIDs ) without evidence of clinically significant adverse interactions .	DDI-false
METHOD : This study was a multicentre randomised double-blind study in 101 patients randomly receiving 1:1:1 to receive everolimus tablets at doses of 0.5 mg, 1 mg or 2 mg twice daily. @DRUG$ and @DRUG$.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$-@DRUG$ The intestine can sterilize and reduce the vitamin K contribution to the body through the intestinal microflora.	DDI-false
@DRUG$ (5 mg/kg), moclobemide (30 mg/kg), clonazepam (0.25 mg/kg), fluoxetine (20 mg/kg) @DRUG$ (30 mg/kg) or vehicle was administered.	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (alcohol, barbiturates, @DRUG$, sedatives, @DRUG$) should be considered.	DDI-false
Based on the chemical resemblance of itraconazole and @DRUG$, coadministration of astemizole with @DRUG$ is contraindicated.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general @DRUG$, @DRUG$, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
- @DRUG$ (e.g., @DRUG$) or	DDI-false
iodine or iodine excess may affect the effect of carbimazole and a @DRUG$ Deficiency can increase the effect of @DRUG$.	DDI-effect
Because @DRUG$ has not been shown to produce any additional effect beyond that obtained with aspirin alone and because aspirin increases the rate of excretion of Nalfon, the concomitant use of Nalfon and @DRUG$ is not recommended.	DDI-false
@DRUG$ (e.g., spironolactone, @DRUG$, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with @DRUG$, @DRUG$, felodipine, digoxin, warfarin, isosorbide mononitrate, carvedilol, ethanol or itraconazole.	DDI-false
Central Nervous System Depressants : The concomitant use of DURAGESIC   ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other @DRUG$ , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , @DRUG$ , skeletal muscle relaxants, and alcohol, may result in respiratory depression, hypotension, and deep sedation, or possibly in coma or death.	DDI-false
Take special care with ROMAZICON in overdose with mixed medicinal products as the toxic effects (such as cramps and heart rhythm disorders) of other medicinal products taken with overdose (especially: @DRUG$ The inverse effect of benzodiazepine by @DRUG$ may occur.	DDI-false
The zidovudine study was conducted at 1200 mg/ day. @DRUG$ ( n = 7 ) ( later changed to 600 mg/day [ n = 5 ] ) for Days 8 to 21 of a 21-day course of 100 mg , five times/day of @DRUG$.	DDI-false
In addition , Fondaparinux neither influenced the pharmacodynamics of @DRUG$ - acetylsalicylic acid, piroxicam and @DRUG$ The pharmacokinetics of digoxin in steady state.	DDI-false
Warfarin: The effect of @DRUG$ on the anti-coagulant effect of @DRUG$ was studied in a group of healthy subjects receiving daily doses of 2-5 mg of warfarin.	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine , although theoretically , coadministration of other drugs known to alter cardiac conduction ( eg , anti-arrhythmic or @DRUG$ - Calcium channel blockers, antihistamines or @DRUG$ Also tricyclic antidepressants and phenothiazines could contribute to an extension of the QTc interval.	DDI-false
This appears to be the only clinically relevant interaction of this kind with @DRUG$, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, calcium channel blockers, @DRUG$ or H1-blocking agents, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-effect
There are 3 types of indications : specific (for the treatment of some forms of @DRUG$ deficit i.e. acute ) , pharmacological ( i.e. without alterations of @DRUG$ status ) and mixed -- pharmacological and aetiopathogenic--(for example complications of chronic alcoholism ) .	DDI-false
Because of the increased risk of adverse reactions in patients who: @DRUG$ At regular intervals, it is particularly important that doctors carefully monitor patients or their guardians over benzodiazepine, alcohol and @DRUG$ Use ROMAZICON as part of the story before any method in which the use of ROMAZICON is planned.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an @DRUG$ (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that @DRUG$ may impair absorption of fosinopril.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, @DRUG$, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, @DRUG$ and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
@DRUG$ has been shown to have neuromuscular blocking properties that may enhance the action of other @DRUG$.	DDI-effect
These data suggest that levetiracetam does not affect the plasma concentration of other AEDs and that the plasma concentrations of levetiracetam are similar to those of other AEDs. @DRUG$ do not influence the pharmacokinetics of @DRUG$.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, @DRUG$, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
There was not a significant difference ( p > 0.05 ) in AUC ( 48.59 + /- 8.52 vs. 49.9 + /- 9.93 ) , Cmax ( 7.73 + /- 2.6 vs. 6.6 + /- 2.0 ) , and tmax ( 1.1 + /- 0.6 vs. 1.6 + /- 1.1 ) for levofloxacin versus @DRUG$/@DRUG$ regimens .	DDI-false
Lithium: @DRUG$ toxicity has been reported in patients receiving @DRUG$ concomitantly with drugs which cause elimination of sodium, including ACE inhibitors.	DDI-false
These results suggest that both @DRUG$ and @DRUG$, and possibly other glucocorticoids and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF.	DDI-false
This drug may interact with @DRUG$ Anticholinergic drugs or other anticholinergic drugs (anticholinergic effects can be intensified if these drugs are combined with @DRUG$ ) , and monoamine oxidase ( MAO ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines ) .	DDI-false
Because Nalfon has not been shown to produce any additional effect beyond that obtained with aspirin alone and because @DRUG$ increases the rate of excretion of Nalfon , the concomitant use of Nalfon and @DRUG$ It's not recommended.	DDI-false
Particular caution is necessary when using @DRUG$ in cases of mixed drug overdosage since the toxic effects (such as convulsions and cardiac dysrhythmias) of other drugs taken in overdose (especially @DRUG$) may emerge with the reversal of the benzodiazepine effect by flumazenil.	DDI-effect
Benzthiazide may interact with alcohol, blood thinners, @DRUG$ (allergy, cold, and sinus medicines), diabetic drugs, @DRUG$, norepinephrine, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Other reported interactions with amiodarone: @DRUG$ (CYP3A4 substrate) in combination with @DRUG$ may cause hypotension, bradycardia, and decreased cardiac output.	DDI-false
The similarity of the TYSABRI -associated adverse event profile between Study 1 (without co-administered AVONEX ) and Study 2 (with co-administered @DRUG$ ) indicates that this alteration in clearance does not necessitate reduction of the @DRUG$  dose to maintain safety, General).	DDI-false
These results suggest that both dexamethasone and retinyl acetate, and possibly other glucocorticoids and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of @DRUG$ and @DRUG$.	DDI-false
@DRUG$ Congestive Heart Failure Post-myocardial infarction In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists ( @DRUG$/ARB).	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, @DRUG$, barbiturates, @DRUG$, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, doxorubicin, @DRUG$, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Hypotension : patients receiving diuretic therapy : patients below @DRUG$ and especially those in whom diuretic therapy was recently instituted , may occasionally experience an excessive reduction of blood pressure after initiation of therapy with @DRUG$ or enalaprilat .	DDI-effect
Suppression by @DRUG$ of bombesin-enhanced peritoneal metastasis of intestinal adenocarcinomas induced by @DRUG$ in wistar rats.	DDI-false
@DRUG$: Plasma @DRUG$ levels and digoxin clearance at steady-state were not affected by co-administration of 0.2 mg cerivastatin sodium.	DDI-false
@DRUG$ Angiotensin II receptor antagonists (hypertension)- In clinical trials in patients with hypertension, the addition of INSPRA 50 to 100 mg @DRUG$ Angiotensin II receptor antagonists slightly increased the mean serum potassium (approximately 0.09 - 0.13 mEq/L).	DDI-false
It was concluded that oral @DRUG$ and @DRUG$ can be administered concomitantly without a significant decrease in AUC, Cmax, or tmax.	DDI-false
Central Nervous System Depressants : The concomitant use of DURAGESIC   ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other @DRUG$ , sedatives , hypnotics , tranquilizers ( e.g. , @DRUG$ ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	DDI-false
apomorphine - prior ingestion of @DRUG$ may decrease the @DRUG$ response to apomorphine in the treatment of poisoning.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum @DRUG$, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, @DRUG$, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Limited comparative data in patients with high viral loads treated with @DRUG$- or @DRUG$-based regimens currently exist .	DDI-false
Interaction on the anticoagulant effect between @DRUG$ And enkephaline or @DRUG$.	DDI-effect
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, @DRUG$, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as @DRUG$), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Antacids : In a clinical pharmacology study, concomitant administration of antacids (aluminium hydroxide, magnesium hydroxide and simethicone) with @DRUG$ This suggests that antacids may affect the absorption of @DRUG$.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including @DRUG$, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing @DRUG$, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
@DRUG$ decreased the hyperuricemic effect of @DRUG$.	DDI-effect
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ACE ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac @DRUG$ , diuretics , H2 antagonists , HMG-CoA reductase inhibitors , @DRUG$ ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac @DRUG$, diuretics, H2 antagonists, @DRUG$, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
acetaminophen/theophylline, @DRUG$/quinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Potential drug interactions between @DRUG$  and other AEDs (carbamazepine, gabapentin, @DRUG$, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Other Drug Interactions Oral @DRUG$ @DRUG$  (500 mg twice daily) did not influence the pharmacokinetics of an oral contraceptive containing 0.03 mg ethinyl estradiol and 0.15 mg levonorgestrel, or of the luteinizing hormone and progesterone levels, indicating that impairment of contraceptive efficacy is unlikely.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Central Nervous System Depressants : The concomitant use of DURAGESIC   ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other @DRUG$ , sedatives, hypnotics, sedatives (e.g. benzodiazepines), general anesthetics, phenothiazines, @DRUG$ , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Cephalosporine-@DRUG$ containing side chains of N-methylthiotetrazole (Cefmenoxime), @DRUG$ , cefotetan , cefamandole , latamoxef ) or methylthiadiazole ( cefazolin ) can cause vitamin K deficiency and hypoprothrombinemia .	DDI-false
Tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , @DRUG$ , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and @DRUG$ This delays elimination and increases blood levels of these drugs.	DDI-false
@DRUG$ , barbiturates , or @DRUG$ : potentiation of orthostatic hypotension may occur .	DDI-false
This drug may interact with alcohol or other @DRUG$ (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and @DRUG$ (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
Concurrent administration of HEXALEN and @DRUG$ may cause severe orthostatic hypotension.@DRUG$, an inhibitor of microsomal drug metabolism, increased altretamines half-life and toxicity in a rat model.	DDI-false
Aspirin: When Lodine is administered with @DRUG$, its protein binding is reduced, although the clearance of free @DRUG$ is not altered.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Benzthiazide may interact with alcohol , blood thinners , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , @DRUG$ like @DRUG$ or Ibuprofen , and high blood pressure medications .	DDI-false
Example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , @DRUG$ , nicardipine , propofol , protease inhibitors , @DRUG$ , and verapamil .	DDI-false
While all the selective serotonin reuptake inhibitors (SSRIs), e.g., citalopram, @DRUG$, @DRUG$, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other @DRUG$, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and @DRUG$, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus @DRUG$) without receiving antiretroviral therapy.	DDI-false
Reciprocal interactions may occur with concomitant use of Antizol and drugs that increase or inhibit the cytochrome P450 system (e.g., @DRUG$, carbamazepine, @DRUG$, ketoconazole), though this has not been studied	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with @DRUG$ concomitantly with anxiolytics, hypnotics and sedatives (including benzodiazepines), or @DRUG$ was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, @DRUG$, @DRUG$, and isoniazid.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, @DRUG$, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as @DRUG$), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
As with other antipsychotics, it should be noted that: @DRUG$ CNS depressants such as anaesthetics may potentiate, @DRUG$ And alcohol.	DDI-effect
@DRUG$ may decrease arterial responsiveness to @DRUG$.	DDI-effect
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and @DRUG$) with fosinopril reduced serum levels and urinary excretion of @DRUG$ as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
In order to evaluate the effects of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL ), the authors retrospectively compared a group of 24 patients with HIV-NHL who had been treated with the @DRUG$ , doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, tenipide and prednisone). @DRUG$ Bleomycin) without antiretroviral therapy.	DDI-false
Drug Interactions : Flupenthixol may interact with some drugs , like @DRUG$ ( MAOI ): MAOI could theoretically affect flupenthixol pharmacodynamics - @DRUG$ Eproxindine - ethanol : flupenthixol and ethanol cause additive CNS depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants	DDI-false
Antiarrhythmics : @DRUG$ , bepridil , flecainide , propafenone , @DRUG$ CONTRAINDICATE because of the potential for serious and/or life-threatening reactions.	DDI-false
Anticoagulants: potentiation of the warfarin type ( CYP2C9 and @DRUG$ Anticoagulant response is almost always observed in patients who: @DRUG$ and can result in serious or fatal bleeding .	DDI-false
Bacteriostatic Antibiotics : @DRUG$ Erythromycins, sulphonamides, or @DRUG$ may interfere with the bactericidal effect of penicillins .	DDI-false
Coadministration of Itraconazole and @DRUG$, tacrolimus or @DRUG$ has led to increased plasma concentrations of the latter three drugs.	DDI-false
The addition of 540 mg/kg/day of @DRUG$ (approximately 340 times the maximum recommended daily inhalation dose in adults on a mg/m2 basis) to 2.7 mg/kg/day of @DRUG$ (approximately 7 times the maximum recommended daily inhalation dose in adults on a mg/m2 basis) appears to have increased the incidence of both resorptions and malformations.	DDI-effect
@DRUG$ may enhance the effects of @DRUG$ , barbiturates , and other CNS depressants .	DDI-effect
Acetaminophen: In normal volunteers, concomitant administration of @DRUG$ and @DRUG$ resulted in an approximate 50% increase in plasma levels of acetaminophen.	DDI-mechanism
@DRUG$ had no significant impact on the Cmax and AUC of @DRUG$ , although it significantly decreased the zidovudine tmax by 44 % and increased the intracellular exposure to phosphorylated zidovudine by 110 % .	DDI-false
In addition, fondaparinux did not affect the pharmacodynamics of warfarin, @DRUG$ , @DRUG$ The pharmacokinetics of digoxin in steady state.	DDI-false
Stavudine and @DRUG$ Ribavirin may antagonistise the antiviral activity of stavudine in vitro and @DRUG$ against HIV .	DDI-false
In a 12-week endoscopy study conducted in OA patients there was no difference in the cumulative incidence of endoscopic gastroduodenal ulcers in patients taking low-dose (81 mg) enteric coated @DRUG$ plus @DRUG$ 25 mg daily, as compared to those taking ibuprofen 2400 mg daily alone.	DDI-false
Medicines that inhibit or induce cytochrome P450 3A4 enzymes @DRUG$ undergoes extensive metabolism by CYP3A4 , and concomitant administration of strong inhibitors or inducers of CYP3A4 alter @DRUG$ concentrations significantly .	DDI-false
METHOD: This study was a multicenter randomized double-blind study of 101 patients who were randomly assigned 1:1:1 to receive everolimus tablets at doses of 0.5 mg, 1 mg, or 2 mg twice daily with @DRUG$ and @DRUG$.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a @DRUG$, including @DRUG$, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, @DRUG$, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, @DRUG$, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ generally should not be given with diuretics because they reduce @DRUG$s renal clearance and add a high risk of lithium toxicity.	DDI-false
INOmax has been administered with @DRUG$, dopamine, dobutamine, steroids, @DRUG$, and high-frequency ventilation.	DDI-false
Co-medicines that induce CYP3A4 (e.g. dexamethasone, phenytoin, carbamazepine, @DRUG$ , @DRUG$ or St.	DDI-false
Antimycobacterial Agents: rifampin CONTRAINDICATED since the coadministration of this product with saquinavir in an @DRUG$ regimen reduces the plasma concentrations of @DRUG$.	DDI-false
As with other antipsychotic agents, it should be noted that HALDOL may be capable of potentiating CNS depressants such as @DRUG$, @DRUG$, and alcohol.	DDI-false
These medicines include thiazides and other diuretics, corticosteroids, phenothiazines, @DRUG$ , estrogens , oral contraceptives , phenytoin , @DRUG$ , sympathomimetics, calcium channel block drugs, and isoniazid.	DDI-false
The possibility of hypotensive effects with enalapril or enalaprilat can be minimized by either discontinuing the @DRUG$ Before starting treatment with Enalapril or @DRUG$ increase or increase salt intake.	DDI-false
ACE inhibitors and angiotensin II receptor antagonists (congestive heart failure after myocardial infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25-50 mg also received ACE inhibitors or @DRUG$ ( ACEI/@DRUG$ ).	DDI-false
In general, lithium should not be co-administered with @DRUG$ Because they reduce the renal clearance of @DRUG$ and increase a high risk of lithium toxicity.	DDI-false
Acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen and valproic acid/phenobarbital.	DDI-false
Other Drug Interactions: No pharmacokinetic interactions were observed between vardenafil and the following drugs: glyburide, @DRUG$, @DRUG$, Maalox, and ranitidine.	DDI-false
@DRUG$-Concomitant intake of cholestyramine and @DRUG$ may reduce the absorption of vitamin K.	DDI-false
It is therefore necessary to be familiar with the clinical and paraclinical pattern of the magnesium deficit and between @DRUG$ • Lack due to insufficient @DRUG$ intake which only requires oral physiological supplementation and magnesium depletion related to a dysregulation of the control mechanisms of magnesium status which requires more or less specific regulation of its causal dysregulation .	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose @DRUG$ and antineoplastic agents, specifically, @DRUG$, cis-platinum, tamoxifen and interferon-alfa.	DDI-effect
Acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen and valproic acid/phenobarbital.	DDI-false
For example, inhibitors are azole antimycotics, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, @DRUG$ , isoniazid, nefazodon, @DRUG$ Propofol, protease inhibitors, quinidine and verapamil.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, @DRUG$, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Warfarin: @DRUG$ 3 mg administered daily for 5 days did not affect the pharmacokinetics of (R)- or @DRUG$, nor were there any changes in the pharmacodynamic profile (prothrombin time) following a single 25 mg oral dose of warfarin	DDI-false
Central Nervous System Depressants: The concomitant use of @DRUG$  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, @DRUG$, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics , @DRUG$ , haloperidol , phenothiazines , monoamine oxidase ( MAO ) inhibitors , tricyclic antidepressants or some @DRUG$.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and @DRUG$.	DDI-false
@DRUG$: @DRUG$ has been reported to produce clinically significant fluctuations in steady-state serum concentrations of various tricyclic antidepressants.	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, Dapson, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporin, ergot derivatives, pimozide, @DRUG$ , @DRUG$ , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, @DRUG$, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
However, @DRUG$ stimulated, but did not significantly inhibit, proliferation in the presence of @DRUG$.	DDI-effect
These results suggest that both @DRUG$ and retinyl acetate , and possibly other glucocorticoids and retinoids , may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of @DRUG$ and EGF .	DDI-effect
Antihypertensives : Amiodarone should be used with caution in patients receiving   -receptor blocking agents ( e.g. , @DRUG$ , a CYP3A4 inhibitor) or calcium channel antagonists (e. g. @DRUG$ , a CYP3A4 substrate and diltiazem, a CYP3A4 inhibitor ) because of the potential for bradycardia, sinus arrest and AV block;	DDI-false
@DRUG$/Hypnotics: triazolam, @DRUG$ CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as prolonged or increased sedation or respiratory depression.	DDI-false
@DRUG$: Probenecid interferes with renal tubular secretion of @DRUG$ and produces an increase in the level of ciprofloxacin in serum.	DDI-false
@DRUG$ : Other antiarrhythmic drugs , such as @DRUG$ Procainamide, disopyramide and phenytoin were used concomitantly with amiodarone.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , doxorubicin , @DRUG$ , and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$ , doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without antiretroviral therapy.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, @DRUG$, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Compounds tested in man include @DRUG$, theophylline, phenytoin, diazepam, aminopyrine and @DRUG$.	DDI-false
Lithium: Increased serum @DRUG$ levels and symptoms of @DRUG$ toxicity have been reported in patients receiving concomitant lithium and ACE inhibitor therapy.	DDI-false
ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving @DRUG$ 25 to 50 mg also received @DRUG$ or angiotensin II receptor antagonists (ACEI/ARB).	DDI-false
Other concomitant therapy Although no specific interaction studies have been conducted, 1 mg or more of fissteride doses have been co-administered in clinical trials with acetaminophen, @DRUG$ , A-blockers, analgesics, angiotensin converting enzyme ( ACE) inhibitors, anticonvulsants, benzodiazepines, beta-blockers, calcium channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also known as NSAIDs), and @DRUG$ Without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ ; : Simultaneous application of @DRUG$ may reduce plasma levels of diflunisal .	DDI-false
Plasma valproate concentration should be monitored when isoniazid and @DRUG$ are co administered, and appropriate dosage adjustments of @DRUG$ should be made.	DDI-false
Analysis of the concentration of @DRUG$ following ultracentrifugation indicated that there is rapid equilibration of @DRUG$ Between the Survanta and the aqueous phase.	DDI-false
Methotrexate : In an interaction study with rheumatoid arthritis patients @DRUG$ , @DRUG$ did not have a significant effect on the pharmacokinetics of methotrexate .	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of @DRUG$, fibric acid derivatives, niacin (@DRUG$), erythromycin, azole antifungals.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, @DRUG$ (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and @DRUG$, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, @DRUG$, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Multivalent Cation-Containing products: Concomitant administration of quinolone, including ciprofloxacin, with multivalent cation-containing products such as @DRUG$ Antacids or antacids of aluminium, @DRUG$ VIDEX chewable/buffer tablets or paediatric powders or products containing calcium, iron or zinc may significantly reduce the absorption of ciprofloxacin, resulting in significantly lower serum and urine levels than desired.	DDI-false
Other chemotherapy agents In a separate study, concomitant use of @DRUG$ with @DRUG$ did not meaningfully alter the pharmacokinetics of either agent ( or the metabolites of capecitabine ) .	DDI-false
@DRUG$ : When @DRUG$ 10 or 20 mg was given to healthy volunteers either simultaneously or 6 hours after a 10 mg dose of terazosin , significant hypotension developed in a substantial number of subjects .	DDI-false
Data from in vitro studies of alprazolam suggest a possible drug interaction with alprazolam for the following: @DRUG$ and @DRUG$.	DDI-false
Intravenous @DRUG$ (@DRUG$) has been effectively administered in the presence of other cardioactive drugs, such as quinidine, beta-adrenergic blocking agents, calcium channel blocking agents, and angiotensin converting enzyme inhibitors, without any change in the adverse reaction profile.	DDI-false
However, the absolute number of @DRUG$-related deaths is far greater than the number of deaths in @DRUG$ or heroin users.	DDI-false
Micro-dosed @DRUG$ Preparations: Micro-dosed progesterone preparations (minipills that do not contain an estrogen) may be an inadequate method of contraception during @DRUG$ therapy.	DDI-false
however , no deleterious interactions were seen when ROMAZICON was administered after @DRUG$ , inhalation anaesthetics, @DRUG$ and muscle relaxant antagonists administered in conjunction with sedation or anesthesia .	DDI-false
Both @DRUG$ and @DRUG$ enhance the locomotor and/or stereotypic effects of stimulants .	DDI-false
In the presence of these methylxanthines , larger doses of @DRUG$ may be required or @DRUG$ Maybe not be effective.	DDI-false
The acute symptoms should be treated with short-acting, inhaled treatment. @DRUG$ such as @DRUG$ (The doctor should provide the patient with such medication and instruct the patient how to use it).	DDI-false
Interaction between @DRUG$ and @DRUG$ in the development of spontaneous motility in chick embryos.	DDI-effect
acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
- @DRUG$ ( e.g. , @DRUG$ ) or	DDI-false
@DRUG$ may displace acidic drugs such as @DRUG$ or tolbutamide from their binding sites.	DDI-mechanism
Multivalent Cation-Containing Products : Simultaneous Application of a @DRUG$ , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , VIDEX chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or @DRUG$ The absorption of ciprofloxacin can be significantly reduced, resulting in significantly lower serum and urine levels than desired.	DDI-mechanism
Other concomitant therapy Although no specific interaction studies have been conducted, 1 mg or more of finasteride doses have been reported in clinical trials with acetaminophen, acetylsalicylic acid, A-blockers, analgesics, angiotensin converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, @DRUG$ , calcium channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also known as @DRUG$ In addition, quinolones anti-infections with no evidence of clinically significant adverse interactions.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other @DRUG$, including but not limited to other @DRUG$, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Cyclosporine , Digoxin , Methotrexate @DRUG$ As with other NSAIDs, due to effects on renal prostaglandins, changes in the elimination of these drugs can lead to increased serum levels of cyclosporin, digoxin, @DRUG$ , and increased toxicity .	DDI-mechanism
Central Nervous System Depressants: The concomitant use of @DRUG$  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, @DRUG$, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
In a similar study with @DRUG$ in healthy volunteers, 1 of 24 subjects dosed with Vardenafil 20 mg and @DRUG$ 0.4 mg separated by 6 hours experienced a standing systolic blood pressure below 85 mm Hg.	DDI-false
@DRUG$ It may suppress certain CYP450 enzymes, including CYP1A2, CYP2C9, CYP2D6 and @DRUG$.	DDI-false
To determine whether injection of @DRUG$ would permit larger doses of cisplatin to be administered , a fixed 9.9-g/m2 dose of @DRUG$ The intravenous administration was administered for three hours at the same time as cisplatin.	DDI-false
Caution should be exercised if an @DRUG$ is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones, such as @DRUG$, spironolactone, and cimetidine.	DDI-advise
@DRUG$ • Probenecid, a renal tubular secretion blocking agent, administered at a dose of 500 mg four times a day, did not alter the pharmacokinetics of @DRUG$ 1000 mg twice daily.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., @DRUG$) or hepatotoxic (e.g., methotrexate, asparaginase) effects with @DRUG$ may increase toxicity in these organ systems.	DDI-effect
@DRUG$ : @DRUG$ , bepridil , flecainide , propafenone , quinidine CONTRAINDICATED due to potential for serious and/or life-threatening reactions .	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$, and valproic acid/@DRUG$.	DDI-false
Bacteriostatic Antibiotics: Chloramphenicol, erythromycins, @DRUG$, or @DRUG$ may interfere with the bactericidal effect of penicillins.	DDI-false
Benzthiazide may interact with alcohol, blood thinners, @DRUG$ (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like Aleve or @DRUG$, and high blood pressure medications.	DDI-false
- @DRUG$ (e.g., @DRUG$) Use of methotrexate with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of methotrexate	DDI-false
Drugs That Induce CYP3A4 (@DRUG$) Racemic zopiclone exposure was decreased 80% by concomitant useof @DRUG$, a potent inducer of CYP3A4.	DDI-false
The effects of adenosine are determined by: @DRUG$ such as @DRUG$ and theophylline .	DDI-false
- Anabolic steroids ( @DRUG$ [ e.g. Anaboline ], Oxandrolone [ e.g. Anavar ], Oxymetholone [ e.g. Anadrol ], @DRUG$ [ e.g. , Winstrol ] ) or	DDI-false
Benzthiazide may interact with alcohol, @DRUG$s, @DRUG$ (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
Benzthiazide can interact with alcohol, blood thinners, @DRUG$ ( allergy , cold , and sinus medicines ) , diabetic drugs , @DRUG$ , norepinephrine , NSAIDs like Aleve or Ibuprofen , and high blood pressure medications .	DDI-false
Non-selective MAO inhibitors including tranylcypromine sulfate, phenelzine sulfate, and pargyline HC1: Concomitant use of @DRUG$ and non-selective @DRUG$ may cause hypertension.	DDI-effect
Anticoagulants including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as @DRUG$ (NSAIDs), and aspirin may increase the risk of bleeding when administered concomitantly with @DRUG$.	DDI-effect
ACE inhibitors: Reports suggest that @DRUG$ may diminish the antihypertensive effect of @DRUG$.	DDI-effect
Other interactions: no pharmacokinetic interactions between: @DRUG$ and the following drugs : @DRUG$ , warfarin, digoxin, Maalox, and ranitidine.	DDI-false
These medicines include thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$ , sympathomimetics, calcium channel block drugs, and @DRUG$.	DDI-false
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., narcotics, analgesics, @DRUG$, @DRUG$, tranquilizers).	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (@DRUG$), platelet inhibitors (acetylsalicylic acid), NSAIDs (@DRUG$), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
The successive application of @DRUG$ ( 5 or 10 mg/kg egg weight ( e.w . ) and glutamate ( 15 mg/kg e.w . ) in a 10 min interval significantly increased the activation of spontaneous motility of 17-day-old chick embryos in comparison with the effect of @DRUG$ alone .	DDI-false
In EM individuals treated with @DRUG$ or fluoxetine, the AUC of @DRUG$ is approximately 6- to 8-fold and Css , max is about 3- to 4-fold greater than atomoxetine alone .	DDI-mechanism
@DRUG$ may decrease the amount of digoxin (Lanoxin, @DRUG$) that gets absorbed into your body.	DDI-false
In addition, additional interaction studies with: @DRUG$ Propranolol and propranolol have no effect on @DRUG$ Plasma levels and administration to a patient population receiving chronic digoxin did not differ in the extent of bioavailability of digoxin compared to control data.	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of @DRUG$ and these @DRUG$ during placebo-controlled clinical studies.	DDI-false
These drugs include thiazides and other @DRUG$ , @DRUG$ , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, warfarin, @DRUG$, carvedilol, @DRUG$ or itraconazole.	DDI-false
@DRUG$: Plasma digoxin levels and digoxin clearance at steady-state were not affected by co-administration of 0.2 mg @DRUG$.	DDI-false
@DRUG$ (e.g., spironolactone, triamterene, or amiloride), @DRUG$ supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Drug Interactions : @DRUG$ may interact with some drugs , like Monoamine oxidase inhibitors ( MAOI ): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol : Flupenthixol and Ethanol cause additive CNS depression - @DRUG$ Flupentixol increases the effect of tricyclic antidepressants	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
OBJECTIVE: Our objective was to characterize the steady-state pharmacokinetics of @DRUG$ and cyclosporine (INN, @DRUG$) when coadministered in de novo kidney allograft recipients during the first year after transplantation.	DDI-false
Although drug interaction studies have not been conducted, it has been established that: @DRUG$ or @DRUG$ treatment of relapses for periods of up to 28 days has been administered to patients ( N=180 ) receiving Betaseron .	DDI-false
acetaminophen/@DRUG$, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Anticoagulants including coumarin derivatives, indandione derivatives, and @DRUG$ such as @DRUG$ (NSAIDs), and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
Dose adjustment is not recommended . Levetiracetam had no effect on plasma concentrations of carbamazepine , @DRUG$ ##############################################################################################################################################################################################################################################################################################################################################################################################################################################################################################################################	DDI-false
MAO Inhibitors : DURAGESIC   is not recommended for use in patients who have received MAOI within 14 days because severe and unpredictable potentiation by @DRUG$ has been reported with @DRUG$	DDI-advise
however , it adversely affected response duration suggesting that @DRUG$ should not be administered with HEXALEN and/or @DRUG$.1	DDI-advise
As with other @DRUG$, it should be noted that @DRUG$ may be capable of potentiating CNS depressants such as anesthetics, opiates, and alcohol.	DDI-false
The administration of local @DRUG$ containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors, @DRUG$ or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-effect
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with @DRUG$ may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other @DRUG$ may potentiate the hypotension seen with PROLEUKIN.	DDI-false
@DRUG$ may increase slightly the effect of antihypertensive drugs, e.g., guanethidine, methyldopa, @DRUG$.	DDI-effect
@DRUG$ : Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving concomitant lithium and @DRUG$ therapy .	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., @DRUG$, asparaginase) effects with @DRUG$ may increase toxicity in these organ systems.	DDI-effect
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, @DRUG$, @DRUG$, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
In addition, @DRUG$ neither influenced the pharmacodynamics of warfarin, acetylsalicylic acid, @DRUG$, and digoxin, nor the pharmacokinetics of digoxin at steady state.	DDI-false
For example, inhibitors are azole antimycotics, @DRUG$ , clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodon, nicardipine, propofol, protease inhibitors, quinidine, and @DRUG$.	DDI-false
The intensity, uniformity and time course of anticoagulant interference by @DRUG$, secobarbital, glutethimide, chloral hydrate and @DRUG$ were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
As with other antipsychotic agents , it should be noted that HALDOL may be capable of potentiating @DRUG$ Like anesthetics, @DRUG$ And alcohol.	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, Dapson, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$ , cyclosporin, ergot derivatives, pimozide, carbamazepine, @DRUG$ Concomitant use with saquinavir may result in increased plasma concentrations.	DDI-false
@DRUG$ may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, @DRUG$, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.	DDI-int
Therefore, when @DRUG$ and @DRUG$ are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained.	DDI-advise
The administration of local anesthetic solutions containing @DRUG$ or @DRUG$ to patients receiving monoamine oxidase inhibitors, tricyclic antidepressants or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-false
The possibility of hypotensive effects with @DRUG$ , can be minimized by either @DRUG$ About one week before starting treatment with captopril (captopril tablets, USP) or starting therapy with small doses ( 6.25 or 12.5 mg) or increasing salt intake.	DDI-effect
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, @DRUG$, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Other concomitant therapy Although no specific interaction studies have been performed, clinical trials with 1 mg or more of finasteride doses have been conducted at the same time. @DRUG$ , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ACE ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , H2 antagonists , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as @DRUG$ ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
Results of studies in multiple sclerosis patients taking TYSABRI   and concomitant interferon beta-1a ( AVONEX   30 mcg IM once weekly ) or @DRUG$ This was not conclusive in terms of the need for dose adjustment of the beta interferon or @DRUG$.	DDI-false
This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or @DRUG$), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with @DRUG$ may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
however , no deleterious interactions were seen when ROMAZICON was administered after narcotics , inhalational @DRUG$ , @DRUG$ Muscle relaxant antagonists used in combination with sedation or anaesthesia.	DDI-false
@DRUG$: When multiple doses of atorvastatin and @DRUG$ were coadministered, steady-state plasma digoxin concentrations increased by approximately 20%.	DDI-false
In addition, Fondaparinux neither influenced the pharmacodynamics of warfarin, @DRUG$, piroxicam, and @DRUG$, nor the pharmacokinetics of digoxin at steady state.	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with @DRUG$, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or @DRUG$ than with pentobarbital.	DDI-false
There is therefore potential for interaction with other medicinal products metabolised by CYP 1A2 (e.g. @DRUG$ Takrin, and @DRUG$ ) .	DDI-false
Erythromycin : In healthy people, plasma concentrations of @DRUG$ increased approximately 40 % with coadministration of atorvastatin and @DRUG$ A known inhibitor of cytochrome P450 3A4.	DDI-false
@DRUG$ - prior ingestion of @DRUG$ may decrease the emetic response to apomorphine in the treatment of poisoning.	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, dapsones, @DRUG$ , @DRUG$ Amiodarone, quinidine, warfarin, tacrolimus, cyclosporin, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam and triazolam) may have increased plasma concentrations when co-administered with saquinavir;	DDI-false
Anticoagulants including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as @DRUG$ (@DRUG$), and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
Previous studies have demonstrated a significant reduction in the oral bioavailability of @DRUG$ and @DRUG$ when administered concomitantly with an intravenous opiate such as morphine.	DDI-false
@DRUG$ Retinyl acetate also inhibits and stimulates EGF or @DRUG$-induced prostatic epithelium proliferation.	DDI-effect
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, @DRUG$, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
These drugs include the thiazides and other @DRUG$ , @DRUG$ , phe-nothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, @DRUG$, @DRUG$, carvedilol, ethanol or itraconazole.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other @DRUG$ , @DRUG$ , haloperidol , phenothiazines , monoamine oxidase ( MAO ) inhibitors , tricyclic antidepressants or some antihistamines .	DDI-false
Oral @DRUG$: Coadministration of atorvastatin and an oral @DRUG$ increased AUC values for norethindrone and ethinyl estradiol by approximately 30% and 20%.	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with @DRUG$ may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided . 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with @DRUG$.	DDI-false
@DRUG$ Because atorvastatin does not affect the pharmacokinetics of antipyrin, interactions with other @DRUG$ metabolized via the same cytochrome isozymes are not expected .	DDI-false
Monoamine Oxidase Inhibitors and Tricyclic Antidepressants : @DRUG$ In patients treated with monoamine oxidase inhibitors or tricyclic antidepressants, the use should be carried out with extreme caution as the effect of @DRUG$ On the cardiovascular system can be potentiated by these active substances.	DDI-false
@DRUG$: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of @DRUG$.	DDI-false
Coadministration of terfenadine with @DRUG$ has led to elevated plasma concentrations of @DRUG$, resulting in rare instances of life- threatening cardiac dysrhythmias and one death.	DDI-false
Based on the results of these studies , it is concluded that @DRUG$ It can be safely used together with both. @DRUG$ and dideoxyinosine .	DDI-false
ANTACID (@DRUG$): Cerivastatin plasma concentrations were not affected by co-administration of @DRUG$.	DDI-false
ACE inhibitors and angiotensin II receptor antagonists (hypertension)- In clinical trials in patients with hypertension, the addition of @DRUG$ 50 to 100 mg up to @DRUG$ Angiotensin II receptor antagonists slightly increased the mean serum potassium (approximately 0.09 - 0.13 mEq/L).	DDI-effect
Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving Alprazolam (caution is recommended during coadministration with alprazolam): Coadministration of @DRUG$ with alprazolam increased the maximum plasma concentration of @DRUG$ by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, @DRUG$, and @DRUG$.	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, dapsones, disopyramide, @DRUG$ Amiodarone, quinidine, warfarin, @DRUG$ (e. g. cyclosporin, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam and triazolam) may exhibit increased plasma concentrations when co-administered with saquinavir;	DDI-false
@DRUG$ - prior ingestion of diphenidol may decrease the emetic response to @DRUG$ in the treatment of poisoning .	DDI-false
Reciprocal interactions may occur with concomitant use of Antizol and drugs that increase or inhibit the cytochrome P450 system ( e.g. , phenytoin , @DRUG$ , @DRUG$ , ketoconazole), although this has not been studied	DDI-false
Acetaminophene: Pharmacokinetic or pharmacodynamic drug-effect interactions between @DRUG$ and concomitantly administered aspirin ( 162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1   g/kg/min . over 4 hours ) or @DRUG$ ( 1000 mg orally administered 12, 6 and 0 hours before, and 6 and 12 hours after, start of argatroban 1.5 g/kg/min. over 18 hours).	DDI-false
@DRUG$ (neostgmine, physostigmine), @DRUG$, quinine, procainamide can enhance toxicity and cause cardio respiratory depression.	DDI-false
Tetracyclines : Concomitant treatment with @DRUG$ The use of Accutane has been associated with a number of cases of pseudotumor cerebri (benign intracranial hypertension), some of which are associated with concomitant use of @DRUG$	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect @DRUG$ pharmacodynamics - Arecoline - Eproxindine - Ethanol: @DRUG$ and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Benzthiazide may interact with alcohol, @DRUG$s, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like @DRUG$ or Ibuprofen, and high blood pressure medications.	DDI-false
In rats, simultaneous ingestion of disulfiram and @DRUG$ in the diet for 78 weeks has been reported to cause tumors, and it has been suggested that @DRUG$ may react with nitrites in the rat stomach to form a nitrosamine, which is tumorigenic.	DDI-false
SINCE THE CONCOMITANT ADMINISTRATION OF THESE TWO DRUGS CAN LEAD TO @DRUG$ INTOXICATION, PRIOR TO ADMINISTERING DISULFIRAM TO A PATIENT ON @DRUG$ THERAPY, A BASELINE PHENYTOIN SERUM LEVEL SHOULD BE OBTAINED.	DDI-false
@DRUG$: In some patients, the administration of a @DRUG$ can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics.	DDI-false
Possible interactions between Keppra and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and @DRUG$ (i.e., by estimating serum concentrations of @DRUG$ These AEDs during placebo-controlled clinical trials.	DDI-false
Molecular basis for the selective toxicity of @DRUG$ for yeast and @DRUG$ for animal cells.	DDI-false
In clinical studies performed with Fondaparinux , the concomitant use of oral @DRUG$ ( warfarin ) , platelet inhibitors ( acetylsalicylic acid ) , NSAIDs ( piroxicam ) , and @DRUG$ did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium .	DDI-false
In a comparison of @DRUG$ tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of @DRUG$ needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with pentobarbital.	DDI-false
@DRUG$: @DRUG$, a renal tubular secretion blocking agent, administered at a dose of 500 mg four times a day, did not change the pharmacokinetics of levetiracetam 1000 mg twice daily.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as @DRUG$ or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing @DRUG$, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
@DRUG$ and @DRUG$ Ribavirin can antagonize the in vitro antiviral activity of stavudine and zidovudine against HIV .	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, @DRUG$ or some @DRUG$.	DDI-false
Benzthiazide may interact with alcohol , blood thinners , @DRUG$ ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , @DRUG$ like Aleve or Ibuprofen , and high blood pressure medications .	DDI-false
@DRUG$ , including norfloxacin , may enhance the effects of oral anticoagulants , including @DRUG$ or its derivatives or similar agents .	DDI-effect
This appears to be the only clinically relevant interaction of this kind with Mefloquine , although theoretically , coadministration of other drugs known to alter cardiac conduction ( eg , @DRUG$ Calcium channel blockers, antihistamines or beta-adrenergic blockers @DRUG$ Also tricyclic antidepressants and phenothiazines could contribute to an extension of the QTc interval.	DDI-false
These drugs include the @DRUG$ and other @DRUG$, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Drug Interactions: @DRUG$ may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: @DRUG$ increases the effect of Tricyclic antidepressants	DDI-false
@DRUG$ A case of severe hypoglycaemia has been reported in a type II diabetic treated 11 days after the administration of tolazamide ( 1 gm/ day). @DRUG$ ( 75 mg/day ) .	DDI-false
Similarly dialyzed were phenobarbital, @DRUG$, and @DRUG$, both alone at therapeutic concentrations in serum and with ethanol at three different concentrations in serum.	DDI-false
BACKGROUND : The effects of combined administration of bombesin and @DRUG$ (Verapamil), a calcium channel blocker induced by azoxymethane by the incidence of peritoneal metastases of intestinal adenocarcinoma ( @DRUG$ ) and the labeling index of intestinal cancers were investigated in male Wistar rats .	DDI-false
Agents Having Vasodilator Activity : Data on the effect of concomitant use of other @DRUG$ in patients receiving @DRUG$ For heart failure are not available ;	DDI-false
- @DRUG$ (e.g., @DRUG$) or	DDI-false
Dexamethasone and @DRUG$ Similarly, EGF or @DRUG$-induced proliferation of the prostate epithelium inhibits and stimulates.	DDI-effect
Example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , @DRUG$ , isoniazid , nefazodone , nicardipine , @DRUG$ , protease inhibitors, quinidine, and verapamil.	DDI-false
@DRUG$/@DRUG$, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and antineoplastic agents , specifically , @DRUG$ , cis-platinum , tamoxifen and @DRUG$.	DDI-false
@DRUG$ , such as verapamil , diltiazem and @DRUG$ , inhibit platelet activation in vitro , and decrease platelet adhesion intravascularly .	DDI-false
Hypotension   Patients on @DRUG$ Therapy: Patients on @DRUG$ and especially those in whom diuretic therapy was recently instituted, as well as those on severe dietary salt restriction or dialysis, may occasionally experience a precipitous reduction of blood pressure usually within the first hour after receiving the initial dose of captopril.	DDI-false
Possible drug interactions between Keppra and other AEDs (carbamazepine, gabapentin, lamotrigine, @DRUG$ , phenytoin , @DRUG$ In placebo-controlled clinical trials, serum concentrations of levetiracetam and these AEDs have also been studied.	DDI-false
@DRUG$ and indinavir: Upon concomitant administration of 5 mg of Vardenafil with 600 mg BID @DRUG$, the Cmax and AUC of ritonavir were reduced by approximately 20%.	DDI-false
The coadministration of aspirin decreases the biologic half-life of @DRUG$ because of an increase in metabolic clearance that results in a greater amount of @DRUG$ in the urine.	DDI-false
Other concomitant therapy Although no specific interaction studies have been conducted, 1 mg or more of finasteride doses have been reported in clinical trials with acetaminophen, acetylsalicylic acid, A-blockers, analgesics, angiotensin converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, @DRUG$ , calcium-channel blockers , cardiac nitrates , @DRUG$ , H2 antagonists , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
Although no specific studies have been performed, co-administration with medicinal products primarily metabolised by CYP3A4 (e. g. @DRUG$ , dapsone , disopyramide , quinine , amiodarone , @DRUG$ , warfarin, tacrolimus, cyclosporin, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have increased plasma concentrations when co-administered with saquinavir;	DDI-false
In these subjects, @DRUG$ did not alter the anticoagulant effect of @DRUG$ as determined by prothrombin time.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an @DRUG$ (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of @DRUG$ as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
Use with Allopurinol : The principal pathway for detoxification of @DRUG$ is inhibited by @DRUG$.	DDI-mechanism
Since the concomitant administration of warfarin with @DRUG$ increases the prothrombin time by 100% after 3 to 4 days, the dose of the @DRUG$ should be reduced by one-third to one-half, and prothrombin times should be monitored closely.	DDI-false
It is assumed that increased interaction between @DRUG$ and high affinity binding sites for @DRUG$ on dopamine2- and serotonin2-receptors underlies the antipsychotic action of neuroleptics after their prolonged administration .	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, @DRUG$, cefotetan, cefamandole, @DRUG$) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
- cholestyramine increase in cholestyramine and @DRUG$ may reduce the absorption of @DRUG$.	DDI-false
However, no harmful interactions were seen when: @DRUG$ was administered after narcotics , inhalational anesthetics , @DRUG$ Muscle relaxant antagonists used in combination with sedation or anaesthesia.	DDI-false
Hypotension : Patients on Diuretic Therapy : Patients on diuretics and especially those in whom diuretic therapy was recently instituted , may occasionally experience an excessive reduction of blood pressure after initiation of therapy with @DRUG$ or @DRUG$.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with @DRUG$, methyldopa, @DRUG$, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Lithium: Increased serum lithium levels and symptoms of @DRUG$ toxicity have been reported in patients receiving concomitant lithium and @DRUG$ therapy.	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with @DRUG$ The antitumour effectiveness of PROLEUKIN can be reduced and should therefore be avoided. 12 @DRUG$ In PROLEUKIN, hypotension and other antihypertensive agents may be increased.	DDI-false
Therefore, @DRUG$ should be discontinued at least two weeks prior to the cautious initiation of therapy with @DRUG$.	DDI-advise
Like ibogaine ( 40 mg/kg ) , @DRUG$ ( 40 mg/ kg ) decreases the intravenous self-injection of @DRUG$ • cocaine and oral self-administration of ethanol and nicotine in rats;	DDI-false
Plasma concentrations of @DRUG$ are reduced when given concurrently with @DRUG$.	DDI-mechanism
Sine bradycardia was treated with oral @DRUG$ in combination with @DRUG$ ( CYP3A4 substrate ) given for local anesthesia .	DDI-false
@DRUG$: @DRUG$ may antagonize the hypotensive effects of antihypertensives.	DDI-false
Two groups (SH/DA; SH/FA) were submitted to daily treatment with synthetic hydroalcoholic solutions containing @DRUG$, methanol, higher @DRUG$ and acetaldehyde in the same proportions as those found in most common distilled and fermented alcoholic beverages;	DDI-false
Coadministration with compounds that are potent inducers of CYP3A4 (eg, phenobarbital, phenytoin, dexamethasone, @DRUG$) may result in decreased plasma levels of @DRUG$.	DDI-mechanism
Administration of rifampin concomitantly with oral amiodarone has been shown to result in decreases in serum concentrations of @DRUG$ and @DRUG$.	DDI-false
• Drug interactions: Flupentixol may interact with some medicines, such as monoamine oxidase inhibitors ( @DRUG$ - Arecolin - eproxindine - ethanol : flupenthixol and ethanol cause additive CNS depression - tricyclic antidepressants : flupenthixol increases the effect of @DRUG$	DDI-false
@DRUG$ It has been reported that the blood pressure lowering effect of systemic clonidine has been blunted. It is not known whether the concomitant use of these active substances with @DRUG$ In humans, disturbances of the IOP-lowering effect may occur.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral @DRUG$, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and @DRUG$.	DDI-false
@DRUG$: Plasma concentrations of @DRUG$ decreased approximately 25% when colestipol and atorvastatin were coadministered.	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, Dapson, disopyramide, quinine, @DRUG$ , @DRUG$ , warfarin, tacrolimus, cyclosporin, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have increased plasma concentrations when co-administered with saquinavir;	DDI-false
Lithium-A study on the interaction of @DRUG$ with @DRUG$ It wasn't done.	DDI-false
Example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , @DRUG$ , @DRUG$ ==References====External links==	DDI-false
Multivitamins, or other products containing iron or zinc, antacids or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of @DRUG$, because they may interfere with absorption resulting in lower serum and urine levels of @DRUG$.	DDI-false
@DRUG$: DURAGESIC  is not recommended for use in patients who have received @DRUG$ within 14 days because severe and unpredictable potentiation by MAO inhibitors has been reported with opioid analgesics	DDI-false
In chronic hepatitis C patients treated with @DRUG$ in combination with @DRUG$ , PEGASYS treatment did not affect ribavirin distribution or clearance .	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., @DRUG$) or hepatotoxic (e.g., @DRUG$, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Pediatric Use The safety and effectiveness of @DRUG$ , alone or in combination with @DRUG$ No evidence was provided in patients under 18 years of age.	DDI-false
@DRUG$: Because of the relationship of Accutane to vitamin A, patients should be advised against taking vitamin supplements containing @DRUG$ to avoid additive toxic effects	DDI-false
Drugs Interactions : Flupentixol may interact with some drugs, such as monoamine oxidase inhibitors (MAOI): MAOI may theoretically affect flupentixol pharmacodynamics - @DRUG$ - Eproxindine - Ethanol : Flupenthixol and @DRUG$ Cause additive CNS depression - Tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants	DDI-false
In clinical studies conducted with fondaparinux, concomitant use of oral anticoagulants ( warfarin), @DRUG$ ( acetylsalicylic acid ) , @DRUG$ Piroxicam and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
When @DRUG$ It is co-administered with oral @DRUG$ , attenuation of immunization can not be excluded .	DDI-effect
Use with @DRUG$ : The use of @DRUG$ To control hypertension in patients with azathioprine, severe leukopenia has been reported.	DDI-false
In the case that you are taking digoxin while taking @DRUG$, higher doses of @DRUG$ may be needed.	DDI-false
In addition to the interactions noted above, chronic (  2 weeks) oral @DRUG$ administration impairs metabolism of phenytoin, @DRUG$, and methotrexate.	DDI-false
@DRUG$: Simvastatin (CYP3A4 substrate) in combination with @DRUG$ has been associated with reports of myopathy/rhabdomyolysis.	DDI-false
Prednisone/@DRUG$: @DRUG$ did not have any clinically important effect on the pharmacokinetics of prednisolone or prednisone.	DDI-false
Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: @DRUG$, cyclosporine, amiodarone, nicardipine, and @DRUG$.	DDI-false
• Numerous drug interactions are possible in some patients. @DRUG$ , such as phenobarbitone and @DRUG$ , which affect liver microsomal enzyme systems.	DDI-false
@DRUG$ is a substrate for both CYP2D6 and @DRUG$.	DDI-false
Central Nervous System Depressants : The concomitant use of @DRUG$ Fentanyl transdermal system with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, @DRUG$ ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	DDI-effect
In a similar study with @DRUG$ 1 out of 24 subjects with @DRUG$ 20 mg and 0.4 mg tamsulosin separated by 6 hours had standing systolic blood pressure below 85 mm Hg.	DDI-false
acetaminophen/theophylline , @DRUG$/quinidine , phenobarbital/acetaminophen , phenobarbital/valproic acid , @DRUG$/lidocaine , theophylline/acetaminophen , and valproic acid/phenobarbital .	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics , amantadine , haloperidol , phenothiazines , monoamine oxidase ( MAO ) inhibitors , @DRUG$ or some @DRUG$.	DDI-false
• Corticosteroids, methylxanthine and diuretics: concomitant treatment with xanthine derivatives, steroids or @DRUG$ A possible hypocalemic effect of @DRUG$	DDI-effect
Antacids : In a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of @DRUG$ as compared with fosinopril administered alone , suggesting that @DRUG$ The absorption of Fosinopril may be impaired.	DDI-false
Antacids : In a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , @DRUG$ -, and simethicon) with fosinopril reduced serum levels and urinary excretion of fosinoprilat compared to @DRUG$ Administration alone, suggesting that antacids may affect the absorption of fosinopril.	DDI-false
acetaminophen/theophylline, @DRUG$/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
@DRUG$ and Zidovudine Ribavirin can antagonize the in vitro antiviral activity of @DRUG$ and zidovudine against HIV.	DDI-false
CONCLUSIONS/INTERPRETATION: @DRUG$ and @DRUG$ can exert additive vasodilator properties on renal and ocular circulation.	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, fibric acid derivatives, @DRUG$ (@DRUG$), erythromycin, azole antifungals.	DDI-false
While all selective serotonin reuptake inhibitors ( @DRUG$ ), e.g., citalopram, escitalopram, @DRUG$ , sertraline , and paroxetine , inhibit P450 2D6 , they may vary in the extent of inhibition .	DDI-false
@DRUG$ had no effect on plasma levels of @DRUG$.	DDI-false
@DRUG$ and tricyclic anti-depressants could exaggerate the prolongation of the QT interval observed with @DRUG$.	DDI-effect
Some drugs/substances are known to speed up metabolism @DRUG$ by stimulating the synthesis of @DRUG$ ( enzyme induction ) .	DDI-false
@DRUG$: @DRUG$ causes increase (by about 80%) in the free fraction of etodolac.	DDI-false
At higher than recommended doses , @DRUG$ 75 mg administered once daily for 10 days increased plasma concentrations by 23%, as measured by AUC0 - 24 hours in patients who: @DRUG$ 7.5 to 15 mg/week for rheumatoid arthritis .	DDI-mechanism
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, @DRUG$, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, @DRUG$, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , @DRUG$ , probenecid , coumarins , @DRUG$ And beta-adrenergic blockers.	DDI-false
Anticoagulants: Potentiation of warfarin-type (@DRUG$ and CYP3A4 substrate) anticoagulant response is almost always seen in patients receiving @DRUG$ and can result in serious or fatal bleeding.	DDI-false
Use with Allopurinol: The principal pathway for detoxification of @DRUG$ is inhibited by @DRUG$.	DDI-mechanism
The concomitant use of nitrofurantoin is not recommended since @DRUG$ may antagonize the antibacterial effect of @DRUG$ in the urinary tract.	DDI-effect
The intensity, uniformity and time course of the anticoagulant interference by phenobarbital, secobarbital, @DRUG$ , @DRUG$ In 16 patients receiving coumarin therapy, methaqualone and methaqualone were systematically studied.	DDI-false
• Anabolic steroids ( @DRUG$ [ e.g. , Anabolin ] , oxandrolone [ e.g. , Anavar ] , oxymetholone [ e.g. , Anadrol ] , stanozolol [ e.g. , @DRUG$ ] ) or	DDI-false
For example, inhibitors are azole antimycotics, ciprofloxacin, @DRUG$ , @DRUG$ , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .	DDI-false
Example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , @DRUG$ , doxycycline , erythromycin , imatinib , @DRUG$ , Nefazodone, Nicardipine, Propofol, Protease inhibitors, quinidine, and verapamil.	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride, including anti-arrhythmic agents such as @DRUG$ and procainamide, @DRUG$ and tricyclic anti-depressants.	DDI-false
@DRUG$: The concomitant use of @DRUG$  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with @DRUG$, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When @DRUG$ is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
INOmax has been administered with tolazoline , @DRUG$ , dobutamine , @DRUG$ , surfactant , and high-frequency ventilation .	DDI-false
Aspirin/@DRUG$: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered @DRUG$ (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
Benzthiazide may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, @DRUG$, NSAIDs like Aleve or @DRUG$, and high blood pressure medications.	DDI-false
@DRUG$-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, cefotetan, cefamandole, latamoxef) or methylthiadiazole (@DRUG$) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
The administration of local anesthetic solutions containing @DRUG$ or norepinephrine to patients receiving @DRUG$, tricyclic antidepressants or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-effect
Benzthiazide may interact with alcohol, @DRUG$s, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, @DRUG$ like Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
These drugs include the thiazides and other @DRUG$, @DRUG$, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Drug interactions : Flupentixol may interact with some medicines, such as monoamine oxidase inhibitors (MAOI): @DRUG$ - Arecolin - eproxindine - ethanol : flupenthixol and ethanol cause additive CNS depression - @DRUG$ Flupentixol increases the effect of tricyclic antidepressants	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other @DRUG$, @DRUG$, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.	DDI-false
Although @DRUG$ have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with @DRUG$.	DDI-false
It has been shown that @DRUG$ antagonized evidently the antinociceptive effect of @DRUG$ And their analogy.	DDI-effect
Nonsteroidal Anti-Inflammatory Drugs: The administration of @DRUG$ to normal volunteers receiving @DRUG$ decreased the renal clearance and significantly increased the plasma levels of indomethacin.	DDI-mechanism
SINCE THE CONCOMITANT ADMINISTRATION OF THESE TWO DRUGS CAN LEAD TO PHENYTOIN INTOXICATION , PRIOR TO ADMINISTERING DISULFIRAM TO A PATIENT ON @DRUG$ THERAPY, A BASELINE @DRUG$ ....................................................................................................................................................................................................................................................................	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, @DRUG$, digoxin, warfarin, isosorbide mononitrate, @DRUG$, ethanol or itraconazole.	DDI-false
OTHER CONCOMITANT THERAPY : Although specific interaction studies were not performed , in clinical studies , @DRUG$ was used concomitantly with angiotensin- converting enzyme ( ACE ) inhibitors , betablockers , calcium-channel blockers , diuretics , and nonsteroidal anti-inflammatory drugs ( @DRUG$ ) without evidence of clinically significant adverse interactions .	DDI-false
@DRUG$ This had a similar effect in the presence of @DRUG$.	DDI-false
The hypoglycemic action of @DRUG$ may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , @DRUG$ , monoamine oxidase inhibitors, and beta-adrenergic blockers.	DDI-effect
Cyclosporine , Digoxin , Methotrexate @DRUG$ As with other NSAIDs, due to effects on renal prostaglandins, changes in the elimination of these drugs can lead to increased serum levels of cyclosporin, @DRUG$ , methotrexate, and increased toxicity.	DDI-mechanism
Consequently, drugs with a low therapeutic margin, such as vitamin K antagonists, @DRUG$, and @DRUG$, could have a delayed elimination and increases in their serum half-life leading to a toxic level.	DDI-false
@DRUG$ could exaggerate the depression of AV nodal conduction observed with @DRUG$.	DDI-effect
Cholestyramine and colestipol @DRUG$: Absorption of hydrochlorothiazide is impaired in the presence of @DRUG$.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with @DRUG$ administered alone, suggesting that @DRUG$ may impair absorption of fosinopril.	DDI-false
Lithium: @DRUG$ toxicity has been reported in patients receiving lithium concomitantly with drugs which cause elimination of sodium, including @DRUG$.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, @DRUG$, imatinib, isoniazid, nefazodone, nicardipine, @DRUG$, protease inhibitors, quinidine, and verapamil.	DDI-false
Ritonavir (600 mg b.i.d.) co-administered with Vardenafil 5 mg resulted in a 49-fold increase in @DRUG$ AUC and a 13-fold increase in @DRUG$ Cmax.	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, dapsones, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporin, ergot derivatives, pimozide, carbamazepine, @DRUG$ , alfentanyl , alprazolam , and @DRUG$ Concomitant use with saquinavir may result in increased plasma concentrations.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when @DRUG$ It is co-administered with other antimuscarinics, amantadine, haloperidol, @DRUG$ , monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.	DDI-effect
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, @DRUG$, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, @DRUG$, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received @DRUG$ or angiotensin II receptor antagonists (ACEI/ARB).	DDI-false
Other Drugs:Drugs such as quinidine, @DRUG$, procainamide, phenothiazines, @DRUG$, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
Potassium-sparing diuretics (e.g., @DRUG$, @DRUG$, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
The following eight target drug/added drug combinations were studied: @DRUG$/@DRUG$.	DDI-false
Other reported interactions with amiodarone: @DRUG$ ( CYP3A4 substrate ) in combination with @DRUG$ may cause hypotension , bradycardia , and decreased cardiac output .	DDI-false
Antiarrhythmics: Other antiarrhythmic drugs, such as @DRUG$, procainamide, disopyramide, and phenytoin, have been used concurrently with @DRUG$.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - @DRUG$ - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, @DRUG$ and valproate) were also assessed by evaluating the serum concentrations of @DRUG$ and these AEDs during placebo-controlled clinical studies.	DDI-false
These drugs include the @DRUG$ and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and @DRUG$.	DDI-false
Other interactions : Vardenafil had no effect on the pharmacodynamics of @DRUG$ glucose and insulin concentrations) and @DRUG$ (prothrombin time or other pharmacodynamic parameters).	DDI-false
Potential drug interactions between: @DRUG$   and other AEDs ( @DRUG$ , gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also evaluated by the evaluation of levetiracetam serum concentrations and these AEDs during placebo-controlled clinical trials.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or @DRUG$ antacids, sucralfate, @DRUG$ chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Drug Interactions : Flupenthixol may interact with some drugs , like Monoamine oxidase inhibitors ( @DRUG$ MAOI may theoretically affect flupentixol pharmacodynamics - Arecoline - Eproxindine - Ethanol : Flupentixol and ethanol cause additive CNS depression - Tricyclic antidepressants : @DRUG$ increases the effect of Tricyclic antidepressants	DDI-false
Drug/Laboratory Test Interaction Because @DRUG$ may affect the APTT assay, @DRUG$ present in plasma samples may interfere with one-stage coagulation assays based on the APTT (such as factor VIII, IX, and XI assays).	DDI-false
It differs structurally from the other currently available @DRUG$ ( @DRUG$ , simvastatin , and pravastatin ) , leading to unique biopharmaceutical properties relative to the other agents of this class .	DDI-false
@DRUG$ including @DRUG$, phenelzine sulfate, and pargyline HC1: Concomitant use of L-tyrosine and non-selective MAO inhibitors may cause hypertension.	DDI-false
Oral @DRUG$: Coadministration of @DRUG$ and an oral contraceptive increased AUC values for norethindrone and ethinyl estradiol by approximately 30% and 20%.	DDI-false
Intravenous @DRUG$ (adenosine) has been effectively administered in the presence of other cardioactive drugs, such as quinidine, @DRUG$, calcium channel blocking agents, and angiotensin converting enzyme inhibitors, without any change in the adverse reaction profile.	DDI-false
Co-administration of single 25-mg dose @DRUG$ had no effect on the pharmacokinetics of total @DRUG$.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
It is recommended to avoid concurrent administration of ethambutol with @DRUG$ containing @DRUG$ for at least 4 hours following ethambutol administration.	DDI-false
When Itraconazole was coadministered with phenytoin , @DRUG$ , or H2 antagonists, reduced plasma concentrations of @DRUG$ were reported .	DDI-false
It may be necessary to adjust the dosage of oral anticoagulants upon beginning or stopping @DRUG$. since @DRUG$ may prolong prothrombin time.	DDI-false
Use in Ambulatory Patients The effects of @DRUG$ may wear off before a @DRUG$ is completely cleared from the body.	DDI-false
- @DRUG$ (nandrolone [e.g., Anabolin], oxandrolone [e.g., @DRUG$], oxymetholone [e.g., Anadrol], stanozolol [e.g., Winstrol]) or	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (@DRUG$, barbiturates, @DRUG$, sedatives, anesthetics) should be considered.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, @DRUG$, imatinib, isoniazid, @DRUG$, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , disopyramide , @DRUG$ Amiodarone, quinidine, warfarin, tacrolimus, cyclosporin, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazoam and triazolam may have increased plasma concentrations if combined with @DRUG$ ;	DDI-mechanism
Short-term pharmacokinetic studies have demonstrated that concomitant administration of @DRUG$ and Lodine  (etodolac capsules and tablets) results in reduced protein binding of @DRUG$, but there was no change in the clearance of free warfarin.	DDI-false
In case you take @DRUG$ while taking aminosalicylic acid , higher doses of @DRUG$ It may be necessary.	DDI-false
A drug interaction study investigated the effect of using ACZONE gel, 5%, in combination with double strength (160 mg/800 mg) @DRUG$/sulfamethoxazole ( @DRUG$/SMX ).	DDI-false
Rifampin: Co-administration of @DRUG$ with @DRUG$ 600 mg daily, a potent inducer of hepatic metabolism, produced an approximate 50% decrease in rofecoxib plasma concentrations.	DDI-mechanism
No formal clinical studies have been conducted to assess if there is an interactive effect on bone loss between @DRUG$ and @DRUG$.	DDI-false
- Vitamin K ( e.g. , AquaMEPHYTON , @DRUG$ ) Use of @DRUG$ with these medicines may increase the chance of side effects affecting the blood	DDI-false
A possible interaction between @DRUG$ and ciprofloxacin, a @DRUG$, has been reported, resulting in a potentiation of the hypoglycemic action of glyburide.	DDI-false
Other cardiovascular agents : enalapril and @DRUG$ IV have been used concomitantly with beta adrenergic-blocking agents , methyldopa , @DRUG$ , calcium-blocking agents , hydralazine , prazosin and digoxin without evidence of clinically significant adverse interactions .	DDI-false
Drug-Drug Interactions Between @DRUG$ And other antiepileptic drugs ( @DRUG$ Phenytoin Keppra (3,000 mg daily) did not affect the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy.	DDI-false
Antacids : In a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , @DRUG$ , and simethicon) with fosinopril reduced serum levels and urinary excretion of fosinoprilat compared to fosinopril alone, suggesting that antacids may affect the absorption of @DRUG$.	DDI-false
Caution should be exercised if an @DRUG$ is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones, such as ketoconazole, spironolactone, and @DRUG$.	DDI-advise
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, @DRUG$, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, @DRUG$, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an @DRUG$ (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of @DRUG$.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general @DRUG$, phenothiazines, skeletal muscle relaxants, and @DRUG$, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Withdrawal of @DRUG$ decreased the @DRUG$ requirement by 50%.	DDI-mechanism
• Substances that are strong inhibitors of CYP3A4 activity (e.g. ketoconazole and itraconazole) decrease @DRUG$ metabolism and increase @DRUG$ plasma concentrations .	DDI-false
Bacteriostatic Antibiotics: Chloramphenicol, erythromycins, @DRUG$, or tetracyclines may interfere with the bactericidal effect of @DRUG$.	DDI-effect
No Important Interactions To Date @DRUG$ does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, warfarin, isosorbide mononitrate, carvedilol, ethanol or @DRUG$.	DDI-false
Alcohol, @DRUG$, or @DRUG$: potentiation of orthostatic hypotension may occur.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, @DRUG$, digoxin, @DRUG$, isosorbide mononitrate, carvedilol, ethanol or itraconazole.	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , @DRUG$ Co-administration of carbamazepine, fentanyl, alfentanyl, alprazolem and triazolam may result in increased plasma concentrations. @DRUG$ ;	DDI-mechanism
Hypotension    Patients on Diuretic Therapy : Patients on @DRUG$ And above all those in whom @DRUG$ therapy was recently instituted , as well as those on severe dietary salt restriction or dialysis , may occasionally experience a precipitous reduction of blood pressure usually within the first hour after receiving the initial dose of captopril .	DDI-false
Interaction with @DRUG$, lidocaine and @DRUG$ has also been reported to produce adverse clinical effects.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - @DRUG$: Flupenthixol and @DRUG$ cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
@DRUG$ The therapeutic effect of other @DRUG$ may be increased or increased.	DDI-effect
However, high doses of @DRUG$ may reduce the efficacy of intrathecally administered @DRUG$.	DDI-effect
@DRUG$ should be used with caution in patients taking @DRUG$ , and renal function should be carefully monitored .	DDI-advise
Central Nervous System Depressants: The concomitant use of @DRUG$  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other @DRUG$, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
@DRUG$: Coadministration of eszopiclone 3 mg and @DRUG$ 10 mg produced a decrease in DSST scores.	DDI-false
Both efavirenz and nevirapine have been compared to triple therapy with the PI @DRUG$ For more than 48 weeks as initial therapy, with similar response rates that @DRUG$ regimens and superiority observed with efavirenz .	DDI-false
@DRUG$ In diabetic patients who: @DRUG$ and tolbutamide , no significant effects were seen on tolbutamide plasma levels or fasting blood glucose .	DDI-false
Co-administration: Concomitant use of @DRUG$ with @DRUG$, thrombolytics, and other anticoagulants may increase the risk of bleeding.	DDI-effect
@DRUG$/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including @DRUG$ and other drugs that are highly protein bound, salicylates, sulfonamides, @DRUG$, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
Tetracyclines: Concomitant treatment with @DRUG$ and tetracyclines should be avoided because Accutane use has been associated with a number of cases of pseudotumor cerebri (benign intracranial hypertension), some of which involved concomitant use of @DRUG$	DDI-false
bacteriostatic antibiotics : chloramphenicol, erythromycins, @DRUG$ , or tetracyclines may interfere with the bactericidal effect of @DRUG$.	DDI-effect
@DRUG$ Tricyclic amphetamines can increase the activity of @DRUG$ or sympathomimetic agents ;	DDI-false
@DRUG$: @DRUG$ 75 mg once daily for 11 days does not alter the plasma concentration profile or renal elimination of digoxin after a single 0.5 mg oral dose.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$ , acetylsalicylic acid , a-blockers , analgesics , @DRUG$ , anticonvulsants, benzodiazepines, beta-blockers, calcium channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also known as NSAIDs), and quinolone anti-infections without evidence of clinically significant adverse interactions.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , @DRUG$ , A-blockers, analgesics, angiotensin converting enzyme ( ACE) inhibitors, anticonvulsants, benzodiazepines, beta-blockers, calcium channel blockers, cardiac nitrates, diuretics, H2 antagonists, @DRUG$ Prostaglandin synthetase inhibitors (also known as NSAIDs) and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
The hypoglycemic action of @DRUG$ may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, @DRUG$, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-effect
@DRUG$ may augment the activity of other @DRUG$.	DDI-effect
@DRUG$ Do not use in patients who: @DRUG$ ..	DDI-advise
Cyclosporine , Digoxin , Methotrexate @DRUG$ As with other NSAIDs, due to effects on renal prostaglandins, changes in the elimination of these drugs may lead to increased serum levels of @DRUG$ , digoxin, methotrexate, and increased toxicity.	DDI-mechanism
Micro-dosed progesterone preparations : Micro-dosed progesterone preparations @DRUG$ preparations ( minipills that do not contain an @DRUG$ ) may be an inadequate contraceptive method during Accutane therapy.	DDI-false
Other concomitant therapy Although no specific interaction studies have been conducted, 1 mg or more of finasteride doses have been reported in clinical trials with acetaminophen, acetylsalicylic acid, A-blockers, analgesics, angiotensin converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, @DRUG$ , calcium-channel blockers , cardiac @DRUG$ , diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also known as NSAIDs), and quinolones anti-infections without evidence of clinically significant adverse interactions.	DDI-false
Haloperidol: @DRUG$ blocks dopamine receptors, thus inhibiting the central stimulant effects of @DRUG$.	DDI-effect
In patients receiving @DRUG$ , the addition of @DRUG$ to therapy could prolong the prothrombin time .	DDI-effect
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: @DRUG$ and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
@DRUG$ : When multiple doses of @DRUG$ and digoxin were coadministered , steady-state plasma digoxin concentrations increased by approximately 20 % .	DDI-false
Rhabdomyolysis has been observed in patients receiving HMG-CoA reductase inhibitors administered alone ( at recommended dosages ) or concomitantly with @DRUG$ including @DRUG$.	DDI-false
Potential pharmacokinetic interactions have been reported in clinical pharmacokinetic studies (phenytoin, valproate, oral @DRUG$ , @DRUG$ , warfarin, probenecid) and pharmacokinetic screening in placebo-controlled clinical trials in epilepsy patients.	DDI-false
Multivalent Cation-Containing Products : Simultaneous Application of a @DRUG$ , including ciprofloxacin, containing multivalent cation products such as: @DRUG$ Or aluminum antacids, sucralfat, VIDEX chew/buffer tablets or child powder, or products that contain calcium, iron or zinc can significantly reduce the absorption of ciprofloxacin, resulting in serum and urine levels significantly lower than desired.	DDI-mechanism
@DRUG$ and Angiotensin II Receptor Antagonists (Hypertension)- In clinical studies of patients with hypertension , the addition of @DRUG$ 50 to 100 mg to ACE inhibitors and angiotensin II receptor antagonists slightly increased the mean serum potassium (approximately 0.09 - 0.13 mEq/L).	DDI-false
The AUC of @DRUG$ was increased 2.2-fold by coadministration of @DRUG$, a potent inhibitor of CYP3A4, 400 mg daily for 5 days.	DDI-mechanism
Example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , @DRUG$ , imatinib , isoniazid , nefazodone , @DRUG$ Propofol, protease inhibitors, quinidine and verapamil.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and antineoplastic agents , specifically , @DRUG$ , @DRUG$ , tamoxifen and interferon-alfa .	DDI-false
In clinical studies performed with @DRUG$, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of @DRUG$.	DDI-false
Multivalent Cation-Containing Products : Concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , @DRUG$ , VIDEX chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or @DRUG$ may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .	DDI-false
Edema has been reported in patients treated with @DRUG$ and @DRUG$.	DDI-effect
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril , beta-blockers , @DRUG$ , digoxin, warfarin, isosorbide mononitrate, geschnitztilol, @DRUG$ or itraconazole .	DDI-false
- @DRUG$ , orally (diabetes medicine you take through your mouth) @DRUG$ Sulfapyridine may increase the likelihood of side effects affecting blood and/ or side effects or oral antidiabetic agents.	DDI-false
Reciprocal interactions may occur with concomitant use of antizole and medicinal products that potentiate or inhibit the cytochrome P450 system (e.g. @DRUG$ , carbamazepine , @DRUG$ , ketoconazole ) , though this has not been studied	DDI-false
MAO Inhibitors: DURAGESIC  is not recommended for use in patients who have received @DRUG$ within 14 days because severe and unpredictable potentiation by MAO inhibitors has been reported with @DRUG$	DDI-false
Central Nervous System Depressants : The concomitant use of DURAGESIC   ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , @DRUG$ , sedatives (e.g., @DRUG$ ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	DDI-false
only @DRUG$ Elevated @DRUG$-induced increase in accumbal dopamine.	DDI-effect
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, dapsones, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporin, ergot derivatives, pimozide, carbamazepine, @DRUG$ , @DRUG$ , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
DIGOXIN: Plasma digoxin levels and @DRUG$ clearance at steady-state were not affected by co-administration of 0.2 mg @DRUG$.	DDI-false
@DRUG$ @DRUG$  (1000 mg twice daily) did not influence the pharmacokinetics and pharmacodynamics (ECG) of digoxin given as a 0.25 mg dose every day.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, @DRUG$, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Injection : Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system if with @DRUG$ , phenothiazines , barbiturates , MAO inhibitors , and other antidepressants . When scopolamine is used concomitantly with injectable @DRUG$ An increased incidence of sedation, hallucinations, and irrational behaviour has been observed.	DDI-false
In clinical trials with: @DRUG$ , concomitant use of oral anticoagulants ( @DRUG$ ), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam) and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (@DRUG$, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that @DRUG$ may impair absorption of fosinopril.	DDI-false
acetaminophen/theophylline , lidocaine/quinidine , @DRUG$/acetaminophen , phenobarbital/@DRUG$ , quinidine/lidocaine , theophylline/acetaminophen , and valproic acid/phenobarbital .	DDI-false
Multivitamins , or other products containing iron or @DRUG$ , antacids or @DRUG$ should not be administered concomitantly with , or within 2 hours of , the administration of norfloxacin , because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin .	DDI-false
@DRUG$ : @DRUG$ There is no apparent pharmacokinetic interaction with glyburide.	DDI-false
Concomitant @DRUG$ , doxorubicin , @DRUG$ , and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related , non-Hodgkin lymphoma .	DDI-false
Corticosteroids , Methylxanthines and Diuretics : Concomitant treatment with xanthine derivatives , @DRUG$ Diuretics may potentiate a possible hypokalemic effect @DRUG$	DDI-effect
Drugs that may alter imatinib plasma concentrations Drugs that may increase @DRUG$ plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, erythromycin, @DRUG$).	DDI-false
Cephalosporins-@DRUG$ containing side chains of N-methylthiotetrazole ( @DRUG$ , cefoperazone , cefotetan , cefamandole , latamoxef ) or methylthiadiazole ( cefazolin ) can cause vitamin K deficiency and hypoprothrombinemia .	DDI-false
For example, inhibitors are azole antimycotics, ciprofloxacin, @DRUG$ , diclofenac , doxycycline , erythromycin , imatinib , @DRUG$ , Nefazodone, Nicardipine, Propofol, Protease inhibitors, quinidine, and verapamil.	DDI-false
These drugs include the thiazides and other diuretics, @DRUG$, phenothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Antihistamines: @DRUG$*, @DRUG$* CONTRAINDICATED due to potential for serious and/or life-threatening cardiac arrhythmias.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of @DRUG$, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, @DRUG$, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, cefotetan, cefamandole, @DRUG$) or methylthiadiazole (@DRUG$) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Nephrotoxicity has been reported following concomitant administration of @DRUG$ and @DRUG$.	DDI-effect
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
A possible interaction between glyburide and @DRUG$ , a @DRUG$ , has been reported to enhance the hypoglycaemic effect of glyburide.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or @DRUG$ antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, @DRUG$, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ACE ) inhibitors , @DRUG$ , @DRUG$ , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , H2 antagonists , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
Carbamazepine: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of @DRUG$ toxicity should be monitored closely, and appropriate dosage adjustment of the @DRUG$ should be made.	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, @DRUG$ , @DRUG$ , MAO inhibitors , and other antidepressants . When scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .	DDI-false
The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving @DRUG$ , @DRUG$ Or phenothiazines can cause severe, prolonged hypotension or hypertension.	DDI-false
Since @DRUG$ - is a substrate for @DRUG$ There is the potential that the use of St. John's word in patients receiving amiodarone could lead to reduced amiodarone levels.	DDI-false
Other Drug Interactions: No pharmacokinetic interactions were observed between @DRUG$ and the following drugs: glyburide, warfarin, @DRUG$, Maalox, and ranitidine.	DDI-false
The AUC of @DRUG$ was increased 2.2-fold by coadministration of @DRUG$ A potent inhibitor of CYP3A4, 400 mg daily for 5 days.	DDI-mechanism
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., @DRUG$), general anesthetics, phenothiazines, skeletal muscle relaxants, and @DRUG$, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
@DRUG$ in large amounts may counteract the antiepileptic effect of phenobarbital, phenytoin and @DRUG$, and increase the frequency of seizures in susceptible pediatric patients.	DDI-effect
@DRUG$: Chlorpromazine blocks dopamine and norepinephrine receptors, thus inhibiting the central stimulant effects of @DRUG$ and can be used to treat amphetamine poisoning.	DDI-false
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, @DRUG$, glutethimide, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving @DRUG$ therapy.	DDI-false
Notably, systemic exposure (AUC0-12) of dapsone hydroxylamine (@DRUG$) was more than doubled in the presence of @DRUG$/SMX.	DDI-false
No pharmacokinetic interactions between dexmedetomidine and isoflurane, @DRUG$ , @DRUG$ ==References====External links==	DDI-false
Therefore , when @DRUG$ The patient should be closely monitored to determine whether the desired effect of the @DRUG$ ==References==	DDI-false
Antiarrhythmics: Amiodarone, bepridil, @DRUG$, propafenone, @DRUG$ CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
As higher doses of ketoconazole (400 mg daily) may lead to higher Cmax and AUC increases, a single dose of 2.5 mg may be necessary. @DRUG$ When used in combination with @DRUG$ 400 mg daily.	DDI-advise
Multivalent Cation-Containing Products : Concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as @DRUG$ Antacids or antacids of aluminium, sucralfat, VIDEX tablets, chewable/buffered tablets or pediatric powders or products which: @DRUG$ , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Carbamazepine : Isoniazid is known to slow the metabolism of @DRUG$ Carbamazepine levels should be determined prior to co-administration with isooniazide, signs and symptoms of carbamazepine toxicity should be closely monitored and appropriate dose adjustment of the @DRUG$ It should be done.	DDI-false
Aspirin : In normal volunteers, a small decrease in @DRUG$ levels was observed when multiple doses of diflunisal and @DRUG$ They were administered at the same time.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, @DRUG$, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, @DRUG$, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, betablockers, calcium-channel blockers, @DRUG$, and nonsteroidal anti-inflammatory drugs (@DRUG$) without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$: Concomitant administration of antacids may reduce plasma levels of @DRUG$.	DDI-false
The aim of this paper was to study the interaction between @DRUG$ and both @DRUG$ or its synthetic analogue D-Ala2-metenkephalinamide, or tuftsin, on the antinonciceptive effect of these peptides in mice after intracisternal injection.	DDI-false
Multivitamins , or other products containing iron or @DRUG$ , @DRUG$ or sucralfate should not be administered concomitantly with , or within 2 hours of , the administration of norfloxacin , because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin .	DDI-false
Elevated serum levels of @DRUG$ have been reported with concomitant use of cyclosporine with @DRUG$.	DDI-false
In vitro binding studies with human serum proteins indicate that @DRUG$ binds differently than @DRUG$ and does not interact with salicylate or dicumarol.	DDI-false
A 5-mg @DRUG$ The dose should not be exceeded if used in combination with 200 mg once daily @DRUG$.	DDI-advise
Example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , @DRUG$ , isoniazid , nefazodone , nicardipine , propofol , @DRUG$ , quinidine , and verapamil .	DDI-false
No Important Interactions To Date @DRUG$ does not have clinically important pharmacokinetic interactions with captopril, @DRUG$, felodipine, digoxin, warfarin, isosorbide mononitrate, carvedilol, ethanol or itraconazole.	DDI-false
Theophylline : As with some other quinolones , concurrent administration of ciprofloxacin with @DRUG$ It can lead to increased serum concentrations. @DRUG$ and prolongation of its elimination half-life .	DDI-false
Like ibogaine ( 40 mg/kg ) , @DRUG$ ( 40 mg/kg ) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of @DRUG$ nicotine in rats;	DDI-false
Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving @DRUG$ (caution is recommended during coadministration with alprazolam): Coadministration of fluoxetine with alprazolam increased the maximum plasma concentration of @DRUG$ by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance.	DDI-false
Acetaminophen/@DRUG$, lidocaine/chinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen and valproic acid/phenobarbital.	DDI-false
Similarly dialyzed were @DRUG$, quinidine, and theophylline, both alone at therapeutic concentrations in serum and with @DRUG$ at three different concentrations in serum.	DDI-false
- @DRUG$, oral (diabetes medicine you take by mouth) Use of oral antidiabetics with @DRUG$ may increase the chance of side effects affecting the blood and/or the side effects or oral antidiabetics	DDI-false
These results suggest that both @DRUG$ and @DRUG$ , and possibly other glucocorticoids and retinoids , may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF .	DDI-false
@DRUG$ will increase plasmaconcentration of other CYP3A4 metabolized drugs (e.g., triazolo-benzodiazepines, dihydropyridine calcium channel blockers, certain @DRUG$, etc.).	DDI-mechanism
@DRUG$ : When Lodine is administered with aspirin , its protein binding is reduced , although the clearance of free @DRUG$ It's not changing.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , @DRUG$ , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , H2 antagonists , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and @DRUG$ Without evidence of clinically significant adverse interactions.	DDI-false
Colestipol-Concomitant intake of colestipol and @DRUG$ The absorption of @DRUG$ can be reduced.	DDI-false
Antiarrhythmics: Other @DRUG$ drugs, such as quinidine, procainamide, disopyramide, and @DRUG$, have been used concurrently with amiodarone.	DDI-false
Based on the chemical similarity of itraconazole and @DRUG$ , coadministration of @DRUG$ with itraconazole is contraindicated .	DDI-false
The risk of myopathy during treatment with medicines in this class is associated with the use of @DRUG$ , fibric acid derivatives , niacin ( @DRUG$ ) , erythromycin , azole antifungals .	DDI-false
Hypotension : patients receiving diuretic therapy : patients below @DRUG$ and especially those in whom diuretic therapy was recently instituted , may occasionally experience an excessive reduction of blood pressure after initiation of therapy with enalapril or @DRUG$.	DDI-effect
Central nervous system depressants : Co-administration of @DRUG$ Fentanyl transdermal system (Fentanyl transdermal system) with other @DRUG$ , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	DDI-effect
@DRUG$ : In normal volunteers , concomitant administration of @DRUG$ and hydrochlorothiazide resulted in significantly increased plasma levels of hydrochlorothiazide .	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, @DRUG$), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, asparaginase) effects with @DRUG$ may increase toxicity in these organ systems.	DDI-effect
Tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , @DRUG$ , certain tricyclic antidepressants, @DRUG$ , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Carbamazepine: Isoniazid is known to slow the metabolism of @DRUG$ and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of @DRUG$ toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, @DRUG$, angiotensin-converting enzyme (ACE) inhibitors, @DRUG$, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Tolazamide: A case of severe hypoglycemia has been reported in a type II diabetic patient maintained on @DRUG$ (1 gm/day) 11 days after the addition of @DRUG$ (75 mg/day).	DDI-effect
The addition of 540 mg/kg/day @DRUG$ 340 times the recommended daily dose of inhalation in adults on mg/m2 basis) to 2.7 mg/kg/day @DRUG$ ( approximately 7 times the maximum recommended daily inhalation dose in adults on a mg/m2 basis ) appears to have increased the incidence of both resorptions and malformations .	DDI-effect
Drug Interactions : Flupenthixol may interact with some drugs , like Monoamine oxidase inhibitors ( MAOI ): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - @DRUG$ Flupentixol and ethanol cause additive CNS depression - tricyclic antidepressants : flupentixol increases the effect of tricyclic antidepressants	DDI-false
Other Drug Interactions: No pharmacokinetic interactions were observed between @DRUG$ and the following drugs: @DRUG$, warfarin, digoxin, Maalox, and ranitidine.	DDI-false
@DRUG$: Dihydroergotamine, ergonovine, ergotamine, @DRUG$ CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ACE ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , @DRUG$ HMG-CoA reductase inhibitors, @DRUG$ ==See also==*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID==References==	DDI-false
Two of 16 subjects dosed simultaneously with @DRUG$ 10 mg and @DRUG$ 0.4 mg experienced a standing systolic blood pressure below 85 mm Hg.	DDI-effect
This effect can be mediated by the ability to @DRUG$ It is used to induce microsomal enzymes and thus the catabolism of @DRUG$.	DDI-mechanism
The plasma valproate concentration should be monitored if: @DRUG$ and @DRUG$ When co-administered, appropriate dose adjustments of valproate should be made.	DDI-advise
Other concomitant therapy Although no specific interaction studies have been conducted, 1 mg or more of finasteride doses have been used in clinical trials with acetaminophen, acetylsalicylic acid, A-blockers, @DRUG$ , angiotensin-converting enzyme ( ACE ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , @DRUG$ H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also known as NSAIDs) and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
The intensity, uniformity and time course of the anticoagulant interference by @DRUG$ , secobarbital , glutethimide , chloral hydrate and methaqualone were systematically investigated in 16 patients receiving @DRUG$ therapy .	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, hypnotics and @DRUG$ (including @DRUG$), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
Co-administration of BOTOX and @DRUG$ or other agents interfering with neuromuscular transmission (e.g., curare-like compounds) should only be performed with caution as the effect of the @DRUG$ may be potentiated.	DDI-false
Probenecid: @DRUG$, a renal tubular secretion blocking agent, administered at a dose of 500 mg four times a day, did not change the pharmacokinetics of @DRUG$ 1000 mg twice daily.	DDI-false
Data from in vitro studies of benzodiazepines other than @DRUG$ suggest a possible drug interaction for the following: ergotamine, cyclosporine, amiodarone, @DRUG$, and nifedipine.	DDI-int
The administration of local anesthetic solutions containing epinephrine or @DRUG$ Patients receiving monoamine oxidase inhibitors, @DRUG$ Or phenothiazines can cause severe, prolonged hypotension or hypertension.	DDI-effect
@DRUG$ • no significant impact on the @DRUG$ pharmacokinetics .	DDI-false
- Anabolic steroids (@DRUG$ [e.g., Anabolin], @DRUG$ [e.g., Anavar], oxymetholone [e.g., Anadrol], stanozolol [e.g., Winstrol]) or	DDI-false
@DRUG$     @DRUG$ antagonism	DDI-false
Patients receiving high doses of @DRUG$ concomitantly with @DRUG$, as in rheumatic disease, may experience salicylate toxicity at lower doses because of competitive renal excretory sites.	DDI-effect
Central Nervous System Depressants: The concomitant use of DURAGESIC  (@DRUG$ transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and @DRUG$, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
In a comparison of @DRUG$ tolerance in dogs anesthetized with ketamine, @DRUG$, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with pentobarbital.	DDI-false
ACE inhibitors and angiotensin II receptor antagonists (hypertension)- In clinical trials in patients with hypertension, the addition of @DRUG$ 50 to 100 mg to ACE inhibitors and @DRUG$ increased mean serum potassium slightly ( about 0.09 - 0.13 mEq/L ) .	DDI-effect
Anticoagulants : potentiation of the warfarin type ( @DRUG$ Anticoagulant response is almost always observed in patients who: @DRUG$ And can lead to severe or fatal bleeding.	DDI-false
Therefore you may need to take a @DRUG$ Supplement while taking @DRUG$.	DDI-advise
Injection : Lorazepam injection, as other injectable @DRUG$ , produces depression of the central nervous system when administered with ethyl alcohol, phenothiazine, barbiturates, MAO inhibitors and other @DRUG$.If scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations and irrational behaviour has been observed.	DDI-effect
ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving @DRUG$ 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (ACEI/@DRUG$).	DDI-false
Patients on @DRUG$ treatment should be closely monitored when @DRUG$ is introduced or withdrawn.	DDI-advise
Although no studies have been conducted, concomitant administration of Itraconazole and @DRUG$ may alter the metabolism of @DRUG$;	DDI-false
These drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , @DRUG$ , estrogens , oral contraceptives , @DRUG$ , nicotinic acid, sympathomimetics, calcium channel block drugs, and isoniazid.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
The effects of DCG-IV and @DRUG$ After phencyclidine (@DRUG$)-induced movement and behavioural changes in mice.	DDI-false
@DRUG$ therapy Urinary excretion of @DRUG$ is increased, and efficacy is reduced by acidifying agents used in methenamine therapy.	DDI-false
Hypotension   Patients on @DRUG$ Therapy: Patients on diuretics and especially those in whom @DRUG$ therapy was recently instituted, as well as those on severe dietary salt restriction or dialysis, may occasionally experience a precipitous reduction of blood pressure usually within the first hour after receiving the initial dose of captopril.	DDI-false
- Anabolic steroids (nandrolone [e.g., @DRUG$], oxandrolone [e.g., Anavar], @DRUG$ [e.g., Anadrol], stanozolol [e.g., Winstrol]) or	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., @DRUG$, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, @DRUG$) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, @DRUG$, coumarins, monoamine oxidase inhibitors, and @DRUG$.	DDI-false
@DRUG$ effects are potentiated by @DRUG$.	DDI-effect
Particular caution is necessary when using ROMAZICON in cases of mixed drug overdosage since the toxic effects (such as convulsions and cardiac dysrhythmias) of other drugs taken in overdose (especially @DRUG$) may emerge with the reversal of the @DRUG$ effect by flumazenil.	DDI-false
Although neither dexamethasone nor retinyl acetate affected the proliferation of prostatic epithelium in RPMI1640 containing @DRUG$ alone, they modify the mitogenic effect of EGF and @DRUG$.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, @DRUG$, digoxin, warfarin, isosorbide mononitrate, carvedilol, ethanol or @DRUG$.	DDI-false
Garlic capsules Garlic capsules should not be used during ingestion @DRUG$ ( FORTOVASE ) as the sole @DRUG$ Because of the risk of decreased saquinavir plasma concentration.	DDI-false
• Exact monitoring and careful dose adjustment are required if: @DRUG$ is used with other anticholinergic drugs or @DRUG$.	DDI-advise
Another oral @DRUG$ ketoconazole inhibits metabolism @DRUG$ This results in increased plasma concentrations of astemizole and its active metabolite desmethylastermizole, which may prolong QT intervals.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (@DRUG$): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of @DRUG$	DDI-false
Drugs that cause significant sustained elevation in gastric pH (@DRUG$ such as ranitidine or @DRUG$) may reduce plasma concentrations of IRESSA and therefore potentially may reduce efficacy.	DDI-false
Slow-channel calcium blockers, such as verapamil, @DRUG$ and @DRUG$, inhibit platelet activation in vitro, and decrease platelet adhesion intravascularly.	DDI-false
In clinical studies performed with Fondaparinux , the concomitant use of oral anticoagulants ( warfarin ) , platelet inhibitors ( acetylsalicylic acid ) , NSAIDs ( @DRUG$ ) , and @DRUG$ The pharmacokinetics/pharmacodynamics of fondaparinux sodium were not significantly affected.	DDI-false
Benzthiazide may interact with alcohol, @DRUG$s, decongestant medications (allergic, cold, and sinus drugs), diabetics, lithium, norepinephrine, NSAIDs such as Aleve or @DRUG$ , and high blood pressure medications .	DDI-false
OBJECTIVE : Our objective was to characterize the steady-state pharmacokinetics of @DRUG$ and cyclosporine ( INN , @DRUG$ ) when coadministered in de novo kidney allograft recipients during the first year after transplantation .	DDI-false
Co-administration of @DRUG$ with @DRUG$ produced a 25% increase in AUC and a 33% increase in the Cmax of acamprosate.	DDI-mechanism
@DRUG$ : Amphetamines inhibit the hypotensive effect of @DRUG$.	DDI-false
It is desirable to monitor @DRUG$ Plasma levels if: @DRUG$ It is administered at the same time as another medicine, which is known to be an inhibitor of P450 2D6.	DDI-false
Acetaminophen , lidocaine , phenobarbital , @DRUG$ , theophylline , and @DRUG$ The pooled human serum was added at therapeutic concentrations.	DDI-false
Physiological oral @DRUG$ supplementation (5 mg/kg/day) is easy and can be carried out in the diet or with @DRUG$s, with practically only one contra-indication: overt renal failure.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, @DRUG$, calcium-channel blockers, cardiac nitrates, diuretics, @DRUG$, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$-Concomitant intake of @DRUG$ and vitamin K may reduce the absorption of vitamin K.	DDI-false
Because Nalfon has not been shown to produce any additional effect beyond that obtained with aspirin alone and because aspirin increases the rate of excretion of @DRUG$ , the concomitant use of Nalfon and @DRUG$ It's not recommended.	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase @DRUG$ plasma concentrations : Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family ( e.g. , ketoconazole , itraconazole , @DRUG$ ,,,,,,,,,,,	DDI-false
Other Cardiovascular Agents : Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents , methyldopa , nitrates , @DRUG$ , hydralazine , @DRUG$ and digoxin without evidence of clinically significant adverse interactions .	DDI-false
Potassium Supplements and Potassium-Sparing Diuretics : @DRUG$ can attenuate potassium loss caused by @DRUG$.	DDI-effect
Bacteriostatic Antibiotics: Chloramphenicol, @DRUG$, @DRUG$, or tetracyclines may interfere with the bactericidal effect of penicillins.	DDI-false
Antidepressants, @DRUG$ Amphetamines may enhance the activity of tricyclic antidepressants or @DRUG$;	DDI-false
These drugs include the @DRUG$ and other diuretics, corticosteroids, phenothiazines, @DRUG$, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with @DRUG$, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of @DRUG$, with ketamine or Innovar than with pentobarbital.	DDI-false
Example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , @DRUG$ , doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, @DRUG$ ==References====External links==	DDI-false
@DRUG$ Dihydroergotamine, ergonovine, ergotamine, @DRUG$ CONTRAINDICATE because of the potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasms and ischaemia of extremities and other tissues.	DDI-false
In a pharmacokinetic interaction study with @DRUG$ , bioavailability parameters , the degree of protein binding , and the anticoagulant effect ( measured by prothrombin time ) of @DRUG$ were not significantly changed .	DDI-false
These increases should be considered when selecting an oral dose. @DRUG$ For a woman taking @DRUG$.	DDI-advise
Drug Interactions : Flupenthixol may interact with some drugs , like Monoamine oxidase inhibitors ( MAOI ): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol : Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants : Flupenthixol increases the effect of @DRUG$	DDI-false
@DRUG$: (oral agents and @DRUG$) - dosage adjustment of the antidiabetic drug may be required.	DDI-false
Aspirin: @DRUG$ (10 mg and 20 mg) did not potentiate the increase in bleeding time caused by @DRUG$ (two 81 mg tablets).	DDI-false
Example inhibitors include @DRUG$ , ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodon, @DRUG$ , propofol , protease inhibitors , quinidine , and verapamil .	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with @DRUG$ , Innovar Vet, or @DRUG$ The dosage of Ouabain needed to cause ventricular tachycardia was significantly higher, such as the LD50 of Ouabain, with ketamine or innovar than with pentobarbital.	DDI-false
Theophylline: As with some other @DRUG$, concurrent administration of ciprofloxacin with theophylline may lead to elevated serum concentrations of @DRUG$ and prolongation of its elimination half-life.	DDI-false
Since amiodarone is a substrate for @DRUG$, there is the potential that the use of St. John s Wort in patients receiving amiodarone could result in reduced @DRUG$ levels.	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with @DRUG$ may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with @DRUG$.	DDI-false
@DRUG$, or other products containing iron or zinc, antacids or @DRUG$ should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, @DRUG$, oral contraceptives, @DRUG$, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Pretreatment of healthy volunteers with multiple doses of @DRUG$ followed by a single dose of Gleevec, increased @DRUG$ oral-dose clearance by 3.8-fold, which significantly (p 0.05) decreased mean cmax and AUC(0-8).	DDI-false
@DRUG$: Chloramphenicol, erythromycins, sulfonamides, or tetracyclines may interfere with the bactericidal effect of @DRUG$.	DDI-false
@DRUG$ (20 mg) did not potentiate the hypotensive effects of @DRUG$ during the 4-hour observation period in healthy volunteers when administered with alcohol (0.5 g/kg body weight).	DDI-false
Vitamin A : Because of the relationship between Accutane and @DRUG$ Patients should be prevented from: @DRUG$ Containing vitamin A to avoid additive toxic effects	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Studies in rats have shown that neomycin administration attenuates certain types of @DRUG$ dependent hypertension, including @DRUG$ hypertension.	DDI-false
Tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , @DRUG$ , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , @DRUG$ Theophylline, and metronidazole, delaying the elimination and increase in blood levels of these drugs.	DDI-false
It is recommended to avoid concurrent administration of @DRUG$ with aluminum hydroxide containing @DRUG$ for at least 4 hours following ethambutol administration .	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , @DRUG$ , disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolem, and @DRUG$ Concomitant use with saquinavir may result in increased plasma concentrations.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, @DRUG$, benzodiazepines, @DRUG$, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ : Administration of nonsteroial anti-inflammatory drugs concomitantly with cyclosporine has been associated with an increase in @DRUG$-induced toxicity , possibly due to decreased synthesis of renal prostacyclin .	DDI-false
Potential drug interactions between @DRUG$  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and @DRUG$) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase @DRUG$ plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, @DRUG$, clarithromycin).	DDI-false
@DRUG$ MAOI antidepressants , as well as a metabolite of furazolidone , slow @DRUG$ metabolism .	DDI-false
ANTACID (magnesium-aluminium hydroxide): @DRUG$ plasma concentrations were not affected by co-administration of @DRUG$.	DDI-false
Other Drug Interactions Oral @DRUG$ Keppra  (500 mg twice daily) did not influence the pharmacokinetics of an oral contraceptive containing 0.03 mg ethinyl estradiol and 0.15 mg @DRUG$, or of the luteinizing hormone and progesterone levels, indicating that impairment of contraceptive efficacy is unlikely.	DDI-false
Standard monitoring of @DRUG$-related toxicity should be continued if VIOXX and @DRUG$ are administered concomitantly.	DDI-false
Concurrent administration of @DRUG$ and @DRUG$ may cause severe orthostatic hypotension . Cimetidine , an inhibitor of microsomal drug metabolism , increased altretamines half-life and toxicity in a rat model .	DDI-effect
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, Dapson, disopyramide, quinine, amiodarone, quinidine, @DRUG$ , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , @DRUG$ , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing @DRUG$, iron, or zinc may substantially decrease the absorption of @DRUG$, resulting in serum and urine levels considerably lower than desired.	DDI-false
Other Drug Interactions Oral Contraceptives @DRUG$  (500 mg twice daily) did not influence the pharmacokinetics of an oral @DRUG$ containing 0.03 mg ethinyl estradiol and 0.15 mg levonorgestrel, or of the luteinizing hormone and progesterone levels, indicating that impairment of contraceptive efficacy is unlikely.	DDI-false
Antimycobacterial Agents : @DRUG$ CONTRAINDICATED since the coadministration of this product with saquinavir in an antiretroviral regimen reduces the plasma concentrations of @DRUG$.	DDI-false
@DRUG$: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of @DRUG$ toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.	DDI-false
This medication can be used with alcohol or other CNS depressants (may potentiate the CNS depressive effect of either these medications or @DRUG$ ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( MAO ) inhibitors ( concurrent use with @DRUG$ may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines ) .	DDI-false
As with other antipsychotics, it should be noted that: @DRUG$ may be capable of potentiating CNS depressants such as anesthetics , opiates , and @DRUG$.	DDI-effect
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , disopyramide , @DRUG$ , amiodarone , @DRUG$ , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
The hypoglycemic effect of @DRUG$ has been reported to increase when @DRUG$ is given concurrently .	DDI-effect
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain @DRUG$, lidocaine, theophylline and @DRUG$, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Suppression by verapamil of @DRUG$-enhanced peritoneal metastasis of intestinal adenocarcinomas induced by @DRUG$ in wistar rats.	DDI-false
@DRUG$ may suppress certain CYP450 enzymes , including CYP1A2 , CYP2C9 , @DRUG$ , and CYP3A4.	DDI-false
@DRUG$: As with some other quinolones, concurrent administration of ciprofloxacin with @DRUG$ may lead to elevated serum concentrations of theophylline and prolongation of its elimination half-life.	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced adverse reactions such as fever, renal failure, hyperbilirubinaemia, confusion and dyspnoea, concomitant administration of these agents with PROLEUKIN may reduce the efficacy of antitumours. @DRUG$ 12 beta blockers and others @DRUG$ may potentiate the hypotension seen with PROLEUKIN .	DDI-false
"Ergot derivatives: dihydroergotamine, @DRUG$ , ergotamine, methylergonovine CONTRAINDICATED due to the potential for serious and life-threatening reactions such as acute @DRUG$ Toxicity characterized by peripheral vasospasm and ischemia of extremities and other tissues.	DDI-false
@DRUG$, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, @DRUG$, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-mechanism
@DRUG$: The rate and extent of absorption of @DRUG$ was bioequivalent when Proquin XR was given alone or when Proquin XR was given 2 hours after omeprazole at the dose that maximally suppresses gastric acid secretion.	DDI-false
Intravenous Adenocard (adenosine) has been effectively administered in the presence of other cardioactive drugs, such as quinidine, beta-adrenergic blocking agents, @DRUG$, and @DRUG$, without any change in the adverse reaction profile.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, doxorubicin, teniposide, and prednisone with @DRUG$ plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Because of the increased risk of adverse reactions in patients who have been taking benzodiazepines on a regular basis, it is particularly important that physicians query patients or their guardians carefully about benzodiazepine, @DRUG$ and @DRUG$ use as part of the history prior to any procedure in which the use of ROMAZICON is planned.	DDI-false
Multivalent Cation-Containing Products : Concomitant administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminium @DRUG$ , @DRUG$ , VIDEX chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .	DDI-false
Lithium : NSAIDs have produced an elevation of plasma @DRUG$ Concentrations and a reduction in kidneys @DRUG$ clearance .	DDI-false
The concomitant administration of medicinal products that are nephrotoxic (e.g. aminoglycosides, indomethacin), myelotoxic (e.g. cytotoxic chemotherapy), cardiotoxic (e.g. doxorubicin) or hepatotoxic (e.g. methotrexate), @DRUG$ ) effects with @DRUG$ may increase toxicity in these organ systems .	DDI-effect
acetaminophen/theophylline , lidocaine/quinidine , @DRUG$/acetaminophen , phenobarbital/valproic acid , quinidine/lidocaine , theophylline/acetaminophen , and valproic acid/@DRUG$.	DDI-false
Anticholinesterases (neostgmine, @DRUG$ ) , lignocaine , @DRUG$ , procainamide can enhance toxicity and cause cardio respiratory depression .	DDI-false
Other strong inhibitors of CYP3A4 (e.g., @DRUG$, clarithromycin, nefazodone, troleandomycin, @DRUG$, nelfinavir) would be expected to behave similarly.	DDI-false
Multivitamins, or other products containing @DRUG$ or zinc, antacids or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of @DRUG$.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ACE ) inhibitors , anticonvulsants , @DRUG$ , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , H2 antagonists , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and @DRUG$ without evidence of clinically significant adverse interactions .	DDI-false
Although neither dexamethasone nor retinyl acetate influenced the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone, they modify the mitogenic effect of @DRUG$ and @DRUG$.	DDI-false
Cimetidine (400 mg b.i.d.) did not affect @DRUG$ bioavailability ( AUC ) and maximum concentration ( Cmax ) of vardenafil when co-administered with 20 mg @DRUG$ in healthy volunteers .	DDI-false
The conversion of @DRUG$ to @DRUG$ is catalyzed by aldehyde oxidase.	DDI-false
After multiple dosing, interferon beta-1a (@DRUG$  30 mcg IM once weekly) reduced @DRUG$  clearance by approximately 30%.	DDI-mechanism
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, @DRUG$, warfarin, isosorbide mononitrate, @DRUG$, ethanol or itraconazole.	DDI-false
In vitro binding studies with human serum proteins indicate that @DRUG$ binds differently than tolbutamide and does not interact with salicylate or @DRUG$.	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, @DRUG$, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of @DRUG$ and these AEDs during placebo-controlled clinical studies.	DDI-false
- mineral oil compositional intake of mineral oil and @DRUG$ may reduce the absorption of @DRUG$.	DDI-false
Therefore, prothrombin time should be carefully monitored in patients receiving @DRUG$ and @DRUG$-like drugs simultaneously.	DDI-advise
Benzthiazide may interact with @DRUG$, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like @DRUG$ or Ibuprofen, and high blood pressure medications.	DDI-false
Iodine or @DRUG$ excess may decrease the effect of @DRUG$ , and an iodine deficiency can increase the effect of Carbimazole .	DDI-false
@DRUG$ : Lithium toxicity has been reported in patients receiving lithium concomitantly with drugs which cause elimination of sodium , including @DRUG$.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Non-steroidal anti-inflammatory drugs : In some patients, the administration of a @DRUG$ can reduce the diuretic , natriuretic , and antihypertensive effects of @DRUG$.	DDI-effect
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of @DRUG$ as compared with fosinopril administered alone, suggesting that @DRUG$ may impair absorption of fosinopril.	DDI-false
@DRUG$ : When Lodine is administered with @DRUG$ , its protein binding is reduced , although the clearance of free etodolac is not altered .	DDI-false
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, @DRUG$, glutethimide, chloral hydrate and @DRUG$ were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
Prednisone/@DRUG$ : @DRUG$ did not have any clinically important effect on the pharmacokinetics of prednisolone or prednisone .	DDI-false
Concurrent administration of @DRUG$ and androgens may result in elevated serum levels of @DRUG$.	DDI-false
@DRUG$ generally should not be given with diuretics because they reduce lithiums renal clearance and add a high risk of @DRUG$ toxicity.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, @DRUG$, hypnotics, tranquilizers (e.g., benzodiazepines), general @DRUG$, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Central nervous system depressants: the concomitant use of DURAGESIC ( @DRUG$ transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , @DRUG$ ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	DDI-effect
Corticosteroids , @DRUG$ and @DRUG$ : Concomitant treatment with xanthine derivatives , steroids , or diuretics may potentiate a possible hypokalemic effect of   beta2-agonists .	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, Dapson, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporin, @DRUG$ , pimozide , carbamazepine , @DRUG$ , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
Drugs Interactions : Flupentixol may interact with some medicines such as monoamine oxidase inhibitors (MAOI): MAOI may theoretically affect flupentixol pharmacodynamics - Arecoline - Eproxindine - @DRUG$ : Flupenthixol and @DRUG$ cause additive CNS depression - Tricyclic antidepressants : Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Potassium-sparing diuretics ( e.g. , @DRUG$ , triamterene , or amiloride ) , @DRUG$ supplements , or potassium-containing salt substitutes may lead to significant increases in serum potassium .	DDI-false
In the present study, the atypical antipsychotic @DRUG$ was tested in combination with an active dose of @DRUG$ in two-lever drug discrimination and mixed signalled-unsignalled differential-reinforcement-of-low-rates (DRL) procedures.	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , @DRUG$ , dapsone , @DRUG$ , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
@DRUG$ has been administered with tolazoline , dopamine , @DRUG$ , steroids , surfactant , and high-frequency ventilation .	DDI-false
These medicines include thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$ , nicotinic acid , sympathomimet-ics , @DRUG$ ==References====External links==	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of @DRUG$ • Deficit and discrimination between magnesium deficiency due to insufficient @DRUG$ The intake, which requires only oral physiological supplement and magnesium deficiency, related to a dysregulation of the control mechanisms of magnesium status, which requires more or less specific regulation of its causal dysregulation.	DDI-false
Fulminant rhabdomyolysis has been seen as early as three weeks after initiation of combined therapy with another @DRUG$ and @DRUG$ but may be seen after several months .	DDI-effect
MAO Inhibitors : @DRUG$ The use in patients who received MAOI within 14 days is not recommended as severe and unpredictable potentiation due to: @DRUG$ Opioid analgesics have been reported	DDI-false
Dose adjustment is not recommended.@DRUG$ had no effect on plasma concentrations of carbamazepine , valproate , topiramate , or @DRUG$.	DDI-false
Non-steroidal Anti-inflammatory Drugs : In some patients , the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic , natriuretic , and antihypertensive effects of @DRUG-DRUG$.	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5 % Ophthalmic Solution , the possibility of an additive or potentiating effect with CNS depressants ( alcohol , barbiturates , opiates , @DRUG$ , @DRUG$ ) should be considered.	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, cefotetan, @DRUG$, @DRUG$) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Atromide-S can be acidic medicines such as @DRUG$ or @DRUG$ from their binding sites .	DDI-false
Both efavirenz and @DRUG$ have been compared to triple therapy with the PI indinavir over 48 weeks as initial therapy, with similar responses being observed with @DRUG$ regimens and superiority observed with efavirenz.	DDI-false
Although neither dexamethasone nor @DRUG$ affected the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone, they modify the mitogenic effect of @DRUG$ and insulin.	DDI-effect
@DRUG$ Patients who: @DRUG$ ( disulfiram , Wyeth-Ayerst Laboratories ) .	DDI-advise
Example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , @DRUG$ , imatinib, isoniazid, nefazodon, nicardipine, propofol, protease inhibitors, @DRUG$ ==References====External links==	DDI-false
Drug Interactions: @DRUG$ may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of @DRUG$	DDI-false
Micro-dosed Progesterone Preparations: Micro-dosed @DRUG$ preparations (minipills that do not contain an estrogen) may be an inadequate method of contraception during @DRUG$ therapy.	DDI-effect
@DRUG$ , Methylxanthines and Diuretics : Concomitant treatment with xanthine derivatives , steroids , or @DRUG$ A potential hypokalemic effect of beta2-agonists may be increased.	DDI-false
Moreover, additional interaction studies with @DRUG$ and propranolol have not demonstrated any effect on @DRUG$ plasma levels, and administration to a patient population chronically receiving digoxin resulted in no difference in the extent of bioavailability of digoxin relative to control data.	DDI-false
Human pharmacokinetics data indicate that oral @DRUG$ potently inhibits the metabolism of cisapride resulting in an eight-fold increase in the mean AUC of @DRUG$.	DDI-false
@DRUG$, Methylxanthines and Diuretics: Concomitant treatment with xanthine derivatives, steroids, or @DRUG$ may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
Co-administration: Concomitant use of @DRUG$ with antiplatelet agents, thrombolytics, and other @DRUG$ may increase the risk of bleeding.	DDI-effect
@DRUG$ @DRUG$ , as well as a metabolite of furazolidone , slow amphetamine metabolism .	DDI-false
Potassium-sparing diuretics ( e.g. , @DRUG$ , @DRUG$ Potassium supplements or salt substitutes containing potassium may lead to significant increases in serum potassium.	DDI-false
@DRUG$ : Amiodarone should be used with caution in patients receiving   -receptor blocking agents ( e.g. , propranolol , a @DRUG$ inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a CYP3A4 substrate , and diltiazem , a CYP3A4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and AV block ;	DDI-false
Aspirin: Concurrent administration of @DRUG$ may lower @DRUG$ plasma levels, possibly by competing for protein-binding sites.	DDI-mechanism
Aminosalicylic acid can reduce the amount of aminosalicylic acid @DRUG$ ( Lanoxin , @DRUG$ ) that gets absorbed into your body .	DDI-false
The intensity, uniformity and time course of the anticoagulant interference by phenobarbital, secobarbital, glutethimide, @DRUG$ and methaqualone were systematically investigated in 16 patients receiving @DRUG$ therapy .	DDI-false
Caution should be exercised when an HMG-CoA reductase inhibitor is administered concomitantly with medicinal products that may reduce the concentration or activity of endogenous steroid hormones, such as: @DRUG$ , @DRUG$ ==References====External links==	DDI-false
Monoamine Oxidase Inhibitors and Tricyclic Antidepressants: FORADIL should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or @DRUG$ because the action of @DRUG$ on the cardiovascular system may be potentiated by these agents.	DDI-false
apomorphine - prior ingestion of @DRUG$ may decrease the emetic response to @DRUG$ in the treatment of poisoning.	DDI-effect
Concomitant @DRUG$ , doxorubicin , vincristine , and @DRUG$ chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related , non-Hodgkin lymphoma .	DDI-false
Quetiapine fumarate ( ' @DRUG$ ==References====External links== @DRUG$ with demonstrated efficacy in the treatment of positive and negative symptoms of schizophrenia .	DDI-false
Possible drug interactions between Keppra and other AEDs (carbamazepine, gabapentin, lamotrigine, @DRUG$ , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these @DRUG$ during placebo-controlled clinical studies .	DDI-false
@DRUG$: In a study conducted in healthy subjects, mean steady-state lithium plasma levels increased approximately 17% in subjects receiving lithium 450 mg BID with CELEBREX 200 mg BID as compared to subjects receiving @DRUG$ alone.	DDI-false
@DRUG$ In healthy subjects receiving the CYP3A4 inducer, carbamazepine, with 100 mg twice daily for 3 days and 200 mg twice daily for 17 days, systemic exposure (AUC) of @DRUG$ 72% decreased.	DDI-false
@DRUG$ and Tricyclic Antidepressants : @DRUG$ should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents .	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing @DRUG$, @DRUG$, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
The effects of oral @DRUG$ on @DRUG$ induced hypertension were examined in conscious sheep.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, @DRUG$, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
These drugs include the @DRUG$ and other diuretics , corticosteroids , phenothiazines , thyroid products , @DRUG$ , oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel block drugs, and isoniazide.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as @DRUG$ or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or @DRUG$ may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Data from in vitro studies of @DRUG$ other than alprazolam suggest a possible drug interaction for the following: ergotamine, cyclosporine, amiodarone, @DRUG$, and nifedipine.	DDI-int
Thus , smaller doses of @DRUG$ It can be effective in the presence of @DRUG$.	DDI-effect
There have been case reports of increased steady-state levels of @DRUG$ , procainamide and @DRUG$ • during concomitant therapy with amiodarone.	DDI-false
@DRUG$      @DRUG$ antagonism	DDI-false
This drug may interact with alcohol or other @DRUG$ (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with @DRUG$), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
@DRUG$ , other , especially diazoxide , or preanesthetic and anesthetic agents used in surgery or @DRUG$ , not depolarizing, used in surgery	DDI-false
Because of the increased risk of adverse reactions in patients who have been taking benzodiazepines on a regular basis, it is particularly important that physicians query patients or their guardians carefully about @DRUG$, alcohol and sedative use as part of the history prior to any procedure in which the use of @DRUG$ is planned.	DDI-false
Protectors of children who have been prescribed @DRUG$ should be alerted to the general concern regarding asthma therapy compliance , especially neglect of anti-inflammatory therapy and overuse of @DRUG$.	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, dapsones, @DRUG$ , quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$ When co-administered with saquinavir, increased plasma concentrations may occur;	DDI-false
The bioavailability of the capsule formulation of @DRUG$ was not affected when administered 5 minutes following an @DRUG$.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
These drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid products , estrogens , oral @DRUG$ , phenytoin , nicotinic acid , sympathomimet-ics , calcium channel blocking drugs , and @DRUG$.	DDI-false
Injection : Lorazepam injection , like other injectable @DRUG$ , produces depression of the central nervous system when with ethyl alcohol, phenothiazine, barbiturates, @DRUG$ An increased incidence of sedation, hallucinations and irrational behaviour was observed with co-administration of scopolamine with injectable lorazepam.	DDI-effect
- Antidiabetics , oral ( diabetes medicine you take by mouth ) Use of oral @DRUG$ When sulfapyridin is used, the likelihood of adverse reactions affecting blood and/ or side effects or oral administration of sulfapyridin may be increased. @DRUG$	DDI-false
In EM individuals treated with @DRUG$ or fluoxetine, the AUC of atomoxetine is approximately 6- to 8-fold and Css,max is about 3- to 4-fold greater than @DRUG$ alone.	DDI-false
Other medicines: medicines such as quinidine, @DRUG$ Procainamide, phenothiazine, @DRUG$ , and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
No pharmacokinetic interactions between dexmedetomidine and @DRUG$ , propofol , alfentanil , and @DRUG$ have been demonstrated .	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics , amantadine , haloperidol , @DRUG$ , monoamine oxidase ( MAO ) inhibitors , @DRUG$ or some antihistamines .	DDI-false
@DRUG$ The effect of celecoxib on the anticoagulant effect of warfarin has been studied in a group of healthy subjects receiving daily doses of 2-5 mg @DRUG$.	DDI-false
@DRUG$ may decrease the amount of digoxin ( @DRUG$ Lanoxicaps that are absorbed into your body.	DDI-mechanism
Interaction on the antinociceptive effect between @DRUG$ and @DRUG$ or tuftsin.	DDI-effect
(In some patients, the steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of loop, @DRUG-DRUG$.	DDI-false
- @DRUG$ ( e.g. , @DRUG$ The use of sulfapyridin with these medicines may increase the likelihood of side effects of these medicines.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Other reported interactions with @DRUG$ : @DRUG$ ( CYP3A4 substrate ) in combination with amiodarone may cause hypotension , bradycardia , and decreased cardiac output .	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, dapsones, disopyramide, @DRUG$ , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , @DRUG$ , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
@DRUG$ Keppra   ( 1500 mg twice daily ) did not alter the pharmacokinetics of @DRUG$ For healthy volunteers.	DDI-false
Antihypertensives : Amiodarone should be used with caution in patients receiving   -receptor blocking agents ( e.g. , propranolol , a CYP3A4 inhibitor ) or calcium channel antagonists ( e.g. , @DRUG$ , a CYP3A4 substrate , and diltiazem , a @DRUG$ Inhibitor) because of the potential for bradycardia, sinus arrest and AV block;	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as @DRUG$ or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of @DRUG$, resulting in serum and urine levels considerably lower than desired.	DDI-false
Central Nervous System Depressants : The concomitant use of DURAGESIC   ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general @DRUG$ , phenothiazines , skeletal muscle relaxants , and @DRUG$ , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	DDI-false
@DRUG$ The amount of digoxin (lanoxin, @DRUG$ It is absorbed in your body.	DDI-false
Sinus bradycardia has been reported with oral amiodarone in combination with @DRUG$ (@DRUG$ substrate) given for local anesthesia.	DDI-false
Aspirin/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between @DRUG$ and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or @DRUG$ (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
Ergot Derivatives: @DRUG$, ergonovine, @DRUG$, methylergonovine CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
@DRUG$ Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be used prior to concomitant administration with isoniazid, signs and symptoms of @DRUG$ toxicity should be monitored closely , and appropriate dosage adjustment of the anticonvulsant should be made .	DDI-false
Antiarrhythmics : Other antiarrhythmic drugs , such as @DRUG$ , procainamide , disopyramide , and phenytoin , have been used concurrently with @DRUG$.	DDI-false
However, reports show that: @DRUG$ The antihypertensive effect of @DRUG$ can be reduced.	DDI-effect
The effects of ruthenium red (RR) on @DRUG$ (@DRUG$)-induced responses were studied in rat bone marrow megakaryocytes with the patch-clamp whole-cell recording technique in combination with fura-2 microfluorometry.	DDI-false
The steady state plasma concentrations of @DRUG$ and @DRUG$ have been reported to be increased an average of 31 % and 20 % , respectively , by the concomitant administration of alprazolam tablets in doses up to 4 mg/day .	DDI-false
Co-administration: Concomitant use of Argatroban with antiplatelet agents, @DRUG$, and other @DRUG$ may increase the risk of bleeding.	DDI-false
@DRUG$ When vardenafil 5 mg is co-administered with 600 mg twice daily @DRUG$ , the Cmax and AUC of ritonavir were reduced by approximately 20 % .	DDI-false
Acetaminophen, @DRUG$, phenobarbital, @DRUG$, theophylline, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
Colestipol: Plasma concentrations of @DRUG$ decreased approximately 25% when @DRUG$ and atorvastatin were coadministered.	DDI-false
@DRUG$ Amiodarone should be used with caution in patients receiving receptor blockers (e. g. @DRUG$ , a CYP3A4 inhibitor ) or calcium channel antagonists (e.g. verapamil, a CYP3A4 substrate and diltiazem, a CYP3A4 inhibitor ) because of the potential for bradycardia, sinus arrest and AV block;	DDI-false
Injection: Lorazepam injection, like other injectable @DRUG$, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other @DRUG$.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-effect
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, @DRUG$, calcium-channel blockers, diuretics, and nonsteroidal anti-inflammatory drugs (@DRUG$) without evidence of clinically significant adverse interactions.	DDI-false
These data indicate that levetiracetam does not influence the plasma concentration of other @DRUG$ and that these @DRUG$ Do not affect the pharmacokinetics of levetiracetam.	DDI-false
In addition , @DRUG$ - did not affect the pharmacodynamics of warfarin, acetylsalicylic acid, piroxicam and digoxin, or the pharmacokinetics of @DRUG$ at steady state .	DDI-false
Ritonavir ( 600 mg b.i.d . ) co-administered with @DRUG$ 5 mg resulted in a 49-fold increase in vardenafil AUC and a 13-fold increase in @DRUG$ Cmax .	DDI-false
@DRUG$ In a clinical pharmacology study, the concomitant use of antacids ( @DRUG$ In combination with fosinopril, serum levels and urinary excretion of fosinoprilat were reduced compared to fosinopril alone, suggesting that antacids may affect the absorption of fosinopril.	DDI-false
Central Nervous System Depressants : The concomitant use of DURAGESIC   ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , @DRUG$ Anaesthetics (e.g. benzodiazepines), general @DRUG$ , phenothiazine, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and deep sedation, or possibly coma or death.	DDI-false
Beta-blocking Agents : The concomitant use of @DRUG$ and @DRUG$ has been well tolerated in patients with stable angina .	DDI-false
These results suggest that both dexamethasone and retinyl acetate, and possibly other @DRUG$ The proliferation of prostate epithelium can be caused by a dose-dependent change in the activity of @DRUG$ and EGF .	DDI-effect
The availability of potent @DRUG$ (@DRUG$)-based regimens for antiretroviral therapy and concerns regarding protease inhibitor (PI)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection.	DDI-false
Tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , @DRUG$ , @DRUG$ , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .	DDI-false
Nifedipine: @DRUG$ 20 mg, when co-administered with slow-release @DRUG$ 30 mg or 60 mg once daily, did not affect the relative bioavailability (AUC) or maximum concentration (Cmax) of nifedipine, a drug that is metabolized via CYP3A4.	DDI-false
@DRUG$ , including norfloxacin , may enhance the effects of oral @DRUG$ , including warfarin or its derivatives or similar agents .	DDI-effect
Possible drug interactions between Keppra and other AEDs (carbamazepine, gabapentin, lamotrigine, @DRUG$ , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of @DRUG$ These AEDs during placebo-controlled clinical trials.	DDI-false
The concomitant use of itraconazole and @DRUG$ , tacrolimus or @DRUG$ The plasma concentrations of the last three drugs have been increased.	DDI-false
Other concomitant therapies : In clinical trials , the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics , @DRUG$ and @DRUG$ The use of placebo with these concomitant medications was similar to that of volunteers (including benzodiazepines), or non-opioid analgesics.	DDI-false
@DRUG$ MAOI antidepressants, as well as a metabolite of furazolidone, slow @DRUG$ metabolism.	DDI-false
@DRUG$-containing therapies should not be used with @DRUG$ as they may diminish its pharmacologic action.	DDI-advise
Data from in vitro studies of @DRUG$ suggest a possible drug interaction with alprazolam for the following: sertraline and @DRUG$.	DDI-false
INOmax has been administered with tolazoline, dopamine, dobutamine, @DRUG$, @DRUG$, and high-frequency ventilation.	DDI-false
Lithium : @DRUG$ have produced an elevation of plasma lithium levels and a reduction in renal @DRUG$ clearance .	DDI-false
Lithium: NSAIDs have produced an elevation of plasma @DRUG$ levels and a reduction in renal @DRUG$ clearance.	DDI-false
Nevertheless, clinical studies, as well as postmarketing observations have shown that @DRUG$ can reduce the natriuretic effect of furosemide and @DRUG$ in some patients.	DDI-effect
Results of studies in multiple sclerosis patients taking @DRUG$  and concomitant interferon beta-1a (AVONEX  30 mcg IM once weekly) or @DRUG$ were inconclusive with regard to the need for dose adjustment of the beta-interferon or glatiramer acetate.	DDI-false
ACE inhibitors and angiotensin II receptor antagonists (congestive heart failure after myocardial infarction)- In EPHESUS, 3020 (91%) patients also received INSPRA 25-50 mg. @DRUG$ Angiotensin II receptor antagonists (ACEI/@DRUG$).	DDI-false
Benzthiazide may interact with alcohol, @DRUG$s, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, @DRUG$, norepinephrine, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
@DRUG$: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the @DRUG$ should be made.	DDI-false
- Anabolic steroids (@DRUG$ [e.g., Anabolin], oxandrolone [e.g., Anavar], oxymetholone [e.g., Anadrol], @DRUG$ [e.g., Winstrol]) or	DDI-false
Coadministration of Itraconazole and @DRUG$, @DRUG$ or digoxin has led to increased plasma concentrations of the latter three drugs.	DDI-false
Potentiation occurs with @DRUG-DRUG$.	DDI-false
Compounds that have been tested in man include antipyrine, digoxin, @DRUG$, theophylline, and @DRUG$ and no clinically meaningful interactions were found.	DDI-false
Anti-arrhythmics and @DRUG$ could exaggerate the prolongation of the QT interval observed with @DRUG$.	DDI-effect
Other Drugs:Drugs such as @DRUG$, disopyramide, procainamide, phenothiazines, @DRUG$, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , @DRUG$ , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and @DRUG$ ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, @DRUG$ and sedatives (including @DRUG$), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
(In some patients, the steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of @DRUG-DRUG$.	DDI-false
BACKGROUND : The effects of combined administration of @DRUG$ and @DRUG$ ( verapamil ) , a calcium channel blocker , on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane ( AOM ) and the labeling index of intestinal cancers were investigated in male Wistar rats .	DDI-false
Inhibitors Of Endogenous Prostaglandin Synthesis It has been reported that @DRUG$ may reduce the antihypertensive effect of @DRUG$ , especially in cases of low renin hypertension.	DDI-effect
Potassium-sparing diuretics (e.g., spironolactone, @DRUG$, or amiloride), potassium supplements, or @DRUG$-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
Anticoagulants including coumarin derivatives , indandione derivatives , and platelet aggregation inhibitors such as nonsteroidal anti-inflammatory drugs ( @DRUG$ ) , and @DRUG$ The risk of bleeding may be increased when co-administered with ardeparin.	DDI-false
The antihypertensive effect of Enalapril and Enalapril IV is increased by: @DRUG$ , which cause the release of renin (e.g., @DRUG$ ) .	DDI-false
Warfarin Keppra  (1000 mg twice daily) did not influence the pharmacokinetics of @DRUG-DRUG$.	DDI-false
Co-administration of @DRUG$ with @DRUG$ has been shown to increase the mean half-life and the area under the concentration-time curve.	DDI-mechanism
Note: dissolution of aerosol particles of @DRUG$ in @DRUG$, a model lung surfactant.	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or @DRUG$, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of @DRUG$, with ketamine or Innovar than with pentobarbital.	DDI-false
The blood pressure effect of @DRUG$ tended to be greater in patients on atenolol than in patients on no other @DRUG$ therapy.	DDI-false
Monitoring the amiodarone toxicity and serial measurement of @DRUG$ serum concentration during concomitant @DRUG$ Treatment should be considered.	DDI-advise
- @DRUG$ ( e.g. , @DRUG$ ) or	DDI-false
Delayed Adverse Reactions to @DRUG$: A review of the literature revealed that 12.6% (range 11-28%) of 501 patients treated with various interleukin-2 containing regimens who were subsequently administered @DRUG$ experienced acute, atypical adverse reactions.	DDI-false
These drugs include the thiazides and other diuretics , corticosteroids , @DRUG$ , thyroid products , estrogens , oral contraceptives , phenytoin , @DRUG$ , sympathomimetics , calcium channel blocking drugs , and isoniazid .	DDI-false
- Anabolic steroids (nandrolone [e.g., @DRUG$], oxandrolone [e.g., Anavar], oxymetholone [e.g., Anadrol], stanozolol [e.g., @DRUG$]) or	DDI-false
Carbamazepine: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels @DRUG$ levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the @DRUG$ should be made.	DDI-false
Drug Interactions : Flupenthixol may interact with some drugs , like Monoamine oxidase inhibitors ( @DRUG$ ): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol : @DRUG$ and Ethanol cause additive CNS depression - Tricyclic antidepressants : Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Therefore , when @DRUG$ The patient should be closely monitored to determine whether the desired effect of the @DRUG$ is obtained .	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , @DRUG$ , chloramphenicol , @DRUG$ , Cumarine, monoamine oxidase inhibitors, and beta-adrenergic blockers.	DDI-false
Compounds tested in man include warfarin, @DRUG$, phenytoin, diazepam, aminopyrine and @DRUG$.	DDI-false
METHODS: From the beginning of the experiment, rats were given 10 weekly subcutaneous injections of @DRUG$ (7.4 mg/kg body weight) and subcutaneous injections of @DRUG$ (40 microg/kg body weight) every other day, and from week 16, intraperitoneal injections of verapamil (10 or 20 mg/kg body weight) every other day until the end fo the experiment in week 45.	DDI-false
High-dose cyclosporin A resulting in concentrations above 2000 ng/mL administered with oral etoposide has led to an 80% increase in @DRUG$ exposure with a 38% decrease in total body clearance of etoposide compared to @DRUG$ alone.	DDI-false
As with other @DRUG$ , it should be noted that HALDOL may be capable of potentiating CNS depressants such as anesthetics , @DRUG$ , and alcohol .	DDI-effect
Antihypertensives: @DRUG$ may antagonize the hypotensive effects of @DRUG$.	DDI-effect
Colestipol-Concomitant intake of @DRUG$ and vitamin K may reduce the absorption of @DRUG$.	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, @DRUG$, @DRUG$, saquinavir, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
ACE Inhibitors and @DRUG$ (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or @DRUG$ (ACEI/ARB).	DDI-false
@DRUG$ : @DRUG$ , erythromycins , sulfonamides , or tetracyclines may interfere with the bactericidal effect of penicillins .	DDI-false
It has been reported that @DRUG$-related adverse reactions have been reported in patients on concomitant therapy with @DRUG$ and theophylline .	DDI-false
(In some patients, the @DRUG$ can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium sparing, and @DRUG$.	DDI-effect
Close supervision and careful adjustment of the dosage are required when @DRUG$ is used with other anticholinergic drugs or @DRUG$.	DDI-advise
- @DRUG$ (e.g., @DRUG$) or	DDI-false
Vitamin A: Because of the relationship of Accutane to @DRUG$, patients should be advised against taking @DRUG$ containing vitamin A to avoid additive toxic effects	DDI-false
Example inhibitors include @DRUG$ , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , @DRUG$ , protease inhibitors, quinidine, and verapamil.	DDI-false
Patients receiving high doses of @DRUG$ concomitantly with furosemide, as in rheumatic disease, may experience @DRUG$ toxicity at lower doses because of competitive renal excretory sites.	DDI-false
High-dose @DRUG$ resulting in concentrations above 2000 ng/mL administered with oral etoposide has led to an 80 % increase in etoposide exposure with a 38 % decrease in total body clearance of etoposide compared to @DRUG$ alone .	DDI-false
Coingestion of @DRUG$ Theophylline, phenobarbital with acetaminophene and @DRUG$ with phenobarbital at high to toxic concentrations decreases the binding of the target drug .	DDI-false
To evaluate the effects of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma ( HIV-NHL), the authors retrospectively compared a group of 24 patients with HIV-NHL treated with the cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or a CHOP-like regimen (i.e. cyclophosphamide), @DRUG$ , teniposide , and prednisone with vincristine plus @DRUG$ ) without antiretroviral therapy.	DDI-false
Co-administration : Concomitant use of Argatroban with @DRUG$ , thrombolytics , and other @DRUG$ may increase the risk of bleeding .	DDI-false
acetaminophen/@DRUG$, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
The administration of local anesthetic solutions containing @DRUG$ or norepinephrine to patients receiving monoamine oxidase inhibitors or @DRUG$ may produce severe, prolonged hypertension.	DDI-effect
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and antineoplastic agents, specifically, @DRUG$, cis-platinum, @DRUG$ and interferon-alfa.	DDI-false
Antihypertensives : @DRUG$ Propranolol, an inhibitor of CYP3A4 or calcium channel antagonists (e.g. verapamil, @DRUG$ substrate , and diltiazem , a CYP3A4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and AV block ;	DDI-false
HMG-CoA Reductase Inhibitors: @DRUG$ (@DRUG$ substrate) in combination with amiodarone has been associated with reports of myopathy/rhabdomyolysis.	DDI-false
Therefore, there is a potential for an interaction with other drugs that are metabolized by CYP 1A2 (e.g., @DRUG$, tacrine, and @DRUG$).	DDI-false
medicines that cause a significant sustained increase in the pH of the stomach ( @DRUG$ such as @DRUG$ IRESSA plasma concentrations can be reduced and may therefore reduce efficacy.	DDI-false
Acute symptoms should be treated with a short-acting, inhaled  @DRUG$ such as @DRUG$ (the physician should provide the patient with such medication and instruct the patient in how it should be used).	DDI-false
The co-administration of alcohol and @DRUG$ does not affect the pharmacokinetics of either @DRUG$ or acamprosate .	DDI-false
• Co-administration with compounds that are potent CYP3A4 inducers (e. g. @DRUG$ , @DRUG$ Dexamethasone, carbamazepine) may lead to decreased plasma levels of saquinavir.	DDI-false
@DRUG$, including @DRUG$, may enhance the effects of oral anticoagulants, including warfarin or its derivatives or similar agents.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, @DRUG$, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and @DRUG$ with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Other medicinal products Interactions oral contraceptives @DRUG$   ( 500 mg twice daily ) did not influence the pharmacokinetics of an oral contraceptive containing 0.03 mg ethinyl estradiol and 0.15 mg @DRUG$ , or luteinising hormone and progesterone levels, suggesting that adverse effects on contraceptive efficacy are unlikely.	DDI-false
Monoamine Oxidase Inhibitors and @DRUG$: FORADIL should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants because the action of @DRUG$ on the cardiovascular system may be potentiated by these agents.	DDI-false
Administration of rifampin concomitantly with oral @DRUG$ has been shown to result in decreases in serum concentrations of @DRUG$ and desethylamiodarone.	DDI-false
This seems to be the only clinically relevant interaction of this species with mefloquines, although theoretically, the concomitant use of other drugs is known to alter heart conduction (e.g., @DRUG$ or beta-adrenergic blocking agents , calcium channel blockers , antihistamines or H1-blocking agents , tricyclic antidepressants and @DRUG$ ) could also contribute to an extension of the QTc interval.	DDI-false
@DRUG$ : @DRUG$ inhibit the hypotensive effect of veratrum alkaloids .	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, @DRUG$ or @DRUG$, calcium channel blockers, antihistamines or H1-blocking agents, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-false
While all the @DRUG$ (SSRIs), e.g., citalopram, escitalopram, fluoxetine, @DRUG$, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$, @DRUG$, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
• Lack of an effect of @DRUG$ on the disposition of zidovudine and @DRUG$ In HIV-infected patients.	DDI-false
♪ Drugs that can change ♪ @DRUG$ plasma concentrations Drugs that may increase imatinib plasma concentrations : Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family ( e.g. , @DRUG$ Itraconazole, erythromycin, clarithromycin).	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, warfarin, @DRUG$, carvedilol, ethanol or @DRUG$.	DDI-false
The pharmacokinetics of @DRUG$ are unaltered in the presence of @DRUG$ And vice versa.	DDI-false
Potential drug interactions between Keppra  and other AEDs (@DRUG$, gabapentin, lamotrigine, phenobarbital, phenytoin, @DRUG$ and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , @DRUG$ , chlordiazepoxide, diazepam, certain tricyclic antidepressants, @DRUG$ Theophylline, and metronidazole, delaying the elimination and increase in blood levels of these drugs.	DDI-false
OTHER CONCOMITANT THERAPY : Although specific interaction studies were not performed , in clinical studies , @DRUG$ It was also used at the same time as @DRUG$ , betablockers , calcium-channel blockers , diuretics , and nonsteroidal anti-inflammatory drugs ( NSAIDs ) without evidence of clinically significant adverse interactions .	DDI-false
Benzthiazide may interact with @DRUG$ , blood thinners, @DRUG$ ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , NSAIDs like Aleve or Ibuprofen , and high blood pressure medications .	DDI-false
This drug may interact with alcohol or other CNS depressants ( may potentiate the CNS depressant effects of either these medications or antihistamines ) , @DRUG$ Anticholinergic effects may be increased if these drugs are used concomitantly with antihistamines and monoamine oxidase (MAO) inhibitors (co-administration with @DRUG$ may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines ) .	DDI-false
Example inhibitors include azole antifungals , @DRUG$ , clarithromycin, diclofenac, @DRUG$ , erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Antacids : In a clinical pharmacology study, concomitant administration of antacids (aluminium hydroxide, magnesium hydroxide and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat compared to @DRUG$ administered alone , suggesting that antacids may impair absorption of @DRUG$.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an @DRUG$ (aluminum hydroxide, magnesium hydroxide, and @DRUG$) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
Because of the increased risk of adverse reactions in patients who have been taking benzodiazepines on a regular basis, it is particularly important that physicians query patients or their guardians carefully about @DRUG$, alcohol and @DRUG$ use as part of the history prior to any procedure in which the use of ROMAZICON is planned.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, @DRUG$, @DRUG$ and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Although neither dexamethasone nor @DRUG$ affected the proliferation of prostatic epithelium in RPMI1640 containing @DRUG$ Alone, they modify the mitogenic effect of EGF and insulin.	DDI-false
The compounds tested in humans include warfarin, @DRUG$ , phenytoin , @DRUG$ , aminopyrine and antipyrine .	DDI-false
Intravenous Adenocard (adenosine) has been effectively administered in the presence of other cardioactive drugs, such as @DRUG$, beta-adrenergic blocking agents, calcium channel blocking agents, and @DRUG$, without any change in the adverse reaction profile.	DDI-false
Co-administration of @DRUG$ and @DRUG$ did not alter the pharmacokinetics of cerivastatin sodium.	DDI-false
- Anabolic steroids (nandrolone [e.g., Anabolin], oxandrolone [e.g., Anavar], oxymetholone [e.g., @DRUG$], stanozolol [e.g., @DRUG$]) or	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or @DRUG$ antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of @DRUG$, resulting in serum and urine levels considerably lower than desired.	DDI-false
Betaseron administration to three cancer patients over a dose range of 0.025 mg to 2.2 mg led to a dose-dependent inhibition of @DRUG$ 14 The effect of 0.25 mg @DRUG$ on drug metabolism in MS patients is unknown .	DDI-false
Further , no effects on either @DRUG$ In a study with concomitant use of @DRUG$ and fluvastatin .	DDI-false
Cyclosporine, Digoxin, Methotrexate @DRUG$, like other @DRUG$, through effects on renal prostaglandins, may cause changes in the elimination of these drugs leading to elevated serum levels of cyclosporine, digoxin, methotrexate, and increased toxicity.	DDI-false
These results would seem to dictate against the clinical use of methotrexate with @DRUG$ , or during the period following @DRUG$ therapy when plasma asparagine levels are below normal .	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a @DRUG$ inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a @DRUG$ inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
It differs structurally from the other HMGCoA reductase inhibitors currently available ( @DRUG$ , @DRUG$ , and pravastatin ) , leading to unique biopharmaceutical properties relative to the other agents of this class .	DDI-false
For example, inhibitors are azole antimycotics, ciprofloxacin, @DRUG$ , diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, @DRUG$ , quinidine, and verapamil.	DDI-false
@DRUG$ : DURAGESIC   is not recommended for use in patients who have received @DRUG$ Within 14 days severe and unforeseeable potentiation by MAO inhibitors in opioid analgesics has been reported.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and antineoplastic agents , specifically , dacarbazine , @DRUG$ , tamoxifen and @DRUG$.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, @DRUG$, certain tricyclic antidepressants, @DRUG$, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Potassium Supplements and @DRUG$ : @DRUG$ Potassium loss can be mitigated by thiazide diuretics.	DDI-false
Antihypertensives : Amiodarone should be used with caution in patients receiving   -receptor blocking agents ( e.g. , @DRUG$ , a CYP3A4 inhibitor) or calcium channel antagonists (e.g. verapamil, a CYP3A4 substrate and @DRUG$ , a CYP3A4 inhibitor) because of the potential for bradycardia, sinus arrest, and AV block;	DDI-false
Acetaminophen: Pharmacokinetic or pharmacodynamic drug-effect interactions between argatroban and concomitant use of argatroban have not been established. @DRUG$ ( 162.5 mg orally given 26 and 2 hours prior to initiation of @DRUG$ 1 g/kg/min for 4 hours) or acetaminophen ( 1000 mg orally administered 12, 6 and 0 hours before and 6 and 12 hours after starting argatroban 1.5 g/kg/min for 18 hours).	DDI-false
Data from in vitro studies with alprazolem suggest a potential interaction with: @DRUG$ For the following : sertralin and @DRUG$.	DDI-int
Imipramin ( 5 mg/ kg ), @DRUG$ ( 30 mg/ kg ), @DRUG$ ( 0.25 mg/kg ) , fluoxetine ( 20 mg/kg ) sertraline ( 30 mg/kg ) or vehicle was administered .	DDI-false
Drug Interactions : Flupenthixol may interact with some drugs , like Monoamine oxidase inhibitors ( MAOI ): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol : Flupenthixol and Ethanol cause additive CNS depression - @DRUG$ Flupenthixol increases the effect of @DRUG$	DDI-false
However, concomitant administration of @DRUG$ with CELEBREX may result in an increased rate of GI ulceration or other complications, compared to use of @DRUG$ alone.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (@DRUG$ transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., @DRUG$), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
@DRUG$ : The concomitant use of DURAGESIC   ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and @DRUG$ , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	DDI-false
Antiarrhythmics: Other antiarrhythmic drugs, such as quinidine, @DRUG$, disopyramide, and @DRUG$, have been used concurrently with amiodarone.	DDI-false
Omeprazole: The rate and extent of absorption of @DRUG$ was bioequivalent when Proquin XR was given alone or when @DRUG$ was given 2 hours after omeprazole at the dose that maximally suppresses gastric acid secretion.	DDI-false
Because of the increased risk of adverse reactions in patients who have been taking benzodiazepines on a regular basis, it is particularly important that physicians query patients or their guardians carefully about benzodiazepine, @DRUG$ and sedative use as part of the history prior to any procedure in which the use of @DRUG$ is planned.	DDI-false
In clinical studies performed with Fondaparinux , the concomitant use of oral anticoagulants ( @DRUG$ , platelet inhibitors ( @DRUG$ ) , NSAIDs ( piroxicam ) , and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium .	DDI-false
@DRUG$ as potent @DRUG$ of glucocorticoid-induced mouse mammary tumor virus gene expression .	DDI-false
Multivalent Cation-Containing Products : Concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , @DRUG$ , @DRUG$ The chewable/buffered tablets or paediatric powders, or products that contain calcium, iron or zinc can significantly reduce the absorption of ciprofloxacin, resulting in serum and urine levels significantly lower than desired.	DDI-false
In the present study , the atypical antipsychotic @DRUG$ was tested in combination with an active dose of @DRUG$ in two-lever drug discrimination and mixed signalled-unsignalled differential-reinforcement-of-low-rates ( DRL ) procedures .	DDI-false
Injection : @DRUG$ injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , @DRUG$ An increased incidence of sedation, hallucinations and irrational behaviour was observed with co-administration of scopolamine with injectable lorazepam.	DDI-effect
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (@DRUG$, @DRUG$, opiates, sedatives, anesthetics) should be considered.	DDI-false
In a similar study with tamsulosin in healthy subjects, 1 in 24 subjects were treated with @DRUG$ 20 mg and @DRUG$ 0.4 mg separated by 6 hours of standing systolic blood pressure below 85 mm Hg.	DDI-effect
Anticholinesterases (neostgmine, physostigmine), @DRUG$, @DRUG$, procainamide can enhance toxicity and cause cardio respiratory depression.	DDI-false
If a @DRUG$ is also used , it may increase the risk of @DRUG$ toxicity .	DDI-effect
Digoxin: When multiple doses of atorvastatin and @DRUG$ were coadministered, steady-state plasma @DRUG$ concentrations increased by approximately 20%.	DDI-false
Cimetidine (400 mg b.i.d.) had no effect on @DRUG$ bioavailability (AUC) and maximum concentration (Cmax) of vardenafil when co-administered with 20 mg @DRUG$ in healthy volunteers.	DDI-false
- Anabolic steroids (nandrolone [e.g., @DRUG$], oxandrolone [e.g., Anavar], oxymetholone [e.g., @DRUG$], stanozolol [e.g., Winstrol]) or	DDI-false
Benzthiazide may interact with alcohol, blood thinners, @DRUG$ (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, @DRUG$ like Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
- @DRUG$ (nandrolone [e.g., Anabolin], oxandrolone [e.g., Anavar], oxymetholone [e.g., @DRUG$], stanozolol [e.g., Winstrol]) or	DDI-false
There was no significant difference in the pharmacodynamic effect of warfarin administered alone and @DRUG$ administered with @DRUG$ as measured by prothrombin time.	DDI-false
medicines that cause a significant sustained increase in the pH of the stomach ( @DRUG$ such as ranitidine or @DRUG$ IRESSA may decrease plasma concentrations and may reduce efficacy.	DDI-false
Dosage adjustment of @DRUG$ When co-administered with CYP2D6 inhibitors, it may be necessary, e.g. @DRUG$ , fluoxetine , and quinidine .	DDI-advise
Aspirin : Concomitant administration of low-dose @DRUG$ with @DRUG$ This may lead to an increased rate of GI ulceration or other complications compared to the use of VIOXX alone.	DDI-effect
Other concomitant therapies : In clinical trials, the safety profile in patients treated with acamprosate concomitantly with anxiolytics, @DRUG$ and sedatives ( including @DRUG$ ) , or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications .	DDI-false
Based on the chemical resemblance of itraconazole and ketoconazole, coadministration of @DRUG$ with @DRUG$ is contraindicated.	DDI-advise
acetaminophen/theophylline, @DRUG$/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
The interaction is a consequence of the hepatic-metabolism blocking of @DRUG$ by @DRUG$ A highly effective CYP3A4 inhibitor that also inhibits CYP2C9.	DDI-mechanism
Cyclosporine, Digoxin, Methotrexate @DRUG$, like other NSAIDs, through effects on renal prostaglandins, may cause changes in the elimination of these drugs leading to elevated serum levels of @DRUG$, digoxin, methotrexate, and increased toxicity.	DDI-mechanism
These drugs include the thiazides and other diuretics, @DRUG$, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, @DRUG$, calcium channel blocking drugs, and isoniazid.	DDI-false
Benzthiazide may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, @DRUG$, @DRUG$, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
Use With @DRUG$ @DRUG$ is genotoxic and mutagenic .	DDI-false
Another oral @DRUG$ , ketoconazole , inhibits the metabolism of astemizole , resulting in elevated plasma concentrations of astemizole and its active metabolite @DRUG$ , which can prolong QT intervals.	DDI-false
Concomitant use of LEVSIN with other antimuscarinic agents, amantadine, may lead to additive side effects due to cholinergic blockade. @DRUG$ , @DRUG$ , monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.	DDI-false
In the first study, the co-administration of 0.2 mg @DRUG$ and 12 g @DRUG$ This resulted in a decrease in AUC of more than 22% and Cmax of 40% compared to the dose of cerivastatin sodium alone.	DDI-mechanism
There have been more than 2-fold increases in plasma levels of other @DRUG$ , including nortriptyline , when @DRUG$ has been administered in combination with these agents .	DDI-mechanism
Compounds that have been tested in man include antipyrine, @DRUG$, propranolol, theophylline, and @DRUG$ and no clinically meaningful interactions were found.	DDI-false
Although neither @DRUG$ nor retinyl acetate affected the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone, they modify the mitogenic effect of EGF and @DRUG$.	DDI-effect
These drugs include the @DRUG$ and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, @DRUG$, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Steady-state serum concentrations of @DRUG$ are reported to fluctuate significantly when @DRUG$ The medication is either added or removed from the medication regimen.	DDI-mechanism
@DRUG$ decreased the hyperuricemic effect of @DRUG$.	DDI-effect
Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: ergotamine, @DRUG$, amiodarone, nicardipine, and @DRUG$.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
The administration of local @DRUG$ containing epinephrine or norepinephrine to patients receiving @DRUG$ or tricyclic antidepressants may produce severe, prolonged hypertension.	DDI-false
Drug-Drug Interactions Between Keppra  And Other Antiepileptic Drugs (@DRUG$) Phenytoin @DRUG$  (3000 mg daily) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy.	DDI-false
Antacids : In a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium hydroxide , and simethicone ) with @DRUG$ reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that @DRUG$ The absorption of Fosinopril may be impaired.	DDI-false
@DRUG$: The anorectic and stimulatory effects of @DRUG$ may be inhibited by lithium carbonate.	DDI-false
Ergot Derivatives : @DRUG$ , ergonovine , @DRUG$ , Methylergonovine CONTRAINDICATED due to the potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischaemia of extremities and other tissues.	DDI-false
This appears to be the only clinically relevant interaction of this kind with @DRUG$, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, calcium channel blockers, antihistamines or H1-blocking agents, @DRUG$ and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-effect
@DRUG$, other, especially diazoxide, or pre@DRUG$ and anesthetic agents used in surgery or skeletal-muscle relaxants, nondepolarizing, used in surgery	DDI-false
Other concomitant therapy Although specific interaction studies have not been performed, 1 mg or more of finasteride doses have been co-administered in clinical trials with acetaminophen, acetylsalicylic acid, A-blockers, analgesics, angiotensin converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta-blockers, calcium channel blockers, cardiac nitrates, diuretics, @DRUG$ HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also known as NSAIDs) and @DRUG$ without evidence of clinically significant adverse interactions .	DDI-false
@DRUG$ ==References====External links== @DRUG$ Potassium supplements or salt substitutes containing potassium may lead to significant increases in serum potassium.	DDI-false
Substances that are potent inhibitors of CYP3A4 activity (eg, @DRUG$ and itraconazole) decrease gefitinib metabolism and increase @DRUG$ plasma concentrations.	DDI-mechanism
Therefore, the combined use of @DRUG$ with @DRUG$ should generally be avoided.	DDI-advise
@DRUG$ Serum levels should be monitored and appropriate dose adjustments considered in patients receiving theophylline and @DRUG$.	DDI-false
The effects of @DRUG$ (RR) on inositol 1,4,5-trisphosphate (@DRUG$)-induced responses were studied in rat bone marrow megakaryocytes with the patch-clamp whole-cell recording technique in combination with fura-2 microfluorometry.	DDI-false
@DRUG$: Etodolac has no apparent pharmacokinetic interaction when administered with @DRUG$.	DDI-false
@DRUG$ in large amounts may counteract the antiepileptic effect of phenobarbital, @DRUG$ and primidone, and increase the frequency of seizures in susceptible pediatric patients.	DDI-effect
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, haloperidol, @DRUG$, monoamine oxidase (MAO) inhibitors, @DRUG$ or some antihistamines.	DDI-false
Lithium : @DRUG$ • have caused an increase in plasma @DRUG$ The concentrations and a reduction in renal lithium clearance.	DDI-mechanism
It may be necessary to adjust the dosage of oral @DRUG$ upon beginning or stopping @DRUG$. since disulfiram may prolong prothrombin time.	DDI-advise
However , if @DRUG$ Treatment with heparin should be initiated after discontinuation of heparin therapy, so that sufficient time is given for the effect of heparin on the aPTT to decrease before starting treatment. @DRUG$ therapy .	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, @DRUG$, estrogens, oral contraceptives, phenytoin, @DRUG$, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, Dapson, disopyramide, quinine, @DRUG$ , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , @DRUG$ , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
Therefore, when @DRUG$ is given to a patient receiving @DRUG$, the dosage of warfarin should be reduced to prevent excessive prolongation of the prothrombin time.	DDI-advise
Other Drug Interactions: No pharmacokinetic interactions were observed between vardenafil and the following drugs: glyburide, @DRUG$, digoxin, @DRUG$, and ranitidine.	DDI-false
In clinical trials with: @DRUG$ , the concomitant use of oral anticoagulants ( warfarin ) , platelet inhibitors ( acetylsalicylic acid ) , @DRUG$ ( piroxicam ) , and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium .	DDI-false
Naproxen : The concomitant administration of diflunisal and @DRUG$ in normal volunteers had no effect on the plasma levels of @DRUG$ , but significantly decreased the urinary excretion of naproxen and its glucuronide metabolite .	DDI-false
Previous studies have demonstrated a significant reduction in the oral bioavailability of @DRUG$ and ciprofloxacin when administered concomitantly with an intravenous @DRUG$ such as morphine.	DDI-mechanism
Diuretics: Patients on @DRUG$, especially those with intravascular volume depletion, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with @DRUG$.	DDI-effect
Other concomitant therapy Although no specific interaction studies have been conducted, 1 mg or more of finasteride doses have been co-administered in clinical trials with acetaminophen, acetylsalicylic acid, A-blockers, analgesics, angiotensin converting enzyme (ACE) inhibitors, anticonvulsants, @DRUG$ , @DRUG$ , calcium-channel blockers , cardiac nitrates , diuretics , H2 antagonists , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, calcium channel blockers, @DRUG$ or @DRUG$, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , @DRUG$ , tacrolimus, cyclosporin, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolem, and @DRUG$ ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
The effect of @DRUG$   on @DRUG$ was not studied .	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, @DRUG$, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these @DRUG$ during placebo-controlled clinical studies.	DDI-false
These drugs include the thiazides and other diuretics , @DRUG$ , phe-nothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , @DRUG$ , sympathomimetics, calcium channel block drugs, and isoniazid.	DDI-false
Non-selective MAO inhibitors including tranylcypromine sulfate, @DRUG$, and pargyline HC1: Concomitant use of @DRUG$ and non-selective MAO inhibitors may cause hypertension.	DDI-false
FLEXERIL may enhance the effects of @DRUG$, barbiturates, and other @DRUG$.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral @DRUG$, @DRUG$, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , @DRUG$ , quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$ When co-administered with saquinavir, increased plasma concentrations may occur when it contains its derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam and triazolam.	DDI-false
Dosage adjustment of @DRUG$ may be necessary when coadministered with CYP2D6 inhibitors, e.g., paroxetine, @DRUG$, and quinidine.	DDI-advise
• Furosemide has a tendency to relax the skeletal musculature effect of @DRUG$ And can reinforce the action of @DRUG$.	DDI-false
• Medicines that cause a significant sustained increase in the pH of the stomach (histamine H2 receptor antagonists such as @DRUG$ or @DRUG$ IRESSA may decrease plasma concentrations and may reduce efficacy.	DDI-false
The administration of local @DRUG$ containing @DRUG$ Patients receiving monoamine oxidase inhibitors, tricyclic antidepressants or phenothiazine may experience severe, prolonged hypotension or hypertension.	DDI-false
ERYTHROMYCIN: In hypercholesterolemic patients, steady-state @DRUG$ AUC and Cmax increased approximately 50% and 24% respectively after 10 days with co-administration of @DRUG$, a known inhibitor of cytochrome P450 3A4.	DDI-mechanism
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a @DRUG$ inhibitor) or @DRUG$ antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with @DRUG$ administered alone, suggesting that antacids may impair absorption of @DRUG$.	DDI-false
Based on the chemical resemblance of @DRUG$ and ketoconazole, coadministration of astemizole with @DRUG$ is contraindicated.	DDI-false
Pharmacokinetic or pharmacodynamic drug interactions between argatroban and co-administered aspirin (administered 162.5 mg orally 26 and 2 hours before starting treatment with aspirin/acetaminophen) have not been demonstrated. @DRUG$ 1   g/kg/min . over 4 hours ) or @DRUG$ ( 1000 mg orally administered 12, 6 and 0 hours before, and 6 and 12 hours after, start of argatroban 1.5 g/kg/min. over 18 hours).	DDI-false
acetaminophen/@DRUG$, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Sinus bradycardia has been reported with oral @DRUG$ in combination with @DRUG$ (CYP3A4 substrate) given for local anesthesia.	DDI-false
Acetaminophen/theophylline, lidocaine/chinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen and valproic acid/@DRUG$.	DDI-false
Antacids : In a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , @DRUG$ , and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat compared to fosinopril alone, suggesting that: @DRUG$ The absorption of Fosinopril may be impaired.	DDI-false
These medicines include thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$ , nicotinic acid , sympathomimet-ics , calcium channel blocking drugs , and @DRUG$.	DDI-false
Naproxen: The concomitant administration of @DRUG$ and naproxen in normal volunteers had no effect on the plasma levels of @DRUG$, but significantly decreased the urinary excretion of naproxen and its glucuronide metabolite.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, @DRUG$, @DRUG$, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Benzthiazide can be used with @DRUG$ - blood thinners, decongestant medications (allergic agents, colds, and sinus drugs), diabetes medications, @DRUG$ , norepinephrine , NSAIDs like Aleve or Ibuprofen , and high blood pressure medications .	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, dapsones, disopyramide, @DRUG$ Amiodarone, quinidine, warfarin, tacrolimus, cyclosporin, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$ When co-administered with saquinavir, increased plasma concentrations may occur;	DDI-false
In vitro binding studies with human serum proteins indicate that: @DRUG$ binds differently than tolbutamide and does not interact with salicylate or @DRUG$.	DDI-false
@DRUG$ and Tricyclic Antidepressants : FORADIL should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or @DRUG$ Because the effect of formoterol on the cardiovascular system can be enhanced by these active substances.	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, Dapson, disopyramide, quinine, amiodarone, @DRUG$ , warfarin , @DRUG$ (e. g. cyclosporin, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam and triazolam) may exhibit increased plasma concentrations when co-administered with saquinavir;	DDI-false
Single doses of either @DRUG$ or @DRUG$ resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent , respectively .	DDI-false
HMG-CoA Reductase Inhibitors : @DRUG$ ( @DRUG$ The substrate) in combination with amiodarone has been associated with myopathy/rhabdomyolysis reports.	DDI-false
@DRUG$: @DRUG$ (10 mg and 20 mg) did not potentiate the increase in bleeding time caused by aspirin (two 81 mg tablets).	DDI-false
Co-medications that induce CYP3A4 ( e.g. , dexamethasone , @DRUG$ , carbamazepine , @DRUG$ , phenobarbital or St.	DDI-false
@DRUG$-Concomitant intake of colestipol and vitamin K may reduce the absorption of @DRUG$.	DDI-false
Hypotension   Patients on Diuretic Therapy: Patients on @DRUG$ and especially those in whom @DRUG$ therapy was recently instituted, as well as those on severe dietary salt restriction or dialysis, may occasionally experience a precipitous reduction of blood pressure usually within the first hour after receiving the initial dose of captopril.	DDI-false
Vitamin A: Because of the relationship of Accutane to vitamin A, patients should be advised against taking @DRUG$ containing @DRUG$ to avoid additive toxic effects	DDI-false
Combination of @DRUG$ For other antiarrhythmic therapies, patients with life-threatening ventricular arrhythmias that respond incompletely to a single drug or respond to @DRUG$ should be reserved.	DDI-false
Benzthiazide may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, @DRUG$ like Aleve or @DRUG$, and high blood pressure medications.	DDI-false
The effects of @DRUG$ and of Innovar anesthesia on @DRUG$ tolerance in dogs.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, @DRUG$, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as @DRUG$), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Oral doses of @DRUG$ ( 10 - 20 mg/kg ) , via alcohol dehydrogenase inhibition , significantly reduced the rate of elimination of @DRUG$ The dose is administered to healthy volunteers at moderate doses (by about 40%).	DDI-mechanism
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril , beta-blockers , felodipine , @DRUG$ , warfarin, isosorbide mononitrate, schnitztilol, ethanol or @DRUG$.	DDI-false
However, a crossover study in healthy subjects receiving either Tagamet 300 mg q.i.d. or 800 mg h.s. concomitantly with a 300 mg b.i.d. dosage of theophylline (@DRUG$ , Key Pharmaceuticals, Inc.) demonstrated less alteration in steady-state @DRUG$ peak serum levels with the 800 mg h.s. regimen, particularly in subjects aged 54 years and older.	DDI-false
To assess the effects of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL), the authors retrospectively compared a group of 24 patients with HIV-NHL treated with the cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, tenipide and prednisone). @DRUG$ plus @DRUG$ ) without antiretroviral therapy.	DDI-false
In a clinical pharmacology study , @DRUG$ or @DRUG$ was administered to hypertensive patients receiving VASOTEC .	DDI-false
Although neither dexamethasone nor retinyl acetate affected the proliferation of prostatic epithelium in RPMI1640 containing @DRUG$ alone, they modify the mitogenic effect of @DRUG$ and insulin.	DDI-false
Drug Interactions : @DRUG$ MAOI could theoretically influence flupenthixol pharmacodynamics - arecoline - eproxindine - @DRUG$ : Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants : Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Both @DRUG$ and @DRUG$ enhance the locomotor and/or stereotypic effects of stimulants.	DDI-false
Another oral azole antifungal, @DRUG$ , inhibits the metabolism of astemizole, resulting in increased plasma concentrations of astemizole and its active metabolite @DRUG$ , which can prolong QT intervals.	DDI-false
@DRUG$: Plasma concentrations of atorvastatin decreased approximately 25% when @DRUG$ and atorvastatin were coadministered.	DDI-false
Antidepressants, tricyclic amphetamines can increase the activity of @DRUG$ or @DRUG$ ;	DDI-false
Glyburide: The concomitant administration of @DRUG$ with the sulfonylurea @DRUG$ has, on rare occasions, resulted in severe hypoglycemia.	DDI-effect
Use with @DRUG$ : The use of angiotensin converting enzyme inhibitors to control hypertension in patients on @DRUG$ It has been reported that severe leukopenia is induced.	DDI-false
These drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , @DRUG$ , oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel block drugs, and @DRUG$.	DDI-false
In clinical trials with: @DRUG$ co-administration of oral anticoagulants (warfarin), platelet inhibitors ( @DRUG$ ) , NSAIDs ( piroxicam ) , and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium .	DDI-false
The superiority of @DRUG$ over @DRUG$-based regimens has been observed in comparative data in a subset of patients with high viral loads.	DDI-false
The data from in vitro studies with benzodiazepines other than alprazolam indicate a possible interaction with the following medicinal products: ergotamine, @DRUG$ , amiodarone , @DRUG$ And nifedipine.	DDI-false
Therefore , interactions could occur following concomitant administration of psychotropic drugs ( e.g. , narcotics , analgesics , @DRUG$ , sedatives , @DRUG$ ) .	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including @DRUG$ and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, @DRUG$, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
Multivalent Cation-Containing Products : Concurrent administration of a @DRUG$ , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , @DRUG$ VIDEX chewable/buffer tablets or paediatric powders or products containing calcium, iron or zinc may significantly reduce the absorption of ciprofloxacin, resulting in significantly lower serum and urine levels than desired.	DDI-mechanism
Use with @DRUG$: The principal pathway for detoxification of @DRUG$ is inhibited by allopurinol.	DDI-false
A drug interaction study investigated the effect of using ACZONE gel, 5%, in combination with double strength ( 160 mg/800 mg ) Trimethoprim/@DRUG$ ( TMP/@DRUG$ ).	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (@DRUG$), @DRUG$ (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
however, it adversely affected response duration suggesting that @DRUG$ should not be administered with @DRUG$ and/or cisplatin.1	DDI-advise
Drug Interactions : @DRUG$ MAOI could theoretically influence flupenthixol pharmacodynamics - Arecolin - eproxindine - ethanol: flupenthixol and @DRUG$ Cause additive CNS depression - Tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants	DDI-false
Aspirin : In normal volunteers , a small decrease in diflunisal levels was observed when multiple doses of @DRUG$ and @DRUG$ were administered concomitantly .	DDI-mechanism
Other Drug Interactions Oral Contraceptives @DRUG$  (500 mg twice daily) did not influence the pharmacokinetics of an oral contraceptive containing 0.03 mg ethinyl estradiol and 0.15 mg @DRUG$, or of the luteinizing hormone and progesterone levels, indicating that impairment of contraceptive efficacy is unlikely.	DDI-false
Example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , @DRUG$ , @DRUG$ , nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine , Innovar Vet , or pentobarbital , the dosage of ouabain needed to cause ventricular tachycardia was significantly higher , as was the LD50 of @DRUG$ , with @DRUG$ or Innovar than with pentobarbital .	DDI-false
@DRUG$ and Tricyclic Antidepressants: FORADIL should be administered with extreme caution in patients being treated with @DRUG$ or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-false
Co-administration of @DRUG$ and aminoglycosides or other agents interfering with neuromuscular transmission (e.g., curare-like compounds) should only be performed with caution as the effect of the @DRUG$ may be potentiated.	DDI-false
It has been reported that @DRUG$ enhances the anticoagulant effect of @DRUG$-like drugs .	DDI-effect
Since @DRUG$ is a substrate for CYP3A4 and CYP2C8, drugs/substances that inhibit these isoenzymes may decrease the metabolism and increase serum concentration of @DRUG$.	DDI-false
With simultaneous dosing of @DRUG$ 10 mg and @DRUG$ 10 mg, 6 of 8 subjects experienced a standing systolic blood pressure of less than 85 mm Hg.	DDI-effect
Tetracycline : Accompanying treatment with Accutane and @DRUG$ should be avoided because @DRUG$ The application was associated with a number of cases of pseudotumor cerebri (benign intracranial hypertension), some of which involved concomitant use of tetracyclines.	DDI-false
@DRUG$: The concomitant administration of diflunisal and naproxen in normal volunteers had no effect on the plasma levels of @DRUG$, but significantly decreased the urinary excretion of naproxen and its glucuronide metabolite.	DDI-false
@DRUG$ Amiodarone should be used with caution in patients who are receptor blockers (e.g. propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g. verapamil, a CYP3A4 substrate and diltiazem, a @DRUG$ Inhibitor) because of the potential for bradycardia, sinus arrest and AV block;	DDI-false
Concurrent administration of drugs possessing nephrotoxic ( e.g. , aminoglycosides , indomethacin ) , myelotoxic ( e.g. , cytotoxic chemotherapy ) , cardiotoxic ( e.g. , doxorubicin ) or hepatotoxic ( e.g. , @DRUG$ , asparaginase ) effects with @DRUG$ The toxicity in these organ systems can be increased.	DDI-effect
Benzthiazide may interact with alcohol, blood thinners, @DRUG$ (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like @DRUG$ or Ibuprofen, and high blood pressure medications.	DDI-false
Lithium: In a study conducted in healthy subjects, mean steady-state @DRUG$ plasma levels increased approximately 17% in subjects receiving lithium 450 mg BID with @DRUG$ 200 mg BID as compared to subjects receiving lithium alone.	DDI-false
Therefore, interactions after concomitant use of @DRUG$ ( e.g. , @DRUG$ , analgesics , antiemetics , sedatives , tranquilizers ) .	DDI-false
Anticoagulant inhibition was observed during the administration of @DRUG$ , secobarbital and @DRUG$ ;	DDI-false
@DRUG$ may potentiate the adverse effects of other @DRUG$ administered concomitantly.	DDI-effect
- @DRUG$ (e.g., @DRUG$) or	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, phenothiazines, thyroid products, estrogens, oral @DRUG$, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Rifampin: Co-administration of @DRUG$ with rifampin 600 mg daily, a potent inducer of hepatic metabolism, produced an approximate 50% decrease in @DRUG$ plasma concentrations.	DDI-false
@DRUG$ From: In a study in young healthy male subjects no evidence of direct pharmacokinetic @DRUG$ digoxin interaction could be found.	DDI-false
Lithium : Increased serum lithium levels and symptoms @DRUG$ Toxicity has been reported in patients who are at the same time: @DRUG$ and ACE inhibitor therapy .	DDI-false
In addition, @DRUG$ does not affect the in vitro glucuronidation of @DRUG$.	DDI-false
No significant interactions were found between nisoldipine and @DRUG$ or @DRUG$.	DDI-false
These data suggest that levetiracetam is the plasma concentration of other @DRUG$ and that these AEDs do not influence the pharmacokinetics of @DRUG$.	DDI-false
The steady state plasma concentrations of @DRUG$ and @DRUG$ have been reported to be increased an average of 31% and 20%, respectively, by the concomitant administration of alprazolam tablets in doses up to 4 mg/day.	DDI-false
The concomitant intake of @DRUG$ and Acamprosate does not affect the pharmacokinetics of either alcohol or @DRUG$.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, @DRUG$, estrogens, oral contraceptives, phenytoin, nicotinic acid, @DRUG$, calcium channel blocking drugs, and isoniazid.	DDI-false
@DRUG$ : In a study of young healthy male subjects no evidence of a direct pharmacokinetic captopril-@DRUG$ interaction could be found .	DDI-false
The possibility of hypotensive effects with @DRUG$ or enalaprilat can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with enalapril or @DRUG$.	DDI-false
Antihypertensives : Amiodarone should be used with caution in patients receiving   -@DRUG$ blocking agents ( e.g. , propranolol , a CYP3A4 inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a CYP3A4 substrate , and diltiazem , a @DRUG$ Inhibitor) because of the potential for bradycardia, sinus arrest and AV block;	DDI-false
In comparison to the digital tolerance in dogs stunned with ketamine, @DRUG$ , or @DRUG$ The dosage of Ouabain needed to cause ventricular tachycardia was significantly higher, such as the LD50 of Ouabain, with ketamine or innovar than with pentobarbital.	DDI-false
Prostatic epithelium proliferates in a defined medium consisting of basal medium RPMI1640 containing transferrin (1 microgram/ml), @DRUG$ (10 ng/ml), and @DRUG$ (3.7 micrograms/ml or 0.1 IU/ml).	DDI-false
The use of @DRUG$ in patients receiving @DRUG$ may be rarely associated with ventricular fibrillation.	DDI-effect
Although there are no study data to evaluate the possibility, @DRUG$, including sodium nitroprusside and nitroglycerin, may have an additive effect with @DRUG$ on the risk of developing methemoglobinemia.	DDI-effect
Monitoring for @DRUG$ toxicity and serial measurement of @DRUG$ serum concentration during concomitant protease inhibitor therapy should be considered.	DDI-false
The effects of ruthenium red ( RR ) on @DRUG$ (@DRUG$)-induced responses were studied in rat bone marrow megakaryocytes with the patch-clamp whole-cell recording technique in combination with fura-2 microfluorometry .	DDI-false
Earlier studies showed a significant reduction in oral bioavailability of @DRUG$ Ciprofloxacin is co-administered with an intravenous opiate such as @DRUG$.	DDI-mechanism
Injection: Lorazepam injection, like other injectable @DRUG$, produces depression of the central nervous system when administered with @DRUG$, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-effect
BACKGROUND: The effects of combined administration of @DRUG$ and @DRUG$ (verapamil), a calcium channel blocker, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane (AOM) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
Stavudine and Zidovudine Ribavirin can antagonize the in vitro antiviral activity of @DRUG$ and @DRUG$ against HIV .	DDI-false
Therefore, it would be expected that a dosing schedule of @DRUG$ given at bedtime and cholestyramine given before the evening meal would not result in a significant decrease in the clinical effect of @DRUG$.	DDI-false
Other CONCOMITANT THERAPY: Although specific interaction studies have not been performed, in clinical studies cerivastatin sodium was used together with angiotensin converting enzyme ( ACE) inhibitors, beta-blockers, calcium channel blockers, @DRUG$ , and @DRUG$ ( NSAIDs ) without evidence of clinically significant adverse interactions .	DDI-false
Drug Interactions: @DRUG$ may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: @DRUG$ and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
In patients receiving Nalfon and a steroid concomitantly, any reduction in @DRUG$ dosage should be gradual in order to avoid the possible complications of sudden @DRUG$ withdrawal.	DDI-false
The effects of pressure @DRUG$ For example, dopamine or @DRUG$ The Bretylium tosylate is reinforced by the Bretylium tosylate.	DDI-false
Phenytoin : @DRUG$ has no apparent pharmacokinetic interaction when administered with @DRUG$.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, @DRUG$, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ : Potentiation of warfarin-type ( CYP2C9 and @DRUG$ The substrate) Anticoagulant response is almost always seen in patients receiving amiodarone and can lead to severe or fatal bleeding.	DDI-false
Because Nalfon has not been shown to produce any additional effect beyond that obtained with @DRUG$ - alone and because aspirin increases the rate of excretion of Nalfon, the concomitant use of Nalfon and @DRUG$ is not recommended .	DDI-false
@DRUG$: In diabetic patients receiving @DRUG$ and tolbutamide, no significant effects were seen on tolbutamide plasma levels or fasting blood glucose.	DDI-false
@DRUG$: @DRUG$ appear to have no significant effect on the bioavailability of ciprofloxacin.	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), @DRUG$ (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of @DRUG$.	DDI-false
Edema has been reported in patients concomitantly receiving @DRUG$ and @DRUG$.	DDI-effect
To evaluate the effect of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL), the authors retrospectively compared a group of 24 patients with HIV-NHL treated with cyclophosphamide, @DRUG$ , vincristine , and prednisone ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , doxorubicin , teniposide , and prednisone with vincristine plus @DRUG$ ) without antiretroviral therapy.	DDI-false
@DRUG$ and indinavir: Upon concomitant administration of 5 mg of Vardenafil with 600 mg BID ritonavir, the Cmax and AUC of @DRUG$ were reduced by approximately 20%.	DDI-false
The effect of @DRUG$  on @DRUG$ was not studied.	DDI-false
@DRUG$ " : Reports indicate that @DRUG$ The antihypertensive effect of angiotensin converting enzymes ( ACE) inhibitors may be reduced.	DDI-false
These data indicate that levetiracetam does not influence the plasma concentration of other @DRUG$ and that these @DRUG$ do not influence the pharmacokinetics of levetiracetam.	DDI-false
The effects of non-benzodiazepinegonists on benzodiazepine receptors, such as: @DRUG$ Also triazolopyridazine and others are blocked by @DRUG$.	DDI-effect
When Itraconazole was coadministered with @DRUG$, rifampin, or H2antagonists, reduced plasma concentrations of @DRUG$ were reported.	DDI-false
ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or @DRUG$ (ACEI/@DRUG$).	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, @DRUG$, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, @DRUG$, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ACE ) inhibitors , @DRUG$ , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , @DRUG$ , H2 antagonists , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
@DRUG$/prednisolone : Rofecoxib did not have any clinically important effect on the pharmacokinetics of @DRUG$ or prednisone .	DDI-false
• Numerous drug interactions are possible in some patients. @DRUG$ , such as @DRUG$ From and phenytoin affecting liver microsomal enzyme systems.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, @DRUG$, diclofenac, doxycycline, erythromycin, @DRUG$, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
The concomitant intake of @DRUG$ and @DRUG$ does not affect the pharmacokinetics of either alcohol or acamprosate.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, @DRUG$, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, @DRUG$, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Medicines that may alter the plasma concentration of imatinib Medicines that may increase the plasma concentration of imatinib : Caution should be exercised when gleevec is administered with CYP3A4 inhibitors (e.g. ketoconazole, @DRUG$ , @DRUG$ ,,,,,,,,,,,	DDI-false
@DRUG$ (200 mg once daily) produced a 10-fold increase in @DRUG$ AUC and a 4-fold increase in Cmax when co-administered with Vardenafil (5 mg) in healthy volunteers.	DDI-mechanism
Both ibogaine and @DRUG$ block morphine-induced and @DRUG$-induced dopamine release in the nucleus accumbens;	DDI-effect
Injection : Lorazepam injection , like other injectable @DRUG$ , produces depression of the central nervous system when administered with @DRUG$ , phenothiazines , barbiturates , MAO inhibitors , and other antidepressants . When scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .	DDI-effect
The possibility of hypotensive effects with @DRUG$ or @DRUG$ It can be minimized by stopping the diuretic or increasing salt intake prior to initiation of Enalapril or enalaprilat treatment.	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of magnesium deficit and to discriminate between magnesium deficiency due to an insufficient @DRUG$ intake which only requires oral physiological supplementation and magnesium depletion related to a dysregulation of the control mechanisms of @DRUG$ status which requires more or less specific regulation of its causal dysregulation.	DDI-false
Antacids : In a clinical pharmacology study , coadministration of an @DRUG$ ( @DRUG$ , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, @DRUG$, @DRUG$, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, @DRUG$, @DRUG$, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
The hypoglycemic action of @DRUG$ It can be reinforced by certain drugs, including non-steroidal anti-inflammatory drugs and other drugs that are highly protein-bound, @DRUG$ , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .	DDI-effect
This drug may interact with @DRUG$ or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with @DRUG$), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
- Mineral oil compositional intake of @DRUG$ The intake of @DRUG$ can be reduced by vitamin K.	DDI-false
Orlistat-@DRUG$ may decrease the absorption of @DRUG$.	DDI-mechanism
CYP2D6 inhibitors - @DRUG$ is primarily metabolized by the CYP2D6 pathway to @DRUG$.	DDI-false
In addition, additional interaction studies with niacin and propranolol have no effect on @DRUG$ Plasma levels and administration to a patient population that is chronically @DRUG$ The bioavailability of digoxin compared to control data was not different.	DDI-false
Reciprocal interactions may occur with concomitant use of @DRUG$ , and medicines that increase or inhibit the cytochrome P450 system (e.g., phenytoin, @DRUG$ , cimetidine, ketoconazole), although this has not been studied	DDI-mechanism
- @DRUG$ (e.g., @DRUG$) or	DDI-false
• Broadband spectrum antibiotics-@DRUG$ can sterilize the intestine and the @DRUG$ Contribution to the body through the intestinal microflora.	DDI-false
@DRUG$/Acetaminophen : Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between @DRUG$ 1 g/kg/min) or acetaminophen ( 1000 mg orally administered 12, 6 and 0 hours before and 6 and 12 hours after the start of argatroban 1.5 g/kg/min. for 18 hours.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
Drugs that cause significant sustained elevation in gastric pH (histamine H2-receptor antagonists such as @DRUG$ or cimetidine) may reduce plasma concentrations of @DRUG$ and therefore potentially may reduce efficacy.	DDI-mechanism
), phenobarbital/acetaminophen, phenobarbital/ valproic acid, quinidine/ lidocaine, theophylline/acetaminophen and valproic acid/phenobarbital.	DDI-false
Therefore, there is a potential for an interaction with other drugs that are metabolized by CYP 1A2 (e.g., amitriptyline, @DRUG$, and @DRUG$).	DDI-false
Anticoagulants: potentiation of the warfarin type ( CYP2C9 and CYP3A4 substrate) @DRUG$ response is almost always seen in patients receiving @DRUG$ and can result in serious or fatal bleeding .	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and antineoplastic agents, specifically, @DRUG$, cis-platinum, tamoxifen and @DRUG$.	DDI-false
No Important Interactions To Date @DRUG$ does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, warfarin, isosorbide mononitrate, carvedilol, @DRUG$ or itraconazole.	DDI-false
Potential drug interactions between Keppra  and other @DRUG$ (carbamazepine, gabapentin, @DRUG$, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
The hypoglycemic action of @DRUG$ may be potentiated by certain drugs including @DRUG$ and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-effect
However , if Argatroban is to be initiated after cessation of @DRUG$ Treatment, sufficient time for heparin effect on the aPTT to @DRUG$ therapy .	DDI-false
Coadministration of Itraconazole and cyclosporine , @DRUG$ or @DRUG$ has led to increased plasma concentrations of the latter three drugs .	DDI-false
Further , in clinical studies with @DRUG$ ( @DRUG$ , 5 mg ) when used in older men who have benign prostatic hyperplasia ( BPH ) , PSA levels are decreased by approximately 50 % .	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, @DRUG$, calcium channel blocking drugs, and isoniazid.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, @DRUG$, oral contraceptives, phenytoin, @DRUG$, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Lithium : In a study conducted in healthy subjects , mean steady-state @DRUG$ Plasma levels increased in patients who: @DRUG$ 450 mg BID with CELEBREX 200 mg BID as compared to subjects receiving lithium alone .	DDI-false
When comparing digitalis tolerance in dogs anaesthetized with ketamine, Innovar Vet or pentobarbital, the dose of Ouabain required to cause ventricular tachycardia was significantly higher than the LD50 of Ouabain, with ketamine or @DRUG$ than with @DRUG$.	DDI-false
@DRUG$ : Coadministration of single doses of eszopiclone 3 mg and @DRUG$ 20 mg daily for 7 days showed no pharmacokinetic or pharmacodynamic interactions.	DDI-false
Use with Angiotensln Converting Enzyme Inhibitors: The use of @DRUG$ to control hypertension in patients on @DRUG$ has been reported to induce severe leukopenia.	DDI-effect
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
The following eight target drug/added drug combinations were studied : @DRUG$/@DRUG$.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Another oral @DRUG$ , @DRUG$ , inhibits the metabolism of astemizole , resulting in elevated plasma concentrations of astemizole and its active metabolite desmethylastermizole which may prolong QT intervals .	DDI-false
Drug-Drug Interactions Between Keppra  And Other Antiepileptic Drugs (AEDs) @DRUG$ Keppra  (3000 mg daily) had no effect on the pharmacokinetic disposition of @DRUG$ in patients with refractory epilepsy.	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), @DRUG$ (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of @DRUG$.	DDI-false
Ergot Derivatives: Dihydroergotamine, ergonovine, @DRUG$, methylergonovine CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute @DRUG$ toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole ( cefmenoxime , @DRUG$ , cefotetan , @DRUG$ Methylthiadiazole (cefazolin) may cause vitamin K deficiency and hypoprothrombinaemia.	DDI-false
Antiarrhythmics : Amiodarone , bepridil , @DRUG$ , propafenone , @DRUG$ CONTRAINDICATED due to potential for serious and/or life-threatening reactions .	DDI-false
Both efavirenz and nevirapine have been compared to triple therapy with the @DRUG$ indinavir over 48 weeks as initial therapy, with similar responses being observed with @DRUG$ regimens and superiority observed with efavirenz.	DDI-false
Dose adjustment is not recommended.@DRUG$ did not affect the plasma concentrations of carbamazepine, @DRUG$ , topiramate, or lamotrigine.	DDI-false
Drug-drug interactions have not been observed between Argatroban and @DRUG$ or @DRUG$.	DDI-false
acetaminophen/theophylline , lidocaine/@DRUG$ , phenobarbital/@DRUG$ , phenobarbital/valproic acid , quinidine/lidocaine , theophylline/acetaminophen , and valproic acid/phenobarbital .	DDI-false
While 18-MC and @DRUG$ 18-MC has much lower affinities than @DRUG$ for NMDA and sigma-2 receptors , sodium channels , and the 5-HT transporter .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
High-dose cyclosporin A resulting in concentrations above 2000 ng/mL administered with oral @DRUG$ has led to an 80% increase in etoposide exposure with a 38% decrease in total body clearance of @DRUG$ compared to etoposide alone.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, @DRUG$, estrogens, oral contraceptives, @DRUG$, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Antimycobacterial Agents : rifampin CONTRAINDICATED since the coadministration of this product with saquinavir in an @DRUG$ The regimen reduces the plasma concentrations of @DRUG$.	DDI-false
Tagamet, apparently due to an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, @DRUG$ , certain @DRUG$ , lidocaine, theophylline and metronidazole, delaying the elimination and increase in blood levels of these drugs.	DDI-false
Bacteriostatic Antibiotics: @DRUG$, erythromycins, sulfonamides, or tetracyclines may interfere with the bactericidal effect of @DRUG$.	DDI-effect
@DRUG$ (e.g., spironolactone, triamterene, or amiloride), potassium supplements, or @DRUG$-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
Paroxetine: Coadministration of single doses of @DRUG$ 3 mg and @DRUG$ 20 mg daily for 7 days produced no pharmacokinetic or pharmacodynamic interaction.	DDI-false
Vitamin A: Because of the relationship of @DRUG$ to @DRUG$, patients should be advised against taking vitamin supplements containing vitamin A to avoid additive toxic effects	DDI-effect
@DRUG$, and to a lesser extent, @DRUG$, enhanced the translocating action of oleate and increased its effectiveness in transferring the phosphohydrolase from the soluble to the microsomal fraction.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as @DRUG$ or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, @DRUG$, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Carbamazepine: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with @DRUG$, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the @DRUG$ should be made.	DDI-false
Possible drug interactions of HUMORSOL with @DRUG$ or with other @DRUG$.	DDI-false
@DRUG$ : Simvastatin ( @DRUG$ The substrate) in combination with amiodarone has been associated with myopathy/rhabdomyolysis reports.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, @DRUG$, tranquilizers (e.g., benzodiazepines), general @DRUG$, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a @DRUG$, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing @DRUG$, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
Concomitant @DRUG$, @DRUG$, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, @DRUG$, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable @DRUG$, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
Anticholinesterases (neostgmine, @DRUG$), lignocaine, quinine, @DRUG$ can enhance toxicity and cause cardio respiratory depression.	DDI-false
Dose adjustment is not recommended.@DRUG$ did not affect the plasma concentrations of carbamazepine, valproate, @DRUG$ Or lamotrigine.	DDI-false
While all the selective serotonin reuptake inhibitors (SSRIs), e.g., citalopram, @DRUG$, fluoxetine, sertraline, and @DRUG$, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
@DRUG$ : Concomitant treatment with accutane and tetracyclines should be avoided as: @DRUG$ The application was associated with a number of cases of pseudotumor cerebri (benign intracranial hypertension), some of which involved concomitant use of tetracyclines.	DDI-false
@DRUG$/theophylline , lidocaine/quinidine , phenobarbital/acetaminophen , phenobarbital/@DRUG$ , quinidine/lidocaine , theophylline/acetaminophen , and valproic acid/phenobarbital .	DDI-false
Compounds tested in man include warfarin, theophylline, phenytoin, @DRUG$, @DRUG$ and antipyrine.	DDI-false
Concomitant @DRUG$ , @DRUG$ , vincristine , and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related , non-Hodgkin lymphoma .	DDI-false
This interaction should be given consideration in patients taking @DRUG$ concomitantly with @DRUG$.	DDI-advise
Compounds that have been tested in humans include antipyrin, digoxin, @DRUG$ , theophylline , and @DRUG$ No clinically significant interactions were found.	DDI-false
Concomitant @DRUG$, doxorubicin, vincristine, and prednisone chemotherapy plus @DRUG$ therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, @DRUG$, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, @DRUG$, and verapamil.	DDI-false
Amiodarone may suppress certain CYP450 enzymes, including CYP1A2, CYP2C9, @DRUG$, and @DRUG$.	DDI-false
These medicines include thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$ , @DRUG$ , sympathomimetics, calcium channel block drugs, and isoniazid.	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , @DRUG$ , chloramphenicol , probenecid , @DRUG$ , monoamine oxidase inhibitors , and beta adrenergic blocking agents .	DDI-false
These results would seem to dictate against the clinical use of methotrexate with @DRUG$, or during the period following @DRUG$ therapy when plasma asparagine levels are below normal.	DDI-false
Corticosteroids, @DRUG$ and Diuretics: Concomitant treatment with xanthine derivatives, @DRUG$, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
While all the selective serotonin reuptake inhibitors (SSRIs), e.g., @DRUG$, escitalopram, @DRUG$, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
Furosemide has a tendency to antagonize the skeletal muscle relaxing effect of @DRUG$ and may potentiate the action of @DRUG$.	DDI-false
In the case that you are taking @DRUG$ while taking @DRUG$, higher doses of digoxin may be needed.	DDI-advise
These drugs include the thiazides and other diuretics, corticosteroids, @DRUG$, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, @DRUG$, calcium channel blocking drugs, and isoniazid.	DDI-false
@DRUG$: Administration of nonsteroial anti-inflammatory drugs concomitantly with @DRUG$ has been associated with an increase in cyclosporine-induced toxicity, possibly due to decreased synthesis of renal prostacyclin.	DDI-false
In order to evaluate the effects of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL ), the authors retrospectively compared a group of 24 patients with HIV-NHL who had been treated with the @DRUG$ , doxorubicin , vincristine , and prednisone ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , @DRUG$ , teniposide, and prednisone with vincristine plus bleomycin) without antiretroviral therapy.	DDI-false
Example inhibitors include azole antifungals , @DRUG$ , clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodon, nicardipine, propofol, @DRUG$ , quinidine , and verapamil .	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, Dapson, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporin, @DRUG$ , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and @DRUG$ ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
@DRUG$: @DRUG$ has no apparent pharmacokinetic interaction when administered with phenytoin.	DDI-false
- anabolic steroids (Nandrolone [e.g. Anaboline ], Oxandrolone [e.g., @DRUG$ oxymethol [e.g. anadrol], @DRUG$ [ e.g. , Winstrol ] ) or	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (@DRUG$, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of @DRUG$ as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, @DRUG$, @DRUG$, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
No Important Interactions To Date @DRUG$ does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, @DRUG$, warfarin, isosorbide mononitrate, carvedilol, ethanol or itraconazole.	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, Dapson, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporin, ergot derivatives, @DRUG$ , carbamazepine, fentanyl, @DRUG$ When co-administered with saquinavir, increased plasma concentrations may occur;	DDI-false
Another oral azole antifungal , @DRUG$ , inhibits the metabolism of @DRUG$ , resulting in elevated plasma concentrations of astemizole and its active metabolite desmethylastermizole which may prolong QT intervals .	DDI-mechanism
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of @DRUG$, phenytoin, propranolol, nifedipine, @DRUG$, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Effect of @DRUG$ in Pediatric Patients There was about a 22% increase of apparent total body clearance of levetiracetam when it was co-administered with enzyme-inducing @DRUG$.	DDI-false
Nevertheless, the effects of @DRUG$ on travelers receiving comedication, particularly diabetics or patients using @DRUG$, should be checked before departure.	DDI-advise
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and antineoplastic agents , specifically , dacarbazine , cis-platinum , @DRUG$ and @DRUG$.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a @DRUG$, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or @DRUG$ may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
@DRUG$/Acetaminophen : Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered aspirin ( 162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1   g/kg/min . over 4 hours ) or acetaminophen ( 1000 mg orally given 12 , 6 and 0 hours prior to , and 6 and 12 hours subsequent to , initiation of @DRUG$ 1.5   g/kg/min . over 18 hours ) .	DDI-false
Triazolam, @DRUG$ CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as prolonged or increased sedation or respiratory depression .	DDI-false
@DRUG$ , lidocaine, phenobarbital, quinidine, @DRUG$ , and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or @DRUG$), @DRUG$ or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
The effects of adenosine are antagonized by @DRUG$ such as @DRUG$ and theophylline.	DDI-false
Central Nervous System Depressants : The concomitant use of DURAGESIC   ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , @DRUG$ Anaesthetics (e.g. benzodiazepines), general anaesthetics, phenothiazines, @DRUG$ , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	DDI-false
Non-selective MAO inhibitors including @DRUG$, @DRUG$, and pargyline HC1: Concomitant use of L-tyrosine and non-selective MAO inhibitors may cause hypertension.	DDI-false
Micro-dosed @DRUG$ Preparations : Micro-dosed @DRUG$ Preparations (minipills that do not contain estrogen) may be an inadequate method of contraception during Accutane therapy.	DDI-false
Concurrent administration of @DRUG$ and of @DRUG$ may cause severe, persistent hypertension or cerebrovascular accidents.	DDI-false
Because Nalfon has not been shown to produce any additional effect beyond that obtained with aspirin alone and because aspirin increases the rate of excretion of @DRUG$, the concomitant use of Nalfon and @DRUG$ is not recommended.	DDI-false
Corticosteroids, Methylxanthines and Diuretics: Concomitant treatment with xanthine derivatives, steroids, or @DRUG$ may potentiate a possible hypokalemic effect of  @DRUG$	DDI-effect
Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving Alprazolam (caution is recommended during coadministration with @DRUG$): Coadministration of fluoxetine with alprazolam increased the maximum plasma concentration of @DRUG$ by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance.	DDI-false
@DRUG$ or iodine excess may decrease the effect of Carbimazole , and an iodine deficiency can increase the effect of @DRUG$.	DDI-false
When LEVSIN is co-administered with others @DRUG$ , amantadine , haloperidol , @DRUG$ , monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.	DDI-false
Olanzapine: Coadministration of @DRUG$ 3 mg and @DRUG$ 10 mg produced a decrease in DSST scores.	DDI-effect
Cholestyramine-Concomitant intake of cholestyramine and @DRUG$ may reduce the absorption of @DRUG$.	DDI-false
Therophylline : A recent study has shown that concomitan administration of isoniazid and theophylline may cause elevated plasma levels of @DRUG$ , and in some instances a slight decrease in the elimination of @DRUG$.	DDI-false
@DRUG$, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, @DRUG$, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-mechanism
The pharmacokinetics of @DRUG$ and its major metabolite @DRUG$ were unaffected following co-administration with Acamprosate.	DDI-false
Nephrotoxicity has been reported following concomitant administration of @DRUG$ with aminoglycoside antibiotics or potent diuretics such as @DRUG$.	DDI-effect
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$, @DRUG$, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
• Carbamazepine: It is known that isoniazid has slowed down the metabolism of carbamazepine and increased serum levels. @DRUG$ , signs and symptoms of @DRUG$ The toxicity should be closely monitored and an appropriate dose adjustment of the anticonvulsant should be made.	DDI-false
Therefore, the concomitant use of @DRUG$ with @DRUG$ is contraindicated .	DDI-advise
- Oral @DRUG$ ( birth control pills ) containing @DRUG$ or	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , @DRUG$ , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and @DRUG$ Concomitant use with saquinavir may result in increased plasma concentrations.	DDI-false
Multivitamins or other products containing iron @DRUG$ Antacids or sucralfate should not be administered concomitantly with or within 2 hours of administration of @DRUG$ , because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin .	DDI-advise
This medication may be used with alcohol or other CNS depressants (may potentiate the CNS depressive effects of either these drugs or antihistamines), anticholinergics or other anticholinergic drugs (anticholinergic effects may be intensified if these drugs are used concomitantly with @DRUG$ ) , and monoamine oxidase ( MAO ) inhibitors ( concurrent use with @DRUG$ The anticholinergic and CNS depressive effects of antihistamines may be prolonged and intensified.	DDI-false
Other reported interactions with @DRUG$: Fentanyl (@DRUG$ substrate) in combination with amiodarone may cause hypotension, bradycardia, and decreased cardiac output.	DDI-false
Physiological oral @DRUG$ load constitutes the best tool for diagnosis of @DRUG$ Deficiency and the first step of his treatment.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, @DRUG$, and @DRUG$) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, @DRUG$, anticonvulsants, benzodiazepines, @DRUG$, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
The high dose of cyclosporin A, which resulted in concentrations above 2000 ng/ml administered with oral etoposide, resulted in an 80% increase in etoposide exposure with a 38% decrease in total body clearance of @DRUG$ compared to @DRUG$ alone .	DDI-false
- Anabolic steroids (nandrolone [e.g., @DRUG$], oxandrolone [e.g., Anavar], oxymetholone [e.g., Anadrol], @DRUG$ [e.g., Winstrol]) or	DDI-false
Antacids : In a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium hydroxide , and @DRUG$ ) with @DRUG$ reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .	DDI-mechanism
However, no harmful interactions were seen when: @DRUG$ - was administered after anaesthesia, inhalation. @DRUG$ , muscle relaxants and muscle relaxant antagonists administered in conjunction with sedation or anesthesia .	DDI-false
Adequate monitoring of theophylline plasma concentrations should be considered when therapy with @DRUG$ is initiated or changed in patients receiving @DRUG$.	DDI-advise
Drug Interactions : Flupenthixol may interact with some drugs , like Monoamine oxidase inhibitors ( @DRUG$ ): MAOI could theoretically affect flupenthixol pharmacodynamics - @DRUG$ Eproxindine - ethanol : flupenthixol and ethanol cause additive CNS depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants	DDI-false
Sinus bradycardia has been reported with oral @DRUG$ In combination with lidocaine ( CYP3A4 substrate ) for local @DRUG$.	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (@DRUG$), NSAIDs (@DRUG$), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Coadministration of @DRUG$ With 40 mg SULAR tablets in epileptic patients, the @DRUG$ plasma concentrations to undetectable levels .	DDI-false
Other concomitant therapies : In clinical trials, the safety profile in patients with @DRUG$ concomitantly with anxiolytics , hypnotics and @DRUG$ ( including benzodiazepines ) , or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications .	DDI-false
In the presence of these methylxanthines, larger doses of @DRUG$ may be required or @DRUG$ may not be effective.	DDI-false
@DRUG$-Concomitant intake of mineral oil and @DRUG$ may reduce the absorption of vitamin K.	DDI-false
Example inhibitors include azole antifungals , ciprofloxacin , @DRUG$ , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , @DRUG$ , and verapamil .	DDI-false
Co-medications that induce CYP3A4 (e.g., dexamethasone, @DRUG$, @DRUG$, rifampin, phenobarbital or St.	DDI-false
@DRUG$ : Quinolones have been reported to enhance the effects of the oral @DRUG$ Warfarin or its derivatives.	DDI-false
acetaminophen/theophylline, @DRUG$/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Results of studies in multiple sclerosis patients taking TYSABRI   and concomitant interferon beta-1a ( @DRUG$   30 mcg IM once weekly ) or @DRUG$ were inconclusive with regard to the need for dose adjustment of the beta-interferon or glatiramer acetate .	DDI-false
- @DRUG$ ( e.g. , @DRUG$ ) or	DDI-false
Although no specific drug interactions with topical glaucoma or systemic drugs have been identified in clinical studies with IOPIDINE 0.5 % ophthalmic solution, there is a possibility of additive or potentiating effects with CNS depressants (alcohol, barbiturates, @DRUG$ , sedatives , @DRUG$ ) should be considered .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, @DRUG$, @DRUG$, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Haemodynamic effects of glucose and @DRUG$ were additive when @DRUG$ was co-administered but not under basal conditions.	DDI-false
@DRUG$: Eszopiclone 3 mg administered daily for 5 days did not affect the pharmacokinetics of (R)- or (S)-warfarin, nor were there any changes in the pharmacodynamic profile (prothrombin time) following a single 25 mg oral dose of @DRUG$	DDI-false
The co-administration of medicinal products which are nephrotoxic (e. g. @DRUG$ , indomethacin ) , myelotoxic ( e.g. , cytotoxic chemotherapy ) , cardiotoxic ( e.g. , @DRUG$ Hepatotoxic (e.g. methotrexate, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, @DRUG$, calcium channel blocking drugs, and isoniazid.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, @DRUG$, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, @DRUG$, and verapamil.	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of @DRUG$ deficit and to discriminate between magnesium deficiency due to an insufficient magnesium intake which only requires oral physiological supplementation and magnesium depletion related to a dysregulation of the control mechanisms of @DRUG$ status which requires more or less specific regulation of its causal dysregulation.	DDI-false
Although no studies have been performed, the concomitant use of itraconazole and @DRUG$ may alter the metabolism of @DRUG$ ;	DDI-false
@DRUG$: Histamine H2-receptor antagonists appear to have no significant effect on the bioavailability of @DRUG$.	DDI-false
@DRUG$ The ototoxic potential of @DRUG$ , especially in the presence of impaired renal function .	DDI-effect
@DRUG$ Incorporating tranylcypromin sulfate, phenolic acid sulfate and @DRUG$ HC1 : Concurrent use of L-tyrosine and non-selective MAO inhibitors may lead to high blood pressure.	DDI-false
In addition, Fondaparinux neither influenced the pharmacodynamics of warfarin, acetylsalicylic acid, piroxicam, and @DRUG$, nor the pharmacokinetics of @DRUG$ at steady state.	DDI-false
ACE Inhibitors and @DRUG$ In clinical trials in patients with hypertension, the addition of INSPRA 50 to 100 mg to @DRUG$ and angiotensin II receptor antagonists increased mean serum potassium slightly ( about 0.09 - 0.13 mEq/L ) .	DDI-false
These effects were not observed when @DRUG$ 20 mg was taken 24 hours before the @DRUG$.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, @DRUG$, and isoniazid.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
It is recommended to avoid concurrent administration of @DRUG$ with aluminum hydroxide containing antacids for at least 4 hours following @DRUG$ administration.	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , @DRUG$ , carbamazepine , @DRUG$ , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
Since the concomitant use of @DRUG$ with @DRUG$ The prothrombin time should be increased by 100% after 3 to 4 days, the dose of the anticoagulant should be reduced by one third to one half and the prothrombin time closely monitored.	DDI-false
OTHER CONCOMITANT THERAPY : Although specific interaction studies were not performed , in clinical studies , cerivastatin sodium was used concomitantly with @DRUG$ , beta blockers, calcium channel blockers, diuretics and nonsteroidal anti-inflammatory drugs ( @DRUG$ ) without evidence of clinically significant adverse interactions.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a @DRUG$ inhibitor) or calcium channel antagonists (e.g., @DRUG$, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
The coadministration of @DRUG$ decreases the biologic half-life of @DRUG$ because of an increase in metabolic clearance that results in a greater amount of hydroxylated fenoprofen in the urine.	DDI-mechanism
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of @DRUG$, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and @DRUG$, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
A possible interaction between glyburide and @DRUG$ , a fluoroquinolone antibiotic , has been reported , resulting in a potentiation of the hypoglycemic action of @DRUG$.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -@DRUG$ blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a @DRUG$ substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Digoxin and @DRUG$ use may be rarely associated with ventricular fibrillation when combined with @DRUG$.	DDI-effect
Clinical interaction studies with @DRUG$ and @DRUG$ indicated that the coadministration of Femara with these drugs does not result in clinically- significant drug interactions.	DDI-false
acetaminophen/theophylline, @DRUG$/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, @DRUG$ (also referred to as NSAIDs), and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Sedatives/@DRUG$: @DRUG$, midazolam CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as prolonged or increased sedation or respiratory depression.	DDI-false
@DRUG$ and indinavir: Upon concomitant administration of 5 mg of @DRUG$ with 600 mg BID ritonavir, the Cmax and AUC of ritonavir were reduced by approximately 20%.	DDI-false
Cyclosporin : administration of non-sterioal anti-inflammatory medicinal products at the same time as @DRUG$ has been associated with an increase in @DRUG$-induced toxicity , possibly due to decreased synthesis of renal prostacyclin .	DDI-false
Other Cardiovascular Agents : Enalapril and @DRUG$ IV have been used concomitantly with @DRUG$ , methyldopa , nitrates , calcium-blocking agents , hydralazine , prazosin and digoxin without evidence of clinically significant adverse interactions .	DDI-false
@DRUG$ or iodine excess may decrease the effect of @DRUG$, and an iodine deficiency can increase the effect of Carbimazole.	DDI-effect
@DRUG$: In a study of young healthy male subjects no evidence of a direct pharmacokinetic @DRUG$-digoxin interaction could be found.	DDI-false
In patients with mild to moderate hypertension, administration of 25 mg daily of VIOXX with the @DRUG$ benazepril, 10 to 40 mg for 4 weeks, was associated with an average increase in mean arterial pressure of about 3 mm Hg compared to @DRUG$ alone.	DDI-false
Administration of rifampin concomitantly with oral @DRUG$ has been shown to result in decreases in serum concentrations of amiodarone and @DRUG$.	DDI-false
The initiation of @DRUG$ or @DRUG$ use may be precipitated by similar personality characteristics in the user , such as impulsivity and sensation seeking .	DDI-false
Colestipol-Concomitant intake of colestipol and @DRUG$ may reduce the absorption of @DRUG$.	DDI-false
The similarity of the @DRUG$ -associated adverse event profile between Study 1 ( without co-administered @DRUG$ Study 2 (with concomitant use of AVONEX) shows that this change in clearance does not require a reduction in TYSABRI dose to maintain safety.	DDI-false
acetaminophen/theophylline , lidocaine/quinidine , phenobarbital/acetaminophen , phenobarbital/@DRUG$ , quinidine/lidocaine , theophylline/acetaminophen , and @DRUG$/phenobarbital .	DDI-false
Oral Contraceptives : Coadministration of atorvastatin and an oral @DRUG$ Elevated AUC values for @DRUG$ Ethinylestradiol by about 30% and 20%.	DDI-false
Other Cardiovascular Agents : Enalapril and enalapril IV have been used concomitantly with @DRUG$ , methyldopa , nitrates , calcium-blocking agents , hydralazine , @DRUG$ and digoxin without evidence of clinically significant adverse interactions .	DDI-false
Iodine or @DRUG$ excess may decrease the effect of Carbimazole , and an iodine deficiency can increase the effect of @DRUG$.	DDI-false
Although no studies have been performed, concomitant use of @DRUG$ and phenytoin may alter the metabolism of @DRUG$ ;	DDI-false
@DRUG$, tricyclic Amphetamines may enhance the activity of @DRUG$ or sympathomimetic agents;	DDI-false
The intensity, uniformity and time course of @DRUG$ interference by phenobarbital, secobarbital, glutethimide, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving @DRUG$ therapy.	DDI-false
- Anabolic steroids (nandrolone [e.g., Anabolin], oxandrolone [e.g., Anavar], oxymetholone [e.g., Anadrol], @DRUG$ [e.g., @DRUG$]) or	DDI-false
Multivalent Cation-Containing products: co-administration of quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or @DRUG$ Antacids, sucralfate, VIDEX chewable/buffer tablets or children's powder, or products containing calcium, iron, or @DRUG$ The absorption of ciprofloxacin can be significantly reduced, resulting in significantly lower serum and urine levels than desired.	DDI-false
For example, inhibitors are azole antimycotics, @DRUG$ , @DRUG$ , diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Results of studies in multiple sclerosis patients taking TYSABRI  and concomitant interferon beta-1a (AVONEX  30 mcg IM once weekly) or @DRUG$ were inconclusive with regard to the need for dose adjustment of the beta-interferon or @DRUG$.	DDI-false
Concomitant administration of @DRUG$ and other related compounds ( eg , @DRUG$ , quinidine and chloroquine ) may produce electrocardiographic abnormalities and increase the risk of convulsions .	DDI-effect
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , @DRUG$ , fentanyl, alfentanyl, alprazolem, and @DRUG$ ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
The use of local anesthetics containing epinephrine or norepinephrine in patients receiving monoamine oxidase inhibitors, @DRUG$ or @DRUG$ For this reason, severe, prolonged hypotension or hypertension may occur.	DDI-false
Gleevec increases plasma concentrations of other CYP3A4 metabolised medicinal products (e.g. triazolobenzodiazepines, @DRUG$ , certain @DRUG$ , etc . ) .	DDI-false
Although neither @DRUG$ nor @DRUG$ affected the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone, they modify the mitogenic effect of EGF and insulin.	DDI-false
Warfarin: Eszopiclone 3 mg administered daily for 5 days did not affect the pharmacokinetics of@DRUG-DRUG$, nor were there any changes in the pharmacodynamic profile (prothrombin time) following a single 25 mg oral dose of warfarin	DDI-false
Other CONCOMITANT THERAPY : Although specific interaction studies have not been conducted in clinical trials, @DRUG$ ), beta blockers, calcium channel blockers, diuretics, and @DRUG$ ( NSAIDs ) without evidence of clinically significant adverse interactions .	DDI-false
The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving @DRUG$ or @DRUG$ may produce severe, prolonged hypertension.	DDI-false
Compounds that have been tested in man include @DRUG$ , @DRUG$ , propranolol , theophylline , and warfarin and no clinically meaningful interactions were found .	DDI-false
Treatment with CYP3A4 inhibitors (e.g. @DRUG$ , intraconazole, ritonavir, indinavir, saquinavir, @DRUG$ , etc . ) is indicated , reduction of the budesonide dose should be considered .	DDI-false
@DRUG$: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or @DRUG$ antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Central nervous system depressants : Concomitant use of DURAGESIC (Fentanyl transdermal system ) with other central nervous system depressants, including but not limited to others @DRUG$ , sedatives, hypnosis, sedatives (e.g. benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and @DRUG$ , respiratory depression, hypotension, and deep sedation, or possibly lead to coma or death.	DDI-false
Potential drug interactions between Keppra   and other AEDs ( @DRUG$ , gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also evaluated by the evaluation of levetiracetam serum concentrations. @DRUG$ during placebo-controlled clinical studies .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, @DRUG$, beta blockers, calcium-channel blockers, cardiac nitrates, @DRUG$, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
For example, @DRUG$ (e.g., @DRUG$) may activate the renin-angiotensin-aldosterone system.	DDI-false
Phenytoin: @DRUG$ may delay intestinal absorption of @DRUG$;	DDI-mechanism
Cardiac Glycosides: In a study of young healthy male subjects no evidence of a direct pharmacokinetic @DRUG$-@DRUG$ interaction could be found.	DDI-false
Colestipol-Concomitant intake of @DRUG$ and @DRUG$ may reduce the absorption of vitamin K.	DDI-mechanism
These drugs include the @DRUG$ and other diuretics , corticosteroids , phe-nothiazines , thyroid products , estrogens , oral contraceptives , @DRUG$ , nicotinic acid, sympathomimetics, calcium channel block drugs, and isoniazid.	DDI-false
Carbamazepine: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels @DRUG$ levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of @DRUG$ toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.	DDI-false
Note : dissolution of aerosol particles of @DRUG$ in Survanta , a model @DRUG$.	DDI-false
Drug Interactions : Flupenthixol may interact with some drugs , like Monoamine oxidase inhibitors ( MAOI ): @DRUG$ could theoretically affect @DRUG$ pharmacodynamics - Arecoline - Eproxindine - Ethanol : Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants : Flupenthixol increases the effect of Tricyclic antidepressants	DDI-effect
Although other @DRUG$ are highly effective, there have been reports of pregnancy from women who have used @DRUG$, as well as topical/injectable/implantable/insertable hormonal birth control products.	DDI-false
Antidiabetic drugs : ( oral agents and @DRUG$ ) - dosage adjustment of the @DRUG$ may be required .	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, @DRUG$, chloramphenicol, probenecid, coumarins, @DRUG$, and beta adrenergic blocking agents.	DDI-false
In comparison to the digital tolerance in dogs stunned with ketamine, @DRUG$ , or pentobarbital, the dose of Ouabain was needed to cause ventricular tachycardia significantly higher, such as the LD50 of @DRUG$ , with ketamine or innovar as with pentobarbital.	DDI-false
@DRUG$ and colestipol resins : Absorption of hydrochlorothiazide is impaired in the presence of @DRUG$.	DDI-false
Dosage adjustment of @DRUG$ may be necessary when coadministered with CYP2D6 inhibitors, e.g., @DRUG$, fluoxetine, and quinidine.	DDI-advise
Antihypertensives: Amiodarone should be used with caution in patients receiving  -@DRUG$ blocking agents (e.g., @DRUG$, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
@DRUG$ The concomitant use of DURAGESIC ( @DRUG$ Transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotic agents, sedatives (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants and alcohol, may result in respiratory depression, hypotension and deep sedation, or possibly in coma or death.	DDI-false
Data from in vitro studies of benzodiazepines other than @DRUG$ * Ergotamine, cyclosporin, amiodarone, nicardipine and @DRUG$.	DDI-int
Central nervous system depressants : Co-administration of DURAGESIC (Fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), generally @DRUG$ , phenothiazines , @DRUG$ And alcohol, can cause respiratory depression, hypotension, and deep sedation, or possibly lead to coma or death.	DDI-false
Because of the increased risk of adverse reactions in patients who: @DRUG$ At regular intervals, it is particularly important that doctors consult patients or their guardians carefully about benzodiazepine, @DRUG$ The sedative use of ROMAZICON is intended to be part of the story before any process in which the use of ROMAZICON is planned.	DDI-false
Multivalent Cation-Containing products: Concomitant administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminium antacids, sucralfate, VIDEX chewable tablets or pediatric powder or products which: @DRUG$ , @DRUG$ Zinc can significantly reduce the absorption of ciprofloxacin, resulting in serum and urine levels significantly lower than desired.	DDI-false
Coingestion of acetaminophen with @DRUG$, phenobarbital with acetaminophen, and valproic acid with @DRUG$ at high to toxic concentrations decreases the binding of the target drug.	DDI-false
While all the @DRUG$ ( SSRIs ) , e.g. , citalopram , escitalopram , fluoxetine , sertraline , and @DRUG$ , inhibit P450 2D6, they may vary in extent of inhibition.	DDI-false
therefore , @DRUG$ or other nitrates ( as used for management of angina ) or other drugs having vasodilator activity should , if possible , be discontinued before starting @DRUG$.	DDI-advise
Methotrexate Renal tubular transport of @DRUG$ may be inhibited by concomitant administration of @DRUG$, potentially leading to increased plasma levels of methotrexate.	DDI-mechanism
@DRUG$ (400 mg b.i.d.) had no effect on vardenafil bioavailability (AUC) and maximum concentration (Cmax) of vardenafil when co-administered with 20 mg @DRUG$ in healthy volunteers.	DDI-false
No data are available for the coadministration of INVIRASE/@DRUG$ or FORTOVASE/@DRUG$ and garlic capsules.	DDI-false
Coadministration of @DRUG$ Cyclosporin, tacrolimus or @DRUG$ The plasma concentrations of the last three drugs have been increased.	DDI-mechanism
- drug interactions between argatroban and co-administered aspirin ( 162.5 mg orally 26 and 2 hours before starting argatroban 1 g/kg/min for 4 hours), or @DRUG$ ( 1000 mg orally administered 12, 6 and 0 hours before, and 6 and 12 hours after, start of argatroban 1.5 g/kg/min. over 18 hours).	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., @DRUG$, @DRUG$, erythromycin, clarithromycin).	DDI-false
There is no pharmacokinetic interaction between @DRUG$ and @DRUG$.	DDI-false
Oral Contraceptives: Coadministration of @DRUG$ and an oral @DRUG$ increased AUC values for norethindrone and ethinyl estradiol by approximately 30% and 20%.	DDI-mechanism
In patients with mild to moderate hypertension, administration of VIOXX 25 mg daily with the ACE inhibitor @DRUG$ , 10 to 40 mg for 4 weeks, with an average increase in mean arterial pressure of approximately 3 mm Hg compared to @DRUG$ alone .	DDI-false
@DRUG$: The concomitant use of @DRUG$ and beta-blocking agents has been well tolerated in patients with stable angina.	DDI-false
@DRUG$: Concomitant treatment with Accutane and @DRUG$ should be avoided because Accutane use has been associated with a number of cases of pseudotumor cerebri (benign intracranial hypertension), some of which involved concomitant use of tetracyclines	DDI-false
Nephrotoxicity has been reported following concomitant administration of @DRUG$ with @DRUG$ or potent diuretics such as furosemide.	DDI-effect
For example , when vitamin K antagonists are administered concomitantly with @DRUG$ The prothrombin time should be carefully monitored and, if necessary, the dose of @DRUG$ should be reduced .	DDI-false
Cholestyramine and @DRUG$ @DRUG$ : Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins .	DDI-false
Levosimendan has no clinically important pharmacokinetic interactions with captopril, beta-blockers, @DRUG$ , @DRUG$ , warfarin, isosorbide mononitrate, knitztilol, ethanol or itraconazole.	DDI-false
@DRUG$ In a clinical pharmacology study, concomitant administration of antazide (aluminium hydroxide, magnesium hydroxide and simethicone) with fosinopril reduced serum levels and urinary excretion of @DRUG$ In comparison to Fosinopril alone, which suggests that antacids may affect the absorption of Fosinopril.	DDI-false
Anticoagulants: Potentiation of @DRUG$-type (CYP2C9 and CYP3A4 substrate) @DRUG$ response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding.	DDI-false
apomorphine - prior ingestion of diphenidol may decrease the @DRUG$ response to @DRUG$ in the treatment of poisoning.	DDI-false
Drugs that may alter @DRUG$ Plasma concentrations Drugs that may increase @DRUG$ Plasma concentrations: Caution should be exercised when gleevec is administered with inhibitors of the CYP3A4 family (e.g. ketoconazole, itraconazole, erythromycin, clarithromycin).	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, @DRUG$, phenothiazines, @DRUG$, tricyclic antidepressants or some antihistamines.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other @DRUG$, amantadine, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, @DRUG$ or some antihistamines.	DDI-false
However, the absolute number of alcohol-related deaths is far greater than the number of deaths in @DRUG$ or @DRUG$ users.	DDI-false
@DRUG$ Other, mainly diazoxide, or pre@DRUG$ and anesthetics used in surgery or skeletal muscle relaxants, not depolarizing, used in surgery	DDI-false
WARFARIN : Co- administration of @DRUG$ This did not result in changes in prothrombin time or coagulation factor VII compared to co-administration of cerivastatin in healthy volunteers. @DRUG$ and placebo .	DDI-false
In addition, certain drugs that are metabolized by this isoenzyme, including many antidepressants (@DRUG$, @DRUG$, and others), may inhibit the activity of this isoenzyme, and thus may make normal metab-olizers resemble poor metabolizers with regard to concomitant therapy with other drugs metabolized by this enzyme system, leading to drug interactions.	DDI-false
If cholinergic blockades occur, additive undesirable effects may occur if: @DRUG$ is administered concomitantly with other antimuscarinics , amantadine , haloperidol , phenothiazines , monoamine oxidase ( MAO ) inhibitors , @DRUG$ Or some antihistamines.	DDI-effect
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, calcium channel blockers, @DRUG$ or H1-blocking agents, @DRUG$ and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, @DRUG$, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, @DRUG$, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Other Drug Interactions: No pharmacokinetic interactions were observed between @DRUG$ and the following drugs: glyburide, @DRUG$, digoxin, Maalox, and ranitidine.	DDI-false
Methotrexate Renal tubular transport of methotrexate may be inhibited by concomitant use of methotrexate. @DRUG$ This may lead to increased plasma levels of @DRUG$.	DDI-false
@DRUG$: Potentiation of warfarin-type (@DRUG$ and CYP3A4 substrate) anticoagulant response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding.	DDI-false
Lithium : In a study conducted in healthy subjects , mean steady-state lithium plasma levels increased approximately 17 % in subjects receiving lithium 450 mg BID with @DRUG$ 200 mg BID as compared to subjects receiving @DRUG$ alone .	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, @DRUG$, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, @DRUG$ or some antihistamines.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, @DRUG$, nefazodone, @DRUG$, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Examples of inhibitors are azole antimycotics, ciprofloxacin, clarithromycin, diclofenac, @DRUG$ , erythromycin , imatinib , isoniazid , @DRUG$ , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .	DDI-false
Phenylbutazone : @DRUG$ The free share of @DRUG$ increases by about 80%.	DDI-mechanism
Sinus bradycardia has been reported with oral amiodarone in combination with lidocaine (@DRUG$ substrate) given for local @DRUG$.	DDI-false
The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors, @DRUG$ or @DRUG$ may produce severe, prolonged hypotension or hypertension.	DDI-false
@DRUG$ : @DRUG$ 75 mg once daily for 11 days does not alter the plasma concentration profile or renal elimination of digoxin after a single oral dose of 0.5 mg.	DDI-false
Concomitant administration of Mefloquine and other related compounds (eg, quinine, @DRUG$ and @DRUG$) may produce electrocardiographic abnormalities and increase the risk of convulsions.	DDI-false
Other concomitant therapy Although specific interaction studies have not been performed, 1 mg or more of finasteride doses have been co-administered in clinical trials with acetaminophen, acetylsalicylic acid, A-blockers, analgesics, angiotensin converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta-blockers, @DRUG$ , cardiac @DRUG$ , diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also known as NSAIDs), and quinolones anti-infections without evidence of clinically significant adverse interactions.	DDI-false
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., narcotics, @DRUG$, @DRUG$, sedatives, tranquilizers).	DDI-false
In general , these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride , including @DRUG$ ♪ Like quinidine and @DRUG$ , cardiac glycosides and tricyclic anti-depressants .	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine , although theoretically , coadministration of other drugs known to alter cardiac conduction ( eg , @DRUG$ or beta-adrenergic blocking agents , @DRUG$ , antihistamines or H1-blocking agents , tricyclic antidepressants and phenothiazines ) might also contribute to a prolongation of the QTc interval .	DDI-false
Results of studies in multiple sclerosis patients taking @DRUG$  and concomitant interferon beta-1a (AVONEX  30 mcg IM once weekly) or glatiramer acetate were inconclusive with regard to the need for dose adjustment of the beta-interferon or @DRUG$.	DDI-false
@DRUG$ No effect on the bioavailability of vardenafil (AUC) and maximum concentration (Cmax) of vardenafil (400 mg body weight) was observed. @DRUG$ When co-administered with 20 mg vardenafil in healthy volunteers.	DDI-false
@DRUG$ In large quantities, the anti-epileptic effect of phenobarbital can counteract, @DRUG$ and primidone , and increase the frequency of seizures in susceptible pediatric patients .	DDI-effect
Because Nalfon has not been shown to produce any additional effect beyond that obtained with aspirin alone and because aspirin increases the rate of excretion of @DRUG$, the concomitant use of @DRUG$ and salicylates is not recommended.	DDI-false
Additional drugs that are not recommended for coadministration with @DRUG$ and @DRUG$ are included below.	DDI-false
- Anabolic steroids (@DRUG$ [e.g., Anabolin], oxandrolone [e.g., Anavar], @DRUG$ [e.g., Anadrol], stanozolol [e.g., Winstrol]) or	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
In particular, convulsions have been reported when @DRUG$ is administered with @DRUG$ and special care should be taken when the treatment regimen includes both of these drugs.	DDI-effect
These medicines include thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$ , sympathomimet-ics , calcium channel blocking drugs , and @DRUG$.	DDI-false
These drugs include the thiazides and other diuretics , @DRUG$ , @DRUG$ , thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel block drugs, and isoniazide.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
The similarity of the @DRUG$ -associated adverse event profile between Study 1 (without co-administered AVONEX ) and Study 2 (with co-administered AVONEX ) indicates that this alteration in clearance does not necessitate reduction of the @DRUG$  dose to maintain safety, General).	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, @DRUG$, thyroid products, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , @DRUG$ , @DRUG$ , monoamine oxidase inhibitors, and beta-adrenergic blockers.	DDI-false
There was not a significant difference (p > 0.05) in AUC (48.59 +/- 8.52 vs. 49.9 +/- 9.93), Cmax (7.73 +/- 2.6 vs. 6.6 +/- 2.0), and tmax (1.1 +/- 0.6 vs. 1.6 +/- 1.1) for @DRUG$ versus @DRUG$/oxycodone regimens.	DDI-false
Injection: @DRUG$ injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, @DRUG$, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-effect
Although neither @DRUG$ Retinyl acetate affected prostatic epithelium proliferation in RPMI1640 with @DRUG$ alone , they modify the mitogenic effect of EGF and insulin .	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, dapsones, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporin, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolem, and @DRUG$ ) may have elevated plasma concentrations when coadministered with @DRUG$ ;	DDI-mechanism
The extent to which SSRI-@DRUG$ interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the @DRUG$ involved.	DDI-false
If treatment with inhibitors of CYP3A4 activity ( such as ketoconazole , @DRUG$ , ritonavir , indinavir , @DRUG$ , erythromycin , etc . ) is indicated , reduction of the budesonide dose should be considered .	DDI-false
The effects of nonbenzodiazepine agonists at benzodiazepine receptors, such as @DRUG$, triazolopyridazines and others, are also blocked by @DRUG$.	DDI-effect
Corticosteroids , @DRUG$ • diuretics: concomitant treatment with @DRUG$ Steroids, or diuretics may potentiate a potential hypocalemic effect of beta2-agonists.	DDI-false
SINCE THE CONCOMPITANT MANAGEMENT OF THE TWO THROUGH THE PHENYTOIN INTOXICATION BEFORE DEVELOPMENT @DRUG$ TO A PATIENT ON PHENYTOIN THERAPY , A BASELINE @DRUG$ ....................................................................................................................................................................................................................................................................	DDI-false
Both @DRUG$ and nevirapine have been compared to triple therapy with the @DRUG$ indinavir over 48 weeks as initial therapy, with similar responses being observed with nevirapine regimens and superiority observed with efavirenz.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, @DRUG$, isoniazid, @DRUG$, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
While 18-MC and @DRUG$ have similar affinities for kappa opioid and possibly nicotinic receptors, 18-MC has much lower affinities than @DRUG$ for NMDA and sigma-2 receptors, sodium channels, and the 5-HT transporter.	DDI-false
@DRUG$ : @DRUG$ are known to cause osteoporosis .	DDI-false
• Drug interactions: Flupentixol may interact with some medicines, such as monoamine oxidase inhibitors ( @DRUG$ ): MAOI could theoretically influence flupentixol pharmacodynamics - Arecoline - Eproxindine - @DRUG$ : Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants : Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
The effect of rifampin on the @DRUG$ The need of our patient seemed to be a maximum of 5 to 7 days after the start of treatment. @DRUG$ and extended a similar length of time after rifampin withdrawal .	DDI-false
@DRUG$ ( increases bioavailability by 50 % ) , @DRUG$ And valproates.	DDI-false
Monoamine Oxidase Inhibitors and @DRUG$: FORADIL should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or @DRUG$ because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-false
Blood glucose concentrations should be carefully monitored when @DRUG$ and oral @DRUG$ are coadministered .	DDI-advise
@DRUG$: In normal volunteers, a small decrease in @DRUG$ levels was observed when multiple doses of diflunisal and aspirin were administered concomitantly.	DDI-false
Central Nervous System Depressants: The concomitant use of @DRUG$  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, @DRUG$, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
@DRUG$ and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of @DRUG$.	DDI-false
Monoamine oxidase inhibitors and tricyclic antidepressants: FORADIL should be used in patients treated with @DRUG$ or tricyclic antidepressants because the action of @DRUG$ On the cardiovascular system can be potentiated by these active substances.	DDI-false
Central Nervous System Depressants : The concomitant use of @DRUG$   ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , @DRUG$ , skeletal muscle relaxants, and alcohol, may result in respiratory depression, hypotension, and deep sedation, or possibly in coma or death.	DDI-effect
@DRUG$/Prednisolone : Rofecoxib had no clinically important effect on the pharmacokinetics of prednisolone or @DRUG$.	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride, including anti-arrhythmic agents such as quinidine and @DRUG$, cardiac glycosides and @DRUG$.	DDI-false
Cardiovasculars : Cardiac glycosides : In patients receiving @DRUG$ therapy , administration of oral @DRUG$ This regularly leads to an increase in digoxin serum concentration, which can reach toxic concentrations with resulting clinical toxicity.	DDI-false
This effect may be mediated by the ability of @DRUG$ to induce microsomal enzymes and, thus, the catabolism of @DRUG$.	DDI-mechanism
Oral Contraceptives: Coadministration of atorvastatin and an oral @DRUG$ increased AUC values for @DRUG$ and ethinyl estradiol by approximately 30% and 20%.	DDI-false
SINCE THE CONCOMITANT ADMINISTRATION OF THESE TWO DRUGS CAN LEAD TO PHENYTOIN INTOXICATION, PRIOR TO ADMINISTERING DISULFIRAM TO A PATIENT ON @DRUG$ THERAPY, A BASELINE @DRUG$ SERUM LEVEL SHOULD BE OBTAINED.	DDI-false
Injection : @DRUG$ injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , @DRUG$ , MAO inhibitors , and other antidepressants . When scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .	DDI-effect
Caution should be exercised when an HMG-CoA reductase inhibitor is administered concomitantly with medicinal products that may reduce the concentration or activity of endogenous steroid hormones, such as: @DRUG$ , spironolactone , and @DRUG$.	DDI-false
As with other @DRUG$ , it should be noted that @DRUG$ Maybe it is able to increase CNS depressants such as anesthetics, opiates and alcohol.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , @DRUG$ , anticonvulsants, benzodiazepines, beta-blockers, calcium channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also known as @DRUG$ ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
Concomitantly given @DRUG$ The inclusion of a tablet of @DRUG$ has not been affected.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, @DRUG$, @DRUG$, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, @DRUG$, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
* Pharmacokinetic or pharmacodynamic drug interactions between argatroban and co-administered aspirin ( 162.5 mg orally 26 and 2 hours before starting treatment with argatroban 1 g/ kg/ min for 4 hours), or @DRUG$ ( 1000 mg orally administered 12, 6 and 0 hours before, and 6 and 12 hours after, beginning of the @DRUG$ 1.5 g/kg/min over 18 hours).	DDI-false
The possibility of hypotensive effects can be minimized by: @DRUG$ Before starting treatment with @DRUG$ salt intake is increased or increased.	DDI-effect
Based on the chemical resemblance of @DRUG$ and @DRUG$, coadministration of astemizole with itraconazole is contraindicated.	DDI-false
This appears to be the only clinically relevant interaction of this species with mefloquines, although theoretically the concomitant use of other medicinal products is known to alter the heart conduction (e.g. anti-arrhythmic or @DRUG$ , @DRUG$ , antihistamines or H1-blocking agents , tricyclic antidepressants and phenothiazines ) might also contribute to a prolongation of the QTc interval .	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, @DRUG$, and @DRUG$.	DDI-false
Since amiodarone is a substrate for CYP3A4, there is a potential for St. John's Word to be used in patients who: @DRUG$ • could lead to a reduction in unemployment. @DRUG$ levels .	DDI-false
Benzthiazide may interact with @DRUG$, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, @DRUG$, norepinephrine, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
This drug may interact with alcohol or other @DRUG$ ( may potentiate the CNS depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( MAO ) inhibitors ( concurrent use with @DRUG$ The anticholinergic and CNS depressive effects of antihistamines may be prolonged and intensified.	DDI-false
These results suggest that both dexamethasone and retinyl acetate, and possibly other @DRUG$ and @DRUG$ , may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF .	DDI-false
- @DRUG$ ( e.g. , @DRUG$ ) or	DDI-false
In patients with chronic hepatitis C treated with @DRUG$ in combination with COPEGUS, @DRUG$ treatment did not affect ribavirin distribution or clearance.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, @DRUG$, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and @DRUG$.	DDI-false
The hypoglycemic action of @DRUG$ may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and @DRUG$.	DDI-effect
@DRUG$/@DRUG$ : Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered aspirin ( 162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1   g/kg/min . over 4 hours ) or acetaminophen ( 1000 mg orally given 12 , 6 and 0 hours prior to , and 6 and 12 hours subsequent to , initiation of Argatroban 1.5   g/kg/min . over 18 hours ) .	DDI-false
The extent to which @DRUG$-TCA interactions can cause clinical problems depends on the degree of inhibition and pharmacokinetics of patients. @DRUG$ involved .	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$, sympathomimetics, calcium channel blocking drugs, and @DRUG$.	DDI-false
Therefore , when @DRUG$ and @DRUG$ When co-administered, the patient should be closely monitored to determine whether the desired effect of the diuretic is achieved.	DDI-advise
@DRUG$ Incorporating coumarin derivatives, indandion derivatives and @DRUG$ Like nonsteroidal anti-inflammatory drugs (NSAIDs) and aspirin, the risk of bleeding can increase when administered concomitantly with ardeparin.	DDI-false
- Anabolic steroids ( nandrolone [ e.g. , @DRUG$ ], oxandrolone [e.g., Anavar], @DRUG$ [ e.g. , Anadrol ] , stanozolol [ e.g. , Winstrol ] ) or	DDI-false
The effect of @DRUG$ The patient's warfarin requirement seemed to be a maximum of 5 to 7 days after the onset of rifampin and extended a similar period of time after the onset of rifampin. @DRUG$ withdrawal .	DDI-false
Other concomitant therapy Although specific interaction studies have not been performed, @DRUG$ Doses of 1 mg or more were used concomitantly in clinical trials with acetaminophene, acetylsalicylic acid, A-blockers, analgesics, angiotensin converting enzyme inhibitors (ACE), @DRUG$ , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , H2 antagonists , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
Monoamine Oxidase Inhibitors and Tricyclic Antidepressants: @DRUG$ should be administered with extreme caution in patients being treated with @DRUG$ or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-advise
Fenfluramine may increase slightly the effect of @DRUG$, e.g., guanethidine, @DRUG$, reserpine.	DDI-false
Fenfluramine may slightly increase the effect of antihypertensive agents, e.g. guanethidine, @DRUG$ , @DRUG$.	DDI-false
In an in vitro study of human liver microsomes, CYP2A6 inhibits hydroxylation of @DRUG$ by @DRUG$ ( 200 m m M i.e. , 350 mg/L ) was 17 - 28 % .	DDI-mechanism
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and @DRUG$ with @DRUG$ plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Both @DRUG$ and 18-MC block @DRUG$-induced and nicotine-induced dopamine release in the nucleus accumbens ;	DDI-effect
The effects of @DRUG$ were very strong and completely depressed the @DRUG$-induced hyperlocomotion .	DDI-effect
BACKGROUND : Effects of combined administration of bombsin and verapamil hydrochloride ( @DRUG$ ) , a calcium channel blocker , on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane ( @DRUG$ ) and the index of colorectal cancers were studied in male Wistar rats.	DDI-false
Drugs That Induce CYP3A4 ( @DRUG$ The Racemic zopiclone exposure was achieved by the simultaneous use of @DRUG$ , a potent inducer of CYP3A4 .	DDI-false
BACKGROUND: The effects of combined administration of bombesin and verapamil hydrochloride (@DRUG$), a calcium channel blocker, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane (@DRUG$) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
Potassium-sparing diuretics ( e.g. , spironolactone , @DRUG$ , or @DRUG$ Potassium supplements or salt substitutes containing potassium may lead to significant increases in serum potassium.	DDI-false
Concurrent administration of drugs possessing nephrotoxic ( e.g. , aminoglycosides , indomethacin ) , myelotoxic ( e.g. , @DRUG$ chemotherapy ) , cardiotoxic ( e.g. , doxorubicin ) or hepatotoxic ( e.g. , methotrexate , asparaginase ) effects with @DRUG$ may increase toxicity in these organ systems .	DDI-effect
@DRUG$-Vitamin K can antagonize the effect of @DRUG$	DDI-false
- anabolic steroids (Nandrolone [e.g. Anaboline], Oxandrolone [e.g., Anavar], @DRUG$ [ e.g. Anadrol ], @DRUG$ (e.g. Winstrol ]) or	DDI-false
However, in the second study, administration of 12 g @DRUG$ 1 hour before the evening meal and 0.3 mg cerivastatin sodium approximately 4 hours after the same evening meal resulted in a decrease in the cerivastatin AUC of less than 8%, and a decrease in Cmax of about 30% when compared to dosing @DRUG$ alone.	DDI-false
@DRUG$: In normal volunteers, concomitant administration of diflunisal and hydrochlorothiazide resulted in significantly increased plasma levels of @DRUG$.	DDI-false
Methotrexate : In an interaction study in patients with rheumatoid arthritis taking methotrexate, @DRUG$ The pharmacokinetics of @DRUG$ were not significantly affected.	DDI-false
Patients receiving both indomethacin and @DRUG$ should be observed closely to determine if the desired diuretic and/or antihypertensive effect of @DRUG$ is achieved.	DDI-false
If treatment with inhibitors of CYP3A4 activity ( such as ketoconazole , @DRUG$ , @DRUG$ , indinavir, saquinavir, erythromycin, etc.) is indicated, reduction of budesonide dose should be considered.	DDI-false
Lithium : @DRUG$ Toxicity has been reported in patients who: @DRUG$ Accompanied by medicines that cause the excretion of sodium, including ACE inhibitors.	DDI-false
@DRUG$ may interact with alcohol , blood thinners , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , @DRUG$ Such as Aleve or ibuprofen, and high blood pressure medications.	DDI-int
As with other @DRUG$ , it should be noted that HALDOL may be capable of potentiating CNS depressants such as anesthetics , opiates , and @DRUG$.	DDI-effect
Antacids: In a clinical pharmacology study, coadministration of an @DRUG$ (aluminum hydroxide, magnesium hydroxide, and simethicone) with @DRUG$ reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-mechanism
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - @DRUG$ - Eproxindine - Ethanol: @DRUG$ and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
This appears to be the only clinically relevant interaction of this kind with @DRUG$, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, calcium channel blockers, antihistamines or @DRUG$, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-effect
In general , these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride , including anti-arrhythmic agents such as quinidine and procainamide , @DRUG$ and @DRUG$.	DDI-false
The administration of local @DRUG$ containing epinephrine or @DRUG$ to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.	DDI-false
@DRUG$ , @DRUG$ Amphetamines may enhance the activity of tricyclic antidepressants or sympathomimetic agents ;	DDI-false
Fluconazole : Concomitant administration of @DRUG$ at 200 mg QD resulted in a two-fold increase in @DRUG$ plasma concentration .	DDI-mechanism
@DRUG$ have been reported to blunt the hypotensive effect of systemic @DRUG$.It is not known whether the concurrent use of these agents with ALPHAGAN P in humans can lead to resulting interference with the IOP lowering effect.	DDI-effect
- Anabolic steroids (@DRUG$ [e.g., Anabolin], oxandrolone [e.g., @DRUG$], oxymetholone [e.g., Anadrol], stanozolol [e.g., Winstrol]) or	DDI-false
Drugs That Induce CYP3A4 (@DRUG$) Racemic @DRUG$ exposure was decreased 80% by concomitant useof rifampicin, a potent inducer of CYP3A4.	DDI-false
- Antidiabetics , oral ( diabetes medicine you take by mouth ) Use of oral @DRUG$ with @DRUG$ may increase the chance of side effects affecting the blood and/or the side effects or oral antidiabetics	DDI-effect
Tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , @DRUG$ , propranolol, nifedipine, chlordiazepoxide, diazepam, certain @DRUG$ , lidocaine, theophylline and metronidazole, delaying the elimination and increase in blood levels of these drugs.	DDI-false
For example, inhibitors are azole antimycotics, ciprofloxacin, @DRUG$ , diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodon, @DRUG$ Propofol, protease inhibitors, quinidine and verapamil.	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, @DRUG$, @DRUG$, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, @DRUG$, probenecid, coumarins, @DRUG$, and beta adrenergic blocking agents.	DDI-false
In order to evaluate the effects of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL ), the authors retrospectively compared a group of 24 patients with HIV-NHL who had been treated with the @DRUG$ , doxorubicin , vincristine , and @DRUG$ ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , doxorubicin , teniposide , and prednisone with vincristine plus bleomycin ) without receiving antiretroviral therapy .	DDI-false
Other Drug Interactions Oral Contraceptives Keppra  (500 mg twice daily) did not influence the pharmacokinetics of an oral @DRUG$ containing 0.03 mg ethinyl estradiol and 0.15 mg @DRUG$, or of the luteinizing hormone and progesterone levels, indicating that impairment of contraceptive efficacy is unlikely.	DDI-false
No pharmacokinetic interactions between dexmedetomidine and @DRUG$, propofol, alfentanil, and @DRUG$ have been demonstrated.	DDI-false
Antiarrhythmics: Other antiarrhythmic drugs, such as @DRUG$, procainamide, disopyramide, and @DRUG$, have been used concurrently with amiodarone.	DDI-false
(@DRUG$ may increase the responsiveness to @DRUG$.)	DDI-effect
Both @DRUG$ and 18-MC block @DRUG$-induced and nicotine-induced dopamine release in the nucleus accumbens;	DDI-effect
Acetaminophen/@DRUG$, lidocaine/chinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen and valproic acid/phenobarbital.	DDI-false
Dexamethasone and retinyl acetate similarly inhibit and stimulate @DRUG$- or @DRUG$-induced proliferation of prostatic epithelium.	DDI-false
Based on these data, @DRUG$ should not be used in patients on @DRUG$ therapy.	DDI-advise
This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), @DRUG$ or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of @DRUG$).	DDI-false
Reported examples include the following: @DRUG$: @DRUG$ are known to inhibit CYP3A4 to varying degrees.	DDI-false
However, the absolute number of @DRUG$-related deaths is far greater than the number of deaths in amphetamine or @DRUG$ users.	DDI-false
@DRUG$ (600 mg B.i.d.) with @DRUG$ 5 mg resulted in a 49-fold increase in vardenafil AUC and a 13-fold increase in vardenafil Cmax.	DDI-mechanism
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, fibric acid derivatives, @DRUG$ (nicotinic acid), erythromycin, @DRUG$.	DDI-false
- corticosteroids, methylxanthine and @DRUG$ : Concomitant treatment with xanthine derivatives , steroids , or diuretics may potentiate a possible hypokalemic effect of   @DRUG$	DDI-false
Levosimendan has no clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, @DRUG$ , @DRUG$ ==References====External links==	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , disopyramide , @DRUG$ , amiodarone , quinidine , warfarin , tacrolimus , @DRUG$ , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
Specific studies have confirmed these effects with sevoflurane , @DRUG$ , propofol , @DRUG$ , and midazolam.	DDI-false
Injection: @DRUG$ injection, like other injectable @DRUG$, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
Aminosalicylic acid may decrease the amount of digoxin (@DRUG$, @DRUG$) that gets absorbed into your body.	DDI-false
Both efavirenz and nevirapine have been compared to triple therapy with the @DRUG$ indinavir over 48 weeks as initial therapy , with similar responses being observed with @DRUG$ Regimes and superiority observed with efavirenz.	DDI-false
@DRUG$ Isoniazid is known to slow down the metabolism of carbamazepine and increase its serum levels @DRUG$ levels should be determined prior to concurrent administration with isoniazid , signs and symptoms of carbamazepine toxicity should be monitored closely , and appropriate dosage adjustment of the anticonvulsant should be made .	DDI-false
@DRUG$: Chloramphenicol, erythromycins, @DRUG$, or tetracyclines may interfere with the bactericidal effect of penicillins.	DDI-false
- @DRUG$ (e.g. Mexat ) use of @DRUG$ Sulfapyridine may increase the likelihood of adverse reactions affecting the liver and/ or the side effects of methotrexate.	DDI-false
Other potent inhibitors of CYP3A4 (e.g. itraconazole, clarithromycin, @DRUG$ , troleandomycin , @DRUG$ nelfinavir is expected to behave similarly.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, @DRUG$, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, @DRUG$, and verapamil.	DDI-false
acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
An interaction study with @DRUG$ There was no clinically significant effect of anastrozole on @DRUG$ pharmacokinetics or anticoagulant activity .	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, @DRUG$, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
The intensity, uniformity and time course of @DRUG$ interference by phenobarbital, secobarbital, glutethimide, chloral hydrate and @DRUG$ were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, @DRUG$, warfarin, @DRUG$, carvedilol, ethanol or itraconazole.	DDI-false
The compounds tested in humans include: @DRUG$ , theophylline, phenytoin, @DRUG$ , aminopyrine and antipyrine .	DDI-false
Some @DRUG$/substances are known to accelerate the metabolism of @DRUG$ Invigorating for the synthesis of CYP3A4 (enzymination).	DDI-false
To determine if the injection of thiosulfate is larger doses of thiosulfate @DRUG$ to be administered , a fixed 9.9-g/m2 dose of thiosulfate was given intravenously over three hours concurrently with escalating doses of @DRUG$.	DDI-false
ACE inhibitors and angiotensin II receptor antagonists (congestive heart failure after myocardial infarction)- In EPHESUS, 3020 (91%) patients also received INSPRA 25-50 mg. @DRUG$ or @DRUG$ ( ACEI/ARB ).	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including @DRUG$, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or @DRUG$ may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
Medicines detected as CYP3A inhibitors of possible clinical significance based on clinical studies @DRUG$ ( caution is recommended during coadministration with @DRUG$ Concomitant administration of fluoxetine and alprazolam increased the maximum plasma concentration of alprazolam by 46%, decreased clearance by 21%, increased half-life by 17% and decreased measured psychomotor performance.	DDI-false
Hypotension: Patients on Diuretic Therapy: Patients on @DRUG$ and especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with @DRUG$ or enalaprilat.	DDI-effect
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, calcium channel blockers, antihistamines or H1-blocking agents, @DRUG$ and @DRUG$) might also contribute to a prolongation of the QTc interval.	DDI-false
- Methotrexate ( e.g. , @DRUG$ ) Use of @DRUG$ with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of methotrexate	DDI-false
@DRUG$ ( 5 mg/ kg ), moclobemid ( 30 mg/ kg ), @DRUG$ Fluoxetine ( 20 mg/ kg ) sertraline ( 30 mg/ kg ) or vehicle was administered.	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of @DRUG$ 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (alcohol, @DRUG$, opiates, sedatives, anesthetics) should be considered.	DDI-advise
@DRUG$ : @DRUG$ causes increase ( by about 80 % ) in the free fraction of etodolac .	DDI-false
Other potent inhibitors of CYP3A4 (e.g. itraconazole, @DRUG$ , nefazodone , troleandomycin , ritonavir , @DRUG$ It would be expected that it would behave in a similar way.	DDI-false
Fulminant rhabdomyolysis has been seen as early as three weeks after initiation of combined therapy with another @DRUG$ and @DRUG$ but may be seen after several months.	DDI-effect
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (@DRUG$), NSAIDs (piroxicam), and @DRUG$ did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
In EM individuals treated with paroxetine or @DRUG$, the AUC of @DRUG$ is approximately 6- to 8-fold and Css,max is about 3- to 4-fold greater than atomoxetine alone.	DDI-mechanism
Other concomitant therapy Although specific interaction studies have not been performed, 1 mg or more of finasteride doses have been co-administered in clinical trials with acetaminophen, acetylsalicylic acid, A-blockers, analgesics, angiotensin converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta-blockers, calcium channel blockers, heart @DRUG$ , diuretics , H2 antagonists , @DRUG$ , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
Administration of rifampin concomitantly with oral amiodarone has been shown to result in decreases in serum concentrations of @DRUG$ and @DRUG$.	DDI-false
Drugs that may alter @DRUG$ plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., @DRUG$, itraconazole, erythromycin, clarithromycin).	DDI-false
Concomitant cyclophosphamide, doxorubicin, vincristine, and @DRUG$ chemotherapy plus @DRUG$ therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
Hypotension: Patients on Diuretic Therapy: Patients on diuretics and especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with @DRUG$ or @DRUG$.	DDI-false
acetaminophen/@DRUG$ , lidocaine/quinidine , phenobarbital/acetaminophen , phenobarbital/valproic acid , quinidine/@DRUG$ , theophylline/acetaminophen , and valproic acid/phenobarbital .	DDI-false
- Anabolic steroids (nandrolone [e.g., Anabolin], oxandrolone [e.g., Anavar], @DRUG$ [e.g., Anadrol], @DRUG$ [e.g., Winstrol]) or	DDI-false
Drug-Drug Interactions Between @DRUG$  And Other Antiepileptic Drugs (AEDs) @DRUG$ Keppra  (3000 mg daily) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy.	DDI-false
@DRUG$ The toxicity may be caused by the first release of norepinephrine caused by: @DRUG$ Injection .	DDI-effect
This drug may interact with @DRUG$ or other @DRUG$ (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
There have been reports of QTc prolongation , with or without TdP , in patients taking @DRUG$ when fluoroquinolones , @DRUG$ , or azoles were administered concomitantly .	DDI-false
@DRUG$ , Methylxanthines and Diuretics : Concomitant treatment with @DRUG$ , steroids , or diuretics may potentiate a possible hypokalemic effect of   beta2-agonists .	DDI-false
It is therefore necessary to be familiar with the clinical and paraclinical pattern @DRUG$ Deficit and to discriminate between magnesium deficiency due to insufficient magnesium uptake, which requires only oral physiological supplement and magnesium degradation, which with a dysregulation of the control mechanisms of @DRUG$ status which requires more or less specific regulation of its causal dysregulation .	DDI-false
In rats, simultaneous ingestion of disulfiram and @DRUG$ in the diet for 78 weeks has been reported to cause tumors, and it has been suggested that disulfiram may react with @DRUG$ in the rat stomach to form a nitrosamine, which is tumorigenic.	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, Dapson, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporin, ergot derivatives, pimozide, @DRUG$ , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with @DRUG$ ;	DDI-mechanism
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, @DRUG$, a-blockers, @DRUG$, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
• Co-administration with compounds that are potent CYP3A4 inducers (e. g. @DRUG$ , phenytoin , @DRUG$ , carbamazepine ) may result in decreased plasma levels of saquinavir .	DDI-false
@DRUG$: Reports suggest that @DRUG$ may diminish the antihypertensive effect of Angiotensin Converting Enzyme (ACE) inhibitors.	DDI-false
Other interactions: no pharmacokinetic interactions between: @DRUG$ And the following medications : glyburide, @DRUG$ , digoxin , Maalox , and ranitidine .	DDI-false
Anticoagulants: Potentiation of warfarin-type (CYP2C9 and CYP3A4 substrate) @DRUG$ response is almost always seen in patients receiving @DRUG$ and can result in serious or fatal bleeding.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, @DRUG$, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, @DRUG$ (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
It is structurally distinct from the other currently available @DRUG$ (@DRUG$, simvastatin, and pravastatin), leading to unique biopharmaceutical properties relative to the other agents of this class.	DDI-false
Therefore , when hydroflumethiazide and @DRUG$ When co-administered, the patient should be closely monitored to determine whether the desired effect of the @DRUG$ ==References==	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, fibric acid derivatives, niacin (nicotinic acid), @DRUG$, @DRUG$.	DDI-false
However, the impact of the @DRUG$ For travellers receiving comedies, especially diabetics or patients who: @DRUG$ , should be checked before departure.	DDI-advise
The concomitant use of @DRUG$ is not recommended since nitrofurantoin may antagonize the antibacterial effect of @DRUG$ in the urinary tract.	DDI-false
Ergot Derivatives : Dihydroergotamine , ergonovine , ergotamine , @DRUG$ CONTRAINDICATE because of the potential for serious and life-threatening reactions such as acute @DRUG$ toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues .	DDI-false
Therophylline : A recent study has shown that the concomitant administration of isoniazid and @DRUG$ Elevated plasma levels may occur. @DRUG$ , and in some instances a slight decrease in the elimination of isoniazid .	DDI-false
This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), @DRUG$ or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and @DRUG$ (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
These medicines include thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, orally @DRUG$ , phenytoin, nicotinic acid, sympathomimetics, calcium channel block drugs, and @DRUG$.	DDI-false
@DRUG$ : The concomitant administration of @DRUG$ and sulindac in normal volunteers resulted in lowering of the plasma levels of the active sulindac sulfide metabolite by approximately one-third .	DDI-false
Nonsteroidal Anti-Inflammatory Drugs (@DRUG$)-A drug interaction study of eplerenone with an @DRUG$ has not been conducted.	DDI-false
Another oral @DRUG$, ketoconazole, inhibits the metabolism of astemizole, resulting in elevated plasma concentrations of @DRUG$ and its active metabolite desmethylastermizole which may prolong QT intervals.	DDI-false
To evaluate the effects of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL), the authors retrospectively compared a group of 24 patients with HIV-NHL treated with cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$ , doxorubicin , teniposide , and prednisone with vincristine plus @DRUG$ ) without receiving antiretroviral therapy .	DDI-false
Norepinephrine : @DRUG$ Elevate the adrenergic effect of @DRUG$.	DDI-effect
While all the selective serotonin reuptake inhibitors (SSRIs), e.g., citalopram, escitalopram, @DRUG$, sertraline, and @DRUG$, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
These medicines include thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, orally @DRUG$ , @DRUG$ , nicotinic acid, sympathomimetics, calcium channel block drugs, and isoniazid.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and antineoplastic agents, specifically, dacarbazine, cis-platinum, @DRUG$ and @DRUG$.	DDI-false
Numerous drug interactions are possible with some anticonvulsant agents, such as @DRUG$ and @DRUG$, which affect hepatic microsomal enzyme systems.	DDI-false
These drugs include thiazides and other @DRUG$ , corticosteroids , phe-nothiazines , thyroid products , estrogens , oral @DRUG$ , phenytoin, nicotinic acid, sympathomimetics, calcium channel block drugs, and isoniazide.	DDI-false
Specific studies have confirmed these effects with @DRUG$, isoflurane, @DRUG$, alfentanil, and midazolam.	DDI-false
@DRUG$: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with @DRUG$ administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
Like @DRUG$ (40 mg/kg), @DRUG$ (40 mg/kg) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of ethanol and nicotine in rats;	DDI-false
High-dose @DRUG$ with @DRUG$ protection.	DDI-effect
In patients receiving @DRUG$ and a steroid concomitantly, any reduction in steroid dosage should be gradual in order to avoid the possible complications of sudden @DRUG$ withdrawal.	DDI-false
however, no deleterious interactions were seen when @DRUG$ was administered after @DRUG$, inhalational anesthetics, muscle relaxants and muscle relaxant antagonists administered in conjunction with sedation or anesthesia.	DDI-false
Warfarin @DRUG$   ( 1000 mg twice daily ) did not influence the pharmacokinetics of R and @DRUG$.	DDI-false
Acetaminophen: In normal volunteers, concomitant administration of @DRUG$ and acetaminophen resulted in an approximate 50% increase in plasma levels of @DRUG$.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Concomitant @DRUG$ , doxorubicin, vincristine and prednisone chemotherapy plus @DRUG$ therapy in patients with human immunodeficiency virus-related , non-Hodgkin lymphoma .	DDI-false
@DRUG$ may block the antihypertensive action of @DRUG$ and similarly acting compounds.	DDI-effect
High-dose @DRUG$ resulting in concentrations above 2000 ng/mL administered with oral etoposide has led to an 80% increase in @DRUG$ exposure with a 38% decrease in total body clearance of etoposide compared to etoposide alone.	DDI-false
Because @DRUG$ has not been shown to produce any additional effect beyond that obtained with @DRUG$ alone and because aspirin increases the rate of excretion of Nalfon , the concomitant use of Nalfon and salicylates is not recommended .	DDI-false
In clinical studies performed with @DRUG$ Co-administration of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs ( @DRUG$ Digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, @DRUG$, diazepam, certain tricyclic antidepressants, @DRUG$, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Drug-drug interactions have not been observed between @DRUG$ and @DRUG$ or erythromycin.	DDI-false
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies ( @DRUG$ , @DRUG$ , oral contraceptive , digoxin , warfarin , probenecid ) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients .	DDI-false
Coingestion of acetaminophen with theophylline, phenobarbital with acetaminophen, and @DRUG$ with @DRUG$ at high to toxic concentrations decreases the binding of the target drug.	DDI-effect
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$, acetylsalicylic acid, a-blockers, analgesics, @DRUG$, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Other medicinal products Interactions: No pharmacokinetic interactions between vardenafil and the following medicines have been observed: glyburide, warfarin, @DRUG$ , Maalox , and @DRUG$.	DDI-false
Studies in rats have shown that the administration of neomycin to certain types of @DRUG$ Conditional hypertension, including @DRUG$ hypertension .	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (@DRUG$), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of @DRUG$.	DDI-false
In addition, certain drugs that are metabolized by this isoenzyme, including many @DRUG$ (@DRUG$, selective serotonin reuptake inhibitors, and others), may inhibit the activity of this isoenzyme, and thus may make normal metab-olizers resemble poor metabolizers with regard to concomitant therapy with other drugs metabolized by this enzyme system, leading to drug interactions.	DDI-false
If a @DRUG$ is also used, it may increase the risk of @DRUG$ toxicity.	DDI-effect
Like ibogaine (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of morphine and @DRUG$ and the oral self-administration of ethanol and @DRUG$ in rats;	DDI-false
Several drug interaction studies have been completed with both @DRUG$ and @DRUG$.	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with @DRUG$, @DRUG$, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with pentobarbital.	DDI-false
Monoamine Oxidase Inhibitors and @DRUG$ : FORADIL should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants because the action of @DRUG$ On the cardiovascular system can be potentiated by these active substances.	DDI-false
Antacids : In a clinical pharmacology study, the concomitant use of antacids (aluminium hydroxide, @DRUG$ , and @DRUG$ In combination with fosinopril reduced serum levels and urinary excretion of fosinoprilat given alone, suggesting that antacids may impair the absorption of fosinopril.	DDI-false
Sine bradycardia was treated with oral @DRUG$ In combination with lidocaine ( @DRUG$ ==References====External links==	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, phenothiazines, thyroid products, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Clinical studies with @DRUG$ have identified potentially significant interactions with @DRUG$ and lithium .	DDI-int
Nephrotoxicity following co-administration of cephalosporins with @DRUG$ or potent @DRUG$ For example, furosemide.	DDI-false
The intensity , uniformity and time course of anticoagulant interference by phenobarbital , @DRUG$ , glutethimide , chloral hydrate and @DRUG$ were systematically investigated in 16 patients receiving coumarin therapy .	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, Dapson, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$ , ergot derivatives , pimozide , carbamazepine , @DRUG$ Concomitant use with saquinavir may result in increased plasma concentrations.	DDI-false
These results suggest that both dexamethasone and retinyl acetate, and possibly other glucocorticoids and retinoids, may cause prostatic epithelium proliferation due to a dose-dependent change in the activity of @DRUG$ and @DRUG$.	DDI-false
Like ibogaine ( 40 mg/kg ) , 18-MC ( 40 mg/kg ) decreases the intravenous self-administration of morphine and @DRUG$ and the oral self-administration of ethanol and @DRUG$ in rats ;	DDI-false
Myocardial injury , including myocardial infarction , myocarditis , ventricular hypokinesia , and severe rhabdomyolysis appear to be increased in patients receiving @DRUG$ and @DRUG$ concurrently .	DDI-effect
The effects of @DRUG$ and L-CCG-1 upon @DRUG$ (PCP)-induced locomotion and behavioral changes in mice.	DDI-false
Amiodarone may suppress certain CYP450 enzymes, including @DRUG$, CYP2C9, @DRUG$, and CYP3A4.	DDI-false
Example inhibitors include @DRUG$ , ciprofloxacin , clarithromycin , @DRUG$ , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .	DDI-false
However , in the second study , administration of 12 g cholestyramine 1 hour before the evening meal and 0.3 mg @DRUG$ About 4 hours after the same evening meal, cerivastatin AUC decreased by less than 8% and Cmax decreased by about 30% compared to the dose. @DRUG$ alone .	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , @DRUG$ , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , @DRUG$ , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
The extent to which SSRI@DRUG$ interactions can cause clinical problems depends on the degree of inhibition and pharmacokinetics of patients. @DRUG$ involved .	DDI-false
Other Cardiovascular Agents: @DRUG$ and enalapril IV have been used concomitantly with @DRUG$, methyldopa, nitrates, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Elevated serum levels of @DRUG$ It was used via a concomitant use of @DRUG$ with norfloxacin .	DDI-false
Acetaminophen/theophylline, lidocaine/chinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen, and @DRUG$/Phenobarbital.	DDI-false
Therefore , interactions could occur following concomitant administration of @DRUG$ ( e.g. , narcotics , @DRUG$ , antiemetics , sedatives , tranquilizers ) .	DDI-false
This appears to be the only clinically relevant interaction of this species with mefloquines, although theoretically the concomitant use of other medicinal products is known to alter the heart conduction (e.g. anti-arrhythmic or @DRUG$ Calcium channel blockers, @DRUG$ Tricyclic antidepressants and phenothiazines can also contribute to the prolongation of the QTc interval.	DDI-false
Concomitant administration of @DRUG$ The AUC for @DRUG$ has been doubled.	DDI-mechanism
Vitamin A : Because of the relationship of @DRUG$ to @DRUG$ Patients should be prevented from taking vitamin A-containing supplements to avoid additive toxic effects.	DDI-effect
Drug Interactions : Flupenthixol may interact with some drugs , like @DRUG$ MAOI could theoretically influence flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol : Flupenthixol and ethanol cause additive CNS depression - Tricyclic antidepressants : Flupenthixol increases the effect of @DRUG$	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., @DRUG$, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and @DRUG$, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
acetaminophen/theophylline, @DRUG$/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (@DRUG$, cefoperazone, cefotetan, cefamandole, latamoxef) or methylthiadiazole (@DRUG$) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Garlic Capsules Garlic capsules should not be used while taking saquinavir (FORTOVASE) as the sole @DRUG$ due to the risk of decreased @DRUG$ plasma concentrations.	DDI-false
Anticoagulants: Potentiation of @DRUG$-type (CYP2C9 and @DRUG$ substrate) anticoagulant response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding.	DDI-false
In general , these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride , including anti-arrhythmic agents such as quinidine and @DRUG$ , Herzglycosides and @DRUG$.	DDI-false
Concomitant administration of @DRUG$ , quinidine and other related compounds (e.g. quinine, quinidine and @DRUG$ ) may produce electrocardiographic abnormalities and increase the risk of convulsions .	DDI-effect
At a median follow-up of 33 months, the combination of @DRUG$ and @DRUG$ did not demonstrate any efficacy benefit when compared with tamoxifen in all patients as well as in the hormone receptor-positive subpopulation.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, @DRUG$, @DRUG$, and verapamil.	DDI-false
As higher doses of @DRUG$ A single dose of 2.5 mg ( 400 mg daily) may lead to higher Cmax and AUC increases. @DRUG$ When used in combination with ketoconazole 400 mg daily, the dose should not be exceeded in a 24-hour period.	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , @DRUG$ , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and @DRUG$ Concomitant use with saquinavir may result in increased plasma concentrations.	DDI-false
therefore, close monitoring of prothrombin time is recommended, and adjustment of the @DRUG$ dose may be necessary when @DRUG$ is administered concomitantly.	DDI-advise
Benzthiazide can interact with alcohol, blood thinners, decongestant medications (allergic, cold, and sinus drugs), diabetes medications, lithium, norepinephrine, @DRUG$ like Aleve or @DRUG$ , and high blood pressure medications .	DDI-false
To determine whether injection of thiosulfate would permit larger doses of cisplatin to be administered , a fixed 9.9-g/m2 dose of @DRUG$ was given intravenously over three hours concurrently with escalating doses of @DRUG$.	DDI-false
Antimycobacterial Agents: @DRUG$ CONTRAINDICATED since the coadministration of this product with @DRUG$ in an antiretroviral regimen reduces the plasma concentrations of saquinavir.	DDI-false
@DRUG$ may suppress certain CYP450 enzymes, including CYP1A2, @DRUG$, CYP2D6, and CYP3A4.	DDI-false
Caution should be exercised if an @DRUG$ • co-administered with medicinal products that may reduce the levels or activity of endogenous steroid hormones, such as: @DRUG$ , spironolactone , and cimetidine .	DDI-advise
These drugs include thiazides and other @DRUG$ , corticosteroids , phe-nothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , @DRUG$ , sympathomimetics, calcium channel block drugs, and isoniazid.	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, @DRUG$, @DRUG$, clarithromycin).	DDI-false
@DRUG$ : Plasma @DRUG$ The steady-state concentrations and digoxin clearance were not affected by concomitant administration of cerivastatin sodium 0.2 mg.	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , @DRUG$ , pimozide , carbamazepine , fentanyl , alfentanyl , @DRUG$ , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
@DRUG$ Renal tubular transport of methotrexate may be inhibited by concomitant administration of @DRUG$ This may lead to increased plasma levels of methotrexate.	DDI-false
High-dose cyclosporin A resulting in concentrations above 2000 ng/mL administered with oral @DRUG$ has led to an 80 % increase in etoposide exposure with a 38 % decrease in total body clearance of @DRUG$ compared to etoposide alone .	DDI-false
because of this, the dosage of @DRUG$ should be adjusted when these @DRUG$ are administered concomitantly.	DDI-false
Lithium generally should not be given with diuretics because they reduce @DRUG$s renal clearance and add a high risk of @DRUG$ toxicity .	DDI-false
Therophylline : A recent study has shown that @DRUG$ and @DRUG$ may cause elevated plasma levels of theophylline , and in some instances a slight decrease in the elimination of isoniazid .	DDI-mechanism
@DRUG$ may interact with alcohol , @DRUG$s , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , NSAIDs like Aleve or Ibuprofen , and high blood pressure medications .	DDI-int
Acetaminophen/theophylline, @DRUG$/chinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen and valproic acid/phenobarbital.	DDI-false
Drug/Laboratory Test Interaction Fosinopril may cause a false low measurement of serum @DRUG$ Levels with the Digi Tab RIA Kit for @DRUG$.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
The AUC and Cmax of both (R) and (S) isomers @DRUG$ The concomitant administration of 0.3 mg @DRUG$ was not affected.	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, ritonavir, indinavir, @DRUG$, erythromycin, etc.) is indicated, reduction of the @DRUG$ dose should be considered.	DDI-advise
Antihypertensives : Amiodarone should be used with caution in patients receiving   -receptor blocking agents ( e.g. , propranolol , a @DRUG$ inhibitor ) or @DRUG$ • antagonists (e.g. verapamil, a CYP3A4 substrate and diltiazem, a CYP3A4 inhibitor) because of the potential for bradycardia, sinus arrest and AV block;	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (@DRUG$, magnesium hydroxide, and @DRUG$) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, @DRUG$, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, @DRUG$, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Central Nervous System Depressants: The concomitant use of @DRUG$  (fentanyl transdermal system) with other @DRUG$, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
Agents Having Vasodilator Activity: Data on the effect of concomitant use of other @DRUG$ in patients receiving @DRUG$ for heart failure are not available;	DDI-false
These medicines include thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, @DRUG$ , and @DRUG$.	DDI-false
The effects of pressure @DRUG$ Like dopamine or norepinephrine, @DRUG$ amplifies.	DDI-effect
Nifedipine : @DRUG$ 20 mg , when co-administered with slow-release @DRUG$ 30 mg or 60 mg once daily , did not affect the relative bioavailability ( AUC ) or maximum concentration ( Cmax ) of nifedipine , a drug that is metabolized via CYP3A4 .	DDI-false
@DRUG$: @DRUG$ has no apparent pharmacokinetic interaction when administered with glyburide.	DDI-false
Interaction on the antinociceptive effect between neurotensin and @DRUG$ or @DRUG$.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (@DRUG$ transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general @DRUG$, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
For example , @DRUG$ ( e.g. , @DRUG$ ) may activate the renin-angiotensin-aldosterone system .	DDI-false
In a median follow-up of 33 months, the combination of @DRUG$ There was no benefit in efficacy compared to tamoxifen. @DRUG$ in all patients as well as in the hormone receptor-positive subpopulation .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
In addition , Fondaparinux neither influenced the pharmacodynamics of warfarin , acetylsalicylic acid , piroxicam , and @DRUG$ , the pharmacokinetics of @DRUG$ At Steady State.	DDI-false
@DRUG$ is a substrate for both @DRUG$ and CYP3A4.	DDI-false
Benzthiazide may interact with alcohol , blood thinners , @DRUG$ ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , NSAIDs like @DRUG$ or Ibuprofen , and high blood pressure medications .	DDI-false
Central Nervous System Depressants : The concomitant use of @DRUG$   ( @DRUG$ Transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotic agents, sedatives (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants and alcohol, may result in respiratory depression, hypotension and deep sedation, or possibly in coma or death.	DDI-false
Folic acid in large amounts may counteract the antiepileptic effect of @DRUG$, phenytoin and @DRUG$, and increase the frequency of seizures in susceptible pediatric patients.	DDI-false
Then , the effects of metabotropic glutamate receptor ( mGluR ) agonists , DCG-IV and @DRUG$ To the above behavioral changes induced by @DRUG$ were found .	DDI-false
@DRUG$ , or other products containing iron or zinc , antacids or @DRUG$ The use of norfloxacin should not be performed simultaneously with or within 2 hours after the administration of norfloxacin as it may impair absorption, resulting in lower serum and urine levels of norfloxacin.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, @DRUG$, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, @DRUG$ (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Other interactions: Vardenafil had no effect on the pharmacodynamics of @DRUG$ (glucose and insulin concentrations) and @DRUG$ (prothrombin time or other pharmacodynamic parameters).	DDI-false
@DRUG$ may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, @DRUG$, norepinephrine, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.	DDI-int
Co-medications that induce CYP3A4 ( e.g. , dexamethasone , @DRUG$ , carbamazepine, rifampin, @DRUG$ or St.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and antineoplastic agents, specifically, dacarbazine, @DRUG$, @DRUG$ and interferon-alfa.	DDI-false
Corticosteroids, Methylxanthines and @DRUG$: Concomitant treatment with @DRUG$, steroids, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
Two groups (SH/DA; SH/FA) were treated daily with synthetic hydroalcoholic solutions which: @DRUG$ , methanol, higher alcohols and @DRUG$ in the same proportions as those found in most common distilled and fermented alcoholic beverages ;	DDI-false
BACKGROUND : The effects of the combined administration of bombsin and @DRUG$ (Verapamil ), @DRUG$ , on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane ( AOM ) and the labeling index of intestinal cancers were investigated in male Wistar rats .	DDI-false
The authors investigated the possibility of a similar interaction between @DRUG$ and @DRUG$.	DDI-false
No data are available for the coadministration of INVIRASE/@DRUG$ or @DRUG$/ritonavir and garlic capsules.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$, and @DRUG$/phenobarbital.	DDI-false
@DRUG$ may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, @DRUG$ like Aleve or Ibuprofen, and high blood pressure medications.	DDI-int
Limited comparative data in patients with high viral loads treated with @DRUG$- or @DRUG$-based regimens currently exist.	DDI-false
Both @DRUG$ and 18-MC decrease extracellular levels of dopamine in the nucleus accumbens, but only @DRUG$ increases extracellular levels of serotonin in the nucleus accumbens.	DDI-false
- @DRUG$, oral (diabetes medicine you take by mouth) Use of oral @DRUG$ with sulfapyridine may increase the chance of side effects affecting the blood and/or the side effects or oral antidiabetics	DDI-false
Cephalosporins-@DRUG$ containing side chains of N-methylthiotetrazole ( cefmenoxime , cefoperazone , @DRUG$ , cefamandol, latamoxef) or methylthiadiazole (cefazolin) may cause vitamin K deficiency and hypoprothrombinaemia.	DDI-false
The antihypertensive effect of enalapril and @DRUG$ It is enhanced by antihypertensive agents that cause the release of renin (e.g. @DRUG$ ) .	DDI-effect
Ritonavir and @DRUG$ : Upon concomitant administration of 5 mg of @DRUG$ with 600 mg BID ritonavir , the Cmax and AUC of ritonavir were reduced by approximately 20 % .	DDI-false
apomorphine - prior ingestion of @DRUG$ may decrease the emetic response to @DRUG$ In the treatment of poisoning.	DDI-effect
The coadministration of @DRUG$ decreases the biologic half-life of fenoprofen because of an increase in metabolic clearance that results in a greater amount of @DRUG$ In the urine.	DDI-false
omeprazole: The rate and extent of absorption of ciprofloxacin was bioequivalent if @DRUG$ ==References====External links== @DRUG$ at the dose that maximally suppresses gastric acid secretion .	DDI-false
INOmax was co-administered with tolazolin, dopamine, @DRUG$ , steroids , @DRUG$ And high-frequency ventilation.	DDI-false
Other medicines: medicines such as quinidine, @DRUG$ , procainamide , @DRUG$ , antihistamines , and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia .	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, @DRUG$, estrogens, oral @DRUG$, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
@DRUG$ 400 mg B.i.d.) had no effect on @DRUG$ bioavailability ( AUC ) and maximum concentration ( Cmax ) of vardenafil when co-administered with 20 mg Vardenafil in healthy volunteers .	DDI-false
Tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , @DRUG$ , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and @DRUG$ This delays elimination and increases blood levels of these drugs.	DDI-false
Nifedipine : @DRUG$ 20 mg, when administered concomitantly with slow-release nifedipine 30 mg or 60 mg once daily, did not affect the relative bioavailability (AUC) or the maximum concentration (Cmax) of @DRUG$ , a drug that is metabolized via CYP3A4 .	DDI-false
@DRUG$ In healthy volunteers, ketoconazole, a CYP3A4 inhibitor, with 200 mg twice daily for 7 days, systemic exposure ( AUC ) @DRUG$ was increased to approximately 3.6-fold of control and half-life increased to 1.7-fold of control .	DDI-false
The risk of a potential interaction between @DRUG$ and @DRUG$ Concentrates have not been adequately studied in preclinical or clinical studies.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, @DRUG$, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, @DRUG$, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Although studies designed to examine drug interactions have not been done, it was noted that @DRUG$ or ACTH treatment of relapses for periods of up to 28 days has been administered to patients (N=180) receiving @DRUG$.	DDI-false
Central Nervous System Depressants : The concomitant use of DURAGESIC   ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , @DRUG$ , @DRUG$ , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	DDI-false
Oral Contraceptives: Coadministration of @DRUG$ and an oral contraceptive increased AUC values for norethindrone and @DRUG$ by approximately 30% and 20%.	DDI-mechanism
ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving @DRUG$ 25 to 50 mg also received ACE inhibitors or @DRUG$ (ACEI/ARB).	DDI-false
@DRUG$ and @DRUG$ : Upon concomitant administration of 5 mg of Vardenafil with 600 mg BID ritonavir , the Cmax and AUC of ritonavir were reduced by approximately 20 % .	DDI-false
The concomitant use of other CYP3A4 inhibitors such as @DRUG$ and erythromycin with transdermal fentanyl may also result in an increase in @DRUG$ plasma concentrations, which could increase or prolong adverse drug effects and may cause serious respiratory depression.	DDI-false
Multivalent Cation-Containing Products : Concurrent administration of a quinolone , including @DRUG$ With multivalent cation-containing products such as magnesium or aluminium @DRUG$ , Sucralfat, VIDEX chew/buffer tablets or children's powder, or products that contain calcium, iron or zinc can significantly reduce the absorption of ciprofloxacin, resulting in serum and urine levels significantly lower than desired.	DDI-mechanism
HIV Protease Inhibitors: Indinavir (800 mg t.i.d.) co-administered with @DRUG$ 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in @DRUG$ Cmax and a 2-fold increase in vardenafil half-life.	DDI-false
Antiarrhythmics: @DRUG$, bepridil, @DRUG$, propafenone, quinidine CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
Central nervous system depressants : the concomitant use of DURAGESIC (Fentanyl transdermal system ) with other central nervous system depressants, including but not limited to other opioids, @DRUG$ , hypnotics , tranquilizers ( e.g. , @DRUG$ ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	DDI-false
@DRUG$ The concomitant use of DURAGESIC (Fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, @DRUG$ , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	DDI-false
@DRUG$ : In normal volunteers , a small decrease in diflunisal levels was observed when multiple doses of diflunisal and @DRUG$ were administered concomitantly .	DDI-false
A drug-drug interaction study evaluated the effect of the use of @DRUG$ 5 % gel in combination with double strength ( 160 mg/800 mg ) trimethoprim/sulfamethoxazole ( @DRUG$/SMX ).	DDI-false
- ketoconazole, intraconazole, ritonavir, indinavir, @DRUG$ , @DRUG$ , etc . ) is indicated , reduction of the budesonide dose should be considered .	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and @DRUG$) were also assessed by evaluating the serum concentrations of levetiracetam and these @DRUG$ during placebo-controlled clinical studies.	DDI-false
ACE Inhibitors and @DRUG$ In clinical trials in patients with hypertension, the addition of INSPRA 50 to 100 mg to ACE inhibitors, and @DRUG$ increased mean serum potassium slightly ( about 0.09 - 0.13 mEq/L ) .	DDI-false
Other drugs : Drugs like @DRUG$ , disopyramide , @DRUG$ , phenothiazines, antihistamines and tricyclic antidepressants may be associated with QT interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , @DRUG$ , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , @DRUG$ Concomitant use with saquinavir may result in increased plasma concentrations.	DDI-false
There was not a significant difference (p > 0.05) in AUC (48.59 +/- 8.52 vs. 49.9 +/- 9.93), Cmax (7.73 +/- 2.6 vs. 6.6 +/- 2.0), and tmax (1.1 +/- 0.6 vs. 1.6 +/- 1.1) for @DRUG$ versus levofloxacin/@DRUG$ regimens.	DDI-false
Drug Interactions : Flupenthixol may interact with some drugs , like Monoamine oxidase inhibitors ( MAOI ): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol : Flupenthixol and Ethanol cause additive CNS depression - @DRUG$ : @DRUG$ Increases the effect of tricyclic antidepressants	DDI-false
@DRUG$ may increase the ototoxic potential of @DRUG$, especially in the presence of impaired renal function.	DDI-effect
Drug Interactions: @DRUG$ may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and @DRUG$ cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Little has been studied of the adverse effects of the exposure of the liver to the interaction of @DRUG$ with its congeners and @DRUG$ , coexisted in the content of alcoholic beverages.	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, @DRUG$ was used concomitantly with @DRUG$, betablockers, calcium-channel blockers, diuretics, and nonsteroidal anti-inflammatory drugs (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ In controlled studies in healthy subjects, bepridil hydrochloride either had no effect (one study) or was associated with a slight increase, approximately 30% (two studies) in steady-state serum. @DRUG$ concentrations .	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , @DRUG$ , cyclosporin, ergo derivatives, pimozide, @DRUG$ , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
These effects were not observed if: @DRUG$ 20 mg was taken 24 hours before @DRUG$.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a @DRUG$, including ciprofloxacin, with multivalent cation-containing products such as @DRUG$ or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
@DRUG$ potentiates the muscle relaxant effect of all muscle relaxants, most notably @DRUG$, and MAC (minimum alveolar concentration) is reduced by concomitant administration of N 2O.	DDI-effect
Although in clinical studies with IOPIDINE 0.5 % ophthalmic solution no specific drug interactions with topical glaucoma or systemic drugs have been identified, there is a possibility of additive or potentiating effects with: @DRUG$ ( alcohol , barbiturates , opiates , sedatives , @DRUG$ ) should be considered .	DDI-false
Higher concentrations of @DRUG$ (10(-8) - 10(-6) M) or @DRUG$ (3 X 10(-8) - 10(-7) M) enhance the mitogenic activity of EGF.	DDI-false
@DRUG$ In general, should not be combined with @DRUG$ Because they reduce renal clearance of lithium and increase a high risk of lithium toxicity.	DDI-advise
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including @DRUG$ and other drugs that are highly protein bound, @DRUG$, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
@DRUG$ : Plasma concentrations of @DRUG$ decreased approximately 25 % when colestipol and atorvastatin were coadministered .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, @DRUG$, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Hemodynamic and electrophysiological interactions have also been reported after concomitant use of @DRUG$ , @DRUG$ , and verapamil .	DDI-false
Monoamine Oxidase Inhibitors and Tricyclic Antidepressants: FORADIL should be administered with extreme caution in patients being treated with @DRUG$ or @DRUG$ because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-false
ACE inhibitors reports suggest that: @DRUG$ may diminish the antihypertensive effect of @DRUG$.	DDI-effect
In general , these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride , including @DRUG$ such as @DRUG$ And procainamide, cardiac glycosides and tricyclic antidepressants.	DDI-false
Other concomitant therapy Although no specific interaction studies have been performed, clinical trials with 1 mg or more of finasteride doses have been conducted at the same time. @DRUG$ acetylsalicylic acid, A-blocker, @DRUG$ , angiotensin-converting enzyme ( ACE ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , H2 antagonists , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
There was no significant difference in the pharmacodynamic effect of @DRUG$ administered alone and @DRUG$ administered with Lodine as measured by prothrombin time.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other @DRUG$, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general @DRUG$, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Potential drug interactions between Keppra   and other AEDs ( carbamazepine , gabapentin , @DRUG$ , phenobarbital , @DRUG$ , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies .	DDI-false
@DRUG$: @DRUG$, erythromycins, sulfonamides, or tetracyclines may interfere with the bactericidal effect of penicillins.	DDI-false
Injection : Lorazepam injection, as other injectable @DRUG$ , produces depression of the central nervous system when administered with ethyl alcohol, phenothiazine, barbiturates, MAO inhibitors and other antidepressants. If scopolamine is used simultaneously with injectable @DRUG$ , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .	DDI-false
This drug may interact with alcohol or other CNS depressants ( may potentiate the CNS depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and @DRUG$ • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • @DRUG$ may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines ) .	DDI-false
Other strong inhibitors of CYP3A4 (e.g., itraconazole, clarithromycin, nefazodone, @DRUG$, ritonavir, @DRUG$) would be expected to behave similarly.	DDI-false
In vitro data suggest that @DRUG$, when compared to ketoconazole, has a less pronounced effect on the biotransformation system responsible for the metabolism of @DRUG$.	DDI-mechanism
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, @DRUG$, @DRUG$, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Cefmenoxime, cefoperazone, cefotetan, cefamandol, @DRUG$ ) or methylthiadiazole ( cefazolin ) can cause vitamin K deficiency and hypoprothrombinemia .	DDI-false
"Ergot derivatives: dihydroergotamine, @DRUG$ , @DRUG$ , methylergonovine CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues .	DDI-false
Non-selective MAO inhibitors including tranylcypromine sulfate , phenelzine sulfate , and @DRUG$ HC1 : Concurrent use of L-tyrosine and nonselective @DRUG$ may cause hypertension .	DDI-false
These drugs include the thiazides and other @DRUG$ , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and @DRUG$.	DDI-false
As with other antipsychotic agents, it should be noted that HALDOL may be able to: @DRUG$ such as @DRUG$ , opiates , and alcohol .	DDI-false
This effect is small with occasional doses of @DRUG$, but may be clinically significant when @DRUG$ are used on a continuous schedule.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Non-selective MAO inhibitors including tranylcypromine sulfate, phenelzine sulfate, and @DRUG$ HC1: Concomitant use of L-tyrosine and non-selective @DRUG$ may cause hypertension.	DDI-false
Little has been studied of the adverse effects of the exposure of the liver to the interaction of @DRUG$ with its congeners and @DRUG$, coexisting in the contents of alcoholic beverages.	DDI-false
Anticholinesterases (neostgmine, @DRUG$), lignocaine, @DRUG$, procainamide can enhance toxicity and cause cardio respiratory depression.	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , @DRUG$ , quinine , amiodarone , @DRUG$ , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
Acetaminophen/@DRUG$, lidocaine/chinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen and valproic acid/phenobarbital.	DDI-false
Theophylline : As with some others @DRUG$ co-administration of ciprofloxacin with @DRUG$ It may lead to increased serum concentrations of theophylline and an extension of the elimination half-life.	DDI-mechanism
Warfarin: @DRUG$ have been reported to enhance the effects of the oral anticoagulant @DRUG$ or its derivatives.	DDI-effect
@DRUG$ Adrenergic blockers are inhibited by @DRUG$.	DDI-false
@DRUG$: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a @DRUG$ substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
@DRUG$ may enhance the effects of @DRUG$, barbiturates, and other CNS depressants.	DDI-effect
- Anabolic steroids ( @DRUG$ [ e.g. Anaboline ], Oxandrolone [ e.g. Anavar ], Oxymetholone [ e.g., @DRUG$ ] , stanozolol [ e.g. , Winstrol ] ) or	DDI-false
Notably, systemic exposure (AUC0-12) of @DRUG$ (@DRUG$) was more than doubled in the presence of TMP/SMX.	DDI-false
@DRUG$ has a tendency to antagonize the skeletal muscle relaxing effect of @DRUG$ and may potentiate the action of succinylcholine.	DDI-effect
Tagamet, apparently due to an effect on certain microsomal enzyme systems, has been reported to reduce hepatic metabolism @DRUG$ , phenytoin , @DRUG$ , nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying the elimination and increase in blood levels of these drugs.	DDI-false
BACKGROUND: The effects of combined administration of bombesin and verapamil hydrochloride (verapamil), a calcium channel blocker, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by @DRUG$ (@DRUG$) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
ACE inhibitors and angiotensin II receptor antagonists (congestive heart failure after myocardial infarction)- In EPHESUS, 3020 (91%) patients received @DRUG$ ACE inhibitors or angiotensin II receptor antagonists (ACEI/@DRUG$) were also administered 25 to 50 mg.	DDI-false
Effect of @DRUG$ in Pediatric Patients There was about a 22% increase of apparent total body clearance of @DRUG$ when it was co-administered with enzyme-inducing AEDs.	DDI-false
The aim of this paper was to study the interaction between @DRUG$ and both enkephalins or its synthetic analogue @DRUG$ , or tuftsin, the anti-non-ciceptive effect of these peptides in mice after intracistern injection.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, @DRUG$, prazosin and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Human pharmacokinetic data show that oral ketoconazole strongly inhibits the metabolism of ketoconazole. @DRUG$ This resulted in an eight-fold increase in mean AUC of @DRUG$.	DDI-false
Other CONCOMITANT THERAPY: Although no specific interaction studies have been conducted, cerivastatin sodium was used in clinical trials with angiotensin converting enzyme inhibitors (ACE), @DRUG$ , @DRUG$ , diuretics , and nonsteroidal anti-inflammatory drugs ( NSAIDs ) without evidence of clinically significant adverse interactions .	DDI-false
Example inhibitors include azole antifungals, @DRUG$, @DRUG$, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
- @DRUG$ ( e.g. , Mexate ) Use of methotrexate with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of @DRUG$	DDI-false
Multivalent Cation-Containing Products : Concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or @DRUG$ antacids , sucralfate , VIDEX chewable/buffered tablets or pediatric powder , or products containing calcium , @DRUG$ , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .	DDI-false
Warfarin : Anticoagulant activity should be monitored , particularly in the first few days after initiating or changing @DRUG$ therapy in patients receiving @DRUG$ These patients have an increased risk of bleeding complications.	DDI-advise
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, @DRUG$, ritonavir, indinavir, saquinavir, erythromycin, etc.) is indicated, reduction of the @DRUG$ dose should be considered.	DDI-advise
Multivalent Cation-Containing Products : Concurrent administration of a quinolone , including @DRUG$ , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , VIDEX chewable/buffered tablets or pediatric powder , or products containing calcium , @DRUG$ Zinc can significantly reduce the absorption of ciprofloxacin, resulting in serum and urine levels significantly lower than desired.	DDI-mechanism
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, hydralazine, @DRUG$ and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other @DRUG$, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and @DRUG$, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Although @DRUG$ It has been shown that PROLEUKIN-induced side effects such as fever, renal failure, hyperbilirubinaemia, confusion and dyspnoea, concomitant use of these agents with @DRUG$ Beta-blockers and other antihypertensive agents may increase hypotension in PROLEUKIN.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$: In normal volunteers, concomitant administration of diflunisal and @DRUG$ resulted in an approximate 50% increase in plasma levels of acetaminophen.	DDI-false
Additional, higher than expected @DRUG$ The values were observed in patients already taking @DRUG$.	DDI-mechanism
In the case that you are taking digoxin while taking @DRUG$ , higher doses of @DRUG$ It may be necessary.	DDI-false
@DRUG$ and @DRUG$ (Hypertension)- In clinical studies of patients with hypertension, the addition of INSPRA 50 to 100 mg to ACE inhibitors and angiotensin II receptor antagonists increased mean serum potassium slightly (about 0.09-0.13 mEq/L).	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - @DRUG$: @DRUG$ and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Other concomitant therapy Although no specific interaction studies have been conducted, 1 mg or more finasteride doses have been reported in clinical trials with acetaminophen, acetylsalicylic acid, A-blockers, analgesics, angiotensin converting enzyme (ACE) inhibitors, @DRUG$ , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , @DRUG$ , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
Other cardiovascular agents: Enalapril and Enalapril IV were co-administered with @DRUG$ , methyldopa, nitrates, calcium blockers, hydralacin, prazosin and @DRUG$ Without evidence of clinically significant adverse interactions.	DDI-false
Concomitant cyclophosphamide , @DRUG$ , @DRUG$ , and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related , non-Hodgkin lymphoma .	DDI-false
Although there are no study data to evaluate the possibility, @DRUG$, including @DRUG$ and nitroglycerin, may have an additive effect with INOmax on the risk of developing methemoglobinemia.	DDI-false
@DRUG$: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, @DRUG$ (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
In addition, certain drugs that are metabolized by this isoenzyme, including many @DRUG$ (tricyclic antidepressants, @DRUG$, and others), may inhibit the activity of this isoenzyme, and thus may make normal metab-olizers resemble poor metabolizers with regard to concomitant therapy with other drugs metabolized by this enzyme system, leading to drug interactions.	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and @DRUG$.	DDI-false
@DRUG$ (NSAIDs)-A drug interaction study of eplerenone with an @DRUG$ has not been conducted.	DDI-false
The effects of ketamine and of @DRUG$ anesthesia on @DRUG$ tolerance in dogs.	DDI-false
@DRUG$ including tranylcypromine sulfate, phenelzine sulfate, and pargyline HC1: Concomitant use of L-tyrosine and non-selective @DRUG$ may cause hypertension.	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , @DRUG$ , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , @DRUG$ When co-administered with saquinavir, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam and triazolam may exhibit increased plasma concentrations;	DDI-false
@DRUG$ : Serious side effects and even death have been reported following the concomitant use of certain drugs with @DRUG$.	DDI-false
Since chronic dosing is required for therapeutic efficacy of @DRUG$, future studies should focus on investigation of chronic dosing effects of these drugs in combination with @DRUG$.	DDI-false
Hemodynamic and electrophysiologic interactions have also been observed after concomitant administration with @DRUG$, @DRUG$, and verapamil.	DDI-false
Aspirin/Acetaminophen : Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered @DRUG$ ( 162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1   g/kg/min . over 4 hours ) or @DRUG$ ( 1000 mg orally administered 12, 6 and 0 hours before, and 6 and 12 hours after, start of argatroban 1.5 g/kg/min. over 18 hours).	DDI-false
The administration of local anesthetic solutions containing @DRUG$ or norepinephrine to patients receiving monoamine oxidase inhibitors , tricyclic antidepressants or @DRUG$ may produce severe , prolonged hypotension or hypertension .	DDI-effect
Substances that are potent inhibitors of CYP3A4 activity (eg, ketoconazole and @DRUG$) decrease gefitinib metabolism and increase @DRUG$ plasma concentrations.	DDI-mechanism
@DRUG$: In normal volunteers, concomitant administration of @DRUG$ and hydrochlorothiazide resulted in significantly increased plasma levels of hydrochlorothiazide.	DDI-false
HIV Protease Inhibitors: @DRUG$ (800 mg t.i.d.) co-administered with Vardenafil 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in @DRUG$ Cmax and a 2-fold increase in vardenafil half-life.	DDI-false
Potential drug interactions between Keppra   and other AEDs ( carbamazepine , gabapentin , lamotrigine , phenobarbital , @DRUG$ , primidone and valproate ) were also assessed by evaluating the serum concentrations of @DRUG$ These AEDs during placebo-controlled clinical trials.	DDI-false
Drug Interactions : Flupenthixol may interact with some drugs , like Monoamine oxidase inhibitors ( MAOI ): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol : @DRUG$ and @DRUG$ cause additive CNS depression - Tricyclic antidepressants : Flupenthixol increases the effect of Tricyclic antidepressants	DDI-effect
Administering @DRUG$ together with @DRUG$ (100-500 microM) inhibited InsP(3)-induced responses (both Ca(2+) and current responses) in a dose-dependent fashion.	DDI-effect
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with @DRUG$, hypnotics and sedatives (including @DRUG$), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
Carbamazepine: @DRUG$ is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the @DRUG$ should be made.	DDI-false
These drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , @DRUG$ , @DRUG$ , calcium channel block drugs, and isoniazid.	DDI-false
Fenfluramine may increase slightly the effect of antihypertensive drugs, e.g., @DRUG$, methyldopa, @DRUG$.	DDI-false
Elevated plasma levels of @DRUG$ have been reported with concomitant @DRUG$ use.	DDI-mechanism
Therefore , there is a potential for an interaction with other drugs that are metabolized by CYP 1A2 ( e.g. , amitriptyline , @DRUG$ , and @DRUG$ ) .	DDI-false
Results of studies in multiple sclerosis patients taking TYSABRI   and concomitant interferon beta-1a ( @DRUG$ 30 mcg IM once weekly) or glatiramer acetate were not consistent with the need for dose adjustment of the beta interferon or @DRUG$.	DDI-false
These drugs include the @DRUG$ and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
These drugs include thiazides and other @DRUG$ , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , @DRUG$ , sympathomimetics , calcium channel blocking drugs , and isoniazid .	DDI-false
@DRUG$-@DRUG$ The effect of warfarin may be antagonistic	DDI-false
Stavudine and Zidovudine @DRUG$ can antagonize the in vitro antiviral activity of @DRUG$ and zidovudine against HIV.	DDI-effect
Anticoagulant inhibition was observed during the administration of phenobarbital, @DRUG$ and @DRUG$;	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
With simultaneous dosing of @DRUG$ 20 mg and @DRUG$ 10 mg, 2 of 9 subjects experienced a standing systolic blood pressure of less than 85 mm Hg.	DDI-effect
Therefore, it would be expected that a dosage regimen of @DRUG$ given at bedtime and cholestyramine given before the evening meal would not result in a significant decrease in the clinical effect of @DRUG$.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., @DRUG$, a @DRUG$ substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
This medication can be used with alcohol or other CNS depressants (may potentiate the CNS depressive effect of either these medications or @DRUG$ ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with @DRUG$ Inhibitors (co-administration with antihistamines may prolong and increase the anticholinergic and CNS depressive effects of antihistamines).	DDI-false
An interaction study with @DRUG$ showed no clinically significant effect of @DRUG$ on warfarin pharmacokinetics or anticoagulant activity.	DDI-false
ANTACID (Magnesium-Aluminum Hydroxide): @DRUG$ plasma concentrations were not affected by co-administration of @DRUG$.	DDI-false
Adverse reactions related to @DRUG$s, such as CNS, cardiac, and systemic (eg, flu-like) effects may be more severe in the elderly and caution should be exercised in the use of @DRUG$ in this population.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., @DRUG$ chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, @DRUG$) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Stavudine and @DRUG$ Ribavirin can antagonize the in vitro antiviral activity of @DRUG$ and zidovudine against HIV.	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, @DRUG$ or beta-adrenergic blocking agents, calcium channel blockers, antihistamines or H1-blocking agents, tricyclic antidepressants and @DRUG$) might also contribute to a prolongation of the QTc interval.	DDI-false
Therophylline: A recent study has shown that concomitan administration of @DRUG$ and @DRUG$ may cause elevated plasma levels of theophylline, and in some instances a slight decrease in the elimination of isoniazid.	DDI-mechanism
@DRUG$ : Patients on @DRUG$ , especially those with intravascular volume depletion , may occasionally experience an excessive reduction of blood pressure after initiation of therapy with fosinopril sodium .	DDI-false
These drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , @DRUG$ , calcium channel block drugs, and @DRUG$.	DDI-false
Example inhibitors include azole antifungals, @DRUG$, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, @DRUG$, protease inhibitors, quinidine, and verapamil.	DDI-false
No pharmacokinetic interactions between dexmedetomidine and isoflurane , @DRUG$ , alfentanil , and @DRUG$ have been demonstrated .	DDI-false
It is concluded that chloral hydrate and @DRUG$ may be administered safely without additional caution in prothrombin test monitoring during oral @DRUG$ therapy .	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, @DRUG$, calcium-blocking agents, hydralazine, prazosin and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Other concomitant therapy Although no specific interaction studies have been conducted, 1 mg or more of finasteride doses have been used in clinical trials with acetaminophen, acetylsalicylic acid, A-blockers, @DRUG$ , angiotensin-converting enzyme ( ACE ) inhibitors , anticonvulsants , benzodiazepines , @DRUG$ , calcium channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also known as NSAIDs), and quinolone anti-infections without evidence of clinically significant adverse interactions.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other @DRUG$, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, @DRUG$, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
If treatment with inhibitors of CYP3A4 activity ( such as @DRUG$ , intraconazole, ritonavir, indinavir, @DRUG$ , erythromycin , etc . ) is indicated , reduction of the budesonide dose should be considered .	DDI-false
Antiarrhythmics: Other antiarrhythmic drugs, such as quinidine, procainamide, disopyramide, and @DRUG$, have been used concurrently with @DRUG$.	DDI-false
therefore, the use of @DRUG$ does not necessitate an adjustment in @DRUG$ dose to maintain therapeutic digoxin levels.	DDI-false
@DRUG$: NSAIDs have produced an elevation of plasma @DRUG$ levels and a reduction in renal lithium clearance.	DDI-false
@DRUG$: Lithium toxicity has been reported in patients receiving @DRUG$ concomitantly with drugs which cause elimination of sodium, including ACE inhibitors.	DDI-false
@DRUG$ : @DRUG$ The intestinal absorption of ethosuximide may be delayed.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, @DRUG$ chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of @DRUG$, resulting in serum and urine levels considerably lower than desired.	DDI-false
These drugs include the @DRUG$ and other diuretics, @DRUG$, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Studies in rats have shown that @DRUG$ administration attenuates certain types of @DRUG$ dependent hypertension, including ACTH hypertension.	DDI-false
The urine of patients who: @DRUG$ The presence of phenol metabolites of @DRUG$ may lead to a false-positive reaction in urinary bilirubin (urobilin).	DDI-false
Compounds that have been tested in humans include antipyrin, digoxin, @DRUG$ , @DRUG$ , and warfarin and no clinically meaningful interactions were found .	DDI-false
INOmax has been administered with @DRUG$ , dopamine , dobutamine , @DRUG$ , surfactant, and high-frequency ventilation.	DDI-false
- Anabolic steroids (nandrolone [e.g., Anabolin], @DRUG$ [e.g., Anavar], oxymetholone [e.g., Anadrol], stanozolol [e.g., @DRUG$]) or	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), @DRUG$ or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with @DRUG$ may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
Cholestyramine increases enterohepatic elimination of @DRUG$ and may reduce its serum levels and @DRUG$/2.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, @DRUG$, felodipine, digoxin, warfarin, isosorbide mononitrate, @DRUG$, ethanol or itraconazole.	DDI-false
A possible interaction between @DRUG$ and @DRUG$ , a fluoroquinolone antibiotic , has been reported , resulting in a potentiation of the hypoglycemic action of glyburide .	DDI-int
Coadministration of @DRUG$ did not affect the pharmacokinetics of @DRUG$.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, @DRUG$, anticonvulsants, benzodiazepines, beta blockers, @DRUG$, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
These increases should be considered when selecting an oral @DRUG$ for a woman taking @DRUG$.	DDI-advise
With simultaneous dosing of @DRUG$ 10 mg and @DRUG$ 10 mg, 6 in 8 subjects experienced a standing systolic blood pressure of less than 85 mm Hg.	DDI-effect
Cardiovasculars: Cardiac glycosides: In patients receiving @DRUG$ therapy, administration of oral @DRUG$ regularly results in an increase in serum digoxin concentration that may reach toxic levels with resultant clinical toxicity.	DDI-false
@DRUG$/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
It is recommended not to exceed a single dose of 2.5 mg. @DRUG$ dose in a 24-hour period when used in combination with @DRUG$.	DDI-advise
Since chronic dosing is required for therapeutic efficacy of @DRUG$ Future studies should focus on investigating the chronic dose effects of these drugs in combination with @DRUG$.	DDI-false
This effect is small with occasional doses of @DRUG$ , but may be clinically significant when @DRUG$ ==References====External links==	DDI-false
Tetracyclines: Concomitant treatment with @DRUG$ and @DRUG$ should be avoided because Accutane use has been associated with a number of cases of pseudotumor cerebri (benign intracranial hypertension), some of which involved concomitant use of tetracyclines	DDI-advise
No Important Interactions To Date @DRUG$ does not have clinically important pharmacokinetic interactions with @DRUG$ , beta-blockers, felodipine, digoxin, warfarin, isosorbide mononitrate, scotilol, ethanol or itraconazole.	DDI-false
@DRUG$: The concomitant use of Bepridil with long- and short-acting @DRUG$ has been safely tolerated in patients with stable angina pectoris.	DDI-false
This appears to be the only clinically relevant interaction of this species with @DRUG$ Although theoretically, concomitant use of other drugs is known to alter cardiac conduction (e.g., anti-arrhythmic or beta-adrenergic blockers, calcium channel blockers, antihistamines, or @DRUG$ Also tricyclic antidepressants and phenothiazines could contribute to an extension of the QTc interval.	DDI-effect
The possibility of hypotensive effects with @DRUG$ can be minimized by either discontinuing the diuretic or increasing the salt intake approximately one week prior to initiation of treatment with @DRUG$ (Captopril tablets, USP) or initiation of small doses (6.25 or 12.5 mg).	DDI-false
- @DRUG$ , oral ( diabetes medicine you take by mouth ) Use of oral antidiabetics with @DRUG$ The likelihood of side effects affecting blood and/or side effects or oral antidiabetic agents may be increased.	DDI-false
Other Cardiovascular Agents : Enalapril and @DRUG$ IV have been used concomitantly with beta adrenergic-blocking agents , methyldopa , nitrates , calcium-blocking agents , hydralazine , prazosin and @DRUG$ Without evidence of clinically significant adverse interactions.	DDI-false
If cholinergic blockades occur, additive undesirable effects may occur if: @DRUG$ is administered concomitantly with other antimuscarinics , amantadine , haloperidol , phenothiazines , @DRUG$ , tricyclic antidepressants or some antihistamines .	DDI-effect
@DRUG$/Hypnotics : @DRUG$ , Midazolam CONTRAINDICATES due to the potential for serious and/ or life-threatening reactions such as prolonged or increased sedation or respiratory depression.	DDI-false
@DRUG$ Supplements and Potassium-Sparing Diuretics: @DRUG$ can attenuate potassium loss caused by thiazide diuretics.	DDI-false
Co-medicines that induce CYP3A4 (e.g. @DRUG$ , phenytoin , carbamazepine , rifampin , @DRUG$ or St.	DDI-false
Vardenafil (20 mg) did not potentiate the hypotensive effects of @DRUG$ during the 4-hour observation period in healthy volunteers when administered with @DRUG$ (0.5 g/kg body weight).	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , doxorubicin , vincristine , and prednisone ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , doxorubicin , teniposide , and prednisone with @DRUG$ plus bleomycin ) without receiving @DRUG$ therapy .	DDI-false
Like ibogaine (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of @DRUG$ and cocaine and the oral self-administration of ethanol and @DRUG$ in rats;	DDI-false
Other Chemotherapy Agents In a separate study, concomitant administration of @DRUG$ with @DRUG$ did not meaningfully alter the pharmacokinetics of either agent (or the metabolites of capecitabine).	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, @DRUG$, H2 antagonists, @DRUG$, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, @DRUG$, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , @DRUG$ Angiotensin converting enzymes (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium channel blockers, heart @DRUG$ , diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also known as NSAIDs), and quinolones anti-infections without evidence of clinically significant adverse interactions.	DDI-false
Other potent inhibitors of CYP3A4 (e.g. itraconazole, @DRUG$ , nefazodone , @DRUG$ Ritonavir, nelfinavir, is expected to behave similarly.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including @DRUG$, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, @DRUG$ chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole ( cefmenoxime , @DRUG$ , cefotetan, cefamandole, @DRUG$ Methylthiadiazole (Cefazolin) may cause vitamin K deficiency and hypoprothrombinaemia.	DDI-false
@DRUG$-Concomitant intake of colestipol and @DRUG$ may reduce the absorption of vitamin K.	DDI-false
There are currently no data available from prospective clinical trials comparing the 3 approved active substances ( @DRUG$ , nevirapine or @DRUG$ ) .	DDI-false
Other concomitant therapy Although specific interaction studies have not been performed, 1 mg or more of finasteride doses have been co-administered in clinical trials with acetaminophen, acetylsalicylic acid, A-blockers, analgesics, angiotensin converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta-blockers, calcium channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also known as @DRUG$ ) , and @DRUG$ Without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ : Vardenafil 20 mg , when co-administered with slow-release nifedipine 30 mg or 60 mg once daily , did not affect the relative bioavailability ( AUC ) or maximum concentration ( Cmax ) of @DRUG$ A drug that is metabolised by CYP3A4.	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with @DRUG$ (alcohol, barbiturates, @DRUG$, sedatives, anesthetics) should be considered.	DDI-false
These medicines include thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, orally @DRUG$ , phenytoin, nicotinic acid, @DRUG$ , calcium channel block drugs, and isoniazid.	DDI-false
Garlic Capsules Garlic capsules should not be used while taking @DRUG$ (FORTOVASE) as the sole protease inhibitor due to the risk of decreased @DRUG$ plasma concentrations.	DDI-false
Other Drug Interactions : No pharmacokinetic interactions were observed between vardenafil and the following drugs : glyburide , @DRUG$ , digoxin , @DRUG$ ==References====External links==	DDI-false
In addition to the above interactions, chronic (2 weeks) oral administration of Cordaron affects the metabolism of phenytoin, @DRUG$ , and @DRUG$.	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, @DRUG$ and sedatives (including benzodiazepines), or @DRUG$ was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
Other cardiovascular agents: Enalapril and Enalapril IV were co-administered with @DRUG$ , methyldopa , nitrates , @DRUG$ , hydralazine , prazosin and digoxin without evidence of clinically significant adverse interactions .	DDI-false
@DRUG$ and @DRUG$ interact pharmacologically with orally administered anticoagulant agents, but the effect is not clinically significant.	DDI-false
The concomitant use of other CYP3A4 inhibitors such as diltiazem and @DRUG$ With transdermal fentanyl it can also lead to an increase in @DRUG$ Plasma concentrations that may increase or prolong adverse drug reactions and may cause severe respiratory depression.	DDI-false
Although no specific studies have been performed, co-administration with medicinal products primarily metabolised by CYP3A4 (e. g. @DRUG$ , Dapson, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$ When co-administered with saquinavir, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam and triazolam may exhibit increased plasma concentrations;	DDI-false
The administration of local anesthetic solutions containing @DRUG$ or norepinephrine to patients receiving monoamine oxidase inhibitors , @DRUG$ Or phenothiazines can cause severe, prolonged hypotension or hypertension.	DDI-effect
Ritonavir and indinavir: Upon concomitant administration of 5 mg of Vardenafil with 600 mg BID @DRUG$, the Cmax and AUC of @DRUG$ were reduced by approximately 20%.	DDI-false
Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: ergotamine, cyclosporine, amiodarone, @DRUG$, and @DRUG$.	DDI-false
HIV Protease Inhibitors : Indinavir ( 800 mg t.i.d . ) co-administered with @DRUG$ 10 mg resulted in a 16-fold increase in vardenafil AUC , a 7-fold increase in vardenafil Cmax and a 2-fold increase in @DRUG$ half-life .	DDI-false
In the second experiment , non-diabetic and streptozotocin-induced diabetic rats were fasted , and the same procedures were followed for estimation of @DRUG$ tolerance 30 min after @DRUG$ overload .	DDI-false
It was shown that @DRUG$ antagonized evidently the antinociceptive effect of @DRUG$ and their analogue.	DDI-effect
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ : @DRUG$ It has been reported that clinically significant fluctuations in steady-state serum concentrations of various tricyclic antidepressants occur.	DDI-false
@DRUG$, @DRUG$, and azoles are known to cause QTc prolongation.	DDI-false
Injection : Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system if with @DRUG$ , Phenothiazine, Barbiturates, MAO inhibitors, and other antidepressants. When @DRUG$ It is administered concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations and irrational behaviour has been observed.	DDI-false
Data from in vitro studies of @DRUG$ other than alprazolam suggest a possible drug interaction for the following: ergotamine, cyclosporine, @DRUG$, nicardipine, and nifedipine.	DDI-int
Theophylline: As with some other quinolones, concomitant use of @DRUG$ with theophylline may lead to elevated serum concentrations of @DRUG$ and prolongation of its elimination half-life .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$ , @DRUG$ , A-blockers, analgesics, angiotensin converting enzyme ( ACE) inhibitors, anticonvulsants, benzodiazepines, beta-blockers, calcium channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also known as NSAIDs), and quinolone anti-infections without evidence of clinically significant adverse interactions.	DDI-false
FLEXERIL may enhance the effects of @DRUG$, @DRUG$, and other CNS depressants.	DDI-false
In a comparison of @DRUG$ tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of @DRUG$, with ketamine or Innovar than with pentobarbital.	DDI-false
@DRUG$ ( 20 mg ) did not potentiate the hypotensive effects of @DRUG$ During the 4-hour observation period in healthy volunteers with alcohol ( 0.5 g/kg body weight ).	DDI-false
Patients receiving @DRUG$, sulfonamides, or @DRUG$ should be observed for increased activity of these drugs and, therefore, signs of toxicity from these drugs.	DDI-false
Example inhibitors include azole antifungals, @DRUG$, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, @DRUG$, and verapamil.	DDI-false
Cimetidine : @DRUG$ plasma concentrations and LDL-C reduction were not altered by coadministration of @DRUG$.	DDI-false
The effect of the blood pressure of @DRUG$ In chronic renal failure patients, the @DRUG$ As in patients who did not receive any other antihypertensive therapy.	DDI-effect
Cephalosporine cephalosporine containing side chains of N-methylthiotetrazole ( @DRUG$ , cefoperazone , cefotetan , cefamandole , latamoxef ) or methylthiadiazole ( @DRUG$ ) may cause vitamin K deficiency and hypoprothrombinaemia.	DDI-false
Data from in vitro studies of @DRUG$ other than alprazolam suggest a possible drug interaction for the following : ergotamine , cyclosporine , amiodarone , nicardipine , and @DRUG$.	DDI-int
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, @DRUG$, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Both @DRUG$ and @DRUG$ have been compared to triple therapy with the PI indinavir over 48 weeks as initial therapy , with similar responses being observed with nevirapine regimens and superiority observed with efavirenz .	DDI-false
@DRUG$ : @DRUG$ enhances the effect of warfarin .	DDI-effect
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies (phenytoin, valproate, oral @DRUG$, digoxin, warfarin, @DRUG$) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients.	DDI-false
Acetaminophen/theophylline, lidocaine/@DRUG$, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen and valproic acid/phenobarbital.	DDI-false
Other Cardiovascular Agents: @DRUG$ and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, @DRUG$, nitrates, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), @DRUG$ (@DRUG$), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Concomitant cyclophosphamide , doxorubicin , @DRUG$ , and prednisone chemotherapy plus @DRUG$ Treatment in patients with human immunodeficiency virus-associated non-Hodgkin lymphoma.	DDI-false
@DRUG$ may augment the activity of other @DRUG$.	DDI-effect
Other Cardiovascular Agents : @DRUG$ and @DRUG$ Co-administered with beta-adrenergic blockers, methyldopa, nitrates, calcium blockers, hydralacin, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole ( cefmenoxime , @DRUG$ , @DRUG$ , cefamandole , latamoxef ) or methylthiadiazole ( cefazolin ) can cause vitamin K deficiency and hypoprothrombinemia .	DDI-false
Nephrotoxicity following concomitant administration of @DRUG$ with aminoglycoside antibiotics or potent @DRUG$ For example, furosemide.	DDI-effect
; Naproxen : Simultaneous use of @DRUG$ and @DRUG$ In normal subjects, this did not affect naproxene plasma levels, but significantly reduced renal excretion of naproxene and its glucuronide metabolite.	DDI-mechanism
@DRUG$ NSAIDs have caused an increase in plasma @DRUG$ The concentrations and a reduction in renal lithium clearance.	DDI-false
If @DRUG$ is administered with drugs that inhibit Pgp , increased concentrations of @DRUG$ are likely , and caution should be exercised .	DDI-false
Because @DRUG$ has not been shown to produce any additional effect beyond that obtained with aspirin alone and because @DRUG$ increases the rate of excretion of Nalfon, the concomitant use of Nalfon and salicylates is not recommended.	DDI-false
Cephalosporine-@DRUG$ containing side chains of N-methylthiotetrazole (Cefmenoxime, cefoperazone, cefotetan, cefamandol, latamoxef) or methylthiadiazol ( @DRUG$ ) can cause vitamin K deficiency and hypoprothrombinemia .	DDI-false
Acetaminophen, lidocaine, @DRUG$, quinidine, theophylline, and @DRUG$ were added to pooled human serum at therapeutic concentrations.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like @DRUG$ (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of @DRUG$	DDI-false
Anticoagulants: Potentiation of warfarin-type (CYP2C9 and @DRUG$ substrate) @DRUG$ response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding.	DDI-false
HIV protease inhibitors : @DRUG$ ( 800 mg t.i.d . ) co-administered with Vardenafil 10 mg resulted in a 16-fold increase in vardenafil AUC , a 7-fold increase in @DRUG$ Cmax and a 2-fold increase in vardenafil half-life .	DDI-false
The conversion of @DRUG$ to @DRUG$ is catalyzed by aldehyde oxidase .	DDI-false
@DRUG$: @DRUG$ enhance the adrenergic effect of norepinephrine.	DDI-false
@DRUG$-Concomitant intake of @DRUG$ and vitamin K may reduce the absorption of vitamin K.	DDI-false
Other medicines: medicines such as quinidine, @DRUG$ , @DRUG$ , phenothiazines , antihistamines , and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia .	DDI-false
only @DRUG$ enhances @DRUG$-induced increases in accumbal dopamine.	DDI-effect
As with other @DRUG$, it should be noted that HALDOL may be capable of potentiating CNS depressants such as @DRUG$, opiates, and alcohol.	DDI-effect
Cyclosporine: Administration of @DRUG$ concomitantly with @DRUG$ has been associated with an increase in cyclosporine-induced toxicity, possibly due to decreased synthesis of renal prostacyclin.	DDI-mechanism
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, ritonavir, @DRUG$, @DRUG$, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
A drug-drug interaction study evaluated the effect of the use of ACZONE Gel, 5%, in combination with double strength (160 mg/800 mg) @DRUG$/sulfamethoxazole (@DRUG$/SMX).	DDI-false
Drug-Drug Interactions Between Keppra  And Other @DRUG$ (AEDs) @DRUG$ Keppra  (3000 mg daily) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy.	DDI-false
Mephenytoin (e.g. @DRUG$ ) Use of @DRUG$ with these medicines may increase the chance of side effects of these medicines	DDI-false
When @DRUG$ was coadministered with @DRUG$, rifampin, or H2antagonists, reduced plasma concentrations of itraconazole were reported.	DDI-mechanism
When LEVSIN is co-administered with other antimuscarinic agents, amantadine, haloperidol, @DRUG$ , @DRUG$ , tricyclic antidepressants or some antihistamines.	DDI-false
Take special care with ROMAZICON in overdose with mixed medicinal products as the toxic effects (such as cramps and heart rhythm disorders) of other medicinal products taken with overdose (especially: @DRUG$ ) may emerge with the reversal of the @DRUG$ effect by flumazenil .	DDI-false
Antihypertensive medications, other, especially @DRUG$, or preanesthetic and anesthetic agents used in surgery or @DRUG$, nondepolarizing, used in surgery	DDI-false
Injection : Lorazepam injection , like other injectable @DRUG$ , produces depression of the central nervous system when with ethyl alcohol, phenothiazine, @DRUG$ , MAO inhibitors , and other antidepressants . When scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .	DDI-effect
Dose adjustment is not recommended. Levetiracetam had no effect on plasma concentrations of @DRUG$ , Valproat, Topiramat, or @DRUG$.	DDI-false
@DRUG$ : Administration of nonsteroial anti-inflammatory drugs concomitantly with @DRUG$ has been associated with an increase in cyclosporine-induced toxicity , possibly due to decreased synthesis of renal prostacyclin .	DDI-false
In clinical studies performed with Fondaparinux , the concomitant use of oral anticoagulants ( warfarin ) , @DRUG$ ( acetylsalicylic acid ) , NSAIDs ( piroxicam ) , and @DRUG$ The pharmacokinetics/pharmacodynamics of fondaparinux sodium were not significantly affected.	DDI-false
While all the @DRUG$ (SSRIs), e.g., citalopram, escitalopram, @DRUG$, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or @DRUG$ antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing @DRUG$, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Levosimendan has no clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, warfarin, @DRUG$ , geschnitztilol, ethanol or @DRUG$.	DDI-false
Particular caution is necessary when using ROMAZICON in cases of mixed drug overdosage since the toxic effects ( such as convulsions and cardiac dysrhythmias ) of other drugs taken in overdose ( especially cyclic antidepressants ) may emerge with the reversal of the @DRUG$ effect by @DRUG$.	DDI-false
Concurrent administration of @DRUG$ and @DRUG$ This may lead to increased serum levels of oxyphenbutazone.	DDI-mechanism
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , @DRUG$ , @DRUG$ , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or @DRUG$ antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a @DRUG$ inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
In clinical studies performed with @DRUG$, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (@DRUG$), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Results of studies in multiple sclerosis patients taking TYSABRI  and concomitant interferon beta-1a (@DRUG$  30 mcg IM once weekly) or glatiramer acetate were inconclusive with regard to the need for dose adjustment of the @DRUG$ or glatiramer acetate.	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , @DRUG$ , disopyramide, quinine, @DRUG$ , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
A potential interaction between oral @DRUG$ and oral @DRUG$ leading to severe hypoglycemia has been reported .	DDI-int
In comparison of the digitalis tolerance in dogs stunned with @DRUG$ , Innovar Vet , or pentobarbital , the dosage of ouabain needed to cause ventricular tachycardia was significantly higher , as was the LD50 of ouabain , with @DRUG$ Or Innovar as with Pentobarbital.	DDI-false
"It is concluded that @DRUG$ Methaqualone can be used without additional caution in prothrombin test monitoring during oral administration. @DRUG$ therapy .	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, @DRUG$, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, @DRUG$, quinidine, and verapamil.	DDI-false
Potential drug interactions between Keppra  and other AEDs (@DRUG$, gabapentin, lamotrigine, @DRUG$, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
SINCE THE CONCOMITANT ADMINISTRATION OF THESE TWO DRUGS CAN LEAD TO @DRUG$ INTOXICATION, PRIOR TO ADMINISTERING DISULFIRAM TO A PATIENT ON PHENYTOIN THERAPY, A BASELINE @DRUG$ SERUM LEVEL SHOULD BE OBTAINED.	DDI-false
Tagamet, apparently due to an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, @DRUG$ , propranolol , @DRUG$ , chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, which delays the elimination and increase in blood levels of these drugs.	DDI-false
Stavudine and @DRUG$ @DRUG$ can antagonize the in vitro antiviral activity of stavudine and zidovudine against HIV.	DDI-false
Benzthiazide may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, @DRUG$, norepinephrine, @DRUG$ like Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
@DRUG$: In a study of healthy male volunteers no significant pharmacokinetic interaction occurred when @DRUG$ and allopurinol were administered concomitantly for 6 days.	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride, including @DRUG$ such as quinidine and procainamide, cardiac glycosides and @DRUG$.	DDI-false
The effect of orally ingested @DRUG$ or @DRUG$ from breast milk on the nursing infant has not been evaluated.	DDI-false
The possibility of hypotensive effects with captopril can be minimized by either discontinuing the diuretic or increasing the salt intake approximately one week prior to initiation of treatment with @DRUG$ (@DRUG$ tablets, USP) or initiating therapy with small doses (6.25 or 12.5 mg).	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, Dapson, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$ , ergotic derivatives, @DRUG$ When co-administered with saquinavir, carbamazepine, fentanyl, alfentanyl, alprazolam and triazolam may exhibit increased plasma concentrations;	DDI-false
Chlorpromazine : @DRUG$ blocks dopamine and norepinephrine receptors , thus inhibiting the central stimulant effects of @DRUG$ And can be used to treat amphetamine poisoning.	DDI-effect
Drugs Interactions between Keppra and other antiepileptics ( AEDs ) @DRUG$ @DRUG$ In patients with refractory epilepsy, the administration of phenytoin (3,000 mg daily) had no effect on the pharmacokinetics of phenytoin.	DDI-false
A possible interaction between oral @DRUG$ and oral @DRUG$ leading to severe hypoglycemia has been reported .	DDI-effect
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, @DRUG$, @DRUG$, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
Multivalent Cation-Containing Products : Concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , @DRUG$ , VIDEX chewable/buffered tablets or pediatric powder , or products containing calcium , @DRUG$ , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .	DDI-false
In vitro studies have shown that precipitation occurs when eye drops, @DRUG$ are mixed with @DRUG$.	DDI-false
Reciprocal interactions may occur with concomitant use of Antizol and drugs that increase or inhibit the cytochrome P450 system ( e.g. , @DRUG$ , carbamazepine , cimetidine , @DRUG$ ), although this has not yet been studied.	DDI-false
To evaluate the effect of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL), the authors retrospectively compared a group of 24 patients with HIV-NHL treated with cyclophosphamide, @DRUG$ , vincristine and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, tenipide and prednisone with @DRUG$ plus bleomycin ) without receiving antiretroviral therapy .	DDI-false
Oral Contraceptives : Coadministration of @DRUG$ AUC values for oral contraceptives and oral contraceptives increased @DRUG$ Ethinylestradiol by about 30% and 20%.	DDI-mechanism
Injection : Lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , @DRUG$ , barbiturates , MAO inhibitors , and other @DRUG$.When scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .	DDI-false
Therefore, interactions after concomitant use of @DRUG$ - narcotics, analgesics, @DRUG$ , sedatives , tranquilizers ) .	DDI-false
The use of local anaesthetics containing epinephrine or norepinephrine in patients who: @DRUG$ , tricyclic antidepressants or @DRUG$ For this reason, severe, prolonged hypotension or hypertension may occur.	DDI-false
Tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , @DRUG$ , diazepam, certain tricyclic antidepressants, lidocaine, @DRUG$ And metronidazole, which delays the elimination and increase in blood levels of these drugs.	DDI-false
Warfarin: Eszopiclone 3 mg administered daily for 5 days did not affect the pharmacokinetics of@DRUG$n, nor were there any changes in the pharmacodynamic profile (prothrombin time) following a single 25 mg oral dose of @DRUG$	DDI-false
Drugs Interactions : Flupentixol may interact with some medicines, such as monoamine oxidase inhibitors (MAOI): MAOI may theoretically affect @DRUG$ pharmacodynamics - arecoline - eproxindine - ethanol : flupentixol and ethanol lead to additive CNS depression - tricyclic antidepressants : flupentixol increases the effect of @DRUG$	DDI-false
The benzodiazepines are a family of @DRUG$ and @DRUG$.	DDI-false
Acetaminophene, lidocaine, @DRUG$ , quinidine , @DRUG$ , and valproic acid were added to pooled human serum at therapeutic concentrations .	DDI-false
Acetaminophen : In normal volunteers , concomitant administration of @DRUG$ Acetaminophene and acetaminophene resulted in an approximately 50% increase in @DRUG$ plasma levels.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, @DRUG$, teniposide, and prednisone with vincristine plus @DRUG$) without receiving antiretroviral therapy.	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, @DRUG$, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and @DRUG$.	DDI-false
The administration of local anesthetic solutions containing epinephrine or @DRUG$ to patients receiving monoamine oxidase inhibitors , tricyclic antidepressants or @DRUG$ For this reason, severe, prolonged hypotension or hypertension may occur.	DDI-effect
These drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , @DRUG$ , nicotinic acid , sympathomimetics , @DRUG$ , and isoniazid .	DDI-false
Phenothiazines and @DRUG$ may reduce or reverse the pressor effect of @DRUG$.	DDI-effect
Drugs Interactions : Flupentixol may interact with some medicines such as monoamine oxidase inhibitors (MAOI): MAOI may theoretically affect flupentixol pharmacodynamics - Arecoline - Eproxindine - @DRUG$ : Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants : @DRUG$ increases the effect of Tricyclic antidepressants	DDI-false
Warfarin : Eszopiclone 3 mg administered daily for 5 days did not affect the pharmacokinetics of (R)- or @DRUG$ There were also no changes in the pharmacodynamic profile (prothrombin time) after a single oral dose of 25 mg. @DRUG$	DDI-false
Acetaminophen/theophylline, lidocaine/chinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$ and @DRUG$/Phenobarbital.	DDI-false
Example inhibitors include @DRUG$, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and @DRUG$.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - @DRUG$ - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: @DRUG$ increases the effect of Tricyclic antidepressants	DDI-false
@DRUG$: Vardenafil 20 mg, when co-administered with slow-release nifedipine 30 mg or 60 mg once daily, did not affect the relative bioavailability (AUC) or maximum concentration (Cmax) of @DRUG$, a drug that is metabolized via CYP3A4.	DDI-false
Cyclosporine, Digoxin, Methotrexate @DRUG$, like other NSAIDs, through effects on renal prostaglandins, may cause changes in the elimination of these drugs leading to elevated serum levels of cyclosporine, @DRUG$, methotrexate, and increased toxicity.	DDI-mechanism
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, @DRUG$, @DRUG$, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, phe-nothiazines, @DRUG$, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Acetaminophen/theophylline, lidocaine/chinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen and @DRUG$/Phenobarbital.	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of @DRUG$ deficit and to discriminate between magnesium deficiency due to an insufficient magnesium intake which only requires oral physiological supplementation and @DRUG$ depletion related to a dysregulation of the control mechanisms of magnesium status which requires more or less specific regulation of its causal dysregulation.	DDI-false
Although glucocorticoids have been shown to reduce @DRUG$-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 @DRUG$ and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-false
Myocardial injury, including myocardial infarction, myocarditis, ventricular hypokinesia, and severe rhabdomyolysis appear to be increased in patients receiving @DRUG$ and @DRUG$ concurrently.	DDI-effect
@DRUG$ : In a study conducted in healthy subjects , mean steady-state @DRUG$ plasma levels increased approximately 17 % in subjects receiving lithium 450 mg BID with CELEBREX 200 mg BID as compared to subjects receiving lithium alone .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, @DRUG$, anticonvulsants, @DRUG$, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$, but not @DRUG$, decreases heart rate at high doses.	DDI-false
There have been more than 2-fold increases in plasma levels of other antidepressants, including: @DRUG$ , when @DRUG$ has been administered in combination with these agents .	DDI-mechanism
Clinical implications of @DRUG$ interactions with five @DRUG$.	DDI-int
The effects of DCG-IV and @DRUG$ upon @DRUG$ (PCP)-induced locomotion and behavioral changes in mice.	DDI-false
Both @DRUG$ and 18-MC block morphine-induced and @DRUG$-induced dopamine release in the nucleus accumbens;	DDI-effect
Drug/Laboratory Test Interactions @DRUG$, including @DRUG$, are known to occasionally induce a positive direct Coombs test.	DDI-false
@DRUG$ and Zidovudine Ribavirin can antagonize the in vitro antiviral activity of @DRUG$ and zidovudine against HIV .	DDI-false
Some @DRUG$/substances are known to accelerate the metabolism of amiodarone by stimulating the synthesis of @DRUG$ (enzyme induction).	DDI-false
Aerosol particles of @DRUG$ were generated from an @DRUG$ solution, dried, and collected by a cascade impactor for characterization or by a liquid impinger for dissolution experiments.	DDI-false
Intravenous Adenocard (@DRUG$) has been effectively administered in the presence of other cardioactive drugs, such as quinidine, beta-adrenergic blocking agents, @DRUG$, and angiotensin converting enzyme inhibitors, without any change in the adverse reaction profile.	DDI-false
These drugs include the thiazides and other diuretics, @DRUG$, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Phenothiazines and @DRUG$ The print effect of @DRUG$ can be reduced or undone.	DDI-effect
- @DRUG$ (e.g., @DRUG$) or	DDI-false
Digoxin : When multiple doses of @DRUG$ and digoxin were coadministered , steady-state plasma @DRUG$ Concentrations increased by about 20%.	DDI-false
It is concluded that @DRUG$ and @DRUG$ may be administered safely without additional caution in prothrombin test monitoring during oral anticoagulant therapy.	DDI-false
@DRUG$ reduce the renal clearance of lithium and add a high risk of @DRUG$ toxicity .	DDI-effect
Drugs Interactions between Keppra and other antiepileptics (AEDs) Phenytoin @DRUG$ 3 000 mg daily had no effect on the pharmacokinetics of @DRUG$ In patients with refractory epilepsy.	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of magnesium deficit and to discriminate between @DRUG$ deficiency due to an insufficient magnesium intake which only requires oral physiological supplementation and @DRUG$ depletion related to a dysregulation of the control mechanisms of magnesium status which requires more or less specific regulation of its causal dysregulation.	DDI-false
however , it adversely affected response duration suggesting that @DRUG$ It should not be combined with @DRUG$ and/or cisplatin.1	DDI-advise
however, no deleterious interactions were seen when ROMAZICON was administered after @DRUG$, inhalational @DRUG$, muscle relaxants and muscle relaxant antagonists administered in conjunction with sedation or anesthesia.	DDI-false
In the @DRUG$ study, @DRUG$ had no effect on the prothrombin time or other pharmacodynamic parameters.	DDI-false
@DRUG$: In a study of healthy male volunteers no significant pharmacokinetic interaction occurred when captopril and @DRUG$ were administered concomitantly for 6 days.	DDI-false
Cephalosporins-@DRUG$ containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, cefotetan, @DRUG$, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
These drugs include: @DRUG$ and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and @DRUG$.	DDI-false
Hypotension   Patients on @DRUG$ Therapy: Patients on diuretics and especially those in whom diuretic therapy was recently instituted, as well as those on severe dietary salt restriction or dialysis, may occasionally experience a precipitous reduction of blood pressure usually within the first hour after receiving the initial dose of @DRUG$.	DDI-false
@DRUG$: Indinavir (800 mg t.i.d.) co-administered with Vardenafil 10 mg resulted in a 16-fold increase in @DRUG$ AUC, a 7-fold increase in vardenafil Cmax and a 2-fold increase in vardenafil half-life.	DDI-false
Drug Interactions: @DRUG$ may interact with some drugs, like Monoamine oxidase inhibitors (@DRUG$): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-int
The availability of potent non-nucleoside reverse transcriptase inhibitor (NNRTI)-based regimens for antiretroviral therapy and concerns regarding @DRUG$ (@DRUG$)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection .	DDI-false
@DRUG$ Influence can be with alcohol, blood thinners, inflammatory medications (allergic, cold, and sinus drugs), diabetics, lithium, norepinephrine, NSAIDs such as Aleve or @DRUG$ , and high blood pressure medications .	DDI-int
However, concomitant administration of @DRUG$ with @DRUG$ may result in an increased rate of GI ulceration or other complications, compared to use of CELEBREX alone.	DDI-effect
Example inhibitors include @DRUG$ , ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazide, @DRUG$ , nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., @DRUG$) or hepatotoxic (e.g., methotrexate, @DRUG$) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (alcohol, @DRUG$, opiates, @DRUG$, anesthetics) should be considered.	DDI-false
Compounds that have been tested in man include @DRUG$, digoxin, @DRUG$, theophylline, and warfarin and no clinically meaningful interactions were found.	DDI-false
@DRUG$ may suppress certain CYP450 enzymes, including CYP1A2, CYP2C9, CYP2D6, and @DRUG$.	DDI-false
Drug Interactions : Flupenthixol may interact with some drugs , like Monoamine oxidase inhibitors ( MAOI ): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - @DRUG$ Flupentixol and ethanol cause additive CNS depression - @DRUG$ Flupentixol increases the effect of tricyclic antidepressants	DDI-false
The aim of this paper was to study the interaction between @DRUG$ and both enkephalins or its synthetic analogue @DRUG$, or tuftsin, on the antinonciceptive effect of these peptides in mice after intracisternal injection.	DDI-false
The administration of other @DRUG$ with @DRUG$ has been shown to reduce the antihypertensive effect in some patients and result in severe hyperkalemia in patients with impaired renal function.	DDI-effect
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or @DRUG$, calcium channel blockers, antihistamines or H1-blocking agents, tricyclic antidepressants and @DRUG$) might also contribute to a prolongation of the QTc interval.	DDI-false
Lithium : @DRUG$ have produced an elevation of plasma lithium levels and a reduction in renal @DRUG$ clearance .	DDI-false
Serious anticholinergic symptoms ( severe dry mouth , urinary retention , blurred vision ) have been associated with elevations in the serum levels of @DRUG$ when @DRUG$ The medication is added to the medication regimen.	DDI-effect
@DRUG$ " : Reports indicate that @DRUG$ may diminish the antihypertensive effect of Angiotensin Converting Enzyme ( ACE ) inhibitors .	DDI-false
(In some patients, the @DRUG$ can reduce the diuretic, natriuretic, and antihypertensive effects of loop, @DRUG$.	DDI-effect
Other concomitant therapy Although no specific interaction studies have been conducted, 1 mg or more finasteride doses have been reported in clinical trials with acetaminophen, acetylsalicylic acid, A-blockers, analgesics, angiotensin converting enzyme (ACE) inhibitors, @DRUG$ , benzodiazepines , @DRUG$ , calcium channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also known as NSAIDs), and quinolone anti-infections without evidence of clinically significant adverse interactions.	DDI-false
As higher doses of @DRUG$ A single dose of 2.5 mg vardenafil should not be exceeded in a 24-hour period when used in combination with @DRUG$ 400 mg daily.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., @DRUG$, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a @DRUG$ inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
However, a crossover study in healthy subjects receiving either Tagamet 300 mg q.i.d. or 800 mg h.s. simultaneously with a 300 mg b.i.d. dose. @DRUG$ ( @DRUG$ , Key Pharmaceuticals , Inc. ) demonstrated less alteration in steady-state theophylline peak serum levels with the 800 mg h.s . regimen , particularly in subjects aged 54 years and older .	DDI-false
@DRUG$ may increase sensitivity to the @DRUG$.	DDI-effect
Anticoagulants including coumarin derivatives, indandione derivatives, and @DRUG$ such as nonsteroidal anti-inflammatory drugs (NSAIDs), and aspirin may increase the risk of bleeding when administered concomitantly with @DRUG$.	DDI-effect
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, @DRUG$, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Results of studies in multiple sclerosis patients taking TYSABRI  and concomitant @DRUG$ (AVONEX  30 mcg IM once weekly) or glatiramer acetate were inconclusive with regard to the need for dose adjustment of the beta-interferon or @DRUG$.	DDI-false
Example inhibitors include @DRUG$ , ciprofloxacin , @DRUG$ , diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
@DRUG$: Potentiation of warfarin-type (CYP2C9 and @DRUG$ substrate) anticoagulant response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding.	DDI-false
Intravenous @DRUG$ ( @DRUG$ ) has been effectively administered in the presence of other cardioactive drugs , such as quinidine , beta-adrenergic blocking agents , calcium channel blocking agents , and angiotensin converting enzyme inhibitors , without any change in the adverse reaction profile .	DDI-false
As with other @DRUG$, it should be noted that HALDOL may be capable of potentiating CNS depressants such as anesthetics, @DRUG$, and alcohol.	DDI-effect
Drug-Drug Interactions Between Keppra  And Other Antiepileptic Drugs (@DRUG$) @DRUG$ Keppra  (3000 mg daily) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy.	DDI-false
@DRUG$ taken concomitantly with @DRUG$ The plasma concentrations of procainamide and n-acetylprocainamide are increased by 55% and 33% respectively for less than seven days.	DDI-false
For example, inhibitors are azole antimycotics, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, @DRUG$ , nefazodone , nicardipine , propofol , @DRUG$ , quinidine, and verapamil.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$, @DRUG$, calcium channel blocking drugs, and isoniazid.	DDI-false
Central nervous system depressants: the concomitant use of DURAGESIC ( @DRUG$ Transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, @DRUG$ Anaesthetics (e.g. benzodiazepines), general anaesthetics, phenothiazines, skeletal muscle relaxants and alcohol can cause respiratory depression, hypotension and deep sedation, or possibly lead to coma or death.	DDI-effect
Monoamine Oxidase Inhibitors and @DRUG$ FORADIL should be used with extreme caution in patients who are treated with: @DRUG$ Or tricyclic antidepressants, because the effect of formoterol on the cardiovascular system can be enhanced by these active substances.	DDI-false
To evaluate the effect of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL), the authors retrospectively compared a group of 24 patients with HIV-NHL treated with cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or CHOP-like regimen (i.e., cyclophosphamide, doxorubicin), @DRUG$ , and @DRUG$ • with vincristine plus bleomycin) without antiretroviral therapy.	DDI-false
Although there are no study data to evaluate the possibility , nitric oxide donor compounds , including sodium nitroprusside and @DRUG$ , may have an additive effect with @DRUG$ About the risk of developing methaemoglobinaemia.	DDI-effect
These drugs include the @DRUG$ and other @DRUG$ , corticosteroids , phe-nothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .	DDI-false
Mineral Oil-Concomitant intake of @DRUG$ and vitamin K may reduce the absorption of @DRUG$.	DDI-false
It was concluded that oral @DRUG$ and @DRUG$ Concomitant administration may take place without a significant decrease in AUC, Cmax or tmax.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed , @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$ Acetylsalicylic acid, A-blockers, analgesics, angiotensin converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta-blockers, calcium channel blockers, heart nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also known as NSAIDs) and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Particular caution is recommended when administering @DRUG$ with CYP3A4 substrates that have a narrow therapeutic window (e.g., cyclosporine or @DRUG$).	DDI-advise
Example inhibitors include azole antifungals , @DRUG$ , clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodon, nicardipine, @DRUG$ , protease inhibitors , quinidine , and verapamil .	DDI-false
- Vitamin K (e.g., AquaMEPHYTON, @DRUG$) Use of @DRUG$ with these medicines may increase the chance of side effects affecting the blood	DDI-false
medicines that inhibit CYP3A4 ( @DRUG$ CYP3A4 is an important metabolic pathway for elimination of @DRUG$.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, @DRUG$, erythromycin, imatinib, isoniazid, nefazodone, @DRUG$, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
@DRUG$ taken concomitantly with procainamide for less than seven days increases plasma concentrations of procainamide and n-acetyl @DRUG$ by 55 % and 33 % , respectively .	DDI-false
@DRUG$: As with some other quinolones, concurrent administration of @DRUG$ with theophylline may lead to elevated serum concentrations of theophylline and prolongation of its elimination half-life.	DDI-false
Concurrent administration of @DRUG$ Cimetidine, an inhibitor of microsomal drug metabolism, increased @DRUG$s half-life and toxicity in a rat model. Cimetidine, an inhibitor of microsomal drug metabolism, increased @DRUG$s half-life and toxicity in a rat model.	DDI-false
acetaminophen/theophylline , lidocaine/quinidine , phenobarbital/@DRUG$ , phenobarbital/valproic acid , quinidine/lidocaine , @DRUG$/acetaminophen , and valproic acid/phenobarbital .	DDI-false
Acetaminophen/theophylline, lidocaine/chinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen and valproic acid/@DRUG$.	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, ritonavir, indinavir, @DRUG$, @DRUG$, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
Other CONCOMITANT THERAPY: Although specific interaction studies have not been performed, in clinical studies cerivastatin sodium was used together with angiotensin converting enzyme ( ACE) inhibitors, beta-blockers, @DRUG$ , @DRUG$ , and nonsteroidal anti-inflammatory drugs ( NSAIDs ) without evidence of clinically significant adverse interactions .	DDI-false
@DRUG$: Concomitant treatment with @DRUG$ and tetracyclines should be avoided because Accutane use has been associated with a number of cases of pseudotumor cerebri (benign intracranial hypertension), some of which involved concomitant use of tetracyclines	DDI-false
Oral @DRUG$: Pharmacokinetic drug-drug interactions between Argatroban and @DRUG$ (7.5 mg single oral dose) have not been demonstrated.	DDI-false
Multivalent Cation-Containing Products : Concurrent administration of a quinolone , including @DRUG$ , with multivalent cation-containing products such as @DRUG$ or aluminum antacids , sucralfate , VIDEX chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .	DDI-mechanism
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of @DRUG$, with ketamine or Innovar than with @DRUG$.	DDI-false
In post-marketing experience, bleeding events have been reported, predominantly in the elderly, in association with increases in prothrombin time in patients receiving @DRUG$ concurrently with @DRUG$.	DDI-effect
Central Nervous System Depressants : The concomitant use of DURAGESIC   ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , @DRUG$ , skeletal muscle relaxants, and @DRUG$ , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	DDI-false
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., @DRUG$, analgesics, antiemetics, @DRUG$, tranquilizers).	DDI-false
Then , the effects of metabotropic glutamate receptor ( mGluR ) agonists , @DRUG$ and L-CCG-1 , on the above behavioral changes induced by @DRUG$ were found .	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other @DRUG$, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, @DRUG$, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
No important interactions to date @DRUG$ does not have clinically important pharmacokinetic interactions with captopril , beta-blockers , felodipine , digoxin , @DRUG$ , isosorbide mononitrate, knitztilol, ethanol or itraconazole.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, @DRUG$, and prednisone with @DRUG$ plus bleomycin) without receiving antiretroviral therapy.	DDI-false
@DRUG$ Including coumarin derivatives, indandion derivatives and platelet aggregation inhibitors such as non-steroidal anti-inflammatory drugs ( @DRUG$ Aspirin may increase the risk of bleeding when administered at the same time as ardeparin.	DDI-false
Co-administration of @DRUG$ and cerivastatin did not alter the pharmacokinetics of @DRUG$.	DDI-false
@DRUG$: DURAGESIC  is not recommended for use in patients who have received MAOI within 14 days because severe and unpredictable potentiation by MAO inhibitors has been reported with @DRUG$	DDI-false
It is assumed that increased interaction between 3H-spiroperidol and high affinity binding sites for @DRUG$ on dopamine2- and serotonin2-receptors underlies the antipsychotic action of @DRUG$ after their prolonged administration.	DDI-false
Acetaminophen : A report of severe @DRUG$ toxicity was reported in a patient receiving @DRUG$.	DDI-effect
==References====External links== @DRUG$ , diltiazem and @DRUG$ , inhibit platelet activation in vitro , and decrease platelet adhesion intravascularly .	DDI-false
Non-steroidal anti-inflammatory drugs : In some patients, the administration of a non-steroidal anti-inflammatory agent may reduce the diuretics, natriuretics and antihypertensive effects of the loop, @DRUG-DRUG$.	DDI-false
• Medicines that cause a significant sustained increase in the pH of the stomach (histamine H2 receptor antagonists such as @DRUG$ Cimetidine) may increase the plasma concentration of @DRUG$ For this reason, effectiveness can be reduced.	DDI-mechanism
This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with @DRUG$ may prolong and intensify the anticholinergic and CNS depressant effects of @DRUG$).	DDI-false
Reciprocal interactions may occur with concomitant use of @DRUG$ and drugs that increase or inhibit the cytochrome P450 system (e.g., phenytoin, @DRUG$, cimetidine, ketoconazole), though this has not been studied	DDI-mechanism
ACE Inhibitors and Angiotensin II Receptor Antagonists (Hypertension)- In clinical studies of patients with hypertension, the addition of INSPRA 50 to 100 mg to @DRUG$ and @DRUG$ increased mean serum potassium slightly (about 0.09-0.13 mEq/L).	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , disopyramide , @DRUG$ , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , @DRUG$ , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, doxorubicin, teniposide, and @DRUG$ with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Antagonism between @DRUG$ and @DRUG$ In vitro has been shown.	DDI-effect
Drug Interactions: @DRUG$ may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - @DRUG$: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
The concomitant use of @DRUG$ tablets and other @DRUG$ is not recommended due to the increased possibility of gastrointestinal toxicity, with little or no increase in efficacy.	DDI-effect
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of @DRUG$ 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with @DRUG$ (alcohol, barbiturates, opiates, sedatives, anesthetics) should be considered.	DDI-advise
Drug Interactions : @DRUG$ may interact with some drugs , like @DRUG$ MAOI could theoretically influence flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol : Flupenthixol and ethanol cause additive CNS depression - Tricyclic antidepressants : Flupenthixol increases the effect of tricyclic antidepressants	DDI-int
@DRUG$ has been reported to increase the @DRUG$ requirements in human subjects ingesting these agents simultaneously.	DDI-mechanism
Thus, concomitant therapy with @DRUG$ and @DRUG$ should not require dosage adjustment of either drug.	DDI-false
Lack of an effect of @DRUG$ on the disposition of @DRUG$ and dideoxyinosine in HIV-infected patients.	DDI-false
This medication may interact with alcohol or other CNS depressants (may potentiate the CNS depressive effect of either these drugs or antihistamines), @DRUG$ Anticholinergic effects may be increased if these drugs are used concomitantly with antihistamines, and monoamine oxidase (MAO) inhibitors ( concomitant use with antihistamines may cause the anticholinergic and CNS depressive effects of @DRUG$ ) .	DDI-false
The concomitant intake of @DRUG$ and @DRUG$ The pharmacokinetics of alcohol or acamprosate are not affected.	DDI-false
METHODS: Since the start of the experiment, the rats received 10 weekly subcutaneous injections of AOM (7.4 mg/kg body weight) and subcutaneous injections of AOM (7.5 mg/kg body weight). @DRUG$ 40 μg/kg body weight every other day and from week 16 intraperitoneal injections @DRUG$ ( 10 or 20 mg/kg body weight ) every other day until the end fo the experiment in week 45 .	DDI-false
Potential drug interactions between @DRUG$  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these @DRUG$ during placebo-controlled clinical studies.	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, @DRUG$, cefamandole, latamoxef) or methylthiadiazole (@DRUG$) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, @DRUG$, diclofenac, doxycycline, erythromycin, imatinib, @DRUG$, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
@DRUG$-based therapies can have multiple benefits over @DRUG$-based therapy for first or longer therapy, including more convenient regimens, lower tablet volume, fewer drug interactions, and central nervous system penetration.	DDI-false
@DRUG$, tricyclic @DRUG$ may enhance the activity of tricyclic antidepressants or sympathomimetic agents;	DDI-false
The possibility of hypotensive effects with captopril can be minimized by either discontinuing the @DRUG$ or increasing the salt intake approximately one week prior to initiation of treatment with @DRUG$ (captopril tablets, USP) or initiating therapy with small doses (6.25 or 12.5 mg).	DDI-false
@DRUG$ The plasma concentrations of cerivastatin were not affected by the concomitant use of @DRUG$.	DDI-false
Hypotension   Patients on Diuretic Therapy: Patients on diuretics and especially those in whom @DRUG$ therapy was recently instituted, as well as those on severe dietary salt restriction or dialysis, may occasionally experience a precipitous reduction of blood pressure usually within the first hour after receiving the initial dose of @DRUG$.	DDI-false
Other Drug Interactions: No pharmacokinetic interactions were observed between vardenafil and the following drugs: glyburide, warfarin, digoxin, @DRUG$, and @DRUG$.	DDI-false
Bacteriostatic Antibiotics: Chloramphenicol, erythromycins, sulfonamides, or @DRUG$ may interfere with the bactericidal effect of @DRUG$.	DDI-effect
Then , the effects of metabotropic glutamate receptor ( mGluR ) agonists , @DRUG$ and @DRUG$ To the above behavioral changes induced by PCP were found.	DDI-false
WARFARIN: Co- administration of @DRUG$ and cerivastatin to healthy volunteers did not result in any changes in prothrombin time or clotting factor VII when compared to co-administration of @DRUG$ and placebo.	DDI-false
The aim of this paper was to study the interaction between neurotensin and both @DRUG$ or its synthetic analogue D-Ala2-metenkephalinamide, or @DRUG$, on the antinonciceptive effect of these peptides in mice after intracisternal injection.	DDI-false
Example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , @DRUG$ , imatinib , @DRUG$ , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .	DDI-false
No data are available for the coadministration of INVIRASE/@DRUG$ or @DRUG$/ritonavir and garlic capsules .	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -@DRUG$ blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and @DRUG$, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
These data indicate that levetiracetam does not influence the plasma concentration of other AEDs and that these @DRUG$ do not influence the pharmacokinetics of @DRUG$.	DDI-false
@DRUG$ ( @DRUG$ ): Cerivastatin plasma concentrations were not affected by co-administration of antacid .	DDI-false
Both @DRUG$ and nevirapine have been compared to triple therapy with the PI @DRUG$ over 48 weeks as initial therapy, with similar responses being observed with nevirapine regimens and superiority observed with efavirenz.	DDI-false
Like ibogaine (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of @DRUG$ and @DRUG$ in rats;	DDI-false
@DRUG$: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and @DRUG$, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
@DRUG$ , other , especially @DRUG$ , or preanesthetic and anesthetic agents used in surgery or skeletal-muscle relaxants , nondepolarizing , used in surgery	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, @DRUG$ , @DRUG$ , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, dapsones, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporin, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$ , @DRUG$ , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
In addition , Fondaparinux neither influenced the pharmacodynamics of @DRUG$ , @DRUG$ , piroxicam , and digoxin , nor the pharmacokinetics of digoxin at steady state .	DDI-false
The most common seizures have been reported if: @DRUG$ is administered with @DRUG$ and special care should be taken when the treatment regimen includes both of these drugs .	DDI-effect
@DRUG$: @DRUG$ 20 mg, when co-administered with slow-release nifedipine 30 mg or 60 mg once daily, did not affect the relative bioavailability (AUC) or maximum concentration (Cmax) of nifedipine, a drug that is metabolized via CYP3A4.	DDI-false
Aspirin: Concomitant administration of low-dose @DRUG$ with VIOXX may result in an increased rate of GI ulceration or other complications, compared to use of @DRUG$ alone.	DDI-false
However , a crossover study in healthy subjects receiving either Tagamet 300 mg q.i.d . or 800 mg h.s . concomitantly with a 300 mg b.i.d . dosage of theophylline ( @DRUG$ , Key Pharmaceuticals , Inc. ) demonstrated less alteration in steady-state @DRUG$ Peak serum levels with the 800 mg h.s. regimen, especially in subjects aged 54 years and older.	DDI-false
BACKGROUND: The effects of combined administration of bombesin and @DRUG$ (verapamil), a calcium channel blocker, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane (@DRUG$) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
- @DRUG$ (Nandrolone [e.g. Anaboline], Oxandrolone [e.g. Anavar], @DRUG$ [ e.g. , Anadrol ] , stanozolol [ e.g. , Winstrol ] ) or	DDI-false
@DRUG$: Amiodarone, bepridil, @DRUG$, propafenone, quinidine CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
- Anabolic steroids ( nandrolone [ e.g. , @DRUG$ ] , @DRUG$ [ e.g. Anavar ], oxymetholone [ e.g. Anadrol ], Stanozolol [ e.g. Winstrol ] or	DDI-false
Particular caution is necessary when using ROMAZICON in cases of mixed drug overdosage since the toxic effects (such as convulsions and cardiac dysrhythmias) of other drugs taken in overdose (especially @DRUG$) may emerge with the reversal of the benzodiazepine effect by @DRUG$.	DDI-false
@DRUG$: Atorvastatin had no clinically significant effect on prothrombin time when administered to patients receiving chronic @DRUG$ treatment.	DDI-false
Although @DRUG$ have been shown to reduce PROLEUKIN-induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided . 12 @DRUG$ In PROLEUKIN, hypotension and other antihypertensive agents may be increased.	DDI-false
The initiation of @DRUG$ or @DRUG$ use may be precipitated by similar personality characteristics in the user, such as impulsivity and sensation seeking.	DDI-false
@DRUG$ 200 mg once daily) resulted in a 10-fold increase in @DRUG$ AUC and a 4-fold increase in Cmax when co-administered with vardenafil ( 5 mg ) in healthy subjects.	DDI-mechanism
Dosage adjustment of STRATTERA may be necessary when coadministered with CYP2D6 inhibitors, e.g., paroxetine, @DRUG$, and @DRUG$.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, @DRUG$ chewable/buffered tablets or pediatric powder, or products containing @DRUG$, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, @DRUG$, @DRUG$, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
@DRUG$: @DRUG$ may counteract the sedative effect of antihistamines.	DDI-false
Potential drug interactions between @DRUG$  and other AEDs (carbamazepine, gabapentin, lamotrigine, @DRUG$, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine , Innovar Vet , or @DRUG$ , the dosage of @DRUG$ The need to cause ventricular tachycardia was significantly higher than the LD50 of Ouabain, with ketamine or innovar than with pentobarbital.	DDI-effect
The similarity of the TYSABRI -associated adverse event profile between Study 1 ( without co-administered @DRUG$ Study 2 (with co-administration) @DRUG$ ) indicates that this alteration in clearance does not necessitate reduction of the TYSABRI   dose to maintain safety , General ) .	DDI-false
Although there are no study data to evaluate the possibility , @DRUG$ , including sodium nitroprusside and @DRUG$ , may have an additive effect with INOmax on the risk of developing methaemoglobinaemia.	DDI-false
This may occur because @DRUG$ competitively displaces @DRUG$ from protein binding sites .	DDI-mechanism
@DRUG$: Quinolones have been reported to enhance the effects of the oral @DRUG$ warfarin or its derivatives.	DDI-false
Although there are no study data to evaluate the possibility, nitric oxide donor compounds, including @DRUG$ and @DRUG$, may have an additive effect with INOmax on the risk of developing methemoglobinemia.	DDI-false
It may be necessary to adjust the dosage of oral @DRUG$ After the start or stop of disulfiram. since @DRUG$ may prolong prothrombin time .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, @DRUG$, @DRUG$ (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ and butyrophenones may reduce or reverse the pressor effect of @DRUG$.	DDI-effect
@DRUG$ taken concomitantly with procainamide for less than seven days increases plasma concentrations of procainamide and n-acetyl @DRUG$ by 55% and 33%, respectively.	DDI-false
In addition , Fondaparinux neither influenced the pharmacodynamics of @DRUG$ Acetylsalicylic acid, piroxicam and digoxin, nor the pharmacokinetics of @DRUG$ at steady state .	DDI-false
Inhibitors Of Endogenous Prostaglandin Synthesis It has been reported that @DRUG$ may reduce the antihypertensive effect of @DRUG$, especially in cases of low renin hypertension.	DDI-effect
ACE Inhibitors and @DRUG$ In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists ( @DRUG$/ARB).	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$, nicotinic acid, @DRUG$, calcium channel blocking drugs, and isoniazid.	DDI-false
For these reasons, it is felt that, in most subjects who have had an unsatisfactory lipid response to either drug alone, the possible benefits of combined therapy with @DRUG$ and a @DRUG$ do not outweigh the risks of severe myopathy, rhabdomyolysis, and acute renal failure.	DDI-effect
Previous studies have demonstrated a significant reduction in the oral bioavailability of trovafloxacin and @DRUG$ when administered concomitantly with an intravenous opiate such as @DRUG$.	DDI-mechanism
Medicines that may alter the plasma concentration of imatinib Medicines that may increase the plasma concentration of imatinib: Caution should be exercised when administering imatinib @DRUG$ with inhibitors of the CYP3A4 family ( e.g. , ketoconazole , itraconazole , erythromycin , @DRUG$ ) .	DDI-advise
@DRUG$ and @DRUG$ exert additive ocular and renal vasodilator effects on healthy humans.	DDI-false
Cyclosporin, digoxin, methotrexate lodine, like others @DRUG$ Effects on renal prostaglandins may cause changes in the elimination of these medicinal products to increase serum levels. @DRUG$ , digoxin , methotrexate , and increased toxicity .	DDI-mechanism
Carbamazepine : Isoniazid is known to slow the metabolism of @DRUG$ and increase its serum levels @DRUG$ levels should be determined prior to concurrent administration with isoniazid , signs and symptoms of carbamazepine toxicity should be monitored closely , and appropriate dosage adjustment of the anticonvulsant should be made .	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: @DRUG$ increases the effect of Tricyclic antidepressants	DDI-false
However, in the second study, administration of 12 g @DRUG$ 1 hour before the evening meal and 0.3 mg @DRUG$ approximately 4 hours after the same evening meal resulted in a decrease in the cerivastatin AUC of less than 8%, and a decrease in Cmax of about 30% when compared to dosing cerivastatin sodium alone.	DDI-mechanism
Nevertheless, clinical studies, as well as postmarketing observations have shown that @DRUG$ can reduce the natriuretic effect of @DRUG$ and thiazides in some patients.	DDI-effect
Other Cardiovascular Agents : Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents , @DRUG$ , nitrates, calcium blockers, hydralacin, @DRUG$ and digoxin without evidence of clinically significant adverse interactions .	DDI-false
however, no deleterious interactions were seen when @DRUG$ was administered after narcotics, inhalational @DRUG$, muscle relaxants and muscle relaxant antagonists administered in conjunction with sedation or anesthesia.	DDI-false
Previous studies have demonstrated a significant reduction in the oral bioavailability of trovafloxacin and ciprofloxacin when administered concomitantly with an intravenous @DRUG$ such as @DRUG$.	DDI-false
In vitro binding studies with human serum proteins show that glipizide binds differently than @DRUG$ And don't interact with Salicylat or @DRUG$.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and @DRUG$ , in particular, dacarbazine, cis-platinum, @DRUG$ and interferon-alfa .	DDI-false
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., narcotics, analgesics, @DRUG$, sedatives, @DRUG$).	DDI-false
Steady-state serum concentrations of @DRUG$ are reported to fluctuate significantly when @DRUG$ is either added or deleted from the drug regimen.	DDI-mechanism
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, @DRUG$, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus @DRUG$) without receiving antiretroviral therapy.	DDI-false
@DRUG$ , including @DRUG$ , may enhance the effects of oral anticoagulants , including warfarin or its derivatives or similar agents .	DDI-false
Antidepressants, @DRUG$ @DRUG$ may enhance the activity of tricyclic antidepressants or sympathomimetic agents;	DDI-false
@DRUG$: The rate and extent of absorption of ciprofloxacin was bioequivalent when Proquin XR was given alone or when Proquin XR was given 2 hours after @DRUG$ at the dose that maximally suppresses gastric acid secretion.	DDI-false
Antiarrhythmics : Amiodarone , @DRUG$ , flecainide , @DRUG$ , quinidine CONTRAINDICATED due to potential for serious and/or life-threatening reactions .	DDI-false
Then, the effects of metabotropic glutamate receptor (mGluR) agonists, DCG-IV and @DRUG$, on the above behavioral changes induced by @DRUG$ were found.	DDI-false
@DRUG$ : @DRUG$ Increase the adrenergic effect of norepinephrine.	DDI-false
@DRUG$-A @DRUG$ With lithium was not performed.	DDI-false
Antihypertensives : @DRUG$ should be used with caution in patients receiving   -@DRUG$ blocking agents ( e.g. , propranolol , a CYP3A4 inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a CYP3A4 substrate , and diltiazem , a CYP3A4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and AV block ;	DDI-false
@DRUG$ Because of the relationship between Accutane and @DRUG$ , patients should be advised against taking vitamin supplements containing vitamin A to avoid additive toxic effects	DDI-false
The effects of ruthenium red ( @DRUG$ ) on @DRUG$ The reactions induced with InsP(3) were studied in combination with Fura-2 microfluorometry on megacaryocytes of the rat's bone marrow with the patch-clamp whole cell recording technique.	DDI-false
Bacteriostatic Antibiotics: Chloramphenicol, @DRUG$, sulfonamides, or tetracyclines may interfere with the bactericidal effect of @DRUG$.	DDI-effect
In a comparison of @DRUG$ The tolerance in dogs stunned with ketamine, Innovar Vet, or pentobarbital, was the dosage of Ouabain needed to cause ventricular tachycardia significantly higher, such as the LD50 of Ouabain, with @DRUG$ or Innovar than with pentobarbital .	DDI-false
@DRUG$/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered @DRUG$ (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
Adequate monitoring of @DRUG$ Plasma concentrations should be considered if treatment with: @DRUG$ Theophylline therapy is initiated or altered in patients receiving theophylline.	DDI-false
These drugs include the @DRUG$ and other diuretics, corticosteroids, @DRUG$ , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .	DDI-false
@DRUG$ serum levels should be monitored and appropriate dose adjustments considered for patients given both theophylline and @DRUG$.	DDI-false
These drugs include the @DRUG$ and other diuretics, corticosteroids, @DRUG$, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Administration to outpatients The effects of @DRUG$ may wear off before a @DRUG$ The body is completely cleared.	DDI-false
While all the selective serotonin reuptake inhibitors ( SSRIs ) , e.g. , @DRUG$ , escitalopram , @DRUG$ , sertraline, and paroxetine, inhibit P450 2D6, they may vary in extent of inhibition.	DDI-false
Interaction with phenytoin, @DRUG$ and @DRUG$ has also been reported to produce adverse clinical effects.	DDI-false
Drugs That Inhibit CYP3A4 (@DRUG$) CYP3A4 is a major metabolic pathway for elimination of @DRUG$.	DDI-false
@DRUG$ ( 5 mg/ kg ), moclobemid ( 30 mg/ kg ), clonazepam ( 0.25 mg/ kg ), fluoxetine ( 20 mg/ kg ) @DRUG$ 30 mg/ kg) or vehicle.	DDI-false
In clinical studies performed with @DRUG$ , the concomitant use of oral anticoagulants ( warfarin ) , platelet inhibitors ( acetylsalicylic acid ) , NSAIDs ( piroxicam ) , and @DRUG$ The pharmacokinetics/pharmacodynamics of fondaparinux sodium were not significantly affected.	DDI-false
The possibility of hypotensive effects with enalapril or @DRUG$ The treatment can be either by stopping the diuretic or by increasing the intake of salt before starting treatment with @DRUG$ or enalaprilat .	DDI-false
These results would seem to dictate against the clinical use of @DRUG$ with @DRUG$, or during the period following ELSPAR therapy when plasma asparagine levels are below normal.	DDI-advise
- @DRUG$ ( e.g. , @DRUG$ ) or	DDI-false
· High dose cyclosporin A with concentrations above 2000 ng/ml administered with oral @DRUG$ has led to an 80 % increase in @DRUG$ Exposure with a 38% decrease in total body clearance of etoposide compared to etoposide alone.	DDI-false
Example inhibitors include azole antifungals, @DRUG$, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, @DRUG$, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
The administration of local @DRUG$ • contains epinephrine or norepinephrine for patients receiving monoamine oxidase inhibitors, or @DRUG$ For this reason, severe, prolonged hypertension can arise.	DDI-false
BACKGROUND : The effects of the combined administration of bombsin and @DRUG$ ( @DRUG$ A calcium channel blocker, the incidence of peritoneal metastasis of intestinal adenocarcinoma induced by azoxymethane (AOM) and the index of colorectal cancers were studied in male Wistar rats.	DDI-false
The administration of local anesthetic solutions containing epinephrine or @DRUG$ to patients receiving monoamine oxidase inhibitors, @DRUG$ or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-effect
The effects of @DRUG$ (@DRUG$) on inositol 1,4,5-trisphosphate (InsP(3))-induced responses were studied in rat bone marrow megakaryocytes with the patch-clamp whole-cell recording technique in combination with fura-2 microfluorometry.	DDI-false
Vitamin A : Because of the relationship between Accutane and Vitamin A, patients should be recommended from taking it @DRUG$ containing @DRUG$ To avoid additive toxic effects	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, @DRUG$, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$: rifampin CONTRAINDICATED since the coadministration of this product with @DRUG$ in an antiretroviral regimen reduces the plasma concentrations of saquinavir.	DDI-false
@DRUG$ and indinavir : Upon concomitant administration of 5 mg of Vardenafil with 600 mg BID ritonavir , the Cmax and AUC of @DRUG$ were reduced by approximately 20 % .	DDI-false
Other concomitant therapy Although no specific interaction studies have been conducted, 1 mg or more of finasteride doses have been used in clinical trials with acetaminophen, acetylsalicylic acid, A-blockers, @DRUG$ , angiotensin-converting enzyme ( ACE ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , H2 antagonists , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and @DRUG$ Without evidence of clinically significant adverse interactions.	DDI-false
In addition to the interactions noted above, chronic (  2 weeks) oral @DRUG$ administration impairs metabolism of @DRUG$, dextromethorphan, and methotrexate.	DDI-false
Plasma @DRUG$ concentration should be monitored when @DRUG$ and valproate are co administered, and appropriate dosage adjustments of valproate should be made.	DDI-false
@DRUG$ should not be used concomitantly with @DRUG$ because of the possibility of ototoxicity.	DDI-advise
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
The availability of potent @DRUG$ (NNRTI)-based regimens for @DRUG$ therapy and concerns regarding protease inhibitor (PI)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection.	DDI-false
In the present study, the @DRUG$ @DRUG$ was tested in combination with an active dose of PCP in two-lever drug discrimination and mixed signalled-unsignalled differential-reinforcement-of-low-rates ( DRL ) procedures .	DDI-false
It is structurally distinct from the other currently available HMGCoA reductase inhibitors ( lovastatin , @DRUG$ , and @DRUG$ ) , leading to unique biopharmaceutical properties relative to the other agents of this class .	DDI-false
Short-term pharmacokinetic studies have demonstrated that concomitant administration of @DRUG$ and @DRUG$   ( etodolac capsules and tablets ) results in reduced protein binding of warfarin , but there was no change in the clearance of free warfarin .	DDI-mechanism
The administration of local anesthetic solutions containing epinephrine or @DRUG$ to patients receiving monoamine oxidase inhibitors, tricyclic antidepressants or @DRUG$ may produce severe, prolonged hypotension or hypertension.	DDI-effect
Potential pharmacokinetic interactions have been studied in clinical pharmacokinetic studies ( @DRUG$ , valproate, orally @DRUG$ , digoxin, warfarin, probenecid) and pharmacokinetic screening in placebo-controlled clinical trials in epilepsy patients.	DDI-false
Potential drug interactions between @DRUG$ AEDs and other AEDs (carbamazepine, gabapentin, @DRUG$ , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies .	DDI-false
Elevated serum levels of @DRUG$ have been reported with concomitant use of cyclosporine with @DRUG$.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed , @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ACE ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , H2 antagonists , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as @DRUG$ In addition, quinolones anti-infections with no evidence of clinically significant adverse interactions.	DDI-false
Therefore, interactions may occur after concomitant administration of psychotropic medicinal products (e. g. @DRUG$ , analgesics, antiemetics, sedatives, @DRUG$ ) .	DDI-false
Antipyrine: Because @DRUG$ does not affect the pharmacokinetics of antipyrine, interactions with other @DRUG$ metabolized via the same cytochrome isozymes are not expected.	DDI-false
@DRUG$/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Stavudine and @DRUG$ Ribavirin can antagonize the in vitro antiviral activity of stavudine and @DRUG$ against HIV.	DDI-false
@DRUG$ , like verapamil, @DRUG$ and nifedipine , inhibit platelet activation in vitro , and decrease platelet adhesion intravascularly .	DDI-false
Short-term pharmacokinetic studies have demonstrated that concomitant administration of warfarin and Lodine   ( etodolac capsules and tablets ) results in reduced protein binding of @DRUG$ However, there was no change in the release of free @DRUG$.	DDI-false
@DRUG$ It can cause acidic drugs such as phenytoin or @DRUG$ From their binding sites.	DDI-mechanism
Digoxin : In controlled studies of healthy volunteers, @DRUG$ 2 studies) in steady-state serum @DRUG$ concentrations .	DDI-mechanism
Other concomitant therapies : In clinical trials, the safety profile in patients with acamprosate concomitantly with @DRUG$ Hypnotic agents and sedatives (including benzodiazepines) or @DRUG$ was similar to that of subjects taking placebo with these concomitant medications .	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of @DRUG$ 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (alcohol, barbiturates, opiates, sedatives, @DRUG$) should be considered.	DDI-advise
John s wort) may increase the formation of @DRUG$, a metabolite of @DRUG$ associated with hemolysis.	DDI-false
Medicines detected as CYP3A inhibitors of possible clinical significance based on clinical studies @DRUG$ Co-administration of fluoxetine and alprazoleam increased the maximum plasma concentration of @DRUG$ by 46 % , decreased clearance by 21 % , increased half-life by 17 % , and decreased measured psychomotor performance .	DDI-false
The administration of local @DRUG$ containing epinephrine or @DRUG$ to patients receiving monoamine oxidase inhibitors, tricyclic antidepressants or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-false
@DRUG$ is metabolized to @DRUG$ by the cytochrome P450 (CYP450) enzyme group, specifically cytochromes P450 3A4 (CYP3A4) and CYP2C8.	DDI-false
These drugs include: @DRUG$ and other diuretics, @DRUG$ , phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blockers and isonazide.	DDI-false
@DRUG$: Amphetamines may delay intestinal absorption of @DRUG$;	DDI-false
Both ibogaine and @DRUG$ block @DRUG$-induced and nicotine-induced dopamine release in the nucleus accumbens;	DDI-effect
Antihypertensives : @DRUG$ should be used with caution in patients receiving   -receptor blocking agents ( e.g. , @DRUG$ , a CYP3A4 inhibitor ) or calcium channel antagonists (e.g. verapamil, a CYP3A4 substrate and diltiazem, a CYP3A4 inhibitor ) because of the potential for bradycardia, sinus arrest and AV block;	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus @DRUG$) without receiving antiretroviral therapy.	DDI-false
@DRUG$ Amiodarone should be used with caution in patients who are receptor blockers (e.g. propranolol, CYP3A4 inhibitor) or calcium channel antagonists (e.g. @DRUG$ , a CYP3A4 substrate and diltiazem, a CYP3A4 inhibitor ) because of the potential for bradycardia, sinus arrest and AV block;	DDI-false
A drug-drug interaction study evaluated the effect of the use of @DRUG$ Gel, 5%, in combination with double strength (160 mg/800 mg) @DRUG$/sulfamethoxazole (TMP/SMX).	DDI-false
@DRUG$, or other products containing iron or zinc, antacids or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of @DRUG$.	DDI-false
@DRUG$, or other products containing iron or @DRUG$, antacids or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.	DDI-false
Monoamine Oxidase Inhibitors and @DRUG$: @DRUG$ should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-false
No important interactions to date @DRUG$ There are no clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, @DRUG$ , warfarin, isosorbide mononitrate, knitztilol, ethanol or itraconazole.	DDI-false
These medicines include thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, orally @DRUG$ , phenytoin , @DRUG$ , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .	DDI-false
@DRUG$: Lithium toxicity has been reported in patients receiving lithium concomitantly with drugs which cause elimination of sodium, including @DRUG$.	DDI-false
Consequently, drugs with a low therapeutic margin, such as @DRUG$, @DRUG$, and theophylline, could have a delayed elimination and increases in their serum half-life leading to a toxic level.	DDI-false
ACE inhibitors: Reports suggest that @DRUG$ may diminish the antihypertensive effect of @DRUG$.	DDI-effect
@DRUG$ , @DRUG$ Azole is known to cause QTc prolongation.	DDI-false
@DRUG$ had a similar effect in the presence of @DRUG$.	DDI-false
Drugs That Induce CYP3A4 ( Rifampicin ) Racemic @DRUG$ The exposure was increased by 80 % by the concomitant use of @DRUG$ , a potent inducer of CYP3A4 .	DDI-mechanism
@DRUG$ may suppress certain CYP450 enzymes , including CYP1A2 , @DRUG$ , CYP2D6 , and CYP3A4 .	DDI-false
BACKGROUND: The effects of combined administration of @DRUG$ and verapamil hydrochloride (verapamil), a @DRUG$, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane (AOM) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
Medicines detected as CYP3A inhibitors of a possible clinical significance based on clinical trials involving alprazoleam ( Caution is recommended when co-administered with alprazoleam): @DRUG$ with @DRUG$ increased the maximum plasma concentration of alprazolam by 46 % , decreased clearance by 21 % , increased half-life by 17 % , and decreased measured psychomotor performance .	DDI-mechanism
@DRUG$ and @DRUG$ (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (ACEI/ARB).	DDI-false
Benzthiazide can interact with alcohol, blood thinners, @DRUG$ ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , @DRUG$ , NSAIDs such as Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
Antiarrhythmics : Other antiarrhythmic drugs , such as quinidine , @DRUG$ , disopyramide , and phenytoin , have been used concurrently with @DRUG$.	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride, including anti-arrhythmic agents such as quinidine and procainamide, @DRUG$ and @DRUG$.	DDI-false
Antimycobacterial Agents: @DRUG$ CONTRAINDICATED since the coadministration of this product with saquinavir in an @DRUG$ regimen reduces the plasma concentrations of saquinavir.	DDI-false
Other Cardiovascular Agents: @DRUG$ and @DRUG$ IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
These drugs include the thiazides and other diuretics , @DRUG$ , phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, @DRUG$ , calcium channel blocking drugs , and isoniazid .	DDI-false
@DRUG$ decreased the hyperuricemic effect of @DRUG$.	DDI-effect
@DRUG$ and @DRUG$ Interaction pharmacologically with orally administered anticoagulants, but the effect is not clinically significant.	DDI-false
Anticholinesterases ( neostgmine, physostigmine), @DRUG$ , quinine , @DRUG$ can enhance toxicity and cause cardio respiratory depression .	DDI-false
• Isoflurane potentiates the muscle relaxant effect of all @DRUG$ , most notably @DRUG$ MAC (minimum alveolar concentration) is reduced by the concomitant use of N 2O.	DDI-false
Naproxen: The concomitant administration of @DRUG$ and @DRUG$ in normal volunteers had no effect on the plasma levels of naproxen, but significantly decreased the urinary excretion of naproxen and its glucuronide metabolite.	DDI-mechanism
Antihistamines : @DRUG$ * , @DRUG$ * CONTRAINDICATED due to the potential for serious and/or life-threatening cardiac arrhythmias.	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or @DRUG$, calcium channel blockers, @DRUG$ or H1-blocking agents, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-false
Corticosteroids, Methylxanthines and Diuretics: Concomitant treatment with xanthine derivatives, @DRUG$, or @DRUG$ may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
- Anabolic steroids (nandrolone [e.g., Anabolin], @DRUG$ [e.g., Anavar], @DRUG$ [e.g., Anadrol], stanozolol [e.g., Winstrol]) or	DDI-false
Drug Interactions : Flupenthixol may interact with some drugs , like Monoamine oxidase inhibitors ( MAOI ): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol : Flupenthixol and @DRUG$ cause additive CNS depression - @DRUG$ Flupentixol increases the effect of tricyclic antidepressants	DDI-false
The concomitant use of cholestyramine and @DRUG$ The absorption of vitamin K can be reduced.	DDI-false
@DRUG$ : The rate and extent of absorption of @DRUG$ The bioequivalent was when Proquin XR was given alone or when Proquin XR was administered 2 hours after omeprazole at the dose that suppresses gastric acid secretion maximum.	DDI-false
ACE Inhibitors and @DRUG$ 3020 (91%) patients receiving INSPRA 25 to 50 mg also received @DRUG$ Angiotensin II receptor antagonists ( ACEI/ ARB).	DDI-false
Concurrent administration of @DRUG$ ( for the treatment of hypotension related to obstetric blocks ) and @DRUG$ may cause severe , persistent hypertension or cerebrovascular accidents .	DDI-effect
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
- @DRUG$ ( e.g. , @DRUG$ ) or	DDI-false
@DRUG$ : Potentiation of warfarin-type ( @DRUG$ The anticoagulant response is almost always observed in patients receiving amiodarone and may lead to severe or fatal bleeding.	DDI-false
The possibility of hypotensive effects with captopril can be minimized by either @DRUG$ About one week before the start of treatment with @DRUG$ (Captopril tablets, USP) or initiation of small doses (6.25 or 12.5 mg).	DDI-false
Acetaminophen/theophylline, lidocaine/chinidine, phenobarbital/@DRUG$, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen and valproic acid/phenobarbital.	DDI-false
Atorvastatin plasma concentrations decreased approximately 25% if: @DRUG$ and @DRUG$ were coadministered .	DDI-mechanism
Antiarrhythmics: Other antiarrhythmic drugs, such as @DRUG$, procainamide, @DRUG$, and phenytoin, have been used concurrently with amiodarone.	DDI-false
To assess the effect of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL), the authors retrospectively compared a group of 24 patients with HIV-NHL treated with cyclophosphamide, doxorubicin, @DRUG$ , and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or with a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide and prednisone). @DRUG$ Bleomycin) without antiretroviral therapy.	DDI-false
Drugs With A Narrow Therapeutic Index @DRUG$ A single dose of eszopiclone 3 mg did not affect the pharmacokinetics of @DRUG$ measured at steady state following dosing of 0.5 mg twice daily for one day and 0.25 mg daily for the next 6 days.	DDI-false
Nursing Mothers It is not known whether @DRUG$ or @DRUG$ or its components are excreted in human milk.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, @DRUG$, and prednisone with vincristine plus bleomycin) without receiving @DRUG$ therapy.	DDI-false
Compounds tested in humans include antipyrin, @DRUG$ , propranolol , theophylline , and @DRUG$ No clinically significant interactions were found.	DDI-false
Examples of inhibitors are azole antimycotics, ciprofloxacin, clarithromycin, @DRUG$ , doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, @DRUG$ , quinidine , and verapamil .	DDI-false
Anticoagulants: @DRUG$ type potentiation ( CYP2C9 and CYP3A4 substrate ) Anticoagulants response is almost always observed in patients who: @DRUG$ and can result in serious or fatal bleeding .	DDI-false
Another oral @DRUG$ ketoconazole inhibits the metabolism of astemizole, resulting in increased plasma concentrations of @DRUG$ The active metabolite desmethylastermizole may prolong the QT interval.	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase @DRUG$ plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., @DRUG$, itraconazole, erythromycin, clarithromycin).	DDI-false
• Amiodarone together with @DRUG$ increases @DRUG$ The serum concentration by 33% after two days.	DDI-false
Other Cardiovascular Agents: Enalapril and @DRUG$ IV have been used concomitantly with beta adrenergic-blocking agents, @DRUG$, nitrates, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Potential pharmacokinetic interactions have been reported in clinical pharmacokinetic studies (phenytoin, valproate, oral contraceptive drug, @DRUG$ , warfarin , @DRUG$ ) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients .	DDI-false
@DRUG$ : @DRUG$ Caution should be exercised in patients receiving receptor blockers (e.g. propranolol, CYP3A4 inhibitor) or calcium channel antagonists (e.g. verapamil, CYP3A4 substrates and diltiazem, CYP3A4 inhibitor) due to the possible increase in bradycardia, sinus arrest and AV block.	DDI-false
Levosimendan has no clinically important pharmacokinetic interactions with captopril, @DRUG$ , @DRUG$ , digoxin, warfarin, isosorbide mononitrate, schnitztilol, ethanol or itraconazole.	DDI-false
The aim of this paper was to investigate the interaction between neurotensin and both. @DRUG$ or its synthetic analogue @DRUG$ , or tuftsin, the anti-non-ciceptive effect of these peptides in mice after intracistern injection.	DDI-false
Examples of inhibitors are azole antimycotics, ciprofloxacin, clarithromycin, @DRUG$ , doxycycline, erythromycin, imatinib, isoniazid, @DRUG$ , nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Medicines detected as CYP3A inhibitors of possible clinical significance based on clinical studies @DRUG$ Caution is recommended when co-administered with alprazolem: @DRUG$ with alprazolam increased the maximum plasma concentration of alprazolam by 46 % , decreased clearance by 21 % , increased half-life by 17 % , and decreased measured psychomotor performance .	DDI-false
Bacteriostatic Antibiotics: @DRUG$, @DRUG$, sulfonamides, or tetracyclines may interfere with the bactericidal effect of penicillins.	DDI-false
@DRUG$, Methylxanthines and @DRUG$: Concomitant treatment with xanthine derivatives, steroids, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed , @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ACE ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , @DRUG$ , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
These drugs include thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, @DRUG$ , oral contraceptives, @DRUG$ , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac @DRUG$, @DRUG$, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, warfarin, @DRUG$, @DRUG$, ethanol or itraconazole.	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or @DRUG$, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or @DRUG$ than with pentobarbital.	DDI-false
Anticoagulants including coumarin derivatives, indandione derivatives, and @DRUG$ such as nonsteroidal anti-inflammatory drugs (NSAIDs), and @DRUG$ may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
Specific studies have confirmed these effects with sevoflurane, isoflurane. @DRUG$ , @DRUG$ , and midazolam.	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine , Innovar Vet , or pentobarbital , the dosage of @DRUG$ The need to cause ventricular tachycardia was significantly higher than the LD50 of ouabain, with @DRUG$ Or Innovar as with Pentobarbital.	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, Dapson, disopyramide, quinine, @DRUG$ , quinidine, warfarin, tacrolimus, cyclosporin, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$ When co-administered with saquinavir, increased plasma concentrations may occur;	DDI-false
@DRUG$ : Eszopiclone 3 mg administered daily for 5 days did not affect the pharmacokinetics of@DRUG$n , nor were there any changes in the pharmacodynamic profile ( prothrombin time ) following a single 25 mg oral dose of warfarin	DDI-false
Other Drugs:Drugs such as quinidine, disopyramide, @DRUG$, phenothiazines, @DRUG$, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
Antihypertensives : @DRUG$ should be used with caution in patients receiving   -receptor blocking agents ( e.g. , propranolol , a CYP3A4 inhibitor ) or calcium channel antagonists ( e.g. , @DRUG$ , a CYP3A4 substrate and diltiazem, a CYP3A4 inhibitor ) because of the potential for bradycardia, sinus arrest and AV block;	DDI-false
Prednisone/Prednisolone : rofecoxib had no clinically important effect on the pharmacokinetics of @DRUG$ or @DRUG$.	DDI-false
For treatment with CYP3A4 inhibitors (such as ketoconazole, intraconazole, @DRUG$ , indinavir , saquinavir , erythromycin , etc . ) is indicated , reduction of the @DRUG$ dose should be considered .	DDI-advise
To assess the effect of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL), the authors retrospectively compared a group of 24 patients with HIV-NHL treated with cyclophosphamide, doxorubicin, vincristine, and @DRUG$ ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , @DRUG$ , doxorubicin , teniposide , and prednisone with vincristine plus bleomycin ) without receiving antiretroviral therapy .	DDI-false
Data from in vitro studies of alprazolam suggest a possible drug interaction with @DRUG$ for the following: @DRUG$ and paroxetine.	DDI-int
Example inhibitors include azole antifungals, @DRUG$, clarithromycin, diclofenac, @DRUG$, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
This drug may interact with alcohol or other @DRUG$ (may potentiate the CNS depressant effects of either these medications or @DRUG$), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
Imipramine ( 5 mg/kg ) , @DRUG$ ( 30 mg/kg ) , clonazepam ( 0.25 mg/kg ) , @DRUG$ ( 20 mg/kg ) sertraline ( 30 mg/kg ) or vehicle was administered .	DDI-false
Exacerbation or the initial presentation of a number of autoimmune and inflammatory disorders has been observed following concurrent use of @DRUG$ and @DRUG$, including crescentic IgA glomerulonephritis, oculo-bulbar myasthenia gravis, inflammatory arthritis, thyroiditis, bullous pemphigoid, and Stevens-Johnson syndrome.	DDI-effect
Ergot Derivatives : @DRUG$ , @DRUG$ , ergotamine , methylergonovine CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues .	DDI-false
Therefore, @DRUG$ serum levels should be monitored and appropriate @DRUG$ dosage adjustments made when these drugs are used concomitantly.	DDI-false
@DRUG$ and Tricyclic Antidepressants: @DRUG$ should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-false
Although other @DRUG$ are highly effective , there have been reports of pregnancy from women who have used @DRUG$ As well as topical/injectable/implantable/inertable hormonal birth control products.	DDI-false
It is therefore necessary to be familiar with the clinical and paraclinical pattern of the magnesium deficit and between @DRUG$ deficiency due to an insufficient magnesium intake which only requires oral physiological supplementation and @DRUG$ depletion related to a dysregulation of the control mechanisms of magnesium status which requires more or less specific regulation of its causal dysregulation .	DDI-false
Antimycobacterial agents : rifampin, which has been used since the concomitant use of this medicinal product with @DRUG$ in an antiretroviral regimen reduces the plasma concentrations of @DRUG$.	DDI-false
The use of local anesthetics containing epinephrine, or @DRUG$ Patients receiving monoamine oxidase inhibitors, or @DRUG$ For this reason, severe, prolonged hypertension can arise.	DDI-effect
Nevertheless, clinical studies, as well as postmarketing observations have shown that Lodine can reduce the natriuretic effect of @DRUG$ and @DRUG$ in some patients.	DDI-false
Although no studies have been conducted, concomitant administration of @DRUG$ and phenytoin may alter the metabolism of @DRUG$;	DDI-false
Co-administration of @DRUG$ and @DRUG$ The pharmacokinetics of cerivastatin sodium have not changed.	DDI-false
@DRUG$ may increase sensitivity to the @DRUG$.	DDI-effect
Antihypertensives: @DRUG$ should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a @DRUG$ substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
This interaction should be given consideration in patients taking @DRUG$ concomitantly with @DRUG$.	DDI-advise
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ACE ) inhibitors , @DRUG$ , benzodiazepines, beta-blockers, calcium channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also known as NSAIDs), and @DRUG$ Without evidence of clinically significant adverse interactions.	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, Dapson, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$ , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with @DRUG$ ;	DDI-mechanism
@DRUG$: In an interaction study of rheumatoid arthritis patients taking methotrexate, CELEBREX did not have a significant effect on the pharmacokinetics of @DRUG$.	DDI-false
Monoamine Oxidase Inhibitors and Tricyclic Antidepressants : @DRUG$ should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or @DRUG$ because the action of formoterol on the cardiovascular system may be potentiated by these agents .	DDI-advise
Multivitamins or other products which: @DRUG$ or zinc , @DRUG$ or sucralfate should not be administered concomitantly with , or within 2 hours of , the administration of norfloxacin , because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin .	DDI-false
@DRUG$ and glutethimide should not be administered to patients receiving @DRUG$.	DDI-advise
In rats, simultaneous ingestion of disulfiram and nitrite in the diet for 78 weeks has been reported to cause tumors, and it has been suggested that @DRUG$ may react with @DRUG$ in the rat stomach to form a nitrosamine, which is tumorigenic.	DDI-effect
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of @DRUG$ , @DRUG$ Niacin (nicotinic acid), erythromycin, azole antimycotics.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, @DRUG$, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other @DRUG$ , amantadine , haloperidol , phenothiazines , monoamine oxidase ( MAO ) inhibitors , @DRUG$ Or some antihistamines.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (@DRUG$): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - @DRUG$: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Examples of inhibitors are azole antimycotics, ciprofloxacin, clarithromycin, diclofenac, doxycycline, @DRUG$ , imatinib , isoniazid , @DRUG$ , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .	DDI-false
In a comparison of digital tolerance in dogs stunned with ketamine, Innovar Vet, or pentobarbital, the dosage of @DRUG$ The need to cause ventricular tachycardia was significantly higher, as was the LD50 of Ouabain, with ketamine or @DRUG$ As with Pentobarbital.	DDI-false
Agents Causing Renin Release: The antihypertensive effect of @DRUG$ and @DRUG$ IV is augmented by antihypertensive agents that cause renin release (e.g., diuretics).	DDI-false
Because of the potential for adverse reactions from the drugs in nursing infants, a decision must be made whether to discontinue nursing or discontinue @DRUG$ and @DRUG$ treatment.	DDI-false
@DRUG$, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain @DRUG$, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-mechanism
@DRUG$: @DRUG$ interferes with renal tubular secretion of ciprofloxacin and produces an increase in the level of ciprofloxacin in serum.	DDI-false
In clinical studies with fondaparinux, the concomitant use of oral anticoagulants ( @DRUG$ ) , platelet inhibitors ( acetylsalicylic acid ) , NSAIDs ( piroxicam ) , and @DRUG$ did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium .	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , @DRUG$ , sulphonamides, chloramphenicol, probenecid, @DRUG$ , monoamine oxidase inhibitors, and beta-adrenergic blockers.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
This appears to be the only clinically relevant interaction of this kind with @DRUG$ , although theoretically , coadministration of other drugs known to alter cardiac conduction ( eg , anti-arrhythmic or beta-adrenergic blocking agents , @DRUG$ , antihistamines or H1-blocking agents , tricyclic antidepressants and phenothiazines ) might also contribute to a prolongation of the QTc interval .	DDI-effect
@DRUG$: In diabetic patients receiving diflunisal and @DRUG$, no significant effects were seen on tolbutamide plasma levels or fasting blood glucose.	DDI-false
@DRUG$ and procainamide doses should be reduced by one-third when either is administered with @DRUG$.	DDI-false
omeprazole : The rate and extent of absorption of @DRUG$ If Proquin XR was given alone or if: @DRUG$ was given 2 hours after omeprazole at the dose that maximally suppresses gastric acid secretion .	DDI-false
If cholinergic blockades occur, additive undesirable effects may occur if: @DRUG$ is administered concomitantly with other antimuscarinics , amantadine , @DRUG$ , phenothiazines , monoamine oxidase ( MAO ) inhibitors , tricyclic antidepressants or some antihistamines .	DDI-effect
Other concomitant therapy Although no specific interaction studies have been conducted, 1 mg or more of finasteride doses have been reported in clinical trials with acetaminophen, acetylsalicylic acid, A-blockers, analgesics, angiotensin converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, @DRUG$ Calcium channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also known as NSAIDs) and @DRUG$ Without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ Meclofenamate sodium increases the effect of @DRUG$.	DDI-false
Severe hypoglycemia has been reported in patients concomitantly receiving @DRUG$ and oral @DRUG$.	DDI-effect
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, @DRUG$) effects with @DRUG$ may increase toxicity in these organ systems.	DDI-effect
@DRUG$ FORADIL should be used with extreme caution in patients treated with monoamine oxidase inhibitors or tricyclic antidepressants, as the effect of @DRUG$ On the cardiovascular system can be potentiated by these active substances.	DDI-false
acetaminophen/theophylline, @DRUG$/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$ Amphetamines can counteract the sedative effect of @DRUG$.	DDI-false
@DRUG$ : Co- administration of warfarin and cerivastatin to healthy volunteers did not result in any changes in prothrombin time or clotting factor VII when compared to co-administration of @DRUG$ and placebo .	DDI-false
Compounds that have been tested in man include @DRUG$ , digoxin , propranolol , theophylline , and @DRUG$ and no clinically meaningful interactions were found .	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a @DRUG$, including ciprofloxacin, with multivalent cation-containing products such as magnesium or @DRUG$ antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
Potassium-sparing diuretics ( e.g. , spironolactone , triamterene , or amiloride ) , @DRUG$ Food supplements or salt substitutes containing @DRUG$ may lead to a significant increase in serum potassium.	DDI-false
Moreover, additional interaction studies with niacin and @DRUG$ have not demonstrated any effect on fluvastatin plasma levels, and administration to a patient population chronically receiving digoxin resulted in no difference in the extent of bioavailability of @DRUG$ relative to control data.	DDI-false
Prednisone/prednisolone: @DRUG$ did not have any clinically important effect on the pharmacokinetics of @DRUG$ or prednisone.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ACE ) inhibitors , anticonvulsants , @DRUG$ , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , H2 antagonists , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as @DRUG$ In addition, quinolones anti-infections with no evidence of clinically significant adverse interactions.	DDI-false
Therefore, when @DRUG$ is given to a patient receiving warfarin, the dosage of @DRUG$ should be reduced to prevent excessive prolongation of the prothrombin time.	DDI-false
No significant interactions were found between nisoldipine and @DRUG$ or @DRUG$.	DDI-false
Acetaminophen , @DRUG$ , @DRUG$ , quinidine, theophylline, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
Anticoagulants including coumarin derivatives, indandion derivatives and @DRUG$ Like non-steroidal anti-inflammatory drugs (NSAIDs) and aspirin, the risk of bleeding can be increased when administered at the same time as @DRUG$.	DDI-effect
These drugs include the thiazides and other diuretics, @DRUG$, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Possible drug interactions between Keppra and other AEDs (carbamazepine, @DRUG$ , lamotrigine , phenobarbital , phenytoin , @DRUG$ and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies .	DDI-false
However, a crossover study in healthy subjects receiving either @DRUG$ 300 mg q.i.d. or 800 mg h.s. concomitantly with a 300 mg b.i.d. dosage of theophylline (Theo-Dur , Key Pharmaceuticals, Inc.) demonstrated less alteration in steady-state @DRUG$ peak serum levels with the 800 mg h.s. regimen, particularly in subjects aged 54 years and older.	DDI-false
@DRUG$: Cimetidine has been reported to produce clinically significant fluctuations in steady-state serum concentrations of various @DRUG$.	DDI-false
Aspirin/Acetaminophen : Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between @DRUG$ 1 g/kg/min for 4 hours) or acetaminophene (1000 mg orally administered 12, 6 and 0 hours before and 6 and 12 hours after the start of treatment) or acetaminophene (1000 mg orally administered 12, 6 and 0 hours before and 12 hours after the start of treatment). @DRUG$ 1.5   g/kg/min . over 18 hours ) .	DDI-false
Coadministration of this oral @DRUG$ did not influence the pharmacokinetics of @DRUG$.	DDI-false
In patients with mild to moderate hypertension, administration of 25 mg daily of @DRUG$ with the ACE inhibitor benazepril, 10 to 40 mg for 4 weeks, was associated with an average increase in mean arterial pressure of about 3 mm Hg compared to @DRUG$ alone.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (@DRUG$): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and @DRUG$ cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
@DRUG$ : DURAGESIC   is not recommended for use in patients who have received MAOI within 14 days because severe and unpredictable potentiation by @DRUG$ Opioid analgesics have been reported	DDI-false
These medicines include thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$ , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and @DRUG$.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
* Drug interactions : Flupentixol may interact with some drugs, such as @DRUG$ ( MAOI ): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol : Flupenthixol and Ethanol cause additive CNS depression - @DRUG$ Flupentixol increases the effect of tricyclic antidepressants	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum @DRUG$, sucralfate, @DRUG$ chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other @DRUG$ Amantadine, haloperidol, phenothiazine, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some @DRUG$.	DDI-false
@DRUG$ and colestipol resins : Absorption of @DRUG$ is impaired in the presence of anionic exchange resins .	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , @DRUG$ , fentanyl , alfentanyl , @DRUG$ When co-administered with saquinavir, increased plasma concentrations may occur;	DDI-false
Carbamazepine : @DRUG$ is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid , signs and symptoms of carbamazepine toxicity should be monitored closely , and appropriate dosage adjustment of the @DRUG$ It should be done.	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, @DRUG$, chloramphenicol, @DRUG$, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
Quetiapine fumarate ('@DRUG$') is a newly introduced @DRUG$ with demonstrated efficacy in the treatment of positive and negative symptoms of schizophrenia.	DDI-false
Glyburide: The concomitant administration of @DRUG$ with the @DRUG$ glyburide has, on rare occasions, resulted in severe hypoglycemia.	DDI-effect
Cholestyramine and @DRUG$ Resins : The absorption of hydrochlorothiazide is impaired in the presence of @DRUG$.	DDI-false
Antiarrhythmia: amiodarone, bepridil, flecainide, @DRUG$ , @DRUG$ CONTRAINDICATED due to potential for serious and/or life-threatening reactions .	DDI-false
@DRUG$ : In some patients with compromised renal function who are being treated with @DRUG$ Concomitant use of Enalapril may lead to further deterioration of renal function.	DDI-false
@DRUG$: Serious side effects and even death have been reported following the concomitant use of certain drugs with @DRUG$.	DDI-false
@DRUG$ This is inhibited by @DRUG$.	DDI-mechanism
These results suggest that both dexamethasone and dexamethasone @DRUG$ , and possibly other @DRUG$ and retinoids , may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF .	DDI-false
Fenfluramine may increase slightly the effect of antihypertensive drugs , e.g. , @DRUG$ , @DRUG$ , reserpine .	DDI-false
Nevertheless , caution is indicated in the co-administration of @DRUG$ with any of the @DRUG$ And also when changing from one class to another.	DDI-advise
These drugs include the thiazides and other diuretics , corticosteroids , @DRUG$ , thyroid products , @DRUG$ , oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel block drugs, and isoniazide.	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, @DRUG$, cefotetan, @DRUG$, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Benzthiazide can be used with @DRUG$ , blood thinners, inflammatory medications (allergy, cold, and sinus drugs), diabetes medications, lithium, norepinephrine, NSAIDs such as @DRUG$ or Ibuprofen , and high blood pressure medications .	DDI-false
Potential drug interactions between Keppra  and other @DRUG$ (carbamazepine, @DRUG$, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Oral Contraceptives : Coadministration of atorvastatin and an oral contraceptive increased AUC values for @DRUG$ and @DRUG$ - about 30% and 20%.	DDI-false
Like @DRUG$ 40 mg/kg and 18-MC ( 40 mg/kg) reduce intravenous self-administration of morphine and cocaine and oral self-administration of @DRUG$ and nicotine in rats ;	DDI-false
- Methotrexate (e.g., Mexate) Use of @DRUG$ with @DRUG$ may increase the chance of side effects affecting the liver and/or the side effects of methotrexate	DDI-effect
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, @DRUG$, @DRUG$, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Agents Causing Renin Release: The antihypertensive effect of enalapril and @DRUG$ IV is augmented by antihypertensive agents that cause renin release (e.g., @DRUG$).	DDI-effect
@DRUG$ , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , @DRUG$ , nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying the elimination and increase in blood levels of these drugs.	DDI-mechanism
Potassium-sparing diuretics (e.g., @DRUG$, triamterene, or amiloride), potassium supplements, or @DRUG$-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
Naproxen : The concomitant administration of diflunisal and naproxen in normal volunteers had no effect on the plasma levels of @DRUG$ , but significantly decreased the urinary excretion of @DRUG$ and its glucuronide metabolite .	DDI-false
Central Nervous System Depressants : The concomitant use of @DRUG$ Fentanyl transdermal system (Fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotic agents, sedatives (e.g., @DRUG$ Common anaesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may result in respiratory depression, hypotension and deep sedation, or possibly coma or death.	DDI-effect
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or @DRUG$, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with @DRUG$.	DDI-false
These drugs include thiazides and other diuretics, @DRUG$ , phe-nothiazines, thyroid products, estrogens, orally @DRUG$ , phenytoin , nicotinic acid , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .	DDI-false
Other interactions: @DRUG$ had no effect on the pharmacodynamics of glyburide (glucose and insulin concentrations) and @DRUG$ (prothrombin time or other pharmacodynamic parameters).	DDI-false
Antacids: Concomitant administration of @DRUG$ may reduce plasma levels of @DRUG$.	DDI-mechanism
Possible interactions between Keppra and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, @DRUG$ The serum concentrations of valproate and valproate have also been studied by @DRUG$ These AEDs during placebo-controlled clinical trials.	DDI-false
Particular caution is recommended when administering @DRUG$ CYP3A4 substrates with a narrow therapeutic window (e.g. cyclosporin or @DRUG$ ) .	DDI-advise
BACKGROUND: The effects of combined administration of @DRUG$ and verapamil hydrochloride (verapamil), a calcium channel blocker, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by @DRUG$ (AOM) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
These medicines include thiazides and other diuretics, corticosteroids, phe-nothiazines, @DRUG$ , @DRUG$ , oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel block drugs, and isoniazid.	DDI-false
Aspirin/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of @DRUG$ 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of @DRUG$ 1.5  g/kg/min. over 18 hours).	DDI-false
The data suggest that: @DRUG$ has a narrower spectrum of actions and will have a substantially greater therapeutic index than @DRUG$.	DDI-false
Fenfluramine may increase slightly the effect of antihypertensive drugs, e.g., @DRUG$, @DRUG$, reserpine.	DDI-false
@DRUG$ and Zidovudine Ribavirin can antagonize the in vitro antiviral activity of stavudine and @DRUG$ against HIV.	DDI-false
Other oral interactions @DRUG$ @DRUG$ The pharmacokinetics of an oral contraceptive containing 0.03 mg ethinylestradiol and 0.15 mg levonorgestrel or luteinisation hormone and progesterone levels were not affected, suggesting that contraceptive efficacy is unlikely to be impaired.	DDI-false
Other reported interactions with @DRUG$: Fentanyl (CYP3A4 substrate) in combination with @DRUG$ may cause hypotension, bradycardia, and decreased cardiac output.	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, @DRUG$ was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, @DRUG$, calcium-channel blockers, diuretics, and nonsteroidal anti-inflammatory drugs (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
DIGOXIN : Plasma @DRUG$ The steady-state concentrations and digoxin clearance were not affected by concomitant administration of 0.2 mg @DRUG$.	DDI-false
Oral @DRUG$ Co-administration of atorvastatin and oral contraceptives increased AUC values for @DRUG$ and ethinyl estradiol by approximately 30 % and 20 % .	DDI-false
Other concomitant therapy Although no specific interaction studies have been performed, clinical trials with 1 mg or more of finasteride doses have been conducted at the same time. @DRUG$ Acetylsalicylic acid, A-blockers, analgesics, angiotensin converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, @DRUG$ , calcium channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also known as NSAIDs), and quinolone anti-infections without evidence of clinically significant adverse interactions.	DDI-false
Other concomitant therapy Although no specific interaction studies have been performed, clinical trials with 1 mg or more of finasteride doses have been conducted at the same time. @DRUG$ , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ACE ) inhibitors , anticonvulsants , @DRUG$ , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , H2 antagonists , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
Although in clinical studies with IOPIDINE 0.5 % ophthalmic solution no specific drug interactions with topical glaucoma or systemic drugs have been identified, there is a possibility of additive or potentiating effects with CNS depressants (alcohol, @DRUG$ , opiates , @DRUG$ Anaesthetics) should be considered.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and @DRUG$, a @DRUG$ inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
@DRUG$: Administration of @DRUG$ concomitantly with cyclosporine has been associated with an increase in cyclosporine-induced toxicity, possibly due to decreased synthesis of renal prostacyclin.	DDI-false
The intensity, uniformity and time course of anticoagulant interference by @DRUG$, secobarbital, glutethimide, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving @DRUG$ therapy.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and @DRUG$ with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Colestipol: Plasma concentrations of @DRUG$ decreased approximately 25% when colestipol and @DRUG$ were coadministered.	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with @DRUG$, betablockers, calcium-channel blockers, diuretics, and nonsteroidal anti-inflammatory drugs (@DRUG$) without evidence of clinically significant adverse interactions.	DDI-false
High-dose cyclosporin A resulting in concentrations above 2000 ng/mL administered with oral etoposide has led to an 80% increase in etoposide exposure with a 38% decrease in total body clearance of @DRUG$ compared to @DRUG$ alone.	DDI-false
Substances that are potent inhibitors of CYP3A4 activity (e.g. @DRUG$ and @DRUG$ ) decrease gefitinib metabolism and increase gefitinib plasma concentrations .	DDI-false
While all selective serotonin reuptake inhibitors ( @DRUG$ ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, @DRUG$ Fluoxetine, sertraline, and paroxetine, inhibit P450 2D6, they may vary in extent of inhibition.	DDI-false
In clinical studies performed with Fondaparinux , the concomitant use of oral anticoagulants ( warfarin ) , platelet inhibitors ( @DRUG$ ) , NSAIDs ( piroxicam ) , and @DRUG$ The pharmacokinetics/pharmacodynamics of fondaparinux sodium were not significantly affected.	DDI-false
The possibility of hypotensive effects with enalapril or enalaprilat can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with @DRUG$ or @DRUG$.	DDI-false
Ergot Derivatives: @DRUG$, ergonovine, ergotamine, methylergonovine CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute @DRUG$ toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
The effect of rifampin on the warfarin requirement of our patient appeared to be maximal 5 to 7 days after the initiation of @DRUG$ and extended a similar length of time after @DRUG$ withdrawal .	DDI-false
Antihypertensives : Amiodarone should be used with caution in patients receiving   -receptor blocking agents ( e.g. , propranolol , a @DRUG$ Inhibitor) or calcium channel antagonists (e.g. verapamil, a CYP3A4 substrate and @DRUG$ , a CYP3A4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and AV block ;	DDI-false
Bacteriostatic Antibiotics : Chloramphenicol , erythromycins , @DRUG$ , or @DRUG$ The bactericidal effect of penicillins may be impaired.	DDI-false
The effects of ruthenium red (@DRUG$) on inositol 1,4,5-trisphosphate (@DRUG$)-induced responses were studied in rat bone marrow megakaryocytes with the patch-clamp whole-cell recording technique in combination with fura-2 microfluorometry.	DDI-false
Antihypertensives: @DRUG$ should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., @DRUG$, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
@DRUG$: The effects of warfarin and @DRUG$ on GI bleeding are synergistic, such that users of both drugs together have a risk of serious GI bleeding higher than that of users of either drug alone.	DDI-false
However , a crossover study in healthy subjects receiving either @DRUG$ 300 mg q.i.d . or 800 mg h.s . concomitantly with a 300 mg b.i.d . dosage of theophylline ( Theo-Dur , Key Pharmaceuticals , Inc. ) demonstrated less alteration in steady-state @DRUG$ peak serum levels with the 800 mg h.s . regimen , particularly in subjects aged 54 years and older .	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect @DRUG$ pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - @DRUG$: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
The concomitant administration of medicinal products that are nephrotoxic (e.g. aminoglycosides, indomethacin), myelotoxic (e.g. cytotoxic chemotherapy), cardiotoxic (e.g. doxorubicin) or hepatotoxic (e.g., @DRUG$ , @DRUG$ Effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
- anabolic steroids (Nandrolone [e.g. Anaboline ], @DRUG$ [ e.g. , Anavar ] , oxymetholone [ e.g. , @DRUG$ ] , stanozolol [ e.g. , Winstrol ] ) or	DDI-false
@DRUG$: Concomitant treatment with Accutane and tetracyclines should be avoided because @DRUG$ use has been associated with a number of cases of pseudotumor cerebri (benign intracranial hypertension), some of which involved concomitant use of tetracyclines	DDI-false
Moreover, additional interaction studies with niacin and @DRUG$ have not demonstrated any effect on @DRUG$ plasma levels, and administration to a patient population chronically receiving digoxin resulted in no difference in the extent of bioavailability of digoxin relative to control data.	DDI-false
The concomitant use of other CYP3A4 inhibitors such as diltiazem and erythromycin with transdermal @DRUG$ This can also lead to an increase in @DRUG$ plasma concentrations , which could increase or prolong adverse drug effects and may cause serious respiratory depression .	DDI-false
Possible interactions between Keppra and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, @DRUG$ , primidone and @DRUG$ The serum concentrations of levetiracetam and these AEDs were also evaluated in placebo-controlled clinical trials.	DDI-false
@DRUG$ : Anticoagulant activity should be monitored , particularly in the first few days after initiating or changing @DRUG$ Treatment in patients receiving warfarin or similar active substances as these patients have an increased risk of bleeding complications.	DDI-false
Central nervous system depressants: the concomitant use of DURAGESIC ( @DRUG$ transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , @DRUG$ , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	DDI-effect
After multiple dosing, @DRUG$ (AVONEX  30 mcg IM once weekly) reduced @DRUG$  clearance by approximately 30%.	DDI-mechanism
Combination of amiodarone with other @DRUG$ therapy should be reserved for patients with life-threatening ventricular arrhythmias who are incompletely responsive to a single agent or incompletely responsive to @DRUG$.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., @DRUG$, indomethacin), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., @DRUG$) or hepatotoxic (e.g., methotrexate, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Coadministration of phenytoin with 40 mg @DRUG$ tablets in epileptic patients lowered the @DRUG$ plasma concentrations to undetectable levels.	DDI-false
Multivalent Cation-Containing Products : Simultaneous Application of a @DRUG$ , including ciprofloxacin, containing multivalent cational products such as magnesium or @DRUG$ antacids , sucralfate , VIDEX chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .	DDI-mechanism
Simultaneous use of Argatroban with @DRUG$ , @DRUG$ , and other anticoagulants may increase the risk of bleeding .	DDI-false
Other cardiovascular agents : enalapril and @DRUG$ For co-administration with beta-adrenergic blockers, @DRUG$ Nitrates, calcium blockers, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
This appears to be the only clinically relevant interaction of this species with mefloquines, although theoretically the concomitant use of other drugs known to alter the heart conduction (e.g. anti-arrhythmic or beta-adrenergic blockers, @DRUG$ Antihistamines or H1-blockers, tricyclic antidepressants and @DRUG$ ) could also contribute to an extension of the QTc interval.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other @DRUG$, amantadine, haloperidol, @DRUG$, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, haloperidol, @DRUG$, @DRUG$, tricyclic antidepressants or some antihistamines.	DDI-false
Central nervous system depressants: the concomitant use of DURAGESIC ( @DRUG$ Transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotic agents, sedatives (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and @DRUG$ , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	DDI-effect
This drug may interact with @DRUG$ or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of @DRUG$).	DDI-false
Nevertheless , clinical studies , as well as postmarketing observations have shown that Lodine can reduce the natriuretic effect of @DRUG$ and @DRUG$ in some patients .	DDI-false
In patients with chronic hepatitis C treated with @DRUG$ in combination with @DRUG$, PEGASYS treatment did not affect ribavirin distribution or clearance.	DDI-false
@DRUG$: In healthy subjects receiving @DRUG$, a CYP3A4 inhibitor, at 200 mg twice daily for 7 days, systemic exposure (AUC) to lapatinib was increased to approximately 3.6-fold of control and half-life increased to 1.7-fold of control.	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, phe-nothiazines, thyroid products, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Intravenous Adenocard (@DRUG$) has been effectively administered in the presence of other cardioactive drugs, such as quinidine, beta-adrenergic blocking agents, calcium channel blocking agents, and @DRUG$, without any change in the adverse reaction profile.	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with @DRUG$ may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided . 12 Beta-blockers and other @DRUG$ Hypotension observed with PROLEUKIN may be increased.	DDI-false
While all the selective serotonin reuptake inhibitors ( @DRUG$ ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, @DRUG$ , escitalopram , fluoxetine , sertraline , and paroxetine , inhibit P450 2D6 , they may vary in the extent of inhibition .	DDI-false
@DRUG$-Orlistat may decrease the absorption of @DRUG$.	DDI-false
Other concomitant therapy Although no specific interaction studies have been conducted, 1 mg or more of finasteride doses have been used in clinical trials with acetaminophen, acetylsalicylic acid, A-blockers, @DRUG$ Angiotensin converter enzyme inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium channel blockers, cardiac nitrates, diuretics, H2 antagonists, @DRUG$ Prostaglandin synthetase inhibitors (also known as NSAIDs) and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
This drug may interact with alcohol or other @DRUG$ (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with @DRUG$ may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , @DRUG$ , ergot derivatives , pimozide , carbamazepine , fentanyl , @DRUG$ When co-administered with saquinavir, increased plasma concentrations may occur;	DDI-false
ACE Inhibitors and Angiotensin II Receptor Antagonists ( Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS , 3020 ( 91 % ) patients receiving @DRUG$ 25 to 50 mg also received @DRUG$ or angiotensin II receptor antagonists ( ACEI/ARB ) .	DDI-false
@DRUG$: Coadministration of single doses of eszopiclone 3 mg and @DRUG$ 20 mg daily for 7 days produced no pharmacokinetic or pharmacodynamic interaction.	DDI-false
Co-administration of other CYP3A4 inhibitors such as @DRUG$ and @DRUG$ Transdermal fentanyl may also increase fentanyl plasma concentrations, which may increase or prolong adverse drug reactions and lead to severe respiratory depression.	DDI-false
Coingestion of @DRUG$ with theophylline , @DRUG$ with acetaminophen , and valproic acid with phenobarbital at high to toxic concentrations decreases the binding of the target drug .	DDI-false
@DRUG$: In an interaction study of rheumatoid arthritis patients taking @DRUG$, CELEBREX did not have a significant effect on the pharmacokinetics of methotrexate.	DDI-false
Potential drug interactions between @DRUG$ The serum concentrations of levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) have also been studied. @DRUG$ during placebo-controlled clinical studies .	DDI-false
The concomitant use of itraconazole and @DRUG$ , @DRUG$ Digoxin has led to increased plasma concentrations of the last three drugs.	DDI-false
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, secobarbital, glutethimide, @DRUG$ and @DRUG$ were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
The @DRUG$ are a family of anxiolytic and @DRUG$.	DDI-false
• The intake of acetaminophene with theophylline, phenobarbital with @DRUG$ , and @DRUG$ with phenobarbital at high to toxic concentrations decreases the binding of the target drug .	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, @DRUG$, haloperidol, phenothiazines, @DRUG$, tricyclic antidepressants or some antihistamines.	DDI-false
Anticholinesterases (neostgmine, @DRUG$), @DRUG$, quinine, procainamide can enhance toxicity and cause cardio respiratory depression.	DDI-false
Antipyrine: Because atorvastatin does not affect the pharmacokinetics of @DRUG$, interactions with other @DRUG$ metabolized via the same cytochrome isozymes are not expected.	DDI-false
The inhibition of anticoagulants was observed during the use of phenobarbital, @DRUG$ and @DRUG$ ;	DDI-false
Other Drug Interactions : No pharmacokinetic interactions were observed between @DRUG$ And the following medications: glyburide, warfarin, digoxin, Maalox and @DRUG$.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, @DRUG$, @DRUG$, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
@DRUG$: Potentiation of @DRUG$-type (CYP2C9 and CYP3A4 substrate) anticoagulant response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding.	DDI-false
Nonsteroidal Anti-Inflammatory Drugs (@DRUG$)-A drug interaction study of @DRUG$ with an NSAID has not been conducted .	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, Dapson, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$ In combination with other medicinal products (e. g., ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam), increased plasma concentrations may be achieved with concomitant administration of @DRUG$ ;	DDI-mechanism
Other Drug Interactions Oral @DRUG$ Keppra ( 500 mg twice daily ) affected the pharmacokinetics of an oral contraceptive with 0.03 mg ethinylestradiol and 0.15 mg @DRUG$ , or luteinising hormone and progesterone levels, suggesting that adverse effects on contraceptive efficacy are unlikely.	DDI-false
Other Drugs : Drugs such as quinidine , disopyramide , procainamide , @DRUG$ , antihistamines, and @DRUG$ It may be associated with QT interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
The availability of potent @DRUG$ (NNRTI)-based regimens for antiretroviral therapy and concerns regarding @DRUG$ (PI)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection.	DDI-false
@DRUG$ The co-administration of VIOXX with 600 mg rifampin daily, a potent inducer of hepatic metabolism, resulted in an approximately 50% decrease in @DRUG$ plasma concentrations .	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of @DRUG$, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, @DRUG$ and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
- @DRUG$ (nandrolone [e.g. anaboline], @DRUG$ [ e.g. , Anavar ] , oxymetholone [ e.g. , Anadrol ] , stanozolol [ e.g. , Winstrol ] ) or	DDI-false
Caution should be exercised if an HMG-CoA reductase inhibitor is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones, such as ketoconazole, @DRUG$, and @DRUG$.	DDI-false
INOmax was co-administered with @DRUG$ , dopamine , @DRUG$ , steroids, surfactant, and high-frequency ventilation.	DDI-false
Therefore, interactions following concomitant administration of psychotropic medicinal products (e.g. narcotics, @DRUG$ , antiemetics , @DRUG$ , sedatives).	DDI-false
Tetracyclines: Concomitant treatment with @DRUG$ and tetracyclines should be avoided because @DRUG$ use has been associated with a number of cases of pseudotumor cerebri (benign intracranial hypertension), some of which involved concomitant use of tetracyclines	DDI-false
• Carbamazepine : Isoniazid is known to slow down the metabolism of carbamazepine and increase serum levels @DRUG$ levels should be determined prior to concurrent administration with isoniazid , signs and symptoms of carbamazepine toxicity should be monitored closely , and appropriate dosage adjustment of the @DRUG$ It should be done.	DDI-false
Other concomitant therapy Although no specific interaction studies have been conducted, 1 mg or more of finasteride doses have been co-administered in clinical trials with acetaminophen, acetylsalicylic acid, A-blockers, analgesics, angiotensin converting enzyme (ACE) inhibitors, anticonvulsants, @DRUG$ , beta blockers , calcium-channel blockers , cardiac nitrates , @DRUG$ , H2 antagonists , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
Levosimendan has no clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, @DRUG$ , warfarin , @DRUG$ ==References====External links==	DDI-false
Data from in vitro studies of @DRUG$ other than @DRUG$ suggest a possible drug interaction for the following: ergotamine, cyclosporine, amiodarone, nicardipine, and nifedipine.	DDI-false
Possible interactions between Keppra and other medicinal products @DRUG$ (carbamazepine, gabapentin, lamotrigine, @DRUG$ , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies .	DDI-false
Although neither @DRUG$ nor retinyl acetate affected the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone, they modify the mitogenic effect of @DRUG$ and insulin.	DDI-effect
Specific studies have these effects with: @DRUG$ , isoflurane , propofol , @DRUG$ , and midazolam .	DDI-false
Intravenous Adenocard ( adenosine ) has been effectively administered in the presence of other cardioactive drugs , such as quinidine , @DRUG$ , @DRUG$ , and angiotensin converting enzyme inhibitors , without any change in the adverse reaction profile .	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , @DRUG$ , @DRUG$ , and beta adrenergic blocking agents .	DDI-false
• Carbamazepine : Isoniazid is known to slow down the metabolism of carbamazepine and increase serum levels @DRUG$ Concentrations should be determined prior to co-administration with isoniazid, signs and symptoms of isoniazid. @DRUG$ The toxicity should be closely monitored and an appropriate dose adjustment of the anticonvulsant should be made.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, @DRUG$, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies (@DRUG$, valproate, oral @DRUG$, digoxin, warfarin, probenecid) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients.	DDI-false
Therefore, there is a potential for an interaction with other drugs that are metabolized by CYP 1A2 (e.g., @DRUG$, @DRUG$, and zileuton).	DDI-false
INOmax has been administered with tolazoline , dopamine , dobutamine , @DRUG$ , @DRUG$ And high-frequency ventilation.	DDI-false
Interaction on the antinociceptive effect between @DRUG$ and enkephalins or @DRUG$.	DDI-effect
Injection : Lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , MAO inhibitors , and other @DRUG$.When @DRUG$ is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .	DDI-false
Multivitamins, or other products containing @DRUG$ or @DRUG$, antacids or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.	DDI-false
These medicines include thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, orally @DRUG$ , @DRUG$ , nicotinic acid , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .	DDI-false
Since @DRUG$ is a substrate for CYP3A4, there is the potential that the use of St. John s Wort in patients receiving @DRUG$ could result in reduced amiodarone levels.	DDI-false
This medication can be used with alcohol or other CNS depressants (may potentiate the CNS depressive effect of either these medications or @DRUG$ Anticholinergic agents, anticholinergic agents or other medicines with anticholinergic activity (anticholinergic effects can be increased if these drugs are used at the same time as antihistamines) and monoamine oxidase (MAO) inhibitors ( concomitant use with antihistamines may prolong and intensify anticholinergic and CNS depressive effects). @DRUG$ ) .	DDI-false
Aspirin/@DRUG$ : Pharmacokinetic or pharmacodynamic drug interactions between argatroban and co-administered aspirin (162.5 mg orally administered 26 and 2 hours before starting argatroban 1 g/kg/min over 4 hours) or acetaminophen ( 1000 mg orally administered 12, 6 and 0 hours before starting and 6 and 12 hours after starting argatroban @DRUG$ 1.5   g/kg/min . over 18 hours ) .	DDI-false
Injection: @DRUG$ injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with @DRUG$, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-effect
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, @DRUG$, @DRUG$, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Analysis of the concentration of @DRUG$ following ultracentrifugation indicated that there is rapid equilibration of budesonide between the @DRUG$ and aqueous phase.	DDI-false
These drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid products , @DRUG$ , oral contraceptives , @DRUG$ , nicotinic acid , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain @DRUG$, lidocaine, @DRUG$ and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
- @DRUG$ (e.g., @DRUG$) or	DDI-false
Other Drugs : Drugs such as @DRUG$ , disopyramide, procainamide, phenothiazine, antihistamines and @DRUG$ It may be associated with QT interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
In clinical studies performed with Fondaparinux , the concomitant use of oral anticoagulants ( warfarin ) , @DRUG$ ( @DRUG$ NSAIDs (piroxicam) and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
There are currently no data available from prospective clinical trials comparing the 3 approved active substances ( @DRUG$ , @DRUG$ or delavirdine ) .	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other @DRUG$, amantadine, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some @DRUG$.	DDI-false
These drugs include: @DRUG$ And other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, @DRUG$ , and isoniazid .	DDI-false
Acetaminophen/theophylline, lidocaine/chinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen and valproic acid/phenobarbital.	DDI-false
@DRUG$ : A report of severe @DRUG$ toxicity was reported in a patient receiving Isoniazid .	DDI-false
Coadministration with compounds that are potent inducers of CYP3A4 (eg, phenobarbital, @DRUG$, dexamethasone, carbamazepine) may result in decreased plasma levels of @DRUG$.	DDI-mechanism
Other concomitant therapies : In clinical trials , the safety profile in subjects treated with @DRUG$ concomitantly with anxiolytics , hypnotics and sedatives ( including @DRUG$ The use of placebo with these concomitant drugs was similar to that of subjects who used placebo (e. g., non-opioid analgesics).	DDI-false
Dose adjustment is not recommended. Levetiracetam did not affect the plasma concentrations of carbamazepine, @DRUG$ , @DRUG$ , or lamotrigine .	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of @DRUG$ deficit and to discriminate between magnesium deficiency due to an insufficient @DRUG$ intake which only requires oral physiological supplementation and magnesium depletion related to a dysregulation of the control mechanisms of magnesium status which requires more or less specific regulation of its causal dysregulation.	DDI-false
Elevated plasma levels of @DRUG$ have been reported with concomitant @DRUG$ use .	DDI-mechanism
@DRUG$ : In a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with @DRUG$ administered alone , suggesting that antacids may impair absorption of fosinopril .	DDI-false
@DRUG$: When multiple doses of atorvastatin and digoxin were coadministered, steady-state plasma @DRUG$ concentrations increased by approximately 20%.	DDI-false
Garlic capsules Garlic capsules should not be used while taking saquinavir (Fortovase) alone @DRUG$ Because of the risk of decline @DRUG$ plasma concentrations .	DDI-false
Although no studies have been conducted , concomitant administration of @DRUG$ and @DRUG$ The metabolism of phenytoin may change;	DDI-mechanism
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, @DRUG$, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, @DRUG$ and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Other medicines: medicines such as quinidine, disopyramide, @DRUG$ , phenothiazines , @DRUG$ , and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia .	DDI-false
Drug Interactions : Flupenthixol may interact with some drugs , like Monoamine oxidase inhibitors ( MAOI ): @DRUG$ - Arecolin - eproxindine - ethanol : flupenthixol and ethanol cause additive CNS depression - tricyclic antidepressants : @DRUG$ Increases the effect of tricyclic antidepressants	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, hypnotics and sedatives (including @DRUG$), or @DRUG$ was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$: @DRUG$ (0.5 g/kg body weight: approximately 40 mL of absolute alcohol in a 70 kg person) and vardenafil plasma levels were not altered when dosed simultaneously.	DDI-false
Numerous drug interactions are possible with some @DRUG$, such as phenobarbitone and @DRUG$, which affect hepatic microsomal enzyme systems.	DDI-false
For example, inhibitors are azole antimycotics, ciprofloxacin, @DRUG$ , diclofenac, doxycycline, erythromycin, imatinib, isoniazide, @DRUG$ , nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
An additive hypotensive effect has been reported with the combination of systemic @DRUG$ and @DRUG$ therapy.	DDI-effect
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other @DRUG$.When scopolamine is used concomitantly with injectable @DRUG$, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
@DRUG$ , or other products containing @DRUG$ or zinc , antacids or sucralfate should not be administered concomitantly with , or within 2 hours of , the administration of norfloxacin , because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin .	DDI-false
@DRUG$: In healthy subjects receiving the CYP3A4 inducer, @DRUG$, at 100 mg twice daily for 3 days and 200 mg twice daily for 17 days, systemic exposure (AUC) to lapatinib was decreased approximately 72%.	DDI-false
Oral doses of @DRUG$ (10-20 mg/kg), via alcohol dehydrogenase inhibition, significantly reduced the rate of elimination of @DRUG$ (by approximately 40%) given to healthy volunteers in moderate doses.	DDI-mechanism
Warfarin : @DRUG$ enhances the effect of @DRUG$.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Levosimendan has no clinically important pharmacokinetic interactions with captopril, beta-blockers, @DRUG$ , digoxin , warfarin , isosorbide mononitrate , @DRUG$ , ethanol or itraconazole .	DDI-false
Intravenous adenocard (adenosine) was effectively administered in the presence of other cardiovascular drugs such as quinidine. @DRUG$ - Calcium channel blockers and @DRUG$ , without changing the adverse reaction profile.	DDI-false
Since @DRUG$ does not markedly inhibit CYP450s (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, or CYP3A4) in vitro, @DRUG$ is not expected to significantly interact with other drugs in vivo by inhibition of metabolism mediated by these isozymes.	DDI-false
@DRUG$ • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • @DRUG$ 3 mg and lorazepam 2 mg did not have clinically relevant effects on the pharmacodynamics or pharmacokinetics of either drug .	DDI-false
@DRUG$: Amphetamines may delay intestinal absorption of @DRUG$.	DDI-false
Compounds tested in man include @DRUG$ , Theophylline, Phenytoin, Diazepam, Aminopyrin and @DRUG$.	DDI-false
@DRUG$ (Magnesium-Aluminum Hydroxide): @DRUG$ plasma concentrations were not affected by co-administration of antacid.	DDI-false
@DRUG$ The simultaneous use of Bepridil and @DRUG$ has been well tolerated in patients with stable angina .	DDI-false
There are case reports of patients who developed increased BUN , serum creatinine and serum potassium levels , and weight gain when @DRUG$ was used in conjunction with @DRUG$.	DDI-effect
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided . 12 @DRUG$ @DRUG$ may increase hypotension and other antihypertensive agents.	DDI-effect
Coadministration of @DRUG$ with 40 mg @DRUG$ tablets in epileptic patients lowered the nisoldipine plasma concentrations to undetectable levels .	DDI-mechanism
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ will increase plasmaconcentration of other CYP3A4 metabolized drugs ( e.g. , triazolo-benzodiazepines , @DRUG$ , certain HMG-CoA reductase inhibitors, etc.).	DDI-mechanism
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
• Furosemid : Clinical studies, as well as post-marketing observations, have shown that NSAIDs have the natriuretic effect of @DRUG$ and @DRUG$ In some patients.	DDI-false
@DRUG$ (20 mg) did not potentiate the hypotensive effects of alcohol during the 4-hour observation period in healthy volunteers when administered with @DRUG$ (0.5 g/kg body weight).	DDI-false
These drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , @DRUG$ , @DRUG$ , sympathomimetics, calcium channel block drugs, and isoniazid.	DDI-false
Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving Alprazolam ( caution is recommended during coadministration with alprazolam ): Coadministration of fluoxetine with @DRUG$ increased the maximum plasma concentration of @DRUG$ The clearance decreased by 46%, the half-life decreased by 17% and the measured psychomotor performance decreased.	DDI-false
The hypoglycemic action of @DRUG$ may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, @DRUG$, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-effect
@DRUG$ Elevated blood and moclobemide @DRUG$ At different times after glucose overload.	DDI-false
Cholestyramine and colestipol @DRUG$ : Absorption of @DRUG$ In the presence of anionic exchange resins the effect is impaired.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, @DRUG$, protease inhibitors, quinidine, and @DRUG$.	DDI-false
@DRUG$ " should not be used at the same time as @DRUG$ because of the possibility of ototoxicity .	DDI-advise
Other medicinal products Interactions: no pharmacokinetic interactions between vardenafil and the following medicinal products have been observed: glyburide, @DRUG$ , digoxin , Maalox , and @DRUG$.	DDI-false
Concomitant @DRUG$, doxorubicin, vincristine, and @DRUG$ chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
@DRUG$: The concomitant use of @DRUG$ with long- and short-acting nitrates has been safely tolerated in patients with stable angina pectoris.	DDI-false
@DRUG$ Eszopiclone 3 mg administered daily for 5 days had no effect on the pharmacokinetics of (R)- or @DRUG$ There were still changes in the pharmacodynamic profile (prothrombin time) after a single oral dose of 25 mg warfarin.	DDI-false
In these subjects, @DRUG$ The anticoagulant effect of @DRUG$ as determined by prothrombin time .	DDI-false
In the first study, concomitant administration of 0.2 mg cerivastatin sodium and 12 g @DRUG$ resulted in decreases of more than 22% for AUC and 40% for Cmax when compared to dosing @DRUG$ alone.	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, @DRUG$, sulfonamides, @DRUG$, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
Anti-arrhythmics and @DRUG$ could exaggerate the prolongation of the QT interval observed with @DRUG$.	DDI-effect
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, @DRUG$, nicardipine, propofol, protease inhibitors, quinidine, and @DRUG$.	DDI-false
Methotrexate: In an interaction study of rheumatoid arthritis patients taking @DRUG$, @DRUG$ did not have a significant effect on the pharmacokinetics of methotrexate.	DDI-false
Drugs that may alter @DRUG$ plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, @DRUG$, clarithromycin).	DDI-false
• Co-administration with compounds that are potent CYP3A4 inducers (e. g. @DRUG$ , phenytoin, dexamethasone, carbamazepine) may lead to decreased plasma levels of @DRUG$.	DDI-mechanism
Dose adjustment is not recommended.@DRUG$ had no effect on plasma concentrations of carbamazepine, valproate, topiramate, or @DRUG$.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of @DRUG$, @DRUG$, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Tricyclic antidepressants have been reported to blunt the hypotensive effect of systemic @DRUG$.It is not known whether the concurrent use of these agents with @DRUG$ in humans can lead to resulting interference with the IOP lowering effect.	DDI-false
Caution should be exercised if an HMG-CoA reductase inhibitor is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones, such as @DRUG$, spironolactone, and @DRUG$.	DDI-false
Dose adjustment is not recommended.@DRUG$ had no effect on plasma concentrations of @DRUG$, valproate, topiramate, or lamotrigine.	DDI-false
The effects of concomitant @DRUG$ administration on the steady-state pharmacokinetics of @DRUG$.	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, @DRUG$ or beta-adrenergic blocking agents, calcium channel blockers, @DRUG$ or H1-blocking agents, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-false
Study results in patients with multiple sclerosis, TYSABRI and concomitantly @DRUG$ ( AVONEX 30 mcg IM once weekly ) or glatiramer acetate were not consistent with the need for dose adjustment of the beta interferon or @DRUG$.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - @DRUG$: Flupenthixol and Ethanol cause additive CNS depression - @DRUG$: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
@DRUG$ produced distinctive effects in each task: it substituted for the training dose in @DRUG$ discrimination and it increased the number of responses with short (<3 s) interresponse times as well as increasing overall response rates in the DRL schedule.	DDI-false
This interaction should be given consideration in patients taking @DRUG$ concomitantly with @DRUG$.	DDI-advise
Antacids : In a clinical pharmacology study, the concomitant use of antacids (aluminium hydroxide, magnesium hydroxide, and @DRUG$ ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that @DRUG$ may impair absorption of fosinopril .	DDI-false
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)-A drug interaction study of @DRUG$ with an @DRUG$ has not been conducted.	DDI-false
Potential drug interactions between @DRUG$ AEDs and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, @DRUG$ In placebo-controlled clinical trials, serum concentrations of levetiracetam and these AEDs have also been studied.	DDI-false
For example, inhibitors are azole antimycotics, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, @DRUG$ , nefazodone , @DRUG$ Propofol, protease inhibitors, quinidine and verapamil.	DDI-false
The availability of potent @DRUG$ (NNRTI)-based regimens for antiretroviral therapy and concerns regarding protease inhibitor (@DRUG$)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection .	DDI-false
In addition, Fondaparinux neither influenced the pharmacodynamics of warfarin, acetylsalicylic acid, @DRUG$, and @DRUG$, nor the pharmacokinetics of digoxin at steady state.	DDI-false
@DRUG$ may interact with any of the following: - Acetaminophen (e.g., @DRUG$) (with long-term, high-dose use) or	DDI-int
Acetaminophene, lidocaine, @DRUG$ , quinidine , theophylline , and @DRUG$ The pooled human serum was added at therapeutic concentrations.	DDI-false
Coadministration with compounds that are potent inducers of CYP3A4 ( eg , phenobarbital , phenytoin , dexamethasone , @DRUG$ @DRUG$ may decrease plasma levels.	DDI-mechanism
Exposure from the proposed topical dose is about 1 % of that from the 100 mg oral dose , even when co-administered with @DRUG$/@DRUG$.	DDI-false
BACKGROUND: The effects of combined administration of bombesin and verapamil hydrochloride (verapamil), a @DRUG$, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by @DRUG$ (AOM) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
Analysis of the concentration of @DRUG$ following ultracentrifugation indicated that there is rapid equilibration of @DRUG$ between the Survanta and aqueous phase.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when @DRUG$ is administered concomitantly with other antimuscarinics, @DRUG$, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.	DDI-effect
@DRUG$, or other products containing iron or zinc, @DRUG$ or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.	DDI-false
• Drug interactions: Flupentixol may interact with some medicines, such as monoamine oxidase inhibitors ( @DRUG$ MAOI may theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol : Flupenthixol and ethanol cause additive CNS depression - @DRUG$ Flupentixol increases the effect of tricyclic antidepressants	DDI-false
In addition , @DRUG$ neither influenced the pharmacodynamics of warfarin , acetylsalicylic acid , @DRUG$ The pharmacokinetics of digoxin in steady state.	DDI-false
Ritonavir and indinavir: When administered concomitantly with 5 mg @DRUG$ with 600 mg BID @DRUG$ , the Cmax and AUC of ritonavir were reduced by approximately 20 % .	DDI-mechanism
When @DRUG$ Co-administration of phenytoin, rifampin or H2antagonists reduced plasma concentrations of @DRUG$ were reported .	DDI-false
Patients receiving @DRUG$ and @DRUG$ concomitantly should have a dose reduction of azathioprine, to approximately 1/3 to 1/4 the usual dose.	DDI-advise
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including @DRUG$ and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, @DRUG$, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
Chloral hydrate and @DRUG$ interact pharmacologically with orally administered @DRUG$ However, the effect is not clinically significant.	DDI-int
Oral contraceptives: concomitant use of @DRUG$ and an oral @DRUG$ increased AUC values for norethindrone and ethinyl estradiol by approximately 30 % and 20 % .	DDI-mechanism
The risk of myopathy during treatment with medicines in this class is increased when cyclosporin is co-administered. @DRUG$ , niacin ( @DRUG$ Erythromycin, azole antifungals.	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine , although theoretically , coadministration of other drugs known to alter cardiac conduction ( eg , @DRUG$ or beta-adrenergic blocking agents , calcium channel blockers , antihistamines or H1-blocking agents , @DRUG$ ) could also contribute to an extension of the QTc interval.	DDI-false
@DRUG$/@DRUG$ , lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen and valproic acid/phenobarbital.	DDI-false
The effects of pressure @DRUG$ such as @DRUG$ or norepinephrine are enhanced by Bretylium Tosylate .	DDI-false
Nephrotoxicity has been reported following concomitant administration of @DRUG$ with @DRUG$ or potent diuretics such as furosemide .	DDI-effect
The effects of @DRUG$ and of Innovar anesthesia on @DRUG$ Tolerance in dogs.	DDI-false
Data from in vitro studies of @DRUG$ other than alprazolam suggest a possible drug interaction for the following: @DRUG$, cyclosporine, amiodarone, nicardipine, and nifedipine.	DDI-int
Co-administration : Concomitant use of @DRUG$ with @DRUG$ Thrombolytics and other anticoagulants may increase the risk of bleeding.	DDI-effect
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or @DRUG$ than with @DRUG$.	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (alcohol, barbiturates, opiates, @DRUG$, @DRUG$) should be considered.	DDI-false
The availability of potent non-nucleoside reverse transcriptase inhibitor (@DRUG$)-based regimens for antiretroviral therapy and concerns regarding protease inhibitor (@DRUG$)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection.	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with @DRUG$ or Innovar than with @DRUG$.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, @DRUG$, thyroid products, estrogens, oral @DRUG$, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Lithium : NSAIDs have generated an increase in plasma @DRUG$ levels and a reduction in renal @DRUG$ clearance .	DDI-false
Cyclosporine: Administration of nonsteroial anti-inflammatory drugs concomitantly with @DRUG$ has been associated with an increase in @DRUG$-induced toxicity, possibly due to decreased synthesis of renal prostacyclin.	DDI-false
@DRUG$ : In an interaction study of rheumatoid arthritis patients taking methotrexate , CELEBREX did not have a significant effect on the pharmacokinetics of @DRUG$.	DDI-false
Coadministration with compounds that are potent inducers of CYP3A4 (eg, @DRUG$, phenytoin, dexamethasone, @DRUG$) may result in decreased plasma levels of saquinavir.	DDI-false
Non-selective MAO inhibitors including @DRUG$ , Phenelzinsulfate, and @DRUG$ HC1 : Concomitant use of L-tyrosine and non-selective MAO inhibitors may cause hypertension .	DDI-false
Drug Interactions: @DRUG$ may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - @DRUG$: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
@DRUG$ In an interaction study in rheumatoid arthritis patients taking methotrexate, @DRUG$ did not have a significant effect on the pharmacokinetics of methotrexate .	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering @DRUG$ with inhibitors of the CYP3A4 family (e.g., ketoconazole, @DRUG$, erythromycin, clarithromycin).	DDI-advise
- @DRUG$ ( e.g. , @DRUG$ ) or	DDI-false
Drug-Drug Interactions Between Keppra  And Other @DRUG$ (AEDs) Phenytoin @DRUG$  (3000 mg daily) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy.	DDI-false
Other Drug Interactions : No pharmacokinetic interactions were observed between vardenafil and the following drugs : @DRUG$ , warfarin , digoxin , @DRUG$ , and ranitidine .	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, Dapson, disopyramide, quinine, amiodarone, @DRUG$ , warfarin, tacrolimus, cyclosporin, ergot derivatives, pimozide, @DRUG$ (e. g., fentanyl, alfentanyl, alprazolam and triazolam) may exhibit increased plasma concentrations when co-administered with saquinavir;	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of @DRUG$ needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or @DRUG$ than with pentobarbital.	DDI-false
Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving Alprazolam (caution is recommended during coadministration with alprazolam): Coadministration of fluoxetine with @DRUG$ increased the maximum plasma concentration of @DRUG$ by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance.	DDI-false
@DRUG$ had no significant impact on the Cmax and AUC of @DRUG$, although it significantly decreased the zidovudine tmax by 44% and increased the intracellular exposure to phosphorylated zidovudine by 110%.	DDI-false
- Anabolic steroids ( nandrolone [ e.g. , @DRUG$ ] , oxandrolone [ e.g. , Anavar ] , oxymetholone [ e.g. , @DRUG$ ], stanozolol [ e.g. Winstrol ] or	DDI-false
- @DRUG$ (nandrolone [e.g., @DRUG$], oxandrolone [e.g., Anavar], oxymetholone [e.g., Anadrol], stanozolol [e.g., Winstrol]) or	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, @DRUG$ and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these @DRUG$ during placebo-controlled clinical studies.	DDI-false
Co-administration of @DRUG$ and @DRUG$ or other agents interfering with neuromuscular transmission (e.g., curare-like compounds) should only be performed with caution as the effect of the toxin may be potentiated.	DDI-advise
Concurrent administration of oxyphenbutazone and @DRUG$ may result in elevated serum levels of @DRUG$.	DDI-false
This time window is different than for other oral formulations of @DRUG$ Usually given 2 hours before or 6 hours after @DRUG$.	DDI-advise
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , @DRUG$ , chloramphenicol , probenecid , coumarins , @DRUG$ , and beta adrenergic blocking agents .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , @DRUG$ , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , @DRUG$ , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
Acetaminophen/theophylline, lidocaine/chinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/@DRUG$ and valproic acid/phenobarbital.	DDI-false
Cimetidine: @DRUG$ plasma concentrations and LDL-C reduction were not altered by coadministration of @DRUG$.	DDI-false
@DRUG$ , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , @DRUG$ Theophylline, and metronidazole, delaying the elimination and increase in blood levels of these drugs.	DDI-mechanism
The analysis of the Budesonide concentration after ultracentrifugation indicates that there is rapid equilibrium. @DRUG$ between the @DRUG$ and aqueous phase .	DDI-false
@DRUG$ : Co-administration of @DRUG$ Rifampin 600 mg daily, a potent inducer of hepatic metabolism, resulted in an approximate 50% decrease in rofecoxib plasma concentrations.	DDI-false
Naproxen: The concomitant administration of @DRUG$ and naproxen in normal volunteers had no effect on the plasma levels of naproxen, but significantly decreased the urinary excretion of @DRUG$ and its glucuronide metabolite.	DDI-false
There have been case reports of increased steady-state levels of quinidine, @DRUG$, and @DRUG$ during concomitant therapy with amiodarone.	DDI-false
@DRUG$ ; Amiodaron, bepridil, @DRUG$ , propafenone, quinidine CONTRAINDICATES due to the potential for serious and/or life-threatening reactions.	DDI-false
Therefore, agents affecting sympathetic activity (e.g., @DRUG$ or @DRUG$) should be used with caution.	DDI-false
Dexamethasone and @DRUG$ Similarly, @DRUG$ or insulin-induced proliferation of prostate epithelium inhibits and stimulates.	DDI-effect
Co-medications that induce CYP3A4 ( e.g. , dexamethasone , phenytoin , @DRUG$ , @DRUG$ , phenobarbital or St.	DDI-false
Multivitamins, or other products containing iron or zinc, antacids or @DRUG$ should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of @DRUG$.	DDI-false
Nitrates: The concomitant use of @DRUG$ with long- and short-acting @DRUG$ has been safely tolerated in patients with stable angina pectoris.	DDI-false
Certain endocrine and liver function tests may be affected by @DRUG$-containing oral @DRUG$.	DDI-false
As with other antipsychotic agents, it should be noted that HALDOL may be capable of potentiating CNS depressants such as anesthetics, @DRUG$, and @DRUG$.	DDI-false
These results suggest that both dexamethasone and dexamethasone @DRUG$ , and possibly other glucocorticoids and retinoids , may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and @DRUG$.	DDI-effect
For information on the pharmacokinetics of @DRUG$ and @DRUG$ in combination, see Drug Interactions under CLINICAL PHARMACOLOGY section.	DDI-false
- Anabolic steroids ( nandrolone [ e.g. , @DRUG$ ], Oxandrolone [e.g., Anavar], Oxymetholone [e.g., Anadrol], @DRUG$ (e.g. Winstrol ]) or	DDI-false
While all selective serotonin reuptake inhibitors ( SSRIs), e.g., citalopram, escitalopram, @DRUG$ , @DRUG$ , and paroxetine , inhibit P450 2D6 , they may vary in the extent of inhibition .	DDI-false
The use of acetaminophene with acetaminophene @DRUG$ , phenobarbital with @DRUG$ Valproic acid with phenobarbital in high to toxic concentrations decreases the binding of the target drug.	DDI-false
Example inhibitors include @DRUG$ , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , @DRUG$ , quinidine, and verapamil.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, @DRUG$, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, @DRUG$, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$: @DRUG$ plasma concentrations and LDL-C reduction were not altered by coadministration of cimetidine.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
@DRUG$ The plasma concentrations of atorvastatin decreased by about 25% if: @DRUG$ and atorvastatin were coadministered .	DDI-false
Co-administration of aspirin reduces the biological half-life of @DRUG$ Because of an increase in metabolic clearance, which leads to a greater amount of @DRUG$ In the urine.	DDI-false
Although neither @DRUG$ nor retinyl acetate affected the proliferation of prostatic epithelium in RPMI1640 containing @DRUG$ alone, they modify the mitogenic effect of EGF and insulin.	DDI-false
ACE inhibitors: reports suggest that @DRUG$ The antihypertensive effect of @DRUG$ can be reduced.	DDI-effect
Both the toxicity of @DRUG$ and the therapeutic value of @DRUG$ These polyenic antibiotics showed different effects on the cells ;	DDI-false
In clinical studies performed with @DRUG$ , the concomitant use of oral @DRUG$ The pharmacokinetics/pharmacodynamics of fondaparinux sodium are not significantly affected by warfarin, platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin.	DDI-false
@DRUG$: When Lodine is administered with @DRUG$, its protein binding is reduced, although the clearance of free etodolac is not altered.	DDI-false
Simultaneous use of @DRUG$ with antiplatelet agents , thrombolytics , and other @DRUG$ may increase the risk of bleeding .	DDI-effect
Cholestyramine and @DRUG$ resins: Absorption of @DRUG$ is impaired in the presence of anionic exchange resins.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: @DRUG$ and @DRUG$ cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-effect
The hypoglycaemic effect of sulphonylureas can be enhanced by certain drugs, including nonsteroidal anti-inflammatory drugs and other medicines that are highly protein bound, salicylates, sulphonamides, chloramphenicol, @DRUG$ , coumarins , @DRUG$ , and beta adrenergic blocking agents .	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and @DRUG$) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with @DRUG$ administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
@DRUG$ : Dihydroergotamine , ergonovine , ergotamine , methylergonovine CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute @DRUG$ toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues .	DDI-false
[ Quantitative approach to Incisive Treatment @DRUG$ by therapeutic monitoring ] ; The problems encountered during the longterm treatment of psychotic patients with @DRUG$ are illustrated by six typical case reports .	DDI-false
acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
Reciprocal interactions may occur with concomitant use of @DRUG$ and drugs that increase or inhibit the cytochrome P450 system ( e.g. , phenytoin , carbamazepine , cimetidine , @DRUG$ ) , though this has not been studied	DDI-mechanism
OTHER CONCOMITANT THERAPY : Although specific interaction studies were not performed , in clinical studies , cerivastatin sodium was used concomitantly with angiotensin- converting enzyme ( ACE ) inhibitors , @DRUG$ , calcium channel blockers, diuretics, and @DRUG$ ( NSAIDs ) without evidence of clinically significant adverse interactions .	DDI-false
These drugs include the thiazides and other diuretics, @DRUG$, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, @DRUG$, and isoniazid.	DDI-false
Dose adjustment is not recommended. Levetiracetam did not affect the plasma concentrations of carbamazepine, valproate, @DRUG$ , or @DRUG$.	DDI-false
In addition, higher than expected steady-state serum concentrations of @DRUG$ At the start of therapy, therapy was observed in patients already taking @DRUG$.	DDI-mechanism
@DRUG$ may suppress certain CYP450 enzymes, including @DRUG$, CYP2C9, CYP2D6, and CYP3A4.	DDI-false
This appears to be the only clinically relevant interaction of this kind with @DRUG$, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, @DRUG$, antihistamines or H1-blocking agents, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-effect
@DRUG$: In some patients with compromised renal function who are being treated with nonsteroidal anti-inflammatory drugs, the co-administration of @DRUG$ may result in a further deterioration of renal function.	DDI-false
Compounds tested in man include warfarin, theophylline, @DRUG$, diazepam, aminopyrine and @DRUG$.	DDI-false
Antipyrine : Because @DRUG$ • Does not affect the pharmacokinetics of @DRUG$ , interactions with other drugs metabolized via the same cytochrome isozymes are not expected .	DDI-false
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies (phenytoin, @DRUG$, oral contraceptive, digoxin, @DRUG$, probenecid) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients.	DDI-false
Indinavir (800 mg t.i.d.) with vardenafil 10 mg resulted in a 16-fold increase in @DRUG$ AUC , a 7-fold increase in vardenafil Cmax and a 2-fold increase in @DRUG$ half-life .	DDI-false
In clinical studies with fondaparinux, the concomitant use of oral anticoagulants ( @DRUG$ ) , @DRUG$ Acetylsalicylic acid, NSAIDs (piroxicam) and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Drug-Drug Interactions Between Keppra  And Other Antiepileptic Drugs (@DRUG$) Phenytoin Keppra  (3000 mg daily) had no effect on the pharmacokinetic disposition of @DRUG$ in patients with refractory epilepsy.	DDI-false
- Anabolic steroids (nandrolone [e.g., Anabolin], oxandrolone [e.g., @DRUG$], @DRUG$ [e.g., Anadrol], stanozolol [e.g., Winstrol]) or	DDI-false
Potential drug interactions between Keppra   and other @DRUG$ (Carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and @DRUG$ ) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies .	DDI-false
Dose adjustment is not recommended.@DRUG$ had no effect on plasma concentrations of carbamazepine, valproate, @DRUG$, or lamotrigine.	DDI-false
Aspirin/@DRUG$: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between @DRUG$ and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , doxorubicin , vincristine , and prednisone ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , @DRUG$ , @DRUG$ , and prednisone with vincristine plus bleomycin ) without receiving antiretroviral therapy .	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of @DRUG$ needed to cause ventricular tachycardia was significantly higher, as was the LD50 of @DRUG$, with ketamine or Innovar than with pentobarbital.	DDI-false
Drug Interactions : @DRUG$ MAOI could theoretically influence flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol : Flupenthixol and ethanol cause additive CNS depression - Tricyclic antidepressants : Flupenthixol increases the effect of @DRUG$	DDI-false
In addition, fondaparinux did not affect the pharmacodynamics of warfarin, acetylsalicylic acid, @DRUG$ , and @DRUG$ , nor the pharmacokinetics of digoxin at steady state .	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (@DRUG$), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of @DRUG$.	DDI-false
Therefore, a starting daily dose of 25 mg of @DRUG$ should be considered for the treatment of osteoarthritis when @DRUG$ is co-administered with potent inducers of hepatic metabolism.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (@DRUG$, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with @DRUG$ administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
Both the toxicity of @DRUG$ The therapeutic value of amphotericin B can be rationalised at both cellular and molecular level by the following observations: (i ) these @DRUG$ · showed differential effects on the cells ;	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride, including anti-arrhythmic agents such as @DRUG$ and procainamide, cardiac glycosides and @DRUG$.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, @DRUG$, @DRUG$, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , @DRUG$ Elevated plasma concentrations may occur when pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam and triazolam are co-administered. @DRUG$ ;	DDI-mechanism
@DRUG$ : In a study conducted in healthy subjects , mean steady-state lithium plasma levels increased approximately 17 % in subjects receiving lithium 450 mg BID with CELEBREX 200 mg BID as compared to subjects receiving @DRUG$ alone .	DDI-false
It is recommended not to exceed a single 2.5 mg @DRUG$ dose in a 24-hour period when used in combination with @DRUG$.	DDI-advise
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Iodine or @DRUG$ excess may decrease the effect of Carbimazole, and an iodine deficiency can increase the effect of @DRUG$.	DDI-false
Central Nervous System Depressants: The concomitant use of @DRUG$  (@DRUG$ transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
@DRUG$ Eszopiclon 3 mg administered daily for 5 days had no effect on the pharmacokinetics of (R) or (S) warfarin, nor was there any effect on the pharmacokinetics of (R) or (S) warfarin after a single oral dose of 25 mg. @DRUG$	DDI-false
@DRUG$: Co- administration of @DRUG$ and cerivastatin to healthy volunteers did not result in any changes in prothrombin time or clotting factor VII when compared to co-administration of warfarin and placebo.	DDI-false
Patients receiving @DRUG$ and allopurinol concomitantly should have a dose reduction of @DRUG$, to approximately 1/3 to 1/4 the usual dose.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ : In a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , @DRUG$ , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .	DDI-false
@DRUG$ ('Seroquel') is a newly introduced @DRUG$ with demonstrated efficacy in the treatment of positive and negative symptoms of schizophrenia.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and @DRUG$.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, @DRUG$ (e.g., benzodiazepines), general @DRUG$, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Therefore , when meclofenamate sodium is given to a patient receiving @DRUG$ , the dosage of @DRUG$ should be reduced to prevent excessive prolongation of the prothrombin time .	DDI-false
Example inhibitors include @DRUG$, ciprofloxacin, clarithromycin, @DRUG$, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Ergot Derivatives: @DRUG$, @DRUG$, ergotamine, methylergonovine CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
@DRUG$ : Plasma digoxin levels and @DRUG$ The steady-state clearance was not affected by co-administration of cerivastatin sodium 0.2 mg.	DDI-false
Nonsteroidal Anti-Inflammatory Drugs: The administration of @DRUG$ to normal volunteers receiving indomethacin decreased the renal clearance and significantly increased the plasma levels of @DRUG$.	DDI-false
@DRUG$ : The anorectic and stimulatory effects of @DRUG$ may be inhibited by lithium carbonate .	DDI-false
Intravenous Adenocard (@DRUG$) has been effectively administered in the presence of other cardioactive drugs, such as @DRUG$, beta-adrenergic blocking agents, calcium channel blocking agents, and angiotensin converting enzyme inhibitors, without any change in the adverse reaction profile.	DDI-false
Other reported interactions with amiodarone: @DRUG$ (@DRUG$ substrate) in combination with amiodarone may cause hypotension, bradycardia, and decreased cardiac output.	DDI-false
This appears to be the only clinically relevant interaction of this species with mefloquines, although theoretically the concomitant use of other drugs known to alter cardiac conduction (e.g. anti-arrhythmic or beta-adrenergic blockers, calcium channel blockers, antihistamines, or @DRUG$ , @DRUG$ and phenothiazines ) might also contribute to a prolongation of the QTc interval .	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and antineoplastic agents, specifically, dacarbazine, @DRUG$, tamoxifen and @DRUG$.	DDI-false
Other concomitant therapy Although no specific interaction studies have been conducted, 1 mg or more of finasteride doses have been reported in clinical trials with acetaminophen, acetylsalicylic acid, A-blockers, analgesics, angiotensin converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, @DRUG$ , calcium-channel blockers , cardiac nitrates , diuretics , @DRUG$ , HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also known as NSAIDs) and quinolone anti-infections without evidence of clinically significant adverse interactions.	DDI-false
Coadministration of @DRUG$ did not influence the pharmacokinetics of @DRUG$.	DDI-false
In clinical studies with fondaparinux, the concomitant use of oral anticoagulants ( @DRUG$ ), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam) and digoxin did not significantly affect @DRUG$ pharmacokinetics/pharmacodynamics.	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations : Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family ( e.g. , ketoconazole , itraconazole , @DRUG$ , @DRUG$ ) .	DDI-false
Naproxen: The concomitant administration of diflunisal and @DRUG$ in normal volunteers had no effect on the plasma levels of naproxen, but significantly decreased the urinary excretion of @DRUG$ and its glucuronide metabolite.	DDI-false
In the case that you are taking @DRUG$ while taking aminosalicylic acid, higher doses of @DRUG$ may be needed.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
When @DRUG$ is taken concurrently with oral @DRUG$, attenuation of immunization cannot be excluded.	DDI-effect
@DRUG$ : In an interaction study of rheumatoid arthritis patients taking @DRUG$ CELEBREX had no significant effect on the pharmacokinetics of methotrexate.	DDI-false
High-dose @DRUG$ with @DRUG$ protection .	DDI-effect
- @DRUG$ ( nandrolone [ e.g. , @DRUG$ ], Oxandrolone [e.g. Anavar], Oxymetholone [e.g. Anadrol], Stanozolol [e.g. Winstrol]) or	DDI-false
@DRUG$ In normal subjects, co-administration of diflunisal and acetaminophen resulted in an increase in plasma levels of approximately 50% of @DRUG$.	DDI-false
To assess the effect of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL), the authors retrospectively compared a group of 24 patients with HIV-NHL treated with cyclophosphamide, doxorubicin, vincristine, and @DRUG$ ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , doxorubicin , teniposide , and prednisone with vincristine plus @DRUG$ ) without antiretroviral therapy.	DDI-false
acetaminophen/@DRUG$, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
Broad-Spectrum Antibiotics-@DRUG$ may sterilize the bowel and decrease the @DRUG$ contribution to the body by the intestinal microflora.	DDI-false
Tagamet, apparently due to an effect on certain microsomal enzyme systems, has been reported to reduce hepatic metabolism @DRUG$ , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , @DRUG$ and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .	DDI-false
It is recommended that the concomitant use of ethambutol with @DRUG$ containing antacids for at least 4 hours following @DRUG$ administration .	DDI-false
@DRUG$ will increase plasmaconcentration of other CYP3A4 metabolized drugs ( e.g. , triazolo-benzodiazepines , dihydropyridine calcium channel blockers , certain @DRUG$ ..............................................................................................................................................................................................................................................................................................................................................................................	DDI-mechanism
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., narcotics, analgesics, antiemetics, @DRUG$, @DRUG$).	DDI-false
Effect of @DRUG$ in Pediatric Patients There was about a 22 % increase of apparent total body clearance of levetiracetam when it was co-administered with enzyme-inducing @DRUG$.	DDI-false
Carbamazepine : Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with @DRUG$ , signs and symptoms of carbamazepine toxicity should be closely monitored and appropriate dose adjustment of carbamazepine toxicity should be performed. @DRUG$ should be made .	DDI-false
Pregnancy: Category X: Use With @DRUG$ (see CONTRAINDICATIONS) Significant teratogenic and/or embryocidal effects have been demonstrated in all animal species exposed to @DRUG$.	DDI-false
Antiarrhythmics : Other @DRUG$ Medicines such as quinidine, procainamide, disopyramide and phenytoin were used concomitantly with @DRUG$.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, @DRUG$, teniposide, and @DRUG$ with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
@DRUG$ • the concomitant use of DURAGESIC (Fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, @DRUG$ , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	DDI-false
Benzthiazide can interact with alcohol, blood thinners, decongestant medications (allergic agents, colds, and sinus drugs), diabetic drugs, @DRUG$ , @DRUG$ , NSAIDs such as Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , @DRUG$ , disopyramide, quinine, amiodarone, @DRUG$ , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine , Innovar Vet , or @DRUG$ , the dosage of ouabain needed to cause ventricular tachycardia was significantly higher , as was the LD50 of ouabain , with ketamine or @DRUG$ As with Pentobarbital.	DDI-false
@DRUG$ have been reported to blunt the hypotensive effect of systemic @DRUG$.	DDI-effect
In the present study , the @DRUG$ Clozapine was used in combination with an active dose of @DRUG$ in two-lever drug discrimination and mixed signalled-unsignalled differential-reinforcement-of-low-rates ( DRL ) procedures .	DDI-false
Other concomitant therapy Although specific interaction studies have not been performed, 1 mg or more of finasteride doses have been co-administered in clinical trials with acetaminophen, acetylsalicylic acid, A-blockers, analgesics, angiotensin converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta-blockers, @DRUG$ , cardiac nitrates , diuretics , H2 antagonists , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as @DRUG$ ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
Drugs Interactions : Flupentixol may interact with some drugs, such as monoamine oxidase inhibitors (MAOI): MAOI may theoretically affect flupentixol pharmacodynamics - @DRUG$ - Eproxindine - ethanol : flupenthixol and ethanol cause additive CNS depression - @DRUG$ : Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Human pharmacokinetics data indicate that oral @DRUG$ • strongly inhibits the metabolism of @DRUG$ resulting in an eight-fold increase in the mean AUC of cisapride .	DDI-mechanism
@DRUG$ did not alter the plasma levels of @DRUG$ when taken in combination.	DDI-false
Example inhibitors include @DRUG$ , ciprofloxacin, clarithromycin, diclofenac, @DRUG$ , erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (alcohol, @DRUG$, @DRUG$, sedatives, anesthetics) should be considered.	DDI-false
Carbamazepine: @DRUG$ is known to slow the metabolism of carbamazepine and increase its serum levels @DRUG$ levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.	DDI-false
Potential drug interactions between Keppra   and other AEDs ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and @DRUG$ Serum concentrations of levetiracetam and @DRUG$ during placebo-controlled clinical studies .	DDI-false
The administration of local @DRUG$ containing @DRUG$ or norepinephrine to patients receiving monoamine oxidase inhibitors, tricyclic antidepressants or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-false
Iodine or @DRUG$ excess may decrease the effect of Carbimazole, and an @DRUG$ deficiency can increase the effect of Carbimazole.	DDI-false
Coingestion of @DRUG$ with @DRUG$ , phenobarbital with acetaminophen , and valproic acid with phenobarbital at high to toxic concentrations decreases the binding of the target drug .	DDI-effect
Example inhibitors include azole antifungals, ciprofloxacin, @DRUG$, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, @DRUG$, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Moreover, additional interaction studies with @DRUG$ and propranolol have not demonstrated any effect on fluvastatin plasma levels, and administration to a patient population chronically receiving @DRUG$ resulted in no difference in the extent of bioavailability of digoxin relative to control data.	DDI-false
- anabolic steroids (Nandrolone [e.g. Anaboline], Oxandrolone [e.g., Anavar], @DRUG$ [ e.g. , @DRUG$ ], stanozolol [ e.g. Winstrol ] or	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine , although theoretically , coadministration of other drugs known to alter cardiac conduction ( eg , anti-arrhythmic or beta-adrenergic blocking agents , @DRUG$ , @DRUG$ or H1-blocking agents , tricyclic antidepressants and phenothiazines ) might also contribute to a prolongation of the QTc interval .	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril , @DRUG$ , felodipine, digoxin, warfarin, @DRUG$ ==References====External links==	DDI-false
Injection : @DRUG$ injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , MAO inhibitors , and other antidepressants . When @DRUG$ is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .	DDI-false
Cardiovasculars: @DRUG$: In patients receiving @DRUG$ therapy, administration of oral amiodarone regularly results in an increase in serum digoxin concentration that may reach toxic levels with resultant clinical toxicity.	DDI-false
@DRUG$ also increased rate of dissolution, in a manner similar to @DRUG$.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, @DRUG$, imatinib, isoniazid, nefazodone, @DRUG$, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, @DRUG$, diclofenac, doxycycline, @DRUG$, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Betaseron administration to three cancer patients over a dose range of 0.025 mg to 2.2 mg led to a dose-dependent inhibition of @DRUG$ elimination.14 The effect of alternate-day administration of 0.25 mg of @DRUG$ on drug metabolism in MS patients is unknown.	DDI-false
The concomitant administration of medicinal products that are nephrotoxic (e.g. aminoglycosides, indomethacin) is myelotoxic (e.g. @DRUG$ chemotherapy), cardiotoxic (e. g., @DRUG$ ) or hepatotoxic ( e.g. , methotrexate , asparaginase ) effects with PROLEUKIN may increase toxicity in these organ systems .	DDI-false
This drug may interact with @DRUG$ or other CNS depressants ( may potentiate the CNS depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( MAO ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of @DRUG$ ) .	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a @DRUG$, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum @DRUG$, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
Medicines that may alter the plasma concentration of imatinib Drugs that may increase the plasma concentration of imatinib @DRUG$ plasma concentrations : Caution is recommended when administering @DRUG$ With inhibitors of the CYP3A4 family (e.g. ketoconazole, itraconazole, erythromycin, clarithromycin).	DDI-false
Drug/Laboratory Test Interaction @DRUG$ may cause a false low measurement of serum digoxin levels with the Digi- Tab  RIA Kit for @DRUG$.	DDI-false
Concomitant cyclophosphamide , @DRUG$ , vincristine, and @DRUG$ chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-associated non-Hodgkin lymphoma.	DDI-false
@DRUG$: Atorvastatin plasma concentrations and LDL-C reduction were not altered by coadministration of @DRUG$.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , doxorubicin , @DRUG$ , and prednisone ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , doxorubicin , teniposide , and @DRUG$ • with vincristine plus bleomycin) without antiretroviral therapy.	DDI-false
acetaminophen/theophylline , lidocaine/quinidine , phenobarbital/acetaminophen , phenobarbital/valproic acid , @DRUG$/lidocaine , theophylline/@DRUG$ , and valproic acid/phenobarbital .	DDI-false
While @DRUG$ and ibogaine have similar affinities for kappa opioid and possibly nicotinic receptors, 18-MC has much lower affinities than @DRUG$ for NMDA and sigma-2 receptors, sodium channels, and the 5-HT transporter.	DDI-false
Central Nervous System Depressants : The concomitant use of DURAGESIC   ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , @DRUG$ ( e.g. , @DRUG$ ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	DDI-false
Digoxin : If multiple doses @DRUG$ and @DRUG$ Plasma digoxin concentrations at steady-state increased by about 20%.	DDI-mechanism
acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Single doses of either cholestyramine or colestipol @DRUG$ bind the @DRUG$ The absorption from the gastrointestinal tract is reduced by up to 85 and 43 percent respectively.	DDI-false
@DRUG$ .Renal tube transport of @DRUG$ may be inhibited by concomitant administration of ciprofloxacin , potentially leading to increased plasma levels of methotrexate .	DDI-false
@DRUG$, other, especially diazoxide, or preanesthetic and anesthetic agents used in surgery or @DRUG$, nondepolarizing, used in surgery	DDI-false
@DRUG$ : @DRUG$ The plasma levels of vardenafil were not altered when co-administered (0.5 g/ kg body weight: approximately 40 ml absolute alcohol for a 70 kg person).	DDI-false
Expected changes in laboratory assessments of PT and INR were observed after @DRUG$ However, these changes were not due to the concomitant use of @DRUG$ administration .	DDI-false
Vitamin A : Because of the relationship of @DRUG$ to vitamin A , patients should be advised against taking @DRUG$ Containing vitamin A to avoid additive toxic effects	DDI-false
Methotrexate: Caution should be used if @DRUG$ is administered concomitantly with @DRUG$.	DDI-advise
Ergot Derivatives : Dihydroergotamine , ergonovine , @DRUG$ , methylergonovine CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute @DRUG$ Toxicity characterized by peripheral vasospasm and ischemia of extremities and other tissues.	DDI-false
Because of its lack of platelet effects, @DRUG$ is not a substitute for @DRUG$ for cardiovascular prophylaxis.	DDI-false
In addition, higher-than expected steady-state serum concentrations of @DRUG$ have been observed when therapy is initiated in patients already taking @DRUG$.	DDI-mechanism
Primary and secondary @DRUG$ deficiencies constitute the sole indication of physiological oral @DRUG$ therapy .	DDI-false
Observations from drug interaction studies with: @DRUG$ may not be predictive for @DRUG$.	DDI-false
Other Drugs : Drugs such as @DRUG$ , disopyramide, procainamide, @DRUG$ , antihistamines , and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia .	DDI-false
acetaminophen/theophylline , lidocaine/quinidine , @DRUG$/acetaminophen , phenobarbital/valproic acid , quinidine/lidocaine , theophylline/acetaminophen , and @DRUG$/phenobarbital .	DDI-false
Other concomitant therapy Although no specific interaction studies have been conducted, 1 mg or more of finasteride doses have been used in clinical trials with acetaminophen, acetylsalicylic acid, A-blockers, @DRUG$ , angiotensin-converting enzyme ( ACE ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , @DRUG$ , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
Because of the potential for adverse reactions from the drugs in nursing infants , a decision must be made whether to discontinue nursing or discontinue @DRUG$ and @DRUG$ treatment .	DDI-false
For example, inhibitors are azole antimycotics, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, @DRUG$ , Nefazodon, Nicardipine, Propofol, Protease inhibitors, quinidine and @DRUG$.	DDI-false
Iodine or iodine excess may decrease the effect of @DRUG$ , and an iodine deficiency can increase the effect of @DRUG$.	DDI-false
This medicine can be used with alcohol or other forms of interaction. @DRUG$ ( may potentiate the CNS depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( MAO ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of @DRUG$ ) .	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, @DRUG$, @DRUG$, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
MAO inhibitors @DRUG$ , as well as a metabolite of @DRUG$ Slow amphetamine metabolism.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -@DRUG$ blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a @DRUG$ inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Gleevec increases plasma concentrations of other CYP3A4 metabolised medicinal products (e.g. triazolo@DRUG$, dihydropyridine calcium channel blockers, certain @DRUG$ ..............................................................................................................................................................................................................................................................................................................................................................................	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect @DRUG$ pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of @DRUG$	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, @DRUG$, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, @DRUG$, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
The administration of local @DRUG$ containing @DRUG$ or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.	DDI-false
Antiarrhythmics : Other @DRUG$ medicines, such as quinidine, @DRUG$ , disopyramide , and phenytoin , have been used concurrently with amiodarone .	DDI-false
- Methotrexate (e.g., @DRUG$) Use of methotrexate with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of @DRUG$	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including @DRUG$ and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, @DRUG$, and beta adrenergic blocking agents.	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of @DRUG$ 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (@DRUG$, barbiturates, opiates, sedatives, anesthetics) should be considered.	DDI-advise
Other concomitant therapy Although no specific interaction studies have been conducted, 1 mg or more of finasteride doses have been used in clinical trials with acetaminophen, acetylsalicylic acid, A-blockers, analgesics, @DRUG$ , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , H2 antagonists , HMG-CoA reductase inhibitors , @DRUG$ ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
Warfarin Keppra ( 1000 mg twice daily ) did not affect the pharmacokinetics of @DRUG-DRUG$.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, @DRUG$, oral contraceptives, @DRUG$, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Injection : Lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with @DRUG$ If scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations and irrational behaviour has been observed.	DDI-false
Chlorpromazine: Chlorpromazine blocks dopamine and norepinephrine receptors, thus inhibiting the central stimulant effects of @DRUG$ and can be used to treat @DRUG$ poisoning.	DDI-false
acetaminophen/theophylline , lidocaine/quinidine , phenobarbital/acetaminophen , @DRUG$/valproic acid , quinidine/lidocaine , @DRUG$/acetaminophen , and valproic acid/phenobarbital .	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (@DRUG$ transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, @DRUG$, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
While all the @DRUG$ ( SSRIs ) , e.g. , citalopram , escitalopram , @DRUG$ , sertraline , and paroxetine , inhibit P450 2D6 , they may vary in the extent of inhibition .	DDI-false
@DRUG$ The concomitant use of DURAGESIC (Fentanyl transdermal system) with other @DRUG$ , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	DDI-false
Both ibogaine and 18-MC block @DRUG$-induced and @DRUG$-induced dopamine release in the nucleus accumbens;	DDI-false
@DRUG$ Methaqualone is pharmacologically interacting with orally administered @DRUG$ , but the effect is not clinically significant .	DDI-int
Other strong inhibitors of CYP3A4 (e.g., @DRUG$, @DRUG$, nefazodone, troleandomycin, ritonavir, nelfinavir) would be expected to behave similarly.	DDI-false
It is believed that the toxicity may have resulted from a previously unrecognized interaction between @DRUG$ and @DRUG$ and a molecular basis for this interaction has been proposed.	DDI-effect
Antimycobacterial Agents : @DRUG$ CONTRAINDICATED since the coadministration of this product with saquinavir in an @DRUG$ regimen reduces the plasma concentrations of saquinavir .	DDI-false
Administering @DRUG$ together with @DRUG$ InsP(3)-induced reactions ( both Ca(2 + ) and current reactions ) in a dose-dependent manner.	DDI-effect
Fluoxetine and @DRUG$ increased blood @DRUG$ at different times after the glucose overload .	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, @DRUG$, isosorbide mononitrate, carvedilol, ethanol or @DRUG$.	DDI-false
Potential drug interactions between @DRUG$   and other @DRUG$ ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies .	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole ( cefmenoxime , cefoperazone , cefotetan , @DRUG$ , @DRUG$ ) or methylthiadiazole ( cefazolin ) can cause vitamin K deficiency and hypoprothrombinemia .	DDI-false
Other Drug Interactions: No pharmacokinetic interactions were observed between vardenafil and the following drugs: @DRUG$, warfarin, digoxin, @DRUG$, and ranitidine.	DDI-false
@DRUG$ The effect of alcohol, barbiturates and other @DRUG$ can be increased.	DDI-effect
@DRUG$ may increase slightly the effect of antihypertensive drugs , e.g. , guanethidine , methyldopa , @DRUG$.	DDI-effect
Drugs With A Narrow Therapeutic Index @DRUG$ A single dose of @DRUG$ 3 mg did not affect the pharmacokinetics of digoxin measured at steady state following dosing of 0.5 mg twice daily for one day and 0.25 mg daily for the next 6 days.	DDI-false
Single doses of either cholestyramine or colestipol @DRUG$ bind the @DRUG$ and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to @DRUG$, including anti-arrhythmic agents such as quinidine and procainamide, @DRUG$ and tricyclic anti-depressants.	DDI-false
This appears to be the only clinically relevant interaction of this kind with @DRUG$ Although theoretically, concomitant use of other drugs is known to alter the heart conduction (e.g., anti-arrhythmic or beta-adrenergic blockers, calcium channel blockers, antihistamines or H1 blockers, tricyclic antidepressants, and @DRUG$ ) might also contribute to a prolongation of the QTc interval .	DDI-effect
Compounds tested in man include warfarin , theophylline , phenytoin , @DRUG$ , @DRUG$ and antipyrine .	DDI-false
The antihypertensive effect of enalapril and @DRUG$ IV is augmented by @DRUG$ , which cause renin release (e.g., diuretics).	DDI-effect
The possibility of hypotensive effects with @DRUG$ or enalaprilat can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with @DRUG$ or enalaprilat.	DDI-false
Non-steroidal Anti-inflammatory Drugs : In some patients , the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic , natriuretic , and antihypertensive effects of @DRUG-DRUG$.	DDI-false
@DRUG$ ('@DRUG$') is a newly introduced atypical antipsychotic with demonstrated efficacy in the treatment of positive and negative symptoms of schizophrenia.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with @DRUG$ reduced serum levels and urinary excretion of fosinoprilat as compared with @DRUG$ administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
- @DRUG$ The use of oral antidiabetics with sulfapyridine may increase the likelihood of side effects that increase blood and/ or side effects, or @DRUG$	DDI-false
The benzodiazepines are a family of @DRUG$ and @DRUG$.	DDI-false
Both ibogaine and @DRUG$ block morphine-induced and @DRUG$-induced dopamine release in the nucleus accumbens ;	DDI-effect
Co-administration of BOTOX and @DRUG$ Neuromuscular transmissions (e.g. @DRUG$ ) should only be performed with caution as the effect of the toxin may be potentiated .	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral @DRUG$ (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and @DRUG$ did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
These drugs include the thiazides and other diuretics, @DRUG$, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and @DRUG$.	DDI-false
Concurrent administration of HEXALEN and antidepressants of the MAO inhibitor class may cause severe orthostatic hypotension.@DRUG$, an inhibitor of microsomal drug metabolism, increased @DRUG$s half-life and toxicity in a rat model.	DDI-mechanism
@DRUG$ Keppra ( 1000 mg twice daily ) did not affect pharmacokinetics and pharmacodynamics (ECG). @DRUG$ given as a 0.25 mg dose every day .	DDI-false
@DRUG$ In a study in healthy male subjects, no significant pharmacokinetic interactions occurred when captopril and @DRUG$ were administered concomitantly for 6 days .	DDI-false
Concomitant cyclophosphamide , @DRUG$ , vincristine , and prednisone chemotherapy plus @DRUG$ Treatment in patients with human immunodeficiency virus-associated non-Hodgkin lymphoma.	DDI-false
• Exact monitoring and careful dose adjustment are required if: @DRUG$ is used with other @DRUG$ or sympathomimetic drugs .	DDI-advise
@DRUG$ taken concomitantly with @DRUG$ for less than seven days increases plasma concentrations of procainamide and n-acetyl procainamide by 55% and 33%, respectively.	DDI-false
Other Cardiovascular Agents : @DRUG$ and enalapril IV have been used concomitantly with beta adrenergic-blocking agents , methyldopa , @DRUG$ , calcium-blocking agents , hydralazine , prazosin and digoxin without evidence of clinically significant adverse interactions .	DDI-false
@DRUG$    @DRUG$ antagonism	DDI-false
Other Cardiovascular Agents : Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents , methyldopa , nitrates , @DRUG$ , @DRUG$ , prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Benzthiazide may interact with @DRUG$, @DRUG$s, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
@DRUG$: Caution should be used if diflunisal is administered concomitantly with @DRUG$.	DDI-false
ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received @DRUG$ or angiotensin II receptor antagonists (ACEI/@DRUG$).	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with @DRUG$, betablockers, @DRUG$, diuretics, and nonsteroidal anti-inflammatory drugs (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
Multivalent Cation-Containing products: Concomitant administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminium antacids, sucralfate, VIDEX chew/buffer tablets or child powder, or products containing calcium, iron or @DRUG$ may substantially decrease the absorption of @DRUG$ , which leads to serum and urine levels significantly lower than desired.	DDI-false
Therefore, @DRUG$ and @DRUG$ should not be used concomitantly.	DDI-advise
Based on these data, @DRUG$ Treatment should not be used in chronic renal failure patients. @DRUG$ therapy .	DDI-advise
Acetaminophen: In normal volunteers, concomitant administration of diflunisal and @DRUG$ resulted in an approximate 50% increase in plasma levels of @DRUG$.	DDI-false
@DRUG$: Phenylbutazone causes increase (by about 80%) in the free fraction of @DRUG$.	DDI-false
There was no evidence of pharmacokinetic interactions between: @DRUG$ and @DRUG$.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like @DRUG$ (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - @DRUG$ - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Suppression by verapamil of @DRUG$-enhanced peritoneal metastasis of intestinal adenocarcinomas induced by @DRUG$ in wistar rats .	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (@DRUG$), platelet inhibitors (acetylsalicylic acid), @DRUG$ (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Nephrotoxicity has been reported following concomitant administration of cephalosporins with @DRUG$ or potent diuretics such as @DRUG$.	DDI-false
In addition to this pharmacological interaction, this report describes a novel chemical reaction between temazepam (a @DRUG$) and @DRUG$ under acidic conditions similar to those found in vivo, resulting in a 3-ethoxylated product.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (@DRUG$): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: @DRUG$ increases the effect of Tricyclic antidepressants	DDI-false
• Delayed adverse reactions to iodised contrast media : A review of the literature revealed that 12.6% ( range 11 - 28% ) of the 501 patients who had various @DRUG$ Containing dosing regimens that were subsequently administered @DRUG$ experienced acute , atypical adverse reactions .	DDI-effect
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when @DRUG$ is administered concomitantly with other antimuscarinics, amantadine, haloperidol, phenothiazines, @DRUG$, tricyclic antidepressants or some antihistamines.	DDI-effect
The intensity, uniformity and time course of anticoagulant interference by @DRUG$, secobarbital, @DRUG$, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
Moreover, additional interaction studies with niacin and @DRUG$ have not demonstrated any effect on fluvastatin plasma levels, and administration to a patient population chronically receiving @DRUG$ resulted in no difference in the extent of bioavailability of digoxin relative to control data.	DDI-false
Garlic Capsules Garlic capsules should not be used while taking saquinavir (@DRUG$) as the sole @DRUG$ due to the risk of decreased saquinavir plasma concentrations.	DDI-false
Co-medications that induce CYP3A4 (e.g., @DRUG$, phenytoin, @DRUG$, rifampin, phenobarbital or St.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, @DRUG$, isoniazid, nefazodone, nicardipine, propofol, @DRUG$, quinidine, and verapamil.	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of @DRUG$ and thus should be avoided. 12 @DRUG$ and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-false
In addition, certain drugs metabolised by this isoenzyme, including many antidepressants ( @DRUG$ , @DRUG$ , and others ) , may inhibit the activity of this isoenzyme , and thus may make normal metab-olizers resemble poor metabolizers with regard to concomitant therapy with other drugs metabolized by this enzyme system , leading to drug interactions .	DDI-false
Digoxin: @DRUG$ 75 mg once daily for 11 days does not alter the plasma concentration profile or renal elimination of @DRUG$ after a single 0.5 mg oral dose.	DDI-false
Anticholinesterases (neostgmine, physostigmine), lignocaine, @DRUG$, @DRUG$ can enhance toxicity and cause cardio respiratory depression.	DDI-false
Acetaminophen/theophylline, @DRUG$/chinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen and valproic acid/phenobarbital.	DDI-false
@DRUG$ including tranylcypromine sulfate, phenelzine sulfate, and @DRUG$ HC1: Concomitant use of L-tyrosine and non-selective MAO inhibitors may cause hypertension.	DDI-false
@DRUG$: Other @DRUG$ drugs, such as quinidine, procainamide, disopyramide, and phenytoin, have been used concurrently with amiodarone.	DDI-false
Potential drug interactions between Keppra   and other AEDs ( @DRUG$ , gabapentin , @DRUG$ , phenobarbital, phenytoin, primidone and valproate) were also evaluated by the evaluation of levetiracetam serum concentrations and these AEDs in placebo-controlled clinical trials.	DDI-false
This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or @DRUG$), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with @DRUG$), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
Medicines that cause the release of renin : The antihypertensive effect of @DRUG$ and @DRUG$ IV is augmented by antihypertensive agents that cause renin release ( e.g. , diuretics ) .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Lithium: In a study conducted in healthy subjects, mean steady-state lithium plasma levels increased in patients who were @DRUG$ 450 mg BID with CELEBREX 200 mg BID as compared to subjects receiving @DRUG$ alone .	DDI-false
- Methotrexate ( e.g. , Mexate ) Use of @DRUG$ with @DRUG$ may increase the chance of side effects affecting the liver and/or the side effects of methotrexate	DDI-effect
@DRUG$: Eszopiclone 3 mg administered daily for 5 days did not affect the pharmacokinetics of@DRUG$n, nor were there any changes in the pharmacodynamic profile (prothrombin time) following a single 25 mg oral dose of warfarin	DDI-false
Both efavirenz and nevirapine have been compared to triple therapy with the @DRUG$ @DRUG$ For 48 weeks as initial therapy, with similar response rates observed with nevirapine therapies and superiority with efavirenz.	DDI-false
Coingestion of acetaminophen with theophylline, @DRUG$ with acetaminophen, and valproic acid with @DRUG$ at high to toxic concentrations decreases the binding of the target drug.	DDI-false
@DRUG$ : Because atorvastatin does not affect the pharmacokinetics of @DRUG$ , interactions with other drugs metabolized via the same cytochrome isozymes are not expected .	DDI-false
Therefore , when Hydrochlorothiazide and @DRUG$ are used concomitantly , the patient should be observed closely to determine if the desired effect of the @DRUG$ is obtained .	DDI-false
The availability of potent non-nucleoside reverse transcriptase inhibitor (@DRUG$)-based regimens for @DRUG$ therapy and concerns regarding protease inhibitor (PI)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection.	DDI-false
Simultaneous oral administration of @DRUG$ ( a known inhibitor of CYP3A4 activity in the liver and in the intestinal mucosa ) caused an eight-fold increase of the systemic exposure to oral @DRUG$.	DDI-mechanism
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of @DRUG$, @DRUG$, niacin (nicotinic acid), erythromycin, azole antifungals.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$, sympathomimetics, @DRUG$, and isoniazid.	DDI-false
Drugs Interactions : Flupentixol may interact with some medicines, such as monoamine oxidase inhibitors (MAOI): MAOI may theoretically affect @DRUG$ pharmacodynamics - Arecolin - eproxindine - @DRUG$ Flupentixol and ethanol cause additive CNS depression - tricyclic antidepressants : flupentixol increases the effect of tricyclic antidepressants	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, fibric acid derivatives, @DRUG$ (nicotinic acid), @DRUG$, azole antifungals.	DDI-false
@DRUG$ (5 mg/kg), moclobemide (30 mg/kg), @DRUG$ (0.25 mg/kg), fluoxetine (20 mg/kg) sertraline (30 mg/kg) or vehicle was administered.	DDI-false
Treatment with @DRUG$ once weekly for 4 weeks in healthy subjects was associated with an inhibition of P450 1A2 and a 25% increase in @DRUG$ AUC.	DDI-mechanism
It is important that patients understand how to @DRUG$   ( @DRUG$ ) capsules with the supplied AerolizerTM inhalation device and how it should be used in relation to other asthma or COPD medications they are taking .	DDI-false
- Anabolic steroids (nandrolone [e.g., Anabolin], oxandrolone [e.g., @DRUG$], oxymetholone [e.g., Anadrol], @DRUG$ [e.g., Winstrol]) or	DDI-false
Single doses of either @DRUG$ or @DRUG$ resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.	DDI-false
During co-administration @DRUG$ and @DRUG$ They were essentially unchanged.	DDI-false
In patients with mild to moderate hypertension , administration of 25 mg daily of @DRUG$ with the ACE inhibitor benazepril , 10 to 40 mg for 4 weeks , was associated with an average increase in mean arterial pressure of about 3 mm Hg compared to @DRUG$ alone .	DDI-false
Antihypertensive agents: amiodarone should be used with caution in patients with receptor blockers (e.g. propranolol, @DRUG$ Inhibitor) or calcium channel antagonists (e.g. verapamil, a CYP3A4 substrate and diltiazem, a @DRUG$ Inhibitor) because of the potential for bradycardia, sinus arrest and AV block;	DDI-false
As with other @DRUG$ , it should be noted that HALDOL may be capable of potentiating @DRUG$ such as anesthetics , opiates , and alcohol .	DDI-effect
To assess the effect of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL), the authors retrospectively compared a group of 24 patients with HIV-NHL treated with cyclophosphamide, doxorubicin, @DRUG$ , and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide and prednisone with vincristine plus bleomycin) without treatment @DRUG$ therapy .	DDI-false
Prednisone/prednisolone : @DRUG$ did not have any clinically important effect on the pharmacokinetics of prednisolone or @DRUG$.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , doxorubicin , vincristine , and prednisone ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , doxorubicin , teniposide , and @DRUG$ with @DRUG$ Bleomycin) without antiretroviral therapy.	DDI-false
The data from in vitro studies with benzodiazepines other than alprazolam indicate a possible interaction with the following medicinal products: ergotamine, @DRUG$ , Amiodaron, Nicardipine, and @DRUG$.	DDI-false
It is recommended to avoid concurrent administration of @DRUG$ with @DRUG$ containing antacids for at least 4 hours following ethambutol administration.	DDI-advise
Analysis of the concentration of @DRUG$ After ultracentrifugation, it was shown that there was a rapid equilibrium reaction of budesonide between the @DRUG$ Phase and aqueous phase.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., @DRUG$), general @DRUG$, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of @DRUG$ needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with @DRUG$ or Innovar than with pentobarbital.	DDI-false
The successive application of @DRUG$ (5 or 10 mg/kg egg weight (e.w.) and @DRUG$ (15 mg/kg e.w.) in a 10 min interval significantly increased the activation of spontaneous motility of 17-day-old chick embryos in comparison with the effect of glutamate alone.	DDI-effect
Bacteriostatic Antibiotics : Chloramphenicol , @DRUG$ , sulfonamides , or @DRUG$ The bactericidal effect of penicillins may be impaired.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, @DRUG$), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, @DRUG$) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
The steady state plasma concentrations of @DRUG$ and desipramine have been reported to be increased an average of 31% and 20%, respectively, by the concomitant administration of @DRUG$ tablets in doses up to 4 mg/day.	DDI-mechanism
Simultaneous administration of mefloquine and other related compounds (e.g. @DRUG$ , @DRUG$ and chloroquine ) may produce electrocardiographic abnormalities and increase the risk of convulsions .	DDI-false
Co-administration of warfarin and @DRUG$ The pharmacokinetics of @DRUG$ have not been altered.	DDI-false
Antacids : In a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , @DRUG$ , and Simethicon) with @DRUG$ reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .	DDI-mechanism
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), @DRUG$ (acetylsalicylic acid), @DRUG$ (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Simultaneous cyclophosphamide, doxorubicin, @DRUG$ , and @DRUG$ chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-associated non-Hodgkin lymphoma.	DDI-false
Drug interactions : Flupentixol may interact with some medicines such as monoamine oxidase inhibitors (MAOI): MAOI may theoretically affect flupentixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupentixol and @DRUG$ cause additive CNS depression - Tricyclic antidepressants : @DRUG$ increases the effect of Tricyclic antidepressants	DDI-false
@DRUG$ , tricyclic Amphetamines may enhance the activity of tricyclic antidepressants or @DRUG$ ;	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Antihypertensive medicines, others, especially @DRUG$ , or pre@DRUG$ and anesthetics used in surgery or skeletal muscle relaxants, non-depolarizing, in surgery	DDI-false
@DRUG$ : The concomitant use of DURAGESIC   ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , @DRUG$ ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with @DRUG$ or @DRUG$ than with pentobarbital.	DDI-false
Beta-blocking Agents: The concomitant use of @DRUG$ and @DRUG$ has been well tolerated in patients with stable angina.	DDI-false
Tetracyclines: Concomitant treatment with Accutane and tetracyclines should be avoided because @DRUG$ use has been associated with a number of cases of pseudotumor cerebri (benign intracranial hypertension), some of which involved concomitant use of @DRUG$	DDI-effect
Injection : Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when with ethyl alcohol, phenothiazine, barbiturates, @DRUG$ , and other antidepressants . When scopolamine is used concomitantly with injectable @DRUG$ , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .	DDI-false
Multivalent Cation-Containing Products : Concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum @DRUG$ , sucralfate , VIDEX chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of @DRUG$ , which leads to serum and urine levels significantly lower than desired.	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , @DRUG$ , quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$ , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
Monoamine Oxidase Inhibitors and Tricyclic Antidepressants: @DRUG$ should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants because the action of @DRUG$ on the cardiovascular system may be potentiated by these agents.	DDI-false
These drugs include the @DRUG$ And other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blockers and @DRUG$.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, @DRUG$, nifedipine, chlordiazepoxide, @DRUG$, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Intravenous Adenocard (adenosine) has been effectively administered in the presence of other cardioactive drugs, such as quinidine, @DRUG$, calcium channel blocking agents, and @DRUG$, without any change in the adverse reaction profile.	DDI-false
While all the @DRUG$ ( SSRIs), e.g. citalopram, escitalopram, fluoxetine, @DRUG$ , and paroxetine, inhibit P450 2D6, they may vary in extent of inhibition.	DDI-false
Because of its lack of platelet effects , @DRUG$ is not a substitute for @DRUG$ For cardiovascular prophylaxis.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing @DRUG$, iron, or @DRUG$ may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, @DRUG$, @DRUG$ (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
@DRUG$ In some patients, the administration of a non-steroidal anti-inflammatory agent may reduce the diuretic, natriuretic and blood pressure lowering effect of loop, potassium sparing and @DRUG$.	DDI-false
Carbamazepine: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels @DRUG$ levels should be determined prior to concurrent administration with @DRUG$, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.	DDI-advise
These drugs include the @DRUG$ and other diuretics, corticosteroids, phe-nothiazines, @DRUG$, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Nonsteroidal Anti-Inflammatory Drugs: The administration of diflunisal to normal volunteers receiving @DRUG$ decreased the renal clearance and significantly increased the plasma levels of @DRUG$.	DDI-false
Reciprocal interactions may occur with concomitant use of Antizol and drugs that increase or inhibit the cytochrome P450 system (e.g., phenytoin, carbamazepine, @DRUG$, @DRUG$), though this has not been studied	DDI-false
Potential drug interactions between @DRUG$  and other @DRUG$ (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Multivalent Cation-Containing Products : Concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , VIDEX chewable/buffered tablets or pediatric powder , or products containing @DRUG$ , iron , or zinc may substantially decrease the absorption of @DRUG$ , which leads to serum and urine levels significantly lower than desired.	DDI-false
@DRUG$ taken concomitantly with procainamide for less than seven days increases plasma concentrations of @DRUG$ n-acetylprocainamide by 55% and 33% respectively.	DDI-false
In patients receiving @DRUG$, the addition of @DRUG$ to therapy could prolong the prothrombin time.	DDI-effect
Aspirin/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered @DRUG$ (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of @DRUG$ 1.5  g/kg/min. over 18 hours).	DDI-false
In clinical studies performed with @DRUG$, the concomitant use of oral anticoagulants (warfarin), @DRUG$ (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Multivitamins, or other products containing iron or @DRUG$, @DRUG$ or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.	DDI-false
When Itraconazole was coadministered with @DRUG$ , rifampin , or H2antagonists , reduced plasma concentrations of @DRUG$ were reported .	DDI-false
The pressor effects of @DRUG$ such as dopamine or @DRUG$ are enhanced by Bretylium Tosylate.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral @DRUG$, phenytoin, nicotinic acid, sympathomimet-ics, @DRUG$, and isoniazid.	DDI-false
"It is concluded that @DRUG$ and @DRUG$ may be administered safely without additional caution in prothrombin test monitoring during oral anticoagulant therapy .	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, @DRUG$ and @DRUG$ (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
The concomitant use of other CYP3A4 inhibitors such as diltiazem and @DRUG$ with transdermal @DRUG$ may also result in an increase in fentanyl plasma concentrations, which could increase or prolong adverse drug effects and may cause serious respiratory depression.	DDI-mechanism
Azithromycin had no significant impact on the Cmax and AUC of @DRUG$, although it significantly decreased the zidovudine tmax by 44% and increased the intracellular exposure to phosphorylated @DRUG$ by 110%.	DDI-false
Both @DRUG$ and @DRUG$ have been compared to triple therapy with the PI indinavir over 48 weeks as initial therapy, with similar responses being observed with nevirapine regimens and superiority observed with efavirenz.	DDI-false
In addition, certain drugs that are metabolised by this isoenzyme, including many @DRUG$ ( tricyclic antidepressants , @DRUG$ , and others ) , may inhibit the activity of this isoenzyme , and thus may make normal metab-olizers resemble poor metabolizers with regard to concomitant therapy with other drugs metabolized by this enzyme system , leading to drug interactions .	DDI-false
Concomitant administration of @DRUG$ doubled the AUC for @DRUG$.	DDI-mechanism
@DRUG$ : The effects of @DRUG$ and NSAIDs on GI bleeding are synergistic , such that users of both drugs together have a risk of serious GI bleeding higher than that of users of either drug alone .	DDI-false
@DRUG$ Absorption may also include the absorption of @DRUG$ , which can lead to a deficiency .	DDI-mechanism
Previous studies have demonstrated a significant reduction in the oral bioavailability of @DRUG$ Ciprofloxacin when co-administered with an intravenous @DRUG$ Like morphine.	DDI-mechanism
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
@DRUG$: Clinical studies, as well as post marketing observations, have shown that @DRUG$ can reduce the natriuretic effect of furosemide and thiazides in some patients.	DDI-false
Cimetidine : @DRUG$ has been reported to produce clinically significant fluctuations in steady-state serum concentrations of various @DRUG$.	DDI-mechanism
Possible drug interactions between Keppra and other AEDs (carbamazepine, gabapentin, @DRUG$ , @DRUG$ , phenytoin, primidone and valproate) were also evaluated by assessing levetiracetam serum concentrations and these AEDs in placebo-controlled clinical trials.	DDI-false
@DRUG$: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving concomitant @DRUG$ and ACE inhibitor therapy.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, @DRUG$, skeletal muscle relaxants, and @DRUG$, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
@DRUG$: In healthy subjects receiving ketoconazole, a CYP3A4 inhibitor, at 200 mg twice daily for 7 days, systemic exposure (AUC) to @DRUG$ was increased to approximately 3.6-fold of control and half-life increased to 1.7-fold of control.	DDI-false
MAO inhibitors MAOI antidepressants, and a metabolite of @DRUG$ , slow @DRUG$ metabolism .	DDI-mechanism
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral @DRUG$, phenytoin, @DRUG$, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
@DRUG$: Altered serum levels of phenytoin (increased and decreased) have been reported in patients receiving concomitant @DRUG$.	DDI-false
- anabolic steroids (Nandrolone [e.g. Anaboline ], Oxandrolone [e.g., @DRUG$ ] , oxymetholone [ e.g. , @DRUG$ ] , stanozolol [ e.g. , Winstrol ] ) or	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other @DRUG$, sedatives, hypnotics, tranquilizers (e.g., @DRUG$), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
To evaluate the effects of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma ( HIV-NHL), the authors retrospectively compared a group of 24 patients with HIV-NHL treated with the cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or a CHOP-like regimen (i.e. cyclophosphamide), @DRUG$ , teniposide , and prednisone with @DRUG$ plus bleomycin ) without receiving antiretroviral therapy .	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, @DRUG$, @DRUG$ chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
• Co-administration with compounds that are potent CYP3A4 inducers (e. g. @DRUG$ , phenytoin , dexamethasone , @DRUG$ ) may result in decreased plasma levels of saquinavir .	DDI-false
Although no specific drug interactions with topical glaucoma or systemic medications have been identified in clinical studies, there has been an increase in the incidence of adverse drug reactions. @DRUG$ 0.5 % Ophthalmic Solution , the possibility of an additive or potentiating effect with CNS depressants ( alcohol , barbiturates , opiates , @DRUG$ Anaesthetics) should be considered.	DDI-advise
Caution should be exercised when administering @DRUG$ with drugs that are known to inhibit phosphatase activities (e.g., @DRUG$).	DDI-advise
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
Antiarrhythmics: Other antiarrhythmic drugs, such as quinidine, @DRUG$, @DRUG$, and phenytoin, have been used concurrently with amiodarone.	DDI-false
Other strong inhibitors of CYP3A4 (e.g., @DRUG$, clarithromycin, nefazodone, @DRUG$, ritonavir, nelfinavir) would be expected to behave similarly.	DDI-false
Drugs Interactions : Flupentixol may interact with some medicines such as monoamine oxidase inhibitors (MAOI): MAOI may theoretically affect flupentixol pharmacodynamics - Arecoline - Eproxindine - @DRUG$ : @DRUG$ - Tricyclic antidepressants : Flupentixol increases the effect of tricyclic antidepressants	DDI-false
Therophylline : A recent study has shown that @DRUG$ Treatment with theophylline may lead to increased plasma levels. @DRUG$ , and in some instances a slight decrease in the elimination of isoniazid .	DDI-false
Other CONCOMITANT THERAPY: Although specific interaction studies have not been performed, in clinical studies cerivastatin sodium was used together with angiotensin converting enzyme ( ACE) inhibitors, beta-blockers, @DRUG$ , diuretics, and @DRUG$ NSAIDs without evidence of clinically significant adverse interactions.	DDI-false
This medication can be used with alcohol or other CNS depressants (may potentiate the CNS depressive effect of either these medications or @DRUG$ ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and @DRUG$ Concomitant use of antihistamines may prolong and increase the anticholinergic and CNS depressive effects of antihistamines.	DDI-false
Prednisone/@DRUG$: Rofecoxib did not have any clinically important effect on the pharmacokinetics of @DRUG$ or prednisone.	DDI-false
Coingestion of acetaminophen with theophylline , phenobarbital with acetaminophen , and @DRUG$ with @DRUG$ at high to toxic concentrations decreases the binding of the target drug .	DDI-effect
In a 12-week endoscopy study conducted in OA patients there was no difference in the cumulative incidence of endoscopic gastroduodenal ulcers in patients taking low-dose (81 mg) enteric coated @DRUG$ plus VIOXX 25 mg daily, as compared to those taking @DRUG$ 2400 mg daily alone.	DDI-false
@DRUG$: May decrease renal tubular secretion of ampicillin resulting in increased blood levels and/or @DRUG$ toxicity.	DDI-false
Serum lithium levels should be monitored frequently if @DRUG$ is administered concomitantly with @DRUG$.	DDI-advise
"In the Steady State, @DRUG$ 50 mg once daily had no effect on the anti-platelet activity of low-dose ( 81 mg once daily ) @DRUG$ , as assessed by ex vivo platelet aggregation and serum TXB2 generation in clotting blood .	DDI-false
@DRUG$ (neostgmine, physostigmine), lignocaine, @DRUG$, procainamide can enhance toxicity and cause cardio respiratory depression.	DDI-false
There have been reports of QTc prolongation, with or without TdP, in patients taking @DRUG$ when @DRUG$, macrolide antibiotics, or azoles were administered concomitantly.	DDI-false
Ritonavir and @DRUG$: Upon concomitant administration of 5 mg of @DRUG$ with 600 mg BID ritonavir, the Cmax and AUC of ritonavir were reduced by approximately 20%.	DDI-false
- antidiabetic medicines, orally (diabetes medicines you take through your mouth) use of oral antidiabetic medicines with @DRUG$ may increase the chance of side effects affecting the blood and/or the side effects or oral @DRUG$	DDI-false
For example, inhibitors are azole antimycotics, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazide, @DRUG$ , @DRUG$ Propofol, protease inhibitors, quinidine and verapamil.	DDI-false
Lithium generally should not be given with @DRUG$ because they reduce lithiums renal clearance and add a high risk of @DRUG$ toxicity.	DDI-false
Drugs With A Narrow Therapeutic Index @DRUG$ A single dose of 3 mg eszopiclone did not affect the pharmacokinetics of eszopiclone. @DRUG$ measured at steady state following dosing of 0.5 mg twice daily for one day and 0.25 mg daily for the next 6 days .	DDI-false
- @DRUG$ ( e.g. , Mesantoin ) Use of @DRUG$ with these medicines may increase the chance of side effects of these medicines	DDI-false
In general , these are drugs that have one or more pharmacologic activities similar to @DRUG$ , including anti-arrhythmic agents such as quinidine and procainamide , cardiac glycosides and @DRUG$.	DDI-false
@DRUG$: In a study of young healthy male subjects no evidence of a direct pharmacokinetic captopril-@DRUG$ interaction could be found.	DDI-false
It differs structurally from the other currently available @DRUG$ (Lovastatin, simvastatin, and @DRUG$ ) , leading to unique biopharmaceutical properties relative to the other agents of this class .	DDI-false
Aminosalicylic acid may reduce the amount of digoxin ( @DRUG$ , @DRUG$ It is absorbed in your body.	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, @DRUG$, and other antidepressants.When @DRUG$ is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
acetaminophen/theophylline , lidocaine/@DRUG$ , phenobarbital/acetaminophen , phenobarbital/valproic acid , quinidine/lidocaine , theophylline/acetaminophen , and valproic acid/@DRUG$.	DDI-false
"Folic acid in large quantities can be the antiepileptic effect of @DRUG$ , @DRUG$ and primidone , and increase the frequency of seizures in susceptible pediatric patients .	DDI-false
Benzthiazide can be used with @DRUG$ , blood thinners, decongestant medications (allergy, cold, and sinus drugs), diabetes medications, lithium, @DRUG$ , NSAIDs such as Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (@DRUG$, cefoperazone, cefotetan, @DRUG$, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Isocarboxazid should be administered with caution to patients receiving @DRUG$ (@DRUG$, Wyeth-Ayerst Laboratories).	DDI-false
Multivalent Cation-Containing Products : Concomitant administration of a quinolone, including @DRUG$ , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , VIDEX chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of @DRUG$ , resulting in serum and urine levels considerably lower than desired .	DDI-mechanism
Patients receiving hydantoins, @DRUG$, or @DRUG$ should be observed for increased activity of these drugs and, therefore, signs of toxicity from these drugs.	DDI-false
@DRUG$ taken concomitantly with quinidine increases @DRUG$ serum concentration by 33% after two days.	DDI-false
- @DRUG$ ( e.g. , @DRUG$ ) or	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine , although theoretically , coadministration of other drugs known to alter cardiac conduction ( eg , @DRUG$ or beta-adrenergic blocking agents , calcium channel blockers , @DRUG$ or H1-blocking agents , tricyclic antidepressants and phenothiazines ) might also contribute to a prolongation of the QTc interval .	DDI-false
Remarkable is systemic exposure ( AUC0 - 12 ) @DRUG$ @DRUG$/SMX has more than doubled (DHA ) in the presence of @DRUG$/SMX.	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with @DRUG$, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable @DRUG$, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
No data are available for the concomitant use of @DRUG$/ritonavir or @DRUG$/ritonavir with garlic capsules.	DDI-false
The effects of @DRUG$ From and L-CCG-1 after phencyclidine (@DRUG$)-induced movement and behavioural changes in mice.	DDI-false
Both the toxicity of @DRUG$ and the therapeutic value of amphotericin B can be rationalized at the cellular and molecular level by the following observations: (i) these @DRUG$ showed differential effects on cells;	DDI-false
@DRUG$ For normal volunteers, simultaneous use of diflunisal and @DRUG$ resulted in an approximate 50 % increase in plasma levels of acetaminophen .	DDI-false
These drugs include the @DRUG$ And other diuretics, corticosteroids, phe-nothiazines, thyroid products, @DRUG$ , oral contraceptives , phenytoin , nicotinic acid , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .	DDI-false
BACKGROUND : Effects of combined administration of bombsin and verapamil hydrochloride ( @DRUG$ ), a calcium channel blocker, induced by the incidence of peritoneal metastases of intestinal adenocarcinoma by @DRUG$ ( AOM ) and the labeling index of intestinal cancers were investigated in male Wistar rats .	DDI-false
Gleevec will increase plasmaconcentration of other CYP3A4 metabolized drugs (e.g., triazolo-@DRUG$, dihydropyridine calcium channel blockers, certain @DRUG$, etc.).	DDI-false
ACE inhibitors and angiotensin II receptor antagonists (congestive heart failure after myocardial infarction)- In EPHESUS, 3020 (91%) patients received @DRUG$ 25 to 50 mg also received ACE inhibitors or @DRUG$ ( ACEI/ARB ) .	DDI-false
The administration of local @DRUG$ containing @DRUG$ Patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may experience severe, prolonged hypertension.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, @DRUG$, nifedipine, chlordiazepoxide, diazepam, certain @DRUG$, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Nifedipine : Vardenafil 20 mg , when co-administered with slow-release @DRUG$ 30 mg or 60 mg once daily , did not affect the relative bioavailability ( AUC ) or maximum concentration ( Cmax ) of @DRUG$ A drug that is metabolised by CYP3A4.	DDI-false
For example, inhibitors are azole antimycotics, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, @DRUG$ , and @DRUG$.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril , beta-blockers , felodipine , @DRUG$ , warfarin , isosorbide mononitrate , @DRUG$ Ethanol or itraconazole.	DDI-false
The concomitant administration of medicinal products that are nephrotoxic (e.g. aminoglycosides, indomethacin) is myelotoxic (e.g. @DRUG$ chemotherapy ) , cardiotoxic ( e.g. , doxorubicin ) or hepatotoxic ( e.g. , @DRUG$ Asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Methotrexate Renal tubular transport of @DRUG$ may be inhibited by concomitant administration of ciprofloxacin, potentially leading to increased plasma levels of @DRUG$.	DDI-false
Antimycobacterial agents : rifampin, which has been used since the concomitant use of this medicinal product with @DRUG$ in an @DRUG$ The regimen reduces the plasma concentrations of saquinavir.	DDI-false
@DRUG$ : Because of the relationship of Accutane to vitamin A , patients should be advised against taking @DRUG$ containing vitamin A to avoid additive toxic effects	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral @DRUG$, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and @DRUG$.	DDI-false
Longitudinal assessment of @DRUG$ in de novo renal transplant recipients over the first post-transplant year : pharmacokinetics , exposure-response relationships , and influence on @DRUG$.	DDI-false
It is structurally distinct from the other currently available @DRUG$ ( lovastatin , @DRUG$ , and pravastatin ) , leading to unique biopharmaceutical properties relative to the other agents of this class .	DDI-false
- Warfarin : Quinolone have been reported to reduce the effects of oral @DRUG$ @DRUG$ ==References==<br>	DDI-false
@DRUG$ Keppra ( 1000 mg twice daily ) did not affect the pharmacokinetics of R and @DRUG$.	DDI-false
@DRUG$ taken concomitantly with quinidine increases @DRUG$ serum concentration by 33 % after two days .	DDI-false
Lithium: @DRUG$ have produced an elevation of plasma lithium levels and a reduction in renal @DRUG$ clearance.	DDI-false
The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving @DRUG$, tricyclic antidepressants or @DRUG$ may produce severe, prolonged hypotension or hypertension.	DDI-false
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies (@DRUG$, valproate, oral contraceptive, @DRUG$, warfarin, probenecid) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics , amantadine , haloperidol , @DRUG$ , monoamine oxidase ( MAO ) inhibitors , tricyclic antidepressants or some @DRUG$.	DDI-false
Similarly dialyzed were phenobarbital , @DRUG$ , and @DRUG$ , both at therapeutic concentrations in serum and with ethanol in three different concentrations in serum.	DDI-false
@DRUG$ It has been reported that the @DRUG$ Requirements for human subjects taking these agents at the same time.	DDI-mechanism
The risk of myopathy during treatment with medicines in this class is increased when cyclosporin is co-administered. @DRUG$ , @DRUG$ - (nicotinic acid), erythromycin, azole antifungals.	DDI-false
@DRUG$-@DRUG$ containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, cefotetan, cefamandole, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
For example, inhibitors are azole antimycotics, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, @DRUG$ , nefazodone, nicardipine, propofol, protease inhibitors, @DRUG$ ==References====External links==	DDI-false
• Anticoagulants : potentiation of the @DRUG$ type ( @DRUG$ and CYP3A4 substrate ) anticoagulant response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding .	DDI-false
The compounds tested in humans include warfarin, @DRUG$ , phenytoin, diazepam, aminopyrin and @DRUG$.	DDI-false
Corticosteroids , Methylxanthines and @DRUG$ : Concomitant treatment with xanthine derivatives , steroids , or @DRUG$ A potential hypokalemic effect of beta2-agonists may be increased.	DDI-false
• Anabolic steroids ( @DRUG$ [ e.g. , @DRUG$ ] , oxandrolone [ e.g. , Anavar ] , oxymetholone [ e.g. , Anadrol ] , stanozolol [ e.g. , Winstrol ] ) or	DDI-false
@DRUG$: Indinavir (800 mg t.i.d.) co-administered with Vardenafil 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in @DRUG$ Cmax and a 2-fold increase in vardenafil half-life.	DDI-false
However , the absolute number of @DRUG$-related deaths is far greater than the number of deaths in @DRUG$ • drug users or heroin users.	DDI-false
This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and @DRUG$ (concurrent use with @DRUG$ may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
" medicinal products identified as CYP3A inhibitors of potential clinical significance based on clinical trials involving alprazoleam (when co-administered with: @DRUG$ ): Coadministration of @DRUG$ With alprazolem, the maximum plasma concentration of alprazoleam increased by 46%, decreased clearance by 21%, increased half-life by 17% and decreased measured psychomotor performance.	DDI-false
Concomitant administration of @DRUG$ and other related compounds ( eg , quinine , @DRUG$ and chloroquine ) may produce electrocardiographic abnormalities and increase the risk of convulsions .	DDI-effect
@DRUG$ , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , @DRUG$ and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .	DDI-mechanism
The effects of @DRUG$ ( @DRUG$ ) on inositol 1,4,5-trisphosphate ( InsP(3))-induced responses were studied in rat bone marrow megakaryocytes with the patch-clamp whole-cell recording technique in combination with fura-2 microfluorometry .	DDI-false
@DRUG$ : @DRUG$ The increase in bleeding time caused by aspirin (two 81 mg tablets) was not increased ( 10 mg and 20 mg).	DDI-false
The effects of adenosine are determined by: @DRUG$ such as caffeine and @DRUG$.	DDI-false
@DRUG$ • the effect of @DRUG$ , e.g. , guanethidine , methyldopa , reserpine .	DDI-effect
Plasma @DRUG$ The concentration should be monitored if: @DRUG$ Valproate and valproate should be administered concomitantly and appropriate dose adjustments of valproate should be made.	DDI-false
@DRUG$ The management of @DRUG$ to normal volunteers receiving indomethacin decreased the renal clearance and significantly increased the plasma levels of indomethacin .	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, hypnotics and @DRUG$ (including benzodiazepines), or @DRUG$ was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
Central Nervous System Depressants: The concomitant use of @DRUG$  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., @DRUG$), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
Antacids : Simultaneous application of @DRUG$ may reduce plasma levels of @DRUG$.	DDI-mechanism
Although neither dexamethasone nor retinyl acetate proliferates in RPMI1640, @DRUG$ alone , they modify the mitogenic effect of @DRUG$ and insulin .	DDI-false
Other reported interactions with @DRUG$ Fentanyl ( CYP3A4 substrate) in combination with @DRUG$ For this reason, hypotension, bradycardia, and reduced cardiac output may occur.	DDI-false
Like ibogaine (40 mg/kg), @DRUG$ (40 mg/kg) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of ethanol and @DRUG$ in rats;	DDI-false
Multivitamins , or other products containing iron or zinc , @DRUG$ Concomitant use of Sucralfate or Sucralfate should not occur with or within 2 hours of administration of Sucralfate or Sucralfate. @DRUG$ , because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin .	DDI-advise
Although glucocorticoids have been shown to reduce @DRUG$-induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with @DRUG$ Beta-blockers and other antihypertensive agents may increase hypotension in PROLEUKIN.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, @DRUG$, estrogens, oral @DRUG$, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
The concomitant use of other CYP3A4 inhibitors such as @DRUG$ and @DRUG$ with transdermal fentanyl may also result in an increase in fentanyl plasma concentrations, which could increase or prolong adverse drug effects and may cause serious respiratory depression.	DDI-false
Because of the increased risk of adverse reactions in patients who have been taking benzodiazepines on a regular basis, it is particularly important that physicians query patients or their guardians carefully about @DRUG$, @DRUG$ and sedative use as part of the history prior to any procedure in which the use of ROMAZICON is planned.	DDI-false
Furthermore it has been proposed that @DRUG$ resulted In induction of P-450IIE1 in the patients liver which , in turn , resulted in a greater proportion of the ingested @DRUG$ It is converted to toxic metabolites.	DDI-mechanism
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., @DRUG$), general anesthetics, phenothiazines, @DRUG$, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
For example, inhibitors are azole antimycotics, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, @DRUG$ , Nefazodon, Nicardipine, @DRUG$ , protease inhibitors , quinidine , and verapamil .	DDI-false
@DRUG$ : Amphetamines enhance the adrenergic effect of @DRUG$.	DDI-false
Two groups ( SH/DA ; SH/FA ) were submitted to daily treatment with synthetic hydroalcoholic solutions containing ethanol , methanol , higher @DRUG$ and @DRUG$ — in the same proportions as in the most frequently distilled and fermented alcoholic beverages;	DDI-false
Lithium: In a study conducted in healthy subjects, mean steady-state lithium plasma levels increased approximately 17% in subjects receiving @DRUG$ 450 mg BID with @DRUG$ 200 mg BID as compared to subjects receiving lithium alone.	DDI-mechanism
@DRUG$: The rate and extent of absorption of ciprofloxacin was bioequivalent when @DRUG$ was given alone or when Proquin XR was given 2 hours after omeprazole at the dose that maximally suppresses gastric acid secretion.	DDI-false
@DRUG$ Angiotensin II receptor antagonists (hypertension)- In clinical trials in patients with hypertension, the addition of INSPRA 50 to 100 mg to ACE inhibitors, and @DRUG$ increased mean serum potassium slightly ( about 0.09 - 0.13 mEq/L ) .	DDI-false
@DRUG$ : Administration of @DRUG$ concomitantly with cyclosporine has been associated with an increase in cyclosporine-induced toxicity , possibly due to decreased synthesis of renal prostacyclin .	DDI-false
Agents Affecting Cytochrome P450 3A4 Isoenzyme System @DRUG$ is metabolized mainly via the human cytochrome P450 3A4 isoenzyme system (CYP3A4), therefore potential interactions may occur when @DRUG$  is given concurrently with agents that affect CYP3A4 activity.	DDI-false
Anticoagulant inhibition was observed during the administration of @DRUG$ , @DRUG$ and glutethimide ;	DDI-false
This medicine can be used with @DRUG$ or other @DRUG$ ( may potentiate the CNS depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( MAO ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines ) .	DDI-false
When Itraconazole was coadministered with phenytoin, @DRUG$, or H2antagonists, reduced plasma concentrations of @DRUG$ were reported.	DDI-false
While all the @DRUG$ (SSRIs), e.g., citalopram, @DRUG$, fluoxetine, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
Example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , @DRUG$ , isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and @DRUG$.	DDI-false
( Concomitant use with @DRUG$ • may increase the possibility of: @DRUG$ Toxicity associated with hypokalaemia. )	DDI-effect
In EM individuals treated with @DRUG$ or fluoxetine, the AUC of @DRUG$ is approximately 6- to 8-fold and Css,max is about 3- to 4-fold greater than atomoxetine alone.	DDI-mechanism
The concomitant use of nitrofurantoin is not recommended as: @DRUG$ The antibacterial effect of @DRUG$ In the urinary tract.	DDI-effect
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, Dapson, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$ - ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam and @DRUG$ Concomitant use with saquinavir may result in increased plasma concentrations.	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, Dapson, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$ , cyclosporine , @DRUG$ , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
Example inhibitors include @DRUG$, ciprofloxacin, clarithromycin, diclofenac, @DRUG$, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
@DRUG$ may enhance the seizure risk in patients taking @DRUG$	DDI-effect
Special care should be taken when administering @DRUG$ in cases of mixed drug overdosage since the toxic effects ( such as convulsions and cardiac dysrhythmias ) of other drugs taken in overdose ( especially @DRUG$ ) may emerge with the reversal of the benzodiazepine effect by flumazenil .	DDI-effect
In a study in healthy male subjects, no significant pharmacokinetic interactions occurred if: @DRUG$ and @DRUG$ They were administered simultaneously for 6 days.	DDI-false
The possibility of hypotensive effects with @DRUG$ One week before starting treatment with captopril, salt intake can be minimized either by stopping the diuretic or by increasing the intake of salt ( @DRUG$ tablets , USP ) or initiating therapy with small doses ( 6.25 or 12.5 mg ) .	DDI-false
Lithium: Increased serum @DRUG$ levels and symptoms of lithium toxicity have been reported in patients receiving concomitant @DRUG$ and ACE inhibitor therapy.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, @DRUG$, @DRUG$, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Data from in vitro studies of alprazolam suggest a possible drug interaction with @DRUG$ for the following : @DRUG$ and paroxetine .	DDI-int
In addition, @DRUG$ neither influenced the pharmacodynamics of warfarin, acetylsalicylic acid, piroxicam, and digoxin, nor the pharmacokinetics of @DRUG$ at steady state.	DDI-false
@DRUG$ The anorectic and stimulating effects of amphetamines can be inhibited by @DRUG$.	DDI-false
Monoamine Oxidase Inhibitors and @DRUG$: FORADIL should be administered with extreme caution in patients being treated with @DRUG$ or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with @DRUG$ concomitantly with @DRUG$, hypnotics and sedatives (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, @DRUG$, @DRUG$, and beta adrenergic blocking agents.	DDI-false
There have been reports of QTc prolongation, with or without TdP, in patients taking @DRUG$ when fluoroquinolones, @DRUG$, or azoles were administered concomitantly.	DDI-false
@DRUG$ : Altered serum levels of @DRUG$ ( increased and decreased ) have been reported in patients receiving concomitant ciprofloxacin .	DDI-false
Carbamazepine: Isoniazid is known to slow the metabolism of @DRUG$ and increase its serum levels @DRUG$ levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.	DDI-false
In general, these drugs have one or more pharmacological activities, similar to @DRUG$ , including antiarrhythmic agents such as quinidine and @DRUG$ , cardiac glycosides and tricyclic anti-depressants .	DDI-false
Acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen and valproic acid/@DRUG$.	DDI-false
Anticoagulants : potentiation of the warfarin type ( @DRUG$ CYP3A4 substrate and CYP3A4 substrate) @DRUG$ The response is almost always observed in patients receiving amiodarone and can lead to severe or fatal bleeding.	DDI-false
Acetaminophen/@DRUG$, lidocaine/chinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen and valproic acid/phenobarbital.	DDI-false
In patients with chronic hepatitis C treated with PEGASYS in combination with COPEGUS, @DRUG$ treatment did not affect @DRUG$ distribution or clearance.	DDI-false
@DRUG$ (neostgmine, @DRUG$), lignocaine, quinine, procainamide can enhance toxicity and cause cardio respiratory depression.	DDI-false
@DRUG$ : @DRUG$ Treatment with prothrombin in patients receiving chronic warfarin treatment had no clinically significant effect on prothrombin time.	DDI-false
Antihypertensive medications , other , especially diazoxide , or pre@DRUG$ and anesthetic agents used in surgery or @DRUG$ , not depolarizing, used in surgery	DDI-false
However, the concomitant use of @DRUG$ and @DRUG$ (5-7.5 mg initial oral dose followed by 2.5-6 mg/day orally for 6-10 days) results in prolongation of the prothrombin time (PT) and International Normalized Ratio (INR).	DDI-effect
@DRUG$ (400 mg b.i.d.) had no effect on vardenafil bioavailability (AUC) and maximum concentration (Cmax) of @DRUG$ when co-administered with 20 mg Vardenafil in healthy volunteers.	DDI-false
@DRUG$: The concomitant administration of @DRUG$ and sulindac in normal volunteers resulted in lowering of the plasma levels of the active sulindac sulfide metabolite by approximately one-third.	DDI-false
Central Nervous System Depressants: The concomitant use of @DRUG$  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and @DRUG$, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, @DRUG$ was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, betablockers, calcium-channel blockers, @DRUG$, and nonsteroidal anti-inflammatory drugs (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, @DRUG$, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, @DRUG$, and isoniazid.	DDI-false
Garlic Capsules Garlic capsules should not be used while taking saquinavir (@DRUG$) as the sole protease inhibitor due to the risk of decreased @DRUG$ plasma concentrations.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, @DRUG$, calcium-channel blockers, cardiac nitrates, @DRUG$, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Imipramin ( 5 mg/ kg ), @DRUG$ ( 30 mg/kg ) , clonazepam ( 0.25 mg/kg ) , fluoxetine ( 20 mg/kg ) @DRUG$ 30 mg/ kg) or vehicle.	DDI-false
@DRUG$, Methylxanthines and Diuretics: Concomitant treatment with @DRUG$, steroids, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), @DRUG$ (@DRUG$), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
@DRUG$ : Atorvastatin plasma concentrations and LDL-C reduction were not altered by coadministration of @DRUG$.	DDI-false
Coingestion of @DRUG$ with theophylline , phenobarbital with acetaminophen , and valproic acid with @DRUG$ At high to toxic concentrations, binding of the target medication is reduced.	DDI-false
Example inhibitors include azole antifungals , @DRUG$ , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , @DRUG$ , and verapamil .	DDI-false
The concomitant intake of alcohol and Acamprosate does not affect the pharmacokinetics of either @DRUG$ or @DRUG$.	DDI-false
The effects of @DRUG$ and of @DRUG$ Anaesthesia on digitalis tolerance in dogs.	DDI-false
It is desirable to monitor @DRUG$ plasma levels whenever a @DRUG$ is going to be co-administered with another drug known to be an inhibitor of P450 2D6.	DDI-false
It is therefore necessary to be familiar with the clinical and paraclinical pattern of the magnesium deficit and between @DRUG$ deficiency due to an insufficient magnesium intake which only requires oral physiological supplementation and magnesium depletion related to a dysregulation of the control mechanisms of @DRUG$ status which requires more or less specific regulation of its causal dysregulation .	DDI-false
If treatment with inhibitors of CYP3A4 activity ( such as ketoconazole , intraconazole , ritonavir , indinavir , @DRUG$ , erythromycin, etc.) is indicated, reduction of @DRUG$ The dose should be considered.	DDI-advise
No significant interactions were found between @DRUG$ and warfarin or @DRUG$.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed , @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , @DRUG$ Angiotensin converting enzymes (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also called NSAIDs) and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Amiodarone may suppress certain CYP450 enzymes , including @DRUG$ , CYP2C9 , CYP2D6 , and @DRUG$.	DDI-false
Patients receiving azathioprine and @DRUG$ At the same time, a dose reduction of @DRUG$ , to approximately 1/3 to 1/4 the usual dose .	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, Dapson, disopyramide, quinine, @DRUG$ , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , @DRUG$ , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
The administration of local @DRUG$ containing epinephrine or norepinephrine to patients receiving @DRUG$, tricyclic antidepressants or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, @DRUG$, hydralazine, @DRUG$ and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, @DRUG$, doxycycline, erythromycin, @DRUG$, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when @DRUG$ is administered concomitantly with other antimuscarinics, amantadine, haloperidol, @DRUG$, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.	DDI-effect
Both the toxicity of filipin and the therapeutic value of @DRUG$ can be rationalized at the cellular and molecular level by the following observations : ( i ) these @DRUG$ showed differential effects on cells ;	DDI-false
@DRUG$ : The concomitant use of @DRUG$   ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	DDI-false
Studies in rats have shown that @DRUG$ administration attenuates certain types of adrenocortical steroid dependent hypertension, including @DRUG$ hypertension.	DDI-effect
Warfarin: @DRUG$ 3 mg administered daily for 5 days did not affect the pharmacokinetics of@DRUG$n, nor were there any changes in the pharmacodynamic profile (prothrombin time) following a single 25 mg oral dose of warfarin	DDI-false
In the presence of these @DRUG$ , larger doses of @DRUG$ may be required or adenosine may not be effective .	DDI-advise
Allopurinol: In a study of healthy male volunteers no significant pharmacokinetic interaction occurred when @DRUG$ and @DRUG$ were administered concomitantly for 6 days.	DDI-false
acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and @DRUG$/phenobarbital.	DDI-false
Non-steroidal Anti-inflammatory Drugs: In some patients, the administration of a @DRUG$ can reduce the diuretic, natriuretic, and antihypertensive effects of @DRUG$.	DDI-effect
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, @DRUG$, MAO inhibitors, and other @DRUG$.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
In addition, additional interaction studies with niacin and propranolol have no effect on @DRUG$ plasma levels , and administration to a patient population chronically receiving digoxin resulted in no difference in the extent of bioavailability of @DRUG$ relative to control data .	DDI-false
Potential drug interactions between Keppra  and other @DRUG$ (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, @DRUG$ and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Diuretic agents reduce the renal clearance of @DRUG$ and add a high risk of @DRUG$ toxicity.	DDI-false
acetaminophen/theophylline, @DRUG$/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Non-steroidal Anti-inflammatory Drugs: In some patients, the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of @DRUG-DRUG$.	DDI-false
INOmax has been administered with tolazoline, @DRUG$, @DRUG$, steroids, surfactant, and high-frequency ventilation.	DDI-false
Coingestion of acetaminophen with theophylline, phenobarbital with @DRUG$, and valproic acid with @DRUG$ at high to toxic concentrations decreases the binding of the target drug.	DDI-false
Other Cardiovascular Agents: Enalapril and @DRUG$ IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, @DRUG$, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Micro-dosed Progesterone Preparations : Micro-dosed @DRUG$ preparations ( minipills that do not contain an estrogen ) may be an inadequate method of contraception during @DRUG$ therapy .	DDI-effect
An enzephalopathic syndrome ( characterised by weakness, lethargy, fever, tremor and confusion, extrapyramidal symptoms, leukocytosis, elevated serum enzymes, BUN, and FBS) followed by irreversible brain damage occurred in a few patients with @DRUG$ plus @DRUG$.	DDI-effect
Warfarin: @DRUG$ had no clinically significant effect on prothrombin time when administered to patients receiving chronic @DRUG$ treatment.	DDI-false
Other concomitant therapy Although no specific interaction studies have been conducted, 1 mg or more of finasteride doses have been co-administered in clinical trials with acetaminophen, acetylsalicylic acid, A-blockers, analgesics, angiotensin converting enzyme (ACE) inhibitors, anticonvulsants, @DRUG$ , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , H2 antagonists , @DRUG$ Prostaglandin synthetase inhibitors (also known as NSAIDs) and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
HIV Protease Inhibitors : @DRUG$ ( 800 mg t.i.d . ) co-administered with Vardenafil 10 mg resulted in a 16-fold increase in @DRUG$ AUC , a 7-fold increase in vardenafil Cmax and a 2-fold increase in vardenafil half-life .	DDI-false
Drug Interactions : Flupenthixol may interact with some drugs , like Monoamine oxidase inhibitors ( MAOI ): MAOI could theoretically affect @DRUG$ pharmacodynamics - Arecolin - eproxindine - ethanol : flupenthixol and ethanol cause additive CNS depression - @DRUG$ Flupentixol increases the effect of tricyclic antidepressants	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with @DRUG$ , Innovar Vet, or pentobarbital, the dosage of @DRUG$ needed to cause ventricular tachycardia was significantly higher , as was the LD50 of ouabain , with ketamine or Innovar than with pentobarbital .	DDI-effect
@DRUG$ : astemizole * , @DRUG$ * CONTRAINDICATED due to the potential for serious and/or life-threatening cardiac arrhythmias.	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Dextromethorphan is a substrate for both @DRUG$ and @DRUG$.	DDI-false
Some @DRUG$/substances are known to accelerate the metabolism of @DRUG$ by stimulating the synthesis of CYP3A4 (enzyme induction).	DDI-false
Data from in vitro studies of @DRUG$ suggest a possible drug interaction with alprazolam for the following: @DRUG$ and paroxetine.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Although studies designed to examine drug interactions have not been done, it was noted that @DRUG$ or @DRUG$ treatment of relapses for periods of up to 28 days has been administered to patients (N=180) receiving Betaseron.	DDI-false
Other Cardiovascular Agents: Enalapril and @DRUG$ IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, hydralazine, prazosin and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
It is believed that increased interactions between 3H-spiroperidol and high affinity binding points for @DRUG$ The antipsychotic effect of dopamine2 and serotonin2 receptors @DRUG$ after their prolonged administration .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as @DRUG$), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$: @DRUG$  is not recommended for use in patients who have received MAOI within 14 days because severe and unpredictable potentiation by MAO inhibitors has been reported with opioid analgesics	DDI-false
@DRUG$ In normal subjects, concomitant administration of diflunisal and hydrochlorothiazide resulted in significantly increased plasma levels of @DRUG$.	DDI-false
Multivitamins or other products which: @DRUG$ or zinc , antacids or @DRUG$ should not be administered concomitantly with , or within 2 hours of , the administration of norfloxacin , because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ACE ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , @DRUG$ , cardiac nitrates , diuretics , H2 antagonists , @DRUG$ Prostaglandin synthetase inhibitors (also known as NSAIDs) and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
BACKGROUND: The effects of combined administration of bombesin and verapamil hydrochloride (@DRUG$), a calcium channel blocker, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by @DRUG$ (AOM) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
This study showed that the potent cytochrome P450 enzyme inducer @DRUG$ In fact, had a significant effect on the metabolism of @DRUG$ , resulting in a 5-fold increase in clearance in patients with DSM-IV-diagnosed schizophrenia, schizoaffective disorder or bipolar disorder.	DDI-mechanism
In a similar study with @DRUG$ in healthy volunteers, 1 of 24 subjects dosed with @DRUG$ 20 mg and tamsulosin 0.4 mg separated by 6 hours experienced a standing systolic blood pressure below 85 mm Hg.	DDI-false
The pharmacokinetics of naltrexone and its main metabolite @DRUG$ After co-administration with @DRUG$, treatment was unaffected.	DDI-false
@DRUG$/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
• Non-selective MAO inhibitors including @DRUG$ , @DRUG$ , and pargyline HC1 : Concomitant use of L-tyrosine and non-selective MAO inhibitors may cause hypertension .	DDI-false
These drugs include thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, @DRUG$ , oral contraceptives , phenytoin , @DRUG$ , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .	DDI-false
and (ii) the effects of @DRUG$ were more efficiently inhibited by added cholesterol, the major membrane sterol in human cells, whereas the effects of @DRUG$ were more efficiently inhibited by ergosterol, the major membrane sterol in yeast.	DDI-false
This drug may interact with alcohol or other @DRUG$ (may potentiate the CNS depressant effects of either these medications or antihistamines), @DRUG$ or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine , although theoretically , coadministration of other drugs known to alter cardiac conduction ( eg , anti-arrhythmic or beta-adrenergic blocking agents , @DRUG$ , antihistamines or @DRUG$ Also tricyclic antidepressants and phenothiazines could contribute to an extension of the QTc interval.	DDI-false
INOmax has been administered with @DRUG$ , @DRUG$ , dobutamine , steroids , surfactant , and high-frequency ventilation .	DDI-false
Compounds tested in man include warfarin , @DRUG$ , @DRUG$ , diazepam , aminopyrine and antipyrine .	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, @DRUG$ (e.g., benzodiazepines), general anesthetics, @DRUG$, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Benzthiazide may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, @DRUG$ like @DRUG$ or Ibuprofen, and high blood pressure medications.	DDI-false
In addition to this pharmacological interaction, this report describes a novel chemical reaction between @DRUG$ (a @DRUG$) and ethanol under acidic conditions similar to those found in vivo, resulting in a 3-ethoxylated product.	DDI-false
These results suggest that both dexamethasone and @DRUG$, and possibly other glucocorticoids and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of @DRUG$ and EGF.	DDI-effect
• Co-administration with compounds that are potent CYP3A4 inducers (e.g. phenobarbital, phenytoin, @DRUG$ , carbamazepine ) may result in decreased plasma levels of @DRUG$.	DDI-mechanism
Example inhibitors include @DRUG$, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, @DRUG$, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
@DRUG$, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, @DRUG$, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-mechanism
In patients with mild to moderate hypertension , administration of 25 mg daily of @DRUG$ with the @DRUG$ Benazepril, 10 to 40 mg for 4 weeks, was associated with an average increase in mean arterial pressure of approximately 3 mm Hg compared to ACE inhibitors alone.	DDI-false
@DRUG$: In controlled studies in healthy volunteers, @DRUG$ either had no effect (one study) or was associated with modest increases, about 30% (two studies) in steady-state serum digoxin concentrations.	DDI-false
Antihypertensives : Amiodarone should be used with caution in patients receiving   -receptor blocking agents ( e.g. , @DRUG$ , a CYP3A4 inhibitor) or calcium channel antagonists (e.g. verapamil, @DRUG$ Substrate, and diltiazem, an inhibitor of CYP3A4) due to the potential for bradycardia, sinus arrest, and AV block;	DDI-false
In addition, Fondaparinux neither influenced the pharmacodynamics of warfarin, @DRUG$, @DRUG$, and digoxin, nor the pharmacokinetics of digoxin at steady state.	DDI-false
Other concomitant therapy Although no specific interaction studies have been conducted, 1 mg or more of finasteride doses have been used in clinical trials with acetaminophen, acetylsalicylic acid, A-blockers, @DRUG$ Angiotensin converting enzymes (ACE) inhibitors, anticonvulsants, benzodiazepines, beta-blockers, @DRUG$ , cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also known as NSAIDs), and quinolone anti-infections without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ , Methylxanthines and Diuretics : Concomitant treatment with xanthine derivatives , @DRUG$ Diuretics may potentiate a possible hypocalemic effect of beta2-agonists.	DDI-false
The compounds tested in humans include warfarin, theophylline, @DRUG$ , @DRUG$ , aminopyrin and antipyrin.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ACE ) inhibitors , @DRUG$ , benzodiazepines, beta blockers, calcium channel blockers, heart @DRUG$ , diuretics , H2 antagonists , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
@DRUG$ should be administered with caution to patients receiving @DRUG$ (disulfiram, Wyeth-Ayerst Laboratories).	DDI-advise
Imipramine (5 mg/kg), @DRUG$ (30 mg/kg), clonazepam (0.25 mg/kg), fluoxetine (20 mg/kg) @DRUG$ (30 mg/kg) or vehicle was administered.	DDI-false
Anticoagulants including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as @DRUG$ (NSAIDs), and @DRUG$ may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of magnesium deficit and to discriminate between magnesium deficiency due to an insufficient @DRUG$ intake which only requires oral physiological supplementation and @DRUG$ depletion related to a dysregulation of the control mechanisms of magnesium status which requires more or less specific regulation of its causal dysregulation.	DDI-false
Omeprazole: The rate and extent of absorption of @DRUG$ was bioequivalent when Proquin XR was given alone or when Proquin XR was given 2 hours after @DRUG$ at the dose that maximally suppresses gastric acid secretion.	DDI-false
Monoamine Oxidase Inhibitors and Tricyclic Antidepressants : FORADIL should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or @DRUG$ because the action of @DRUG$ on the cardiovascular system may be potentiated by these agents .	DDI-false
Non-steroidal anti-inflammatory agents : In some patients with renal impairment who have had @DRUG$ , the concomitant use of @DRUG$ For this reason, further deterioration of renal function may result.	DDI-effect
Several drug interaction studies with both studies have been completed. @DRUG$ and @DRUG$.	DDI-false
Antihypertensive agents: amiodarone should be used with caution in patients receiving receptor blockers (e.g. propranolol, CYP3A4 inhibitor), or @DRUG$ • antagonists (e.g. verapamil, a CYP3A4 substrate and @DRUG$ , a CYP3A4 inhibitor) because of the potential for bradycardia, sinus arrest, and AV block;	DDI-false
Nephrotoxicity has been reported following concomitant administration of @DRUG$ and @DRUG$.	DDI-effect
In vitro binding studies with human serum proteins indicate that @DRUG$ binds differently than tolbutamide and does not interact with @DRUG$ or dicumarol .	DDI-false
INOmax has been administered with tolazoline , dopamine , @DRUG$ , @DRUG$ , surfactant , and high-frequency ventilation .	DDI-false
In addition, Fondaparinux neither influenced the pharmacodynamics of warfarin, @DRUG$, piroxicam, and digoxin, nor the pharmacokinetics of @DRUG$ at steady state.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$, @DRUG$, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
The availability of potent non-nucleoside reverse transcriptase inhibitor (@DRUG$)-based regimens for @DRUG$ therapy and concerns regarding protease inhibitor (PI)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection .	DDI-false
@DRUG$ Renal tubular transport of methotrexate may be inhibited by concomitant administration of ciprofloxacin, which may lead to increased plasma levels of @DRUG$.	DDI-false
In patients with mild to moderate hypertension, administration of 25 mg daily of @DRUG$ with the @DRUG$ benazepril, 10 to 40 mg for 4 weeks, was associated with an average increase in mean arterial pressure of about 3 mm Hg compared to ACE inhibitor alone.	DDI-false
In rats, co-administration of @DRUG$ and nitrite in the diet for 78 weeks has been reported to cause tumors , and it has been suggested that @DRUG$ may react with nitrites in the rat stomach to form a nitrosamine , which is tumorigenic .	DDI-false
Lithium: In a study conducted in healthy subjects, mean steady-state lithium plasma levels increased in patients who were @DRUG$ 450 mg twice daily with @DRUG$ 200 mg twice daily compared to people who only receive lithium.	DDI-mechanism
Cephalosporine cephalosporine containing side chains of N-methylthiotetrazole ( @DRUG$ Cefoperazon, cefotetan, @DRUG$ Methylthiadiazole (cefazolin) may cause vitamin K deficiency and hypoprothrombinaemia.	DDI-false
Another oral azole antifungal, ketoconazole, inhibits the metabolism of @DRUG$, resulting in elevated plasma concentrations of @DRUG$ and its active metabolite desmethylastermizole which may prolong QT intervals.	DDI-false
Antihypertensives: @DRUG$ should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and @DRUG$, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Co-administration of @DRUG$ with @DRUG$ The AUC increased by 25% and the Cmax of acamprosate by 33%.	DDI-mechanism
@DRUG$ Atorvastatin had no clinically significant effect on the prothrombin time when administered to patients with chronic @DRUG$ treatment .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Therefore, interactions could occur following concomitant administration of @DRUG$ (e.g., narcotics, analgesics, @DRUG$, sedatives, tranquilizers).	DDI-false
Acetaminophene, lidocaine, phenobarbital, @DRUG$ , @DRUG$ , and valproic acid were added to pooled human serum at therapeutic concentrations .	DDI-false
Although no specific studies have been performed, co-administration with medicinal products primarily metabolised by CYP3A4 (e. g. @DRUG$ , Dapson, disopyramide, @DRUG$ , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
HIV Protease Inhibitors: Indinavir (800 mg t.i.d.) co-administered with Vardenafil 10 mg resulted in a 16-fold increase in @DRUG$ AUC, a 7-fold increase in @DRUG$ Cmax and a 2-fold increase in vardenafil half-life.	DDI-false
In patients with mild to moderate hypertension, administration of 25 mg daily of VIOXX with the @DRUG$ @DRUG$, 10 to 40 mg for 4 weeks, was associated with an average increase in mean arterial pressure of about 3 mm Hg compared to ACE inhibitor alone.	DDI-false
Tagamet, apparently due to an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, @DRUG$ , certain tricyclic antidepressants , lidocaine , theophylline and @DRUG$ This delays elimination and increases blood levels of these drugs.	DDI-false
Since @DRUG$ is a substrate for @DRUG$, there is the potential that the use of St. John s Wort in patients receiving amiodarone could result in reduced amiodarone levels.	DDI-false
- @DRUG$ (e.g., @DRUG$) or	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Simultaneous absorption of cholestyramine and vitamin K may reduce the absorption of @DRUG$.	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral @DRUG$, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Coadministration of @DRUG$ and cyclosporine , @DRUG$ Digoxin has led to increased plasma concentrations of the last three drugs.	DDI-mechanism
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, calcium channel blockers, antihistamines or @DRUG$, @DRUG$ and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-false
Again , @DRUG$ neutralized the increase in glycemia after @DRUG$ Overload in both diabetic and non-diabetic rats.	DDI-false
@DRUG$ : @DRUG$ may delay intestinal absorption of phenytoin ;	DDI-false
Non-selective MAO inhibitors including @DRUG$, phenelzine sulfate, and @DRUG$ HC1: Concomitant use of L-tyrosine and non-selective MAO inhibitors may cause hypertension.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, @DRUG$, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, @DRUG$, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ effects are potentiated by @DRUG$.	DDI-effect
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
In vitro binding studies with human serum proteins indicate that glipizide binds differently than @DRUG$ and does not interact with @DRUG$ or dicumarol.	DDI-false
Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving Alprazolam ( caution is recommended during coadministration with @DRUG$ Concomitant use of fluoxetine with @DRUG$ The maximum plasma concentration of alprazoleam increased by 46%, clearance by 21%, half-life by 17% and measured psychomotor performance.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including @DRUG$, with multivalent cation-containing products such as magnesium or aluminum @DRUG$, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
Note: dissolution of aerosol particles of @DRUG$ in Survanta, a model @DRUG$.	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, Dapson, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporin, @DRUG$ , @DRUG$ , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., ketoconazole, @DRUG$, erythromycin, @DRUG$).	DDI-false
Based on the chemical resemblance of itraconazole and ketoconazole , coadministration of @DRUG$ with @DRUG$ is contraindicated .	DDI-advise
MAO inhibitors @DRUG$ , as well as a metabolite of furazolidone , slow @DRUG$ metabolism .	DDI-mechanism
Antiarrhythmics: Other antiarrhythmic drugs, such as quinidine, procainamide, @DRUG$, and @DRUG$, have been used concurrently with amiodarone.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/@DRUG$, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of magnesium deficit and to discriminate between @DRUG$ deficiency due to an insufficient magnesium intake which only requires oral physiological supplementation and magnesium depletion related to a dysregulation of the control mechanisms of @DRUG$ status which requires more or less specific regulation of its causal dysregulation.	DDI-false
The intensity, uniformity and time course of @DRUG$ interference by phenobarbital , secobarbital , glutethimide , chloral hydrate and @DRUG$ The treatment was systematically studied in 16 patients receiving coumarin therapy.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, @DRUG$, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, @DRUG$, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (@DRUG$), and @DRUG$ did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Benzthiazide may interact with alcohol , @DRUG$s , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , @DRUG$ , NSAIDs such as Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
These results suggest that both dexamethasone and @DRUG$, and possibly other glucocorticoids and @DRUG$, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF.	DDI-false
Iodine or iodine excess may decrease the effect of Carbimazole, and an @DRUG$ deficiency can increase the effect of @DRUG$.	DDI-effect
Moreover, additional interaction studies with @DRUG$ and propranolol have not demonstrated any effect on fluvastatin plasma levels, and administration to a patient population chronically receiving digoxin resulted in no difference in the extent of bioavailability of @DRUG$ relative to control data.	DDI-false
Non-steroidal anti-inflammation drugs : The administration of diflunisal to normal volunteers who @DRUG$ decreased the renal clearance and significantly increased the plasma levels of @DRUG$.	DDI-false
Anticoagulants including coumarin derivatives , indandione derivatives , and platelet aggregation inhibitors such as @DRUG$ NSAIDs and aspirin may increase the risk of bleeding when administered at the same time as @DRUG$.	DDI-effect
Here we show that a combination of @DRUG$ or 3,7-dihydroxyflavone with @DRUG$ It can be used to sensitize resistant strains of Enterococcus faecalis and Enterococcus faecium to the level of vancomycin-sensitive strains.	DDI-false
Cyclosporine, Digoxin, Methotrexate Lodine, like other NSAIDs, through effects on renal prostaglandins, may cause changes in the elimination of these drugs leading to elevated serum levels of @DRUG$, digoxin, @DRUG$, and increased toxicity.	DDI-false
Quinolones , including @DRUG$ , may enhance the effects of oral @DRUG$ , including warfarin or its derivatives or similar agents.	DDI-effect
@DRUG$ or iodine excess may decrease the effect of Carbimazole, and an @DRUG$ deficiency can increase the effect of Carbimazole.	DDI-false
Specific studies have confirmed these effects with sevoflurane, isoflurane. @DRUG$ , alfentanil, and @DRUG$.	DDI-false
Adequate monitoring of @DRUG$ plasma concentrations should be considered when therapy with @DRUG$ is initiated or changed in patients receiving theophylline.	DDI-false
@DRUG$: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general @DRUG$, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/@DRUG$, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/@DRUG$ and valproic acid/phenobarbital.	DDI-false
Like ibogaine (40 mg/kg), @DRUG$ (40 mg/kg) decreases the intravenous self-administration of morphine and @DRUG$ and the oral self-administration of ethanol and nicotine in rats;	DDI-false
Sinus bradycardia has been reported with oral @DRUG$ in combination with lidocaine (CYP3A4 substrate) given for local @DRUG$.	DDI-false
@DRUG$ diminished the binding of @DRUG$ to human serum by a net change of 5.7% (percentage increase in free drug fraction [FDF], 11.0%) at 662 micromol/L and by a net change of 7.1% (percentage increase in FDF, 13.7%) at 1324 micromol/L.	DDI-mechanism
@DRUG$ ; co-management of @DRUG$ Compared to the concomitant use of warfarin and placebo, the administration of cerivastatin in healthy volunteers did not lead to changes in prothrombin time or coagulation factor VII.	DDI-false
OTHER CONCOMITANT THERAPY : Although specific interaction studies were not performed , in clinical studies , cerivastatin sodium was used concomitantly with angiotensin- converting enzyme ( ACE ) inhibitors , betablockers , calcium-channel blockers , diuretics , and @DRUG$ ( @DRUG$ ) without evidence of clinically significant adverse interactions.	DDI-false
Compounds that have been tested in man include antipyrine, @DRUG$, @DRUG$, theophylline, and warfarin and no clinically meaningful interactions were found.	DDI-false
• Numerous drug interactions are possible with some anticonvulsants, e.g. @DRUG$ and @DRUG$ , which affect liver microsomal enzyme systems.	DDI-false
Clinical studies with @DRUG$ Potentially significant interactions with fluconazole and @DRUG$ have been identified.	DDI-int
Antihypertensives : Amiodarone should be used with caution in patients receiving   -receptor blocking agents ( e.g. , propranolol , a CYP3A4 inhibitor ) or @DRUG$ ==References====External links== @DRUG$ , a CYP3A4 substrate , and diltiazem , a CYP3A4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and AV block ;	DDI-false
In well-controlled patients who are also treated with @DRUG$ , a decrease in the steady-state serum concentrations of @DRUG$ If treatment with Cime-Tidine is discontinued, treatment with Cime-Tidine can be stopped.	DDI-mechanism
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other @DRUG$, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, @DRUG$, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Non-steroidal Anti-inflammatory Agents: In some patients with compromised renal function who are being treated with @DRUG$, the co-administration of @DRUG$ may result in a further deterioration of renal function.	DDI-effect
@DRUG$ may enhance the effects of alcohol , @DRUG$ And other CNS depressants.	DDI-effect
In a clinical pharmacology study , @DRUG$ Sulindac was given to hypertensive patients receiving @DRUG$.	DDI-false
These drugs include the @DRUG$ and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and @DRUG$.	DDI-false
Results of studies in multiple sclerosis patients taking TYSABRI   and concomitant @DRUG$ ( AVONEX   30 mcg IM once weekly ) or glatiramer acetate were inconclusive with regard to the need for dose adjustment of the @DRUG$ or glatiramer acetate .	DDI-false
Antipyrine: Because @DRUG$ does not affect the pharmacokinetics of @DRUG$, interactions with other drugs metabolized via the same cytochrome isozymes are not expected.	DDI-false
Other cardiovascular agents: Enalapril and Enalapril IV were co-administered with beta-adrenergic blockers, @DRUG$ , @DRUG$ , calcium blockers, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole ( @DRUG$ , cefoperazone , @DRUG$ , cefamandol, latamoxef) or methylthiadiazole (cefazolin) may cause vitamin K deficiency and hypoprothrombinaemia.	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided . 12 Beta-blockers and other @DRUG$ may potentiate the hypotension seen with @DRUG$.	DDI-effect
Results of studies in multiple sclerosis patients taking @DRUG$  and concomitant interferon beta-1a (AVONEX  30 mcg IM once weekly) or glatiramer acetate were inconclusive with regard to the need for dose adjustment of the @DRUG$ or glatiramer acetate.	DDI-false
Benzthiazide may interact with @DRUG$ , blood thinners , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , @DRUG$ like Aleve or Ibuprofen , and high blood pressure medications .	DDI-false
@DRUG$ generally should not be given with @DRUG$ because they reduce lithiums renal clearance and add a high risk of lithium toxicity.	DDI-advise
Multivitamins , or other products containing iron or zinc , antacids or @DRUG$ The use of norfloxacin should not occur with, or within 2 hours, as it may impair absorption, resulting in lower serum and urine levels of @DRUG$.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics , amantadine , @DRUG$ , phenothiazines, monoamine oxidase (MAO) inhibitors, @DRUG$ or some antihistamines .	DDI-false
@DRUG$ may interfere with the absorption of @DRUG$.	DDI-mechanism
@DRUG$ may interact with any of the following : - Acetaminophen ( e.g. , @DRUG$ (with a long-term high dose) or	DDI-int
Coingestion of acetaminophen with theophylline, phenobarbital with @DRUG$, and @DRUG$ with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-false
These results suggest that both dexamethasone and retinyl acetate, and possibly other glucocorticoids and @DRUG$ , may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and @DRUG$.	DDI-effect
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other @DRUG$, sedatives, @DRUG$, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
A drug-drug interaction study evaluated the effect of the use of @DRUG$ Gel, 5%, in combination with double strength (160 mg/800 mg) trimethoprim/@DRUG$ (TMP/SMX).	DDI-false
HIV Protease Inhibitors: Indinavir (800 mg t.i.d.) co-administered with Vardenafil 10 mg resulted in a 16-fold increase in @DRUG$ AUC, a 7-fold increase in vardenafil Cmax and a 2-fold increase in @DRUG$ half-life.	DDI-false
While all the selective serotonin reuptake inhibitors ( SSRIs ) , e.g. , @DRUG$ , escitalopram , fluoxetine , sertraline , and @DRUG$ , inhibit P450 2D6, they may vary in extent of inhibition.	DDI-false
"Ergot derivatives: dihydroergotamine, @DRUG$ , ergotamine , @DRUG$ CONTRAINDICATE because of the potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasms and ischaemia of extremities and other tissues.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, @DRUG$, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5 % Ophthalmic Solution , the possibility of an additive or potentiating effect with CNS depressants ( alcohol , @DRUG$ , opiates, sedatives, @DRUG$ ) should be considered .	DDI-false
- Methotrexate ( e.g. , @DRUG$ ) Use of methotrexate with @DRUG$ The likelihood of adverse reactions affecting the liver and/or the side effects of methotrexate may increase.	DDI-false
Drug/Laboratory Test Interaction After treatment with @DRUG$, a false-positive reaction for glucose in the urine may occur with @DRUG$ tests (Benedicts solution, Fehlings solution, or Clinitest tablets) but not with enzyme based tests such as Clinistix and Glucose Enzymatic Test Strip USP.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., @DRUG$, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a @DRUG$ substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , @DRUG$ , @DRUG$ , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .	DDI-false
Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following : @DRUG$ , @DRUG$ , amiodarone , nicardipine , and nifedipine .	DDI-false
@DRUG$: @DRUG$ have been reported to enhance the effects of the oral anticoagulant warfarin or its derivatives.	DDI-false
There is a significant increase in exposure to @DRUG$ when Gleevec is coadministered with @DRUG$ ( CYP3A4 inhibitor ) .	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, @DRUG$, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these @DRUG$ during placebo-controlled clinical studies.	DDI-false
Acetaminophen/theophylline, lidocaine/chinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen and valproic acid/phenobarbital.	DDI-false
Acetaminophen, lidocaine, phenobarbital, @DRUG$, theophylline, and @DRUG$ were added to pooled human serum at therapeutic concentrations.	DDI-false
Possible interactions between Keppra and other medicinal products @DRUG$ ( @DRUG$ , gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also evaluated by the evaluation of levetiracetam serum concentrations and these AEDs during placebo-controlled clinical trials.	DDI-false
Dosage adjustment of STRATTERA may be necessary when coadministered with CYP2D6 inhibitors, e.g., @DRUG$, fluoxetine, and @DRUG$.	DDI-false
Serum @DRUG$ levels should be monitored frequently if INSPRA is administered concomitantly with @DRUG$.	DDI-false
The possibility of hypotensive effects with enalapril or @DRUG$ can be minimized by either discontinuing the @DRUG$ or increasing the salt intake prior to initiation of treatment with enalapril or enalaprilat.	DDI-effect
Central Nervous System Depressants: The concomitant use of DURAGESIC  (@DRUG$ transdermal system) with other @DRUG$, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
MAO Inhibitors : @DRUG$ It is not recommended for use in patients who: @DRUG$ within 14 days because severe and unpredictable potentiation by MAO inhibitors has been reported with opioid analgesics	DDI-advise
@DRUG$ Indinavir (800 mg t.i.d.) together with vardenafil 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in vardenafil Cmax and a 2-fold increase in vardenafil Cmax. @DRUG$ half-life .	DDI-false
@DRUG$ decreased the hyperuricemic effect of @DRUG$.	DDI-effect
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, warfarin, isosorbide mononitrate, carvedilol, @DRUG$ or @DRUG$.	DDI-false
- @DRUG$ ( e.g. , @DRUG$ ) or	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, Dapson, disopyramide, quinine, amiodarone, quinidine, @DRUG$ , tacrolimus , cyclosporine , @DRUG$ , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
All subjects received @DRUG$ monotherapy and after treatment with 100 mg @DRUG$ As a single daily oral dose for seven days.	DDI-false
Warfarin : @DRUG$ had no clinically significant effect on prothrombin time when administered to patients receiving chronic @DRUG$ treatment .	DDI-false
Ritonavir and @DRUG$: Upon concomitant administration of 5 mg of Vardenafil with 600 mg BID @DRUG$, the Cmax and AUC of ritonavir were reduced by approximately 20%.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac @DRUG$, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ has been administered with tolazoline, dopamine, dobutamine, steroids, @DRUG$, and high-frequency ventilation.	DDI-false
Poor metabolisers have higher plasma concentrations than expected. @DRUG$ ( @DRUG$ - if the usual dose is given.	DDI-false
Tagamet, apparently due to an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, @DRUG$ , chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, @DRUG$ And metronidazole, which delays the elimination and increase in blood levels of these drugs.	DDI-false
The immediate release, but not the Coat Core formulation of @DRUG$ increased plasma @DRUG$ Concentrations by about 20%.	DDI-mechanism
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ACE ) inhibitors , anticonvulsants , benzodiazepines , @DRUG$ , calcium-channel blockers , cardiac nitrates , diuretics , H2 antagonists , HMG-CoA reductase inhibitors , @DRUG$ ==See also==*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID==References==	DDI-false
Lithium: In a study conducted in healthy subjects, mean steady-state lithium plasma levels increased approximately 17% in subjects receiving lithium 450 mg BID with @DRUG$ 200 mg BID as compared to subjects receiving @DRUG$ alone.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, @DRUG$, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, @DRUG$, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Tetracyclines : Concomitant treatment with @DRUG$ and @DRUG$ The use of Accutane should be avoided as the use of Accutane has been associated with a number of cases of pseudotumour cerebri (benign intracranial hypertension), some of which involved the concomitant use of tetracyclines.	DDI-advise
High-dose @DRUG$ resulting in concentrations above 2000 ng/mL administered with oral etoposide has led to an 80% increase in etoposide exposure with a 38% decrease in total body clearance of etoposide compared to @DRUG$ alone.	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (@DRUG$, barbiturates, opiates, @DRUG$, anesthetics) should be considered.	DDI-false
Prostatic epithelium proliferates in a defined medium consisting of basal medium RPMI1640 containing @DRUG$ ( 1 micrograms/ ml ), EGF ( 10 ng/ ml ) and @DRUG$ ( 3.7 micrograms/ml or 0.1 IU/ml ) .	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril , beta-blockers , @DRUG$ , digoxin , warfarin , isosorbide mononitrate , carvedilol , ethanol or @DRUG$.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , doxorubicin , vincristine , and prednisone ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , @DRUG$ , doxorubicin , teniposide , and prednisone with @DRUG$ plus bleomycin ) without receiving antiretroviral therapy .	DDI-false
While 18-MC and @DRUG$ have similar affinities for kappa opioid and possibly nicotinic receptors, @DRUG$ has much lower affinities than ibogaine for NMDA and sigma-2 receptors, sodium channels, and the 5-HT transporter.	DDI-false
The intensity, uniformity and time course of the anticoagulant interference by phenobarbital, @DRUG$ , @DRUG$ In 16 patients receiving coumarin therapy, chloral hydrate and methaqualone were systematically studied.	DDI-false
In clinical studies with fondaparinux, co-administration of @DRUG$ ( warfarin ) , platelet inhibitors ( acetylsalicylic acid ) , NSAIDs ( piroxicam ) , and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of @DRUG$.	DDI-false
It is concluded that @DRUG$ and methaqualone may be administered safely without additional caution in prothrombin test monitoring during oral @DRUG$ therapy.	DDI-false
The pressor effects of catecholamines such as @DRUG$ or @DRUG$ are enhanced by Bretylium Tosylate.	DDI-false
Ketoconazole : In healthy volunteers, the @DRUG$ , a CYP3A4 inhibitor , at 200 mg twice daily for 7 days , systemic exposure ( AUC ) to @DRUG$ was increased to approximately 3.6-fold of control and half-life increased to 1.7-fold of control .	DDI-mechanism
injection of @DRUG$ ( @DRUG$ ) were observed by measuring locomotor activity and stereotyped behavior .	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, @DRUG$, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, @DRUG$, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
@DRUG$ These medicines in combination with very high doses of @DRUG$ In preclinical studies, seizures have been shown to occur.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, @DRUG$, doxycycline, erythromycin, imatinib, isoniazid, @DRUG$, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
@DRUG$: Etodolac has no apparent pharmacokinetic interaction when administered with @DRUG$ or hydrochlorothiazide.	DDI-false
- Non-steroidal anti-inflammatory medicines (but not @DRUG$ These medicines in combination with very high doses of @DRUG$ have been shown to provoke convulsions in pre-clinical studies .	DDI-false
In general, these are drugs that have one or more pharmacological activities such as bepridil hydrochloride, including antiarrhythmics such as e.g. @DRUG$ and procainamide , cardiac glycosides and @DRUG$.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and @DRUG$ cause additive CNS depression - Tricyclic antidepressants: @DRUG$ increases the effect of Tricyclic antidepressants	DDI-false
Aspirin/@DRUG$ : Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between @DRUG$ and concomitantly administered aspirin ( 162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1   g/kg/min . over 4 hours ) or acetaminophen ( 1000 mg orally given 12 , 6 and 0 hours prior to , and 6 and 12 hours subsequent to , initiation of Argatroban 1.5   g/kg/min . over 18 hours ) .	DDI-false
For example, inhibitors are azole antimycotics, ciprofloxacin, @DRUG$ , diclofenac , @DRUG$ , erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
@DRUG$ may increase slightly the effect of @DRUG$, e.g., guanethidine, methyldopa, reserpine.	DDI-effect
@DRUG$: In normal volunteers, a small decrease in diflunisal levels was observed when multiple doses of diflunisal and @DRUG$ were administered concomitantly.	DDI-false
The administration of local @DRUG$ containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or @DRUG$ may produce severe, prolonged hypertension.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
As the primary effect of @DRUG$ is to decrease conduction through the A-V node, higher degrees of heart block may be produced in the presence of @DRUG$.	DDI-effect
Cholestyramine-Concomitant intake of @DRUG$ and @DRUG$ The absorption of vitamin K can be reduced.	DDI-mechanism
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , doxorubicin , vincristine , and @DRUG$ ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , @DRUG$ , teniposide, and prednisone with vincristine plus bleomycin) without antiretroviral therapy.	DDI-false
This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with @DRUG$), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of @DRUG$).	DDI-false
Lack of an effect of @DRUG$ on the disposition of zidovudine and @DRUG$ in HIV-infected patients.	DDI-false
However , in the second study , administration of 12 g cholestyramine 1 hour before the evening meal and 0.3 mg @DRUG$ approximately 4 hours after the same evening meal resulted in a decrease in the @DRUG$ AUC of less than 8 % , and a decrease in Cmax of about 30 % when compared to dosing cerivastatin sodium alone .	DDI-false
Prednisone/@DRUG$ : Rofecoxib had no clinically important effect on the pharmacokinetics of prednisolone or @DRUG$.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, @DRUG$, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an @DRUG$ (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with @DRUG$ administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
There have been case reports of increased steady-state levels of quinidine, @DRUG$ , and phenytoin during concomitant therapy with @DRUG$.	DDI-false
These drugs include the @DRUG$ and other diuretics , corticosteroids , phe-nothiazines , thyroid products , estrogens , oral @DRUG$ , phenytoin , nicotinic acid , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .	DDI-false
Coadministration of @DRUG$ and @DRUG$, tacrolimus or digoxin has led to increased plasma concentrations of the latter three drugs.	DDI-mechanism
WARFARIN: Co- administration of @DRUG$ and @DRUG$ to healthy volunteers did not result in any changes in prothrombin time or clotting factor VII when compared to co-administration of warfarin and placebo.	DDI-false
@DRUG$ : Accompanying treatment with Accutane and @DRUG$ should be avoided because Accutane use has been associated with a number of cases of pseudotumor cerebri ( benign intracranial hypertension ) , some of which involved concomitant use of tetracyclines	DDI-false
there was no significant change in prothrombin test results during the trials of @DRUG$ and @DRUG$.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , @DRUG$ , vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without treatment @DRUG$ therapy .	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
therefore, nitroglycerin or other @DRUG$ (as used for management of angina) or other drugs having vasodilator activity should, if possible, be discontinued before starting @DRUG$.	DDI-advise
• Drug-drug interactions between Keppra and others @DRUG$ ( @DRUG$ Phenytoin Keppra (3,000 mg daily) did not affect the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy.	DDI-false
Example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , @DRUG$ , quinidine , and @DRUG$.	DDI-false
Although @DRUG$ have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of @DRUG$ and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-false
@DRUG$ Incorporating tranylcypromin sulfate, @DRUG$ , and pargyline HC1 : Concomitant use of L-tyrosine and non-selective MAO inhibitors may cause hypertension .	DDI-false
Other Drugs : Drugs such as quinidine , disopyramide , procainamide , @DRUG$ , @DRUG$ , and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia .	DDI-false
Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: ergotamine, @DRUG$, @DRUG$, nicardipine, and nifedipine.	DDI-false
Non-selective MAO inhibitors including tranylcypromine sulfate, @DRUG$, and @DRUG$ HC1: Concomitant use of L-tyrosine and non-selective MAO inhibitors may cause hypertension.	DDI-false
Although glucocorticoids have been shown to reduce @DRUG$-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with @DRUG$.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, @DRUG$, @DRUG$, protease inhibitors, quinidine, and verapamil.	DDI-false
In patients receiving @DRUG$ and a @DRUG$ concomitantly, any reduction in steroid dosage should be gradual in order to avoid the possible complications of sudden steroid withdrawal.	DDI-advise
@DRUG$ Treatment Urinary excretion @DRUG$ is increased , and efficacy is reduced by acidifying agents used in methenamine therapy .	DDI-false
• Drug interactions: Flupentixol may interact with some medicines, such as monoamine oxidase inhibitors ( @DRUG$ ): MAOI could theoretically influence @DRUG$ Pharmacodynamics - Arecoline - Eproxindine - Ethanol : Flupentixol and ethanol lead to additive CNS depression - Tricyclic antidepressants : Flupentixol increases the effect of tricyclic antidepressants	DDI-false
acetaminophen/theophylline, @DRUG$/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$ Incorporating coumarin derivatives, indandion derivatives and platelet aggregation inhibitors such as: @DRUG$ ( NSAIDs ) , and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin .	DDI-false
Benzthiazide may interact with alcohol, @DRUG$s, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, @DRUG$, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
The safety and efficacy of @DRUG$ in combination with any @DRUG$ have not been established.	DDI-false
@DRUG$ : Co- administration of warfarin and @DRUG$ No changes in prothrombin time or coagulation factor VII occurred in healthy volunteers compared to co-administration of warfarin and placebo.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, @DRUG$, theophylline and @DRUG$, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
@DRUG$ and methaqualone interact pharmacologically with orally administered @DRUG$, but the effect is not clinically significant.	DDI-int
These drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , @DRUG$ , oral contraceptives, phenytoin, nicotinic acid, @DRUG$ , calcium channel block drugs, and isoniazid.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and @DRUG$ cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of @DRUG$	DDI-false
Potential drug interactions between Keppra   and other AEDs ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of @DRUG$ and these @DRUG$ • during placebo-controlled clinical trials.	DDI-false
This appears to be the only clinically relevant interaction of this kind with @DRUG$, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, calcium channel blockers, antihistamines or H1-blocking agents, tricyclic antidepressants and @DRUG$) might also contribute to a prolongation of the QTc interval.	DDI-effect
Although neither dexamethasone nor retinyl acetate affected the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone, they modify the mitogenic effect of @DRUG$ and @DRUG$.	DDI-false
@DRUG$ Influence of the warfarin type ( CYP2C9 and CYP3A4 substrate) @DRUG$ response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding .	DDI-false
Central Nervous System Depressants: The concomitant use of @DRUG$  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, @DRUG$ (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-effect
@DRUG$: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a @DRUG$ inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
Since the therapeutic range of @DRUG$ is narrow @DRUG$ serum levels should be monitored closely, and appropriate dosage adjustments of theophylline should be made.	DDI-false
( In some patients @DRUG$ can reduce the diuretic , natriuretic , and antihypertensive effects of @DRUG$.	DDI-effect
Since the therapeutic range of theophylline is narrow @DRUG$ serum levels should be monitored closely, and appropriate dosage adjustments of @DRUG$ should be made.	DDI-false
@DRUG$  may interact with drugs known to interact with the conventional formulation of @DRUG$.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose @DRUG$ And antineoplastic agents, especially dacarbazine, @DRUG$ , tamoxifen and interferon alpha.	DDI-effect
Although glucocorticoids have been shown to reduce @DRUG$-induced adverse reactions such as fever, renal failure, hyperbilirubinaemia, confusion and dyspnoea, concomitant administration of these active substances with PROLEUKIN may reduce the efficacy of PROLEUKIN against the tumour and should therefore be avoided. 12 @DRUG$ In PROLEUKIN, hypotension and other antihypertensive agents may be increased.	DDI-false
@DRUG$ may enhance the effects of alcohol, @DRUG$, and other CNS depressants.	DDI-effect
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, @DRUG$, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac @DRUG$, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of @DRUG$, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain @DRUG$, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Imipramine ( 5 mg/kg), moclobemid ( 30 mg/kg), @DRUG$ ( 0.25 mg/kg ) , fluoxetine ( 20 mg/kg ) @DRUG$ 30 mg/ kg) or vehicle.	DDI-false
Barbiturates and @DRUG$ should not be administered to patients receiving @DRUG$.	DDI-advise
Oral @DRUG$ : Pharmacokinetic drug-drug interactions between @DRUG$ No evidence was provided for warfarin (7.5 mg single oral dose) and warfarin (7.5 mg single oral dose).	DDI-false
Colestipol : Plasma concentrations of @DRUG$ About 25% declined if: @DRUG$ and atorvastatin were coadministered .	DDI-false
Rifampin: Co-administration of VIOXX with @DRUG$ 600 mg daily, a potent inducer of hepatic metabolism, produced an approximate 50% decrease in @DRUG$ plasma concentrations.	DDI-false
It is recommended that the concomitant use of ethambutol with aluminium hydroxide is avoided. @DRUG$ At least 4 hours after @DRUG$ administration .	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations: Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family (e.g., @DRUG$, itraconazole, erythromycin, @DRUG$).	DDI-false
@DRUG$ It has been reported that the blood pressure lowering effect of systemic @DRUG$ is dulled.It is not known whether concomitant use of these active substances with ALPHAGAN P in humans can result in a resulting interference with the IOP-lowering effect.	DDI-effect
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, @DRUG$, felodipine, digoxin, warfarin, @DRUG$, carvedilol, ethanol or itraconazole.	DDI-false
Warfarin : The effects of @DRUG$ and @DRUG$ on GI bleeding are synergistic , such that users of both drugs together have a risk of serious GI bleeding higher than that of users of either drug alone .	DDI-effect
@DRUG$ IV has been used concomitantly with @DRUG$ No evidence of clinically relevant adverse reactions.	DDI-false
Plasma concentrations of @DRUG$ When co-administered with @DRUG$, the dose is reduced.	DDI-mechanism
This appears to be the only clinically relevant interaction of this species with @DRUG$ Although theoretically, the concomitant use of other drugs is known to alter the heart conduction (e.g., @DRUG$ or beta-adrenergic blocking agents , calcium channel blockers , antihistamines or H1-blocking agents , tricyclic antidepressants and phenothiazines ) might also contribute to a prolongation of the QTc interval .	DDI-effect
In post-marketing experience , bleeding events have been reported , predominantly in the elderly , in association with increases in prothrombin time in patients receiving @DRUG$ concurrently with @DRUG$.	DDI-effect
No formal clinical studies have been conducted to assess if there is an interactive effect on bone loss between @DRUG$ and @DRUG$.	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine , although theoretically , coadministration of other drugs known to alter cardiac conduction ( eg , anti-arrhythmic or beta-adrenergic blocking agents , calcium channel blockers , antihistamines or @DRUG$ , tricyclic antidepressants and @DRUG$ ) could also contribute to an extension of the QTc interval.	DDI-false
Example inhibitors include @DRUG$ , ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, @DRUG$ , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .	DDI-false
@DRUG$: Coadministration of single doses of @DRUG$ 3 mg and paroxetine 20 mg daily for 7 days produced no pharmacokinetic or pharmacodynamic interaction.	DDI-false
Example inhibitors include @DRUG$, @DRUG$, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
INOmax has been administered with tolazoline, dopamine, @DRUG$, steroids, @DRUG$, and high-frequency ventilation.	DDI-false
@DRUG$ (400 mg b.i.d.) had no effect on @DRUG$ bioavailability (AUC) and maximum concentration (Cmax) of vardenafil when co-administered with 20 mg Vardenafil in healthy volunteers.	DDI-false
Co-medications that induce CYP3A4 ( e.g. , @DRUG$ , phenytoin, carbamazepine, @DRUG$ , phenobarbital or St.	DDI-false
Multivitamins , or other products containing iron or zinc , antacids or sucralfate should not be administered concomitantly with , or within 2 hours of , the administration of @DRUG$ Because they may affect absorption, resulting in lower serum and urine levels of @DRUG$.	DDI-false
This drug may interact with @DRUG$ or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with @DRUG$ may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, Dapson, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporin, ergot derivatives, pimozide, @DRUG$ , fentanyl , @DRUG$ When co-administered with saquinavir, increased plasma concentrations may occur;	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, @DRUG$, cardiac nitrates, diuretics, @DRUG$, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ : In a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that @DRUG$ may impair absorption of fosinopril .	DDI-false
This study shows that the concomitant use of @DRUG$ permits at least a twofold increase in dose and total exposure to @DRUG$.	DDI-mechanism
In clinical studies with fondaparinux, the concomitant use of oral anticoagulants ( @DRUG$ ) , platelet inhibitors ( acetylsalicylic acid ) , NSAIDs ( @DRUG$ Digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
@DRUG$ including tranylcypromine sulfate , phenelzine sulfate , and pargyline HC1 : Concomitant use of @DRUG$ Non-selective MAO inhibitors can lead to hypertension.	DDI-false
Multivalent Cation-Containing Products : Concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum @DRUG$ , Sucralfat, VIDEX chew/buffer tablets or paediatric powders, or products containing calcium, @DRUG$ , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .	DDI-false
An encephalopathic syndrome (characterized by weakness, lethargy, fever, tremulousness and confusion, extrapyramidal symptoms, leukocytosis, elevated serum enzymes, BUN, and FBS) followed by irreversible brain damage has occurred in a few patients treated with @DRUG$ plus @DRUG$.	DDI-effect
No Important Interactions To Date @DRUG$ does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, warfarin, @DRUG$, carvedilol, ethanol or itraconazole.	DDI-false
To determine whether injection of @DRUG$ would permit larger doses of cisplatin to be administered, a fixed 9.9-g/m2 dose of @DRUG$ was given intravenously over three hours concurrently with escalating doses of cisplatin.	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, @DRUG$, @DRUG$, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Aminosalicylic acid may decrease the amount of @DRUG$ (Lanoxin, @DRUG$) that gets absorbed into your body.	DDI-false
These drugs include the thiazides and other diuretics , corticosteroids , @DRUG$ , @DRUG$ , estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel block drugs, and isoniazide.	DDI-false
Accordingly, when @DRUG$ is administered with oral @DRUG$, the prothrombin time should be closely monitored during and for several days after concomitant drug administration.	DDI-advise
Specific studies have confirmed these effects with sevoflurane, isoflurane, propofol, @DRUG$, and @DRUG$.	DDI-false
Other CONCOMITANT THERAPY: Although no specific interaction studies have been conducted, cerivastatin sodium was co-administered with @DRUG$ , @DRUG$ Calcium channel blockers, diuretics and nonsteroidal anti-inflammatory drugs (NSAIDs) without evidence of clinically significant adverse interactions.	DDI-false
In clinical studies with @DRUG$ (@DRUG$, 1 mg) in men 18-41 years of age, the mean value of serum prostate-specific antigen (PSA) decreased from 0.7 ng/mL at baseline to 0.5 ng/mL at Month 12.	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole ( cefmenoxime , cefoperazone , @DRUG$ , @DRUG$ Methylthiadiazole (cefazolin) may cause vitamin K deficiency and hypoprothrombinaemia.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
Central nervous system depressants: Concomitant use of DURAGESIC (Fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, @DRUG$ , and @DRUG$ , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	DDI-false
The extent to which @DRUG$-@DRUG$ interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the SSRI involved .	DDI-int
@DRUG$: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, @DRUG$, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Other concomitant therapies : In clinical trials, the safety profile in patients with acamprosate concomitantly with @DRUG$ , hypnotics and sedatives ( including @DRUG$ ) , or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications .	DDI-false
Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving @DRUG$ The concomitant use of fluoxetine and @DRUG$ increased the maximum plasma concentration of alprazolam by 46 % , decreased clearance by 21 % , increased half-life by 17 % , and decreased measured psychomotor performance .	DDI-false
Cholestyramine increases enterohepatic elimination of @DRUG$ and may reduce its serum levels and @DRUG$/2 .	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with @DRUG$, beta-blockers, felodipine, digoxin, @DRUG$, isosorbide mononitrate, carvedilol, ethanol or itraconazole.	DDI-false
The hypoglycemic action of @DRUG$ may be potentiated by certain drugs including @DRUG$ and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .	DDI-effect
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, @DRUG$, chlordiazepoxide, @DRUG$, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Other concomitant therapy Although no specific interaction studies have been conducted, 1 mg or more of finasteride doses have been reported in clinical trials with acetaminophen, acetylsalicylic acid, A-blockers, analgesics, angiotensin converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, @DRUG$ , calcium channel blockers, cardiac nitrates, diuretics, H2 antagonists, @DRUG$ , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
Antihypertensives : Amiodarone should be used with caution in patients receiving   -receptor blocking agents ( e.g. , @DRUG$ , a CYP3A4 inhibitor ) or @DRUG$ • antagonists (e.g. verapamil, a CYP3A4 substrate and diltiazem, a CYP3A4 inhibitor) because of the potential for bradycardia, sinus arrest and AV block;	DDI-false
@DRUG$: Other antiarrhythmic drugs, such as quinidine, procainamide, disopyramide, and phenytoin, have been used concurrently with @DRUG$.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$: In normal volunteers, a small decrease in diflunisal levels was observed when multiple doses of @DRUG$ and aspirin were administered concomitantly.	DDI-false
@DRUG$ : Probenecid interferes with renal tubular secretion of @DRUG$ This leads to an increase in serum ciprofloxacin levels.	DDI-false
While all the selective serotonin reuptake inhibitors ( SSRIs ) , e.g. , citalopram , @DRUG$ , fluoxetine , sertraline , and @DRUG$ , inhibit P450 2D6 , they may vary in the extent of inhibition .	DDI-false
In order to evaluate the effects of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL ), the authors retrospectively compared a group of 24 patients with HIV-NHL who had been treated with the @DRUG$ , @DRUG$ , vincristine and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, tenipide and prednisone with vincristine plus bleomycin) without antiretroviral therapy.	DDI-false
Other Drugs : Drugs such as quinidine , disopyramide , @DRUG$ , phenothiazines , antihistamines , and @DRUG$ may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia .	DDI-false
( In some patients @DRUG$ can reduce the diuretic , natriuretic , and antihypertensive effects of loop , potassium sparing , and @DRUG$.	DDI-effect
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, Dapson, disopyramide, quinine, amiodarone, @DRUG$ , warfarin, tacrolimus, cyclosporin, ergot derivatives, @DRUG$ , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
Substances that are potent inhibitors of CYP3A4 activity ( eg , ketoconazole and @DRUG$ ) decrease @DRUG$ metabolism and increase gefitinib plasma concentrations .	DDI-mechanism
Other potent inhibitors of CYP3A4 (e.g. itraconazole, @DRUG$ , @DRUG$ , troleandomycin , ritonavir , nelfinavir ) would be expected to behave similarly .	DDI-false
The bioavailability of the capsule formulation of @DRUG$ The effect was not affected by administration of 5 minutes after @DRUG$.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following : ergotamine , cyclosporine , amiodarone , @DRUG$ , and @DRUG$.	DDI-false
There is thus an enhancement effect of @DRUG$ After the reaction of the placenta vessels to @DRUG$ in vitro .	DDI-effect
@DRUG$: Co-administration of VIOXX with @DRUG$ 600 mg daily, a potent inducer of hepatic metabolism, produced an approximate 50% decrease in rofecoxib plasma concentrations.	DDI-false
Antiarrhythmics: Other antiarrhythmic drugs, such as quinidine, procainamide, @DRUG$, and phenytoin, have been used concurrently with @DRUG$.	DDI-false
Although @DRUG$ have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with @DRUG$ may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-false
Nephrotoxicity has been reported following concomitant administration of @DRUG$ with aminoglycoside antibiotics or potent diuretics such as @DRUG$.	DDI-effect
Warfarin : @DRUG$ It has been reported that the effects of oral @DRUG$ Warfarin or its derivatives.	DDI-false
Other concomitant therapy Although specific interaction studies have not been performed, @DRUG$ Doses of 1 mg or more have been associated with acetaminophene, acetylsalicylic acid, A-blockers, analgesics, angiotensin converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta-blockers, calcium channel blockers, heart @DRUG$ , diuretics , H2 antagonists , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to @DRUG$, including anti-arrhythmic agents such as quinidine and @DRUG$, cardiac glycosides and tricyclic anti-depressants.	DDI-false
Another oral azole antifungal, ketoconazole, inhibits the metabolism of astemizole, resulting in elevated plasma concentrations of @DRUG$ and its active metabolite @DRUG$ which may prolong QT intervals.	DDI-false
Antacids : In a clinical pharmacology study , coadministration of an @DRUG$ - (aluminium hydroxide, magnesium hydroxide and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat compared to @DRUG$ Administration alone, suggesting that antacids may affect the absorption of fosinopril.	DDI-false
@DRUG$: generally should not be given with @DRUG$.	DDI-advise
@DRUG$ Reports suggest that NSAIDs may diminish the antihypertensive effect of @DRUG$.	DDI-false
In clinical trials with: @DRUG$ , the concomitant use of oral anticoagulants ( warfarin ) , @DRUG$ Acetylsalicylic acid, NSAIDs (piroxicam) and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Antihypertensives : @DRUG$ Propranolol, a CYP3A4 inhibitor ) or calcium channel antagonists (e.g. verapamil, a CYP3A4 substrate and diltiazem, @DRUG$ inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and AV block ;	DDI-false
Antiarrhythmics : Other @DRUG$ - medicinal products such as quinidine, procainamide, disopyramide and @DRUG$ , were used simultaneously with amiodarone.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, @DRUG$, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, @DRUG$, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ Elevated serum lithium levels and symptoms of lithium toxicity have been reported in patients concomitantly @DRUG$ Treatment and ACE inhibitors.	DDI-false
Although this effect has been established even if: @DRUG$ The dose was given 4 hours before @DRUG$ , this regimen did not result in diminished efficacy .	DDI-effect
Another oral @DRUG$, ketoconazole, inhibits the metabolism of astemizole, resulting in elevated plasma concentrations of astemizole and its active metabolite @DRUG$ which may prolong QT intervals.	DDI-false
Although neither @DRUG$ nor @DRUG$ affected the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone , they modify the mitogenic effect of EGF and insulin .	DDI-false
Multivalent Cation-Containing Products : Concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or @DRUG$ antacids , sucralfate , VIDEX chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of @DRUG$ , resulting in serum and urine levels considerably lower than desired .	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, @DRUG$ , disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$ , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
Paroxetine : Coadministration of single doses of @DRUG$ 3 mg and @DRUG$ 20 mg daily for 7 days showed no pharmacokinetic or pharmacodynamic interactions.	DDI-false
Other potent inhibitors of CYP3A4 (e.g. @DRUG$ , clarithromycin, nefazodon, troleandomycin, @DRUG$ nelfinavir is expected to behave similarly.	DDI-false
However, no harmful interactions have been observed when ROMAZICON is observed after @DRUG$ , inhalational @DRUG$ , muscle relaxants and muscle relaxant antagonists administered in conjunction with sedation or anesthesia .	DDI-false
- Mephenytoin (e.g., @DRUG$) Use of @DRUG$ with these medicines may increase the chance of side effects of these medicines	DDI-false
Examples of inhibitors are azole antimycotics, ciprofloxacin, clarithromycin, diclofenac, @DRUG$ , erythromycin, imatinib, isoniazid, nefazodone, @DRUG$ , propofol , protease inhibitors , quinidine , and verapamil .	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, @DRUG$, @DRUG$, digoxin, warfarin, isosorbide mononitrate, carvedilol, ethanol or itraconazole.	DDI-false
Possible drug interactions between Keppra and other AEDs (carbamazepine, @DRUG$ , @DRUG$ , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies .	DDI-false
1 hour after starting the @DRUG$ or @DRUG$ 500 mg p.o.	DDI-false
Similarly dialyzed were phenobarbital, quinidine, and @DRUG$, both alone at therapeutic concentrations in serum and with @DRUG$ at three different concentrations in serum.	DDI-false
Although glucocorticoids have been shown to reduce @DRUG$-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other @DRUG$ may potentiate the hypotension seen with PROLEUKIN.	DDI-false
The risk of myopathy during treatment with medicines in this class is increased with concomitant administration of cyclosporin, fibric acid derivatives, niacin ( @DRUG$ ) , @DRUG$ Azol Antimycotics.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, @DRUG$, and @DRUG$ with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
@DRUG$: The effect of celecoxib on the anti-coagulant effect of @DRUG$ was studied in a group of healthy subjects receiving daily doses of 2-5 mg of warfarin.	DDI-false
acetaminophen/theophylline, @DRUG$/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Elevated serum levels of @DRUG$ have been reported with concomitant use of @DRUG$ with norfloxacin.	DDI-false
These drugs include the @DRUG$ and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, @DRUG$, and isoniazid.	DDI-false
Plasma valproate concentration should be monitored when @DRUG$ and @DRUG$ are co administered, and appropriate dosage adjustments of valproate should be made.	DDI-advise
Glyburide: @DRUG$ has no apparent pharmacokinetic interaction when administered with @DRUG$.	DDI-false
Therefore, interactions could occur following concomitant administration of @DRUG$ (e.g., narcotics, analgesics, antiemetics, sedatives, @DRUG$).	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, @DRUG$, propranolol, nifedipine, chlordiazepoxide, @DRUG$, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and antineoplastic agents , specifically , @DRUG$ , cis-platinum , @DRUG$ and interferon-alfa .	DDI-false
In a comparison of @DRUG$ The tolerance in dogs stunned with ketamine, Innovar Vet or pentobarbital was significantly higher than the LD50 of Ouabain, with ketamine or @DRUG$ than with pentobarbital .	DDI-false
Stavudine and Zidovudine @DRUG$ In vitro, the antiviral activity of stavudine and @DRUG$ against HIV .	DDI-effect
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ACE ) inhibitors , @DRUG$ , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , H2 antagonists , @DRUG$ , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
Omeprazole: The rate and extent of absorption of ciprofloxacin was bioequivalent when Proquin XR was given alone or when @DRUG$ was given 2 hours after @DRUG$ at the dose that maximally suppresses gastric acid secretion.	DDI-false
Patients taking @DRUG$ concomitantly with @DRUG$ more commonly reported both weight gain and weight loss, compared with patients taking either medication alone.	DDI-effect
Clinical studies of @DRUG$ alone or in combination with @DRUG$ did not include sufficient numbers of subjects aged 65 or over to determine whether they respond differently from younger subjects.	DDI-false
Although in clinical studies with IOPIDINE 0.5 % ophthalmic solution no specific drug interactions with topical glaucoma or systemic drugs have been identified, there is a possibility of additive or potentiating effects with CNS depressants ( @DRUG$ , barbiturates , @DRUG$ , sedatives , anesthetics ) should be considered .	DDI-false
It is concluded that chloral hydrate and @DRUG$ may be administered safely without additional caution in prothrombin test monitoring during oral @DRUG$ therapy.	DDI-false
@DRUG$, other, especially @DRUG$, or preanesthetic and anesthetic agents used in surgery or skeletal-muscle relaxants, nondepolarizing, used in surgery	DDI-false
Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following : @DRUG$ , cyclosporine , amiodarone , nicardipine , and @DRUG$.	DDI-false
These drugs include the thiazides and other diuretics, @DRUG$, phenothiazines, thyroid products, estrogens, oral @DRUG$, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
This time window is different than for other oral formulations of @DRUG$, which are usually administered 2 hours before or 6 hours after @DRUG$.	DDI-advise
@DRUG$ 150 mg twice daily did not interact significantly with @DRUG$ (AUC was decreased by 15-20 %).	DDI-false
This seems to be the only clinically relevant interaction of this species with mefloquines, although theoretically, the concomitant use of other drugs is known to alter heart conduction (e.g., @DRUG$ or @DRUG$ Also calcium channel blockers, antihistamines or H1-blockers, tricyclic antidepressants and phenothiazines could contribute to an extension of the QTc interval.	DDI-false
acetaminophen/@DRUG$, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
For example, inhibitors are azole antimycotics, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazide, @DRUG$ , nicardipine, propofol, @DRUG$ , quinidine, and verapamil.	DDI-false
Although neither dexamethasone nor @DRUG$ affected the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone, they modify the mitogenic effect of EGF and @DRUG$.	DDI-effect
Antacids : In a clinical pharmacology study, the concomitant use of a @DRUG$ ( aluminum hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of @DRUG$.	DDI-false
In addition, @DRUG$ neither influenced the pharmacodynamics of warfarin, acetylsalicylic acid, piroxicam, and @DRUG$, nor the pharmacokinetics of digoxin at steady state.	DDI-false
However, if @DRUG$ is to be initiated after cessation of @DRUG$ therapy, allow sufficient time for heparins effect on the aPTT to decrease prior to initiation of Argatroban therapy.	DDI-false
The aim of this paper was to study the interaction between neurotensin and both @DRUG$ or its synthetic analogue @DRUG$, or tuftsin, on the antinonciceptive effect of these peptides in mice after intracisternal injection.	DDI-false
@DRUG$ has been shown to have neuromuscular blocking properties that may enhance the action of other @DRUG$.	DDI-effect
@DRUG$ administration to three cancer patients over a dose range of 0.025 mg to 2.2 mg led to a dose-dependent inhibition of antipyrine elimination.14 The effect of alternate-day administration of 0.25 mg of @DRUG$ on drug metabolism in MS patients is unknown.	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, @DRUG$, sulfonamides, chloramphenicol, probenecid, coumarins, @DRUG$, and beta adrenergic blocking agents.	DDI-false
Intravenous @DRUG$ (adenosine) has been effectively administered in the presence of other cardioactive drugs, such as quinidine, beta-adrenergic blocking agents, calcium channel blocking agents, and @DRUG$, without any change in the adverse reaction profile.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, @DRUG$, vincristine, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Antiarrhythmics: Other @DRUG$ drugs, such as quinidine, @DRUG$, disopyramide, and phenytoin, have been used concurrently with amiodarone.	DDI-false
@DRUG$ : Clinical studies , as well as post marketing observations , have shown that NSAIDs can reduce the natriuretic effect of @DRUG$ Some patients were diagnosed with thiazides and thiazides.	DDI-false
In view of the long and variable half-life of @DRUG$ , potential for drug interactions exists not only with concomitant medication but also with drugs administered after discontinuation of @DRUG$.	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, dapsones, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporin, ergot derivatives, pimozide, carbamazepine, @DRUG$ , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with @DRUG$ ;	DDI-mechanism
In some patients the combined use of @DRUG$ and @DRUG$ has been associated with fatal gastrointestinal hemorrhage.	DDI-effect
Acetaminophen, @DRUG$, phenobarbital, quinidine, @DRUG$, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
The compounds tested in humans include warfarin, theophylline, @DRUG$ , diazepam , @DRUG$ and antipyrine .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
In a comparison of @DRUG$ Tolerance in dogs stunned with ketamine, Innovar Vet, or @DRUG$ , the dosage of ouabain needed to cause ventricular tachycardia was significantly higher , as was the LD50 of ouabain , with ketamine or Innovar than with pentobarbital .	DDI-false
Drugs That Induce CYP3A4 (Rifampicin) Racemic @DRUG$ exposure was decreased 80% by concomitant useof @DRUG$, a potent inducer of CYP3A4.	DDI-mechanism
Notably, systemic exposure (AUC0-12) of dapsone hydroxylamine (@DRUG$) was more than doubled in the presence of TMP/@DRUG$.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/@DRUG$, and valproic acid/phenobarbital.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, @DRUG$, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, @DRUG$, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
@DRUG$ If multiple doses of atorvastatin and digoxin have been co-administered, steady-state plasma is @DRUG$ Concentrations increased by about 20%.	DDI-false
Rhabdomyolysis has been observed in patients receiving @DRUG$ administered alone (at recommended dosages) or concomitantly with @DRUG$ including cyclosporine.	DDI-effect
Compounds that have been tested in man include antipyrine, @DRUG$, propranolol, @DRUG$, and warfarin and no clinically meaningful interactions were found.	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, @DRUG$, barbiturates, MAO inhibitors, and other @DRUG$.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
@DRUG$ Supplements and @DRUG$: Fosinopril sodium can attenuate potassium loss caused by thiazide diuretics.	DDI-false
Example inhibitors include @DRUG$, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, @DRUG$, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
In a comparison of @DRUG$ tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with @DRUG$.	DDI-false
Data from in vitro studies @DRUG$ other than alprazolam suggest a possible drug interaction for the following : ergotamine , cyclosporine , @DRUG$ , nicardipine, and nifedipine.	DDI-int
@DRUG$ When 5 mg is co-administered @DRUG$ The Cmax and AUC of ritonavir were reduced by approximately 20% with 600 mg BID ritonavir.	DDI-false
- @DRUG$ (e.g., @DRUG$) or	DDI-false
As with other antipsychotic agents, it should be noted that @DRUG$ may be capable of potentiating CNS depressants such as anesthetics, @DRUG$, and alcohol.	DDI-effect
Example inhibitors include azole antifungals, ciprofloxacin, @DRUG$, diclofenac, @DRUG$, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Antacids : In a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium hydroxide , and @DRUG$ ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with @DRUG$ administered alone , suggesting that antacids may impair absorption of fosinopril .	DDI-false
@DRUG$: Concurrent administration of aspirin may lower @DRUG$ plasma levels, possibly by competing for protein-binding sites.	DDI-false
Oral @DRUG$ Co-administration of atorvastatin and oral contraceptives increased AUC levels for norethindrone and @DRUG$ - about 30% and 20%.	DDI-false
medicines that induce CYP3A4 ( @DRUG$ ) Racemic @DRUG$ exposure was decreased 80 % by concomitant useof rifampicin , a potent inducer of CYP3A4 .	DDI-false
Specific studies have confirmed these effects with @DRUG$, isoflurane, propofol, alfentanil, and @DRUG$.	DDI-false
Tolbutamide: In diabetic patients receiving @DRUG$ and @DRUG$, no significant effects were seen on tolbutamide plasma levels or fasting blood glucose.	DDI-false
To determine if the injection of thiosulfate is larger doses of thiosulfate @DRUG$ to be administered , a fixed 9.9-g/m2 dose of @DRUG$ was given intravenously over three hours concurrently with escalating doses of cisplatin .	DDI-false
• prostatic epithelial proliferate in a defined medium consisting of a basal medium RPMI1640 containing transferrin ( 1 micrograms/ ml), @DRUG$ ( 10 ng/ml ) , and @DRUG$ [ 3.7 micrograms/ ml or 0.1 IU/ ml].	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, @DRUG$, certain @DRUG$, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
@DRUG$: rifampin CONTRAINDICATED since the coadministration of this product with saquinavir in an @DRUG$ regimen reduces the plasma concentrations of saquinavir.	DDI-false
These drugs include thiazides and other diuretics, @DRUG$ , phe-nothiazines , @DRUG$ , estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel block drugs, and isoniazide.	DDI-false
@DRUG$ may interact with @DRUG$, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.	DDI-int
Other Drugs:Drugs such as quinidine, disopyramide, procainamide, @DRUG$, antihistamines, and @DRUG$ may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
Although drug interaction studies have not been conducted, corticosteroids or @DRUG$ treatment of relapses for periods of up to 28 days has been administered to patients ( N=180 ) receiving @DRUG$.	DDI-false
@DRUG$ or @DRUG$ excess may decrease the effect of Carbimazole, and an iodine deficiency can increase the effect of Carbimazole.	DDI-false
The pressor effects of @DRUG$ such as dopamine or norepinephrine are enhanced by @DRUG$.	DDI-effect
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, Dapson, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$ , cyclosporin, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$ , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
@DRUG$: The concomitant administration of @DRUG$ with the sulfonylurea glyburide has, on rare occasions, resulted in severe hypoglycemia.	DDI-false
Therefore , when @DRUG$ and @DRUG$ The patient should be closely monitored to determine whether the desired effect of the diuretic is achieved.)	DDI-advise
In a comparison of digitalis tolerance in dogs anesthetized with @DRUG$, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with @DRUG$.	DDI-false
@DRUG$ : In healthy individuals , plasma concentrations of atorvastatin increased approximately 40 % with coadministration of atorvastatin and @DRUG$ , a known inhibitor of cytochrome P450 3A4 .	DDI-false
Sulindac : The concomitant administration of @DRUG$ and @DRUG$ in normal volunteers resulted in lowering of the plasma levels of the active sulindac sulfide metabolite by approximately one-third .	DDI-mechanism
These drugs include the thiazides and other diuretics , corticosteroids , @DRUG$ , thyroid products, estrogens, orally @DRUG$ , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ACE ) inhibitors , anticonvulsants , @DRUG$ Beta blockers, calcium channel blockers, cardiac nitrates, diuretics, @DRUG$ , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
Injection : Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when with ethyl alcohol, phenothiazine, @DRUG$ , MAO inhibitors, and other antidepressants. When @DRUG$ is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .	DDI-false
@DRUG$ : @DRUG$ 20 mg , when co-administered with slow-release nifedipine 30 mg or 60 mg once daily , did not affect the relative bioavailability ( AUC ) or maximum concentration ( Cmax ) of nifedipine , a drug that is metabolized via CYP3A4 .	DDI-false
The possibility of hypotensive effects with enalapril or @DRUG$ can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with @DRUG$ or enalaprilat.	DDI-false
It is recommended to avoid concurrent administration of @DRUG$ with @DRUG$ Containing antacids for at least 4 hours after ethambutol administration.	DDI-advise
Carbamazepine: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with @DRUG$, signs and symptoms of @DRUG$ toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.	DDI-false
Therefore, when meclofenamate sodium is given to a patient receiving @DRUG$, the dosage of @DRUG$ should be reduced to prevent excessive prolongation of the prothrombin time.	DDI-false
Central nervous system depressants : Co-administration of DURAGESIC (Fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, @DRUG$ ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , @DRUG$ , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	DDI-false
@DRUG$, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and @DRUG$, thereby delaying elimination and increasing blood levels of these drugs.	DDI-mechanism
- Methotrexate (e.g., @DRUG$) Use of @DRUG$ with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of methotrexate	DDI-false
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies (phenytoin, @DRUG$, oral contraceptive, @DRUG$, warfarin, probenecid) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients.	DDI-false
Potential drug interactions between Keppra  and other AEDs (@DRUG$, gabapentin, @DRUG$, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Patients with high doses of @DRUG$ concomitantly with @DRUG$ , as in rheumatic disease , may experience salicylate toxicity at lower doses because of competitive renal excretory sites .	DDI-effect
Patients with hypotension @DRUG$ Therapy : Patients on @DRUG$ and especially those in whom diuretic therapy was recently instituted , as well as those on severe dietary salt restriction or dialysis , may occasionally experience a precipitous reduction of blood pressure usually within the first hour after receiving the initial dose of captopril .	DDI-false
Here we show that a combination of @DRUG$ or 3,7-dihydroxyflavone with @DRUG$ may be used to sensitize resistant strains of Enterococcus faecalis and Enterococcus faecium to the level of vancomycin-sensitive strains.	DDI-false
Other drug interactions: no pharmacokinetic interactions between vardenafil and the following medicines have been observed: glyburide, warfarin, digoxin, @DRUG$ , and @DRUG$.	DDI-false
These drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , @DRUG$ , estrogens, orally @DRUG$ , phenytoin, nicotinic acid, sympathomimetics, calcium channel block drugs, and isoniazide.	DDI-false
OBJECTIVES : Our goal was to develop the steady-state pharmacokinetics of @DRUG$ and @DRUG$ INN ( ciclosporin) with concomitant use in de novo renal allographer receivers in the first year after transplantation.	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, @DRUG$, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or @DRUG$ than with pentobarbital.	DDI-false
Benzthiazide can interact with alcohol, blood thinners, @DRUG$ (allergic agents, colds, and sinus drugs), diabetics, lithium, norepinephrine, NSAIDs such as Aleve or @DRUG$ , and high blood pressure medications.	DDI-false
Potential drug interactions between @DRUG$ The serum concentrations of carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate have also been studied. @DRUG$ These AEDs during placebo-controlled clinical trials.	DDI-false
Other medicinal products Interactions: No pharmacokinetic interactions between vardenafil and the following medicinal products have been observed: @DRUG$ , warfarin, digoxin, Maalox, and @DRUG$.	DDI-false
Probenecid : @DRUG$ interferes with renal tubular secretion of @DRUG$ This leads to an increase in serum ciprofloxacin levels.	DDI-mechanism
@DRUG$ : In hypercholesterolemic patients , steady-state cerivastatin AUC and Cmax increased approximately 50 % and 24 % respectively after 10 days with co-administration of @DRUG$ , a known inhibitor of cytochrome P450 3A4 .	DDI-false
Possible drug interactions of: @DRUG$ With succinylcholine or with other @DRUG$.	DDI-int
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies (@DRUG$, valproate, oral contraceptive, digoxin, @DRUG$, probenecid) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients.	DDI-false
These drugs include: @DRUG$ and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral @DRUG$ , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .	DDI-false
A possible interaction between @DRUG$ It has been reported that ciprofloxacin, a fluoroquinolone antibiotic, increased the hypoglycaemic effect of @DRUG$.	DDI-false
Carbamazepine : Isoniazid is known to slow the metabolism of @DRUG$ Carbamazepine levels should be determined prior to co-administration with isoniazide, signs and symptoms of carbamazepine. @DRUG$ The toxicity should be closely monitored and an appropriate dose adjustment of the anticonvulsant should be made.	DDI-false
While all the @DRUG$ (SSRIs), e.g., @DRUG$, escitalopram, fluoxetine, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
Quinolones , including @DRUG$ , may enhance the effects of oral anticoagulants , including @DRUG$ or its derivatives or similar agents .	DDI-effect
- @DRUG$ (@DRUG$ [e.g., Anabolin], oxandrolone [e.g., Anavar], oxymetholone [e.g., Anadrol], stanozolol [e.g., Winstrol]) or	DDI-false
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ACE ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , @DRUG$ , cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also known as NSAIDs), and @DRUG$ without evidence of clinically significant adverse interactions .	DDI-false
Other Drug Interactions: No pharmacokinetic interactions were observed between vardenafil and the following drugs: @DRUG$, @DRUG$, digoxin, Maalox, and ranitidine.	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of @DRUG$, fibric acid derivatives, @DRUG$ (nicotinic acid), erythromycin, azole antifungals.	DDI-false
Use with @DRUG$: The principal pathway for detoxification of azathioprine is inhibited by @DRUG$.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, @DRUG$, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and @DRUG$.	DDI-false
Example inhibitors include azole antifungals , @DRUG$ , clarithromycin , diclofenac , doxycycline , @DRUG$ Imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
The concomitant use of @DRUG$ is not recommended since @DRUG$ may antagonize the antibacterial effect of Norfloxacin in the urinary tract.	DDI-false
While all the @DRUG$ ( SSRIs ) , e.g. , citalopram , @DRUG$ Fluoxetine, sertraline, and paroxetine, inhibit P450 2D6, they may vary in extent of inhibition.	DDI-false
Potassium-sparing diuretics (e.g., @DRUG$, triamterene, or @DRUG$), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, haloperidol, phenothiazines, @DRUG$, tricyclic antidepressants or some @DRUG$.	DDI-false
International Normalized Ratio ( INR ) elevations and/or bleeding events have been reported in some patients taking @DRUG$ while on @DRUG$ therapy .	DDI-effect
Micro-dosed Progesterone Preparations : Micro-dosed progesterone preparations ( minipills that do not contain an @DRUG$ ), an inadequate contraceptive method may be used during @DRUG$ therapy .	DDI-false
acetaminophen/@DRUG$ , lidocaine/quinidine , phenobarbital/acetaminophen , phenobarbital/valproic acid , quinidine/lidocaine , theophylline/@DRUG$ , and valproic acid/phenobarbital .	DDI-false
Imipramine (5 mg/kg), @DRUG$ (30 mg/kg), clonazepam (0.25 mg/kg), @DRUG$ (20 mg/kg) sertraline (30 mg/kg) or vehicle was administered.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, @DRUG$, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, @DRUG$, and isoniazid.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum @DRUG$, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing @DRUG$, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , @DRUG$ , @DRUG$ , protease inhibitors, quinidine, and verapamil.	DDI-false
Treatment with @DRUG$ once weekly for 4 weeks in healthy subjects was associated with an inhibition of P450 1A2 and a 25 % increase in @DRUG$ AUC .	DDI-mechanism
Central nervous system depressants: Concomitant use of DURAGESIC (Fentanyl transdermal system) with others @DRUG$ , including but not limited to other @DRUG$ Anaesthetics, hypnosis, tranquilizers (e.g. benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants and alcohol may cause respiratory depression, hypotension and deep sedation, or possibly lead to coma or death.	DDI-false
No pharmacokinetic interactions between dexmedetomidine and isoflurane, @DRUG$, alfentanil, and @DRUG$ have been demonstrated.	DDI-false
The co-administration of medicinal products which are nephrotoxic (e. g. @DRUG$ , indomethacin ) , myelotoxic ( e.g. , cytotoxic chemotherapy ) , cardiotoxic ( e.g. , doxorubicin ) or hepatotoxic ( e.g. , @DRUG$ , asparaginase ) effects with PROLEUKIN may increase toxicity in these organ systems .	DDI-false
Drug Interactions: @DRUG$ may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - @DRUG$ - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Antihypertensives: @DRUG$ should be used with caution in patients receiving  -receptor blocking agents (e.g., @DRUG$, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
These results suggest that both dexamethasone and @DRUG$, and possibly other glucocorticoids and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and @DRUG$.	DDI-effect
Data from in vitro studies of @DRUG$ other than alprazolam suggest a possible drug interaction for the following: ergotamine, cyclosporine, amiodarone, nicardipine, and @DRUG$.	DDI-int
@DRUG$ should not be used as a substitute for oral or inhaled @DRUG$.	DDI-false
Data from in vitro studies of @DRUG$ other than alprazolam suggest a possible drug interaction for the following: ergotamine, @DRUG$, amiodarone, nicardipine, and nifedipine.	DDI-int
Cardiovasculars : Cardiac glycosides : In patients receiving digoxin therapy , administration of oral @DRUG$ regularly results in an increase in serum @DRUG$ concentration that may reach toxic levels with resultant clinical toxicity .	DDI-false
Example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , @DRUG$ , doxycycline, erythromycin, imatinib, isoniazid, nefazodone, @DRUG$ Propofol, protease inhibitors, quinidine and verapamil.	DDI-false
Multivalent Cation-Containing Products : Concomitant administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminium @DRUG$ , sucralfate , @DRUG$ The chewable/buffered tablets or paediatric powders, or products that contain calcium, iron or zinc can significantly reduce the absorption of ciprofloxacin, resulting in serum and urine levels significantly lower than desired.	DDI-false
These drugs include the thiazides and other diuretics , @DRUG$ , phenothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$ , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .	DDI-false
Therefore, interactions may occur after concomitant administration of psychotropic medicinal products (e. g. @DRUG$ , analgesics , @DRUG$ , sedatives , tranquilizers ) .	DDI-false
Concurrent administration of @DRUG$ and of @DRUG$ may cause severe , persistent hypertension or cerebrovascular accidents .	DDI-false
Although there is little published information on concomitant administration of @DRUG$ and @DRUG$, these drugs are often administered concurrently without any evidence of interactions resulting in adverse effects or diminished efficacy.	DDI-false
Multivalent Cation-Containing products: Concomitant administration of quinolone, including ciprofloxacin, with multivalent cation-containing products such as @DRUG$ or aluminum antacids , sucralfate , VIDEX chewable/buffered tablets or pediatric powder , or products containing calcium , @DRUG$ , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .	DDI-false
The monoamine oxidase inhibits the effect of @DRUG$ may persist for a substantial period after discontinuation of the drug , and this should be borne in mind when another drug is prescribed following @DRUG$.	DDI-false
Example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , @DRUG$ , propofol , @DRUG$ , quinidine , and verapamil .	DDI-false
A drug interaction study investigated the effect of using ACZONE gel, 5%, in combination with double strength (160 mg/800 mg) trimethoprim/sulfamethoxazole ( @DRUG$/@DRUG$ ) .	DDI-false
Compounds that have been tested in man include @DRUG$, digoxin, propranolol, theophylline, and @DRUG$ and no clinically meaningful interactions were found.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when @DRUG$ is administered concomitantly with other @DRUG$, amantadine, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.	DDI-effect
Antihypertensives : Amiodarone should be used with caution in patients receiving   -receptor blocking agents ( e.g. , propranolol , a CYP3A4 inhibitor ) or @DRUG$ antagonists ( e.g. , verapamil , a @DRUG$ Substrate, and diltiazem, an inhibitor of CYP3A4) due to the potential for bradycardia, sinus arrest, and AV block;	DDI-false
Concomitant use of @DRUG$ A lower dose may be required for medicines that may inhibit cytochrome P450 2D6 than normally used for @DRUG$ Or the other drug.	DDI-false
Further , no effects on either @DRUG$ In a study with concomitant administration of warfarin and @DRUG$, levels or prothrombin times were observed.	DDI-false
@DRUG$ produced distinctive effects in each task : it substituted for the training dose in @DRUG$ discrimination and it increased the number of responses with short ( <3 s ) interresponse times as well as increasing overall response rates in the DRL schedule .	DDI-false
@DRUG$ : @DRUG$ Toxicity has been reported in patients receiving lithium concomitantly with medicinal products that cause the excretion of sodium, including ACE inhibitors.	DDI-false
Clinical interaction studies with cimetidine and @DRUG$ indicated that the coadministration of @DRUG$ with these drugs does not result in clinically- significant drug interactions.	DDI-false
Compounds tested in man include warfarin, theophylline, @DRUG$, @DRUG$, aminopyrine and antipyrine.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose @DRUG$ and @DRUG$, specifically, dacarbazine, cis-platinum, tamoxifen and interferon-alfa.	DDI-effect
• Corticosteroids, methylxanthine and diuretics: concomitant treatment with @DRUG$ Steroids or diuretics may potentiate a possible hypocalemic effect @DRUG$	DDI-effect
Benzthiazide can interact with alcohol, @DRUG$s, decongestant medications (allergic, cold, and sinus drugs), diabetes medications, lithium, norepinephrine, @DRUG$ Such as Aleve or ibuprofen, and high blood pressure medications.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, @DRUG$, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Alcohol: @DRUG$ (0.5 g/kg body weight: approximately 40 mL of absolute alcohol in a 70 kg person) and @DRUG$ plasma levels were not altered when dosed simultaneously.	DDI-false
Other reported interactions with @DRUG$ : Fentanyl ( @DRUG$ The substrate) in combination with amiodarone may cause hypotension, bradycardia, and reduced cardiac output.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, @DRUG$, and prednisone with vincristine plus @DRUG$) without receiving antiretroviral therapy.	DDI-false
Lithium: NSAIDs have produced an elevation of plasma @DRUG$ levels and a reduction in renal @DRUG$ clearance.	DDI-false
Pretreatment of megakaryocytes with extracellular @DRUG$ (50 microM) also inhibited @DRUG$-induced responses.	DDI-effect
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, @DRUG$, @DRUG$ and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Other Cardiovascular Agents : @DRUG$ and enalapril IV have been used concomitantly with beta adrenergic-blocking agents , @DRUG$ , nitrates , calcium-blocking agents , hydralazine , prazosin and digoxin without evidence of clinically significant adverse interactions .	DDI-false
Lithium : In a study conducted in healthy subjects , mean steady-state @DRUG$ 17% of patients receiving CELEBREX 200 mg twice daily lithium 450 mg increased compared to patients receiving CELEBREX 200 mg twice daily lithium 450 mg. @DRUG$ alone .	DDI-false
Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following : ergotamine , cyclosporine , @DRUG$ , @DRUG$ , and nifedipine .	DDI-false
@DRUG$ taken concomitantly with procainamide for less than seven days increases plasma concentrations of @DRUG$ and n-acetyl procainamide by 55% and 33%, respectively.	DDI-false
High-dose cyclosporin A resulting in concentrations above 2000 ng/mL administered with oral etoposide has led to an 80 % increase in @DRUG$ Exposure with a 38% decrease in total body clearance @DRUG$ compared to etoposide alone .	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral @DRUG$, phenytoin, nicotinic acid, sympathomimetics, @DRUG$, and isoniazid.	DDI-false
Acetaminophene, lidocaine, @DRUG$ , @DRUG$ Theophylline, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of @DRUG$ , fibrous acid derivatives, niacin (nicotinic acid), @DRUG$ Azol Antimycotics.	DDI-false
Remarkable is systemic exposure ( AUC0 - 12 ) @DRUG$ ( @DRUG$ TMP/SMX was more than doubled in the presence of TMP/SMX.	DDI-false
These drugs include thiazides and other @DRUG$ , corticosteroids, phe-nothiazines, @DRUG$ , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, @DRUG$, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and @DRUG$, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Other potent inhibitors of CYP3A4 (e.g. itraconazole, clarithromycin, nefazodone, troleandomycin, @DRUG$ , @DRUG$ ) would be expected to behave similarly .	DDI-false
These drugs include the @DRUG$ and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral @DRUG$, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
The co-administration of medicinal products which are nephrotoxic (e. g. @DRUG$ , indomethacin), myelotoxic (e.g., @DRUG$ chemotherapy ) , cardiotoxic ( e.g. , doxorubicin ) or hepatotoxic ( e.g. , methotrexate , asparaginase ) effects with PROLEUKIN may increase toxicity in these organ systems .	DDI-false
@DRUG$ The simultaneous use of @DRUG$ with the sulfonylurea glyburide has , on rare occasions , resulted in severe hypoglycemia .	DDI-false
Some drugs/substances are known to accelerate the metabolism of @DRUG$ by stimulating the synthesis of @DRUG$ (enzyme induction).	DDI-false
Other Cardiovascular Agents : Enalapril and @DRUG$ IV have been used concomitantly with beta adrenergic-blocking agents , methyldopa , nitrates , @DRUG$ , hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., @DRUG$, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., @DRUG$, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Antiarrhythmia : Other antiarrhythmic drugs, such as @DRUG$ - procainamide, disopyramide and @DRUG$ , were used simultaneously with amiodarone.	DDI-false
Lithium: In a study conducted in healthy subjects, mean steady-state @DRUG$ plasma levels increased approximately 17% in subjects receiving @DRUG$ 450 mg BID with CELEBREX 200 mg BID as compared to subjects receiving lithium alone.	DDI-false
@DRUG$ therapy Urinary excretion of amphetamines is increased, and efficacy is reduced by acidifying agents used in @DRUG$ therapy.	DDI-false
However , @DRUG$ Speeded up, but not significantly inhibited, proliferation in the presence of @DRUG$.	DDI-effect
• Aspirin: Co-administration of a low dose @DRUG$ With VIOXX, it can lead to an increased rate of GI ulcers or other complications compared to the use of @DRUG$ alone .	DDI-false
Human pharmacokinetics data indicate that oral ketoconazole potently inhibits the metabolism of @DRUG$ resulting in an eight-fold increase in the mean AUC of @DRUG$.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., @DRUG$ chemotherapy), cardiotoxic (e.g., @DRUG$) or hepatotoxic (e.g., methotrexate, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
MAO Inhibitors: DURAGESIC  is not recommended for use in patients who have received @DRUG$ within 14 days because severe and unpredictable potentiation by @DRUG$ has been reported with opioid analgesics	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, @DRUG$, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of @DRUG$, with ketamine or Innovar than with pentobarbital.	DDI-false
Cephalosporine cephalosporine containing side chains of N-methylthiotetrazole (Cefmenoxime, cefoperazone, cefotetan, cefamandol), @DRUG$ or methylthiadiazole ( @DRUG$ ) may cause vitamin K deficiency and hypoprothrombinaemia.	DDI-false
Therefore, medications with a low therapeutic leeway, such as @DRUG$ , phenytoin, and @DRUG$ , could have a delayed elimination and increases in their serum half-life leading to a toxic level .	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, @DRUG$, or @DRUG$, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with pentobarbital.	DDI-false
Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: ergotamine, @DRUG$, amiodarone, @DRUG$, and nifedipine.	DDI-false
@DRUG$ may interact with alcohol, @DRUG$s, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.	DDI-int
Antihypertensives : Amiodarone should be used with caution in patients receiving   -receptor blocking agents ( e.g. , propranolol , a CYP3A4 inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a @DRUG$ Substrate, and diltiazem, a @DRUG$ Inhibitor) because of the potential for bradycardia, sinus arrest and AV block;	DDI-false
Non-steroidal Anti-inflammatory Drugs: In some patients, the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of @DRUG-DRUG$.	DDI-false
Other Drugs:Drugs such as quinidine, disopyramide, procainamide, phenothiazines, @DRUG$, and @DRUG$ may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, @DRUG$, @DRUG$, warfarin, isosorbide mononitrate, carvedilol, ethanol or itraconazole.	DDI-false
This appears to be the only clinically relevant interaction of this species with @DRUG$ , although theoretically , coadministration of other drugs known to alter cardiac conduction ( eg , anti-arrhythmic or beta-adrenergic blocking agents , calcium channel blockers , @DRUG$ Tricyclic antidepressants and phenothiazines can also contribute to the prolongation of the QTc interval.	DDI-effect
Other Cardiovascular Agents: @DRUG$ and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, hydralazine, prazosin and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
The steady state plasma concentrations of imipramine and @DRUG$ have been reported to be increased an average of 31 % and 20 % , respectively , by the concomitant administration of @DRUG$ Tablets at doses up to 4 mg/ day.	DDI-mechanism
Alcohol , @DRUG$ , or @DRUG$ : potentiation of orthostatic hypotension may occur .	DDI-false
- @DRUG$ (nandrolone [e.g., Anabolin], @DRUG$ [e.g., Anavar], oxymetholone [e.g., Anadrol], stanozolol [e.g., Winstrol]) or	DDI-false
@DRUG$ , such as @DRUG$ , diltiazem and nifedipine , inhibit platelet activation in vitro , and decrease platelet adhesion intravascularly .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , doxorubicin , vincristine , and prednisone ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , @DRUG$ , doxorubicin, teniposide, and @DRUG$ with vincristine plus bleomycin ) without receiving antiretroviral therapy .	DDI-false
Intravenous @DRUG$ (adenosine) has been effectively administered in the presence of other cardioactive drugs, such as @DRUG$, beta-adrenergic blocking agents, calcium channel blocking agents, and angiotensin converting enzyme inhibitors, without any change in the adverse reaction profile.	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with @DRUG$ , Innovar Vet, or Pentobarbital, the dosage of Ouabain needed to cause ventricular tachycardia was significantly higher, such as the LD50 of Ouabain, with ketamine or @DRUG$ than with pentobarbital .	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, @DRUG$, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of @DRUG$, resulting in serum and urine levels considerably lower than desired.	DDI-false
In well-controlled patients undergoing concurrent therapy with @DRUG$, a decrease in the steady-state serum concentrations of @DRUG$ may occur when cime-tidine therapy is discontinued.	DDI-mechanism
Potential drug interactions between Keppra  and other @DRUG$ (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of @DRUG$ and these AEDs during placebo-controlled clinical studies.	DDI-false
Among the @DRUG$, many, like @DRUG$, cannot be used clinically because they are toxic;	DDI-false
@DRUG$ Quinolone has been reported to enhance the effects of oral anticoagulant. @DRUG$ or its derivatives .	DDI-false
Since the concomitant administration of warfarin with @DRUG$ The prothrombin time increases by 100% after 3 to 4 days, the dose of @DRUG$ should be reduced by one-third to one-half , and prothrombin times should be monitored closely .	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine , fibric acid derivatives , niacin ( nicotinic acid ) , @DRUG$ , @DRUG$.	DDI-false
No Important Interactions To Date @DRUG$ does not have clinically important pharmacokinetic interactions with @DRUG$, beta-blockers, felodipine, digoxin, warfarin, isosorbide mononitrate, carvedilol, ethanol or itraconazole.	DDI-false
A 5-mg @DRUG$ dose should not be exceeded when used in combination with 200 mg once daily @DRUG$.	DDI-advise
@DRUG$ It had no effect on the plasma levels of @DRUG$.	DDI-false
To determine whether injection of @DRUG$ would permit larger doses of @DRUG$ to be administered, a fixed 9.9-g/m2 dose of thiosulfate was given intravenously over three hours concurrently with escalating doses of cisplatin.	DDI-false
@DRUG$ : Chloramphenicol , erythromycins , @DRUG$ , or tetracyclines may interfere with the bactericidal effect of penicillins .	DDI-false
Antiarrhythmics : Other antiarrhythmic drugs , such as @DRUG$ , @DRUG$ , disopyramide , and phenytoin , have been used concurrently with amiodarone .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , @DRUG$ , a-blockers , analgesics , angiotensin-converting enzyme ( ACE ) inhibitors , anticonvulsants , @DRUG$ Beta blockers, calcium channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also known as NSAIDs) and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Caution should be exercised if an @DRUG$ • co-administered with medicinal products that may reduce the concentration or activity of endogenous steroid hormones such as ketoconazole, @DRUG$ , and cimetidine .	DDI-advise
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum @DRUG$, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or @DRUG$ may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
In addition to the interactions noted above , chronic (   2 weeks ) oral @DRUG$ Administration affects the metabolism of phenytoin, dextromethorphan and @DRUG$.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, @DRUG$, tranquilizers (e.g., benzodiazepines), general anesthetics, @DRUG$, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen and valproic acid/phenobarbital.	DDI-false
These data indicate that @DRUG$ "Does not affect the plasma concentration of other AEDs and that these AEDs do not affect the pharmacokinetics of @DRUG$.	DDI-false
@DRUG$ ( ' @DRUG$ ' ) is a newly introduced atypical antipsychotic with demonstrated efficacy in the treatment of positive and negative symptoms of schizophrenia .	DDI-false
Example inhibitors include azole antifungals, @DRUG$, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, @DRUG$, quinidine, and verapamil.	DDI-false
Erythromycin: In healthy individuals, plasma concentrations of atorvastatin increased approximately 40% with coadministration of @DRUG$ and @DRUG$, a known inhibitor of cytochrome P450 3A4.	DDI-mechanism
@DRUG$ administration to three cancer patients over a dose range of 0.025 mg to 2.2 mg led to a dose-dependent inhibition of @DRUG$ The effect of alternating use of 0.25 mg betaseron on drug metabolism in MS patients is unknown.	DDI-mechanism
@DRUG$ and verapamil use may be rarely associated with ventricular fibrillation when combined with @DRUG$.	DDI-effect
Since Nalfon has not been shown to produce any additional effect beyond that obtained with aspirin alone and because @DRUG$ • increases the rate of excretion of @DRUG$ , the concomitant use of Nalfon and salicylates is not recommended .	DDI-mechanism
Cardiac Glycosides : In a study of young healthy male subjects no evidence of a direct pharmacokinetic @DRUG$-@DRUG$ interaction could be found .	DDI-false
@DRUG$: Eszopiclone 3 mg administered daily for 5 days did not affect the pharmacokinetics of (R)- or @DRUG$, nor were there any changes in the pharmacodynamic profile (prothrombin time) following a single 25 mg oral dose of warfarin	DDI-false
These medicines include thiazides and other diuretics, corticosteroids, phenothiazines, @DRUG$ , @DRUG$ , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .	DDI-false
To avoid @DRUG$ intoxication , appropriate adjustment of the @DRUG$ should be made .	DDI-false
Levosimendan has no clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, warfarin, @DRUG$ , carvedilol , @DRUG$ or itraconazole .	DDI-false
Potential drug interactions between Keppra  and other AEDs (@DRUG$, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of @DRUG$ and these AEDs during placebo-controlled clinical studies.	DDI-false
Central nervous system depressants : Co-administration of DURAGESIC (Fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, @DRUG$ ( e.g. , benzodiazepines ) , general @DRUG$ , phenothiazine, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and deep sedation, or possibly coma or death.	DDI-false
Serious anticholinergic symptoms (severe dry mouth, urinary retention, blurred vision) have been associated with elevations in the serum levels of @DRUG$ when @DRUG$ is added to the drug regimen.	DDI-effect
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or @DRUG$ @DRUG$, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, secobarbital, glutethimide, chloral hydrate and @DRUG$ were systematically investigated in 16 patients receiving @DRUG$ therapy.	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , @DRUG$ , alfentanyl , @DRUG$ , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
Other concomitant therapy Although specific interaction studies have not been performed, 1 mg or more finasteride doses have been reported in clinical trials with acetaminophen, acetylsalicylic acid, A-blockers, analgesics, angiotensin converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta-blockers, calcium channel blockers, heart nitrates, @DRUG$ , H2 antagonists , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and @DRUG$ Without evidence of clinically significant adverse interactions.	DDI-false
In clinical studies performed with Fondaparinux , the concomitant use of oral anticoagulants ( warfarin ) , platelet inhibitors ( @DRUG$ ) , NSAIDs ( @DRUG$ Digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
The similarity of the TYSABRI -associated adverse event profile between Study 1 (without co-administered @DRUG$ ) and Study 2 (with co-administered AVONEX ) indicates that this alteration in clearance does not necessitate reduction of the @DRUG$  dose to maintain safety, General).	DDI-false
However, in the second study, administration of 12 g @DRUG$ 1 hour before the evening meal and 0.3 mg cerivastatin sodium approximately 4 hours after the same evening meal resulted in a decrease in the cerivastatin AUC of less than 8 % , and a decrease in Cmax of about 30 % when compared to dosing @DRUG$ alone .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Drug Interactions : Flupenthixol may interact with some drugs , like Monoamine oxidase inhibitors ( @DRUG$ ): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol : Flupenthixol and @DRUG$ Cause additive CNS depression - Tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants	DDI-false
There have been reports of theophylline-related side effects in patients on concomitant therapy with @DRUG$ and @DRUG$.	DDI-effect
Dexamethasone and @DRUG$ similarly inhibit and stimulate @DRUG$- or insulin-induced proliferation of prostatic epithelium.	DDI-effect
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, @DRUG$, certain tricyclic antidepressants, lidocaine, @DRUG$ and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
Antidiabetic drugs: (oral agents and @DRUG$) - dosage adjustment of the @DRUG$ may be required.	DDI-false
@DRUG$: Plasma concentrations of atorvastatin decreased approximately 25% when colestipol and @DRUG$ were coadministered.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and @DRUG$) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that @DRUG$ may impair absorption of fosinopril.	DDI-false
Data from in vitro studies @DRUG$ A possible interaction with alprazoleam is recommended for the following: sertraline and @DRUG$.	DDI-false
Central nervous system depressants: the concomitant use of DURAGESIC ( @DRUG$ transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , @DRUG$ ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	DDI-effect
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with @DRUG$ reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of @DRUG$.	DDI-false
Notably, systemic exposure (AUC0-12) of @DRUG$ (DHA) was more than doubled in the presence of @DRUG$/SMX.	DDI-false
@DRUG$ : Concomitant treatment with Accutane and Tetracyclines should be avoided as the use of Accutane has been associated with a number of cases of pseudotumour cerebri (benign intracranial hypertension), some of which are associated with concomitant use of @DRUG$	DDI-false
Multivalent Cation-Containing products: Concomitant administration of quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminium antacids, sucralfate, @DRUG$ chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or @DRUG$ may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .	DDI-false
As with other antipsychotic agents, it should be noted that @DRUG$ may be capable of potentiating CNS depressants such as anesthetics, opiates, and @DRUG$.	DDI-effect
Other Drug Interactions Oral Contraceptives Keppra   ( 500 mg twice daily ) did not influence the pharmacokinetics of an oral @DRUG$ containing 0.03 mg ethinyl estradiol and 0.15 mg @DRUG$ , or luteinising hormone and progesterone levels, suggesting that adverse effects on contraceptive efficacy are unlikely.	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , @DRUG$ , Dapson, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$ When co-administered with saquinavir, increased plasma concentrations may occur;	DDI-false
This medicine can be used with @DRUG$ or other CNS depressants ( may potentiate the CNS depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( MAO ) inhibitors ( concurrent use with @DRUG$ may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines ) .	DDI-false
This medicine can be used with alcohol or other forms of interaction. @DRUG$ ( may potentiate the CNS depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and @DRUG$ ( concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines ) .	DDI-false
Concurrent administration of @DRUG$ and antidepressants of the MAO inhibitor class may cause severe orthostatic hypotension.Cimetidine, an inhibitor of microsomal drug metabolism, increased @DRUG$s half-life and toxicity in a rat model.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -@DRUG$ blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., @DRUG$, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Therefore , interactions could occur following concomitant administration of psychotropic drugs ( e.g. , narcotics , @DRUG$ , antiemetics, sedatives, @DRUG$ ) .	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (@DRUG$), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and @DRUG$ did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$ , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ACE ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , H2 antagonists , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and @DRUG$ Without evidence of clinically significant adverse interactions.	DDI-false
Amiodarone may suppress certain CYP450 enzymes, including @DRUG$, CYP2C9, CYP2D6, and @DRUG$.	DDI-false
@DRUG$ It had no significant effect on the Cmax and AUC of zidovudine, although it significantly reduced Zidovudintmax by 44% and the intracellular exposure to phosphorylated @DRUG$ by 110 % .	DDI-mechanism
@DRUG$ "Powers the muscle relaxant effect of all @DRUG$ , most notably nondepolarizing muscle relaxants , and MAC ( minimum alveolar concentration ) is reduced by concomitant administration of N 2O .	DDI-effect
The effect of @DRUG$ on the @DRUG$ requirement of our patient appeared to be maximal 5 to 7 days after the initiation of rifampin and extended a similar length of time after rifampin withdrawal.	DDI-effect
For example, inhibitors are azole antimycotics, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodon, @DRUG$ , propofol , protease inhibitors , quinidine , and @DRUG$.	DDI-false
Coadministration with compounds that are potent inducers of CYP3A4 (eg, phenobarbital, @DRUG$, dexamethasone, @DRUG$) may result in decreased plasma levels of saquinavir.	DDI-false
Coingestion of @DRUG$ with theophylline, @DRUG$ with acetaminophen, and valproic acid with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-false
Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing @DRUG$ therapy in patients receiving @DRUG$ or similar agents, since these patients are at an increased risk of bleeding complications.	DDI-advise
These data indicate that @DRUG$ • Does not affect the plasma concentration of other AEDs and that they @DRUG$ Do not affect the pharmacokinetics of levetiracetam.	DDI-false
However , LDL-C reduction was greater when @DRUG$ and @DRUG$ They were given together as if each drug was given alone.	DDI-effect
There is a significant increase in exposure to @DRUG$ when @DRUG$ is coadministered with ketoconazole (CYP3A4 inhibitor).	DDI-false
Tolbutamide: In diabetic patients receiving diflunisal and @DRUG$, no significant effects were seen on @DRUG$ plasma levels or fasting blood glucose.	DDI-false
ACE Inhibitors and @DRUG$ (Hypertension)- In clinical studies of patients with hypertension, the addition of INSPRA 50 to 100 mg to ACE inhibitors and @DRUG$ increased mean serum potassium slightly (about 0.09-0.13 mEq/L).	DDI-false
While @DRUG$ and ibogaine have similar affinities for kappa opioid and possibly nicotinic receptors , 18-MC has much lower affinities than @DRUG$ For NMDA and Sigma-2 receptors, sodium channels and the 5-HT transporter.	DDI-false
@DRUG$, or other products containing @DRUG$ or zinc, antacids or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.	DDI-false
Injection : Lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , @DRUG$ , and other antidepressants. When @DRUG$ It is administered concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations and irrational behaviour has been observed.	DDI-false
@DRUG$ and @DRUG$ resins : Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins .	DDI-false
@DRUG$ As with some other quinolones, co-administration of ciprofloxacin with theophylline may lead to increased serum concentrations. @DRUG$ Elongation of elimination half-life.	DDI-false
A dose adjustment of STRATTERA may be required when co-administered with CYP2D6 inhibitors, e.g. @DRUG$ , fluoxetine , and @DRUG$.	DDI-false
METHODS: Since the start of the experiment, the rats received 10 weekly subcutaneous injections of @DRUG$ ( 7.4 mg/kg body weight ) and subcutaneous injections of @DRUG$ ( 40 microg/kg body weight ) every other day , and from week 16 , intraperitoneal injections of verapamil ( 10 or 20 mg/kg body weight ) every other day until the end fo the experiment in week 45 .	DDI-false
@DRUG$ : Concomitant administration of fluconazole at 200 mg QD resulted in a two-fold increase in @DRUG$ plasma concentration .	DDI-false
Example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , @DRUG$ , isoniazid , @DRUG$ , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .	DDI-false
Data from in vitro studies of @DRUG$ In addition to alprazolem, a possible interaction may be proposed for the following medicinal products: ergotamine, @DRUG$ , amiodarone, nicardipine, and nifedipine.	DDI-int
There have been case reports of increased steady-state levels of quinidine , procainamide , and @DRUG$ during concomitant therapy with @DRUG$.	DDI-false
MAO inhibitors @DRUG$, as well as a metabolite of @DRUG$, slow amphetamine metabolism.	DDI-false
@DRUG$ The activity of other @DRUG$ can be increased.	DDI-effect
Therefore, close monitoring of prothrombin time is recommended and adjustment of prothrombin time is recommended. @DRUG$ Dose may be necessary if: @DRUG$ It is given at the same time.	DDI-advise
@DRUG$ , apparently due to an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and @DRUG$ This delays elimination and increases blood levels of these drugs.	DDI-mechanism
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, @DRUG$, fentanyl, alfentanyl, @DRUG$, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Other CONCOMITANT THERAPY : Although specific interaction studies have not been conducted in clinical trials, @DRUG$ was used concomitantly with angiotensin- converting enzyme ( ACE ) inhibitors , betablockers , calcium-channel blockers , @DRUG$ , and nonsteroidal anti-inflammatory drugs ( NSAIDs ) without evidence of clinically significant adverse interactions .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ACE ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , @DRUG$ , @DRUG$ , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
Dosage adjustment of @DRUG$ may be necessary when coadministered with CYP2D6 inhibitors, e.g., paroxetine, fluoxetine, and @DRUG$.	DDI-advise
Antacids : In a clinical pharmacology study , coadministration of an @DRUG$ ( aluminum hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that @DRUG$ The absorption of Fosinopril may be impaired.	DDI-false
Nonsteroidal Anti-Inflammatory Drugs (@DRUG$)-A drug interaction study of eplerenone with an @DRUG$ It wasn't done.	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , @DRUG$ , quinidine , warfarin , @DRUG$ , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
The intensity, uniformity and time course of @DRUG$ interference by phenobarbital , secobarbital , @DRUG$ , chloral hydrate and methaqualone were systematically investigated in 16 patients receiving coumarin therapy .	DDI-false
Anticoagulants: Potentiation of @DRUG$-type (CYP2C9 and CYP3A4 substrate) anticoagulant response is almost always seen in patients receiving @DRUG$ and can result in serious or fatal bleeding.	DDI-false
The aim of this paper was to study the interaction between neurotensin and both enkephalins or its synthetic analogue @DRUG$, or @DRUG$, on the antinonciceptive effect of these peptides in mice after intracisternal injection.	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , @DRUG$ , quinidine, warfarin, tacrolimus, cyclosporin, ergot derivatives, pimozide, @DRUG$ (e. g., fentanyl, alfentanyl, alprazolam and triazolam) may exhibit increased plasma concentrations when co-administered with saquinavir;	DDI-false
Azithromycin had no significant impact on the Cmax and AUC of @DRUG$ , although it significantly decreased the zidovudine tmax by 44 % and increased the intracellular exposure to phosphorylated @DRUG$ - 110%.	DDI-false
Antacids : In a clinical pharmacology study , coadministration of an antacid ( @DRUG$ , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that @DRUG$ The absorption of Fosinopril may be impaired.	DDI-false
- results of studies in patients with multiple sclerosis receiving TYSABRI and interferon beta-1a ( AVONEX 30 mcg IM once weekly), or @DRUG$ As regards the need for dose adjustment of @DRUG$ or glatiramer acetate .	DDI-false
@DRUG$: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a @DRUG$ inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
@DRUG$ Lithium toxicity has been reported in patients who: @DRUG$ Accompanied by medicines that cause the excretion of sodium, including ACE inhibitors.	DDI-false
In clinical studies performed with @DRUG$, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (@DRUG$), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
In an in vitro study in human liver microsomes, inhibition of CYP2A6 hydroxylation of @DRUG$ by @DRUG$ (200 m m M i.e., 350 mg/L) was 17-28%.	DDI-mechanism
Bacteriostatic Antibiotics : Chloramphenicol , @DRUG$ , sulfonamides , or tetracyclines may interfere with the bactericidal effect of @DRUG$.	DDI-effect
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum @DRUG$, @DRUG$, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Data from in vitro studies with benzodiazepines other than: @DRUG$ suggest a possible drug interaction for the following : ergotamine , @DRUG$ , amiodarone , nicardipine , and nifedipine .	DDI-int
Micro-dosed @DRUG$ Preparations: micro-dosed progesterone preparations (minipills which do not contain: @DRUG$ ) may be an inadequate contraceptive method during Accutane therapy.	DDI-false
ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or @DRUG$ (@DRUG$/ARB).	DDI-false
This medicine can be used with alcohol or other forms of interaction. @DRUG$ ( may potentiate the CNS depressant effects of either these medications or antihistamines ) , @DRUG$ or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( MAO ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines ) .	DDI-false
Rifampin : Co-administration of @DRUG$ with @DRUG$ 600 mg daily , a potent inducer of hepatic metabolism , produced an approximate 50 % decrease in rofecoxib plasma concentrations .	DDI-mechanism
Iodine or iodine excess may decrease the effect of @DRUG$, and an @DRUG$ deficiency can increase the effect of Carbimazole.	DDI-false
Therefore, it would be expected that a dosing schedule of cerivastatin sodium given at bedtime and @DRUG$ given before the evening meal would not result in a significant decrease in the clinical effect of @DRUG$.	DDI-false
The impact of DCG-IV and L-CCG-1 on @DRUG$ (@DRUG$)-induced locomotion and behavioral changes in mice .	DDI-false
Although neither dexamethasone nor @DRUG$ Influenced the proliferation of prostate epithelium in RPMI1640 with transferrin alone, modifying the mitogenic effect of EGF and @DRUG$.	DDI-effect
The hypoglycaemic effect of sulphonylureas may be due to certain medications, including: @DRUG$ And other drugs that are highly protein-bound, salicylates, @DRUG$ Chloramphenicol, probenecid, coumarine, monoamine oxidase inhibitors and beta-adrenergic blockers.	DDI-false
@DRUG$ should not be used as a substitute for oral or inhaled @DRUG$.	DDI-false
The possibility of hypotensive effects with enalapril or enalaprilat can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with @DRUG$ or @DRUG$.	DDI-false
Corticosteroids, Methylxanthines and Diuretics: Concomitant treatment with @DRUG$, @DRUG$, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of @DRUG$ needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with @DRUG$.	DDI-false
Central Nervous System Depressants : The concomitant use of DURAGESIC   ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , @DRUG$ ), general anaesthetics, phenothiazines, skeletal muscle relaxants, and @DRUG$ , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	DDI-false
Possible interactions between Keppra and other medicinal products @DRUG$ ( carbamazepine , @DRUG$ , lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also evaluated by the evaluation of levetiracetam serum concentrations and these AEDs in placebo-controlled clinical trials.	DDI-false
- slow channel calcium blockers, such as verapamil, @DRUG$ and @DRUG$ , inhibit platelet activation in vitro , and decrease platelet adhesion intravascularly .	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , @DRUG$ , @DRUG$ Chloramphenicol, probenecid, coumarine, monoamine oxidase inhibitors and beta-adrenergic blockers.	DDI-false
Amiodarone may suppress certain CYP450 enzymes , including @DRUG$ , @DRUG$ CYP2D6 and CYP3A4.	DDI-false
Sedatives/@DRUG$: triazolam, @DRUG$ CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as prolonged or increased sedation or respiratory depression.	DDI-false
Based on the results of these studies, it is concluded that @DRUG$ may be safely coadministered with both @DRUG$ and dideoxyinosine.	DDI-false
During transfer to oral @DRUG$, the dose levels of previously administered agents should be reduced by 30 to 50% several days after the addition of oral @DRUG$.	DDI-false
Corticosteroids , Methylxanthines and @DRUG$ : Accompanying treatment with @DRUG$ Steroids, or diuretics may potentiate a potential hypocalemic effect of beta2-agonists.	DDI-false
Non-selective MAO inhibitors including tranylcypromine sulfate, phenelzine sulfate, and @DRUG$ HC1: Concomitant use of @DRUG$ and non-selective MAO inhibitors may cause hypertension.	DDI-false
Other concomitant therapy Although no specific interaction studies have been conducted, 1 mg or more finasteride doses have been reported in clinical trials with acetaminophen, acetylsalicylic acid, A-blockers, analgesics, angiotensin converting enzyme (ACE) inhibitors, @DRUG$ , benzodiazepines, beta-blockers, @DRUG$ , cardiac nitrates , diuretics , H2 antagonists , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
@DRUG$ , or other products containing iron or zinc , antacids or sucralfate should not be administered concomitantly with , or within 2 hours of , the administration of norfloxacin , because they may interfere with absorption resulting in lower serum and urine levels of @DRUG$.	DDI-false
@DRUG$ has been administered with tolazoline, dopamine, dobutamine, @DRUG$, surfactant, and high-frequency ventilation.	DDI-false
Simultaneous use of HEXALEN and @DRUG$ For this reason, severe orthostatic hypotension may occur.@DRUG$, an inhibitor of microsomal metabolism, increased altretamine half-life and toxicity in a rat model.	DDI-false
@DRUG$: Reports suggest that NSAIDs may diminish the antihypertensive effect of @DRUG$.	DDI-false
Injection: @DRUG$ injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable @DRUG$, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
Drug Interactions : @DRUG$ The interaction with some drugs, such as monoamine oxidase inhibitors (MAOI): @DRUG$ - Arecoline - Eproxindine - Ethanol : Flupentixol and ethanol cause additive CNS depression - Tricyclic antidepressants : Flupentixol increases the effect of tricyclic antidepressants	DDI-false
@DRUG$: Haloperidol blocks dopamine receptors, thus inhibiting the central stimulant effects of @DRUG$.	DDI-false
Both @DRUG$ and nevirapine have been compared to triple therapy with the PI indinavir over 48 weeks as initial therapy, with similar responses being observed with nevirapine regimens and superiority observed with @DRUG$.	DDI-false
Data from in vitro studies of benzodiazepines other than @DRUG$ suggest a possible drug interaction for the following: ergotamine, cyclosporine, amiodarone, nicardipine, and @DRUG$.	DDI-int
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, indomethacin), myelotoxic (e.g., @DRUG$ chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., @DRUG$, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
@DRUG$ In diabetic patients receiving diflunisal and tolbutamide, no significant effects on @DRUG$ Plasma levels or fasting blood sugar.	DDI-false
Since higher doses of @DRUG$ (400 mg daily) may result in higher increases in Cmax and AUC, a single 2.5 mg dose of @DRUG$ should not be exceeded in a 24-hour period when used in combination with ketoconazole 400 mg daily.	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of @DRUG$, with ketamine or @DRUG$ than with pentobarbital.	DDI-false
@DRUG$ (neostgmine, physostigmine), lignocaine, quinine, @DRUG$ can enhance toxicity and cause cardio respiratory depression.	DDI-false
Antihistamines : @DRUG$ The sedative effect of @DRUG$ can be counteracted.	DDI-effect
Levosimendan has no clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, @DRUG$ , isosorbide mononitrate, knitztilol, @DRUG$ or itraconazole .	DDI-false
@DRUG$: @DRUG$ may delay intestinal absorption of ethosuximide.	DDI-false
Example inhibitors include @DRUG$, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, @DRUG$, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
The availability of potent non-nucleoside reverse transcriptase inhibitors (@DRUG$)-based antiretroviral therapy regimens and concerns about protease inhibitors (@DRUG$)-related metabolic disorders have led to significant shifts in treatment practices in HIV infection.	DDI-false
The monoamine oxidase inhibitory effects of @DRUG$ may persist for a substantial period after discontinuation of the drug, and this should be borne in mind when another drug is prescribed following @DRUG$.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , doxorubicin , vincristine , and prednisone ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , doxorubicin , teniposide , and @DRUG$ with vincristine plus bleomycin) without reception @DRUG$ therapy .	DDI-false
The extent to which @DRUG$-TCA interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the @DRUG$ involved.	DDI-false
Acetaminophen , @DRUG$ , phenobarbital , quinidine , theophylline , and @DRUG$ were added to pooled human serum at therapeutic concentrations .	DDI-false
Antihypertensive medications , other , especially @DRUG$ , or preanesthetic and anesthetic agents used in surgery or @DRUG$ , not depolarizing, used in surgery	DDI-false
Potential drug interactions between Keppra   and other AEDs ( carbamazepine , @DRUG$ , lamotrigine , @DRUG$ , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies .	DDI-false
@DRUG$ @DRUG$ The pharmacokinetics and pharmacodynamics (ECG) of digoxin administered daily as 0.25 mg did not affect ( 1000 mg twice daily ) the pharmacokinetics and pharmacodynamics (ECG) of digoxin.	DDI-false
• Corticosteroids, methylxanthine and diuretics: concomitant treatment with @DRUG$ , @DRUG$ Diuretics may potentiate a possible hypocalemic effect of beta2-agonists.	DDI-false
Vitamin K (e.g. @DRUG$ , Synkayvite ) Use of @DRUG$ with these medicines may increase the chance of side effects affecting the blood	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5 % Ophthalmic Solution , the possibility of an additive or potentiating effect with @DRUG$ ( alcohol , barbiturates , opiates , @DRUG$ , anesthetics ) should be considered .	DDI-false
The similarity of the TYSABRI -associated adverse event profile between Study 1 ( without co-administered @DRUG$ Study 2 (with concomitant use of AVONEX) shows that this change in clearance does not require a reduction in clearance. @DRUG$   dose to maintain safety , General ) .	DDI-false
Based on the chemical resemblance of itraconazole and @DRUG$, coadministration of @DRUG$ with itraconazole is contraindicated.	DDI-false
Monitoring for @DRUG$ The toxicity and serial measurement of the amiodarone serum concentration during the concomitant @DRUG$ Treatment should be considered.	DDI-false
Tricyclic antidepressants have been reported to blunt the hypotensive effect of systemic @DRUG$.It is not known whether the concurrent use of these agents with @DRUG$ in humans can lead to resulting interference with the IOP lowering effect .	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, @DRUG$, @DRUG$, cefamandole, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Antiarrhythmics: Other @DRUG$ drugs, such as quinidine, procainamide, disopyramide, and phenytoin, have been used concurrently with @DRUG$.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (@DRUG$): MAOI could theoretically affect @DRUG$ pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Theophylline serum levels should be monitored and appropriate dose adjustments considered for patients given both @DRUG$ and @DRUG$.	DDI-advise
@DRUG$ The rate and extent of absorption of ciprofloxacin were bioequivalent if Proquin XR was given alone or if Proquin XR was given 2 hours after @DRUG$ At the dose that suppresses gastric acid secretion maximum.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, @DRUG$, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and @DRUG$, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
- Anabolic steroids (nandrolone [e.g., Anabolin], @DRUG$ [e.g., Anavar], oxymetholone [e.g., Anadrol], @DRUG$ [e.g., Winstrol]) or	DDI-false
Concurrent administration of drugs possessing nephrotoxic ( e.g. , aminoglycosides , @DRUG$ Myelotoxic (e.g. cytotoxic chemotherapy), cardiotoxic (e.g. doxorubicin) or hepatotoxic (e.g. methotrexate), @DRUG$ Effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
@DRUG$-A drug interaction study of @DRUG$ with lithium has not been conducted.	DDI-false
It is therefore necessary to be well acquainted with the clinical and paraclinical pattern of magnesium deficit and to discriminate between magnesium deficiency due to an insufficient @DRUG$ intake which only requires oral physiological supplementation and @DRUG$ depletion related to a dysregulation of the control mechanisms of magnesium status which requires more or less specific regulation of its causal dysregulation .	DDI-false
It is structurally distinct from the other currently available HMGCoA reductase inhibitors (@DRUG$, simvastatin, and @DRUG$), leading to unique biopharmaceutical properties relative to the other agents of this class.	DDI-false
Folic acid in large amounts may counteract the antiepileptic effect of phenobarbital, @DRUG$ and @DRUG$, and increase the frequency of seizures in susceptible pediatric patients.	DDI-false
Aspirin/@DRUG$: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of @DRUG$ 1.5  g/kg/min. over 18 hours).	DDI-false
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , @DRUG$ , A-blockers, analgesics, angiotensin converting enzyme ( ACE) inhibitors, anticonvulsants, benzodiazepines, @DRUG$ , calcium-channel blockers , cardiac nitrates , diuretics , H2 antagonists , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
Other concomitant therapy Although no specific interaction studies have been conducted, 1 mg or more of finasteride doses have been co-administered in clinical trials with acetaminophen, acetylsalicylic acid, A-blockers, analgesics, angiotensin converting enzyme (ACE) inhibitors, anticonvulsants, @DRUG$ , beta blockers , calcium-channel blockers , cardiac @DRUG$ , diuretics , H2 antagonists , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
@DRUG$: In normal volunteers, concomitant administration of diflunisal and @DRUG$ resulted in significantly increased plasma levels of hydrochlorothiazide.	DDI-false
To evaluate the effect of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL), the authors retrospectively compared a group of 24 patients with HIV-NHL treated with cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or CHOP-like regimen (i.e., cyclophosphamide, doxorubicin), @DRUG$ , and prednisone with vincristine plus bleomycin ) without receiving @DRUG$ therapy .	DDI-false
To evaluate the effect of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL), the authors retrospectively compared a group of 24 patients with HIV-NHL treated with cyclophosphamide, @DRUG$ , vincristine , and @DRUG$ ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , doxorubicin , teniposide , and prednisone with vincristine plus bleomycin ) without receiving antiretroviral therapy .	DDI-false
Acetaminophen, lidocaine, phenobarbital, @DRUG$, @DRUG$, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
@DRUG$ The effect of carbimazole and a iodine excess may reduce the effect of carbimazole. @DRUG$ deficiency can increase the effect of Carbimazole .	DDI-false
In EM individuals treated with paroxetine or @DRUG$, the AUC of atomoxetine is approximately 6- to 8-fold and Css,max is about 3- to 4-fold greater than @DRUG$ alone.	DDI-false
In general, these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride, including @DRUG$ such as quinidine and @DRUG$, cardiac glycosides and tricyclic anti-depressants.	DDI-false
These data suggest that: @DRUG$ does not influence the plasma concentration of other @DRUG$ and that these AEDs do not influence the pharmacokinetics of levetiracetam .	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, cefotetan, @DRUG$, latamoxef) or methylthiadiazole (@DRUG$) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Benzthiazide may interact with @DRUG$, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like Aleve or @DRUG$, and high blood pressure medications.	DDI-false
@DRUG$, lidocaine, phenobarbital, @DRUG$, theophylline, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or pentobarbital, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of @DRUG$, with @DRUG$ or Innovar than with pentobarbital.	DDI-false
@DRUG$: The administration of @DRUG$ to normal volunteers receiving indomethacin decreased the renal clearance and significantly increased the plasma levels of indomethacin.	DDI-false
Multivitamins, or other products containing iron or @DRUG$, antacids or @DRUG$ should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.	DDI-false
( In some patients, the steroid may reduce the diuretic, natriuretic and blood pressure lowering effect of loop, @DRUG-DRUG$.	DDI-false
Reciprocal interactions may occur with concomitant use of @DRUG$ and drugs that increase or inhibit the cytochrome P450 system (e.g., @DRUG$, carbamazepine, cimetidine, ketoconazole), though this has not been studied	DDI-mechanism
Both @DRUG$ and @DRUG$ Take extracellular levels of dopamine in the nucleus accumbens, but only ibogain increases extracellular levels of serotonin in the nucleus accumbens.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, @DRUG$, felodipine, digoxin, warfarin, isosorbide mononitrate, carvedilol, @DRUG$ or itraconazole.	DDI-false
acetaminophen/@DRUG$, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Multivalent Cation-Containing Products : Concurrent administration of a quinolone , including @DRUG$ With multivalent cation-containing products such as magnesium or aluminium antacids, @DRUG$ VIDEX chewable/buffer tablets or paediatric powders or products containing calcium, iron or zinc may significantly reduce the absorption of ciprofloxacin, resulting in significantly lower serum and urine levels than desired.	DDI-mechanism
@DRUG$: @DRUG$ 3 mg administered daily for 5 days did not affect the pharmacokinetics of (R)- or (S)-warfarin, nor were there any changes in the pharmacodynamic profile (prothrombin time) following a single 25 mg oral dose of warfarin	DDI-false
@DRUG$ : In healthy subjects receiving @DRUG$ Systemic exposure (AUC) to lapatinib was increased to approximately 3.6-fold control at 200 mg twice daily for 7 days and half-life increased to 1.7-fold control.	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), @DRUG$ (piroxicam), and @DRUG$ did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ACE ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , @DRUG$ , cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, @DRUG$ ==See also==*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID*NSAID==References==	DDI-false
- @DRUG$ ( e.g. , @DRUG$ ) or	DDI-false
Co-medications that induce CYP3A4 (e.g., dexamethasone, @DRUG$, carbamazepine, rifampin, @DRUG$ or St.	DDI-false
It is therefore necessary to be familiar with the clinical and paraclinical pattern @DRUG$ Deficit and discrimination between magnesium deficiency due to insufficient magnesium intake, which requires only oral physiological supplement and @DRUG$ depletion related to a dysregulation of the control mechanisms of magnesium status which requires more or less specific regulation of its causal dysregulation .	DDI-false
Possible drug interactions between Keppra and other AEDs (carbamazepine, gabapentin, @DRUG$ , phenobarbital, phenytoin, primidone and valproate) were also evaluated by the serum concentrations of @DRUG$ and these AEDs during placebo-controlled clinical studies .	DDI-false
The effects of @DRUG$ are antagonized by @DRUG$ such as caffeine and theophylline.	DDI-effect
As with other @DRUG$ It should be noted that HALDOL may be able to treat CNS depressants such as CNS depressants. @DRUG$ , opiates, and alcohol.	DDI-effect
In the present study, the @DRUG$ @DRUG$ was tested in combination with an active dose of PCP in two-lever drug discrimination and mixed signalled-unsignalled differential-reinforcement-of-low-rates (DRL) procedures.	DDI-false
In clinical studies performed with Fondaparinux , the concomitant use of oral anticoagulants ( @DRUG$ ( acetylsalicylic acid), @DRUG$ Piroxicam and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Multivalent Cation-Containing Products : Simultaneous Application of a @DRUG$ , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum @DRUG$ , Sucralfat, VIDEX chew/buffer tablets or children's powder, or products that contain calcium, iron or zinc can significantly reduce the absorption of ciprofloxacin, resulting in serum and urine levels significantly lower than desired.	DDI-mechanism
Oral Contraceptives : Coadministration of @DRUG$ and an oral contraceptive increased AUC values for norethindrone and @DRUG$ - about 30% and 20%.	DDI-mechanism
However, a crossover study in healthy subjects receiving either Tagamet 300 mg q.i.d. or 800 mg h.s. simultaneously with a 300 mg b.i.d. dose. @DRUG$ ( Theo major, Key Pharmaceuticals, Inc. ) showed fewer changes in steady-state @DRUG$ Peak serum levels with the 800 mg h.s. regimen, especially in subjects aged 54 years and older.	DDI-false
Intravenous adenocard (adenosine) has been effectively administered in the presence of other cardiovascular drugs such as quinidine, beta-adrenergic agents, @DRUG$ , and @DRUG$ , without changing the adverse reaction profile.	DDI-false
Treatment with @DRUG$ can directly interfere with blood glucose levels or may interact with @DRUG$.	DDI-int
In rats , simultaneous ingestion of @DRUG$ and nitrite in the diet for 78 weeks has been reported to cause tumors , and it has been suggested that disulfiram may react with @DRUG$ in the rat stomach to form a nitrosamine , which is tumorigenic .	DDI-false
These drugs include the thiazides and other diuretics , @DRUG$ , phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, @DRUG$ , and isoniazid .	DDI-false
@DRUG$: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that @DRUG$ may impair absorption of fosinopril.	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , @DRUG$ , cyclosporin, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$ When co-administered with saquinavir, increased plasma concentrations may occur;	DDI-false
Antihypertensive agents: amiodarone should be used with caution in patients who are receptor blockers (e.g. propranolol, CYP3A4 inhibitor) or calcium channel antagonists (e.g. @DRUG$ , a CYP3A4 substrate and @DRUG$ , a CYP3A4 inhibitor) because of the potential for bradycardia, sinus arrest, and AV block;	DDI-false
Carbamazepine : Isoniazid is known to slow the metabolism of @DRUG$ Carbamazepine levels should be determined and increased prior to concomitant use of carbamazepine. @DRUG$ The signs and symptoms of carbamazepine toxicity should be closely monitored and the anticonvulsant dose adjusted accordingly.	DDI-false
Caution should be exercised if an @DRUG$ is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones, such as ketoconazole, @DRUG$, and cimetidine.	DDI-advise
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with @DRUG$, @DRUG$, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
Omeprazole: The rate and extent of absorption of @DRUG$ was bioequivalent when @DRUG$ was given alone or when Proquin XR was given 2 hours after omeprazole at the dose that maximally suppresses gastric acid secretion.	DDI-false
Injection : Lorazepam injection, as other injectable @DRUG$ , produces depression of the central nervous system when administered with ethyl alcohol, phenothiazine, barbiturates, MAO inhibitors and other antidepressants. @DRUG$ It is administered concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations and irrational behaviour has been observed.	DDI-false
Digoxin: When multiple doses of @DRUG$ and @DRUG$ were coadministered, steady-state plasma digoxin concentrations increased by approximately 20%.	DDI-mechanism
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , @DRUG$ , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , @DRUG$ (e. g., fentanyl, alfentanyl, alprazolam and triazolam) may exhibit increased plasma concentrations when co-administered with saquinavir;	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, doxorubicin, @DRUG$, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
These drugs include: @DRUG$ and other diuretics , @DRUG$ , phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blockers and isoniazide.	DDI-false
Drug interactions : Flupentixol may interact with some medicines, such as monoamine oxidase inhibitors (MAOI): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol : Flupenthixol and @DRUG$ Cause additive CNS depression - Tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants	DDI-false
@DRUG$/theophylline , lidocaine/quinidine , phenobarbital/acetaminophen , phenobarbital/valproic acid , quinidine/lidocaine , theophylline/acetaminophen , and @DRUG$/phenobarbital .	DDI-false
Based on the results of these studies, it is concluded that azithromycin may be safely coadministered with both @DRUG$ and @DRUG$.	DDI-false
Based on the results of these studies, it is concluded that @DRUG$ may be safely coadministered with both zidovudine and @DRUG$.	DDI-false
Multivalent Cation-Containing Products : Concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or @DRUG$ @DRUG$ , sucralfate , VIDEX chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .	DDI-false
- @DRUG$ (e.g., AquaMEPHYTON, @DRUG$) Use of sulfapyridine with these medicines may increase the chance of side effects affecting the blood	DDI-false
Studies in rats have shown that @DRUG$ The application dampens certain types of @DRUG$ dependent hypertension , including ACTH hypertension .	DDI-false
There was no significant difference in the pharmacodynamic effect of @DRUG$ administered alone and warfarin administered with @DRUG$ As measured by prothrombin time.	DDI-false
Injection : Lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , @DRUG$ , MAO inhibitors , and other @DRUG$.When scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .	DDI-false
In the first study, concomitant administration of 0.2 mg @DRUG$ and 12 g @DRUG$ resulted in decreases of more than 22% for AUC and 40% for Cmax when compared to dosing cerivastatin sodium alone.	DDI-mechanism
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, @DRUG$ , disopyramide, quinine, amiodarone, quinidine, @DRUG$ , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
The effect of rifampin on the @DRUG$ requirement of our patient appeared to be maximal 5 to 7 days after the initiation of rifampin and extended a similar length of time after @DRUG$ withdrawal.	DDI-false
@DRUG$ IV has been used concomitantly with @DRUG$ without evidence of clinically significant adverse reactions.	DDI-false
Levosimendan has no clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, @DRUG$ , @DRUG$ , isosorbide mononitrate, knitztilol, ethanol or itraconazole.	DDI-false
Cephalosporins-@DRUG$ containing side chains of N-methylthiotetrazole (cefmenoxime, @DRUG$, cefotetan, cefamandole, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
Drug-Drug Interactions Between @DRUG$  And Other Antiepileptic Drugs (AEDs) Phenytoin Keppra  (3000 mg daily) had no effect on the pharmacokinetic disposition of @DRUG$ in patients with refractory epilepsy.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, warfarin, isosorbide mononitrate, @DRUG$, @DRUG$ or itraconazole.	DDI-false
Particular caution is recommended when administering Gleevec with CYP3A4 substrates that have a narrow therapeutic window (e.g., @DRUG$ or @DRUG$).	DDI-false
• Drugs/Laboratory Test Interaction because: @DRUG$ may affect the APTT assay , @DRUG$ Samples contained in plasma samples may affect single-stage coagulation tests based on the APTT (such as factor VIII, IX and XI tests).	DDI-false
Dose adjustment is not recommended . Levetiracetam had no effect on plasma concentrations of @DRUG$ , valproate , @DRUG$ , or lamotrigine .	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (@DRUG$): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - @DRUG$: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Higher concentrations of dexamethasone ( 10(-8 ) - 10(-6 ) M ) or @DRUG$ ( 3 X 10(-8 ) - 10(-7 ) M ) increase the mitogenic activity of @DRUG$.	DDI-effect
Co-administration: Concomitant use of Argatroban with @DRUG$, thrombolytics, and other @DRUG$ may increase the risk of bleeding.	DDI-false
Other concomitant therapy Although no specific interaction studies have been conducted, 1 mg or more of finasteride doses have been used in clinical trials with acetaminophen, acetylsalicylic acid, A-blockers, @DRUG$ , angiotensin-converting enzyme ( ACE ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , H2 antagonists , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as @DRUG$ ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
Other concomitant therapy Although no specific interaction studies have been performed, clinical trials with 1 mg or more of finasteride doses have been conducted at the same time. @DRUG$ Acetylsalicylic acid, A-blockers, analgesics, angiotensin converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta-blockers, @DRUG$ , cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also known as NSAIDs), and quinolone anti-infections without evidence of clinically significant adverse interactions.	DDI-false
When Itraconazole was coadministered with @DRUG$ , @DRUG$ Itraconazole decreased plasma concentrations have been reported.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, @DRUG$, lamotrigine, @DRUG$, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing a high sequential dose. @DRUG$ and @DRUG$ In particular, dacarbazine, cis-platinum, tamoxifen and interferon alpha.	DDI-effect
Hydrochlorothiazide : In normal volunteers , concomitant administration of @DRUG$ and @DRUG$ resulted in significantly increased plasma levels of hydrochlorothiazide .	DDI-mechanism
In clinical studies with @DRUG$ ( @DRUG$ 1 mg) in men aged 18 to 41 years, the mean value of the prostata specific antigen in serum (PSA) decreased from 0.7 ng/ml at baseline to 0.5 ng/ml at month 12.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: @DRUG$ increases the effect of @DRUG$	DDI-effect
In clinical studies performed with @DRUG$, the concomitant use of oral anticoagulants (@DRUG$), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
While all the selective serotonin reuptake inhibitors ( SSRIs ) , e.g. , citalopram , @DRUG$ , @DRUG$ , sertraline , and paroxetine , inhibit P450 2D6 , they may vary in the extent of inhibition .	DDI-false
Example inhibitors include @DRUG$ , ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, @DRUG$ , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .	DDI-false
@DRUG$ and @DRUG$ (Hypertension)- In clinical studies of patients with hypertension , the addition of INSPRA 50 to 100 mg to ACE inhibitors and angiotensin II receptor antagonists increased mean serum potassium slightly ( about 0.09 - 0.13 mEq/L ) .	DDI-false
In comparison of the digitalis tolerance in dogs stunned with @DRUG$ , Innovar Vet , or pentobarbital , the dosage of ouabain needed to cause ventricular tachycardia was significantly higher , as was the LD50 of ouabain , with ketamine or Innovar than with @DRUG$.	DDI-false
Central Nervous System Depressants : The concomitant use of DURAGESIC   ( fentanyl transdermal system ) with other @DRUG$ , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , @DRUG$ Common anaesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may result in respiratory depression, hypotension and deep sedation, or possibly coma or death.	DDI-false
Carbamazepine : @DRUG$ It is known to slow down your metabolism @DRUG$ Carbamazepine levels should be determined prior to co-administration with isooniazide, signs and symptoms of carbamazepine toxicity should be closely monitored and an appropriate dose adjustment of the anticonvulsant should be made.	DDI-mechanism
@DRUG$, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, @DRUG$, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-mechanism
HIV Protease Inhibitors: @DRUG$ (800 mg t.i.d.) co-administered with Vardenafil 10 mg resulted in a 16-fold increase in @DRUG$ AUC, a 7-fold increase in vardenafil Cmax and a 2-fold increase in vardenafil half-life.	DDI-false
Close supervision and careful adjustment of the dosage are required when @DRUG$ is used with other @DRUG$ or sympathomimetic drugs.	DDI-advise
Aspirin: In normal volunteers, a small decrease in @DRUG$ levels was observed when multiple doses of @DRUG$ and aspirin were administered concomitantly.	DDI-false
Cyclosporin, digoxin, methotrexate lodine, such as other NSAIDs, due to effects on renal prostaglandins, may cause changes in the elimination of these drugs to increase serum levels of cyclosporin, @DRUG$ , @DRUG$ , and increased toxicity.	DDI-false
Diuretic agents reduce the renal clearance of @DRUG$ and add a high risk of @DRUG$ toxicity .	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , @DRUG$ , quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$ , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine , @DRUG$ , or pentobarbital, the dosage of @DRUG$ needed to cause ventricular tachycardia was significantly higher , as was the LD50 of ouabain , with ketamine or Innovar than with pentobarbital .	DDI-effect
No data are available for the coadministration of INVIRASE/ritonavir or @DRUG$/@DRUG$ and garlic capsules.	DDI-false
Drug Interactions: @DRUG$ may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect @DRUG$ pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
In the first study , concomitant administration of 0.2 mg @DRUG$ and 12 g cholestyramine resulted in decreases of more than 22 % for AUC and 40 % for Cmax when compared to dosing @DRUG$ alone .	DDI-false
Warfarin : @DRUG$ 3 mg administered daily for 5 days did not affect the pharmacokinetics of@DRUG$n , nor were there any changes in the pharmacodynamic profile ( prothrombin time ) following a single 25 mg oral dose of warfarin	DDI-false
Dexamethasone and retinyl acetate similarly inhibit and stimulate @DRUG$- or @DRUG$-induced proliferation of prostatic epithelium .	DDI-false
Antiarrhythmics : @DRUG$ , bepridil , @DRUG$ , propafenone , quinidine CONTRAINDICATED due to potential for serious and/or life-threatening reactions .	DDI-false
Other concomitant therapies : In clinical studies, the safety profile in patients with acamprosate concomitantly with anxiolytics, hypnotics and @DRUG$ ( including @DRUG$ ) , or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications .	DDI-false
@DRUG$ In a clinical pharmacology study, the concomitant use of antacids (aluminium hydroxide, magnesium hydroxide, and @DRUG$ ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .	DDI-false
When Itraconazole was coadministered with @DRUG$, @DRUG$, or H2antagonists, reduced plasma concentrations of itraconazole were reported.	DDI-false
@DRUG$: The concomitant administration of @DRUG$ and naproxen in normal volunteers had no effect on the plasma levels of naproxen, but significantly decreased the urinary excretion of naproxen and its glucuronide metabolite.	DDI-false
Patients with hypotension @DRUG$ Therapy : Patients on diuretics and especially those in whom @DRUG$ The therapy has recently been initiated, as well as those who have severe dietary salt restriction or dialysis, may occasionally abruptly reduce blood pressure usually within the first hour after receiving the initial dose of captopril.	DDI-false
@DRUG$: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with @DRUG$ reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
Potential drug interactions between @DRUG$  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, @DRUG$, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
The @DRUG$ study dosed subjects with 1200 mg/day of @DRUG$ (n = 7) (later changed to 600 mg/day [n = 5]) for Days 8 to 21 of a 21-day course of 100 mg, five times/day of zidovudine.	DDI-false
Nifedipine: Vardenafil 20 mg, when co-administered with slow-release @DRUG$ 30 mg or 60 mg once daily, did not affect the relative bioavailability (AUC) or maximum concentration (Cmax) of @DRUG$, a drug that is metabolized via CYP3A4.	DDI-false
Potential drug interactions between @DRUG$   and other AEDs ( carbamazepine , @DRUG$ , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Co-medications that induce CYP3A4 (e.g., dexamethasone, @DRUG$, carbamazepine, @DRUG$, phenobarbital or St.	DDI-false
While all the @DRUG$ ( SSRIs ) , e.g. , @DRUG$ Escitalopram, fluoxetine, sertraline and paroxetine inhibit P450 2D6; they may vary to the extent of inhibition.	DDI-false
Drugs Interactions : Flupentixol may interact with some drugs, such as monoamine oxidase inhibitors (MAOI): MAOI may theoretically affect flupentixol pharmacodynamics - @DRUG$ Eproxindine - ethanol : flupenthixol and ethanol cause additive CNS depression - tricyclic antidepressants : flupenthixol increases the effect of @DRUG$	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, @DRUG$, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Carbamazepine: @DRUG$ is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with @DRUG$, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.	DDI-false
There was no significant difference ( p > 0.05 ) in AUC ( 48.59 + /- 8.52 vs. 49.9 + /- 9.93), Cmax ( 7.73 + /- 2.6 vs. 6.6 + /- 2.0 ) and tmax ( 1.1 + /- 0.6 vs. 1.6 + /- 1.1 ) for @DRUG$ Versus Levofloxacin/@DRUG$ regime.	DDI-false
These drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimet-ics , @DRUG$ , and @DRUG$.	DDI-false
Other Drug Interactions: No pharmacokinetic interactions were observed between vardenafil and the following drugs: glyburide, warfarin, @DRUG$, @DRUG$, and ranitidine.	DDI-false
@DRUG$ and @DRUG$ Ribavirin can antagonize the in vitro antiviral activity of stavudine and zidovudine against HIV.	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, Dapson, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$ , @DRUG$ , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
Notably , systemic exposure ( AUC0 - 12 ) of dapsone hydroxylamine ( DHA ) was more than doubled in the presence of @DRUG$/@DRUG$.	DDI-false
@DRUG$ including tranylcypromine sulfate, phenelzine sulfate, and pargyline HC1: Concomitant use of @DRUG$ and non-selective MAO inhibitors may cause hypertension.	DDI-false
Compounds tested in man include @DRUG$ , @DRUG$ , phenytoin , diazepam , aminopyrine and antipyrine .	DDI-false
Urinary acidifying agents These agents ( @DRUG$ , sodium phosphate, etc.) increase the concentration of ionized types of @DRUG$ ==References====External links==* Official website	DDI-mechanism
OTHER CONCOMITANT THERAPY : Although specific interaction studies were not performed , in clinical studies , cerivastatin sodium was used concomitantly with angiotensin- converting enzyme ( ACE ) inhibitors , @DRUG$ , calcium channel blockers, diuretics and nonsteroidal anti-inflammatory drugs ( @DRUG$ ) without evidence of clinically significant adverse interactions.	DDI-false
Example inhibitors include azole antifungals , ciprofloxacin , @DRUG$ , diclofenac , doxycycline , @DRUG$ Imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with @DRUG$ (alcohol, barbiturates, opiates, @DRUG$, anesthetics) should be considered.	DDI-false
Single doses of either @DRUG$ or colestipol resins bind the @DRUG$ and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.	DDI-mechanism
acetaminophen/theophylline , lidocaine/quinidine , phenobarbital/acetaminophen , phenobarbital/valproic acid , quinidine/lidocaine , theophylline/@DRUG$ , and valproic acid/@DRUG$.	DDI-false
The data from in vitro studies with benzodiazepines other than alprazolam indicate a possible interaction of the following medicinal products: @DRUG$ , cyclosporin, amiodarone, @DRUG$ , and nifedipine .	DDI-false
@DRUG$/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or @DRUG$ (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
Drugs That Inhibit @DRUG$ Metabolism Via Cytochrome P450 3A: The initial step in @DRUG$ metabolism is hydroxylation catalyzed by cytochrome P450 3A (CYP 3A).	DDI-false
How ibogain ( 40 mg/kg ) reduces intravenous self-injection of 18-MC ( 40 mg/kg ) @DRUG$ and @DRUG$ and the oral self-administration of ethanol and nicotine in rats ;	DDI-false
Antiarrhythmics: @DRUG$, @DRUG$, flecainide, propafenone, quinidine CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
Short-term pharmacokinetic studies have demonstrated that concomitant administration of @DRUG$ The result is a reduced protein binding of warfarin, but there was no change in the clearance of free @DRUG$.	DDI-false
@DRUG$ and @DRUG$: FORADIL should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-false
The administration of local anesthetic solutions containing @DRUG$ or norepinephrine to patients receiving monoamine oxidase inhibitors, @DRUG$ or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-effect
Example inhibitors include azole antifungals, @DRUG$, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, @DRUG$, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Potential drug interactions between @DRUG$  and other AEDs (@DRUG$, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, @DRUG$), myelotoxic (e.g., @DRUG$ chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Potential drug interactions between Keppra  and other @DRUG$ (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these @DRUG$ during placebo-controlled clinical studies.	DDI-false
Vitamin A: Because of the relationship of @DRUG$ to vitamin A, patients should be advised against taking vitamin supplements containing @DRUG$ to avoid additive toxic effects	DDI-false
Antacids : In a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , @DRUG$ -, and simethicone) with fosinopril reduced serum levels and urinary excretion of @DRUG$ In comparison to Fosinopril alone, which suggests that antacids may affect the absorption of Fosinopril.	DDI-false
Chloral hydrate and @DRUG$ interact pharmacologically with orally administered @DRUG$, but the effect is not clinically significant.	DDI-int
- Anabolic steroids ( @DRUG$ [ e.g. Anaboline ], @DRUG$ [ e.g. Anavar ], oxymetholone [ e.g. Anadrol ], Stanozolol [ e.g. Winstrol ] or	DDI-false
The results of the studies in patients with multiple sclerosis who: @DRUG$   and concomitant interferon beta-1a ( AVONEX   30 mcg IM once weekly ) or @DRUG$ This was not conclusive in terms of the need for dose adjustment of beta interferon or glatiramer acetate.	DDI-false
Plasma valproate concentration should be monitored when @DRUG$ and valproate are co administered , and appropriate dosage adjustments of @DRUG$ It should be done.	DDI-false
Warfarin : The effect of @DRUG$ To the anticoagulant effect of @DRUG$ It was studied in a group of healthy subjects who received 2-5 mg of warfarin daily.	DDI-false
In clinical studies performed with Fondaparinux , the concomitant use of oral anticoagulants ( warfarin ) , platelet inhibitors ( acetylsalicylic acid ) , @DRUG$ ( @DRUG$ Digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Interaction with @DRUG$ other than @DRUG$ - has not been specifically studied ;	DDI-false
acetaminophen/theophylline , lidocaine/quinidine , @DRUG$/acetaminophen , phenobarbital/valproic acid , quinidine/lidocaine , theophylline/@DRUG$ , and valproic acid/phenobarbital .	DDI-false
@DRUG$ : Anticoagulant activity should be monitored , particularly in the first few days after initiating or changing VIOXX therapy in patients receiving @DRUG$ or similar agents , since these patients are at an increased risk of bleeding complications .	DDI-false
Medicines that may alter the plasma concentration of imatinib Medicines that may increase the plasma concentration of imatinib: Caution should be exercised when using Gleevec with CYP3A4 inhibitors (e.g. @DRUG$ , @DRUG$ , erythromycin , clarithromycin ) .	DDI-false
@DRUG$ and its active metabolite , norfluoxe-tine , have long half-lives ( 4 to 16 days for @DRUG$ ) , that may affect strategies during conversion from one drug to the other .	DDI-false
Nephrotoxicity has been reported following concomitant administration of cephalosporins with @DRUG$ or potent @DRUG$ such as furosemide.	DDI-false
This drug may interact with alcohol or other CNS depressants ( may potentiate the CNS depressant effects of either these medications or antihistamines ) , @DRUG$ or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with @DRUG$ ) , and monoamine oxidase ( MAO ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines ) .	DDI-false
The possibility of hypotensive effects with @DRUG$ or enalaprilat can be minimized by either discontinuing the @DRUG$ or increasing the salt intake prior to initiation of treatment with enalapril or enalaprilat.	DDI-effect
Anticoagulants including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as nonsteroidal anti-inflammatory drugs (@DRUG$), and aspirin may increase the risk of bleeding when administered concomitantly with @DRUG$.	DDI-effect
Chlorpromazine : @DRUG$ blocks dopamine and norepinephrine receptors , thus inhibiting the central stimulant effects of amphetamines and can be used to treat @DRUG$ poisoning .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, @DRUG$, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Lack of an effect of azithromycin on the disposition of @DRUG$ and @DRUG$ in HIV-infected patients.	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and @DRUG$) were also assessed by evaluating the serum concentrations of @DRUG$ and these AEDs during placebo-controlled clinical studies.	DDI-false
Drug Interactions : @DRUG$ may interact with some drugs , like Monoamine oxidase inhibitors ( MAOI ): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol : @DRUG$ and Ethanol cause additive CNS depression - Tricyclic antidepressants : Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or @DRUG$ antacids, @DRUG$, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Drugs With A Narrow Therapeutic Index @DRUG$ A single dose of @DRUG$ 3 mg did not affect the pharmacokinetics of digoxin measured in steady state after 0.5 mg twice daily for one day and 0.25 mg daily for the next 6 days.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, @DRUG$, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Coadministration of @DRUG$ and @DRUG$ , tacrolimus or digoxin has led to increased plasma concentrations of the latter three drugs .	DDI-mechanism
While all the selective serotonin reuptake inhibitors (SSRIs), e.g., @DRUG$, escitalopram, fluoxetine, sertraline, and @DRUG$, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
@DRUG$: The administration of diflunisal to normal volunteers receiving indomethacin decreased the renal clearance and significantly increased the plasma levels of @DRUG$.	DDI-false
There have been greater than 2-fold increases in previously stable plasma levels of other @DRUG$, including nortriptyline, when @DRUG$ has been administered in combination with these agents.	DDI-mechanism
In the presence of these @DRUG$, larger doses of @DRUG$ may be required or adenosine may not be effective.	DDI-advise
Coadministration of @DRUG$ with @DRUG$ has led to elevated plasma concentrations of terfenadine, resulting in rare instances of life- threatening cardiac dysrhythmias and one death.	DDI-mechanism
In a comparison of @DRUG$ tolerance in dogs anesthetized with ketamine , Innovar Vet , or pentobarbital , the dosage of @DRUG$ The need to cause ventricular tachycardia was significantly higher than the LD50 of Ouabain, with ketamine or innovar than with pentobarbital.	DDI-false
- @DRUG$ (e.g., Mexate) Use of methotrexate with @DRUG$ may increase the chance of side effects affecting the liver and/or the side effects of methotrexate	DDI-false
Further, in clinical studies with @DRUG$ (@DRUG$, 5 mg) when used in older men who have benign prostatic hyperplasia (BPH), PSA levels are decreased by approximately 50%.	DDI-false
Patients receiving these drugs who are given @DRUG$ , or any other @DRUG$ The development of the specific toxicities of these drugs should be monitored, and especially patients with altered renal function.	DDI-false
Other reported interactions with amiodarone: Fentanyl (@DRUG$ substrate) in combination with @DRUG$ may cause hypotension, bradycardia, and decreased cardiac output.	DDI-false
While all the selective serotonin reuptake inhibitors (@DRUG$), e.g., citalopram, escitalopram, @DRUG$, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
@DRUG$ ( @DRUG$ It produces psychotomimetic effects in people who are similar to schizophrenia symptoms.	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose PROLEUKIN and @DRUG$, specifically, @DRUG$, cis-platinum, tamoxifen and interferon-alfa.	DDI-false
Potential drug interactions between Keppra   and other AEDs ( carbamazepine , @DRUG$ , lamotrigine, phenobarbital, phenytoin, primidone and @DRUG$ The serum concentrations of levetiracetam and these AEDs were also evaluated in placebo-controlled clinical trials.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac @DRUG$, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as @DRUG$), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ toxicity may be aggravated by the initial release of norepinephrine caused by @DRUG$ Injection.	DDI-effect
@DRUG$-Cephalosporins containing side chains of N-methylthiotetrazole (@DRUG$, cefoperazone, cefotetan, cefamandole, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
The application of local anaesthetic solutions that @DRUG$ or @DRUG$ to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe , prolonged hypertension .	DDI-false
Other concomitant therapy Although specific interaction studies have not been performed, 1 mg or more finasteride doses have been reported in clinical trials with acetaminophen, acetylsalicylic acid, A-blockers, analgesics, angiotensin converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta-blockers, calcium channel blockers, heart nitrates, @DRUG$ , H2 antagonists , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as @DRUG$ ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
Co-administration of @DRUG$ and aminoglycosides or other agents interfering with neuromuscular transmission (e.g., @DRUG$) should only be performed with caution as the effect of the toxin may be potentiated.	DDI-advise
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, @DRUG$, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
The co-administration of medicinal products which are nephrotoxic (e. g. @DRUG$ , indomethacin ) , myelotoxic ( e.g. , cytotoxic chemotherapy ) , cardiotoxic ( e.g. , doxorubicin ) or hepatotoxic ( e.g. , methotrexate , asparaginase ) effects with @DRUG$ The toxicity in these organ systems can be increased.	DDI-effect
@DRUG$: Increased serum lithium levels and symptoms of @DRUG$ toxicity have been reported in patients receiving concomitant lithium and ACE inhibitor therapy.	DDI-false
acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$: In a clinical pharmacology study, coadministration of an antacid (@DRUG$, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
The @DRUG$ study dosed subjects with 1200 mg/day of @DRUG$ ( n = 7 ) ( later changed to 600 mg/day [ n = 5 ] ) for Days 8 to 21 of a 21-day course of 100 mg , five times/day of zidovudine .	DDI-false
Drug-Drug Interactions Between Keppra   And Other @DRUG$ ( AEDs ) @DRUG$ Keppra ( 3000 mg daily ) did not affect the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy.	DDI-false
Coadministration of @DRUG$ with 40 mg SULAR tablets in epileptic patients lowered the @DRUG$ plasma concentrations to undetectable levels.	DDI-false
Compounds tested in man include @DRUG$, @DRUG$, phenytoin, diazepam, aminopyrine and antipyrine.	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , @DRUG$ , warfarin, tacrolimus, @DRUG$ When co-administered with saquinavir, increased plasma concentrations may occur when it contains its derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam and triazolam.	DDI-false
- @DRUG$ (nandrolone [e.g., Anabolin], oxandrolone [e.g., Anavar], oxymetholone [e.g., Anadrol], @DRUG$ [e.g., Winstrol]) or	DDI-false
Benzthiazide can interact with alcohol, @DRUG$s, @DRUG$ ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , NSAIDs like Aleve or Ibuprofen , and high blood pressure medications .	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine , although theoretically , coadministration of other drugs known to alter cardiac conduction ( eg , anti-arrhythmic or @DRUG$ - Calcium channel blockers, antihistamines or H1-blockers, tricyclic antidepressants, and @DRUG$ ) could also contribute to an extension of the QTc interval.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, @DRUG$, nitrates, calcium-blocking agents, hydralazine, @DRUG$ and digoxin without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ will increase plasmaconcentration of other CYP3A4 metabolized drugs (e.g., triazolo-@DRUG$, dihydropyridine calcium channel blockers, certain HMG-CoA reductase inhibitors, etc.).	DDI-mechanism
There have been more than 2-fold increases in plasma levels of other @DRUG$ , including @DRUG$ , when fluoxetine hydrochloride has been administered in combination with these agents .	DDI-false
Amiodarone may suppress certain CYP450 enzymes, including CYP1A2, @DRUG$, CYP2D6, and @DRUG$.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, @DRUG$, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with @DRUG$ plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Probenecid: Probenecid interferes with renal tubular secretion of @DRUG$ and produces an increase in the level of @DRUG$ in serum.	DDI-false
@DRUG$: A case of severe hypoglycemia has been reported in a type II diabetic patient maintained on @DRUG$ (1 gm/day) 11 days after the addition of doxepin (75 mg/day).	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with @DRUG$, Innovar Vet, or @DRUG$, the dosage of ouabain needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with pentobarbital.	DDI-false
Tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , @DRUG$ , @DRUG$ , nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying the elimination and increase in blood levels of these drugs.	DDI-false
@DRUG$ In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or @DRUG$ ( ACEI/ARB ) .	DDI-false
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies (phenytoin, valproate, oral @DRUG$, digoxin, @DRUG$, probenecid) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients.	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, @DRUG$, phenobarbital, @DRUG$, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
These data indicate that levetiracetam does not influence the plasma concentration of other @DRUG$ and that these AEDs do not influence the pharmacokinetics of @DRUG$.	DDI-false
@DRUG$-Vitamin K may have the effect of @DRUG$	DDI-false
Antidepressants , @DRUG$ Amphetamines may enhance the activity of @DRUG$ sympathomimetics;	DDI-false
Haemodynamic effects of glucose and @DRUG$ were additive when @DRUG$ was co-administered but not under basal conditions .	DDI-false
Physiological oral @DRUG$ load constitutes the best tool for diagnosis of @DRUG$ deficiency and the first step of its treatment.	DDI-false
Potassium-sparing diuretics (e.g., spironolactone, @DRUG$, or amiloride), @DRUG$ supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.	DDI-false
@DRUG$ serum levels should be monitored and appropriate dose adjustments considered for patients given both @DRUG$ and PEGASYS .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, @DRUG$, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
@DRUG$ : @DRUG$ It does not appear to have a significant effect on the bioavailability of ciprofloxacin.	DDI-false
METHODS : From the beginning of the experiment , rats were given 10 weekly subcutaneous injections of @DRUG$ ( 7.4 mg/kg body weight ) and subcutaneous injections of bombesin ( 40 microg/kg body weight ) every other day , and from week 16 , intraperitoneal injections of @DRUG$ 10 or 20 mg/kg body weight every other day until the end of the test at week 45.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$ , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ACE ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , @DRUG$ , HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also known as NSAIDs) and quinolone anti-infections without evidence of clinically significant adverse interactions.	DDI-false
Acetaminophen/@DRUG$, lidocaine/chinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen and valproic acid/@DRUG$.	DDI-false
Central Nervous System Depressants : The concomitant use of @DRUG$   ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , @DRUG$ And alcohol, can cause respiratory depression, hypotension, and deep sedation, or possibly lead to coma or death.	DDI-effect
Data from in vitro studies of benzodiazepines other than @DRUG$ - ergotamine, cyclosporin, @DRUG$ , nicardipine , and nifedipine .	DDI-int
Therefore, interactions could occur following concomitant administration of psychotropic drugs (e.g., @DRUG$, analgesics, @DRUG$, sedatives, tranquilizers).	DDI-false
Antacids : In a clinical pharmacology study, the concomitant use of antacids ( @DRUG$ (e. g. magnesium hydroxide and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat compared to @DRUG$ Administration alone, suggesting that antacids may affect the absorption of fosinopril.	DDI-false
While all the selective serotonin reuptake inhibitors (@DRUG$), e.g., citalopram, escitalopram, fluoxetine, @DRUG$, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
Acetaminophen/theophylline, lidocaine/chinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen and @DRUG$/Phenobarbital.	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, @DRUG$, hydralazine, prazosin and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
Both the toxicity of filipin and the therapeutic value of @DRUG$ can be rationalized at the cellular and molecular level by the following observations: (i) these @DRUG$ showed differential effects on cells;	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, @DRUG$, propofol, protease inhibitors, @DRUG$, and verapamil.	DDI-false
Anticoagulants: Potentiation of warfarin-type (CYP2C9 and @DRUG$ substrate) anticoagulant response is almost always seen in patients receiving @DRUG$ and can result in serious or fatal bleeding.	DDI-false
Omeprazole : The rate and extent of absorption of ciprofloxacin was bioequivalent when Proquin XR was given alone or when @DRUG$ was given 2 hours after @DRUG$ at the dose that maximally suppresses gastric acid secretion .	DDI-false
Imipramine (5 mg/kg), moclobemide (30 mg/kg), @DRUG$ (0.25 mg/kg), @DRUG$ (20 mg/kg) sertraline (30 mg/kg) or vehicle was administered.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, @DRUG$, warfarin, isosorbide mononitrate, carvedilol, ethanol or @DRUG$.	DDI-false
These drugs include the @DRUG$ And other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, @DRUG$ , calcium channel blocking drugs , and isoniazid .	DDI-false
Multivitamins , or other products containing iron or zinc , @DRUG$ or sucralfate should not be administered concomitantly with , or within 2 hours of , the administration of norfloxacin , because they may interfere with absorption resulting in lower serum and urine levels of @DRUG$.	DDI-false
Pretreatment of healthy volunteers with multiple doses of @DRUG$ followed by a single dose of @DRUG$, increased Gleevec oral-dose clearance by 3.8-fold, which significantly (p 0.05) decreased mean cmax and AUC(0-8).	DDI-mechanism
The availability of potent non-nucleoside reverse transcriptase inhibitor (NNRTI)-based regimens for @DRUG$ therapy and concerns regarding @DRUG$ (PI)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection.	DDI-false
@DRUG$/@DRUG$: triazolam, midazolam CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as prolonged or increased sedation or respiratory depression.	DDI-false
Although neither dexamethasone nor @DRUG$ affected the proliferation of prostatic epithelium in RPMI1640 containing @DRUG$ alone, they modify the mitogenic effect of EGF and insulin.	DDI-false
Concomitantly given @DRUG$ did not interfere with the absorption of a tablet of @DRUG$.	DDI-false
Clinical interaction studies with @DRUG$ The concomitant use of warfarin and warfarin showed that: @DRUG$ These drugs do not lead to clinically significant drug interactions.	DDI-false
Central Nervous System Depressants : The concomitant use of DURAGESIC   ( fentanyl transdermal system ) with other @DRUG$ , including but not limited to other opioids , sedatives , hypnotics , @DRUG$ • (e.g. benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants and alcohol, may cause respiratory depression, hypotension and deep sedation, or may lead to coma or death.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, @DRUG$, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and @DRUG$.	DDI-false
@DRUG$ FORADIL should be used with extreme caution in patients who are treated with: @DRUG$ or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents .	DDI-false
Short-term pharmacokinetic studies have demonstrated that concomitant administration of @DRUG$ and Lodine   ( etodolac capsules and tablets ) results in reduced protein binding of @DRUG$ However, there was no change in the release of free warfarin.	DDI-false
Quinolones, including @DRUG$, may enhance the effects of oral @DRUG$, including warfarin or its derivatives or similar agents.	DDI-effect
Compounds that have been tested in man include antipyrine , digoxin , propranolol , @DRUG$ , and @DRUG$ No clinically significant interactions were found.	DDI-false
Other strong inhibitors of CYP3A4 (e.g., itraconazole, clarithromycin, nefazodone, troleandomycin, @DRUG$, @DRUG$) would be expected to behave similarly.	DDI-false
OTHER CONCOMITANT THERAPY : Although specific interaction studies were not performed , in clinical studies , @DRUG$ ), beta blockers, @DRUG$ , diuretics , and nonsteroidal anti-inflammatory drugs ( NSAIDs ) without evidence of clinically significant adverse interactions .	DDI-false
Both efavirenz and @DRUG$ have been compared to triple therapy with the @DRUG$ indinavir over 48 weeks as initial therapy, with similar responses being observed with nevirapine regimens and superiority observed with efavirenz.	DDI-false
@DRUG$/@DRUG$: Rofecoxib did not have any clinically important effect on the pharmacokinetics of prednisolone or prednisone.	DDI-false
@DRUG$ Dihydroergotamine, ergonovine, @DRUG$ , Methylergonovine CONTRAINDICATED due to the potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischaemia of extremities and other tissues.	DDI-false
acetaminophen/theophylline , lidocaine/quinidine , phenobarbital/@DRUG$ , phenobarbital/valproic acid , quinidine/lidocaine , theophylline/acetaminophen , and valproic acid/@DRUG$.	DDI-false
Antiarrhythmics : Other antiarrhythmic drugs , such as @DRUG$ , procainamide , @DRUG$ , and phenytoin, were used at the same time as amiodarone.	DDI-false
Potential interactions between Keppra and other AEDs ( @DRUG$ , gabapentin, lamotrigine, phenobarbital, phenytoin, @DRUG$ and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies .	DDI-false
Theophylline: As with some other @DRUG$, concurrent administration of @DRUG$ with theophylline may lead to elevated serum concentrations of theophylline and prolongation of its elimination half-life.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/@DRUG$, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Cyclosporine , Digoxin , Methotrexate Lodine , like other @DRUG$ , through effects on renal prostaglandins , may cause changes in the elimination of these drugs leading to elevated serum levels of cyclosporine , digoxin , @DRUG$ , and increased toxicity.	DDI-mechanism
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , @DRUG$ , ergotic derivatives, pimozide, @DRUG$ , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole ( cefmenoxime , cefoperazone , @DRUG$ , cefamandole , @DRUG$ Methylthiadiazole (Cefazolin) may cause vitamin K deficiency and hypoprothrombinaemia.	DDI-false
Injection : Lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , @DRUG$ , barbiturates , MAO inhibitors , and other antidepressants . When @DRUG$ It is administered concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations and irrational behaviour has been observed.	DDI-false
@DRUG$: NSAIDs have produced an elevation of plasma @DRUG$ levels and a reduction in renal lithium clearance.	DDI-false
@DRUG$-Concomitant intake of @DRUG$ The absorption of vitamin K can be reduced.	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of @DRUG$ 0.5 % Ophthalmic Solution , the possibility of an additive or potentiating effect with CNS depressants ( alcohol , barbiturates , opiates , sedatives , @DRUG$ ) should be considered .	DDI-advise
Antidepressants , tricyclic @DRUG$ • the activity of @DRUG$ sympathomimetics;	DDI-effect
@DRUG$: Because of the relationship of Accutane to vitamin A, patients should be advised against taking @DRUG$ containing vitamin A to avoid additive toxic effects	DDI-false
Possible drug interactions between Keppra and other AEDs (carbamazepine, @DRUG$ , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of @DRUG$ and these AEDs during placebo-controlled clinical studies .	DDI-false
@DRUG$: Administration of nonsteroial anti-inflammatory drugs concomitantly with cyclosporine has been associated with an increase in @DRUG$-induced toxicity, possibly due to decreased synthesis of renal prostacyclin.	DDI-false
Injection : Lorazepam injection , like other injectable @DRUG$ , produces depression of the central nervous system when administered with ethyl alcohol , @DRUG$ , barbiturates , MAO inhibitors , and other antidepressants . When scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .	DDI-effect
Two groups ( SH/DA ; SH/FA ) were submitted to daily treatment with synthetic hydroalcoholic solutions containing @DRUG$ , @DRUG$ , higher alcohols and acetaldehyde in the same proportions as in the most common distilled and fermented alcoholic beverages;	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with @DRUG$ may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 @DRUG$ and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.	DDI-false
Non-steroidal Anti-inflammatory Drugs : In some patients , the administration of a @DRUG$ can reduce the diuretic , natriuretic , and antihypertensive effects of loop , potassium-sparing and @DRUG$.	DDI-effect
@DRUG$ and Angiotensin II Receptor Antagonists (Hypertension)- In clinical studies of patients with hypertension, the addition of @DRUG$ 50 to 100 mg to ACE inhibitors and angiotensin II receptor antagonists increased mean serum potassium slightly (about 0.09-0.13 mEq/L).	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, @DRUG$, @DRUG$, indinavir, saquinavir, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
Drug-drug interactions have not been observed between @DRUG$ and @DRUG$ or erythromycin .	DDI-false
In rats, co-administration of disulfiram and @DRUG$ In the diet for 78 weeks has been reported to cause tumors, and it has been suggested that disulfiram can react with @DRUG$ in the rat stomach to form a nitrosamine , which is tumorigenic .	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, @DRUG$, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and @DRUG$.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, @DRUG$, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of @DRUG$.	DDI-false
@DRUG$ showed the most potent inhibition (66% inhibition at 10 microM), which was far more potent than that of crude @DRUG$.	DDI-false
The blood pressure effect of @DRUG$ The tendency was greater in patients receiving atenolol than in any other patient. @DRUG$ therapy .	DDI-false
@DRUG$ Indinavir (800 mg t.i.d.) with vardenafil 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in @DRUG$ Cmax and a 2-fold increase in vardenafil half-life.	DDI-false
Because of the increased risk of adverse reactions in patients who have regularly taken benzodiazepines, it is particularly important that doctors consult patients or their guardians carefully about benzodiazepine, @DRUG$ and sedative use as part of the history prior to any procedure in which the use of @DRUG$ is planned .	DDI-false
Other strong inhibitors of CYP3A4 ( e.g. , itraconazole , clarithromycin , @DRUG$ , @DRUG$ Ritonavir, nelfinavir, is expected to behave similarly.	DDI-false
Other concomitant therapies : In clinical trials, the safety profile in patients with @DRUG$ concomitantly with anxiolytics , hypnotics and sedatives ( including benzodiazepines ) , or @DRUG$ was similar to that of subjects taking placebo with these concomitant medications .	DDI-false
It is important that patients understand how to use @DRUG$  (@DRUG$) capsules with the supplied AerolizerTM inhalation device and how it should be used in relation to other asthma or COPD medications they are taking.	DDI-false
Similarly dialyzed were @DRUG$ , quinidine , and @DRUG$ , both alone at therapeutic concentrations in serum and with ethanol at three different concentrations in serum .	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other @DRUG$, including but not limited to other opioids, sedatives, hypnotics, @DRUG$ (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Other Drugs:Drugs such as @DRUG$, disopyramide, procainamide, phenothiazines, antihistamines, and @DRUG$ may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
Cholestyramine-Concomitant intake of @DRUG$ and vitamin K may reduce the absorption of @DRUG$.	DDI-false
There have been case reports of increased steady-state levels of @DRUG$ , procainamide and phenytoin during concomitant therapy with @DRUG$.	DDI-false
@DRUG$ : The concomitant administration of diflunisal and @DRUG$ in normal volunteers had no effect on the plasma levels of naproxen , but significantly decreased the urinary excretion of naproxen and its glucuronide metabolite .	DDI-false
While 18-MC and @DRUG$ have similar affinities for kappa opioid and possibly nicotinic receptors , @DRUG$ The affinities for NMDA and Sigma-2 receptors, sodium channels and 5-HT transporters are significantly lower than ibogain.	DDI-false
Specific studies have confirmed these effects with sevoflurane , @DRUG$ , propofol , alfentanil , and @DRUG$.	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, @DRUG$, MAO inhibitors, and other antidepressants.When @DRUG$ is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
Theophylline: As with some other quinolones, concurrent administration of @DRUG$ with @DRUG$ may lead to elevated serum concentrations of theophylline and prolongation of its elimination half-life.	DDI-mechanism
@DRUG$ : Clinical studies, as well as post-marketing observations, have shown that @DRUG$ The natriuretic effects of furosemide and thiazide can be reduced in some patients.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, @DRUG$, isoniazid, nefazodone, @DRUG$, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
• Amiodarone together with @DRUG$ for less than seven days increases plasma concentrations of @DRUG$ and n-acetyl procainamide by 55 % and 33 % , respectively .	DDI-false
A drug interaction study investigated the effect of the use of @DRUG$ Gel , 5 % , in combination with double strength ( 160 mg/800 mg ) trimethoprim/sulfamethoxazole ( TMP/@DRUG$ ) .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with @DRUG$;	DDI-mechanism
@DRUG$ A change in serum levels of phenytoin (increased and decreased) has been reported in patients receiving @DRUG$ at the same time.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
An interaction study with @DRUG$ showed no clinically significant effect of @DRUG$ on warfarin pharmacokinetics or anticoagulant activity .	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or @DRUG$, calcium channel blockers, antihistamines or @DRUG$, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-false
Although no specific studies have been performed, co-administration with medicinal products primarily metabolised by CYP3A4 (e. g. @DRUG$ , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , @DRUG$ , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
No Important Interactions To Date @DRUG$ There are no clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, warfarin, isosorbide mononitrate, scotilol, ethanol or @DRUG$.	DDI-false
There is therefore potential for interaction with other medicinal products metabolised by CYP 1A2 (e.g. @DRUG$ , @DRUG$ , and zileuton ) .	DDI-false
Veratrum alkaloids: @DRUG$ inhibit the hypotensive effect of @DRUG$.	DDI-effect
Similarly , @DRUG$ decreased the rate of elimination of @DRUG$ ( by approximately 50 % ) by the same mechanism .	DDI-mechanism
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose @DRUG$ and antineoplastic agents, specifically, dacarbazine, cis-platinum, tamoxifen and @DRUG$.	DDI-effect
Cyclosporine: Administration of @DRUG$ concomitantly with cyclosporine has been associated with an increase in @DRUG$-induced toxicity, possibly due to decreased synthesis of renal prostacyclin.	DDI-false
There were no significant interactions between: @DRUG$ and @DRUG$ or digoxin .	DDI-false
@DRUG$: @DRUG$ have produced an elevation of plasma lithium levels and a reduction in renal lithium clearance.	DDI-false
therefore , @DRUG$ or other @DRUG$ ( as used for management of angina ) or other drugs having vasodilator activity should , if possible , be discontinued before starting captopril .	DDI-false
@DRUG$ : Amiodarone, Bepridil, Flecainide, Propafenon, @DRUG$ CONTRAINDICATE because of the potential for serious and/or life-threatening reactions.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving @DRUG$ therapy.	DDI-false
HIV Protease Inhibitors: @DRUG$ (800 mg t.i.d.) co-administered with @DRUG$ 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in vardenafil Cmax and a 2-fold increase in vardenafil half-life.	DDI-mechanism
A potential interaction between oral @DRUG$ and oral @DRUG$ leading to severe hypoglycemia has been reported.	DDI-effect
Drugs that may alter imatinib plasma concentrations Drugs that may increase imatinib plasma concentrations : Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family ( e.g. , @DRUG$ , itraconazole , @DRUG$ , clarithromycin ) .	DDI-false
However , concomitant administration of aspirin with @DRUG$ may result in an increased rate of GI ulceration or other complications , compared to use of @DRUG$ alone .	DDI-false
Potential drug interactions between Keppra   and other AEDs ( carbamazepine , @DRUG$ , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these @DRUG$ during placebo-controlled clinical studies .	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of @DRUG$ as compared with fosinopril administered alone, suggesting that antacids may impair absorption of @DRUG$.	DDI-false
@DRUG$: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving concomitant lithium and @DRUG$ therapy.	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, dapsones, @DRUG$ , quinine , amiodarone , quinidine , warfarin , @DRUG$ , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
The effects of @DRUG$ and of @DRUG$ anesthesia on digitalis tolerance in dogs.	DDI-false
@DRUG$ may interact with alcohol , blood thinners , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , @DRUG$ , NSAIDs like Aleve or Ibuprofen , and high blood pressure medications .	DDI-int
The results of the studies in patients with multiple sclerosis who: @DRUG$   and concomitant interferon beta-1a ( AVONEX   30 mcg IM once weekly ) or glatiramer acetate were inconclusive with regard to the need for dose adjustment of the @DRUG$ ==References==<br>	DDI-false
Agents Affecting Cytochrome P450 3A4 Isoenzyme System @DRUG$ is metabolized mainly via the human cytochrome P450 3A4 isoenzyme system ( CYP3A4 ) , therefore potential interactions may occur when @DRUG$   is given concurrently with agents that affect CYP3A4 activity .	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, @DRUG$, and isoniazid.	DDI-false
However, the absolute number of alcohol-related deaths is far greater than the number of deaths in @DRUG$ or @DRUG$ users .	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, @DRUG$, primidone and valproate) were also assessed by evaluating the serum concentrations of @DRUG$ and these AEDs during placebo-controlled clinical studies.	DDI-false
However, it affected the duration of response, indicating that pyridoxin did not co-exist with @DRUG$ and/or @DRUG$.1	DDI-false
In addition to the interactions noted above, chronic (  2 weeks) oral Cordarone administration impairs metabolism of @DRUG$, dextromethorphan, and @DRUG$.	DDI-false
@DRUG$ • can cause acidic drugs such as: @DRUG$ - or tolbutamide from its bindings.	DDI-mechanism
Short-term pharmacokinetic studies have shown that concomitant use of warfarin and @DRUG$ Etodolac capsules and tablets lead to reduced protein binding of warfarin, but there was no change in the clearance of free @DRUG$.	DDI-false
Coingestion of @DRUG$ with theophylline, phenobarbital with @DRUG$, and valproic acid with phenobarbital at high to toxic concentrations decreases the binding of the target drug.	DDI-false
As with other antipsychotic agents, it should be noted that @DRUG$ may be capable of potentiating CNS depressants such as @DRUG$, opiates, and alcohol.	DDI-effect
Mineral Oil-Concomitant intake of @DRUG$ and @DRUG$ may reduce the absorption of vitamin K.	DDI-mechanism
@DRUG$ It can interact with medicines known to interact with the conventional formulation of @DRUG$.	DDI-false
Examples of inhibitors are azole antimycotics, ciprofloxacin, clarithromycin, diclofenac, @DRUG$ , erythromycin , imatinib , @DRUG$ , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .	DDI-false
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies (phenytoin, valproate, oral contraceptive, @DRUG$, @DRUG$, probenecid) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients.	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, @DRUG$ was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, betablockers, calcium-channel blockers, diuretics, and nonsteroidal anti-inflammatory drugs (@DRUG$) without evidence of clinically significant adverse interactions.	DDI-false
A drug-drug interaction study evaluated the effect of the use of ACZONE Gel, 5%, in combination with double strength (160 mg/800 mg) @DRUG$/@DRUG$ (TMP/SMX).	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, @DRUG$, chloramphenicol, probenecid, @DRUG$, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, @DRUG$, phenytoin, @DRUG$ and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Other concomitant therapy Although specific interaction studies have not been performed, 1 mg or more of finasteride doses have been co-administered in clinical trials with acetaminophen, acetylsalicylic acid, A-blockers, analgesics, angiotensin converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta-blockers, @DRUG$ , cardiac nitrates, diuretics, @DRUG$ , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
Treatment with CYP3A4 inhibitors (such as ketoconazole, @DRUG$ , ritonavir , @DRUG$ , saquinavir , erythromycin , etc . ) is indicated , reduction of the budesonide dose should be considered .	DDI-false
Coadministration with compounds that are potent inducers of CYP3A4 (eg, @DRUG$, phenytoin, dexamethasone, carbamazepine) may result in decreased plasma levels of @DRUG$.	DDI-mechanism
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5 % Ophthalmic Solution , the possibility of an additive or potentiating effect with CNS depressants ( @DRUG$ , @DRUG$ , opiates, sedatives, anaesthetics) should be considered.	DDI-false
Reciprocal interactions may occur with concomitant use of Antizol and drugs that increase or inhibit the cytochrome P450 system (e.g., phenytoin, @DRUG$, @DRUG$, ketoconazole), though this has not been studied	DDI-false
- Warfarin : The effect of @DRUG$ The anticoagulant effects of warfarin have been studied in a group of healthy subjects who received 2-5 mg @DRUG$ daily.	DDI-false
• Drug interactions: Flupentixol may interact with some medicines, such as monoamine oxidase inhibitors ( @DRUG$ ): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol : Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants : Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
@DRUG$ : @DRUG$ interferes with renal tubular secretion of ciprofloxacin and produces an increase in the level of ciprofloxacin in serum .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, @DRUG$, teniposide, and prednisone with vincristine plus bleomycin) without receiving @DRUG$ therapy.	DDI-false
Other interactions : @DRUG$ had no effect on the pharmacodynamics of glyburide ( glucose and insulin concentrations ) and @DRUG$ ( prothrombin time or other pharmacodynamic parameters ) .	DDI-false
Histamine H2 receptor antagonists : @DRUG$ appear to have no significant effect on the bioavailability of @DRUG$.	DDI-false
Concurrent administration of HEXALEN and @DRUG$ may cause severe orthostatic hypotension.Cimetidine, an inhibitor of microsomal drug metabolism, increased @DRUG$s half-life and toxicity in a rat model.	DDI-false
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a @DRUG$ inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and @DRUG$, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Antihypertensives: @DRUG$ should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or @DRUG$ antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
In rats, concomitant use of disulfiram and nitrite in the diet for 78 weeks has been reported to cause tumours, and it has been suggested that: @DRUG$ may react with @DRUG$ In the rat's stomach a nitrosamine is formed, which is tumorogenic.	DDI-effect
Concurrent administration of drugs possessing nephrotoxic (e.g., @DRUG$, indomethacin), myelotoxic (e.g., @DRUG$ chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
Azithromycin had no significant influence on the Cmax and AUC of zidovudine, although it significantly reduced the Cmax and AUC of zidovudine. @DRUG$ tmax by 44 % and increased the intracellular exposure to phosphorylated @DRUG$ by 110 % .	DDI-false
Carbamazepine: In healthy subjects receiving the CYP3A4 inducer, @DRUG$, at 100 mg twice daily for 3 days and 200 mg twice daily for 17 days, systemic exposure (AUC) to @DRUG$ was decreased approximately 72%.	DDI-mechanism
Administration of @DRUG$ during therapy with a @DRUG$ has been shown to produce a  stimulating  effect in some depressed patients.	DDI-effect
• Carbamazepine : Isoniazid is known to slow down the metabolism of carbamazepine and increase serum levels @DRUG$ Concentrations should be given prior to co-administration with: @DRUG$ The signs and symptoms of carbamazepine toxicity should be closely monitored and the anticonvulsant dose adjusted accordingly.	DDI-advise
INOmax has been administered with tolazoline, dopamine, @DRUG$, @DRUG$, surfactant, and high-frequency ventilation.	DDI-false
@DRUG$: The concomitant administration of diflunisal and @DRUG$ in normal volunteers had no effect on the plasma levels of naproxen, but significantly decreased the urinary excretion of naproxen and its glucuronide metabolite.	DDI-false
Tolbutamide: In diabetic patients receiving @DRUG$ and tolbutamide, no significant effects were seen on @DRUG$ plasma levels or fasting blood glucose.	DDI-false
Co-administration of @DRUG$ and aminoglycosides or other agents interfering with neuromuscular transmission ( e.g. , curare-like compounds ) should only be performed with caution as the effect of the @DRUG$ It can be potentiated.	DDI-false
Isoflurane potentiates the muscle relaxant effect of all @DRUG$, most notably @DRUG$, and MAC (minimum alveolar concentration) is reduced by concomitant administration of N 2O.	DDI-false
The intensity, uniformity and time course of anticoagulant interference by phenobarbital, secobarbital, @DRUG$, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving @DRUG$ therapy.	DDI-false
Monoamine Oxidase Inhibitors and Tricyclic Antidepressants: @DRUG$ should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or @DRUG$ because the action of formoterol on the cardiovascular system may be potentiated by these agents.	DDI-advise
Moreover , additional interaction studies with niacin and @DRUG$ have not demonstrated any effect on @DRUG$ Plasma levels and administration to a patient population receiving chronic digoxin did not differ in the extent of bioavailability of digoxin compared to control data.	DDI-false
@DRUG$, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of @DRUG$, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-mechanism
@DRUG$ may increase slightly the effect of antihypertensive drugs , e.g. , @DRUG$ , methyldopa , reserpine .	DDI-effect
The administration of local @DRUG$ containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors , @DRUG$ or phenothiazines may produce severe , prolonged hypotension or hypertension .	DDI-effect
@DRUG$-Concomitant intake of @DRUG$ and vitamin K may reduce the absorption of vitamin K.	DDI-false
Acetaminophen/theophylline, lidocaine/chinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/@DRUG$ and valproic acid/phenobarbital.	DDI-false
Withdrawal of @DRUG$ decreased the @DRUG$ - 50 % requirement.	DDI-mechanism
In addition, Fondaparinux neither influenced the pharmacodynamics of @DRUG$, acetylsalicylic acid, piroxicam, and digoxin, nor the pharmacokinetics of @DRUG$ at steady state.	DDI-false
Reciprocal interactions may occur with concomitant use of @DRUG$ and drugs that increase or inhibit the cytochrome P450 system ( e.g. , @DRUG$ , carbamazepine , cimetidine , ketoconazole ) , though this has not been studied	DDI-mechanism
For this reason, the dosage of @DRUG$ should be adjusted when these @DRUG$ The medicine is given at the same time.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, @DRUG$, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, @DRUG$, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
@DRUG$: Patients on @DRUG$, especially those with intravascular volume depletion, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with fosinopril sodium.	DDI-false
The hypoglycaemic effect of sulphonylureas may be due to certain medications, including: @DRUG$ and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , @DRUG$ , monoamine oxidase inhibitors , and beta adrenergic blocking agents .	DDI-false
Drug-Drug Interactions Between @DRUG$   And Other Antiepileptic Drugs ( AEDs ) Phenytoin @DRUG$ In patients with refractory epilepsy, the administration of phenytoin (3,000 mg daily) had no effect on the pharmacokinetics of phenytoin.	DDI-false
Both @DRUG$ and 18-MC block morphine-induced and @DRUG$-induced dopamine release in the nucleus accumbens ;	DDI-effect
Patients receiving @DRUG$ and @DRUG$ At the same time, the dose of azathioprine should be reduced to approximately 1/ 3 to 1/4 of the usual dose.	DDI-advise
Therefore, when @DRUG$ and @DRUG$ are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained.)	DDI-advise
Levosimendan has no clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, digoxin, warfarin, isosorbide mononitrate, @DRUG$ , @DRUG$ or itraconazole .	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, @DRUG$, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, @DRUG$, quinidine, and verapamil.	DDI-false
Dose adjustment is not recommended . Levetiracetam had no effect on plasma concentrations of @DRUG$ , @DRUG$ , topiramate , or lamotrigine .	DDI-false
In vitro data suggest that itraconazole, when compared to @DRUG$, has a less pronounced effect on the biotransformation system responsible for the metabolism of @DRUG$.	DDI-false
Because Nalfon has not been shown to produce any additional effect beyond that obtained with @DRUG$ alone and because aspirin increases the rate of excretion of Nalfon , the concomitant use of @DRUG$ and salicylates is not recommended .	DDI-false
Nitrates : The concomitant use of @DRUG$ With long- and short-acting @DRUG$ has been safely tolerated in patients with stable angina pectoris .	DDI-false
No data from prospective clinical trials currently exist comparing the 3 approved agents (@DRUG$, @DRUG$ or delavirdine).	DDI-false
@DRUG$: Chlorpromazine blocks dopamine and norepinephrine receptors, thus inhibiting the central stimulant effects of amphetamines and can be used to treat @DRUG$ poisoning.	DDI-false
@DRUG$ : @DRUG$ ( CYP3A4 substrate ) in combination with amiodarone has been associated with reports of myopathy/rhabdomyolysis .	DDI-false
Warfarin: The effects of @DRUG$ and @DRUG$ on GI bleeding are synergistic, such that users of both drugs together have a risk of serious GI bleeding higher than that of users of either drug alone.	DDI-effect
@DRUG$: In some patients, the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of loop, @DRUG$.	DDI-false
Co-administration of @DRUG$ with Acamprosate produced a 25% increase in AUC and a 33% increase in the Cmax of @DRUG$.	DDI-false
As with other antipsychotics, it should be noted that: @DRUG$ , may be able to potentiate @DRUG$ Like anesthetics, opiates and alcohol.	DDI-effect
In comparison of digitalis tolerance in dogs anaesthetized with ketamine, Innovar Vet or pentobarbital, the dose of Ouabain required to cause ventricular tachycardia was significantly higher than the LD50 of @DRUG$ , with ketamine or innovar as @DRUG$.	DDI-false
Example inhibitors include @DRUG$, ciprofloxacin, @DRUG$, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Because @DRUG$ It has not been shown that an additional effect beyond that obtained with aspirin alone, and because aspirin increases the rate of excretion of nalfon, the concomitant use of nalfon and @DRUG$ It's not recommended.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, @DRUG$, erythromycin, imatinib, @DRUG$, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
Because Nalfon has not been shown to produce any additional effect beyond that obtained with @DRUG$ alone and because aspirin increases the rate of excretion of @DRUG$, the concomitant use of Nalfon and salicylates is not recommended.	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, @DRUG$ and @DRUG$, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
This appears to be the only clinically relevant interaction of this species with mefloquines, although theoretically the concomitant use of other drugs known to alter the heart conduction (e.g. anti-arrhythmic or beta-adrenergic blockers, @DRUG$ , antihistamines or H1-blocking agents , @DRUG$ ) could also contribute to an extension of the QTc interval.	DDI-false
@DRUG$: Amphetamines enhance the adrenergic effect of @DRUG$.	DDI-false
If treatment with inhibitors of CYP3A4 activity ( such as ketoconazole , @DRUG$ , ritonavir , indinavir , saquinavir , erythromycin , etc . ) is indicated , reduction of the @DRUG$ The dose should be considered.	DDI-advise
@DRUG$ and @DRUG$: a drug interaction.	DDI-int
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , doxorubicin , @DRUG$ , and prednisone ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , doxorubicin , teniposide , and prednisone with vincristine plus @DRUG$ ) without antiretroviral therapy.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including @DRUG$, with multivalent cation-containing products such as @DRUG$ or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
Intravenous Adenocard ( @DRUG$ It was effectively administered in the presence of other cardiovascular drugs, such as quinidine. @DRUG$ , calcium channel blocking agents , and angiotensin converting enzyme inhibitors , without any change in the adverse reaction profile .	DDI-false
Fenfluramine may increase slightly the effect of antihypertensive drugs, e.g., guanethidine, @DRUG$, @DRUG$.	DDI-false
Drugs Interactions : Flupentixol may interact with some drugs, such as monoamine oxidase inhibitors (MAOI): MAOI may theoretically affect flupentixol pharmacodynamics - @DRUG$ - Eproxindine - Ethanol : @DRUG$ - Tricyclic antidepressants : Flupentixol increases the effect of tricyclic antidepressants	DDI-false
The pressor effects of @DRUG$ such as @DRUG$ or norepinephrine are enhanced by Bretylium Tosylate.	DDI-false
Lorazepam : Coadministration of single doses of @DRUG$ 3 mg and @DRUG$ 2 mg had no clinically relevant effects on pharmacodynamics or the pharmacokinetics of either medicinal product.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril , beta-blockers , felodipine , digoxin , warfarin , @DRUG$ , @DRUG$ Ethanol or itraconazole.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with @DRUG$, beta-blockers, @DRUG$, digoxin, warfarin, isosorbide mononitrate, carvedilol, ethanol or itraconazole.	DDI-false
The intensity, uniformity and time course of the anticoagulant interference by phenobarbital, @DRUG$ , glutethimide , chloral hydrate and methaqualone were systematically investigated in 16 patients receiving @DRUG$ therapy .	DDI-false
Antiarrhythmics : @DRUG$ , @DRUG$ , flecainide, propafenone, quinidine CONTRAINDICATES due to the potential for serious and/or life-threatening reactions.	DDI-false
Benzthiazide can interact with alcohol, @DRUG$s, decongestant medications (allergic, cold, and sinus drugs), diabetes medications, @DRUG$ , norepinephrine , NSAIDs like Aleve or Ibuprofen , and high blood pressure medications .	DDI-false
@DRUG$ ; Reports indicate that NSAIDs can reduce the antihypertensive effect of @DRUG$.	DDI-false
@DRUG$ : Phenylbutazone causes increase ( by about 80 % ) in the free fraction of @DRUG$.	DDI-false
There are no data for concomitant use of @DRUG$/ritonavir or FORTOVASE/@DRUG$ and garlic capsules.	DDI-false
Central Nervous System Depressants : The concomitant use of DURAGESIC   ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , @DRUG$ , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , @DRUG$ , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	DDI-false
Possible pharmacokinetic interactions were observed in clinical pharmacokinetic studies (phenytoin, valproate, oral contraceptive, digoxin, @DRUG$ , @DRUG$ ed) and by pharmacokinetic screening in placebo-controlled clinical trials in epilepsy patients.	DDI-false
Benzthiazide may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, @DRUG$, @DRUG$ like Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
Nonsteroidal Anti-Inflammatory Drugs (@DRUG$)-A drug interaction study of @DRUG$ with an NSAID has not been conducted.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, @DRUG$, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, @DRUG$, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
In rats, co-administration of disulfiram and @DRUG$ in the diet for 78 weeks has been reported to cause tumors , and it has been suggested that @DRUG$ may react with nitrites in the rat stomach to form a nitrosamine , which is tumorigenic .	DDI-false
@DRUG$ , @DRUG$ , phenobarbital, quinidine, theophylline, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$, nicotinic acid, sympathomimetics, @DRUG$, and isoniazid.	DDI-false
In general, these drugs have one or more pharmacological activities, similar to @DRUG$ , including anti-arrhythmic agents such as @DRUG$ And procainamide, cardiac glycosides and tricyclic antidepressants.	DDI-false
@DRUG$ The concomitant use of Eszopiclone 3 mg and @DRUG$ 10 mg produced a decrease in DSST scores .	DDI-false
Central nervous system depressants: the concomitant use of DURAGESIC ( @DRUG$ transdermal system ) with other central nervous system depressants , including but not limited to other opioids , @DRUG$ , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	DDI-effect
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of @DRUG$ 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (alcohol, barbiturates, @DRUG$, sedatives, anesthetics) should be considered.	DDI-advise
The administration of local anesthetic solutions containing epinephrine or @DRUG$ to patients receiving @DRUG$ or tricyclic antidepressants may produce severe, prolonged hypertension.	DDI-effect
Other Drugs:Drugs such as quinidine, disopyramide, @DRUG$, @DRUG$, antihistamines, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
Administration of rifampin with oral @DRUG$ has been shown to result in decreases in serum concentrations of amiodarone and @DRUG$.	DDI-false
Aspirin/Acetaminophen : Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between @DRUG$ and concomitantly administered @DRUG$ ( 162.5 mg orally administered 26 and 2 hours before the start of argatroban 1 g/kg/min for 4 hours) or acetaminophen ( 1000 mg orally administered 12, 6 and 0 hours before and 6 and 12 hours after the start of argatroban 1.5 g/kg/min for 18 hours).	DDI-false
Plasma levels of @DRUG$ may become subtherapeutic during @DRUG$ therapy .	DDI-mechanism
It is recommended to avoid concurrent administration of ethambutol with aluminum hydroxide containing @DRUG$ for at least 4 hours following @DRUG$ administration.	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of @DRUG$ 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (alcohol, barbiturates, opiates, @DRUG$, anesthetics) should be considered.	DDI-advise
Cephalosporine cephalosporine containing side chains of N-methylthiotetrazole (Cefmenoxime, cefoperazone), @DRUG$ , cefamandole , latamoxef ) or methylthiadiazole ( @DRUG$ ) can cause vitamin K deficiency and hypoprothrombinemia .	DDI-false
Two groups (SH/DA; SH/FA) were treated daily with synthetic hydroalcoholic solutions containing ethanol. @DRUG$ , higher alcohols and @DRUG$ in the same proportions as those found in most common distilled and fermented alcoholic beverages ;	DDI-false
No important interactions to date @DRUG$ does not have clinically important pharmacokinetic interactions with captopril , beta-blockers , felodipine , digoxin , warfarin , isosorbide mononitrate , carvedilol , @DRUG$ or itraconazole .	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, @DRUG$, estrogens, oral contraceptives, @DRUG$, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
Amiodarone may suppress certain CYP450 enzymes, including CYP1A2, @DRUG$, @DRUG$, and CYP3A4.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, @DRUG$, and @DRUG$.	DDI-false
Substances that are potent inhibitors of CYP3A4 activity ( eg , @DRUG$ and itraconazole ) decrease gefitinib metabolism and increase @DRUG$ plasma concentrations .	DDI-mechanism
Benzthiazide may interact with alcohol , @DRUG$s , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , NSAIDs like @DRUG$ Or ibuprofen, and high blood pressure medications.	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and @DRUG$.	DDI-false
Acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen and @DRUG$/Phenobarbital.	DDI-false
Prednisone/prednisolone : @DRUG$ There was no clinically important effect on the pharmacokinetics of @DRUG$ or prednisone .	DDI-false
Oral Contraceptives: Coadministration of atorvastatin and an oral contraceptive increased AUC values for @DRUG$ and @DRUG$ by approximately 30% and 20%.	DDI-false
Since @DRUG$ Not significantly inhibit CYP2A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1 or CYP3A4 in vitro, @DRUG$ It is not expected that by inhibiting the metabolism mediated by these isozymes, they will significantly interact with other medicinal products in vivo.	DDI-false
@DRUG$ Elevates the deerohepatic elimination of amiodarone and may lower its serum levels and @DRUG$/2.	DDI-false
Antihypertensives : Amiodarone should be used with caution in patients receiving   -receptor blocking agents ( e.g. , propranolol , a @DRUG$ Inhibitor) or calcium channel antagonists (e.g. @DRUG$ , a CYP3A4 substrate , and diltiazem , a CYP3A4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and AV block ;	DDI-false
Injection : Lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , @DRUG$ , @DRUG$ , and other antidepressants . When scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .	DDI-false
Other strong inhibitors of CYP3A4 (e.g., itraconazole, @DRUG$, @DRUG$, troleandomycin, ritonavir, nelfinavir) would be expected to behave similarly.	DDI-false
The hypoglycaemic effect of sulphonylureas can be enhanced by certain medications, including non-steroidal anti-inflammatory drugs and other medicines that are highly protein-bound, @DRUG$ , sulfonamides , chloramphenicol , probenecid , coumarins , @DRUG$ And beta-adrenergic blockers.	DDI-false
Therophylline: A recent study has shown that concomitan administration of isoniazid and theophylline may cause elevated plasma levels of @DRUG$, and in some instances a slight decrease in the elimination of @DRUG$.	DDI-false
Caution should be exercised if an HMG-CoA reductase inhibitor is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones, such as @DRUG$, @DRUG$, and cimetidine.	DDI-false
@DRUG$: Probenecid, a renal tubular secretion blocking agent, administered at a dose of 500 mg four times a day, did not change the pharmacokinetics of @DRUG$ 1000 mg twice daily.	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, @DRUG$, indinavir, @DRUG$, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
Corticosteroids, @DRUG$ and Diuretics: Concomitant treatment with @DRUG$, steroids, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like @DRUG$ (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: @DRUG$ and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
However , in the second study , administration of 12 g @DRUG$ 1 hour before dinner and 0.3 mg @DRUG$ About 4 hours after the same evening meal, cerivastatin AUC decreased by less than 8% and Cmax decreased by about 30% compared to the dose of cerivastatin sodium alone.	DDI-mechanism
Prostatic epithelium proliferates in a defined medium consisting of basal medium RPMI1640 containing @DRUG$ (1 microgram/ml), EGF (10 ng/ml), and @DRUG$ (3.7 micrograms/ml or 0.1 IU/ml).	DDI-false
In clinical studies with fondaparinux, co-administration of @DRUG$ ( @DRUG$ ) , platelet inhibitors ( acetylsalicylic acid ) , NSAIDs ( piroxicam ) , and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium .	DDI-false
Potential drug interactions between @DRUG$ , and other AEDs (carbamazepine, gabapentin, lamotrigine, @DRUG$ , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies .	DDI-false
- @DRUG$ ( e.g. , AquaMEPHYTON , Synkayvite ) Use of @DRUG$ These medicines may increase the likelihood of side effects affecting the blood.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an antacid (@DRUG$, magnesium hydroxide, and simethicone) with @DRUG$ reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-mechanism
WARFARIN : Co- administration of @DRUG$ and @DRUG$ to healthy volunteers did not result in any changes in prothrombin time or clotting factor VII when compared to co-administration of warfarin and placebo .	DDI-false
Acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/@DRUG$ , and valproic acid/phenobarbital.	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , @DRUG$ , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and @DRUG$ Concomitant use with saquinavir may result in increased plasma concentrations.	DDI-false
- Oral @DRUG$ (birth control pills) containing @DRUG$ or	DDI-false
@DRUG$ Keppra  (1000 mg twice daily) did not influence the pharmacokinetics of @DRUG$.	DDI-false
@DRUG$ may enhance the seizure risk in patients taking @DRUG$	DDI-effect
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose @DRUG$ Antineoplastic agents, in particular dacarbazine, cis-platinum, tamoxifen and @DRUG$.	DDI-effect
Examples of inhibitors are azole antimycotics, ciprofloxacin, clarithromycin, @DRUG$ , doxycycline, erythromycin, @DRUG$ , isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
@DRUG$ Reducing renal clearance of @DRUG$ and add a high risk of lithium toxicity .	DDI-mechanism
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: @DRUG$ and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of @DRUG$	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, felodipine, @DRUG$, @DRUG$, isosorbide mononitrate, carvedilol, ethanol or itraconazole.	DDI-false
hypersensitivity reactions have been reported in patients receiving combination regimens with sequentially high-dose PROLEUKIN and @DRUG$ , specifically , @DRUG$ , cis-platinum , tamoxifen and interferon-alfa .	DDI-false
Antipyrine : Because @DRUG$ • Does not affect the pharmacokinetics of antipyrin, interactions with other @DRUG$ metabolized via the same cytochrome isozymes are not expected .	DDI-false
Ethosuximide : @DRUG$ The intestinal absorption of @DRUG$ can be delayed.	DDI-mechanism
acetaminophen/theophylline , @DRUG$/quinidine , phenobarbital/@DRUG$ , phenobarbital/valproic acid , quinidine/lidocaine , theophylline/acetaminophen , and valproic acid/phenobarbital .	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose @DRUG$ and antineoplastic agents, specifically, dacarbazine, @DRUG$, tamoxifen and interferon-alfa.	DDI-effect
Concurrent administration of oxyphenbutazone and @DRUG$ may result in elevated serum levels of @DRUG$.	DDI-false
@DRUG$: Reports suggest that @DRUG$ may diminish the antihypertensive effect of Angiotensin Converting Enzyme (ACE) inhibitors.	DDI-false
These results suggest that both dexamethasone and retinyl acetate, and possibly other @DRUG$ and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and @DRUG$.	DDI-effect
Dosage adjustment of @DRUG$ may be necessary when coadministered with CYP2D6 inhibitors , e.g. , paroxetine , fluoxetine , and @DRUG$.	DDI-advise
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and @DRUG$) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
The concomitant use of @DRUG$ It is not recommended that @DRUG$ may antagonize the antibacterial effect of Norfloxacin in the urinary tract .	DDI-false
Although neither dexamethasone nor @DRUG$ Influenced the proliferation of prostate epithelium in RPMI1640 with transferrin alone, modifying the mitogenic effect of @DRUG$ and insulin .	DDI-effect
Ritonavir (600 mg b.i.d.) with @DRUG$ 5 mg resulted in a 49-fold increase in @DRUG$ AUC and a 13-fold increase in vardenafil Cmax .	DDI-false
Concomitant use with @DRUG$s may result in the reduced absorption of @DRUG$.	DDI-false
@DRUG$ may interact with alcohol , blood thinners , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , @DRUG$ , norepinephrine , NSAIDs like Aleve or Ibuprofen , and high blood pressure medications .	DDI-int
Since @DRUG$ is a substrate for CYP3A4 , there is the potential that the use of St. John s Wort in patients receiving amiodarone could result in reduced @DRUG$ levels .	DDI-false
These medicines include thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, @DRUG$ , @DRUG$ , and isoniazid .	DDI-false
@DRUG$ : Concomitant administration of @DRUG$ This resulted in a double increase in plasma concentrations of celecoxib at 200 mg QD.	DDI-false
Levosimendan has no clinically important pharmacokinetic interactions with @DRUG$ , beta-blockers, felodipine, digoxin, warfarin, isosorbide mononitrate, knitztilol, @DRUG$ or itraconazole .	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect @DRUG$ pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: @DRUG$ increases the effect of Tricyclic antidepressants	DDI-false
Multivalent Cation-Containing products: co-administration of quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or @DRUG$ antacids , @DRUG$ VIDEX chewable/buffer tablets or paediatric powders or products containing calcium, iron or zinc may significantly reduce the absorption of ciprofloxacin, resulting in significantly lower serum and urine levels than desired.	DDI-false
Seizure, associated with increased @DRUG$ concentrations, has been reported with concomitant administration of intravenous @DRUG$.	DDI-false
@DRUG$: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and @DRUG$, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with @DRUG$, phenothiazines, barbiturates, MAO inhibitors, and other @DRUG$.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
@DRUG$ : @DRUG$ * , terfenadine * CONTRAINDICATED due to potential for serious and/or life-threatening cardiac arrhythmias .	DDI-false
@DRUG$ : When @DRUG$ is administered with aspirin , its protein binding is reduced , although the clearance of free etodolac is not altered .	DDI-false
These drugs include the @DRUG$ and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, @DRUG$, calcium channel blocking drugs, and isoniazid.	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine , Innovar Vet , or @DRUG$ , the dosage of ouabain needed to cause ventricular tachycardia was significantly higher , as was the LD50 of ouabain , with @DRUG$ Or Innovar as with Pentobarbital.	DDI-false
No formal clinical studies have been conducted to assess if there is an interactive effect on bone loss between @DRUG$ and @DRUG$.	DDI-false
The intensity, uniformity and time course of @DRUG$ interference by phenobarbital, secobarbital, @DRUG$, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
Other reported interactions with @DRUG$: @DRUG$ (CYP3A4 substrate) in combination with amiodarone may cause hypotension, bradycardia, and decreased cardiac output.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when @DRUG$ is administered concomitantly with other antimuscarinics, amantadine, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some @DRUG$.	DDI-effect
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , @DRUG$ , alprazolam , and @DRUG$ ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with @DRUG$ concomitantly with anxiolytics, @DRUG$ and sedatives (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
The blood pressure effect of SULAR tended to be greater in patients on @DRUG$ than in patients on no other @DRUG$ therapy.	DDI-false
With simultaneous dosing of @DRUG$ 20 mg and @DRUG$ 10 mg, 2 in 9 subjects experienced a standing systolic blood pressure of less than 85 mm Hg.	DDI-effect
Antiarrhythmics : Other @DRUG$ medicines such as quinidine, procainamide, @DRUG$ , and phenytoin, were used at the same time as amiodarone.	DDI-false
Cholestyramine and @DRUG$ resins: Absorption of hydrochlorothiazide is impaired in the presence of @DRUG$.	DDI-false
In contrast to the digital tolerance in dogs, Innovar Vet is anaesthetized with ketamine, or @DRUG$ , the dosage of Ouabain was needed to cause ventricular tachycardia significantly higher, such as the LD50 of @DRUG$ , with ketamine or Innovar than with pentobarbital .	DDI-false
Injection : Lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , MAO inhibitors , and other antidepressants . When @DRUG$ is used concomitantly with injectable @DRUG$ An increased incidence of sedation, hallucinations, and irrational behaviour has been observed.	DDI-effect
Methenamine therapy Urinary excretion of @DRUG$ is increased, and efficacy is reduced by acidifying agents used in @DRUG$ therapy.	DDI-mechanism
Tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain @DRUG$ , lidocaine , @DRUG$ And metronidazole, which delays the elimination and increase in blood levels of these drugs.	DDI-false
Potential interactions between Keppra and other AEDs ( @DRUG$ , @DRUG$ , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies .	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril , beta-blockers , felodipine , digoxin , warfarin , isosorbide mononitrate , @DRUG$ , ethanol or @DRUG$.	DDI-false
Although neither dexamethasone nor retinyl acetate proliferates in RPMI1640, @DRUG$ alone , they modify the mitogenic effect of EGF and @DRUG$.	DDI-false
Cephalosporins-@DRUG$ containing side chains of N-methylthiotetrazole (cefmenoxime, cefoperazone, cefotetan, cefamandole, @DRUG$) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
@DRUG$ and moclobemide increased blood @DRUG$ at different times after the glucose overload.	DDI-false
The AUC and Cmax of both the (R) and (S) isomers of @DRUG$ were unaffected by concurrent dosing of 0.3 mg @DRUG$.	DDI-false
Hemodynamic and electrophysiologic interactions have also been observed after concomitant administration with @DRUG$ , diltiazem , and @DRUG$.	DDI-false
Other medicinal products Interactions: No pharmacokinetic interactions between vardenafil and the following medicinal products have been observed: @DRUG$ , @DRUG$ , digoxin , Maalox , and ranitidine .	DDI-false
The results of the studies in patients with multiple sclerosis who: @DRUG$ Interferon beta-1a ( @DRUG$   30 mcg IM once weekly ) or glatiramer acetate were inconclusive with regard to the need for dose adjustment of the beta-interferon or glatiramer acetate .	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, @DRUG$, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some @DRUG$.	DDI-false
Example inhibitors include azole antifungals , @DRUG$ , clarithromycin , diclofenac , doxycycline , erythromycin , @DRUG$ , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .	DDI-false
Other Cardiovascular Agents : Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents , methyldopa , nitrates , @DRUG$ , hydralacin, prazosin and @DRUG$ without evidence of clinically significant adverse interactions .	DDI-false
@DRUG$: Vardenafil (10 mg and 20 mg) did not potentiate the increase in bleeding time caused by @DRUG$ (two 81 mg tablets).	DDI-false
Antidepressants, tricyclic @DRUG$ may enhance the activity of tricyclic antidepressants or @DRUG$;	DDI-effect
If treatment with inhibitors of CYP3A4 activity (such as @DRUG$, intraconazole, ritonavir, indinavir, @DRUG$, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
No pharmacokinetic interactions between dexmedetomidine and @DRUG$ , @DRUG$ , alfentanil, and midazolam have been detected.	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, dapsones, @DRUG$ , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , @DRUG$ When co-administered with saquinavir, increased plasma concentrations may occur;	DDI-false
Simultaneous use of other @DRUG$ There may be an increase in the side effects of @DRUG$.	DDI-effect
Potential drug interactions between Keppra  and other AEDs (carbamazepine, @DRUG$, lamotrigine, phenobarbital, phenytoin, @DRUG$ and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Therefore , @DRUG$ The treatment should be discontinued at least two weeks before starting careful therapy with @DRUG$.	DDI-advise
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with @DRUG$, methyldopa, nitrates, @DRUG$, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
Adequate monitoring of theophylline plasma concentrations should be considered when therapy with @DRUG$ is initiated or changed in patients receiving @DRUG$.	DDI-advise
@DRUG$: Amiodarone should be used with caution in patients receiving  -@DRUG$ blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., verapamil, a CYP3A4 substrate, and diltiazem, a CYP3A4 inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
The possibility of hypotensive effects with @DRUG$ Enalaprilat or enalaprilat can be minimized by either: @DRUG$ or increasing the salt intake prior to initiation of treatment with enalapril or enalaprilat .	DDI-effect
Amiodarone taken concomitantly with procainamide for less than seven days increases plasma concentrations of @DRUG$ and n-acetyl @DRUG$ by 55 % and 33 % , respectively .	DDI-false
Methotrexate: In an interaction study of rheumatoid arthritis patients taking @DRUG$, CELEBREX did not have a significant effect on the pharmacokinetics of @DRUG$.	DDI-false
Antihypertensives : Amiodarone should be used with caution in patients receiving   -receptor blocking agents ( e.g. , propranolol , a CYP3A4 inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a CYP3A4 substrate , and @DRUG$ , a @DRUG$ Inhibitor) because of the potential for bradycardia, sinus arrest and AV block;	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , @DRUG$ , probenecid , @DRUG$ , monoamine oxidase inhibitors , and beta adrenergic blocking agents .	DDI-false
No data are available for the coadministration of @DRUG$/ritonavir or FORTOVASE/@DRUG$ and garlic capsules.	DDI-false
Patients receiving both indomethacin and @DRUG$ should be observed closely to determine if the desired diuretic and/or antihypertensive effect of @DRUG$ is achieved .	DDI-false
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and @DRUG$ with vincristine plus bleomycin) without receiving @DRUG$ therapy.	DDI-false
If treatment with inhibitors of CYP3A4 activity ( such as @DRUG$ , intraconazole , @DRUG$ , indinavir , saquinavir , erythromycin , etc . ) is indicated , reduction of the budesonide dose should be considered .	DDI-false
Injection: Lorazepam injection, like other injectable @DRUG$, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable @DRUG$, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
Non-selective MAO inhibitors including tranylcypromine sulfate , @DRUG$ , and Pargylin HC1: Simultaneous use of L-tyrosine and non-selective @DRUG$ - May cause high blood pressure.	DDI-false
Compounds tested in man include warfarin , theophylline , phenytoin , diazepam , @DRUG$ and @DRUG$.	DDI-false
- @DRUG$ (nandrolone [e.g., Anabolin], oxandrolone [e.g., Anavar], @DRUG$ [e.g., Anadrol], stanozolol [e.g., Winstrol]) or	DDI-false
Data from in vitro studies with benzodiazepines other than: @DRUG$ suggest a possible drug interaction for the following : @DRUG$ , cyclosporine , amiodarone , nicardipine , and nifedipine .	DDI-int
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (@DRUG$): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: @DRUG$ and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Coadministration of @DRUG$ did not influence the pharmacokinetics of @DRUG$.	DDI-false
@DRUG$, @DRUG$, phenobarbital, quinidine, theophylline, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
@DRUG$ As with some other quinolones, concomitant administration of @DRUG$ with theophylline may lead to elevated serum concentrations of theophylline and prolongation of its elimination half-life .	DDI-false
@DRUG$ • the adverse effects of other @DRUG$ administered concomitantly .	DDI-effect
Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, haloperidol, phenothiazines, @DRUG$, @DRUG$ or some antihistamines.	DDI-false
@DRUG$ and @DRUG$: Upon concomitant administration of 5 mg of Vardenafil with 600 mg BID ritonavir, the Cmax and AUC of ritonavir were reduced by approximately 20%.	DDI-false
Anticoagulants including coumarin derivatives, indandione derivatives, and @DRUG$ such as nonsteroidal anti-inflammatory drugs (@DRUG$), and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
There are currently no data available from prospective clinical studies comparing the 3 approved active substances (efavirenz, @DRUG$ or @DRUG$ ) .	DDI-false
Multivitamins, or other products containing iron or zinc, antacids or @DRUG$ should not be administered concomitantly with, or within 2 hours of, the administration of @DRUG$, because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin.	DDI-advise
Concomitant @DRUG$, doxorubicin, @DRUG$, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
• Carbamazepine: In healthy subjects receiving the CYP3A4 inducer, @DRUG$ , at 100 mg twice daily for 3 days and 200 mg twice daily for 17 days , systemic exposure ( AUC ) to @DRUG$ was decreased approximately 72 % .	DDI-mechanism
The extent to which @DRUG$-@DRUG$ interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the SSRI involved.	DDI-int
@DRUG$: Co-administration of VIOXX with rifampin 600 mg daily, a potent inducer of hepatic metabolism, produced an approximate 50% decrease in @DRUG$ plasma concentrations.	DDI-false
Injection: @DRUG$ injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other @DRUG$.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-effect
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, @DRUG$, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Other Cardiovascular Agents : Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents , methyldopa , @DRUG$ * Calcium blockers, hydralacin, @DRUG$ And digoxin without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ had no significant impact on the Cmax and AUC of zidovudine , although it significantly decreased the @DRUG$ Tmax increased by 44% and intracellular exposure to phosphorylated zidovudine by 110%.	DDI-mechanism
The effects of DCG-IV and @DRUG$ upon phencyclidine (@DRUG$)-induced locomotion and behavioral changes in mice.	DDI-false
A drug-drug interaction study evaluated the effect of the use of ACZONE Gel , 5 % , in combination with double strength ( 160 mg/800 mg ) @DRUG$/sulfamethoxazole ( TMP/@DRUG$ ) .	DDI-false
Aspirin/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered @DRUG$ (162.5 mg orally given 26 and 2 hours prior to initiation of @DRUG$ 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
Caution should be exercised when administering @DRUG$ with drugs that are known to inhibit phosphatase activities ( e.g. , @DRUG$ ) .	DDI-advise
acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, @DRUG$/lidocaine, theophylline/acetaminophen, and valproic acid/@DRUG$.	DDI-false
Pharmacokinetic or pharmacodynamic drug interactions between argatroban and co-administered aspirin (administered 162.5 mg orally 26 and 2 hours before starting therapy with argatroban) have not been established. @DRUG$ 1   g/kg/min . over 4 hours ) or acetaminophen ( 1000 mg orally given 12 , 6 and 0 hours prior to , and 6 and 12 hours subsequent to , initiation of Argatroban 1.5   g/kg/min . over 18 hours ) .	DDI-false
Aspirin : In normal volunteers, a small decrease in @DRUG$ levels was observed when multiple doses of @DRUG$ and aspirin were administered concomitantly .	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, @DRUG$, nicardipine, @DRUG$, protease inhibitors, quinidine, and verapamil.	DDI-false
HMG-CoA Reductase Inhibitors: @DRUG$ (CYP3A4 substrate) in combination with @DRUG$ has been associated with reports of myopathy/rhabdomyolysis.	DDI-false
@DRUG$ 500 mg twice daily did not modify the rate or extent of @DRUG$ Absorption or its plasma clearance or urinary excretion.	DDI-false
Substances that are potent inhibitors of CYP3A4 activity (e.g. ketoconazole and @DRUG$ ) Reduction of gefitinib metabolism and increase @DRUG$ plasma concentrations .	DDI-mechanism
Similarly, @DRUG$ decreased the rate of elimination of @DRUG$ (by approximately 50%) by the same mechanism.	DDI-mechanism
A drug-drug interaction study evaluated the effect of the use of ACZONE Gel, 5%, in combination with double strength (160 mg/800 mg) @DRUG$/sulfamethoxazole (TMP/@DRUG$).	DDI-false
@DRUG$ : rifampin CONTRAINDICATED since the coadministration of this product with saquinavir in an antiretroviral regimen reduces the plasma concentrations of @DRUG$.	DDI-false
@DRUG$/prednisolone : @DRUG$ did not have any clinically important effect on the pharmacokinetics of prednisolone or prednisone .	DDI-false
Chronic administration of @DRUG$ , a known enzyme inducer , may be associated with a decrease in the plasma half-life of @DRUG$.	DDI-mechanism
Antacids : In a clinical pharmacology study , coadministration of an antacid ( @DRUG$ , magnesium hydroxide and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat compared to fosinopril alone, suggesting that antacids may affect the absorption of @DRUG$.	DDI-false
@DRUG$: When Vardenafil 10 or 20 mg was given to healthy volunteers either simultaneously or 6 hours after a 10 mg dose of @DRUG$, significant hypotension developed in a substantial number of subjects.	DDI-false
Short-term pharmacokinetic studies have demonstrated that concomitant administration of warfarin and @DRUG$  (@DRUG$ capsules and tablets) results in reduced protein binding of warfarin, but there was no change in the clearance of free warfarin.	DDI-false
Example inhibitors include @DRUG$ , ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, @DRUG$ ==References====External links==	DDI-false
Possible drug interactions of HUMORSOL with @DRUG$ or with other @DRUG$.	DDI-false
Agents Causing Renin Release : The antihypertensive effect of @DRUG$ Ug and enalapril IV is supplemented by @DRUG$ that cause renin release ( e.g. , diuretics ) .	DDI-effect
The concomitant administration of medicinal products that are nephrotoxic (e.g. aminoglycosides, @DRUG$ ) , myelotoxic ( e.g. , cytotoxic chemotherapy ) , cardiotoxic ( e.g. , @DRUG$ Hepatotoxic (e.g. methotrexate, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
@DRUG$ Amiodarone should be used with caution in patients who are receptor blockers (e.g. propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g. verapamil, a CYP3A4 substrate), and @DRUG$ , a CYP3A4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and AV block ;	DDI-false
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , @DRUG$ , anticonvulsants, benzodiazepines, @DRUG$ , calcium-channel blockers , cardiac nitrates , diuretics , H2 antagonists , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
Alpha-blockers: When @DRUG$ 10 or 20 mg was given to healthy volunteers either simultaneously or 6 hours after a 10 mg dose of @DRUG$, significant hypotension developed in a substantial number of subjects.	DDI-effect
Single doses of any of the following doses: @DRUG$ * Colestipol resins bind the @DRUG$ The absorption from the gastrointestinal tract is reduced by up to 85 and 43 percent respectively.	DDI-mechanism
After multiple dosing , interferon beta-1a ( @DRUG$   30 mcg IM once weekly ) reduced @DRUG$ Clearance is approximately 30%.	DDI-mechanism
@DRUG$ Chlorpromazine blocks dopamine and norepinephrine receptors, which inhibits the central stimulant effect of amphetamines and is used to treat @DRUG$ poisoning .	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, @DRUG$, niacin (nicotinic acid), @DRUG$, azole antifungals.	DDI-false
Other Drugs:Drugs such as quinidine, @DRUG$, procainamide, @DRUG$, antihistamines, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
Severe hypoglycemia has been reported in patients concomitantly receiving @DRUG$ and oral @DRUG$.	DDI-effect
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with @DRUG$, beta-blockers, felodipine, @DRUG$, warfarin, isosorbide mononitrate, carvedilol, ethanol or itraconazole.	DDI-false
Hydrochlorothiazide: In normal volunteers, concomitant administration of @DRUG$ and @DRUG$ resulted in significantly increased plasma levels of hydrochlorothiazide.	DDI-mechanism
apomorphine - prior ingestion of @DRUG$ may decrease the @DRUG$ response to apomorphine in the treatment of poisoning .	DDI-false
Compounds that have been tested in man include antipyrine , @DRUG$ , @DRUG$ Theophylline, warfarin and no clinically significant interactions were found.	DDI-false
Other concomitant therapy Although specific interaction studies have not been performed, 1 mg or more finasteride doses have been reported in clinical trials with acetaminophen, acetylsalicylic acid, A-blockers, analgesics, angiotensin converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta-blockers, calcium channel blockers, heart nitrates, @DRUG$ , H2 antagonists , HMG-CoA reductase inhibitors , @DRUG$ ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
In patients with mild to moderate hypertension , administration of 25 mg daily of VIOXX with the @DRUG$ @DRUG$ 10 to 40 mg for 4 weeks was associated with an average increase in mean arterial pressure of approximately 3 mm Hg compared to ACE inhibitors alone.	DDI-false
@DRUG$ : The concomitant use of Bepridil with long- and short-acting @DRUG$ It was safely tolerated in patients with stable angina pectoris.	DDI-false
Because of the increased risk of adverse reactions in patients who have been taking @DRUG$ on a regular basis, it is particularly important that physicians query patients or their guardians carefully about benzodiazepine, @DRUG$ and sedative use as part of the history prior to any procedure in which the use of ROMAZICON is planned.	DDI-false
@DRUG$ (but not aspirin): These drugs in combination with very high doses of @DRUG$ have been shown to provoke convulsions in pre-clinical studies.	DDI-false
Antiarrhythmics: @DRUG$, bepridil, flecainide, propafenone, @DRUG$ CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
Other cardiovascular agents: Enalapril and Enalapril IV were co-administered with beta-adrenergic blockers, @DRUG$ - Nitrates, calcium blockers, hydralazine, prazosin and @DRUG$ without evidence of clinically significant adverse interactions .	DDI-false
Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: @DRUG$, cyclosporine, amiodarone, @DRUG$, and nifedipine.	DDI-false
@DRUG$ : rifampin CONTRAINDICATED since the coadministration of this product with saquinavir in an @DRUG$ The regimen reduces the plasma concentrations of saquinavir.	DDI-false
- Anabolic steroids (@DRUG$ [e.g., Anabolin], oxandrolone [e.g., Anavar], oxymetholone [e.g., Anadrol], stanozolol [e.g., @DRUG$]) or	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, @DRUG$, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Potential drug interactions between Keppra   and other AEDs ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , @DRUG$ and @DRUG$ ) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies .	DDI-false
The risk of myopathy during treatment with medicines in this class is associated with the use of @DRUG$ , fibrous acid derivatives, niacin (nicotinic acid), erythromycin, @DRUG$.	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (@DRUG$), @DRUG$ (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Central nervous system depressants : Co-administration of @DRUG$   ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other @DRUG$ , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	DDI-effect
for adult-onset diabetics , dosage adjustment of @DRUG$ - may be necessary during and after @DRUG$ therapy ;	DDI-advise
Concomitant cyclophosphamide, @DRUG$, vincristine, and @DRUG$ chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.	DDI-false
Antacids : In a clinical pharmacology study , coadministration of an antacid ( @DRUG$ , @DRUG$ , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .	DDI-false
Antiarrhythmics : Other antiarrhythmic drugs , such as quinidine , @DRUG$ , @DRUG$ , and phenytoin, were used at the same time as amiodarone.	DDI-false
While all the selective serotonin reuptake inhibitors ( SSRIs ) , e.g. , citalopram , escitalopram , fluoxetine , @DRUG$ , and @DRUG$ , inhibit P450 2D6, they may vary in extent of inhibition.	DDI-false
@DRUG$ : Concomitant administration of low-dose aspirin with VIOXX may result in an increased rate of GI ulceration or other complications , compared to use of @DRUG$ alone .	DDI-false
Naproxen: The concomitant administration of diflunisal and @DRUG$ in normal volunteers had no effect on the plasma levels of @DRUG$, but significantly decreased the urinary excretion of naproxen and its glucuronide metabolite.	DDI-false
Antacids : In a clinical pharmacology study , coadministration of an @DRUG$ ( aluminum hydroxide , @DRUG$ In combination with fosinopril, serum concentrations and urinary excretion of fosinoprilat were reduced compared to fosinopril alone, suggesting that antacids may affect the absorption of fosinopril.	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, @DRUG$, ritonavir, @DRUG$, saquinavir, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
There have been case reports of increased steady-state levels of quinidine, @DRUG$, and phenytoin during concomitant therapy with @DRUG$.	DDI-false
- Anabolic steroids (nandrolone [e.g., Anabolin], @DRUG$ [e.g., Anavar], oxymetholone [e.g., @DRUG$], stanozolol [e.g., Winstrol]) or	DDI-false
Aspirin : When Lodine is administered with @DRUG$ , its protein binding is reduced, although the clearance of free @DRUG$ is not altered .	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, @DRUG$, tranquilizers (e.g., @DRUG$), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Hemodynamic and electrophysiologic interactions have also been observed after concomitant administration with propranolol , @DRUG$ , and @DRUG$.	DDI-false
High-dose cyclosporin A resulting in concentrations above 2000 ng/mL administered with oral @DRUG$ has led to an 80 % increase in etoposide exposure with a 38 % decrease in total body clearance of etoposide compared to @DRUG$ alone .	DDI-false
Amiodarone may suppress certain CYP450 enzymes, including CYP1A2, CYP2C9. @DRUG$ , and @DRUG$.	DDI-false
Potential pharmacokinetic interactions have been reported in clinical pharmacokinetic studies (phenytoin, @DRUG$ , oral @DRUG$ , digoxin , warfarin , probenecid ) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients .	DDI-false
Hydrochlorothiazide: In normal volunteers, concomitant administration of diflunisal and @DRUG$ resulted in significantly increased plasma levels of @DRUG$.	DDI-false
Examples of inhibitors are azole antimycotics, ciprofloxacin, clarithromycin, diclofenac, doxycycline, @DRUG$ , @DRUG$ , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .	DDI-false
Reciprocal interactions may occur with concomitant use of @DRUG$ medicines that increase or inhibit the cytochrome P450 system (e.g. phenytoin, carbamazepine, @DRUG$ , ketoconazole ) , though this has not been studied	DDI-mechanism
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, @DRUG$, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, @DRUG$, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Micro-dosed @DRUG$ Preparations: Micro-dosed progesterone preparations (minipills that do not contain an @DRUG$) may be an inadequate method of contraception during Accutane therapy.	DDI-false
* Drug interactions : Flupentixol may interact with some drugs, such as @DRUG$ MAOI (MAOI): MAOI could theoretically influence @DRUG$ pharmacodynamics - Arecoline - Eproxindine - Ethanol : Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants : Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
The risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine, fibric acid derivatives, niacin (@DRUG$), erythromycin, @DRUG$.	DDI-false
Example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , @DRUG$ , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and @DRUG$.	DDI-false
@DRUG$: @DRUG$ have produced an elevation of plasma lithium levels and a reduction in renal lithium clearance.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, @DRUG$, and @DRUG$, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Indinavir ( 800 mg t.i.d.) with vardenafil 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in AUC @DRUG$ Cmax and 2-fold increase in @DRUG$ half-life .	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, @DRUG$, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, ritonavir, @DRUG$, saquinavir, @DRUG$, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
Fenfluramine may increase slightly the effect of @DRUG$, e.g., @DRUG$, methyldopa, reserpine.	DDI-false
The effect of @DRUG$ on the warfarin requirement of our patient appeared to be maximal 5 to 7 days after the initiation of @DRUG$ and extended a similar length of time after rifampin withdrawal.	DDI-false
• Rifampin: concomitant use of @DRUG$ rifampin 600 mg daily, a potent inducer of hepatic metabolism, caused @DRUG$ plasma concentrations .	DDI-false
Potential drug interactions between: @DRUG$ AEDs and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, @DRUG$ In placebo-controlled clinical trials, serum concentrations of levetiracetam and these AEDs have also been studied.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$, sympathomimet-ics, @DRUG$, and isoniazid.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, @DRUG$, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
There have been case reports of increased steady-state levels of @DRUG$ , @DRUG$ , and phenytoin during concomitant therapy with amiodarone .	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, @DRUG$, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
The interaction is a consequence of blocking hepatic metabolism of @DRUG$ by @DRUG$, a highly potent CYP3A4 inhibitor, which also inhibits CYP2C9.	DDI-mechanism
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, @DRUG$, felodipine, digoxin, warfarin, isosorbide mononitrate, carvedilol, ethanol or @DRUG$.	DDI-false
unlike @DRUG$, @DRUG$ does not affect responding for a nondrug reinforcer (water).	DDI-false
Plasma valproate concentration should be monitored when @DRUG$ and valproate are co administered, and appropriate dosage adjustments of @DRUG$ should be made.	DDI-false
Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving Alprazolam (caution is recommended during coadministration with alprazolam): Coadministration of @DRUG$ with @DRUG$ increased the maximum plasma concentration of alprazolam by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance.	DDI-mechanism
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and @DRUG$ did not significantly affect the pharmacokinetics/pharmacodynamics of @DRUG$.	DDI-false
A drug-drug interaction study evaluated the effect of the use of @DRUG$ Gel , 5 % , in combination with double strength ( 160 mg/800 mg ) @DRUG$/sulfamethoxazole ( TMP/SMX ) .	DDI-false
Tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of @DRUG$ , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and @DRUG$ This delays elimination and increases blood levels of these drugs.	DDI-false
While all the @DRUG$ (@DRUG$), e.g., citalopram, escitalopram, fluoxetine, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition.	DDI-false
@DRUG$ and @DRUG$ Elevated blood sugar at different times after glucose overload.	DDI-false
Rhabdomyolysis has been observed in patients receiving @DRUG$ • Alone (at recommended doses) or concomitantly with immunosuppressive medicinal products including @DRUG$.	DDI-effect
This drug may interact with alcohol or other @DRUG$ (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of @DRUG$).	DDI-false
@DRUG$: Dihydroergotamine, ergonovine, ergotamine, methylergonovine CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute @DRUG$ toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
Injection : Lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , @DRUG$ , MAO inhibitors , and other antidepressants . When scopolamine is used concomitantly with injectable @DRUG$ An increased incidence of sedation, hallucinations, and irrational behaviour has been observed.	DDI-false
Potential interactions between Keppra and other AEDs ( @DRUG$ , gabapentin, lamotrigine, phenobarbital, @DRUG$ , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies .	DDI-false
Other Cardiovascular Agents: @DRUG$ and enalapril IV have been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, @DRUG$, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
In patients receiving @DRUG$ and a steroid concomitantly, any reduction in @DRUG$ dosage should be gradual in order to avoid the possible complications of sudden steroid withdrawal.	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, @DRUG$, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these @DRUG$ during placebo-controlled clinical studies.	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other @DRUG$, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, @DRUG$, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (@DRUG$), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of @DRUG$.	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, phenothiazines, @DRUG$, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
The intensity , uniformity and time course of anticoagulant interference by phenobarbital , secobarbital , @DRUG$ , chloral hydrate and methaqualone have been systematically studied in 16 patients who: @DRUG$ therapy .	DDI-false
Other Cardiovascular Agents : Enalapril and enalapril IV have been used concomitantly with beta adrenergic-blocking agents , methyldopa , @DRUG$ - Calcium blockers, @DRUG$ , prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$ and Angiotensin II Receptor Antagonists (Hypertension)- In clinical studies of patients with hypertension, the addition of INSPRA 50 to 100 mg to ACE inhibitors and @DRUG$ increased mean serum potassium slightly (about 0.09-0.13 mEq/L).	DDI-false
Central Nervous System Depressants: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, @DRUG$, hypnotics, tranquilizers (e.g., @DRUG$), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, @DRUG$, benzodiazepines, beta blockers, @DRUG$, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
No Important Interactions To Date Levosimendan does not have clinically important pharmacokinetic interactions with captopril, beta-blockers, @DRUG$, digoxin, warfarin, isosorbide mononitrate, carvedilol, @DRUG$ or itraconazole.	DDI-false
Potential drug interactions between Keppra   and other AEDs ( carbamazepine , gabapentin , lamotrigine , phenobarbital , @DRUG$ , primidone and valproate) were also evaluated by estimating the serum concentrations of levetiracetam and valproate. @DRUG$ • during placebo-controlled clinical trials.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral @DRUG$, phenytoin, nicotinic acid, @DRUG$, calcium channel blocking drugs, and isoniazid.	DDI-false
Short-term pharmacokinetic studies have demonstrated that concomitant administration of @DRUG$ * Excluding and lodines ( @DRUG$ However, there was no change in the clearance of free warfarin.	DDI-mechanism
Other Chemotherapy Agents In a separate study , concomitant administration of lapatinib with @DRUG$ The pharmacokinetics of an active substance (or metabolites of @DRUG$ ) .	DDI-false
An interaction study with @DRUG$ showed no clinically significant effect of anastrozole on @DRUG$ pharmacokinetics or anticoagulant activity.	DDI-false
Aspirin/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between @DRUG$ and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or acetaminophen (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of @DRUG$ 1.5  g/kg/min. over 18 hours).	DDI-false
@DRUG$ and @DRUG$ similarly inhibit and stimulate EGF- or insulin-induced proliferation of prostatic epithelium.	DDI-false
@DRUG$, nondepolarizing (e.g., @DRUG$): possible increased responsiveness to the muscle relaxant.	DDI-false
Multivalent Cation-Containing Products : Concurrent administration of a quinolone , including @DRUG$ , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , VIDEX chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or @DRUG$ may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .	DDI-mechanism
- Antidiabetics, oral (diabetes medicine you take by mouth) Use of oral @DRUG$ with @DRUG$ may increase the chance of side effects affecting the blood and/or the side effects or oral antidiabetics	DDI-effect
Cephalosporins-Cephalosporins containing side chains of N-methylthiotetrazole (@DRUG$, cefoperazone, @DRUG$, cefamandole, latamoxef) or methylthiadiazole (cefazolin) can cause vitamin K deficiency and hypoprothrombinemia.	DDI-false
OBJECTIVE : Our goal was to promote the steady-state pharmacokinetics of everolimus and @DRUG$ ( INN , @DRUG$ ) when co-administered in de novo renal allograft recipients in the first year after transplantation.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the @DRUG$, doxorubicin, vincristine, and @DRUG$ (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
The management of the local @DRUG$ Containing epinephrine or norepinephrine in patients who: @DRUG$ or tricyclic antidepressants may produce severe , prolonged hypertension .	DDI-false
@DRUG$ is metabolized to @DRUG$ Cytochrome P450 ( CYP450 ) enzyme group, especially cytochrome P450 3A4 ( CYP3A4 ) and CYP2C8.	DDI-false
Reciprocal interactions may occur with concomitant use of @DRUG$ and drugs that increase or inhibit the cytochrome P450 system (e.g., phenytoin, carbamazepine, cimetidine, @DRUG$), though this has not been studied	DDI-mechanism
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, @DRUG$, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Tagamet, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of @DRUG$, phenytoin, propranolol, nifedipine, chlordiazepoxide, @DRUG$, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs.	DDI-false
@DRUG$ @DRUG$ are inhibited by amphetamines.	DDI-false
The effects of @DRUG$ ( RR ) on @DRUG$ ( InsP(3))-induced responses were studied in rat bone marrow megakaryocytes with the patch-clamp whole-cell recording technique in combination with fura-2 microfluorometry .	DDI-false
Potential drug interactions between @DRUG$  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, @DRUG$ and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Methotrexate : In an interaction study of rheumatoid arthritis patients taking @DRUG$ CELEBREX had no significant effect on the pharmacokinetics of @DRUG$.	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, @DRUG$, @DRUG$, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-false
Lithium: Lithium toxicity has been reported in patients who: @DRUG$ Simultaneously with medications that cause the excretion of sodium, including @DRUG$.	DDI-effect
Co-medications that induce CYP3A4 (e.g., dexamethasone, phenytoin, @DRUG$, @DRUG$, phenobarbital or St.	DDI-false
There was no significant change in prothrombin test results during @DRUG$ and @DRUG$.	DDI-false
@DRUG$ The recording of @DRUG$ may be affected.	DDI-mechanism
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with @DRUG$, hypnotics and @DRUG$ (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
therefore, @DRUG$ or other nitrates (as used for management of angina) or other drugs having vasodilator activity should, if possible, be discontinued before starting @DRUG$.	DDI-advise
Intravenous @DRUG$ Adenosine was effectively administered in the presence of other cardiovascular drugs such as quinidine. @DRUG$ , calcium channel blocking agents , and angiotensin converting enzyme inhibitors , without any change in the adverse reaction profile .	DDI-false
HMG-CoA Reductase Inhibitors: Simvastatin (@DRUG$ substrate) in combination with @DRUG$ has been associated with reports of myopathy/rhabdomyolysis.	DDI-false
@DRUG$: (oral agents and insulin) - dosage adjustment of the @DRUG$ may be required.	DDI-false
- @DRUG$ ( e.g. , @DRUG$ The use of methotrexate with sulfapyridine may increase the likelihood of side effects affecting the liver and/or side effects of methotrexate.	DDI-false
BACKGROUND : The effects of combined administration of @DRUG$ and verapamil hydrochloride ( verapamil ) , a calcium channel blocker , on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane ( @DRUG$ ) and the labeling index of intestinal cancers were investigated in male Wistar rats .	DDI-false
@DRUG$-@DRUG$ may decrease the absorption of vitamin K.	DDI-false
To evaluate the effect of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL), the authors retrospectively compared a group of 24 patients with HIV-NHL treated with cyclophosphamide, @DRUG$ , vincristine , and prednisone ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , doxorubicin , teniposide , and @DRUG$ • with vincristine plus bleomycin) without antiretroviral therapy.	DDI-false
rifampin pre-treatment of healthy volunteers with multiple doses followed by a single dose @DRUG$ , increased @DRUG$ oral-dose clearance by 3.8-fold , which significantly ( p 0.05 ) decreased mean cmax and AUC(0 - 8) .	DDI-false
Although @DRUG$ have been shown to reduce PROLEUKIN-induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided . 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with @DRUG$.	DDI-false
The concomitant use of @DRUG$ with CELEBREX may result in an increased rate of GI ulceration or other complications , compared to use of @DRUG$ alone .	DDI-false
However, reports suggest that @DRUG$ may diminish the antihypertensive effect of @DRUG$.	DDI-effect
@DRUG$ reduce the renal clearance of @DRUG$ and add a high risk of lithium toxicity.	DDI-mechanism
Antagonism between @DRUG$ and @DRUG$ in vitro has been demonstrated.	DDI-effect
The concomitant intake of @DRUG$ The pharmacokinetics of acamprosate and acamprosate have no effect on the pharmacokinetics of @DRUG$ or acamprosate .	DDI-false
Carbamazepine: @DRUG$ is known to slow the metabolism of @DRUG$ and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.	DDI-mechanism
There have been reports of QTc prolongation, with or without TdP, in patients taking amiodarone when @DRUG$, @DRUG$, or azoles were administered concomitantly.	DDI-false
@DRUG$ including coumarin derivatives, indandione derivatives, and platelet aggregation inhibitors such as nonsteroidal anti-inflammatory drugs (@DRUG$), and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin.	DDI-false
The @DRUG$ are a family of @DRUG$ and hypnotic drugs .	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , @DRUG$ , warfarin, tacrolimus, cyclosporin, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, @DRUG$ , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
- @DRUG$ ( nandrolone [ e.g. , Anabolin ] , oxandrolone [ e.g. , @DRUG$ ] , oxymetholone [ e.g. , Anadrol ] , stanozolol [ e.g. , Winstrol ] ) or	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, Dapson, disopyramide, quinine, amiodarone, quinidine, warfarin, @DRUG$ , cyclosporine , ergot derivatives , @DRUG$ When co-administered with saquinavir, carbamazepine, fentanyl, alfentanyl, alprazolam and triazolam may exhibit increased plasma concentrations;	DDI-false
@DRUG$-@DRUG$ containing side chains of N-methylthiotetrazole ( cefmenoxime , cefoperazone , cefotetan , cefamandole , latamoxef ) or methylthiadiazole ( cefazolin ) can cause vitamin K deficiency and hypoprothrombinemia .	DDI-false
Patients receiving azathioprine and @DRUG$ concomitantly should have a dose reduction of @DRUG$, to approximately 1/3 to 1/4 the usual dose.	DDI-false
@DRUG$ NSAIDs-A drug interaction study of eplerenone with a @DRUG$ It wasn't done.	DDI-false
Injection: @DRUG$ injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, @DRUG$, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-effect
Multivalent Cation-Containing Products: Concurrent administration of a quinolone, including ciprofloxacin, with multivalent cation-containing products such as @DRUG$ or aluminum antacids, @DRUG$, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, iron, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , @DRUG$ , a-blockers , @DRUG$ , angiotensin-converting enzyme ( ACE ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , H2 antagonists , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
Multivitamins , or other products containing @DRUG$ or @DRUG$ Antacids or sucralfate should not be administered concomitantly with or within 2 hours after administration of norfloxacin as they may impair absorption, resulting in lower serum and urine levels of norfloxacin.	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , @DRUG$ , monoamine oxidase inhibitors , and @DRUG$.	DDI-false
Tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , @DRUG$ , certain tricyclic antidepressants , lidocaine , @DRUG$ And metronidazole, which delays the elimination and increase in blood levels of these drugs.	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine, Innovar Vet, or @DRUG$, the dosage of @DRUG$ needed to cause ventricular tachycardia was significantly higher, as was the LD50 of ouabain, with ketamine or Innovar than with pentobarbital.	DDI-effect
Colestipol-Concomitant intake of @DRUG$ and @DRUG$ may reduce the absorption of vitamin K.	DDI-mechanism
@DRUG$ : Because of the relationship of @DRUG$ Patients should be advised not to take vitamin A-containing supplements to avoid additive toxic effects.	DDI-false
Central nervous system depressants: Concomitant use of DURAGESIC (Fentanyl transdermal system) with others @DRUG$ , including but not limited to other opioids , @DRUG$ Hypnosis, sedatives (e.g., benzodiazepines), general anaesthetics, phenothiazines, skeletal muscle relaxants and alcohol, can cause respiratory depression, hypotension and deep sedation, or possibly lead to coma or death.	DDI-false
@DRUG$ taken concomitantly with @DRUG$ increases quinidine serum concentration by 33 % after two days .	DDI-false
@DRUG$: Because of the relationship of @DRUG$ to vitamin A, patients should be advised against taking vitamin supplements containing vitamin A to avoid additive toxic effects	DDI-false
Since amiodarone is a substrate for @DRUG$, there is the potential that the use of St. John s Wort in patients receiving @DRUG$ could result in reduced amiodarone levels.	DDI-false
@DRUG$ @DRUG$   ( 1000 mg twice daily ) did not influence the pharmacokinetics of R and S warfarin .	DDI-false
Quinolones, including @DRUG$, may enhance the effects of oral anticoagulants, including @DRUG$ or its derivatives or similar agents.	DDI-effect
The effects of adenosine are antagonized by @DRUG$ such as caffeine and @DRUG$.	DDI-false
Intravenous @DRUG$ ( adenosine ) has been effectively administered in the presence of other cardioactive drugs , such as quinidine , beta-adrenergic blocking agents , calcium channel blocking agents , and @DRUG$ , without changing the adverse reaction profile.	DDI-false
Other strong inhibitors of CYP3A4 (e.g., @DRUG$, clarithromycin, nefazodone, troleandomycin, ritonavir, @DRUG$) would be expected to behave similarly.	DDI-false
Oral @DRUG$ : Coadministration of @DRUG$ AUC values for norethindron and ethinylestradiol were increased by approximately 30% and 20% by oral contraceptives.	DDI-false
The coingestion of acetaminophen with theophylline, @DRUG$ with acetaminophene and valproic acid with @DRUG$ at high to toxic concentrations decreases the binding of the target drug .	DDI-false
Anticoagulants: Potentiation of @DRUG$-type (@DRUG$ and CYP3A4 substrate) anticoagulant response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding.	DDI-false
Treatment with CYP3A4 inhibitors (e.g. @DRUG$ , intraconazole, ritonavir, @DRUG$ , saquinavir, erythromycin, etc.) is indicated, reduction of budesonide dose should be considered.	DDI-false
Single doses of either @DRUG$ or colestipol @DRUG$ bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.	DDI-false
@DRUG$ ( 600 mg b.i.d . ) co-administered with Vardenafil 5 mg resulted in a 49-fold increase in @DRUG$ AUC and a 13-fold increase in vardenafil Cmax .	DDI-false
Pharmacokinetic or pharmacodynamic drug interactions between argatroban and co-administered aspirin (162.5 mg orally administered 26 and 2 hours prior to treatment) have not been demonstrated. @DRUG$ 1   g/kg/min . over 4 hours ) or acetaminophen ( 1000 mg orally given 12 , 6 and 0 hours prior to , and 6 and 12 hours subsequent to , initiation of Argatroban 1.5   g/kg/min . over 18 hours ) .	DDI-false
BACKGROUND : The effects of combined administration of bombesin and verapamil hydrochloride ( verapamil ) , a @DRUG$ , on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane ( @DRUG$ ) and the index of colorectal cancers were studied in male Wistar rats.	DDI-false
Co-administration of @DRUG$ and aminoglycosides or other agents interfering with neuromuscular transmission ( e.g. , @DRUG$ ) should only be performed with caution as the effect of the toxin may be potentiated .	DDI-advise
Tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of @DRUG$ , phenytoin , propranolol , nifedipine , chlordiazepoxide , @DRUG$ , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .	DDI-false
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of @DRUG$ and thus should be avoided. 12 Beta-blockers and other @DRUG$ may potentiate the hypotension seen with PROLEUKIN.	DDI-false
@DRUG$-Concomitant intake of mineral oil and vitamin K may reduce the absorption of @DRUG$.	DDI-false
Patients taking low-dose @DRUG$ plus @DRUG$ were not studied .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , @DRUG$ , @DRUG$ , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , H2 antagonists , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
@DRUG$-Cephalosporins containing side chains of N-methylthiotetrazole ( cefmenoxime , cefoperazone , cefotetan , @DRUG$ Methylthiadiazole (cefazolin) may cause vitamin K deficiency and hypoprothrombinaemia.	DDI-false
Because of the increased risk of adverse reactions in patients who have been taking benzodiazepines on a regular basis , it is particularly important that physicians query patients or their guardians carefully about @DRUG$ , alcohol and @DRUG$ Use ROMAZICON as part of the story before any method in which the use of ROMAZICON is planned.	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, dapsones, @DRUG$ , quinine , @DRUG$ , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, dapsones, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporin, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$ Elevated plasma concentrations may occur when alprazom is co-administered with triazolam. @DRUG$ ;	DDI-mechanism
@DRUG$ may decrease the amount of digoxin (@DRUG$, Lanoxicaps) that gets absorbed into your body.	DDI-mechanism
- @DRUG$ (e.g., @DRUG$) or	DDI-false
Potential pharmacokinetic interactions have been studied in clinical pharmacokinetic studies ( @DRUG$ , valproate , oral contraceptive , @DRUG$ , warfarin, probenecid) and pharmacokinetic screening in placebo-controlled clinical trials in epilepsy patients.	DDI-false
In patients with chronic hepatitis C treated with PEGASYS in combination with @DRUG$ , @DRUG$ treatment did not affect ribavirin distribution or clearance .	DDI-false
Compounds tested in man include warfarin, @DRUG$, phenytoin, @DRUG$, aminopyrine and antipyrine.	DDI-false
, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen and valproic acid/phenobarbital.	DDI-false
These drugs include the @DRUG$ And other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, @DRUG$ , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .	DDI-false
Tetracyclines: Concomitant treatment with Accutane and @DRUG$ should be avoided because Accutane use has been associated with a number of cases of pseudotumor cerebri (benign intracranial hypertension), some of which involved concomitant use of @DRUG$	DDI-false
- Methotrexate ( e.g. , @DRUG$ The use of methotrexate with sulfapyridine may increase the likelihood of side effects affecting the liver and/or side effects of: @DRUG$	DDI-false
• Co-administration with compounds that are potent CYP3A4 inducers (e.g. phenobarbital, @DRUG$ Dexamethasone, carbamazepine) may lead to decreased plasma levels of @DRUG$.	DDI-mechanism
No pharmacokinetic interactions between dexmedetomidine and @DRUG$ , propofol , @DRUG$ , and midazolam have been demonstrated .	DDI-false
Co-administration of colestipol and @DRUG$ The absorption of vitamin K can be reduced.	DDI-false
While all the selective serotonin reuptake inhibitors ( SSRIs ) , e.g. , citalopram , @DRUG$ , fluoxetine , @DRUG$ , and paroxetine, inhibit P450 2D6, they may vary in extent of inhibition.	DDI-false
Coadministration with compounds that are potent inducers of CYP3A4 (eg, @DRUG$, phenytoin, @DRUG$, carbamazepine) may result in decreased plasma levels of saquinavir.	DDI-false
@DRUG$: Altered serum levels of @DRUG$ (increased and decreased) have been reported in patients receiving concomitant ciprofloxacin.	DDI-false
Higher concentrations of @DRUG$ ( 10(-8 ) - 10(-6 ) M ) or retinyl acetate ( 3 X 10(-8 ) - 10(-7 ) M ) enhance the mitogenic activity of @DRUG$.	DDI-effect
BACKGROUND : The effects of the combined administration of bombsin and verapamil hydrochloride (Verapamil ), a @DRUG$ , on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by @DRUG$ ( AOM ) and the labeling index of intestinal cancers were investigated in male Wistar rats .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, @DRUG$, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Medicines that may alter the plasma concentration of imatinib Drugs that may increase the plasma concentration of imatinib @DRUG$ Plasma concentrations: Caution should be exercised when gleevec is administered with inhibitors of the CYP3A4 family (e.g. ketoconazole, @DRUG$ Erythromycin, clarithromycin, erythromycin, erythromycin, erythromycin.	DDI-false
@DRUG$: @DRUG$ had no clinically significant effect on prothrombin time when administered to patients receiving chronic warfarin treatment.	DDI-false
It is structurally distinct from the other currently available HMGCoA reductase inhibitors (lovastatin, @DRUG$, and @DRUG$), leading to unique biopharmaceutical properties relative to the other agents of this class.	DDI-false
Co-administration of BOTOX and @DRUG$ or other agents interfering with neuromuscular transmission ( e.g. , curare-like compounds ) should only be performed with caution as the effect of the @DRUG$ may be potentiated .	DDI-false
Levosimendan has no clinically important pharmacokinetic interactions with captopril, @DRUG$ , felodipine , digoxin , warfarin , isosorbide mononitrate , @DRUG$ Ethanol or itraconazole.	DDI-false
Both @DRUG$ Nevirapine was compared to triple therapy with PI. @DRUG$ For 48 weeks as initial therapy, with similar response rates observed with nevirapine therapies and superiority with efavirenz.	DDI-false
The hypoglycemic action of @DRUG$ may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , @DRUG$ , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .	DDI-effect
Because of the increased risk of adverse reactions in patients who have regularly taken benzodiazepines, it is particularly important that physicians carefully monitor patients or their guardians. @DRUG$ , @DRUG$ The sedative use of ROMAZICON is intended to be part of the story before any process in which the use of ROMAZICON is planned.	DDI-false
Concomitant administration of Mefloquine and other related compounds (eg, @DRUG$, quinidine and @DRUG$) may produce electrocardiographic abnormalities and increase the risk of convulsions.	DDI-false
@DRUG$ : ( oral agents and insulin ) - dosage adjustment of the @DRUG$ It may be necessary.	DDI-false
In a comparison of digitalis tolerance in dogs anesthetized with ketamine , Innovar Vet , or pentobarbital , the dosage of ouabain needed to cause ventricular tachycardia was significantly higher , as was the LD50 of ouabain , with @DRUG$ or Innovar than with @DRUG$.	DDI-false
Dose adjustment is not recommended.Levetiracetam had no effect on plasma concentrations of @DRUG$, @DRUG$, topiramate, or lamotrigine.	DDI-false
Data from in vitro studies of alprazolam suggest a possible drug interaction with alprazolam for the following : @DRUG$ and @DRUG$.	DDI-false
This drug may interact with @DRUG$ or other CNS depressants (may potentiate the CNS depressant effects of either these medications or @DRUG$), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).	DDI-false
@DRUG$: In healthy individuals, plasma concentrations of atorvastatin increased approximately 40% with coadministration of atorvastatin and @DRUG$, a known inhibitor of cytochrome P450 3A4.	DDI-false
Although the specific drug interaction was not studied in a clinical trial , there have been more than 50 episodes of concomitant use of antifibrinolytic therapies ( i.e. , @DRUG$ , aminocaproic acid ) and @DRUG$.	DDI-false
Agents Causing Renin Release: The antihypertensive effect of enalapril and @DRUG$ IV is augmented by @DRUG$ that cause renin release (e.g., diuretics).	DDI-effect
@DRUG$ and @DRUG$ should not be administered to patients receiving coumarin drugs .	DDI-false
@DRUG$: Dihydroergotamine, @DRUG$, ergotamine, methylergonovine CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
Example inhibitors include @DRUG$, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, @DRUG$, protease inhibitors, quinidine, and verapamil.	DDI-false
These drugs include the thiazides and other @DRUG$ , corticosteroids , @DRUG$ , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .	DDI-false
@DRUG$, Methylxanthines and Diuretics: Concomitant treatment with xanthine derivatives, @DRUG$, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
Both ibogaine and @DRUG$ block @DRUG$-induced and nicotine-induced dopamine release in the nucleus accumbens ;	DDI-effect
Acetaminophen/theophylline, lidocaine/quinidine, @DRUG$/acetaminophen, @DRUG$/valproic acid, quinidine/lidocaine, theophylline/acetaminophen and valproic acid/phenobarbital.	DDI-false
These results would seem to dictate against the clinical use of @DRUG$ with ELSPAR, or during the period following @DRUG$ therapy when plasma asparagine levels are below normal.	DDI-false
Potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies (@DRUG$, @DRUG$, oral contraceptive, digoxin, warfarin, probenecid) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients.	DDI-false
@DRUG$ ; : Simultaneous application of @DRUG$ may lower meclofenamate sodium plasma levels , possibly by competing for protein-binding sites .	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, @DRUG$, @DRUG$ or H1-blocking agents, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , disopyramide , @DRUG$ Amiodarone, quinidine, warfarin, tacrolimus, cyclosporin, @DRUG$ , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
Antihypertensive agents: amiodarone should be used with caution in patients who block -@DRUG$ (e.g. propranolol, CYP3A4 inhibitor) or calcium channel antagonists (e.g. verapamil, @DRUG$ substrate , and diltiazem , a CYP3A4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and AV block ;	DDI-false
Response to @DRUG$ may be enhanced by @DRUG$.	DDI-effect
The successive application of @DRUG$ ( 5 or 10 mg/kg egg weight ( e.w . ) and @DRUG$ 15 mg/kg E.w.) in a 10-minute interval significantly increases the activation of spontaneous mobility of 17-day-old chick embryos compared to the effect of glutamate alone.	DDI-effect
Concomitant administration of @DRUG$ and other related compounds (eg, @DRUG$, quinidine and chloroquine) may produce electrocardiographic abnormalities and increase the risk of convulsions.	DDI-effect
Notably , systemic exposure ( AUC0 - 12 ) of @DRUG$ The DHA was more than doubled in the presence of TMP/@DRUG$.	DDI-false
Antihypertensive medications, other, especially @DRUG$, or pre@DRUG$ and anesthetic agents used in surgery or skeletal-muscle relaxants, nondepolarizing, used in surgery	DDI-false
However , if @DRUG$ ), is after completion of the @DRUG$ The therapy, leave enough time for heparin effect on the aPTT to reduce before starting argatroban therapy.	DDI-false
However, if @DRUG$ is to be initiated after cessation of heparin therapy, allow sufficient time for heparins effect on the aPTT to decrease prior to initiation of @DRUG$ therapy.	DDI-false
To avoid @DRUG$ intoxication, appropriate adjustment of the @DRUG$ should be made.	DDI-false
These drugs include the thiazides and other @DRUG$, corticosteroids, @DRUG$, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
@DRUG$, lidocaine, phenobarbital, quinidine, @DRUG$, and valproic acid were added to pooled human serum at therapeutic concentrations.	DDI-false
Other Cardiovascular Agents : @DRUG$ It was co-administered with beta-adrenerg blockers, methyldopa, nitrates, calcium blockers, hydralazine and enalapril IV. @DRUG$ And digoxin without evidence of clinically significant adverse interactions.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related , systemic , non-Hodgkin lymphoma ( HIV-NHL ) , the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide , doxorubicin , vincristine , and @DRUG$ ( CHOP ) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen ( i.e. , cyclophosphamide , doxorubicin , teniposide , and prednisone with vincristine plus bleomycin ) without receiving @DRUG$ therapy .	DDI-false
The intensity, uniformity and time course of anticoagulant interference by @DRUG$, secobarbital, glutethimide, @DRUG$ and methaqualone were systematically investigated in 16 patients receiving coumarin therapy.	DDI-false
@DRUG$: Amphetamines may antagonize the hypotensive effects of @DRUG$.	DDI-false
Compounds that have been tested in man include @DRUG$ , digoxin , @DRUG$ , theophylline , and warfarin and no clinically meaningful interactions were found .	DDI-false
Tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of @DRUG$ , phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, @DRUG$ , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .	DDI-false
To determine whether injection of thiosulfate would permit larger doses of @DRUG$ to be administered, a fixed 9.9-g/m2 dose of @DRUG$ was given intravenously over three hours concurrently with escalating doses of cisplatin.	DDI-false
- @DRUG$ Using methotrexate with @DRUG$ may increase the chance of side effects affecting the liver and/or the side effects of methotrexate	DDI-false
INOmax has been administered with @DRUG$ , dopamine , dobutamine , steroids , @DRUG$ And high-frequency ventilation.	DDI-false
• Adverse reactions associated with @DRUG$s, such as CNS, heart and systemic (e.g. flu-like) effects may be more severe in elderly patients and may be more severe in the use of @DRUG$ In this population.	DDI-false
Aspirin/@DRUG$: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or @DRUG$ (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of Argatroban 1.5  g/kg/min. over 18 hours).	DDI-false
ACE Inhibitors and @DRUG$ ( Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS , 3020 ( 91 % ) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists ( ACEI/@DRUG$ ) .	DDI-false
Concomitant administration of @DRUG$ and other related compounds (eg, quinine, @DRUG$ and chloroquine) may produce electrocardiographic abnormalities and increase the risk of convulsions.	DDI-effect
These drugs include thiazides and other diuretics, @DRUG$ , phe-nothiazine, thyroid products, @DRUG$ , oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel block drugs, and isoniazid.	DDI-false
Additionally, higher than expected @DRUG$ levels have been observed when they are begun in patients already taking @DRUG$.	DDI-mechanism
Although there are no formal interaction studies except for: @DRUG$ , based on these in vivo and in vitro studies , it is unlikely that co-administration of a 1 mg dose of @DRUG$ This leads to a clinically significant inhibition of the cytochrome P450-mediated metabolism of the other medicines with other medicines.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - @DRUG$: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
@DRUG$ , nondepolarizing ( e.g. , tubocurarine ): possible increased responsiveness to the @DRUG$.	DDI-false
Drugs that cause significant sustained elevation in gastric pH (histamine H2-receptor antagonists such as ranitidine or @DRUG$) may reduce plasma concentrations of @DRUG$ and therefore potentially may reduce efficacy.	DDI-mechanism
Acetaminophen/theophylline, lidocaine/chinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen and @DRUG$/phenobarbital.	DDI-false
ACE Inhibitors and Angiotensin II Receptor Antagonists (Hypertension)- In clinical studies of patients with hypertension, the addition of @DRUG$ 50 to 100 mg to @DRUG$ and angiotensin II receptor antagonists increased mean serum potassium slightly (about 0.09-0.13 mEq/L).	DDI-effect
For example, inhibitors are azole antimycotics, ciprofloxacin, @DRUG$ , diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and @DRUG$.	DDI-false
@DRUG$ , Methylxanthines and @DRUG$ Concomitant treatment with xanthine derivatives, steroids or diuretics may potentiate a potential hypokalemic effect of beta2-agonists.	DDI-false
Garlic Capsules Garlic capsules should not be used while taking @DRUG$ (@DRUG$) as the sole protease inhibitor due to the risk of decreased saquinavir plasma concentrations.	DDI-false
Combination of amiodarone with other @DRUG$ therapy should be reserved for patients with life-threatening ventricular arrhythmias who are incompletely responsive to a single agent or incompletely responsive to @DRUG$.	DDI-false
@DRUG$: When @DRUG$ is administered with aspirin, its protein binding is reduced, although the clearance of free etodolac is not altered.	DDI-false
Antidepressants , @DRUG$ Amphetamines may enhance the activity of tricyclic antidepressants or @DRUG$ ;	DDI-false
Drug-drug interactions have not been observed between @DRUG$ and digoxin or @DRUG$.	DDI-false
Coadministration of @DRUG$ and cyclosporine, tacrolimus or @DRUG$ has led to increased plasma concentrations of the latter three drugs.	DDI-mechanism
The hypoglycemic action of @DRUG$ may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, @DRUG$, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.	DDI-effect
Co-administration of @DRUG$ with Acamprosate produced a 25 % increase in AUC and a 33 % increase in the Cmax of @DRUG$.	DDI-false
This medication can be used with alcohol or other CNS depressants (may potentiate the CNS depressive effect of either these medications or @DRUG$ ) , @DRUG$ or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( MAO ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines ) .	DDI-false
@DRUG$ : The administration of diflunisal to normal volunteers receiving indomethacin decreased the renal clearance and significantly increased the plasma levels of @DRUG$.	DDI-false
The @DRUG$ study dosed subjects with 1200 mg/day of azithromycin (n = 7) (later changed to 600 mg/day [n = 5]) for Days 8 to 21 of a 21-day course of 100 mg, five times/day of @DRUG$.	DDI-false
Central nervous system depressants : the concomitant use of DURAGESIC (Fentanyl transdermal system ) with other central nervous system depressants, including but not limited to other opioids, @DRUG$ , @DRUG$ Anaesthetics (e.g. benzodiazepines), general anaesthetics, phenothiazines, skeletal muscle relaxants and alcohol can cause respiratory depression, hypotension and deep sedation, or possibly lead to coma or death.	DDI-false
@DRUG$ In large quantities, the antiepileptic effect of phenobarbital, phenytoin and @DRUG$ , and increase the frequency of seizures in susceptible paediatric patients.	DDI-effect
These drugs include the thiazides and other @DRUG$ , corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, @DRUG$ ==References====External links==	DDI-false
Clinical implications of @DRUG$ interactions with five @DRUG$.	DDI-int
Central Nervous System Depressants : The concomitant use of DURAGESIC   ( fentanyl transdermal system ) with other @DRUG$ , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and @DRUG$ , respiratory depression, hypotension, and deep sedation, or possibly lead to coma or death.	DDI-false
Antacids: In a clinical pharmacology study, coadministration of an @DRUG$ (@DRUG$, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.	DDI-false
Because Nalfon has not been shown to produce any additional effect beyond that obtained with aspirin alone and because @DRUG$ increases the rate of excretion of @DRUG$, the concomitant use of Nalfon and salicylates is not recommended.	DDI-mechanism
Blood sampling for the pharmacokinetics of @DRUG$ and @DRUG$ was performed on day 1, on weeks 1, 2, 3, and 4, and on months 2, 3, 6, 9, and 12.	DDI-false
@DRUG$ reduce the renal clearance of lithium and add a high risk of @DRUG$ toxicity.	DDI-effect
BACKGROUND : The effects of combined administration of @DRUG$ and verapamil hydrochloride ( verapamil ) , a calcium channel blocker , on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by @DRUG$ The label index for colorectal cancer (AOM) was examined on male Wistar rats.	DDI-false
@DRUG$ (@DRUG$): Cerivastatin plasma concentrations were not affected by co-administration of antacid.	DDI-false
Orlistat-@DRUG$ may decrease the absorption of @DRUG$.	DDI-mechanism
Both @DRUG$ The treatment with nevirapine was compared for 48 weeks with triple therapy with PI indinavir as initial therapy, with similar reactions observed with nevirapine therapies and superiority with @DRUG$.	DDI-false
Other concomitant therapy Although specific interaction studies have not been performed, 1 mg or more of finasteride doses have been co-administered in clinical trials with acetaminophen, acetylsalicylic acid, A-blockers, analgesics, angiotensin converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta-blockers, calcium channel blockers, heart @DRUG$ , diuretics , @DRUG$ , HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also known as NSAIDs) and quinolone anti-infections without evidence of clinically significant adverse interactions.	DDI-false
However, LDL-C reduction was greater when @DRUG$ and @DRUG$ were coadministered than when either drug was given alone.	DDI-effect
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - @DRUG$: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
@DRUG$: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, @DRUG$, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, @DRUG$, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and @DRUG$ without evidence of clinically significant adverse interactions.	DDI-false
In clinical studies conducted with fondaparinux, concomitant use of oral anticoagulants ( warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and @DRUG$ did not significantly affect the pharmacokinetics/pharmacodynamics of @DRUG$.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, @DRUG$, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, @DRUG$, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
The possibility of hypotensive effects with @DRUG$ can be minimized by either discontinuing the diuretic or increasing the salt intake approximately one week prior to initiation of treatment with @DRUG$ (captopril tablets, USP) or initiating therapy with small doses (6.25 or 12.5 mg).	DDI-false
Haemodynamic effects of @DRUG$ and insulin were additive when @DRUG$ was co-administered but not under basal conditions.	DDI-false
In patients receiving Nalfon and a steroid concomitantly , any reduction in @DRUG$ Dosage should be done step by step to avoid possible complications in case of sudden @DRUG$ withdrawal .	DDI-false
Concurrent administration of @DRUG$ The class of MAO inhibitors and antidepressants can cause severe orthostatic hypotension.@DRUG$, an inhibitor of microsomal metabolism, increased altretamine half-life and toxicity in a rat model.	DDI-false
Multivalent Cation-Containing Products: Concurrent administration of a @DRUG$, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminum antacids, sucralfate, VIDEX chewable/buffered tablets or pediatric powder, or products containing calcium, @DRUG$, or zinc may substantially decrease the absorption of ciprofloxacin, resulting in serum and urine levels considerably lower than desired.	DDI-mechanism
@DRUG$ administration to three cancer patients over a dose range of 0.025 mg to 2.2 mg led to a dose-dependent inhibition of antipyrine elimination.14 The effect of alternate-day administration of 0.25 mg of @DRUG$ on drug metabolism in MS patients is unknown .	DDI-false
Antiarrhythmics : @DRUG$ , Bepridil, Flecainide, @DRUG$ , quinidine CONTRAINDICATED due to potential for serious and/or life-threatening reactions .	DDI-false
HIV Protease Inhibitors: Indinavir (800 mg t.i.d.) co-administered with @DRUG$ 10 mg resulted in a 16-fold increase in @DRUG$ AUC, a 7-fold increase in vardenafil Cmax and a 2-fold increase in vardenafil half-life.	DDI-false
Benzthiazide may interact with alcohol, blood thinners, @DRUG$ (allergy, cold, and sinus medicines), diabetic drugs, lithium, @DRUG$, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
Clinical interaction studies with @DRUG$ and warfarin indicated that the coadministration of @DRUG$ with these drugs does not result in clinically- significant drug interactions.	DDI-false
Example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , @DRUG$ , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , @DRUG$ , protease inhibitors, quinidine, and verapamil.	DDI-false
It is structurally distinct from the other currently available HMGCoA reductase inhibitors (@DRUG$, @DRUG$, and pravastatin), leading to unique biopharmaceutical properties relative to the other agents of this class.	DDI-false
Theophylline serum levels should be monitored and appropriate dose adjustments should be considered in patients receiving both patients. @DRUG$ and @DRUG$.	DDI-advise
@DRUG$ (@DRUG$) produces psychotomimetic effects in humans that resemble schizophrenia symptoms.	DDI-false
@DRUG$ As with some other quinolones, co-administration of ciprofloxacin with @DRUG$ It may lead to increased serum concentrations of theophylline and an extension of the elimination half-life.	DDI-false
Multivalent Cation-Containing Products : Simultaneous Application of a @DRUG$ , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , VIDEX chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of @DRUG$ , resulting in serum and urine levels considerably lower than desired .	DDI-false
Possible interactions between Keppra and other medicinal products @DRUG$ (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, @DRUG$ and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies .	DDI-false
In a 12-week endoscopy study conducted in OA patients there was no difference in the cumulative incidence of endoscopic gastroduodenal ulcers in patients taking low-dose (81 mg) enteric coated aspirin plus @DRUG$ 25 mg daily, as compared to those taking @DRUG$ 2400 mg daily alone.	DDI-false
These drugs include the @DRUG$ and other diuretics , corticosteroids , phe-nothiazines , @DRUG$ , estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel block drugs, and isoniazide.	DDI-false
The possibility of hypotensive effects can be minimized by either discontinuing the @DRUG$ or increasing salt intake prior to initiation of treatment with @DRUG$.	DDI-effect
If treatment with inhibitors of CYP3A4 activity (such as @DRUG$, intraconazole, @DRUG$, indinavir, saquinavir, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered.	DDI-false
Multivalent Cation-Containing Products : Concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , @DRUG$ chewable/buffered tablets or pediatric powder , or products containing calcium , @DRUG$ Zinc can significantly reduce the absorption of ciprofloxacin, resulting in serum and urine levels significantly lower than desired.	DDI-false
Like @DRUG$ (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of @DRUG$ and cocaine and the oral self-administration of ethanol and nicotine in rats;	DDI-false
However , caution should be used when administering @DRUG$ with @DRUG$ since these patients are at increased risk of bleeding complications .	DDI-advise
Other Drugs:Drugs such as @DRUG$, disopyramide, @DRUG$, phenothiazines, antihistamines, and tricyclic antidepressants may be associated with QT-interval prolongation and an increased risk of ventricular arrhythmia.	DDI-false
- @DRUG$ (e.g., AquaMEPHYTON, Synkayvite) Use of @DRUG$ with these medicines may increase the chance of side effects affecting the blood	DDI-false
- @DRUG$ (e.g., @DRUG$) Use of sulfapyridine with these medicines may increase the chance of side effects of these medicines	DDI-false
@DRUG$ - can occur with one of the following interactions : - @DRUG$ ( e.g. , Tylenol ) ( with long-term , high-dose use ) or	DDI-int
@DRUG$ : Amiodarone, Bepridil, Flecainide, @DRUG$ , Chinidine CONTRAINDICATES due to the potential for serious and/or life-threatening reactions.	DDI-false
However, a crossover study in healthy subjects receiving either Tagamet 300 mg q.i.d. or 800 mg h.s. concomitantly with a 300 mg b.i.d. dosage of @DRUG$ (Theo-Dur , Key Pharmaceuticals, Inc.) demonstrated less alteration in steady-state @DRUG$ peak serum levels with the 800 mg h.s. regimen, particularly in subjects aged 54 years and older.	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, @DRUG$ and @DRUG$) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, @DRUG$, lamotrigine, phenobarbital, @DRUG$, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
These drugs include the thiazides and other @DRUG$, @DRUG$, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
The availability of potent @DRUG$ NNRTI-based regimens for antiretroviral therapies and concerns about @DRUG$ The (PI)-related metabolic disorders have led to significant shifts in treatment practices in HIV infection.	DDI-false
The pharmacokinetics of @DRUG$ are unaltered in the presence of @DRUG$ and vice versa.	DDI-false
Another oral azole antifungal , ketoconazole , inhibits the metabolism of @DRUG$ , resulting in elevated plasma concentrations of @DRUG$ The active metabolite desmethylastermizole may prolong the QT interval.	DDI-false
Example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , @DRUG$ , isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, @DRUG$ , and verapamil .	DDI-false
Cholestyramine-Concomitant intake of @DRUG$ and vitamin K may reduce the absorption of @DRUG$.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, cyclosporine, @DRUG$, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
The aim of this paper was to establish the interaction between @DRUG$ and both @DRUG$ or its synthetic analogue D-Ala2-metenkephalinamide , or tuftsin , on the antinonciceptive effect of these peptides in mice after intracisternal injection .	DDI-false
- anabolic steroids (Nandrolone [e.g. Anaboline ], @DRUG$ [ e.g. , Anavar ] , oxymetholone [ e.g. , Anadrol ] , @DRUG$ (e.g. Winstrol ]) or	DDI-false
Although no specific studies have been performed, concomitant use with medicinal products primarily metabolised by CYP3A4 (e.g. calcium channel blockers, @DRUG$ , disopyramide , @DRUG$ Amiodarone, quinidine, warfarin, tacrolimus, cyclosporin, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam and triazolam) may have increased plasma concentrations when co-administered with saquinavir;	DDI-false
Earlier studies showed a significant reduction in oral bioavailability of trovafloxacin and @DRUG$ when administered concomitantly with an intravenous opiate such as @DRUG$.	DDI-mechanism
Multivalent Cation-Containing products: Concomitant administration of quinolone, including ciprofloxacin, with multivalent cation-containing products such as magnesium or aluminium antacids, @DRUG$ , VIDEX chewable/buffered tablets or pediatric powder , or products containing @DRUG$ Iron or zinc can significantly reduce the absorption of ciprofloxacin, resulting in significantly lower serum and urine levels than desired.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, @DRUG$, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Use with @DRUG$ The main route to detoxification of azathioprin is inhibited by @DRUG$.	DDI-false
Concurrent administration of drugs possessing nephrotoxic (e.g., aminoglycosides, @DRUG$), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., @DRUG$, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
The aim of this paper was to investigate the interaction between neurotensin and both. @DRUG$ or its synthetic analogue D-Ala2-metenkephalinamide , or @DRUG$ , on the antinonciceptive effect of these peptides in mice after intracisternal injection .	DDI-false
@DRUG$ : Amiodarone should be used with caution in patients receiving   -@DRUG$ blocking agents ( e.g. , propranolol , a CYP3A4 inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a CYP3A4 substrate , and diltiazem , a CYP3A4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and AV block ;	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5 % Ophthalmic Solution , the possibility of an additive or potentiating effect with CNS depressants ( alcohol , @DRUG$ , @DRUG$ , sedatives , anesthetics ) should be considered .	DDI-false
The availability of potent non-nucleoside reverse transcriptase inhibitor (NNRTI)-based regimens for antiretroviral therapy and concerns regarding @DRUG$ (@DRUG$)-related metabolic disturbances have led to significant shifts in treatment practices in HIV infection.	DDI-false
@DRUG$: @DRUG$, bepridil, flecainide, propafenone, quinidine CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	DDI-false
Central nervous system depressants : Co-administration of @DRUG$ Fentanyl transdermal system (Fentanyl transdermal system) with other central nervous system depressants, including but not limited to other opioids, @DRUG$ Hypnosis, sedatives (e.g., benzodiazepines), general anaesthetics, phenothiazines, skeletal muscle relaxants and alcohol, can cause respiratory depression, hypotension and deep sedation, or possibly lead to coma or death.	DDI-effect
Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 @DRUG$ and other antihypertensives may potentiate the hypotension seen with @DRUG$.	DDI-effect
♪ Drugs that can change ♪ @DRUG$ Medicines that may increase the plasma concentration of imatinib: Caution is recommended when administering imatinib @DRUG$ with inhibitors of the CYP3A4 family ( e.g. , ketoconazole , itraconazole , erythromycin , clarithromycin ) .	DDI-false
♪ Drugs that can change ♪ @DRUG$ plasma concentrations Drugs that may increase imatinib plasma concentrations : Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family ( e.g. , ketoconazole , itraconazole , @DRUG$ ,,,,,,,,,,,	DDI-false
Co-medications that induce CYP3A4 (e.g., dexamethasone, phenytoin, carbamazepine, @DRUG$, @DRUG$ or St.	DDI-false
In clinical studies performed with Fondaparinux , the concomitant use of oral anticoagulants ( warfarin ) , @DRUG$ ( acetylsalicylic acid ) , NSAIDs ( @DRUG$ ) , and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium .	DDI-false
If treatment with inhibitors of CYP3A4 activity ( such as @DRUG$ , intraconazole, ritonavir, indinavir, saquinavir, erythromycin, etc.) is indicated, @DRUG$ dose should be considered .	DDI-advise
@DRUG$ Treatment The urinary excretion of amphetamines is increased, and the efficacy is reduced by acidifying agents that are used in @DRUG$ therapy .	DDI-false
Aerosol particles of @DRUG$ were generated from an @DRUG$ Solution, dried, and collected by a cascade impactor for characterization or by a liquid impinger for resolution experiments.	DDI-false
Other strong inhibitors of CYP3A4 (e.g., itraconazole, clarithromycin, nefazodone, @DRUG$, @DRUG$, nelfinavir) would be expected to behave similarly.	DDI-false
Other concomitant therapies: In clinical trials, the safety profile in subjects treated with @DRUG$ concomitantly with anxiolytics, hypnotics and @DRUG$ (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.	DDI-false
Other Drug Interactions: No pharmacokinetic interactions were observed between vardenafil and the following drugs: glyburide, warfarin, @DRUG$, Maalox, and @DRUG$.	DDI-false
acetaminophen/@DRUG$, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/@DRUG$, quinidine/lidocaine, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
@DRUG$ Supplements and @DRUG$ : Fosinopril sodium can attenuate potassium loss caused by thiazide diuretics .	DDI-false
These drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , @DRUG$ , oral contraceptives, phenytoin, @DRUG$ , sympathomimetics , calcium channel blocking drugs , and isoniazid .	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, @DRUG$, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$, doxorubicin, teniposide, and prednisone with vincristine plus bleomycin) without receiving antiretroviral therapy.	DDI-false
Both efavirenz and nevirapine have been compared to triple therapy with the @DRUG$ indinavir over 48 weeks as initial therapy , with similar responses being observed with nevirapine regimens and superiority observed with @DRUG$.	DDI-false
Micro-dosed @DRUG$ Preparations: Micro-dosed @DRUG$ preparations (minipills that do not contain an estrogen) may be an inadequate method of contraception during Accutane therapy.	DDI-false
In addition , @DRUG$ The in vitro glucuronidation of @DRUG$ is not affected.	DDI-false
To evaluate the effects of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL), the authors retrospectively compared a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, tenipoid, and @DRUG$ with vincristine plus @DRUG$ ) without antiretroviral therapy.	DDI-false
Multivitamins, or other products containing iron or zinc, @DRUG$ or sucralfate should not be administered concomitantly with, or within 2 hours of, the administration of norfloxacin, because they may interfere with absorption resulting in lower serum and urine levels of @DRUG$.	DDI-false
Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with @DRUG$ (alcohol, @DRUG$, opiates, sedatives, anesthetics) should be considered.	DDI-false
ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received @DRUG$ or @DRUG$ (ACEI/ARB).	DDI-false
Both efavirenz and @DRUG$ have been compared to triple therapy with the PI indinavir over 48 weeks as initial therapy, with similar responses being observed with nevirapine regimens and superiority observed with @DRUG$.	DDI-false
@DRUG$ : The concomitant administration of diflunisal and naproxen in normal volunteers had no effect on the plasma levels of @DRUG$ , but significantly decreased the urinary excretion of naproxen and its glucuronide metabolite .	DDI-false
Co-administration of naltrexone with @DRUG$ produced a 25% increase in AUC and a 33% increase in the Cmax of @DRUG$.	DDI-false
To evaluate the impact of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin lymphoma (HIV-NHL), the authors compared retrospectively a group of 24 patients with HIV-NHL who were treated with the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients who were treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, teniposide, and @DRUG$ with vincristine plus @DRUG$) without receiving antiretroviral therapy.	DDI-false
Medicines that cause the release of renin : The antihypertensive effect of @DRUG$ Enalapril IV is enhanced by antihypertensive agents that cause the release of renin (e.g. @DRUG$ ) .	DDI-effect
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , @DRUG$ , pimozide , @DRUG$ , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
The risk of a potential interaction between @DRUG$ and @DRUG$ concentrates has not been adequately evaluated in preclinical or clinical studies.	DDI-false
ACE Inhibitors and @DRUG$ (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received @DRUG$ or angiotensin II receptor antagonists (ACEI/ARB).	DDI-false
Drugs that may alter imatinib plasma concentrations Drugs that may increase @DRUG$ plasma concentrations : Caution is recommended when administering Gleevec with inhibitors of the CYP3A4 family ( e.g. , @DRUG$ , itraconazole , erythromycin , clarithromycin ) .	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, @DRUG$ or beta-adrenergic blocking agents, calcium channel blockers, antihistamines or H1-blocking agents, @DRUG$ and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, @DRUG$, nicardipine, propofol, @DRUG$, quinidine, and verapamil.	DDI-false
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, @DRUG$, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these @DRUG$ during placebo-controlled clinical studies.	DDI-false
- Methotrexate (e.g., Mexate) Use of methotrexate with @DRUG$ may increase the chance of side effects affecting the liver and/or the side effects of @DRUG$	DDI-false
Acetaminophen/theophylline, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, @DRUG$/acetaminophen and valproic acid/phenobarbital.	DDI-false
Therefore, the prothrombin time should be used in patients who: @DRUG$ and @DRUG$-like drugs simultaneously .	DDI-advise
The steady state plasma concentrations of @DRUG$ and desipramine have been reported to be increased an average of 31 % and 20 % , respectively , by the concomitant administration of @DRUG$ Tablets at doses up to 4 mg/ day.	DDI-mechanism
@DRUG$ Simultaneous use of low dose aspirin with @DRUG$ may result in an increased rate of GI ulceration or other complications , compared to use of VIOXX alone .	DDI-false
Agents Causing Renin Release: The antihypertensive effect of @DRUG$ and enalapril IV is augmented by antihypertensive agents that cause renin release (e.g., @DRUG$).	DDI-effect
@DRUG$ have been reported to decrease the tubular secretion of @DRUG$ and to potentiate its toxicity.	DDI-mechanism
In addition to the interactions noted above , chronic (   2 weeks ) oral @DRUG$ administration impairs metabolism of @DRUG$ ==References====External links==* Official website	DDI-false
@DRUG$: @DRUG$, ergonovine, ergotamine, methylergonovine CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
Theophylline-related adverse reactions have been reported in patients receiving concomitant therapy with: @DRUG$ and @DRUG$.	DDI-effect
Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, @DRUG$, phenytoin, primidone and @DRUG$) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.	DDI-false
@DRUG$: Concomitant administration of @DRUG$ at 200 mg QD resulted in a two-fold increase in celecoxib plasma concentration.	DDI-false
@DRUG$: In controlled studies in healthy volunteers, bepridil hydrochloride either had no effect (one study) or was associated with modest increases, about 30% (two studies) in steady-state serum @DRUG$ concentrations.	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: @DRUG$ and Ethanol cause additive CNS depression - Tricyclic antidepressants: @DRUG$ increases the effect of Tricyclic antidepressants	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, @DRUG$, antihistamines or H1-blocking agents, @DRUG$ and phenothiazines) might also contribute to a prolongation of the QTc interval.	DDI-false
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including @DRUG$ and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and @DRUG$.	DDI-false
Possible drug interactions between Keppra and other AEDs (carbamazepine, @DRUG$ , lamotrigine, phenobarbital, @DRUG$ , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies .	DDI-false
Iodine or iodine excess may decrease the effect of @DRUG$, and an iodine deficiency can increase the effect of @DRUG$.	DDI-false
Dose adjustment is not recommended.Levetiracetam had no effect on plasma concentrations of @DRUG$, valproate, @DRUG$, or lamotrigine.	DDI-false
@DRUG$ - is a neutralising means for @DRUG$ It protects against kidney damage.	DDI-effect
In patients with mild to moderate hypertension, administration of VIOXX 25 mg daily with @DRUG$ benazepril , 10 to 40 mg for 4 weeks , was associated with an average increase in mean arterial pressure of about 3 mm Hg compared to @DRUG$ alone .	DDI-false
The hypoglycaemic effect of @DRUG$ may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and @DRUG$.	DDI-effect
The hypoglycaemic effect of sulphonylureas can be enhanced by certain drugs, including non-steroidal anti-inflammatory drugs and other drugs that are highly protein bound, salicylates, @DRUG$ , chloramphenicol, probenecid, coumarine, monoamine oxidase inhibitors, and @DRUG$.	DDI-false
The pharmacokinetics of naltrexone and its major metabolite @DRUG$ were unaffected following co-administration with @DRUG$.	DDI-false
Serum lithium levels should be monitored frequently if: @DRUG$ It is given at the same time as @DRUG$.	DDI-advise
@DRUG$ The effect of @DRUG$ type ( CYP2C9 and CYP3A4 substrate) on anticoagulants is almost always observed in patients receiving amiodarone and can lead to severe or fatal bleeding.	DDI-false
Lithium generally should not be given with @DRUG$ because they reduce @DRUG$s renal clearance and add a high risk of lithium toxicity.	DDI-false
Five days of @DRUG$ treatment did not significantly affect steady-state pharmacokinetic variables of @DRUG$ compared with placebo ;	DDI-false
The aim of this paper was to investigate the interaction between neurotensin and both enkephalins or its synthetic analogues. @DRUG$ , or @DRUG$ To the antinonciceptive effect of these peptides in mice after intracistern injection.	DDI-false
Drug/Laboratory Test Interaction After treatment with @DRUG$ A false positive reaction to glucose in the urine can be observed in @DRUG$ tests ( Benedicts solution , Fehlings solution , or Clinitest tablets ) but not with enzyme based tests such as Clinistix and Glucose Enzymatic Test Strip USP .	DDI-false
Two groups (SH/DA; SH/FA) were submitted to daily treatment with synthetic hydroalcoholic solutions containing @DRUG$, @DRUG$, higher alcohols and acetaldehyde in the same proportions as those found in most common distilled and fermented alcoholic beverages;	DDI-false
Acetaminophene: Pharmacokinetic or pharmacodynamic drug-effect interactions between @DRUG$ 162.5 mg orally, 26 and 2 hours before the start of treatment. @DRUG$ 1   g/kg/min . over 4 hours ) or acetaminophen ( 1000 mg orally given 12 , 6 and 0 hours prior to , and 6 and 12 hours subsequent to , initiation of Argatroban 1.5   g/kg/min . over 18 hours ) .	DDI-false
@DRUG$: The concomitant use of DURAGESIC  (fentanyl transdermal system) with other @DRUG$, including but not limited to other opioids, sedatives, hypnotics, tranquilizers (e.g., benzodiazepines), general anesthetics, phenothiazines, skeletal muscle relaxants, and alcohol, may cause respiratory depression, hypotension, and profound sedation, or potentially result in coma or death.	DDI-false
@DRUG$ (@DRUG$)-A drug interaction study of eplerenone with an NSAID has not been conducted .	DDI-false
Sulfapyridine may interact with any of the following: - @DRUG$ (e.g., @DRUG$) (with long-term, high-dose use) or	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, @DRUG$, dapsone, disopyramide, quinine, amiodarone, quinidine, @DRUG$, tacrolimus, cyclosporine, ergot derivatives, pimozide, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
Other medicinal products Interactions oral contraceptives @DRUG$   ( 500 mg twice daily ) did not influence the pharmacokinetics of an oral @DRUG$ containing 0.03 mg ethinyl estradiol and 0.15 mg levonorgestrel , or of the luteinizing hormone and progesterone levels , indicating that impairment of contraceptive efficacy is unlikely .	DDI-false
Data suggest that coadministration of oral @DRUG$ and @DRUG$ The QT interval on the ECG can be extended.	DDI-effect
@DRUG$ Angiotensin II receptor antagonists (Congestive Heart Failure Post-myocardial infarction)- In EPHESUS, 3020 (91%) patients also received INSPRA 25-50 mg. @DRUG$ Angiotensin II receptor antagonists ( ACEI/ ARB).	DDI-false
Omeprazole : The rate and extent of absorption of @DRUG$ • Proquin XR was administered alone or if Proquin XR was administered 2 hours after @DRUG$ at the dose that maximally suppresses gastric acid secretion .	DDI-false
Sinus bradycardia has been reported with oral amiodarone in combination with lidocaine ( @DRUG$ ==References====External links==	DDI-false
Although there are no study data to evaluate the possibility , @DRUG$ , including @DRUG$ Off and nitroglycerin, may have an additive effect with INOmax on the risk of developing methaemoglobinaemia.	DDI-false
- monoamine oxidase inhibitors, and @DRUG$ FORADIL should be used in patients with monoamine oxidase inhibitors or @DRUG$ because the action of formoterol on the cardiovascular system may be potentiated by these agents .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , @DRUG$ , angiotensin-converting enzyme ( ACE ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , H2 antagonists , HMG-CoA reductase inhibitors , @DRUG$ ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
The hypoglycemic action of @DRUG$ may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , @DRUG$ Chloramphenicol, probenecid, coumarine, monoamine oxidase inhibitors and beta-adrenergic blockers.	DDI-effect
@DRUG$ had no significant effect on @DRUG$ pharmacokinetics.	DDI-false
ANTACID ( @DRUG$ ): @DRUG$ plasma concentrations were not affected by co-administration of antacid .	DDI-false
BACKGROUND: The effects of combined administration of bombesin and verapamil hydrochloride (@DRUG$), a @DRUG$, on the incidence of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane (AOM) and the labeling index of intestinal cancers were investigated in male Wistar rats.	DDI-false
This drug may interact with alcohol or other CNS depressants ( may potentiate the CNS depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( MAO ) inhibitors ( concurrent use with @DRUG$ may prolong and intensify the anticholinergic and CNS depressant effects of @DRUG$ ) .	DDI-false
In patients receiving @DRUG$ and a steroid concomitantly , any reduction in @DRUG$ dosage should be gradual in order to avoid the possible complications of sudden steroid withdrawal .	DDI-false
Erythromycin: In healthy individuals, plasma concentrations of @DRUG$ increased approximately 40% with coadministration of atorvastatin and @DRUG$, a known inhibitor of cytochrome P450 3A4.	DDI-false
Aspirin/Acetaminophen: Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered aspirin (162.5 mg orally given 26 and 2 hours prior to initiation of Argatroban 1  g/kg/min. over 4 hours) or @DRUG$ (1000 mg orally given 12, 6 and 0 hours prior to, and 6 and 12 hours subsequent to, initiation of @DRUG$ 1.5  g/kg/min. over 18 hours).	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, estrogens, oral contraceptives, @DRUG$, nicotinic acid, sympathomimet-ics, @DRUG$, and isoniazid.	DDI-false
This drug may interact with alcohol or other @DRUG$ (may increase the CNS depressive effect of either these drugs or antihistamines), anticholinergics or other drugs with anticholinergic activity (anticholinergic effects may be intensified if these drugs are concomitantly administered with @DRUG$ ) , and monoamine oxidase ( MAO ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines ) .	DDI-false
@DRUG$: Indinavir (800 mg t.i.d.) co-administered with Vardenafil 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in vardenafil Cmax and a 2-fold increase in @DRUG$ half-life.	DDI-false
Corticosteroids, @DRUG$ and @DRUG$: Concomitant treatment with xanthine derivatives, steroids, or diuretics may potentiate a possible hypokalemic effect of  beta2-agonists.	DDI-false
@DRUG$ : The concomitant use of DURAGESIC   ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , @DRUG$ , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	DDI-false
@DRUG$: The concomitant use of Bepridil and @DRUG$ has been well tolerated in patients with stable angina.	DDI-false
These drugs include the thiazides and other diuretics, corticosteroids, phe-nothiazines, @DRUG$, estrogens, oral contraceptives, phenytoin, @DRUG$, sympathomimet-ics, calcium channel blocking drugs, and isoniazid.	DDI-false
@DRUG$ @DRUG$   ( 1500 mg twice daily ) did not alter the pharmacokinetics of valproate in healthy volunteers .	DDI-false
Other concomitant therapies : In clinical trials , the safety profile in subjects treated with Acamprosate concomitantly with @DRUG$ , hypnotics and @DRUG$ ( including benzodiazepines ) , or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications .	DDI-false
"John s Spice") may increase the formation of @DRUG$ , a metabolite of @DRUG$ ==References====External links==	DDI-false
@DRUG$ : In some patients , the administration of a @DRUG$ can reduce the diuretic , natriuretic , and antihypertensive effects of loop , potassium-sparing and thiazide diuretics .	DDI-false
Warfarin : @DRUG$ 3 mg administered daily for 5 days did not affect the pharmacokinetics of (R) or (S) warfarin, nor did there be changes in the pharmacodynamic profile (prothrombin time) after a single oral dose of 25 mg @DRUG$	DDI-false
@DRUG$ Including coumarin derivatives, indandion derivatives and platelet aggregation inhibitors such as non-steroidal anti-inflammatory drugs (NSAIDs) and aspirin may increase the risk of bleeding when administered at the same time as @DRUG$.	DDI-effect
Levosimendan has no clinically important pharmacokinetic interactions with @DRUG$ , beta-blockers , felodipine , digoxin , @DRUG$ , isosorbide mononitrate, knitztilol, ethanol or itraconazole.	DDI-false
@DRUG$, nondepolarizing (e.g., tubocurarine): possible increased responsiveness to the @DRUG$.	DDI-false
The pressor effects of catecholamines such as @DRUG$ or @DRUG$ The Bretylium tosylate is reinforced by the Bretylium tosylate.	DDI-false
acetaminophen/theophylline, lidocaine/@DRUG$, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/@DRUG$, theophylline/acetaminophen, and valproic acid/phenobarbital.	DDI-false
The continued need for the other @DRUG$ The active substance should be reviewed after the effects of: @DRUG$ have been established , and discontinuation ordinarily should be attempted .	DDI-false
Hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose @DRUG$ and antineoplastic agents, specifically, dacarbazine, cis-platinum, @DRUG$ and interferon-alfa.	DDI-effect
Drug-Drug Interactions Between Keppra  And Other @DRUG$ (@DRUG$) Phenytoin Keppra  (3000 mg daily) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy.	DDI-false
Pretreatment of healthy volunteers with multiple doses of rifampin followed by a single dose of @DRUG$, increased @DRUG$ oral-dose clearance by 3.8-fold, which significantly (p 0.05) decreased mean cmax and AUC(0-8).	DDI-false
In addition, fondaparinux did not affect the pharmacodynamics of warfarin, @DRUG$ , piroxicam, and digoxin, nor the pharmacokinetics of @DRUG$ at steady state .	DDI-false
Other Drug Interactions Oral Contraceptives @DRUG$   ( 500 mg twice daily ) did not influence the pharmacokinetics of an oral contraceptive containing 0.03 mg @DRUG$ The decisive factor for impairment of the efficacy of contraception is impairment of levonorgestrel and 0.15 mg levonorgestrel or luteinisation hormone and progesterone levels.	DDI-false
MAO inhibitors MAOI antidepressants, as well as a metabolite of @DRUG$, slow @DRUG$ metabolism.	DDI-mechanism
These results suggest that both dexamethasone and retinyl acetate, and possibly other glucocorticoids and @DRUG$, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and @DRUG$.	DDI-effect
Concurrent administration of drugs possessing nephrotoxic (e.g., @DRUG$, @DRUG$), myelotoxic (e.g., cytotoxic chemotherapy), cardiotoxic (e.g., doxorubicin) or hepatotoxic (e.g., methotrexate, asparaginase) effects with PROLEUKIN may increase toxicity in these organ systems.	DDI-false
To assess the effect of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL), the authors retrospectively compared a group of 24 patients with HIV-NHL treated with cyclophosphamide, doxorubicin, @DRUG$ , and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, @DRUG$ , and prednisone with vincristine plus bleomycin ) without receiving antiretroviral therapy .	DDI-false
Since the therapeutic range of @DRUG$ is narrow theophylline serum levels should be monitored closely, and appropriate dosage adjustments of @DRUG$ should be made.	DDI-false
Antacids : In a clinical pharmacology study, the concomitant use of antacids ( @DRUG$ , magnesium hydroxide , and simethicone ) with @DRUG$ reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .	DDI-mechanism
Sine bradycardia was associated with oral amiodarone in combination with @DRUG$ ( @DRUG$ substrate ) given for local anesthesia .	DDI-false
The effect of rifampin on the warfarin requirement of our patient appeared to be maximal 5 to 7 days after the initiation of @DRUG$ and extended a similar length of time after @DRUG$ withdrawal.	DDI-false
Norepinephrine: @DRUG$ enhance the adrenergic effect of @DRUG$.	DDI-effect
Combination of @DRUG$ with other antiarrhythmic therapy should be reserved for patients with life-threatening ventricular arrhythmias who are incompletely responsive to a single agent or incompletely responsive to @DRUG$.	DDI-false
Non-selective MAO inhibitors including tranylcypromine sulfate , phenelzine sulfate , and @DRUG$ HC1 : Simultaneous application of @DRUG$ and non-selective MAO inhibitors may cause hypertension .	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, @DRUG$, erythromycin, imatinib, isoniazid, @DRUG$, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
MAO Inhibitors: @DRUG$  is not recommended for use in patients who have received @DRUG$ within 14 days because severe and unpredictable potentiation by MAO inhibitors has been reported with opioid analgesics	DDI-advise
Although there are no study data to evaluate the possibility, @DRUG$, including sodium nitroprusside and @DRUG$, may have an additive effect with INOmax on the risk of developing methemoglobinemia.	DDI-false
@DRUG$: @DRUG$ blocks dopamine receptors, thus inhibiting the central stimulant effects of amphetamines.	DDI-false
In clinical studies performed with Fondaparinux , the concomitant use of oral @DRUG$ ( warfarin ) , platelet inhibitors ( acetylsalicylic acid ) , @DRUG$ Piroxicam and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Haemodynamic effects of @DRUG$ and @DRUG$ were additive when somatostatin was co-administered but not under basal conditions.	DDI-false
@DRUG$, Methylxanthines and Diuretics: Concomitant treatment with xanthine derivatives, steroids, or diuretics may potentiate a possible hypokalemic effect of  @DRUG$	DDI-false
This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, @DRUG$, antihistamines or H1-blocking agents, tricyclic antidepressants and @DRUG$) might also contribute to a prolongation of the QTc interval.	DDI-false
Guardians of children who have been prescribed @DRUG$ should be alerted to the general concern regarding asthma therapy compliance, especially neglect of anti-inflammatory therapy and overuse of @DRUG$.	DDI-false
To evaluate the effects of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma ( HIV-NHL), the authors retrospectively compared a group of 24 patients with HIV-NHL treated with the cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or a CHOP-like regimen (i.e. cyclophosphamide), @DRUG$ , teniposide , and prednisone with vincristine plus bleomycin ) without receiving @DRUG$ therapy .	DDI-false
Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with @DRUG$, phenothiazines, @DRUG$, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.	DDI-false
The administration of local anesthetic solutions containing epinephrine or @DRUG$ to patients receiving @DRUG$, tricyclic antidepressants or phenothiazines may produce severe, prolonged hypotension or hypertension.	DDI-effect
Antihypertensives: Amiodarone should be used with caution in patients receiving  -receptor blocking agents (e.g., propranolol, a CYP3A4 inhibitor) or calcium channel antagonists (e.g., @DRUG$, a CYP3A4 substrate, and diltiazem, a @DRUG$ inhibitor) because of the possible potentiation of bradycardia, sinus arrest, and AV block;	DDI-false
Because of the increased risk of adverse reactions in patients who have been taking @DRUG$ At regular intervals, it is particularly important that doctors carefully monitor patients or their guardians. @DRUG$ , alcohol and sedative use as part of the history prior to any procedure in which the use of ROMAZICON is planned .	DDI-false
Potassium-sparing diuretics (e.g. spironolactone, @DRUG$ , or amilorid), @DRUG$ Supplements or salt substitutes containing potassium may lead to significant increases in serum potassium.	DDI-false
SINCE THE CONCOMITANT ADMINISTRATION OF THESE TWO DRUGS CAN LEAD TO PHENYTOIN INTOXICATION, PRIOR TO ADMINISTERING @DRUG$ TO A PATIENT ON PHENYTOIN THERAPY, A BASELINE @DRUG$ SERUM LEVEL SHOULD BE OBTAINED.	DDI-false
@DRUG$ Isoniazide is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to co-administration with Isoniazide, signs and symptoms of carbamazepine toxicity should be closely monitored, and appropriate dose adjustment of the @DRUG$ It should be done.	DDI-false
acetaminophen/@DRUG$, lidocaine/quinidine, phenobarbital/acetaminophen, phenobarbital/valproic acid, quinidine/lidocaine, @DRUG$/acetaminophen, and valproic acid/phenobarbital.	DDI-false
Injection : @DRUG$ injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , MAO inhibitors , and other @DRUG$.When scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .	DDI-effect
At steady state, @DRUG$ 50 mg once daily had no effect on the anti-platelet activity of low-dose (81 mg once daily) @DRUG$, as assessed by ex vivo platelet aggregation and serum TXB2 generation in clotting blood.	DDI-false
In addition, @DRUG$ neither influenced the pharmacodynamics of @DRUG$, acetylsalicylic acid, piroxicam, and digoxin, nor the pharmacokinetics of digoxin at steady state.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with @DRUG$ , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ACE ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac @DRUG$ , diuretics , H2 antagonists , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
Drug Interactions: Flupenthixol may interact with some drugs, like @DRUG$ (MAOI): @DRUG$ could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Another oral azole antifungal, ketoconazole, inhibits the metabolism of @DRUG$, resulting in elevated plasma concentrations of astemizole and its active metabolite @DRUG$ which may prolong QT intervals.	DDI-false
@DRUG$ : Because @DRUG$ does not affect the pharmacokinetics of antipyrine , interactions with other drugs metabolized via the same cytochrome isozymes are not expected .	DDI-false
@DRUG$/Acetaminophen : Pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between Argatroban and concomitantly administered @DRUG$ ( 162.5 mg orally administered 26 and 2 hours before the start of argatroban 1 g/kg/min for 4 hours) or acetaminophen ( 1000 mg orally administered 12, 6 and 0 hours before and 6 and 12 hours after the start of argatroban 1.5 g/kg/min for 18 hours).	DDI-false
Erythromycin : In healthy individuals , plasma concentrations of atorvastatin increased approximately 40 % with coadministration of @DRUG$ and @DRUG$ A known inhibitor of cytochrome P450 3A4.	DDI-mechanism
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - @DRUG$ - Eproxindine - @DRUG$: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Benzthiazide may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, @DRUG$, NSAIDs like @DRUG$ or Ibuprofen, and high blood pressure medications.	DDI-false
Antihypertensive agents: amiodarone should be used with caution in patients who block -@DRUG$ (e.g. propranolol, CYP3A4 inhibitor) or @DRUG$ • antagonists (e.g. verapamil, a CYP3A4 substrate and diltiazem, a CYP3A4 inhibitor) because of the potential for bradycardia, sinus arrest and AV block;	DDI-false
Central nervous system depressants: Concomitant use of DURAGESIC (Fentanyl transdermal system) with others @DRUG$ , including but not limited to other opioids, sedatives, hypnotic agents, sedatives (e.g. benzodiazepines), generally @DRUG$ , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .	DDI-false
Bacteriostatic Antibiotics: @DRUG$, erythromycins, @DRUG$, or tetracyclines may interfere with the bactericidal effect of penicillins.	DDI-false
BACKGROUND : The effects of combined administration of @DRUG$ and verapamil hydrochloride ( @DRUG$ A calcium channel blocker, the incidence of peritoneal metastasis of intestinal adenocarcinoma induced by azoxymethane (AOM) and the index of colorectal cancers were studied in male Wistar rats.	DDI-false
Amiodarone taken concomitantly with procainamide for less than seven days increases plasma concentrations of @DRUG$ and n-acetyl @DRUG$ by 55% and 33%, respectively.	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , @DRUG$ , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with @DRUG$ ;	DDI-mechanism
; Naproxen : Simultaneous use of @DRUG$ and naproxen in normal volunteers had no effect on the plasma levels of @DRUG$ , but significantly decreased the urinary excretion of naproxen and its glucuronide metabolite .	DDI-false
@DRUG$ : Coadministration of single doses of eszopiclone 3 mg and @DRUG$ 2 mg did not have clinically relevant effects on the pharmacodynamics or pharmacokinetics of either drug .	DDI-false
Other Cardiovascular Agents: Enalapril and enalapril IV have been used concomitantly with @DRUG$, @DRUG$, nitrates, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.	DDI-false
The management of the local @DRUG$ • Epinephrine or norepinephrine for patients who have monoamine oxidase inhibitors, tricyclic antidepressants, or @DRUG$ may produce severe , prolonged hypotension or hypertension .	DDI-effect
Additive adverse effects resulting from cholinergic blockade may occur when @DRUG$ It is co-administered with other antimuscarinics, @DRUG$ , haloperidol , phenothiazines , monoamine oxidase ( MAO ) inhibitors , tricyclic antidepressants or some antihistamines .	DDI-effect
The mean percentage increase in the @DRUG$ AUC after @DRUG$ administration was 56.9% (range: 35 to 81).	DDI-mechanism
Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect @DRUG$ pharmacodynamics - @DRUG$ - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ACE ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , @DRUG$ , @DRUG$ Prostaglandin synthetase inhibitors (also known as NSAIDs) and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral @DRUG$ (warfarin), platelet inhibitors (acetylsalicylic acid), @DRUG$ (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
HIV Protease Inhibitors : Indinavir ( 800 mg t.i.d . ) co-administered with @DRUG$ 10 mg resulted in a 16-fold increase in @DRUG$ AUC, a 7-fold increase in vardenafil Cmax and a 2-fold increase in vardenafil half-life.	DDI-false
@DRUG$ For normal volunteers, a small decrease of the @DRUG$ levels was observed when multiple doses of diflunisal and aspirin were administered concomitantly .	DDI-false
The use of local anesthetics containing epinephrine, or @DRUG$ to patients receiving @DRUG$ , tricyclic antidepressants or phenothiazines may produce severe , prolonged hypotension or hypertension .	DDI-effect
At a median follow-up of 33 months, the combination of ARIMIDEX and @DRUG$ did not demonstrate any efficacy benefit when compared with @DRUG$ in all patients as well as in the hormone receptor-positive subpopulation.	DDI-false
In addition , Fondaparinux neither influenced the pharmacodynamics of warfarin , acetylsalicylic acid , @DRUG$ , and digoxin, nor the pharmacokinetics of @DRUG$ At Steady State.	DDI-false
The possibility of hypotensive effects with captopril can be minimized by either discontinuing the @DRUG$ or increasing the salt intake approximately one week prior to initiation of treatment with captopril (@DRUG$ tablets, USP) or initiating therapy with small doses (6.25 or 12.5 mg).	DDI-false
Barbiturates and @DRUG$ should not be administered to patients receiving @DRUG$.	DDI-advise
DIGOXIN : Plasma @DRUG$ levels and @DRUG$ clearance at steady-state were not affected by co-administration of 0.2 mg cerivastatin sodium .	DDI-false
Other concomitant therapy Although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , @DRUG$ , anticonvulsants, benzodiazepines, beta-blockers, calcium channel blockers, cardiac nitrates, diuretics, H2 antagonists, @DRUG$ , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
Although @DRUG$ @DRUG$-induced side effects such as fever, renal insufficiency, hyperbilirubinaemia, confusion and dyspnoea have been shown to be reduced, concomitant administration of these agents with PROLEUKIN may reduce the efficacy of PROLEUKIN against the tumour and should therefore be avoided. 12 beta-blockers and other antihypertensive agents may increase hypotension in PROLEUKIN.	DDI-effect
Antiarrhythmics : Other antiarrhythmic drugs , such as quinidine , procainamide , @DRUG$ , and @DRUG$ , were used simultaneously with amiodarone.	DDI-false
Based on the chemical resemblance of @DRUG$ and ketoconazole , coadministration of @DRUG$ Itraconazole is contraindicated.	DDI-false
In these patients whose hypertension was controlled with @DRUG$, @DRUG$ 20 mg produced mean additional supine systolic/diastolic blood pressure reductions of 6/5 mm Hg compared to placebo.	DDI-effect
Therefore , interactions could occur following concomitant administration of psychotropic drugs ( e.g. , narcotics , analgesics , antiemetics , @DRUG$ , @DRUG$ ) .	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, clarithromycin, diclofenac, @DRUG$, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, @DRUG$, protease inhibitors, quinidine, and verapamil.	DDI-false
Probenecid : May cause renal tubular secretion of @DRUG$ This resulted in increased blood levels and/ or @DRUG$ toxicity .	DDI-false
Tagamet, apparently due to an effect on certain microsomal enzyme systems, has been reported to reduce hepatic metabolism @DRUG$ , phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain @DRUG$ , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .	DDI-false
@DRUG$: Dihydroergotamine, ergonovine, @DRUG$, methylergonovine CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
Antiarrhythmics: Other @DRUG$ drugs, such as quinidine, procainamide, @DRUG$, and phenytoin, have been used concurrently with amiodarone.	DDI-false
The intensity, uniformity and time course of the anticoagulant interference by @DRUG$ , secobarbital, glutethimide, chloralhydrate and @DRUG$ The treatment was systematically studied in 16 patients receiving coumarin therapy.	DDI-false
Cyclosporine : Administration of @DRUG$ concomitantly with @DRUG$ has been associated with an increase in cyclosporine-induced toxicity , possibly due to decreased synthesis of renal prostacyclin .	DDI-mechanism
Anticoagulant inhibition was observed during the administration of @DRUG$, @DRUG$ and glutethimide;	DDI-false
@DRUG$ Other antiarrhythmic drugs, such as quinidine, procainamide, disopyramide and phenytoin, were used at the same time as @DRUG$.	DDI-false
@DRUG$ Rofecoxib 75 mg once daily for 11 days does not alter the plasma concentration profile or renal elimination of @DRUG$ After a single dose of 0.5 mg for oral use.	DDI-false
Anticholinesterases (neostgmine, @DRUG$ ) , @DRUG$ , quinine , procainamide can enhance toxicity and cause cardio respiratory depression .	DDI-false
Antiarrhythmia: amiodarone, bepridil, @DRUG$ , @DRUG$ , Chinidine CONTRAINDICATES due to the potential for serious and/or life-threatening reactions.	DDI-false
Drug Interaction During Pregnancy: @DRUG$ and @DRUG$ were studied following subcutaneous injections in pregnant mice.	DDI-false
Compounds that have been tested in man include antipyrine, digoxin, @DRUG$, @DRUG$, and warfarin and no clinically meaningful interactions were found.	DDI-false
No pharmacokinetic interactions between dexmedetomidine and @DRUG$, @DRUG$, alfentanil, and midazolam have been demonstrated.	DDI-false
Cyclosporine, Digoxin, Methotrexate @DRUG$, like other NSAIDs, through effects on renal prostaglandins, may cause changes in the elimination of these drugs leading to elevated serum levels of cyclosporine, digoxin, @DRUG$, and increased toxicity.	DDI-mechanism
These drugs include thiazides and other diuretics, corticosteroids, phe-nothiazines, thyroid products, @DRUG$ , oral @DRUG$ , phenytoin , nicotinic acid , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .	DDI-false
@DRUG$: Alcohol (0.5 g/kg body weight: approximately 40 mL of absolute alcohol in a 70 kg person) and @DRUG$ plasma levels were not altered when dosed simultaneously.	DDI-false
Both @DRUG$ and its major metabolite , @DRUG$ These are inhibitors of the cytochrome P450 3A4 enzyme system.	DDI-false
These drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , @DRUG$ , nicotinic acid , @DRUG$ , calcium channel block drugs, and isoniazid.	DDI-false
Patients receiving both @DRUG$ and furosemide should be observed closely to determine if the desired diuretic and/or antihypertensive effect of @DRUG$ is achieved.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, @DRUG$ doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, @DRUG$, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, @DRUG$, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as @DRUG$), and quinolone anti-infectives without evidence of clinically significant adverse interactions.	DDI-false
@DRUG$: @DRUG$ are known to cause osteoporosis.	DDI-false
Levosimendan has no clinically important pharmacokinetic interactions with captopril, @DRUG$ , felodipine, digoxin, @DRUG$ , isosorbide mononitrate, knitztilol, ethanol or itraconazole.	DDI-false
Additive adverse effects resulting from cholinergic blockade may occur when @DRUG$ It is used at the same time as others. @DRUG$ , amantadine , haloperidol , phenothiazines , monoamine oxidase ( MAO ) inhibitors , tricyclic antidepressants or some antihistamines .	DDI-effect
Like ibogaine (40 mg/kg), @DRUG$ (40 mg/kg) decreases the intravenous self-administration of @DRUG$ and cocaine and the oral self-administration of ethanol and nicotine in rats;	DDI-false
Consequently , drugs with a low therapeutic margin , such as vitamin K antagonists , @DRUG$ , and @DRUG$ , delayed elimination and elevation of their serum half-life could lead to a toxic level.	DDI-false
- Antidiabetics, oral (diabetes medicine you take by mouth) Use of oral @DRUG$ with sulfapyridine may increase the chance of side effects affecting the blood and/or the side effects or oral @DRUG$	DDI-false
METHODS: From the beginning of the experiment, rats were given 10 weekly subcutaneous injections of AOM (7.4 mg/kg body weight) and subcutaneous injections of @DRUG$ (40 microg/kg body weight) every other day, and from week 16, intraperitoneal injections of @DRUG$ (10 or 20 mg/kg body weight) every other day until the end fo the experiment in week 45.	DDI-false
OTHER CONCOMITANT THERAPY: Although specific interaction studies were not performed, in clinical studies, cerivastatin sodium was used concomitantly with angiotensin- converting enzyme (ACE) inhibitors, betablockers, @DRUG$, diuretics, and nonsteroidal anti-inflammatory drugs (@DRUG$) without evidence of clinically significant adverse interactions.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, @DRUG$, @DRUG$, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, and verapamil.	DDI-false
In vitro data suggest that @DRUG$ , when compared to ketoconazole , has a less pronounced effect on the biotransformation system responsible for the metabolism of @DRUG$.	DDI-mechanism
- @DRUG$ (e.g., @DRUG$) or	DDI-false
Short-term pharmacokinetic studies have demonstrated that concomitant administration of @DRUG$ and @DRUG$  (etodolac capsules and tablets) results in reduced protein binding of warfarin, but there was no change in the clearance of free warfarin.	DDI-mechanism
When @DRUG$ was coadministered with phenytoin, @DRUG$, or H2antagonists, reduced plasma concentrations of itraconazole were reported.	DDI-mechanism
Other cardiovascular agents: Enalapril and Enalapril IV were associated with beta-adrenergic blocking agents, methyldopa, nitrates, calcium-blocking agents, @DRUG$ , prazosin and @DRUG$ Without evidence of clinically significant adverse interactions.	DDI-false
Benzthiazide may interact with @DRUG$, blood thinners, @DRUG$ (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.	DDI-false
There have been reports of @DRUG$-related side effects in patients on concomitant therapy with @DRUG$ and theophylline.	DDI-false
Ergot Derivatives: Dihydroergotamine, @DRUG$, @DRUG$, methylergonovine CONTRAINDICATED due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues.	DDI-false
Exposure from the proposed topical dose is about 1% of that from the 100 mg oral dose, even when co-administered with @DRUG$/@DRUG$.	DDI-false
Drugs Interactions : Flupentixol may interact with some drugs, such as monoamine oxidase inhibitors (MAOI): MAOI may theoretically affect flupentixol pharmacodynamics - @DRUG$ - Eproxindine - @DRUG$ : Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants : Flupenthixol increases the effect of Tricyclic antidepressants	DDI-false
Antihypertensives : Amiodarone should be used with caution in patients receiving   -receptor blocking agents ( e.g. , propranolol , a CYP3A4 inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a @DRUG$ substrate , and @DRUG$ , a CYP3A4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and AV block ;	DDI-false
When LEVSIN is co-administered with others @DRUG$ , amantadine , haloperidol , phenothiazines , @DRUG$ , tricyclic antidepressants or some antihistamines.	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral @DRUG$ (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (@DRUG$), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
Poor metabolizers have higher than expected plasma concentrations of @DRUG$ (@DRUG$) when given usual doses.	DDI-false
Although specific studies have not been performed , coadministration with drugs that are mainly metabolized by CYP3A4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , @DRUG$ , @DRUG$ , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;	DDI-false
Monitoring for @DRUG$ toxicity and serial measurement of @DRUG$ serum concentration during concomitant protease inhibitor therapy should be considered .	DDI-false
@DRUG$-@DRUG$ may decrease the absorption of vitamin K.	DDI-false
@DRUG$ (5 mg/kg), moclobemide (30 mg/kg), clonazepam (0.25 mg/kg), @DRUG$ (20 mg/kg) sertraline (30 mg/kg) or vehicle was administered.	DDI-false
MAO Inhibitors : DURAGESIC   is not recommended for use in patients who have received @DRUG$ Within 14 days, because of severe and unpredictable potentialation by @DRUG$ Opioid analgesics have been reported	DDI-false
Concurrent use with @DRUG$ or other drugs significantly eliminated by active renal tubular secretion may result in increased plasma concentrations of @DRUG$.	DDI-mechanism
@DRUG$ It was used with tolazolin, dopamine, dobutamine, @DRUG$ , surfactant , and high-frequency ventilation .	DDI-false
These drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , @DRUG$ , estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, @DRUG$ ==References====External links==	DDI-false
In addition, we have shown that @DRUG$ is a useful pharmacological tool with which to examine the @DRUG$-mediated responses of megakaryocytes .	DDI-false
In rats, simultaneous ingestion of @DRUG$ and nitrite in the diet for 78 weeks has been reported to cause tumors, and it has been suggested that @DRUG$ may react with nitrites in the rat stomach to form a nitrosamine, which is tumorigenic.	DDI-false
Although specific studies have not been performed, coadministration with drugs that are mainly metabolized by CYP3A4 (eg, calcium channel blockers, dapsone, disopyramide, quinine, amiodarone, quinidine, warfarin, tacrolimus, @DRUG$, ergot derivatives, @DRUG$, carbamazepine, fentanyl, alfentanyl, alprazolam, and triazolam) may have elevated plasma concentrations when coadministered with saquinavir;	DDI-false
To evaluate the effects of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL), the authors retrospectively compared a group of 24 patients with HIV-NHL treated with cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or a CHOP-like regimen (i.e., @DRUG$ , @DRUG$ , teniposide, and prednisone with vincristine plus bleomycin) without antiretroviral therapy.	DDI-false
These drugs include the @DRUG$ and other diuretics, corticosteroids, phenothiazines, thyroid products, @DRUG$, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.	DDI-false
Concomitant use with @DRUG$s may result in the reduced absorption of @DRUG$.	DDI-false
Antacids : In a clinical pharmacology study, the concomitant use of a @DRUG$ (aluminium hydroxide, magnesium hydroxide and simethicone) with fosinopril reduced serum levels and urinary excretion of @DRUG$ In comparison to Fosinopril alone, which suggests that antacids may affect the absorption of Fosinopril.	DDI-false
- @DRUG$ ( e.g. , @DRUG$ ) or	DDI-false
Other concomitant therapy Although specific interaction studies have not been performed, @DRUG$ Doses of 1 mg or more were co-administered in clinical trials with acetaminophene, acetylsalicylic acid, A-blockers, analgesics, angiotensin converting enzyme (ACE) inhibitors, anticonvulsants, @DRUG$ , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , H2 antagonists , HMG-CoA reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as NSAIDs ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .	DDI-false
Cardiovasculars : @DRUG$ : In patients receiving digoxin therapy , administration of oral amiodarone regularly results in an increase in serum @DRUG$ Concentration that can achieve toxic values with resulting clinical toxicity.	DDI-false
Colestipol: Plasma concentrations of atorvastatin decreased approximately 25% when @DRUG$ and @DRUG$ were coadministered.	DDI-mechanism
Aspirin: In normal volunteers, a small decrease in @DRUG$ levels was observed when multiple doses of diflunisal and @DRUG$ were administered concomitantly.	DDI-false
In the first study, concomitant administration of 0.2 mg @DRUG$ and 12 g cholestyramine resulted in decreases of more than 22% for AUC and 40% for Cmax when compared to dosing @DRUG$ alone.	DDI-false
Example inhibitors include azole antifungals, ciprofloxacin, @DRUG$, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, @DRUG$, protease inhibitors, quinidine, and verapamil.	DDI-false
@DRUG$ and @DRUG$ resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.	DDI-false
@DRUG$ does not affect serum @DRUG$ levels.	DDI-false
Similarly dialyzed were @DRUG$ , quinidine , and theophylline , both alone at therapeutic concentrations in serum and with @DRUG$ At three different serum concentrations.	DDI-false
Suppression by @DRUG$ of @DRUG$-enhanced peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane in wistar rats.	DDI-effect
However, a crossover study in healthy subjects receiving either Tagamet 300 mg q.i.d. or 800 mg h.s. concomitantly with a 300 mg b.i.d. dosage of @DRUG$ (@DRUG$ , Key Pharmaceuticals, Inc.) demonstrated less alteration in steady-state theophylline peak serum levels with the 800 mg h.s. regimen, particularly in subjects aged 54 years and older.	DDI-false
The hypoglycemic effect of @DRUG$ has been reported to increase when @DRUG$ is given concurrently.	DDI-effect
, lidocaine/quinidine, phenobarbital/@DRUG$, phenobarbital/valproic acid, quinidine/lidocaine, theophylline/acetaminophen and valproic acid/phenobarbital.	DDI-false
Other concomitant therapies : In clinical trials , the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics , hypnotics and @DRUG$ ( including benzodiazepines ) , or @DRUG$ It was similar in patients taking placebo with these concomitant medications as in patients receiving placebo.	DDI-false
Therefore , @DRUG$ and @DRUG$ should not be used concomitantly .	DDI-advise
These results appear to be against the clinical use of @DRUG$ with @DRUG$ , or during the period following ELSPAR therapy when plasma asparagine levels are below normal .	DDI-advise
@DRUG$: Concomitant administration of low-dose aspirin with VIOXX may result in an increased rate of GI ulceration or other complications, compared to use of @DRUG$ alone.	DDI-false
@DRUG$ taken concomitantly with @DRUG$ increases quinidine serum concentration by 33% after two days.	DDI-false
To evaluate the effect of chemotherapy plus HAART on the clinical course of patients with HIV-related, systemic, non-Hodgkin's lymphoma (HIV-NHL), the authors retrospectively compared a group of 24 patients with HIV-NHL treated with the cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) chemotherapy regimen plus HAART with a group of 80 patients treated with CHOP chemotherapy or a CHOP-like regimen (i.e., cyclophosphamide, doxorubicin, tenipide and prednisone with vincristine plus. @DRUG$ ) without receiving @DRUG$ therapy .	DDI-false
In clinical studies performed with Fondaparinux, the concomitant use of oral @DRUG$ (warfarin), platelet inhibitors (@DRUG$), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.	DDI-false
